JP7389980B2 - Artificial production method of human pancreatic tissue-specific stem/progenitor cells - Google Patents

Description

Application of Article 30, Paragraph 2 of the Patent Act 1. Publication by publishing a paper in an online journal International Journal of Molecular Sciences, Volume 19 (2018) (URL: https://www.mdpi.com/1422-0067/19/11/3489) The following in the above URL of the title of Abstract, Full-Text PDF, Full-Text HTML, Full-Text XML, Full-Text Epub, etc. "Induction of Expandable Adipose-Derived Mesenchymal S tem Cells from Aged Mesenchymal Stem Cells by a Synthetic Self-Replicating RNA” Release date: 2018 November 6th

The present invention relates to a method for artificially producing human tissue-specific stem/progenitor cells.

Embryonic stem cells (hereinafter also referred to as "ES cells") and induced pluripotent stem cells (hereinafter also referred to as "iPS cells") are cells that have self-renewal and multipotency. It is. ES/iPS cells have become the mainstream of development in the field of regenerative medicine because it is theoretically possible to create all kinds of cells and organs. However, there are still some problems with ES/iPS cells that remain unresolved.
One of these problems is the possibility of teratoma formation when ES/iPS cells themselves are transplanted into a living body.
Another problem is that an efficient method for inducing differentiation of ES/iPS cells into desired cells has not been established.
Due to these issues, although ES/iPS cells are highly useful and have a variety of possibilities, they are not necessarily a fully established technology and can be said to be at an early stage of development.

By the way, the inventor has so far succeeded in artificially producing mouse pancreatic-specific stem cells (induced tissue-specific stem cells from pancreatic tissue, hereinafter also referred to as "iTS-P cells") (Patent Document 1) ).
This technology collects pancreatic islet cells from mouse pancreatic tissue, reprograms them with reprogramming factors (OCT3/4, SOX2, KLF4, c-MYC), and selects cells that express Pdx1. This is to generate iTS-P cells.

International publication 2012/044486 pamphlet

Artificial tissue-specific stem cells (iTS cells) or induced tissue-specific progenitor cells (hereinafter also referred to as "iTP cells") have a certain degree of self-renewal ability and are capable of inducing tissue-specific differentiation. is possible. In addition, iTS/iTP cells are superior to ES/iPS cells in that they have higher establishment efficiency and differentiation induction efficiency, and do not cause teratoma formation.
However, there are still no reports regarding human iTS/iTP cells.

Therefore, the present invention aims to develop human iTS/iTP cells.

As a result of intensive research, the inventors discovered that human iTS/iTP cells can be obtained by reprogramming somatic cells using human tissue-derived somatic cells and selecting them using tissue markers. completed the invention.

The present invention consists of the following configuration.

The first configuration of the present invention includes a reprogramming step of reprogramming human somatic cells using a reprogramming factor;
a selection step of selecting cells expressing a marker selectively expressed in human tissue stem cells/human tissue progenitor cells derived from the human somatic cells from the cell group initialized in the reprogramming step;
A method for producing human tissue-specific stem/progenitor cells, characterized by comprising:

A second configuration of the present invention is that the human somatic cells are derived from pancreatic tissue, liver tissue, mesenchymal cells, kidney tissue, ureteral tissue, bladder tissue, lung/tracheal tissue, brain/neural tissue, etc. Tissue-derived, retinal tissue-derived, corneal tissue-derived, pharyngeal/oral epithelium-derived, esophageal epithelial-derived, gastric/intestinal epithelial-derived, bile duct/gallbladder tissue-derived, splenic tissue-derived, lymph gland/lymphatic tissue-derived, blood (bone marrow cells) Origin, skeletal muscle tissue, smooth muscle tissue, adipose tissue, heart tissue, vascular tissue, thyroid tissue, parathyroid tissue, adrenal tissue, prostate tissue, gonadal tissue, uterine tissue, skin Preparation of the human tissue-specific stem/progenitor cells according to claim 1, which are derived from tissue, hair root tissue, mammary gland, thymus, placenta tissue, umbilical cord tissue, amniotic tissue, sweat gland tissue, and bone tissue. It's a method.

A third aspect of the present invention is the method for producing human tissue-specific stem/progenitor cells according to claim 1 or 2, wherein the tissue-derived marker is selected from any one or more of markers 1 to 20733. be.

The fourth aspect of the present invention is a method of using markers 1 to 20733 as markers for selecting human tissue-specific stem/progenitor cells.

The present invention has made it possible to provide human iTS/iTP cells.

(A) Diagram showing the method for producing pancreatic-derived human iTS/iTP cells. (B) Diagram showing the differentiation process from iPS cells to insulin-producing cells and expression markers. (A) Diagram showing enlarged photographs of each cell (GTE: intestinal endoderm). (B) Diagram showing the number of colonies of each cell created by each reprogramming factor. (C) Diagram showing the expression of PDX1 mRNA in each cell. (D) Diagram showing the incorporation of a introduced gene (plasmid) into the chromosome. (A) Diagram showing the expression of PDX1 mRNA in each cell. (B) Diagram showing the incorporation of a introduced gene (plasmid) into the chromosome. (A) Diagram showing the expression of ES cell markers in each cell. (B) Diagram showing the expression of endodermal cell markers in each cell. (C) Diagram showing the expression of pancreatic cell markers in each cell. (A) Diagram showing the expression of ES cell markers in each cell. (B) Diagram showing the expression of endodermal cell markers in each cell. (C) Diagram showing the expression of pancreatic cell markers in each cell. (A) Diagram showing the results of examining the proliferation ability of each cell. (B) A diagram showing the expression of insulin protein and C peptide after iTP cells were induced to differentiate. (C) Diagram showing the expression of insulin mRNA in each cell after induction of differentiation. (D) Diagram showing the results of examining the insulin expression level when glucose loading was performed in each cell. (E) Diagram showing the stimulation index in each cell. A diagram showing the state of methylation of each marker promoter region in each cell. (A) Diagram showing the results of genetic analysis using microarray of each cell. (B) Diagram showing the results of gene cluster analysis using microarrays of each cell. (A) Diagram showing the expression of albumin mRNA in each cell when differentiation into hepatocytes was induced. (B) Diagram showing the expression of α1-AT mRNA in each cell when differentiation into hepatocytes was induced. (C) Diagram showing the expression of PECAM1 mRNA in each cell when differentiation into mesodermal cells was induced. (D) Diagram showing the expression of MIXL1 mRNA in each cell when differentiation into mesodermal cells was induced. (E) Diagram showing the expression of ZIC1 mRNA in each cell when differentiation into neuroectodermal cells was induced. (F) Diagram showing the expression of SOX1 mRNA in each cell when differentiation into neuroectodermal cells was induced. A diagram showing a method for producing human mesenchymal cell-derived iTS/iTP cells. (A) Diagram showing the culture of each cell. (B) Diagram showing vector detection results by RT-PCR analysis. (C) Diagram showing the mRNA expression of each ES cell marker in each cell. (D) Diagram showing the proliferation of hADSC and hiTS-M cells. (E) Diagram showing the expression of TERT mRNA in each cell. A diagram showing the expression of surface antigens in each cell investigated by flow cytometry. (A) Diagram showing the mRNA expression of hADSC-specific markers in each cell. (B) Diagram showing the mRNA expression of each marker in each cell. (C) Diagram showing the protein expression of hADSC-specific markers in each cell examined by flow cytometry. (D) Diagram showing the protein expression of hADSC-specific markers in each cell investigated by immunostaining. (A) Diagram showing the oil red staining results when hiTS-M cells were induced to differentiate using adipocyte differentiation induction medium. (B) Diagram showing Alizarin Red S staining results when hiTS-M cells were induced to differentiate using osteoblast differentiation induction medium. (C) Diagram showing the expression level of osteoblast marker RUNX2 mRNA in each cell. A diagram showing the state of methylation of each marker promoter region in each cell. (A) Diagram showing the results of genetic analysis using microarray of each cell. (B) Diagram showing the results of gene cluster analysis using microarrays of each cell.

The method for producing human tissue-specific stem/progenitor cells of the present invention includes a reprogramming step of reprogramming human somatic cells with a reprogramming factor, and a reprogramming step of reprogramming human somatic cells from a group of cells reprogrammed by the reprogramming step. It is characterized by comprising a selection step of selecting cells that express a marker that is selectively expressed in derived human tissue stem cells/human tissue progenitor cells.
That is, human somatic cells are reprogrammed with reprogramming factors, and the resulting cell groups are selected based on the expression of tissue-specific markers.

In the present invention, human somatic cells are not particularly limited as long as they can be collected from humans and can be obtained in accordance with legally and ethically valid procedures, and any human somatic cells can be used.
Such human somatic cells include, for example, pancreatic tissue-derived, liver tissue-derived, mesenchymal cells, kidney tissue-derived, ureteral tissue-derived, bladder tissue-derived, lung/tracheal tissue-derived, brain/neural tissue-derived, and retinal tissue. Origin, derived from corneal tissue, pharyngeal/oral epithelium, esophageal epithelium, gastric/intestinal epithelium, bile duct/gallbladder tissue, spleen tissue, lymph gland/lymphatic tissue, blood (bone marrow cells), skeletal muscle tissue Origin, derived from smooth muscle tissue, derived from adipose tissue, derived from heart tissue, derived from vascular tissue, derived from thyroid tissue, derived from epithelium, derived from adrenal gland tissue, derived from prostate tissue, derived from gonadal tissue, derived from uterine tissue, derived from skin tissue, hair root tissue Those derived from the mammary gland, thymus gland, placenta tissue, umbilical cord tissue, amniotic tissue, sweat gland tissue, and bone tissue can be used.

In the present invention, the reprogramming step is a step of reprogramming human somatic cells using a reprogramming factor to obtain a cell group. The initialization step does not need to be particularly limited as long as such an initialized somatic cell group can be obtained, and an appropriate method depending on the somatic cells can be adopted.

In the reprogramming step, a reprogramming factor gene is introduced into human somatic cells. Regarding gene transfer, there is no need to be particularly limited as long as the gene transfer of the reprogramming factor into human somatic cells is possible, and various methods depending on the human somatic cells can be adopted.
For gene introduction, physical/chemical methods or biological methods can be selected and used as appropriate.

Examples of physical/chemical methods include the calcium phosphate method, DEAE-dextran method, lipofection method, electroporation method, and microinjection method, and preferably, the electroporation method can be used.
Biological methods include methods using viral vectors, such as adenovirus vectors, retrovirus vectors, lentivirus vectors, and the like.

There is no need to particularly limit the reprogramming factor used for gene transfer as long as human somatic cells can be reprogrammed, and any reprogramming factor suitable for human somatic cells can be used.
Typically, four reprogramming factors can be used: OCT3/4, SOX2, KLF4, and c-MYC, which are called Yamanaka factors. Furthermore, for these four reprogramming factors, L-MYC, Nanog, LIN28, SV40LT, p53 shRNA, GLIS1, etc. can be added or replaced as appropriate.
In the case of pancreatic cells, for example, as shown in Experimental Example I, OCT4, p53 shRNA, SOX2, KLF4, L-MYC, and LIN28 can be used as reprogramming factors. In the case of mesenchymal cells, for example, as shown in Experimental Example II, OCT4, SOX2, KLF4, and GLIS1 can be used as reprogramming factors.

The cell population into which the gene of the reprogramming factor has been introduced can be cultured and subcultured using commonly used methods to create colonies. As such a method, for example, for a cell group into which a gene has been introduced, seeding into feeder cells or medium exchange can be performed as appropriate, and this can be repeated until a colony is obtained. Colonies can also be created using a feeder-free medium using matrigel or the like.

In the present invention, the selection step involves selecting markers (hereinafter referred to as "tissue-specific markers") that are selectively expressed in human tissue stem cells/human tissue progenitor cells derived from human somatic cells from the cell group (colony) obtained in the reprogramming step. This is the step of selecting cells that express ``.''). The selection step does not need to be particularly limited as long as human tissue stem cells/human tissue progenitor cells can be selected, and various methods can be employed.
As tissue-specific markers, mRNA, proteins, etc. can be used alone or in combination, depending on the target human tissue stem cells/human tissue progenitor cells. Furthermore, one type of tissue-specific marker or a combination of two or more types can be used.

Any or more of the markers shown in markers 1 to 20733 can be selected as the tissue-specific marker.
That is, since these are not expressed in ES/iPS cells, they were discovered by the inventor as appropriate markers for human tissue stem cells/human tissue progenitor cells. Each marker is A1BG antisense RNA 1 (A1BG-AS1, marker 1), APOBEC1 complementation factor (A1CF, marker 2), APOBEC1 complementation factor (A1CF, marker 3), alpha-2-macroglobulin (A2M, marker 4), A2M antisense RNA 1 (head to head)(A2M-AS1, marker 5),alpha-2-macroglobulin-like 1(A2ML1,marker 6),alpha-2-macroglobulin-like 1(A2ML1,marker 7),alpha- 2-macroglobulin pseudogene 1 (A2MP1, marker 8), alpha 1,4-galactosyltransferase (A4GALT, marker 9), alpha-1,4-N-acetylglucosaminyltransferase (A4GNT, marker 10), uncharacterized LOC100506677 (AA06, marker 11), acetoacetyl-CoA synthetase pseudogene 1 (AACSP1, marker 12), arylacetamide deacetylase (AADAC, marker 13), arylacetamide deacetylase-like 2 (AADACL2, marker 14), arylacetamide deacetylase pseudogene 1 (AADACP1, marker 15), AP2 associated kinase 1( AAK1, marker 16), AP2 associated kinase 1 (AAK1, marker 17), AP2 associated kinase 1 (AAK1, marker 18), AP2 associated kinase 1 (AAK1, marker 19), AP2 associated kinase 1 (AAK1, marker 20), adipogenesis associated, Mth938 domain containing (AAMDC, marker 21), aralkylamine N-acetyltransferase (AANAT, marker 22), aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (AASDHPPT, marker 23), apoptosis associated transcript in bladder cancer (AATBC, marker 24) ,4-aminobutyrate aminotransferase(ABAT, marker 25),ATP binding cassette subfamily A member 1(ABCA1, marker 26),ATP binding cassette subfamily A member 1(ABCA1, marker 27),ATP binding cassette subfamily A member 12(ABCA12, Marker 28), ATP binding cassette subfamily A member 13 (ABCA13, Marker 29), ATP binding cassette subfamily A member 13 (ABCA13, Marker 30), ATP binding cassette subfamily A member 13 (ABCA13, Marker 31), ATP binding cassette subfamily A member 17, pseudogene(ABCA17P, marker 32),ATP binding cassette subfamily A member 2(ABCA2, marker 33),ATP binding cassette subfamily A member 2(ABCA2, marker 34),ATP binding cassette subfamily A member 2(ABCA2, Marker 35), ATP binding cassette subfamily A member 4 (ABCA4, Marker 36), ATP binding cassette subfamily A member 4 (ABCA4, Marker 37), ATP binding cassette subfamily A member 5 (ABCA5, Marker 38), ATP binding cassette subfamily A member 6(ABCA6, marker 39),ATP binding cassette subfamily A member 8(ABCA8, marker 40),ATP binding cassette subfamily A member 8(ABCA8, marker 41),ATP binding cassette subfamily A member 8(ABCA8, marker 42) ),ATP binding cassette subfamily A member 9(ABCA9, marker 43),ATP binding cassette subfamily A member 9(ABCA9, marker 44),ATP binding cassette subfamily A member 9(ABCA9, marker 45),ATP binding cassette subfamily B member 1(ABCB1, marker 46), ATP binding cassette subfamily B member 1(ABCB1, marker 47), ATP binding cassette subfamily B member 1 /// ATP binding cassette subfamily B member 4(ABCB1 /// ABCB4, marker 48), ATP binding cassette subfamily B member 11(ABCB11, marker 49),ATP binding cassette subfamily B member 11(ABCB11, marker 50),ATP binding cassette subfamily B member 4(ABCB4, marker 51),ATP binding cassette subfamily B member 4( ABCB4, marker 52), ATP binding cassette subfamily B member 5 (ABCB5, marker 53), ATP binding cassette subfamily B member 5 (ABCB5, marker 54), ATP binding cassette subfamily B member 5 (ABCB5, marker 55), ATP binding cassette subfamily B member 5(ABCB5, marker 56),ATP binding cassette subfamily B member 6 (Langereis blood group)(ABCB6, marker 57),ATP binding cassette subfamily B member 8(ABCB8, marker 58),ATP binding cassette subfamily B member 8 /// acid sensing ion channel 3(ABCB8 /// ASIC3, marker 59),ATP binding cassette subfamily B member 9(ABCB9, marker 60),ATP binding cassette subfamily B member 9(ABCB9, marker 61),ATP binding cassette subfamily B member 9(ABCB9, marker 62),ATP binding cassette subfamily C member 11(ABCC11, marker 63),ATP binding cassette subfamily C member 11(ABCC11, marker 64),ATP binding cassette subfamily C member 12(ABCC12 , marker 65), ATP binding cassette subfamily C member 12 (ABCC12, marker 66), ATP binding cassette subfamily C member 13, pseudogene (ABCC13, marker 67), ATP binding cassette subfamily C member 13, pseudogene (ABCC13, marker 68) ,ATP binding cassette subfamily C member 13, pseudogene(ABCC13, marker 69),ATP binding cassette subfamily C member 13, pseudogene(ABCC13, marker 70),ATP binding cassette subfamily C member 2(ABCC2, marker 71),ATP binding cassette subfamily C member 3(ABCC3, marker 72),ATP binding cassette subfamily C member 3(ABCC3, marker 73),ATP binding cassette subfamily C member 3(ABCC3, marker 74),ATP binding cassette subfamily C member 3(ABCC3, marker 75),ATP binding cassette subfamily C member 3(ABCC3, marker 76),ATP binding cassette subfamily C member 4(ABCC4, marker 77),ATP binding cassette subfamily C member 6 /// multidrug resistance-associated protein 6(ABCC6 / // LOC105369239, marker 78), ATP binding cassette subfamily C member 6 /// multidrug resistance-associated protein 6(ABCC6 /// LOC105369239, marker 79), ATP binding cassette subfamily C member 6 pseudogene 1 (functional)(ABCC6P1, Marker 80), ATP binding cassette subfamily C member 8 (ABCC8, Marker 81), ATP binding cassette subfamily C member 8 (ABCC8, Marker 82), ATP binding cassette subfamily C member 9 (ABCC9, Marker 83), ATP binding cassette subfamily C member 9(ABCC9, marker 84),ATP binding cassette subfamily C member 9(ABCC9, marker 85),ATP binding cassette subfamily C member 9(ABCC9, marker 86),ATP binding cassette subfamily C member 9(ABCC9, marker 87) ),ATP binding cassette subfamily D member 1(ABCD1, marker 88),ATP binding cassette subfamily D member 1 pseudogene 2(ABCD1P2,marker 89),ATP binding cassette subfamily D member 2(ABCD2,marker 90),ATP binding cassette subfamily D member 4 (ABCD4, marker 91), ATP binding cassette subfamily F member 2 (ABCF2, marker 92), ATP binding cassette subfamily G member 1 (ABCG1, marker 93), ATP binding cassette subfamily G member 1 (ABCG1, marker 94) ),ATP binding cassette subfamily G member 1(ABCG1, marker 95),ATP binding cassette subfamily G member 1(ABCG1, marker 96),ATP binding cassette subfamily G member 4(ABCG4, marker 97),ATP binding cassette subfamily G member 5(ABCG5, marker 98),ATP binding cassette subfamily G member 8(ABCG8, marker 99),abhydrolase domain containing 1(ABHD1,marker 100),abhydrolase domain containing 1(ABHD1,marker 101),abhydrolase domain containing 1(ABHD1 ,marker 102),abhydrolase domain containing 11(ABHD11,marker 103),abhydrolase domain containing 11(ABHD11,marker 104),abhydrolase domain containing 12B(ABHD12B,marker 105),abhydrolase domain containing 12B(ABHD12B,marker 106),abhydrolase domain containing 15(ABHD15, marker 107),abhydrolase domain containing 16A(ABHD16A,marker 108),abhydrolase domain containing 16B(ABHD16B,marker 109),abhydrolase domain containing 17B(ABHD17B,marker 110),abhydrolase domain containing 2(ABHD2, marker 111),abhydrolase domain containing 4(ABHD4,marker 112),abhydrolase domain containing 5(ABHD5,marker 113),abhydrolase domain containing 6(ABHD6,marker 114),abl-interactor 1(ABI1,marker 115),abl- interactor 2 (ABI2, marker 116), ABI family, member 3 (NESH) binding protein (ABI3BP, marker 117), ABI family, member 3 (NESH) binding protein (ABI3BP, marker 118), actin binding LIM protein family, member 2(ABLIM2, Marker 119), actin binding LIM protein family, member 2(ABLIM2, Marker 120), actin binding LIM protein family, member 2(ABLIM2, Marker 121), actin binding LIM protein family, member 2(ABLIM2, Marker 122), actin binding LIM protein family, member 3 (ABLIM3, marker 123), ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (ABO, marker 124) ,ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)(ABO, marker 125),ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) (ABO, marker 126), actin binding Rho activating protein (ABRA, marker 127), actin binding Rho activating protein (ABRA, marker 128), ankyrin repeat and BTB (POZ) domain containing 1(ABTB1, marker 129),ankyrin repeat and BTB (POZ) domain containing 1(ABTB1,marker 130),ankyrin repeat and BTB (POZ) domain containing 1(ABTB1,marker 131),ankyrin repeat and BTB (POZ) domain containing 1(ABTB1, marker 132), ankyrin repeat and BTB (POZ) domain containing 1(ABTB1, marker 133), ankyrin repeat and BTB (POZ) domain containing 2(ABTB2, marker 134), acetyl-CoA carboxylase beta(ACACB , marker 135), acetyl-CoA carboxylase beta (ACACB, marker 136), acyl-CoA dehydrogenase family, member 10 (ACAD10, marker 137), acyl-CoA dehydrogenase, long chain (ACADL, marker 138), acyl-CoA dehydrogenase , long chain(ACADL, marker 139), acyl-CoA dehydrogenase, C-2 to C-3 short chain(ACADS, marker 140), aggrecan(ACAN, marker 141), aggrecan(ACAN, marker 142), aggrecan(ACAN , Marker 143), ArfGAP with coiled-coil, ankyrin repeat and PH domains 1(ACAP1, Marker 144), ArfGAP with coiled-coil, ankyrin repeat and PH domains 1(ACAP1, Marker 145), ArfGAP with coiled-coil, ankyrin repeat and PH domains 2(ACAP2, marker 146),ArfGAP with coiled-coil, ankyrin repeat and PH domains 3(ACAP3, marker 147),acetyl-CoA acetyltransferase 1(ACAT1, marker 148),acetyl-CoA acetyltransferase 1(ACAT1) , marker 149), acyl-CoA binding domain containing 4 (ACBD4, marker 150), angiotensin I converting enzyme (ACE, marker 151), angiotensin I converting enzyme (ACE, marker 152), alkaline ceramidase 1 (ACER1, marker 153) ,alkaline ceramidase 3(ACER3, marker 154),alkaline ceramidase 3(ACER3, marker 155),acetylcholinesterase (Yt blood group)(ACHE,marker 156),acetylcholinesterase (Yt blood group)(ACHE,marker 157),atypical chemokine receptor 1 (Duffy blood group)(ACKR1, marker 158), atypical chemokine receptor 1 (Duffy blood group) /// cell adhesion molecule 3(ACKR1 /// CADM3, marker 159), atypical chemokine receptor 2(ACKR2, marker 160) ,atypical chemokine receptor 2(ACKR2, marker 161),atypical chemokine receptor 2(ACKR2,marker 162),atypical chemokine receptor 3(ACKR3,marker 163),atypical chemokine receptor 4(ACKR4,marker 164),aminocarboxymuconate semialdehyde decarboxylase(ACMSD , marker 165), aconitase 1, soluble(ACO1, marker 165), aconitase 1, soluble(ACO1, marker 165)
acyl-CoA thioesterase 11 (ACOT11, marker 167), acyl-CoA thioesterase 11 (ACOT11, marker 168), acyl-CoA thioesterase 11 (ACOT11, marker 169), acyl-CoA thioesterase 12 (ACOT12, marker 170) ), acyl-CoA thioesterase 6 (ACOT6, marker 171), acyl-CoA oxidase 1, palmitoyl (ACOX1, marker 172), acyl-CoA oxidase 1, palmitoyl (ACOX1, marker 173), acyl-CoA oxidase-like (ACOXL , marker 174), acid phosphatase 1, soluble(ACP1, marker 175), acid phosphatase 6, lysophosphatidic(ACP6, marker 176), acid phosphatase, prostate(ACPP, marker 177), acid phosphatase, prostate(ACPP, marker 178) , acrosin (ACR, marker 179), acrosin binding protein (ACRBP, marker 180), acrosin binding protein (ACRBP, marker 181), acrosin binding protein (ACRBP, marker 182), acrosomal vesicle protein 1 (ACRV1, marker 183), acrosomal vesicle protein 1 (ACRV1, marker 184), acrosomal vesicle protein 1 (ACRV1, marker 185), acrosomal vesicle protein 1 (ACRV1, marker 186), acrosomal vesicle protein 1 (ACRV1, marker 187), acrosomal vesicle protein 1 (ACRV1) , marker 188), acyl-CoA synthetase bubblegum family member 1 (ACSBG1, marker 189), acyl-CoA synthetase bubblegum family member 1 (ACSBG1, marker 190), acyl-CoA synthetase bubblegum family member 2 (ACSBG2, marker 191), acyl-CoA synthetase family member 3(ACSF3, marker 192),acyl-CoA synthetase family member 3(ACSF3, marker 193),acyl-CoA synthetase family member 3(ACSF3, marker 194),acyl-CoA synthetase long-chain family member 4(ACSL4, marker 195),acyl-CoA synthetase long-chain family member 4(ACSL4, marker 196),acyl-CoA synthetase long-chain family member 5(ACSL5, marker 197),acyl-CoA synthetase long-chain family member 5(ACSL5, marker 198),acyl-CoA synthetase long-chain family member 6(ACSL6, marker 199),acyl-CoA synthetase long-chain family member 6(ACSL6, marker 200),acyl-CoA synthetase long- chain family member 6(ACSL6, marker 201),acyl-CoA synthetase long-chain family member 6(ACSL6, marker 202),acyl-CoA synthetase medium-chain family member 1(ACSM1, marker 203),acyl-CoA synthetase medium -chain family member 1(ACSM1, marker 204),acyl-CoA synthetase medium-chain family member 2A(ACSM2A, marker 205),acyl-CoA synthetase medium-chain family member 2A(ACSM2A, marker 206),acyl-CoA synthetase medium-chain family member 2A /// acyl-CoA synthetase medium-chain family member 2B(ACSM2A /// ACSM2B, marker 207),acyl-CoA synthetase medium-chain family member 2A /// acyl-CoA synthetase medium-chain family member 2B(ACSM2A /// ACSM2B, marker 208),acyl-CoA synthetase medium-chain family member 2B(ACSM2B, marker 209),acyl-CoA synthetase medium-chain family member 3(ACSM3, marker 210),acyl- CoA synthetase medium-chain family member 3(ACSM3, marker 211),acyl-CoA synthetase medium-chain family member 5(ACSM5, marker 212),acyl-CoA synthetase medium-chain family member 5(ACSM5, marker 213),acyl -CoA synthetase medium-chain family member 5 (ACSM5, marker 214), acyl-CoA synthetase short-chain family member 1 (ACSS1, marker 215), acyl-CoA synthetase short-chain family member 1 (ACSS1, marker 216), acyl-CoA synthetase short-chain family member 1(ACSS1, marker 217), acyl-CoA synthetase short-chain family member 1(ACSS1, marker 218), actin, alpha 2, smooth muscle, aorta(ACTA2, marker 219), actin, alpha 2, smooth muscle, aorta (ACTA2, marker 220), ACTA2 antisense RNA 1 (ACTA2-AS1, marker 221), actin gamma 1 pseudogene 17 (ACTG1P17, marker 222), actin gamma 1 pseudogene 17 (ACTG1P17, marker 223), actin, gamma 2, smooth muscle, enteric(ACTG2, marker 224), actin-like 10(ACTL10, marker 225), actin-like 6B(ACTL6B, marker 226), actin-like 6B(ACTL6B, marker 227) ), actin-like 7A (ACTL7A, marker 228), actin-like 7B (ACTL7B, marker 229), actin-like 8 (ACTL8, marker 230), actin-like 9 (ACTL9, marker 231), actinin, alpha 1 (ACTN1, marker 232), actinin, alpha 2(ACTN2, marker 233), actinin, alpha 2(ACTN2, marker 234), actinin, alpha 2(ACTN2, marker 235), actinin, alpha 2(ACTN2, marker 236) ,ARP2 actin-related protein 2 homolog (yeast)(ACTR2, marker 237),ARP2 actin-related protein 2 homolog (yeast)(ACTR2, marker 238),ACTR3B pseudogene 2(ACTR3BP2, marker 239),ACTR3B pseudogene 2 // / ACTR3B pseudogene 5(ACTR3BP2 /// ACTR3BP5, marker 240),ARP3 actin-related protein 3 homolog C (yeast)(ACTR3C, marker 241),ARP3 actin-related protein 3 homolog C (yeast)(ACTR3C, marker 242) , actin-related protein T2 (ACTRT2, marker 243), activin A receptor type IB (ACVR1B, marker 244), activin A receptor type IB (ACVR1B, marker 245), activin A receptor type IC (ACVR1C, marker 246), activin A receptor type IL (ACVRL1, marker 247), activin A receptor type IL (ACVRL1, marker 248), aminoacylase 1 (ACY1, marker 249), aminoacylase 3 (ACY3, marker 250), aminoacylase 3 (ACY3, marker 251), adenosine deaminase domain containing 1(ADAD1, marker 252),adenosine deaminase domain containing 1(ADAD1, marker 253),adenosine deaminase domain containing 2(ADAD2, marker 254),ADAM metallopeptidase domain 11(ADAM11, marker 255),ADAM metallopeptidase domain 11 (ADAM11, marker 256), ADAM metallopeptidase domain 12 (ADAM12, marker 257), ADAM metallopeptidase domain 12 (ADAM12, marker 258), ADAM metallopeptidase domain 12 (ADAM12, marker 259), ADAM metallopeptidase domain 12 (ADAM12, marker 260) ),ADAM metallopeptidase domain 12(ADAM12, marker 261),ADAM metallopeptidase domain 17(ADAM17,marker 262),ADAM metallopeptidase domain 18(ADAM18,marker 263),ADAM metallopeptidase domain 18(ADAM18,marker 264),ADAM metallopeptidase domain 19 (ADAM19, marker 265),ADAM metallopeptidase domain 2(ADAM2, marker 266),ADAM metallopeptidase domain 20(ADAM20,marker 267),ADAM metallopeptidase domain 20(ADAM20,marker 268),ADAM metallopeptidase domain 21(ADAM21,marker 269) ,ADAM metallopeptidase domain 21(ADAM21, marker 270),ADAM metallopeptidase domain 22(ADAM22,marker 271),ADAM metallopeptidase domain 22(ADAM22,marker 272),ADAM metallopeptidase domain 22(ADAM22,marker 273),ADAM metallopeptidase domain 22( ADAM22, Marker 274), ADAM metallopeptidase domain 22 (ADAM22, Marker 275), ADAM metallopeptidase domain 22 (ADAM22, Marker 276), ADAM metallopeptidase domain 22 (ADAM22, Marker 277), ADAM metallopeptidase domain 23 (ADAM23, Marker 278), ADAM metallopeptidase domain 28 (ADAM28, marker 279), ADAM metallopeptidase domain 28 (ADAM28, marker 280), ADAM metallopeptidase domain 28 (ADAM28, marker 281), ADAM metallopeptidase domain 29 (ADAM29, marker 282), ADAM metallopeptidase domain 30 (ADAM30) , marker 283), ADAM metallopeptidase domain 30 (ADAM30, marker 284), ADAM metallopeptidase domain 32 (ADAM32, marker 285), ADAM metallopeptidase domain 33 (ADAM33, marker 286), ADAM metallopeptidase domain 3A (pseudogene) (ADAM3A, marker 287) ),ADAM metallopeptidase domain 3B (pseudogene)(ADAM3B, marker 288),ADAM metallopeptidase domain 5 (pseudogene)(ADAM5,marker 289),ADAM metallopeptidase domain 5 (pseudogene)(ADAM5,marker 290),ADAM metallopeptidase domain 6 (pseudogene) )(ADAM6, marker 291),ADAM metallopeptidase domain 7(ADAM7,marker 292),ADAM metallopeptidase domain 7(ADAM7,marker 293),ADAM metallopeptidase domain 7(ADAM7,marker 294),ADAM metallopeptidase domain 8(ADAM8,marker 295) ),ADAM metallopeptidase domain 9(ADAM9, marker 296),ADAM-like, decysin 1(ADAMDEC1, marker 297),ADAM metallopeptidase with thrombospondin type 1 motif 10(ADAMTS10,marker 298),ADAM metallopeptidase with thrombospondin type 1 motif 12( ADAMTS12, Marker 299), ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13, Marker 300), ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13, Marker 301), ADAM metallopeptidase with thrombospondin type 1 motif 14 (ADAMTS14, Marker 302) ,ADAM metallopeptidase with thrombospondin type 1 motif 15(ADAMTS15, marker 303),ADAM metallopeptidase with thrombospondin type 1 motif 17(ADAMTS17, marker 304),ADAM metallopeptidase with thrombospondin type 1 motif 17(ADAMTS17,marker 305),ADAM metallopeptidase with thrombospondin type 1 motif 17(ADAMTS17, marker 306),ADAM metallopeptidase with thrombospondin type 1 motif 2(ADAMTS2, marker 307),ADAM metallopeptidase with thrombospondin type 1 motif 2(ADAMTS2, marker 308),ADAM metallopeptidase with thrombospondin type 1 motif 2( ADAMTS2, marker 309), ADAM metallopeptidase with thrombospondin type 1 motif 20 (ADAMTS20, marker 310), ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS5, marker 311), ADAM metallopeptidase with thrombospondin type 1 motif 6 (ADAMTS6, marker 312) ,ADAM metallopeptidase with thrombospondin type 1 motif 6(ADAMTS6, marker 313),ADAM metallopeptidase with thrombospondin type 1 motif 6(ADAMTS6, marker 314),ADAM metallopeptidase with thrombospondin type 1 motif 7(ADAMTS7, marker 315),ADAM metallopeptidase with thrombospondin type 1 motif 7(ADAMTS7, marker 316),ADAM metallopeptidase with thrombospondin type 1 motif 7(ADAMTS7, marker 317),ADAM metallopeptidase with thrombospondin type 1 motif 8(ADAMTS8, marker 318),ADAM metallopeptidase with thrombospondin type 1 motif 8( ADAMTS8, marker 319), ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9, marker 320), ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9, marker 321), ADAM metallopeptidase with thrombospondin type 1 motif 9 (ADAMTS9, marker 322) ,ADAMTS9 antisense RNA 1(ADAMTS9-AS1, marker 323),ADAMTS9 antisense RNA 1(ADAMTS9-AS1,marker 324),ADAMTS9 antisense RNA 2(ADAMTS9-AS2,marker 325),ADAMTS9 antisense RNA 2(ADAMTS9-AS2,marker 326),ADAMTS9 antisense RNA 2(ADAMTS9-AS2, marker 327),ADAMTS9 antisense RNA 2(ADAMTS9-AS2,marker 328),ADAMTS like 1(ADAMTSL1,marker 329),ADAMTS like 1(ADAMTSL1,marker 330),ADAMTS like 1(ADAMTSL1, marker 331),ADAMTS like 1(ADAMTSL1,marker 332),ADAMTS like 1(ADAMTSL1,marker 333),ADAMTS like 1(ADAMTSL1,marker 334),ADAMTS like 2(ADAMTSL2,marker 335),ADAMTS like 3(ADAMTSL3, marker 336),ADAMTS like 3(ADAMTSL3,marker 337),ADAMTS like 4(ADAMTSL4,marker 338),ADAMTS like 4(ADAMTSL4,marker 339),ADAMTS like 5(ADAMTSL5,marker 340),ArfGAP with dual PH domains 2(ADAP2, marker 341),adenosine deaminase, RNA-specific, B1(ADARB1,marker 342),adenosine deaminase, RNA-specific, B1(ADARB1,marker 343),adenosine deaminase, RNA-specific, B1 (ADARB1, marker 344), adenosine deaminase, RNA-specific, B1(ADARB1, marker 345), adenosine deaminase, RNA-specific, B2 (inactive)(ADARB2, marker 346), adenosine deaminase, RNA-specific, B2 (inactive )(ADARB2, marker 347), aarF domain containing kinase 2(ADCK2, marker 348), aarF domain containing
ng kinase 3(ADCK3, marker 349),aarF domain containing kinase 4(ADCK4,marker 350),aarF domain containing kinase 5(ADCK5,marker 351),adenylate cyclase 1 (brain)(ADCY1,marker 352),adenylate cyclase 1 (brain)(ADCY1, marker 353),adenylate cyclase 1 (brain)(ADCY1,marker 354),adenylate cyclase 1 (brain)(ADCY1,marker 355),adenylate cyclase 10 (soluble)(ADCY10,marker 356),adenylate cyclase 10 (soluble)(ADCY10, marker 357),adenylate cyclase 10 (soluble) pseudogene 1(ADCY10P1,marker 358),adenylate cyclase 10 (soluble) pseudogene 1(ADCY10P1,marker 359),adenylate cyclase 2 (brain)(ADCY2 , marker 360), adenylate cyclase 4 (ADCY4, marker 361), adenylate cyclase 5 (ADCY5, marker 362), adenylate cyclase 5 (ADCY5, marker 363), adenylate cyclase 7 (ADCY7, marker 364), adenylate cyclase 8 (brain )(ADCY8, marker 365), adenylate cyclase 9(ADCY9, marker 366), adenylate cyclase activating polypeptide 1 (pituitary)(ADCYAP1, marker 367), adenylate cyclase activating polypeptide 1 (pituitary)(ADCYAP1, marker 368), adenylate cyclase activating polypeptide 1 (pituitary) receptor type I(ADCYAP1R1, marker 369),ADD3 antisense RNA 1(ADD3-AS1,marker 370),ADD3 antisense RNA 1(ADD3-AS1,marker 371),ADD3 antisense RNA 1(ADD3-AS1 , marker 372), androglobin (ADGB, marker 373), adhesion G protein-coupled receptor A1 (ADGRA1, marker 374), adhesion G protein-coupled receptor B1 (ADGRB1, marker 375), adhesion G protein-coupled receptor B3 (ADGRB3) , marker 376), adhesion G protein-coupled receptor B3 (ADGRB3, marker 377), adhesion G protein-coupled receptor D1 (ADGRD1, marker 378), adhesion G protein-coupled receptor D2 (ADGRD2, marker 379), adhesion G protein -coupled receptor E1 (ADGRE1, marker 380), adhesion G protein-coupled receptor E2 (ADGRE2, marker 381), adhesion G protein-coupled receptor E2 (ADGRE2, marker 382), adhesion G protein-coupled receptor E3 (ADGRE3, marker 383), adhesion G protein-coupled receptor E5 (ADGRE5, marker 384), adhesion G protein-coupled receptor F1 (ADGRF1, marker 385), adhesion G protein-coupled receptor F1 (ADGRF1, marker 386), adhesion G protein-coupled receptor F1 (ADGRF1, marker 387), adhesion G protein-coupled receptor F1 (ADGRF1, marker 388), adhesion G protein-coupled receptor F2 (ADGRF2, marker 389), adhesion G protein-coupled receptor F3 (ADGRF3, marker 390) ,adhesion G protein-coupled receptor F3(ADGRF3, marker 391),adhesion G protein-coupled receptor F4(ADGRF4, marker 392),adhesion G protein-coupled receptor F4(ADGRF4, marker 393),adhesion G protein-coupled receptor F5 (ADGRF5, marker 394), adhesion G protein-coupled receptor F5 (ADGRF5, marker 395), adhesion G protein-coupled receptor G1 (ADGRG1, marker 396), adhesion G protein-coupled receptor G3 (ADGRG3, marker 397), adhesion G protein-coupled receptor G3(ADGRG3, marker 398),adhesion G protein-coupled receptor G4(ADGRG4, marker 399),adhesion G protein-coupled receptor G5(ADGRG5, marker 400),adhesion G protein-coupled receptor G6(ADGRG6) , marker 401), adhesion G protein-coupled receptor G6 (ADGRG6, marker 402), adhesion G protein-coupled receptor G7 (ADGRG7, marker 403), adhesion G protein-coupled receptor L2 (ADGRL2, marker 404), adhesion G protein -coupled receptor L3(ADGRL3, marker 405),adhesion G protein-coupled receptor V1(ADGRV1, marker 406),adhesion G protein-coupled receptor V1(ADGRV1, marker 407),adhesion G protein-coupled receptor V1(ADGRV1, marker 408), adhesion G protein-coupled receptor V1 (ADGRV1, marker 409), alcohol dehydrogenase 1A (class I), alpha polypeptide (ADH1A, marker 410), alcohol dehydrogenase 1B (class I), beta polypeptide (ADH1B, marker 411) ,alcohol dehydrogenase 1B (class I), beta polypeptide(ADH1B, marker 412),alcohol dehydrogenase 1B (class I), beta polypeptide(ADH1B, marker 413),alcohol dehydrogenase 1B (class I), beta polypeptide(ADH1B, marker 414) ), alcohol dehydrogenase 1C (class I), gamma polypeptide(ADH1C, marker 415), alcohol dehydrogenase 4 (class II), pi polypeptide(ADH4, marker 416), alcohol dehydrogenase 4 (class II), pi polypeptide(ADH4, marker 417), alcohol dehydrogenase 4 (class II), pi polypeptide (ADH4, marker 418), alcohol dehydrogenase 4 (class II), pi polypeptide (ADH4, marker 419), alcohol dehydrogenase 6 (class V) (ADH6, marker 420) , alcohol dehydrogenase 6 (class V) (ADH6, marker 421), alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide (ADH7, marker 422), acidreductone dioxygenase 1 (ADI1, marker 423), adipogenin (ADIG, marker 424) ), adipogenin (ADIG, marker 425), adiponectin, C1Q and collagen domain containing (ADIPOQ, marker 426), adipogenesis regulatory factor (ADIRF, marker 427), ADIRF antisense RNA 1 (ADIRF-AS1, marker 428), adrenomedullin 5 ( putative) (ADM5, marker 429), adenosine A1 receptor (ADORA1, marker 430), adenosine A1 receptor (ADORA1, marker 431), ADORA2A antisense RNA 1 (ADORA2A-AS1, marker 432), ADORA2A antisense RNA 1 (ADORA2A-AS1) ADP -ribosylarginine hydrolase(ADPRH, marker 437),ADP-ribosylarginine hydrolase(ADPRH, marker 438),ADP-ribosylhydrolase like 1(ADPRHL1,marker 439),ADP-ribosylhydrolase like 1(ADPRHL1,marker 440),adrenoceptor alpha 1A(ADRA1A) , marker 441), adrenoceptor alpha 1A (ADRA1A, marker 442), adrenoceptor alpha 1A (ADRA1A, marker 443), adrenoceptor alpha 1A (ADRA1A, marker 444), adrenoceptor alpha 1A (ADRA1A, marker 445), adrenoceptor alpha 1A (ADRA1A , marker 446), adrenoceptor alpha 1A (ADRA1A, marker 447), adrenoceptor alpha 1B (ADRA1B, marker 448), adrenoceptor alpha 1D (ADRA1D, marker 449), adrenoceptor alpha 1D (ADRA1D, marker 450), adrenoceptor alpha 2B (ADRA2B) , marker 451), adrenoceptor beta 1 (ADRB1, marker 452), adrenoceptor beta 1 (ADRB1, marker 453), adrenoceptor beta 1 (ADRB1, marker 454), adrenoceptor beta 2, surface (ADRB2, marker 455), adrenoceptor beta 3 (ADRB3, marker 456), adrenoceptor beta 3 (ADRB3, marker 457), adrenergic, beta, receptor kinase 1 (ADRBK1, marker 458), adrenergic, beta, receptor kinase 2 (ADRBK2, marker 459), adenylosuccinate synthase like 1( ADSSL1, marker 460), androgen-dependent TFPI-regulating protein (ADTRP, marker 461), AE binding protein 2 (AEBP2, marker 462), AFAP1 antisense RNA 1 (AFAP1-AS1, marker 463), AFAP1 antisense RNA 1 (AFAP1 -AS1, marker 464), actin filament associated protein 1-like 1 (AFAP1L1, marker 465), AF4/FMR2 family, member 2 (AFF2, marker 466), AF4/FMR2 family, member 3 (AFF3, marker 467), AF4/FMR2 family, member 3(AFF3, marker 468),AF4/FMR2 family, member 3(AFF3, marker 469),AF4/FMR2 family, member 3(AFF3, marker 470),AF4/FMR2 family, member 3( AFF3, marker 471), AF4/FMR2 family, member 3(AFF3, marker 472),AF4/FMR2 family, member 4(AFF4, marker 473),AF4/FMR2 family, member 4(AFF4, marker 474),AFG3- like AAA ATPase 1, pseudogene(AFG3L1P, marker 475),AFG3-like AAA ATPase 2(AFG3L2, marker 476),afamin(AFM,marker 477),arylformamidase(AFMID,marker 478),ankyrin repeat and GTPase domain Arf GTPase activating protein 11(AGAP11, marker 479), ankyrin repeat and GTPase domain Arf GTPase activating protein 11(AGAP11, marker 480), ArfGAP with GTPase domain, ankyrin repeat and PH domain 2(AGAP2, marker 481), ArfGAP with GTPase domain, ankyrin repeat and PH domain 2(AGAP2, marker 482),ArfGAP with GTPase domain, ankyrin repeat and PH domain 2(AGAP2, marker 483),AGAP2 antisense RNA 1(AGAP2-AS1, marker 484),ArfGAP with GTPase domain, ankyrin repeat and PH domain 4 /// ArfGAP with GTPase domain, ankyrin repeat and PH domain 6 /// ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 /// BMS1 ribosome biogenesis factor pseudogene 5 /// arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5-like /// uncharacterized LOC102724455(AGAP4 /// AGAP6 /// AGAP9 /// BMS1P5 /// LOC101060581 /// LOC102724455, marker 485),ArfGAP with GTPase domain, ankyrin repeat and PH domain 6 /// ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 /// BMS1 ribosome biogenesis factor pseudogene 5 /// uncharacterized LOC102724455(AGAP6 /// AGAP9 /// BMS1P5 /// LOC102724455, marker 486) ,ArfGAP with GTPase domain, ankyrin repeat and PH domain 9(AGAP9, marker 487),ArfGAP with GTPase domain, ankyrin repeat and PH domain 9 /// BMS1 ribosome biogenesis factor pseudogene 5 /// uncharacterized LOC102724455(AGAP9 /// BMS1P5 /// LOC102724455, marker 488), ATP/GTP binding protein-like 1 (AGBL1, marker 489), ATP/GTP binding protein-like 2 (AGBL2, marker 490), ATP/GTP binding protein-like 3 (AGBL3, marker 491), ATP/GTP binding protein-like 3 (AGBL3, marker 492), ATP/GTP binding protein-like 4 (AGBL4, marker 493), ATP/GTP binding protein-like 4 (AGBL4, marker 494), advanced glycosylation end product-specific receptor (AGER, marker 495), advanced glycosylation end product-specific receptor (AGER, marker 496), ArfGAP with FG repeats 1 (AGFG1, marker 497), ArfGAP with FG repeats 2 (AGFG2, marker 498) ,ArfGAP with FG repeats 2(AGFG2, marker 499),ArfGAP with FG repeats 2(AGFG2, marker 500),ArfGAP with FG repeats 2(AGFG2, marker 501),ArfGAP with FG repeats 2(AGFG2, marker 502),angiogenic factor with G-patch and FHA domains 1 (AGGF1, marker 503), acylglycerol kinase (AGK, marker 504), agmatinase (AGMAT, marker 505), argonaute RISC catalytic component 4 (AGO4, marker 506), 1-acylglycerol-3 -phosphate O-acyltransferase 3(AGPAT3, marker 507),1-acylglycerol-3-phosphate O-acyltransferase 3(AGPAT3, marker 508),1-acylglycerol-3-phosphate O-acyltransferase 3(AGPAT3, marker 509),anterior gradient 2, protein disulphide isomerase family member(AGR2, marker 510),anterior gradient 2, protein disulphide isomerase family member(AGR2, marker 511),anterior gradient 3, protein disulphide isomerase family member(AGR3, marker 512),agrin(AGRN , marker 513), agrin (AGRN, marker 514), agouti related neuropeptide (AGRP, marker 515), angiotensinogen (serpin peptidase inhibitor, clade A, member 8) (AGT, marker 516), ATP/GTP binding protein 1 (AGTPBP1) , marker 517), angiotensin II receptor, type 1(AGTR1, marker 518), angiotensin II receptor, type 1(AGTR1, marker 519), angiotensin II receptor, type 2(AGTR2, marker 520), angiotensin II receptor, type 2 (AGTR2, Marker 521), angiotensin II receptor, type 2 (AGTR2, Marker 522), alanine-glyoxylate aminotransferase (AGXT, Marker 523), alanine-glyoxylate aminotransferase (AGXT, Marker 524), alanine-glyoxylate aminotransferase (AGXT, Marker 525),alanine--glyoxylate aminotra
nsferase 2 (AGXT2, marker 526), adenosylhomocysteinase like 1 (AHCYL1, marker 527), AT hook, DNA binding motif, containing 1 (AHDC1, marker 528), AT hook, DNA binding motif, containing 1 (AHDC1, marker 529) ,Abelson helper integration site 1(AHI1, marker 530),Abelson helper integration site 1(AHI1, marker 531),AHNAK nucleoprotein(AHNAK,marker 532),AHNAK nucleoprotein(AHNAK,marker 533),AHNAK nucleoprotein(AHNAK,marker 534) ), aryl-hydrocarbon receptor repressor (AHRR, marker 535), AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) (AHSA2, marker 536), alpha hemoglobin stabilizing protein (AHSP, marker 537), activation-induced cytidine deaminase (AICDA, marker 538), activation-induced cytidine deaminase (AICDA, marker 539), allograft inflammatory factor 1 (AIF1, marker 540), allograft inflammatory factor 1 (AIF1, marker 541), allograft inflammatory factor 1 (AIF1, marker 542), allograft inflammatory factor 1 (AIF1, marker 543), apoptosis-inducing factor, mitochondria-associated, 3 (AIFM3, marker 544), androgen-induced 1 (AIG1, marker 545), androgen-induced 1 (AIG1, marker 545) 546), absent in melanoma 1-like (AIM1L, marker 547), aryl hydrocarbon receptor interacting protein-like 1 (AIPL1, marker 548), autoimmune regulator (AIRE, marker 549), adherens junctions associated protein 1 (AJAP1, marker 550) ), adherens junctions associated protein 1 (AJAP1, marker 551), ajuba LIM protein (AJUBA, marker 552), adenylate kinase 1 (AK1, marker 553), adenylate kinase 2 (AK2, marker 554), adenylate kinase 5 (AK5, marker 555), adenylate kinase 7 (AK7, marker 556), adenylate kinase 7 (AK7, marker 557), adenylate kinase 7 (AK7, marker 558), adenylate kinase 8 (AK8, marker 559), adenylate kinase 9 (AK9, marker 560), adenylate kinase 9 (AK9, marker 561), A kinase (PRKA) anchor protein 1 (AKAP1, marker 562), A kinase (PRKA) anchor protein 11 (AKAP11, marker 563), A kinase (PRKA) anchor protein 12(AKAP12, marker 564),A kinase (PRKA) anchor protein 13(AKAP13,marker 565),A kinase (PRKA) anchor protein 13(AKAP13,marker 566),A kinase (PRKA) anchor protein 13(AKAP13, marker 567), A kinase (PRKA) protein anchor 14 (AKAP14, marker 568), A kinase (PRKA) anchor protein 14 (AKAP14, marker 569), A kinase (PRKA) anchor protein 14 (AKAP14, marker 570), A kinase (PRKA) anchor protein 17A(AKAP17A, marker 571),A kinase (PRKA) anchor protein 3(AKAP3, marker 572),A kinase (PRKA) anchor protein 4(AKAP4, marker 573),A kinase (PRKA) anchor protein 5(AKAP5, marker 574),A kinase (PRKA) anchor protein 5(AKAP5, marker 575),A kinase (PRKA) anchor protein 6(AKAP6, marker 576),A kinase (PRKA) anchor protein 6(AKAP6, marker 577), A kinase (PRKA) protein anchor 8-like (AKAP8L, marker 578), A kinase (PRKA) anchor protein 9 (AKAP9, marker 579), A kinase (PRKA) anchor protein 9 (AKAP9, marker 580) ,AT-hook transcription factor(AKNA, marker 581),AKNA domain containing 1(AKNAD1,marker 582),AKNA domain containing 1(AKNAD1,marker 583),AKNA domain containing 1(AKNAD1,marker 584),aldo-keto reductase family 1, member C1(AKR1C1, marker 585),aldo-keto reductase family 1, member C1(AKR1C1, marker 586),aldo-keto reductase family 1, member C1(AKR1C1, marker 587),aldo-keto reductase family 1 , member C1 /// aldo-keto reductase family 1, member C2(AKR1C1 /// AKR1C2, marker 588),aldo-keto reductase family 1, member C2(AKR1C2, marker 589),aldo-keto reductase family 1, member C4 (AKR1C4, marker 590), aldo-keto reductase family 1, member C6, pseudogene (AKR1C6P, marker 591), aldo-keto reductase family 1, member D1 (AKR1D1, marker 592), aldo-keto reductase family 1, member E2(AKR1E2, marker 593),aldo-keto reductase family 1, member E2(AKR1E2,marker 594),aldo-keto reductase family 1, member E2(AKR1E2,marker 595),v-akt murine thymoma viral oncogene homolog 2( AKT2, marker 596),v-akt murine thymoma viral oncogene homolog 2(AKT2,marker 597),v-akt murine thymoma viral oncogene homolog 3(AKT3,marker 598),v-akt murine thymoma viral oncogene homolog 3(AKT3, marker 599),v-akt murine thymoma viral oncogene homolog 3(AKT3, marker 600),v-akt murine thymoma viral oncogene homolog 3(AKT3, marker 601),5'-aminolevulinate synthase 2(ALAS2, marker 602),5 '-aminolevulinate synthase 2(ALAS2, marker 603),albumin(ALB,marker 604),albumin(ALB,marker 605),albumin(ALB,marker 606),albumin(ALB,marker 607),albumin(ALB,marker 608 ), activated leukocyte cell adhesion molecule(ALCAM, marker 609), aldehyde dehydrogenase 1 family, member A2(ALDH1A2, marker 610),aldehyde dehydrogenase 1 family, member A2(ALDH1A2, marker 611),aldehyde dehydrogenase 1 family, member A3( ALDH1A3, marker 612), aldehyde dehydrogenase 1 family, member L1(ALDH1L1, marker 613),ALDH1L1 antisense RNA 2(ALDH1L1-AS2, marker 614),aldehyde dehydrogenase 1 family, member L2(ALDH1L2, marker 615),aldehyde dehydrogenase 1 family, member L2(ALDH1L2, marker 616),aldehyde dehydrogenase 3 family, member A1(ALDH3A1,marker 617),aldehyde dehydrogenase 3 family, member B1(ALDH3B1,marker 618),aldehyde dehydrogenase 3 family, member B1(ALDH3B1,marker 619),aldehyde dehydrogenase 3 family, member B1(ALDH3B1, marker 620),aldehyde dehydrogenase 3 family, member B2(ALDH3B2, marker 621),aldehyde dehydrogenase 3 family, member B2(ALDH3B2, marker 622),aldehyde dehydrogenase 5 family, member A1 (ALDH5A1, marker 623), aldehyde dehydrogenase 6 family, member A1 (ALDH6A1, marker 624), aldehyde dehydrogenase 8 family, member A1 (ALDH8A1, marker 625), aldolase A, fructose-bisphosphate pseudogene 2 (ALDOAP2, marker 626) ),aldolase B, fructose-bisphosphate(ALDOB, marker 627),aldolase B, fructose-bisphosphate(ALDOB,marker 628),aldolase B, fructose-bisphosphate(ALDOB,marker 629),aldolase B, fructose-bisphosphate(ALDOB, marker 630), aldolase B, fructose-bisphosphate(ALDOB, marker 631),aldolase B, fructose-bisphosphate(ALDOB, marker 632),aldolase B, fructose-bisphosphate(ALDOB, marker 633),ALG13, UDP-N-acetylglucosaminyltransferase subunit (ALG13, marker 634), ALG14, UDP-N-acetylglucosaminyltransferase subunit (ALG14, marker 635), ALG2, alpha-1,3/1,6-mannosyltransferase (ALG2, marker 636), ALG5, dolichyl-phosphate beta- glucosyltransferase (ALG5, marker 637), anaplastic lymphoma receptor tyrosine kinase (ALK, marker 638), anaplastic lymphoma receptor tyrosine kinase (ALK, marker 639), ALKBH3 antisense RNA 1 (ALKBH3-AS1, marker 640), ALKBH3 antisense RNA 1( ALKBH3-AS1, marker 641), alkB homolog 7 (ALKBH7, marker 642), alkB homolog 7 (ALKBH7, marker 643), allantoicase (ALLC, marker 644), Alstrom syndrome 1 pseudogene (ALMS1P, marker 645), ALOX12 antisense RNA 1 (ALOX12-AS1, marker 646), ALOX12 antisense RNA 1 (ALOX12-AS1, marker 647), arachidonate 12-lipoxygenase, 12R type (ALOX12B, marker 648), arachidonate 12-lipoxygenase pseudogene 2 (ALOX12P2, marker 649), arachidonate 15-lipoxygenase(ALOX15, marker 650),arachidonate 15-lipoxygenase, type B(ALOX15B, marker 651),arachidonate 15-lipoxygenase, type B(ALOX15B, marker 652),arachidonate 5-lipoxygenase(ALOX5, marker 653), arachidonate 5-lipoxygenase (ALOX5, marker 654), arachidonate 5-lipoxygenase (ALOX5, marker 655), arachidonate 5-lipoxygenase-activating protein (ALOX5AP, marker 656), arachidonate lipoxygenase 3 (ALOXE3, marker 657), arachidonate lipoxygenase 3( ALOXE3, marker 658), alkaline phosphatase, intestinal(ALPI, marker 659),alkaline phosphatase, intestinal(ALPI, marker 660),alpha kinase 1(ALPK1, marker 661),alpha kinase 1(ALPK1, marker 662),alpha kinase 1 (ALPK1, marker 663), alpha kinase 1 (ALPK1, marker 664), alkaline phosphatase, placental (ALPP, marker 665), alkaline phosphatase, placental /// alkaline phosphatase, placental like 2 (ALPP /// ALPPL2, marker 666),alkaline phosphatase, placental like 2(ALPPL2,marker 667),alkaline phosphatase, placental like 2(ALPPL2,marker 668),ALS2, alsin Rho guanine nucleotide exchange factor(ALS2,marker 669),ALS2 C-terminal like( ALS2CL, marker 670), amyotrophic lateral sclerosis 2 chromosome region candidate 11 (ALS2CR11, marker 671), amyotrophic lateral sclerosis 2 chromosome region candidate 11 (ALS2CR11, marker 672), amyotrophic lateral sclerosis 2 chromosome region candidate 11 (ALS2CR11, marker 673) ,amyotrophic lateral sclerosis 2 chromosome region candidate 11(ALS2CR11, marker 674),amyotrophic lateral sclerosis 2 chromosome region candidate 11(ALS2CR11, marker 675),amyotrophic lateral sclerosis 2 chromosome region candidate 11(ALS2CR11, marker 676),amyotrophic lateral sclerosis 2 chromosome region candidate 12 (ALS2CR12, marker 677), amyotrophic lateral sclerosis 2 chromosome region candidate 12 (ALS2CR12, marker 678), ALX homeobox 1 (ALX1, marker 679), ALX homeobox 3 (ALX3, marker 680), ALX homeobox 4 ( ALX4, marker 681), alpha-methylacyl-CoA racemase (AMACR, marker 682), alpha-methylacyl-CoA racemase (AMACR, marker 683), alpha-methylacyl-CoA racemase (AMACR, marker 684), alpha-1-microglobulin /bikunin precursor(AMBP, marker 685),alpha-1-microglobulin/bikunin precursor(AMBP,marker 686),autophagy/beclin-1 regulator 1(AMBRA1,marker 687),autophagy/beclin-1 regulator 1(AMBRA1,marker 688), amidohydrolase domain containing 1 (AMDHD1, marker 689), amelogenin, X-linked (AMELX, marker 690), amelogenin, Y-linked (AMELY, marker 691), APC membrane recruitment protein 1 (AMER1, marker 692), APC membrane recruitment protein 2(AMER2, marker 693),APC membrane recruitment protein 3(AMER3, marker 694),APC membrane recruitment protein 3(AMER3, marker 695),APC membrane recruitment protein 3(AMER3, marker 696),anti- Mullerian hormone (AMH, marker 697), anti-Mullerian hormone receptor, type II (AMHR2, marker 698), adhesion molecule, interacts with CXADR antigen 1 (AMICA1, marker 699), adhesion molecule with Ig-like domain 1 (AMIGO1, marker 700), adhesion molecule with Ig-like domain 3 /// GDP-mannose pyrophosphorylase B(AMIGO3 /// GMPPB, marker 701), Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1(AMMECR1, marker 702 ), amnion associated transmembrane protein (AMN, marker 703), amnion associated transmembrane protein (AMN, marker 704), amnion associated transmembrane protein (AMN, marker 705), angiomotin (AMOT, marker 706), angiomotin like 1 (AMOTL1, marker 707), adenosine monophosphate deaminase 1 (AMPD1, marker 708), adenosine monophosphate deaminase 3 (AMPD3, marker 709), amylase, alpha 1A (salivary) /// amylase, alpha 1B (salivary) /// amylase, alpha 1C ( salivary) /// amylase, alpha 2A (pancreatic) /// amylase, alpha 2B (pancreatic) /// amylase, alpha pse
udogene 1(AMY1A /// AMY1B /// AMY1C /// AMY2A /// AMY2B /// AMYP1, marker 710), archaelysin family metallopeptidase 1(AMZ1, marker 711), anaphase promoting complex subunit 11(ANAPC11, marker 712) ), anaphase promoting complex subunit 13 (ANAPC13, marker 713), anaphase promoting complex subunit 5 (ANAPC5, marker 714), angel homolog 1 (Drosophila) (ANGEL1, marker 715), angel homolog 2 (Drosophila) (ANGEL2, marker 716) ), angiopoietin 1(ANGPT1, marker 717), angiopoietin 1(ANGPT1, marker 718), angiopoietin 2(ANGPT2, marker 719), angiopoietin 2(ANGPT2, marker 720), angiopoietin 2(ANGPT2, marker 721), angiopoietin 2( ANGPT2, marker 722), angiopoietin 4 (ANGPT4, marker 723), angiopoietin like 1 (ANGPTL1, marker 724), angiopoietin like 1 (ANGPTL1, marker 725), angiopoietin like 1 (ANGPTL1, marker 726), angiopoietin like 2 (ANGPTL2) , Angiopoietin like 2 (ANGPTL2, Marker 728), Angiopoietin like 3 (ANGPTL3, Marker 729), Angiopoietin like 3 (ANGPTL3, Marker 730), Angiopoietin like 3 (ANGPTL3, Marker 731), Angiopoietin like 4 (ANGPTL4) , Marker 732), angiopoietin like 6(ANGPTL6, Marker 733), angiopoietin like 7(ANGPTL7, Marker 734), angiopoietin like 8(ANGPTL8, Marker 735), anomalous homeobox(ANHX, Marker 736), anomalous homeobox(ANHX, Marker 737), ankyrin 1, erythrocytic(ANK1, marker 738),ankyrin 1, erythrocytic(ANK1, marker 739),ankyrin 2, neuronal(ANK2, marker 740),ankyrin 2, neuronal(ANK2, marker 741),ankyrin 3, node of Ranvier (ankyrin G)(ANK3, marker 742),ankyrin and armadillo repeat containing(ANKAR, marker 743),ankyrin and armadillo repeat containing(ANKAR, marker 744),ankyrin repeat and death domain containing 1A(ANKDD1A, marker 745 ),ankyrin repeat and EF-hand domain containing 1(ANKEF1, marker 746),ankyrin-repeat and fibronectin type III domain containing 1(ANKFN1, marker 747),ankyrin-repeat and fibronectin type III domain containing 1(ANKFN1, marker 748) ),ankyrin-repeat and fibronectin type III domain containing 1(ANKFN1, marker 749),ankyrin repeat and FYVE domain containing 1(ANKFY1, marker 750),ankyrin repeat and FYVE domain containing 1(ANKFY1, marker 751),ANKH inorganic pyrophosphate transport regulator(ANKH, marker 752),ANKH inorganic pyrophosphate transport regulator(ANKH,marker 753),ANKH inorganic pyrophosphate transport regulator(ANKH,marker 754),ANKH inorganic pyrophosphate transport regulator(ANKH,marker 755),ANKH inorganic pyrophosphate transport regulator (ANKH, marker 756), ankyrin repeat and LEM domain containing 1 (ANKLE1, marker 757), ankyrin repeat and LEM domain containing 2 (ANKLE2, marker 758), ankyrin repeat and MYND domain containing 1 (ANKMY1, marker 759), ankyrin repeat and MYND domain containing 1(ANKMY1, marker 760),ankyrin repeat and MYND domain containing 1(ANKMY1, marker 761),ankyrin repeat domain 10(ANKRD10, marker 762),ankyrin repeat domain 10(ANKRD10, marker 763),ankyrin repeat domain 13A(ANKRD13A, marker 764),ankyrin repeat domain 13C(ANKRD13C,marker 765),ankyrin repeat domain 13 family, member D(ANKRD13D,marker 766),ankyrin repeat domain 17(ANKRD17,marker 767),ankyrin repeat domain 18A (ANKRD18A, marker 768), ankyrin repeat domain 19, pseudogene (ANKRD19P, marker 769), ankyrin repeat domain 2 (stretch responsive muscle) (ANKRD2, marker 770), ankyrin repeat domain 20 family, member A1 /// ankyrin repeat domain 20 family, member A11, pseudogene /// ankyrin repeat domain 20 family, member A2 /// ankyrin repeat domain 20 family, member A3 /// ankyrin repeat domain 20 family, member A4 /// ankyrin repeat domain 20 family, member A5, pseudogene /// ankyrin repeat domain 20 family, member A7, pseudogene /// uncharacterized LOC105379426(ANKRD20A1 /// ANKRD20A11P /// ANKRD20A2 /// ANKRD20A3 /// ANKRD20A4 /// ANKRD20A5P /// ANKRD20A7P // / LOC105379426, marker 771), ankyrin repeat domain 20 family, member A1 /// ankyrin repeat domain 20 family, member A12, pseudogene /// ankyrin repeat domain 20 family, member A2 /// ankyrin repeat domain 20 family, member A3 /// ankyrin repeat domain 20 family, member A4 /// ankyrin repeat domain 20 family, member A8, pseudogene /// ankyrin repeat domain-containing protein 20A2(ANKRD20A1 /// ANKRD20A12P /// ANKRD20A2 /// ANKRD20A3 // / ANKRD20A4 /// ANKRD20A8P /// LOC102723552, marker 772),ankyrin repeat domain 20 family, member A1 /// ankyrin repeat domain 20 family, member A2 /// ankyrin repeat domain 20 family, member A3 /// ankyrin repeat domain 20 family, member A4(ANKRD20A1 /// ANKRD20A2 /// ANKRD20A3 /// ANKRD20A4, marker 773),ankyrin repeat domain 20 family, member A11, pseudogene(ANKRD20A11P, marker 774),ankyrin repeat domain 20 family, member A12 , pseudogene(ANKRD20A12P, marker 775),ankyrin repeat domain 20 family, member A12, pseudogene(ANKRD20A12P, marker 776),ankyrin repeat domain 20 family, member A12, pseudogene /// uncharacterized LOC100289026 /// putative ankyrin repeat domain-containing protein 20A12 pseudogene /// putative ankyrin repeat domain-containing protein 20A12 pseudogene /// uncharacterized LOC102723799 /// uncharacterized LOC105369263 /// uncharacterized LOC105374447 /// putative ankyrin repeat domain-containing protein 20A12 pseudogene(ANKRD20A12P /// LOC1002890 26 // / LOC101060632 /// LOC101927345 /// LOC102723799 /// LOC105369263 /// LOC105374447 /// LOC105379272, marker 777), ankyrin repeat domain 20 family, member A5, pseudogene(ANKRD20A5P, marker 778), ankyrin repeat domain 22(ANKRD22 , marker 779), ankyrin repeat domain 22 (ANKRD22, marker 780), ankyrin repeat domain 23 (ANKRD23, marker 781), ankyrin repeat domain 23 /// ankyrin repeat domain 39 (ANKRD23 /// ANKRD39, marker 782), ankyrin repeat domain 23 /// ankyrin repeat domain 39(ANKRD23 /// ANKRD39, marker 783),ankyrin repeat domain 24(ANKRD24, marker 784),ankyrin repeat domain 24(ANKRD24, marker 785),ankyrin repeat domain 24(ANKRD24, marker 786), ankyrin repeat domain 26 pseudogene 3 (ANKRD26P3, marker 787), ankyrin repeat domain 29 (ANKRD29, marker 788), ankyrin repeat domain 29 (ANKRD29, marker 789), ankyrin repeat domain 30A (ANKRD30A, marker 790), ankyrin repeat domain 30B(ANKRD30B, marker 791),ankyrin repeat domain 30B(ANKRD30B, marker 792),ankyrin repeat domain 30B-like /// ankyrin repeat domain 30B pseudogene 2(ANKRD30BL /// ANKRD30BP2, marker 793),ankyrin repeat domain 30B pseudogene 2(ANKRD30BP2, marker 794),ankyrin repeat domain 30B pseudogene 3(ANKRD30BP3, marker 795),ankyrin repeat domain 30B pseudogene 3(ANKRD30BP3, marker 796),ankyrin repeat domain 30B pseudogene 3(ANKRD30BP3, marker 797), ankyrin repeat domain 31 (ANKRD31, marker 798), ankyrin repeat domain 33 (ANKRD33, marker 799), ankyrin repeat domain 34A (ANKRD34A, marker 800), ankyrin repeat domain 34C (ANKRD34C, marker 801), ankyrin repeat domain 36 (ANKRD36 , marker 802), ankyrin repeat domain 36B pseudogene 2 (ANKRD36BP2, marker 803), ankyrin repeat domain 36B pseudogene 2 (ANKRD36BP2, marker 804), ankyrin repeat domain 36C (ANKRD36C, marker 805), ankyrin repeat domain 37 (ANKRD37, marker 806), ankyrin repeat domain 40 (ANKRD40, marker 807), ankyrin repeat domain 44 (ANKRD44, marker 808), ankyrin repeat domain 44 (ANKRD44, marker 809), ankyrin repeat domain 44 (ANKRD44, marker 810), ankyrin repeat domain 44 (ANKRD44, marker 811), ankyrin repeat domain 44 (ANKRD44, marker 812), ANKRD44 intronic transcript 1 (ANKRD44-IT1, marker 813), ankyrin repeat domain 45 (ANKRD45, marker 814), ankyrin repeat domain 50 (ANKRD50, marker 815), ankyrin repeat domain 53 (ANKRD53, marker 816), ankyrin repeat domain 53 (ANKRD53, marker 817), ankyrin repeat domain 54 (ANKRD54, marker 818), ankyrin repeat domain 55 (ANKRD55, marker 819), ankyrin repeat domain 60 (ANKRD60, marker 820), ankyrin repeat domain 7 (ANKRD7, marker 821), ankyrin repeat domain 9 (ANKRD9, marker 822), ankyrin repeat and sterile alpha motif domain containing 1B (ANKS1B, marker 823), ankyrin repeat and sterile alpha motif domain containing 1B(ANKS1B, marker 824),ankyrin repeat and sterile alpha motif domain containing 1B(ANKS1B, marker 825),ankyrin repeat and sterile alpha motif domain containing 1B(ANKS1B, marker 826),ankyrin repeat and sterile alpha motif domain containing 4B(ANKS4B, marker 827),ankyrin repeat and sterile alpha motif domain containing 6(ANKS6, marker 828),ankyrin repeat and sterile alpha motif domain containing 6(ANKS6, marker 829),ankyrin repeat and ubiquitin domain containing 1 (ANKUB1, marker 830), ankyrin repeat and ubiquitin domain containing 1(ANKUB1, marker 831), ankyrin repeat and ubiquitin domain containing 1(ANKUB1, marker 832), anoctamine 1, calcium activated chloride channel(ANO1, marker 833), anoctamine 1, calcium activated chloride channel(ANO1, marker 834), anoctamine 2, calcium activated chloride channel(ANO2, marker 835), anoctamine 2, calcium activated chloride channel(ANO2, marker 836), anoctamine 3(ANO3, marker 837), anoctamin 4 (ANO4, marker 838), anoctamin 6 (ANO6, marker 839), anoctamin 7 (ANO7, marker 840), anoctamin 7 pseudogene 1 (ANO7P1, marker 841), anosmin 1 (ANOS1, marker 842), anosmin 2, pseudogene (ANOS2P, marker 843), ANP32A intronic transcript 1 (ANP32A-IT1, marker 844), acidic nuclear phosphoprotein 32 family member C (ANP32C, marker 845), acidic nuclear phosphoprotein 32 family member D (ANP32D, marker 846), alanyl (membrane) aminopeptidase (ANPEP, marker 847), alanyl (membrane) aminopeptidase (ANPEP, marker 848), alanyl (membrane) aminopeptidase (ANPEP, marker 849), anthrax toxin receptor 1 (ANTXR1, marker 850), anthrax toxin receptor 1 (ANTXR1, marker 851), anthrax toxin receptor 1 (ANTXR1, marker 852), anthrax toxin receptor 2 (ANTXR2, marker 853), anthrax toxin receptor 2 (ANTXR2, marker 854), annexin A10 (ANXA10, marker 855), annexin A11 (ANXA11, marker 856), annexin A13 (ANXA13, marker 857), annexin A2 (ANXA2, marker 858), annexin A2 pseudogene 1 (ANXA2P1, marker 859), annexin A2 receptor (ANXA2R, marker 860), annexin A6 ( ANXA6, marker 861), annexin A8(ANXA8, marker 862), annexin A8 /// annexin A8-like 1 /// long intergenic non-protein coding RNA 842(ANXA8 /// ANXA8L1 /// LINC00842, marker 863) ,annexin A8-like 1 /// long intergenic non-protein coding RNA 842(ANXA8L1 /// LINC00842, marker 864),acyloxyacyl hydrolase (neutrophil)(AOAH, marker 865),amine oxidase, copper containing 1(AOC1, marker 866),amine oxidase, copper containing 2 (retina-specific)(AOC2, marker 867),amine oxidase, copper containing 3(AOC3, marker 868),amine oxidase, copper containing 4, pseudogene(AOC4P, marker 869),aldehyde oxidase
1 (AOX1, marker 870), aldehyde oxidase 2 pseudogene (AOX2P, marker 871), adapter-related protein complex 1 associated regulatory protein (AP1AR, marker 872), adapter-related protein complex 1, gamma 2 subunit (AP1G2, marker 873) ), adapter-related protein complex 1 sigma 3 subunit (AP1S3, marker 874), adapter-related protein complex 2, alpha 1 subunit (AP2A1, marker 875), adapter-related protein complex 2, alpha 1 subunit (AP2A1, marker 876) ),adaptor-related protein complex 3, beta 2 subunit(AP3B2,marker 877),adaptor-related protein complex 4, beta 1 subunit(AP4B1,marker 878),adaptor-related protein complex 4, beta 1 subunit(AP4B1,marker 879),adaptor-related protein complex 4, epsilon 1 subunit(AP4E1, marker 880),adaptor-related protein complex 4, epsilon 1 subunit(AP4E1, marker 881),adaptor-related protein complex 4, epsilon 1 subunit(AP4E1, marker 882), adapter-related protein complex 4, sigma 1 subunit (AP4S1, marker 883), adapter-related protein complex 5, beta 1 subunit (AP5B1, marker 884), apoptotic peptidase activating factor 1 (APAF1, marker 885), amyloid beta (A4) precursor protein-binding, family A, member 1(APBA1, marker 886),amyloid beta (A4) precursor protein-binding, family A, member 1 /// uncharacterized LOC101929802(APBA1 /// LOC101929802, marker 887), amyloid beta (A4) precursor protein-binding, family A, member 3 (APBA3, marker 888), amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein (APBB1IP, marker 889), amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein(APBB1IP, marker 890), amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein(APBB1IP, marker 891), amyloid beta ( A4) precursor protein-binding, family B, member 2 (APBB2, marker 892), amyloid beta (A4) precursor protein-binding, family B, member 2 (APBB2, marker 893), adenomatous polyposis coli (APC, marker 894) ,adenomatosis polyposis coli(APC, marker 895),adenomatosis polyposis coli 2(APC2, marker 896),adenomatosis polyposis coli 2(APC2, marker 897),adenomatosis polyposis coli down-regulated 1 /// uncharacterized LOC100130468(APCDD1 /// LOC100130468, marker 898), adenomatosis polyposis coli down-regulated 1-like (APCDD1L, marker 899), APCDD1L antisense RNA 1 (head to head) (APCDD1L-AS1, marker 900), APCDD1L antisense RNA 1 (head to head)( APCDD1L-AS1, marker 901), amyloid P component, serum (APCS, marker 902), acylaminoacyl-peptide hydrolase (APEH, marker 903), APH1A gamma secretase subunit (APH1A, marker 904), APAF1 interacting protein (APIP, marker 905) ), aprataxin and PNKP like factor (APLF, marker 906), apelin (APLN, marker 907), apelin receptor (APLNR, marker 908), APOA1 antisense RNA (APOA1-AS, marker 909), apolipoprotein AV (APOA5, marker 910) ), apolipoprotein AV (APOA5, marker 911), apolipoprotein B (APOB, marker 912), apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 (APOBEC1, marker 913), apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 (APOBEC2, marker 914), apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A /// APOBEC3A and APOBEC3B deletion hybrid(APOBEC3A /// APOBEC3A_B, marker 915), apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3D(APOBEC3D, marker 916 ),apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F(APOBEC3F,marker 917),apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F(APOBEC3F,marker 918),apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F / // apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G(APOBEC3F /// APOBEC3G, marker 919),apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G(APOBEC3G, marker 920),apolipoprotein B mRNA editing enzyme, catalytic polypeptide -like 4 (putative)(APOBEC4, marker 921),apolipoprotein B receptor(APOBR,marker 922),apolipoprotein C-II(APOC2,marker 923),apolipoprotein C-II(APOC2,marker 924),apolipoprotein C-II / // apolipoprotein C-IV /// APOC4-APOC2 readthrough (NMD candidate)(APOC2 /// APOC4 /// APOC4-APOC2,marker 925),apolipoprotein C-II /// APOC4-APOC2 readthrough (NMD candidate)( APOC2 /// APOC4-APOC2, marker 926), apolipoprotein C-III (APOC3, marker 927), apolipoprotein C-III (APOC3, marker 928), apolipoprotein D (APOD, marker 929), apolipoprotein E (APOE, marker 930) ), apolipoprotein F (APOF, marker 931), apolipoprotein H (beta-2-glycoprotein I) (APOH, marker 932), apolipoprotein H (beta-2-glycoprotein I) (APOH, marker 933), apolipoprotein L1 (APOL1, marker 934), apolipoprotein L, 2 (APOL2, marker 935), apolipoprotein L, 3 (APOL3, marker 936), apolipoprotein L, 4 (APOL4, marker 937), apolipoprotein L, 4 (APOL4, marker 938), apolipoprotein L , 4(APOL4, marker 939),apolipoprotein L, 5(APOL5, marker 940),apolipoprotein L, 6(APOL6, marker 941),apolipoprotein L, 6(APOL6, marker 942),apolipoprotein L, 6(APOL6, marker 943), apolipoprotein L, 6 (APOL6, marker 944), apolipoprotein L domain containing 1 (APOLD1, marker 945), amyloid beta precursor protein (cytoplasmic tail) binding protein 2 (APPBP2, marker 946), Alu-mediated CDKN1A/p21 transcriptional regulator (non-protein coding)(APTR, marker 947),aprataxin(APTX,marker 948),aquaporin 1 (Colton blood group)(AQP1,marker 949),aquaporin 1 (Colton blood group)(AQP1,marker 950) ,aquaporin 10(AQP10, marker 951),aquaporin 12A /// aquaporin 12B(AQP12A /// AQP12B,marker 952),aquaporin 2 (collecting duct)(AQP2,marker 953),aquaporin 2 (collecting duct)(AQP2, marker 954), aquaporin 2 (collecting duct)(AQP2, marker 955), aquaporin 3 (Gill blood group)(AQP3, marker 956), aquaporin 3 (Gill blood group)(AQP3, marker 957), aquaporin 4(AQP4, marker 958), aquaporin 4 (AQP4, marker 959), aquaporin 4 (AQP4, marker 960), aquaporin 4 (AQP4, marker 961), aquaporin 4 (AQP4, marker 962), AQP4 antisense RNA 1 (AQP4-AS1, marker 963), AQP4 antisense RNA 1 (AQP4-AS1, marker 964), aquaporin 5 (AQP5, marker 965), aquaporin 6, kidney specific (AQP6, marker 966), aquaporin 6, kidney specific (AQP6, marker 967), aquaporin 7 (AQP7, marker 968), aquaporin 8 (AQP8, marker 969), aquaporin 9 (AQP9, marker 970), aquarius intron-binding spliceosomal factor (AQR, marker 971), A-Raf proto-oncogene, serine/threonine kinase (ARAF, marker 972),ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1(ARAP1, marker 973),ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2(ARAP2, marker 974),ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 (ARAP2, marker 975), activity-regulated cytoskeleton-associated protein (ARC, marker 976), amphiregulin (AREG, marker 977), amphiregulin (AREG, marker 978), apoptosis resistant E3 ubiquitin protein ligase 1 (AREL1) , marker 979), apoptosis resistant E3 ubiquitin protein ligase 1 (AREL1, marker 980), ADP-ribosylation factor 1 (ARF1, marker 981), ADP-ribosylation factor 1 (ARF1, marker 982), ADP-ribosylation factor GTPase activating protein 2 (ARFGAP2, marker 983), ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited) (ARFGEF2, marker 984), ARFGEF family member 3 (ARFGEF3, marker 985), arginase 1 (ARG1, marker 986) ,arginase 1(ARG1, marker 987),arginase 1(ARG1,marker 988),arginase 1(ARG1,marker 989),Rho GTPase activating protein 1(ARHGAP1,marker 990),Rho GTPase activating protein 1(ARHGAP1,marker 991) ),Rho GTPase activating protein 15 /// uncharacterized LOC101928361(ARHGAP15 /// LOC101928361, marker 992),Rho GTPase activating protein 18(ARHGAP18, marker 993),ARHGAP19-SLIT1 readthrough (NMD candidate)(ARHGAP19-SLIT1, marker 994 ),Rho GTPase activating protein 20(ARHGAP20, marker 995),Rho GTPase activating protein 20(ARHGAP20, marker 996),Rho GTPase activating protein 22(ARHGAP22,marker 997),Rho GTPase activating protein 22(ARHGAP22,marker 998), Rho GTPase activating protein 22 (ARHGAP22, marker 999), ARHGAP22 intronic transcript 1 (ARHGAP22-IT1, marker 1000), ARHGAP22 intronic transcript 1 (ARHGAP22-IT1, marker 1001), Rho GTPase activating protein 23 (ARHGAP23, marker 1002), Rho GTPase activating protein 23(ARHGAP23, marker 1003),Rho GTPase activating protein 24(ARHGAP24, marker 1004),Rho GTPase activating protein 24(ARHGAP24, marker 1005),Rho GTPase activating protein 24(ARHGAP24, marker 1006),Rho GTPase activating protein 25 (ARHGAP25, marker 1007), Rho GTPase activating protein 25 (ARHGAP25, marker 1008), Rho GTPase activating protein 25 (ARHGAP25, marker 1009), Rho GTPase activating protein 26 (ARHGAP26, marker 1010), ARHGAP26 antisense RNA 1 (ARHGAP26-AS1, marker 1011), Rho GTPase activating protein 27 (ARHGAP27, marker 1012), Rho GTPase activating protein 27 (ARHGAP27, marker 1013), Rho GTPase activating protein 27 (ARHGAP27, marker 1014), Rho GTPase activating protein 27 (ARHGAP27, marker 1015), Rho GTPase activating protein 27 (ARHGAP27, marker 1016), Rho GTPase activating protein 29 (ARHGAP29, marker 1017), Rho GTPase activating protein 29 (ARHGAP29, marker 1018), Rho GTPase activating protein 29 (ARHGAP29) , Marker 1019), Rho GTPase activating protein 30 (ARHGAP30, Marker 1020), Rho GTPase activating protein 30 (ARHGAP30, Marker 1021), Rho GTPase activating protein 31 (ARHGAP31, Marker 1022), Rho GTPase activating protein 31 (ARHGAP31, Marker 1023), Rho GTPase activating protein 33 (ARHGAP33, marker 1024), Rho GTPase activating protein 33 (ARHGAP33, marker 1025), Rho GTPase activating protein 36 (ARHGAP36, marker 1026), Rho GTPase activating protein 42 (ARHGAP42, marker 1027) ,Rho GTPase activating protein 42(ARHGAP42, marker 1028),Rho GTPase activating protein 44(ARHGAP44, marker 1029),Rho GTPase activating protein 5(ARHGAP5, marker 1030),Rho GTPase activating protein 6(ARHGAP6, marker 1031),Rho GTPase activating protein 8 (ARHGAP8, marker 1032), Rho GTPase activating protein 9 (ARHGAP9, marker 1033), Rho GTPase activating protein 9 (ARHGAP9, marker 1034), Rho GTPase activating protein 9 (ARHGAP9, marker 1035), Rho GDP dissociation inhibitor (GDI) beta (ARHGDIB, marker 1036), Rho guanine nucleotide exchange factor 11 (ARHGEF11, marker 1037), Rho guanine nucleotide exchange factor (GEF) 12 (ARHGEF12, marker 1038), Rho guanine nucleotide exchange factor (GEF) 12 (ARHGEF12, marker 1039),Rho guanine nucleotide exchange factor (GEF) 12(ARHGEF12,marker 1040),Rho guanine nucleotide exchange factor (GEF) 12(ARHGEF12,marker 1041),Rho guanine nucleotide exchange factor (GEF) 12(ARHGEF12 , Marker 1042), Rho guanine nucleotide exchange factor (GEF) 12(ARHGEF12, Marker 1043), Rho guanine nucleotide exchange factor (GEF) 12(ARH
GEF12, marker 1044),Rho guanine nucleotide exchange factor (GEF) 12(ARHGEF12,marker 1045),Rho guanine nucleotide exchange factor (GEF) 12(ARHGEF12,marker 1046),Rho guanine nucleotide exchange factor (GEF) 12(ARHGEF12, Marker 1047), Rho guanine nucleotide exchange factor 15(ARHGEF15, Marker 1048), ARHGEF26 antisense RNA 1(ARHGEF26-AS1, Marker 1049), Rho guanine nucleotide exchange factor 28(ARHGEF28, Marker 1050), Rho guanine nucleotide exchange factor 28( ARHGEF28, Marker 1051), Rho guanine nucleotide exchange factor 28 (ARHGEF28, Marker 1052), Rho guanine nucleotide exchange factor 28 (ARHGEF28, Marker 1053), Rho guanine nucleotide exchange factor 33 (ARHGEF33, Marker 1054), Rho guanine nucleotide exchange factor 34, pseudogene /// rho guanine nucleotide exchange factor 5-like /// olfactory receptor, family 2, subfamily A, member 4 /// olfactory receptor, family 2, subfamily A, member 7(ARHGEF34P /// LOC102725117 // / OR2A4 /// OR2A7, Marker 1055), Rho guanine nucleotide exchange factor 37 (ARHGEF37, Marker 1056), Rho guanine nucleotide exchange factor 37 (ARHGEF37, Marker 1057), Rho guanine nucleotide exchange factor 38 (ARHGEF38, Marker 1058), Rho guanine nucleotide exchange factor 4(ARHGEF4, marker 1059),Rho guanine nucleotide exchange factor 4(ARHGEF4, marker 1060),Rho guanine nucleotide exchange factor (GEF) 40(ARHGEF40, marker 1061),Rho guanine nucleotide exchange factor (GEF) 40(ARHGEF40, Marker 1062), Rho guanine nucleotide exchange factor (GEF) 40(ARHGEF40, Marker 1063), Rho guanine nucleotide exchange factor 7(ARHGEF7, Marker 1064), Rho guanine nucleotide exchange factor 7(ARHGEF7, Marker 1065), Rho guanine nucleotide exchange factor 7(ARHGEF7, marker 1066),Rho guanine nucleotide exchange factor 7(ARHGEF7,marker 1067),Rho guanine nucleotide exchange factor 7(ARHGEF7,marker 1068),ARHGEF7 antisense RNA 2(ARHGEF7-AS2,marker 1069 ), ARHGEF7 intronic transcript 1 (ARHGEF7-IT1, marker 1070), AT rich interactive domain 1A (SWI-like) (ARID1A, marker 1071), AT rich interactive domain 1B (SWI1-like) (ARID1B, marker 1072), AT rich interactive domain 1B (SWI1-like) (ARID1B, marker 1073), AT rich interactive domain 4B (RBP1-like) (ARID4B, marker 1074), AT rich interactive domain 4B (RBP1-like) (ARID4B, marker 1075), AT rich interactive domain 5A (MRF1-like) (ARID5A, marker 1076), AT rich interactive domain 5B (MRF1-like) (ARID5B, marker 1077), AT rich interactive domain 5B (MRF1-like) (ARID5B, marker 1078) ,AT rich interactive domain 5B (MRF1-like)(ARID5B, marker 1079),AT rich interactive domain 5B (MRF1-like)(ARID5B, marker 1080),ariadne RBR E3 ubiquitin protein ligase 1(ARIH1,marker 1081),ariadne RBR E3 ubiquitin protein ligase 1 (ARIH1, marker 1082), ariadne homolog 2 opposite strand (ARIH2OS, marker 1083), ADP-ribosylation factor like GTPase 10 (ARL10, marker 1084), ADP-ribosylation factor like GTPase 10 (ARL10, marker 1085),ADP-ribosylation factor like GTPase 10(ARL10, marker 1086),ADP-ribosylation factor like GTPase 11(ARL11, marker 1087),ADP-ribosylation factor like GTPase 11(ARL11, marker 1088),ADP-ribosylation factor like GTPase 14(ARL14, marker 1089),ADP-ribosylation factor like GTPase 17A /// ADP-ribosylation factor like GTPase 17B(ARL17A /// ARL17B, marker 1090),ADP-ribosylation factor like GTPase 17A /// ADP-ribosylation factor like GTPase 17B(ARL17A /// ARL17B, marker 1091),ADP-ribosylation factor like GTPase 17A /// ADP-ribosylation factor like GTPase 17B /// ADP-ribosylation factor-like protein 17 /// ADP-ribosylation factor -like protein 17(ARL17A /// ARL17B /// LOC100294341 /// LOC100996709, marker 1092),ADP-ribosylation factor like GTPase 17A /// ADP-ribosylation factor like GTPase 17B /// ADP-ribosylation factor-like protein 17 /// ADP-ribosylation factor-like protein 17(ARL17A /// ARL17B /// LOC100294341 /// LOC100996709, marker 1093),ADP-ribosylation factor like GTPase 17A /// ADP-ribosylation factor-like protein 17 / // ADP-ribosylation factor-like protein 17 /// uncharacterized LOC101929774 /// uncharacterized LOC105371859 /// uncharacterized LOC105376844(ARL17A /// LOC100294341 /// LOC100996709 /// LOC101929774 /// LOC105371859 // / LOC105376844, Marker 1094 ), ADP-ribosylation factor like GTPase 4D (ARL4D, marker 1095), ADP-ribosylation factor like GTPase 5C (ARL5C, marker 1096), ADP-ribosylation factor like GTPase 9 (ARL9, marker 1097), armadillo repeat containing 12 (ARMC12 ,marker 1098),armadillo repeat containing 2(ARMC2,marker 1099),armadillo repeat containing 3(ARMC3,marker 1100),armadillo repeat containing 4(ARMC4,marker 1101),armadillo repeat containing 8(ARMC8,marker 1102),armadillo repeat containing 9(ARMC9, marker 1103),armadillo repeat containing 9(ARMC9,marker 1104),armadillo repeat containing 9(ARMC9,marker 1105),armadillo repeat containing, X-linked 4(ARMCX4,marker 1106),armadillo repeat containing , X-linked 4(ARMCX4, marker 1107), armadillo repeat containing, X-linked 4(ARMCX4, marker 1108), armadillo repeat containing, X-linked 4(ARMCX4, marker 1109), armadillo repeat containing, X-linked 6 (ARMCX6, marker 1110), aryl hydrocarbon receptor nuclear translocator(ARNT, marker 1111), aryl hydrocarbon receptor nuclear translocator(ARNT, marker 1112), ARNTL2 antisense RNA 1(ARNTL2-AS1, marker 1113), ARPC4-TTLL3 readthrough // / tubulin tyrosine ligase-like family member 3(ARPC4-TTLL3 /// TTLL3, marker 1114),ARPC4-TTLL3 readthrough /// tubulin tyrosine ligase-like family member 3(ARPC4-TTLL3 /// TTLL3, marker 1115), ARPC4-TTLL3 readthrough /// tubulin tyrosine ligase-like family member 3(ARPC4-TTLL3 /// TTLL3, marker 1116), actin related protein 2/3 complex subunit 5(ARPC5, marker 1117), actin related protein 2/3 complex subunit 5 (ARPC5, marker 1118), actin-related protein 2/3 complex inhibitor (ARPIN, marker 1119), actin-related protein 2/3 complex inhibitor (ARPIN, marker 1120), cAMP-regulated phosphoprotein 21kDa (ARPP21, marker 1121), cAMP-regulated phosphoprotein 21kDa (ARPP21, marker 1122), cAMP-regulated phosphoprotein 21kDa (ARPP21, marker 1123), cAMP-regulated phosphoprotein 21kDa (ARPP21, marker 1124), cAMP-regulated phosphoprotein 21kDa (ARPP21, marker 1125) ), cAMP-regulated phosphoprotein 21kDa(ARPP21, marker 1126),arrestin 3, retinal (X-arrestin)(ARR3, marker 1127),arrestin, beta 1(ARRB1, marker 1128),arrestin domain containing 2(ARRDC2, marker 1129) ), ARRDC3 antisense RNA 1 (ARRDC3-AS1, marker 1130), arylsulfatase A (ARSA, marker 1131), arylsulfatase A (ARSA, marker 1132), arylsulfatase B (ARSB, marker 1133), arylsulfatase B (ARSB, marker 1134) ,arylsulfatase D(ARSD, marker 1135),arylsulfatase D(ARSD,marker 1136),arylsulfatase D(ARSD,marker 1137),arylsulfatase F(ARSF,marker 1138),arylsulfatase G(ARSG,marker 1139),arylsulfatase family, member K (ARSK, marker 1140), arylsulfatase family, member K (ARSK, marker 1141), ADP-ribosyltransferase 1 (ART1, marker 1142), ADP-ribosyltransferase 1 (ART1, marker 1143), ADP-ribosyltransferase 1 (ART1, marker 1144), ADP-ribosyltransferase 3 (ART3, marker 1145), ADP-ribosyltransferase 4 (Dombrock blood group) (ART4, marker 1146), ADP-ribosyltransferase 4 (Dombrock blood group) (ART4, marker 1147), artemin (ARTN, marker 1148), artemin (ARTN, marker 1149), ARV1 homolog, fatty acid homeostasis modulator (ARV1, marker 1150), armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF, marker 1151), armadillo repeat gene deleted in velocardiofacial syndrome (ARVCF, marker 1152), aristales related homeobox(ARX, marker 1153), N-acylsphingosine amidohydrolase (acid ceramidase) 1(ASAH1, marker 1154), ASAP1 intronic transcript 1(ASAP1-IT1, marker 1155), ASAP1 intronic transcript 2(ASAP1- IT2,marker 1156),ankyrin repeat and SOCS box containing 1(ASB1,marker 1157),ankyrin repeat and SOCS box containing 10(ASB10,marker 1158),ankyrin repeat and SOCS box containing 10(ASB10,marker 1159),ankyrin repeat and SOCS box containing 10(ASB10, marker 1160),ankyrin repeat and SOCS box containing 11, E3 ubiquitin protein ligase(ASB11, marker 1161),ankyrin repeat and SOCS box containing 12(ASB12, marker 1162),ankyrin repeat and SOCS box containing 14(ASB14, marker 1163),ankyrin repeat and SOCS box containing 14(ASB14, marker 1164),ankyrin repeat and SOCS box containing 15(ASB15, marker 1165),ankyrin repeat and SOCS box containing 16(ASB16, marker 1166) ,ankyrin repeat and SOCS box containing 17(ASB17,marker 1167),ankyrin repeat and SOCS box containing 2(ASB2,marker 1168),ankyrin repeat and SOCS box containing 2(ASB2,marker 1169),ankyrin repeat and SOCS box containing 3 (ASB3, marker 1170),ankyrin repeat and SOCS box containing 4(ASB4, marker 1171),ankyrin repeat and SOCS box containing 4(ASB4, marker 1172),ankyrin repeat and SOCS box containing 4(ASB4, marker 1173),ankyrin repeat and SOCS box containing 4(ASB4, marker 1174),ankyrin repeat and SOCS box containing 4(ASB4, marker 1175),ankyrin repeat and SOCS box containing 4(ASB4, marker 1176),ankyrin repeat and SOCS box containing 5(ASB5 , marker 1177), achaete-scute family bHLH transcription factor 1(ASCL1, marker 1178), achaete-scute family bHLH transcription factor 1(ASCL1, marker 1179), achaete-scute family bHLH transcription factor 1(ASCL1, marker 1180), achaete-scute family bHLH transcription factor 1(ASCL1, marker 1181),achaete-scute family bHLH transcription factor 2(ASCL2, marker 1182),achaete-scute family bHLH transcription factor 2(ASCL2, marker 1183),achaete-scute family bHLH transcription factor 3 (ASCL3, marker 1184), achaete-scute family bHLH transcription factor 5 (ASCL5, marker 1185), asialoglycoprotein receptor 2 (ASGR2, marker 1186), acid sensing ion channel 2 (ASIC2, marker 1187), acid sensing ion channel family member 4 (ASIC4, marker 1188), acid sensing ion channel family member 5 (ASIC5, marker 1189), agouti signaling protein (ASIP, marker 1190), acetylserotonin O-methyltransferase (ASMT, marker 1191), acetylserotonin O-methyltransferase (ASMT, Marker 1192), ASMTL antisense RNA 1 (ASMTL-AS1, Marker 1193), ASMTL antisense RNA 1 (ASMTL-AS1, Marker 1194), ASMTL antisense RNA 1 (ASMTL-AS1, Marker 1195), ASMTL antisense RNA 1 (ASMTL-AS1, marker 1196), asparagine synthetase (glutamine-hydrolyzing) (ASNS, marker 1197), aspartoacylase (ASPA, marker 1198), aspartoacylase (ASPA, marker 1199), aspartate dehydrogenase domain containing (ASPDH, marker 1200), asparaginase (ASPG, marker 1201), asparaginase (ASPG, marker 1202), aspartate beta-hydroxylase (ASPH, marker 1203), asparta
te beta-hydroxylase (ASPH, marker 1204), asporin (ASPN, marker 1205), asporin (ASPN, marker 1206), aspartic peptidase, retroviral-like 1 (ASPRV1, marker 1207), astrotactin 1 (ASTN1, marker 1208), astrotactin 2(ASTN2, marker 1209), additional sex combs like transcriptional regulator 1(ASXL1, marker 1210), additional sex combs like transcriptional regulator 3(ASXL3, marker 1211), additional sex combs like transcriptional regulator 3(ASXL3, marker 1212) ,ankyrin repeat, SAM and basic leucine zipper domain containing 1(ASZ1, marker 1213),ATPase family, AAA domain containing 2B(ATAD2B, marker 1214),ATPase family, AAA domain containing 3B(ATAD3B, marker 1215),ATPase family, AAA domain containing 3C (ATAD3C, marker 1216), arginyltransferase 1 (ATE1, marker 1217), arginyltransferase 1 (ATE1, marker 1218), activating transcription factor 2 (ATF2, marker 1219), activating transcription factor 5 (ATF5, marker 1220) ,activating transcription factor 5(ATF5, marker 1221),activating transcription factor 7(ATF7,marker 1222),activating transcription factor 7(ATF7,marker 1223),autophagy related 10(ATG10,marker 1224),autophagy related 10(ATG10, marker 1225), autophagy related 10 (ATG10, marker 1226), autophagy related 16-like 1 (ATG16L1, marker 1227), autophagy related 16-like 2 (ATG16L2, marker 1228), autophagy related 2B (ATG2B, marker 1229), autophagy related 3(ATG3, marker 1230),autophagy related 7(ATG7,marker 1231),autophagy related 9B(ATG9B,marker 1232),autophagy related 9B(ATG9B,marker 1233),ATH1, acid trehalase-like 1 (yeast) (ATHL1, marker 1234), atlastin GTPase 2 (ATL2, marker 1235), atlastin GTPase 3 (ATL3, marker 1236), ATM serine/threonine kinase (ATM, marker 1237), ATM serine/threonine kinase (ATM, marker 1238) ,ATM serine/threonine kinase(ATM, marker 1239),ATM interactor(ATMIN, marker 1240),atrophin 1(ATN1,marker 1241),atrophin 1(ATN1,marker 1242),atrophin 1(ATN1,marker 1243),atonal bHLH transcription factor 1 (ATOH1, marker 1244), atonal bHLH transcription factor 7 (ATOH7, marker 1245), atonal bHLH transcription factor 7 (ATOH7, marker 1246), atonal bHLH transcription factor 8 (ATOH8, marker 1247), atonal bHLH transcription factor 8(ATOH8, marker 1248),ATPase, class V, type 10A(ATP10A, marker 1249),ATPase, class V, type 10A(ATP10A, marker 1250),ATPase, class V, type 10A(ATP10A, marker 1251) ,ATPase, class V, type 10B(ATP10B, marker 1252),ATPase, class V, type 10B(ATP10B, marker 1253),ATPase, class VI, type 11A(ATP11A, marker 1254),ATPase, class VI, type 11A (ATP11A, Marker 1255), ATP11A antisense RNA 1 (ATP11A-AS1, Marker 1256), ATP11A antisense RNA 1 (ATP11A-AS1, Marker 1257), ATP11A antisense RNA 1 (ATP11A-AS1, Marker 1258), ATPase, class VI , type 11B(ATP11B, marker 1259),ATPase, class VI, type 11B(ATP11B, marker 1260),ATPase, class VI, type 11B(ATP11B, marker 1261),ATPase, class VI, type 11B(ATP11B, marker 1262) ),ATPase, H+/K+ transporting, nongastric, alpha polypeptide(ATP12A, marker 1263),ATPase type 13A4(ATP13A4, marker 1264),ATPase type 13A4(ATP13A4, marker 1265),ATPase type 13A4(ATP13A4, marker 1266), ATPase type 13A4 (ATP13A4, marker 1267), ATP13A4 antisense RNA 1 (ATP13A4-AS1, marker 1268), ATPase type 13A5 (ATP13A5, marker 1269), ATPase type 13A5 (ATP13A5, marker 1270), ATP1A1 antisense RNA 1 (ATP1A1- AS1, marker 1271), ATP1A1 antisense RNA 1 (ATP1A1-AS1, marker 1272), ATPase, Na+/K+ transporting, alpha 3 polypeptide(ATP1A3, marker 1273), ATPase, Na+/K+ transporting, alpha 4 polypeptide(ATP1A4, marker 1274),ATPase, Na+/K+ transporting, alpha 4 polypeptide(ATP1A4, marker 1275),ATPase, Na+/K+ transporting, alpha 4 polypeptide(ATP1A4, marker 1276),ATPase, Na+/K+ transporting, beta 3 polypeptide(ATP1B3, marker 1277), ATPase, Na+/K+ transporting, beta 4 polypeptide(ATP1B4, marker 1278), ATPase, Na+/K+ transporting, beta 4 polypeptide(ATP1B4, marker 1279), ATPase, Ca++ transporting, cardiac muscle, fast twitch 1( ATPase, Ca++ transporting, cardiac muscle, fast twitch 1(ATP2A1, marker 1281),ATPase, Ca++ transporting, cardiac muscle, slow twitch 2(ATP2A2, marker 1282),ATPase, Ca++ transporting, ubiquitous(ATP2A3) , marker 1283),ATPase, Ca++ transporting, ubiquitous(ATP2A3, marker 1284),ATPase, Ca++ transporting, ubiquitous(ATP2A3, marker 1285),ATPase, Ca++ transporting, ubiquitous(ATP2A3, marker 1286),ATPase, Ca++ transporting, plasma membrane 2(ATP2B2, marker 1287),ATPase, Ca++ transporting, plasma membrane 2(ATP2B2, marker 1288),ATPase, Ca++ transporting, plasma membrane 2(ATP2B2, marker 1289),ATPase, Ca++ transporting, plasma membrane 2(ATP2B2, marker 1290),ATPase, Ca++ transporting, plasma membrane 2(ATP2B2, marker 1291),ATPase, Ca++ transporting, membrane plasma 2(ATP2B2, marker 1292),ATPase, Ca++ transporting, plasma membrane 3(ATP2B3, marker 1293),ATPase , Ca++ transporting, plasma membrane 3(ATP2B3, marker 1294),ATPase, Ca++ transporting, plasma membrane 3(ATP2B3, marker 1295),ATPase, Ca++ transporting, plasma membrane 3(ATP2B3, marker 1296),ATPase, Ca++ transporting, plasma membrane 4(ATP2B4, marker 1297),ATPase, Ca++ transporting, type 2C, member 2(ATP2C2, marker 1298),ATPase, Ca++ transporting, type 2C, member 2(ATP2C2, marker 1299),ATPase, Ca++ transporting, type 2C , member 2(ATP2C2, marker 1300),ATPase, H+/K+ exchanging, alpha polypeptide(ATP4A, marker 1301),ATPase, H+/K+ exchanging, beta polypeptide(ATP4B, marker 1302),ATPase, H+/K+ exchanging, beta polypeptide(ATP4B, marker 1303), ATPase, H+/K+ exchanging, beta polypeptide(ATP4B, marker 1304), ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle(ATP5A1, marker 1305), ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit(ATP5E, marker 1306),ATP synthase, H+ transporting, mitochondrial Fo complex subunit B1(ATP5F1, marker 1307),ATP synthase, H+ transporting, mitochondrial Fo complex subunit C2 (subunit 9)( ATP5G2, marker 1308), ATP synthase, H+ transporting, mitochondrial Fo complex subunit F2 (ATP5J2, marker 1309), ATP5J2-PTCD1 readthrough /// pentatricopeptide repeat domain 1 (ATP5J2-PTCD1 /// PTCD1, marker 1310), ATP synthase , H+ transporting, mitochondrial F1 complex, O subunit(ATP5O, marker 1311),ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)(ATP5S, marker 1312),ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B)(ATP5S, marker 1313),ATP5S-like(ATP5SL, marker 1314),ATPase, H+ transporting, lysosomal accessory protein 1-like(ATP6AP1L, marker 1315),ATPase, H+ transporting, lysosomal accessory protein 1-like (ATP6AP1L, marker 1316),ATPase, H+ transporting, lysosomal V0 subunit a2(ATP6V0A2, marker 1317),ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2(ATP6V0D2, marker 1318),ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2(ATP6V0D2, marker 1319),ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2(ATP6V0D2, marker 1320),ATP6V0E2 antisense RNA 1(ATP6V0E2-AS1, marker 1321),ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1(ATP6V1B1, marker 1322),ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1(ATP6V1B1, marker 1323),ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2(ATP6V1C2, marker 1324),ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2(ATP6V1C2, marker 1325),ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3(ATP6V1G3, marker 1326),ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H(ATP6V1H, marker 1327), ATPase, Cu++ transporting, alpha polypeptide(ATP7A, marker 1328), ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1(ATP8A1, marker 1329), ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1(ATP8A1, marker 1330),ATPase, aminophospholipid transporter, class I, type 8A, member 2(ATP8A2, marker 1331),ATPase, aminophospholipid transporter, class I, type 8B, member 3(ATP8B3, marker 1332),ATPase, aminophospholipid transporter, class I, type 8B, member 3(ATP8B3, marker 1333),ATPase, aminophospholipid transporter, class I, type 8B, member 3(ATP8B3, marker 1334),ATPase, class I, type 8B, member 4(ATP8B4, marker 1335),ATPase, class I, type 8B, member 5, pseudogene(ATP8B5P, marker 1336),ATPase, class I, type 8B, member 5, pseudogene(ATP8B5P, marker 1337),ATPase , class II, type 9A(ATP9A, marker 1338),ATPase, class II, type 9B(ATP9B, marker 1339),ATPase, class II, type 9B(ATP9B, marker 1340),ATPase, class II, type 9B(ATP9B , marker 1341), ATPase, class II, type 9B (ATP9B, marker 1342), ATP synthase mitochondrial F1 complex assembly factor 2 (ATPAF2, marker 1343), ATR serine/threonine kinase (ATR, marker 1344), attractin-like 1 (ATRNL1, marker 1345), attractin-like 1(ATRNL1, marker 1346), ataxin 1(ATXN1, marker 1347), ataxin 1(ATXN1, marker 1348), ataxin 2-like(ATXN2L, marker 1349), ataxin 3( ATXN3, marker 1350), ataxin 3 (ATXN3, marker 1351), ataxin 3 (ATXN3, marker 1352), ataxin 3-like (ATXN3L, marker 1353), ataxin 7-like 1 (ATXN7L1, marker 1354), ataxin 7- like 2(ATXN7L2, marker 1355),ATXN8 opposite strand (non-protein coding)(ATXN8OS, marker 1356),autism susceptibility candidate 2(AUTS2,marker 1357),autism susceptibility candidate 2(AUTS2,marker 1358),advillin(AVIL , marker 1359), advillin(AVIL, marker 1360), advillin(AVIL, marker 1361), advillin(AVIL, marker 1362), AVL9 homolog (S. cerevisiase)(AVL9, marker 1363), AVL9 homolog (S. cerevisiase) (AVL9, marker 1364), AVL9 homolog (S. cerevisiase) (AVL9, marker 1365), arginine vasopressin (AVP, marker 1366), arginine vasopressin receptor 1A (AVPR1A, marker 1367), arginine vasopressin receptor 1A (AVPR1A, marker 1368) ), arginine vasopressin receptor 1A (AVPR1A, marker 1369), arginine vasopressin receptor 1A (AVPR1A, marker 1370), arginine vasopressin receptor 1A (AVPR1A, marker 1371), arginine vasopressin receptor 1B (AVPR1B, marker 1372), arginine vasopressin receptor 2 (AVPR2, marker 1373), arginine vasopressin receptor 2(AVPR2, marker 1374), acyl-CoA wax alcohol acyltransferase 1(AWAT1, marker 1375), axonemal dynein light chain domain containing 1(AXDND1, marker 1376), axonemal dynein light chain domain containing 1(AXDND1, marker 1377), alpha-2-glycoprotein 1, zinc-binding(AZGP1, marker 1378), alpha-2-glycoprotein 1, zinc-binding /// alpha-2-glycoprotein 1, zinc-binding pseudogene 1(AZGP1 /// AZGP1P1, marker 1379), alpha-2-glycoprotein 1, zinc-binding pseudogene 1(AZGP1P1, marker 1380), 5-azacytidine induced 2(AZI2, marker 1381), azurocidin 1(AZU1, marker 138
2), beta-2-microglobulin (B2M, marker 1383), beta-1,3-N-acetylgalactosaminyltransferase 2 (B3GALNT2, marker 1384), beta-1,3-N-acetylgalactosaminyltransferase 2 (B3GALNT2, marker 1385), beta -1,3-N-acetylgalactosaminyltransferase 2(B3GALNT2, marker 1386),UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 1(B3GALT1,marker 1387),UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 2(B3GALT2, marker 1388), UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 2(B3GALT2, marker 1389),UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase 4(B3GALT4, marker 1390),UDP-Gal:betaGlcNAc beta 1, 3-galactosyltransferase 5 (B3GALT5, marker 1391), beta-1,3-glucuronyltransferase 2 (B3GAT2, marker 1392), beta-1,3-glucuronyltransferase 2 (B3GAT2, marker 1393), UDP-GlcNAc:betaGal beta-1, 3-N-acetylglucosaminyltransferase 2 (B3GNT2, marker 1394), UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3 (B3GNT3, marker 1395), UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 (B3GNT5, marker 1396), UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6(B3GNT6, marker 1397),UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6(B3GNT6, marker 1398) ,UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7(B3GNT7, marker 1399),UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7(B3GNT7,marker 1400),UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8(B3GNT8, marker 1401),UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1(B3GNTL1,marker 1402),UDP-GlcNAc:betaGal beta-1, 3-N-acetylglucosaminyltransferase-like 1(B3GNTL1, marker 1403),beta-1,4-N-acetyl-galactosaminyl transferase 1(B4GALNT1, marker 1404),beta-1,4-N-acetyl-galactosaminyl transferase 1(B4GALNT1 , marker 1405), beta-1,4-N-acetyl-galactosaminyl transferase 2 (B4GALNT2, marker 1406), beta-1,4-N-acetyl-galactosaminyl transferase 3 (B4GALNT3, marker 1407), beta-1,4 -N-acetyl-galactosaminyl transferase 3(B4GALNT3, marker 1408),beta-1,4-N-acetyl-galactosaminyl transferase 4(B4GALNT4, marker 1409),beta-1,4-N-acetyl-galactosaminyl transferase 4(B4GALNT4) , marker 1410), UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 1(B4GALT1, marker 1411),UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 1(B4GALT1, marker 1412),UDP-Gal :betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 1(B4GALT1, marker 1413),UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 3(B4GALT3, marker 1414),UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase , polypeptide 6 (B4GALT6, marker 1415), B9 protein domain 1 (B9D1, marker 1416), BAALC antisense RNA 2 (BAALC-AS2, marker 1417), BAALC antisense RNA 2 (BAALC-AS2, marker 1418), bile acid- CoA:amino acid N-acyltransferase (BAAT, marker 1419), beta-site APP-cleaving enzyme 2 (BACE2, marker 1420), BTB and CNC homology 1, basic leucine zipper transcription factor 1 (BACH1, marker 1421), BTB and CNC homology 1, basic leucine zipper transcription factor 1(BACH1, marker 1422),BTB and CNC homology 1, basic leucine zipper transcription factor 1 /// GRIK1 antisense RNA 2(BACH1 /// GRIK1-AS2, marker 1423),BTB and CNC homology 1, basic leucine zipper transcription factor 1 /// GRIK1 antisense RNA 2(BACH1 /// GRIK1-AS2, marker 1424),BTB and CNC homology 1, basic leucine zipper transcription factor 1 /// GRIK1 antisense RNA 2 /// long intergenic non-protein coding RNA 189(BACH1 /// GRIK1-AS2 /// LINC00189, marker 1425), BCL2-associated agonist of cell death(BAD, marker 1426), BCL2-associated athanogene 2(BAG2, marker 1427), BCL2 associated athanogene 6(BAG6, marker 1428), B melanoma antigen(BAGE, marker 1429), B melanoma antigen(BAGE, marker 1430), B melanoma antigen(BAGE, marker 1431), B melanoma antigen(BAGE ,marker 1432),BAH domain and coiled-coil containing 1(BAHCC1,marker 1433),BAH domain and coiled-coil containing 1(BAHCC1,marker 1434),BAH domain and coiled-coil containing 1(BAHCC1,marker 1435), BAI1-associated protein 2(BAIAP2, marker 1436),BAI1-associated protein 2(BAIAP2, marker 1437),BAIAP2 antisense RNA 1 (head to head)(BAIAP2-AS1,marker 1438),BAI1-associated protein 2-like 2 (BAIAP2L2, marker 1439),BAI1-associated protein 2-like 2(BAIAP2L2,marker 1440),BAI1-associated protein 3(BAIAP3,marker 1441),BAI1-associated protein 3(BAIAP3,marker 1442),barrier to autointegration factor 2 (BANF2, marker 1443), B-cell scaffold protein with ankyrin repeats 1 (BANK1, marker 1444), BarH-like homeobox 1 (BARHL1, marker 1445), BARX homeobox 1 (BARX1, marker 1446), BARX homeobox 2( BARX2, marker 1447), brain abundant, membrane attached signal protein 1(BASP1, marker 1448), basic leucine zipper transcription factor, ATF-like(BATF, marker 1449), basic leucine zipper transcription factor, ATF-like 2(BATF2, marker 1450), bromodomain adjacent to zinc finger domain 1B(BAZ1B, marker 1451), bromodomain adjacent to zinc finger domain 1B(BAZ1B, marker 1452), bromodomain adjacent to finger zinc domain 2A(BAZ2A, marker 1453), bromodomain adjacent to zinc finger domain 2A(BAZ2A, marker 1453) finger domain 2A(BAZ2A, marker 1454),BBSome interacting protein 1(BBIP1,marker 1455),BBSome interacting protein 1(BBIP1,marker 1456),BBSome interacting protein 1(BBIP1,marker 1457),basal body orientation factor 1(BBOF1 , marker 1458), basal body orientation factor 1(BBOF1, marker 1459), butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1(BBOX1, marker 1460), BBOX1 antisense RNA 1(BBOX1-AS1, marker 1461), Bardet-Biedl syndrome 1 (BBS1, marker 1462), Bardet-Biedl syndrome 9 (BBS9, marker 1463), Bardet-Biedl syndrome 9 (BBS9, marker 1464), bobby sox homolog (Drosophila) (BBX, marker 1465) ),basal cell adhesion molecule (Lutheran blood group)(BCAM, marker 1466),brevican(BCAN,marker 1467),brevican(BCAN,marker 1468),B-cell receptor-associated protein 29(BCAP29,marker 1469),B -cell receptor-associated protein 29(BCAP29, marker 1470),B-cell receptor-associated protein 29(BCAP29, marker 1471),breast cancer anti-estrogen resistance 4 (non-protein coding)(BCAR4,marker 1472),breast carcinoma amplified sequence 1(BCAS1, marker 1473), breast carcinoma amplified sequence 4(BCAS4, marker 1474), breast carcinoma amplified sequence 4(BCAS4, marker 1475), branched chain amino-acid transaminase 2, mitochondrial(BCAT2, marker 1476) ,BCDIN3D antisense RNA 1(BCDIN3D-AS1, marker 1477),BCDIN3D antisense RNA 1(BCDIN3D-AS1,marker 1478),B-cell CLL/lymphoma 10(BCL10,marker 1479),B-cell CLL/lymphoma 11B (zinc finger protein)(BCL11B, marker 1480),B-cell CLL/lymphoma 2(BCL2,marker 1481),B-cell CLL/lymphoma 2(BCL2,marker 1482),B-cell CLL/lymphoma 2(BCL2,marker 1483 ),BCL2-related protein A1(BCL2A1, marker 1484),BCL2-like 10 (apoptosis facilitator)(BCL2L10, marker 1485),BCL2-like 10 (apoptosis facilitator)(BCL2L10, marker 1486),BCL2-like 11 (apoptosis facilitator)(BCL2L11, marker 1487),BCL2-like 13 (apoptosis facilitator)(BCL2L13, marker 1488),BCL2-like 14 (apoptosis facilitator)(BCL2L14, marker 1489),BCL2-like 14 (apoptosis facilitator)(BCL2L14, marker 1490),BCL2-like 14 (apoptosis facilitator)(BCL2L14, marker 1491),BCL2-like 14 (apoptosis facilitator)(BCL2L14, marker 1492),BCL2-like 14 (apoptosis facilitator)(BCL2L14, marker 1493),BCL2 -like 15(BCL2L15, marker 1494),BCL2-like 15(BCL2L15,marker 1495),BCL2-like 15(BCL2L15,marker 1496),B-cell CLL/lymphoma 3(BCL3,marker 1497),B-cell CLL /lymphoma 3(BCL3, marker 1498),B-cell CLL/lymphoma 6(BCL6,marker 1499),B-cell CLL/lymphoma 6, member B(BCL6B,marker 1500),B-cell CLL/lymphoma 6, member B(BCL6B, marker 1501), B-cell CLL/lymphoma 6, member B(BCL6B, marker 1502), beta-carotene oxygenase 1(BCO1, marker 1503), beta-carotene oxygenase 2(BCO2, marker 1504), BCL6 corepressor-like 1(BCORL1, marker 1505),BCL6 corepressor pseudogene 1(BCORP1, marker 1506),breakpoint cluster region pseudogene 3(BCRP3,marker 1507),breakpoint cluster region pseudogene 3(BCRP3,marker 1508),3-hydroxybutyrate dehydrogenase , type 1(BDH1, marker 1509),3-hydroxybutyrate dehydrogenase, type 1 /// uncharacterized LOC100129516(BDH1 /// LOC100129516, marker 1510),3-hydroxybutyrate dehydrogenase, type 2(BDH2, marker 1511),bradykinin receptor B1 (BDKRB1, marker 1512), bradykinin receptor B2 (BDKRB2, marker 1513), BDNF antisense RNA (BDNF-AS, marker 1514), BDNF antisense RNA (BDNF-AS, marker 1515), B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB(BDP1, marker 1516), brain expressed, associated with NEDD4, 1(BEAN1, marker 1517), beclin 1, autophagy related(BECN1, marker 1518), brain-enriched guanylate kinase-associated(BEGAIN, marker 1519),BEN domain containing 2(BEND2, marker 1520),BEN domain containing 4(BEND4, marker 1521),BEN domain containing 5(BEND5, marker 1522),BEN domain containing 6(BEND6, marker 1523),BEN domain containing 7(BEND7, marker 1524), BEN domain containing 7(BEND7, marker 1525), bestrophin 1(BEST1, marker 1526), bestrophin 1(BEST1, marker 1527), bestrophin 1(BEST1, marker 1528), bestrophin 2(BEST2 , marker 1529), bestrophin 3 (BEST3, marker 1530), bestrophin 3 (BEST3, marker 1531), bestrophin 3 (BEST3, marker 1532), bestrophin 4 (BEST4, marker 1533), Bet1 golgi vesicular membrane trafficking protein-like( BET1L, marker 1534), beaded filament structural protein 2, phakinin (BFSP2, marker 1535), BFSP2 antisense RNA 1 (BFSP2-AS1, marker 1536), BFSP2 antisense RNA 1 (BFSP2-AS1, marker 1537), beta globin locus transcript 3 (non-protein coding)(BGLT3, marker 1538), biglycan(BGN, marker 1539), basic helix-loop-helix family, member a15(BHLHA15, marker 1540), basic helix-loop-helix family, member e22( BHLHE22, marker 1541), basic helix-loop-helix family, member e22(BHLHE22, marker 1542), basic helix-loop-helix family, member e23(BHLHE23, marker 1543), basic helix-loop-helix family, member e41 (BHLHE41, marker 1544), basic helix-loop-helix family, member e41(BHLHE41, marker 1545), basic helix-loop-helix family, member e41(BHLHE41, marker 1546), basic helix-loop-helix family, member e41 (BHLHE41, marker 1547), betaine--homocysteine S-methyltransferase 2 (BHMT2, marker 1548), betaine--homocysteine S-methyltransferase 2 (BHMT2, marker 1549), betaine--homocysteine S-methyltransferase 2 (BHMT2, marker 1550), BicC family RNA binding protein 1 (BICC1, marker 1551), bicaudal D homolog 2 (Drosophila) (BICD2, marker 1552), bridging integrator 2 (BIN2, marker 1553), BIN3 intronic transcript 1 (BIN3-IT1, marker 1554), baculoviral IAP repeat containing 3(BIRC3, marker 1555), bac
uloviral IAP repeat containing 3(BIRC3, marker 1556),baculoviral IAP repeat containing 7(BIRC7, marker 1557),BST2 interferon stimulated positive regulator (non-protein coding)(BISPR, marker 1558),basic, immunoglobulin-like variable motif containing (BIVM, marker 1559), basic, immunoglobulin-like variable motif containing(BIVM, marker 1560), basic, immunoglobulin-like variable motif containing(BIVM, marker 1561), bladder cancer associated protein /// uncharacterized LOC105372607 /// uncharacterized LOC105376973(BLCAP /// LOC105372607 /// LOC105376973, Marker 1562), BH3-like motif containing, cell death inducer(BLID, Marker 1563), BLK proto-oncogene, Src family tyrosine kinase(BLK, Marker 1564), BLK proto -oncogene, Src family tyrosine kinase(BLK, marker 1565),B-cell linker(BLNK,marker 1566),BLOC1S1-RDH5 readthrough /// retinol dehydrogenase 5 (11-cis/9-cis)(BLOC1S1-RDH5 // / RDH5, marker 1567), biogenesis of lysosomal organelles complex-1, subunit 3 (BLOC1S3, marker 1568), biliverdin reductase A (BLVRA, marker 1569), biliverdin reductase A (BLVRA, marker 1570), basic leucine zipper nuclear factor 1 (BLZF1, marker 1571), basic leucine zipper nuclear factor 1(BLZF1, marker 1572), bone morphogenetic protein 1(BMP1, marker 1573), bone morphogenetic protein 1(BMP1, marker 1574), bone morphogenetic protein 1(BMP1, marker 1575), bone morphogenetic protein 1 (BMP1, marker 1576), bone morphogenetic protein 10 (BMP10, marker 1577), bone morphogenetic protein 15 (BMP15, marker 1578), BMP2 inducible kinase (BMP2K, marker 1579), BMP2 inducible kinase( BMP2K, marker 1580), bone morphogenetic protein 3 (BMP3, marker 1581), bone morphogenetic protein 6 (BMP6, marker 1582), bone morphogenetic protein 6 (BMP6, marker 1583), bone morphogenetic protein 7 (BMP7, marker 1584), bone morphogenetic protein 8a (BMP8A, marker 1585), bone morphogenetic protein 8a (BMP8A, marker 1586), bone morphogenetic protein 8a (BMP8A, marker 1587), bone morphogenetic protein 8b (BMP8B, marker 1588), bone morphogenetic protein 8b (BMP8B) , marker 1589), bone morphogenetic protein 8b (BMP8B, marker 1590), BMP binding endothelial regulator (BMPER, marker 1591), bone morphogenetic protein receptor type IB (BMPR1B, marker 1592), BMS1 ribosome biogenesis factor pseudogene 17 /// BMS1 ribosome biogenesis factor pseudogene 18(BMS1P17 /// BMS1P18, marker 1593),BMS1 ribosome biogenesis factor pseudogene 20 /// immunoglobulin lambda constant 2 (Kern-Oz- marker) /// immunoglobulin lambda constant 3 (Kern-Oz+ marker) / // immunoglobulin lambda joining 2 /// immunoglobulin lambda joining 3 /// immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 1-44 /// immunoglobulin lambda variable 3-19 /// immunoglobulin lambda variable 3-25( BMS1P20 /// IGLC2 /// IGLC3 /// IGLJ2 /// IGLJ3 /// IGLL5 /// IGLV1-44 /// IGLV3-19 /// IGLV3-25, marker 1594), BMS1 ribosome biogenesis factor pseudogene 21 /// mannose-binding lectin (protein A) 1, pseudogene(BMS1P21 /// MBL1P, marker 1595), BMS1 ribosome biogenesis factor pseudogene 5(BMS1P5, marker 1596), BMX non-receptor tyrosine kinase(BMX, marker 1597) ,basonuclin 2(BNC2, marker 1598),BCL2/adenovirus E1B 19kD interacting protein like(BNIPL,marker 1599),BCL2/adenovirus E1B 19kD interacting protein like(BNIPL,marker 1600),biorientation of chromosomes in cell division 1-like 1 (BOD1L1, marker 1601), bioorientation of chromosomes in cell division 1-like 2 (BOD1L2, marker 1602), bolA family member 2 (BOLA2, marker 1603), BOLA3 antisense RNA 1 (head to head) (BOLA3-AS1, marker 1604), BOLA3 antisense RNA 1 (head to head) (BOLA3-AS1, marker 1605), boule homolog, RNA binding protein (BOLL, marker 1606), BLOC-1 related complex subunit 6 (BORCS6, marker 1607), BLOC- 1 related complex subunit 6(BORCS6, marker 1608), blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)(BPESC1, marker 1609), bactericidal/permeability-increasing protein(BPI, marker 1610), bactericidal/permeability -increasing protein /// uncharacterized LOC149684(BPI /// LOC149684, marker 1611),bactericidal/permeability-increasing protein /// uncharacterized LOC149684(BPI /// LOC149684, marker 1612),BPI fold containing family A, member 1( BPIFA1, marker 1613),BPI fold containing family A, member 2(BPIFA2, marker 1614),BPI fold containing family A, member 3(BPIFA3, marker 1615),BPI fold containing family A, member 4, pseudogene(BPIFA4P, marker 1616),BPI fold containing family B, member 1(BPIFB1, marker 1617),BPI fold containing family B, member 2(BPIFB2, marker 1618),BPI fold containing family B, member 4(BPIFB4, marker 1619),BPI fold containing family B, member 6(BPIFB6, marker 1620),BPI fold containing family C(BPIFC, marker 1621),3'(2'), 5'-bisphosphate nucleotidase 1(BPNT1, marker 1622),basic charge, Y- linked, 2(BPY2, marker 1623),bromodomain containing 3(BRD3,marker 1624),bromodomain containing 4(BRD4,marker 1625),bromodomain containing 4(BRD4,marker 1626),bromodomain containing 7 pseudogene 3(BRD7P3,marker 1627 ),bromodomain containing 7 pseudogene 3(BRD7P3, marker 1628),bromodomain containing 8(BRD8,marker 1629),bromodomain containing 8(BRD8,marker 1630),bromodomain, testis-specific(BRDT,marker 1631),BRE antisense RNA 1 (BRE-AS1, marker 1632),breast cancer estrogen-induced apoptosis 2(BREA2,marker 1633),BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit(BRF1,marker 1634),BRF1, RNA polymerase III transcription initiation factor 90 kDa subunit(BRF1, marker 1635), brain protein I3 /// uncharacterized LOC644975(BRI3 /// FLJ30064, marker 1636), bone morphogenetic protein/retinoic acid inducible neural-specific 1(BRINP1, marker 1637), bone morphogenetic protein/ retinoic acid inducible neural-specific 2(BRINP2, marker 1638), bone morphogenetic protein/retinoic acid inducible neural-specific 3(BRINP3, marker 1639), bromodomain and PHD finger containing 3(BRPF3, marker 1640), bombesin-like receptor 3 (BRS3, marker 1641), bombesin-like receptor 3 (BRS3, marker 1642), BR serine/threonine kinase 1 (BRSK1, marker 1643), BR serine/threonine kinase 2 (BRSK2, marker 1644), BR serine/threonine kinase 2(BRSK2, marker 1645),bromodomain and WD repeat domain containing 1(BRWD1, marker 1646),BRWD1 intronic transcript 2 (non-protein coding)(BRWD1-IT2, marker 1647),BSD domain containing 1(BSDC1, marker 1648) ), bassoon presynaptic cytomatrix protein (BSN, marker 1649), BSN antisense RNA 2 (head to head) (BSN-AS2, marker 1650), barttin CLCNK-type chloride channel accessory beta subunit (BSND, marker 1651), barttin CLCNK- type chloride channel accessory beta subunit(BSND, marker 1652),barttin CLCNK-type chloride channel accessory beta subunit(BSND, marker 1653),B-box and SPRY domain containing(BSPRY, marker 1654),BTB (POZ) domain containing 16 (BTBD16, marker 1655),BTB (POZ) domain containing 17(BTBD17, marker 1656),BTB (POZ) domain containing 18(BTBD18, marker 1657),BTB (POZ) domain containing 19(BTBD19, marker 1658),BTB (POZ) domain containing 19(BTBD19, marker 1659),BTB (POZ) domain containing 7(BTBD7, marker 1660),BTB (POZ) domain containing 8(BTBD8, marker 1661),BTB (POZ) domain containing 9(BTBD9 ,marker 1662),BTB (POZ) domain containing 9(BTBD9,marker 1663),BTB (POZ) domain containing 9(BTBD9,marker 1664),betacellulin(BTC,marker 1665),betacellulin(BTC,marker 1666),biotinidase (BTD, marker 1667), basic transcription factor 3(BTF3, marker 1668), basic transcription factor 3-like 4(BTF3L4, marker 1669), basic transcription factor 3-like 4(BTF3L4, marker 1670), basic transcription factor 3 pseudogene 11 (BTF3P11, marker 1671), B-cell translocation gene 1, anti-proliferative (BTG1, marker 1672), BTG family, member 3 (BTG3, marker 1673), B-cell translocation gene 4 (BTG4, marker 1674) ,B-cell translocation gene 4(BTG4, marker 1675),B-cell translocation gene 4 /// POU class 2 associating factor 1(BTG4 /// POU2AF1, marker 1676),Bruton agammaglobulinemia tyrosine kinase(BTK, marker 1677) ,B and T lymphocyte associated(BTLA, marker 1678),butyrophilin, subfamily 1, member A1(BTN1A1, marker 1679),butyrophilin, subfamily 2, member A1(BTN2A1, marker 1680),butyrophilin, subfamily 2, member A2(BTN2A2) , marker 1681), butyrophilin, subfamily 2, member A2(BTN2A2, marker 1682), butyrophilin, subfamily 2, member A3, pseudogene(BTN2A3P, marker 1683), butyrophilin, subfamily 3, member A1(BTN3A1, marker 1684), butyrophilin , subfamily 3, member A2(BTN3A2, marker 1685),butyrophilin, subfamily 3, member A3(BTN3A3, marker 1686),butyrophilin, subfamily 3, member A3(BTN3A3, marker 1687),butyrophilin-like 2(BTNL2, marker 1688 ), butyrophilin-like 3 (BTNL3, marker 1689), butyrophilin-like 8 (BTNL8, marker 1690), butyrophilin-like 9 (BTNL9, marker 1691), butyrophilin-like 9 (BTNL9, marker 1692), butyrophilin-like 9 (BTNL9, marker 1693), butyrophilin-like 9(BTNL9, marker 1694), butyrophilin-like 9(BTNL9, marker 1695), beta-transducin repeat containing E3 ubiquitin protein ligase(BTRC, marker 1696), beta-transducin repeat containing E3 ubiquitin protein ligase (BTRC, marker 1697), BUB1 mitotic checkpoint serine/threonine kinase (BUB1, marker 1698), BUB1 mitotic checkpoint serine/threonine kinase (BUB1, marker 1699), BUB1 mitotic checkpoint serine/threonine kinase (BUB1, marker 1700), BUB3 mitotic checkpoint protein (BUB3, marker 1701), BUB3 mitotic checkpoint protein (BUB3, marker 1702), BUD31 homolog (BUD31, marker 1703), blood vessel epicardial substance (BVES, marker 1704), BVES antisense RNA 1( BVES-AS1, marker 1705), BZRAP1 antisense RNA 1 (BZRAP1-AS1, marker 1706), BZRAP1 antisense RNA 1 (BZRAP1-AS1, marker 1707), chromosome 10 open reading frame 10 (C10orf10, marker 1708), chromosome 10 open reading frame 10(C10orf10, marker 1709),chromosome 10 open reading frame 107(C10orf107,marker 1710),chromosome 10 open reading frame 11(C10orf11,marker 1711),chromosome 10 open reading frame 113(C10orf113,marker 1712),chromosome 10 open reading frame 12(C10orf12, marker 1713),chromosome 10 open reading frame 126(C10orf126, marker 1714),chromosome 10 open reading frame 128(C10orf128,marker 1715),chromosome 10 open reading frame 128(C10orf128,marker 1716) ,chromosome 10 open reading frame 25(C10orf25,marker 1717),chromosome 10 open reading frame 53(C10orf53,marker 1718),chromosome 10 open reading frame 53(C10orf53,marker 1719),chromosome 10 open reading frame 54(C10orf54,marker 1720),chromosome 10 open reading frame 54(C10orf54, marker 1721)
,chromosome 10 open reading frame 55(C10orf55,marker 1722),chromosome 10 open reading frame 62(C10orf62,marker 1723),chromosome 10 open reading frame 67(C10orf67,marker 1724),chromosome 10 open reading frame 67(C10orf67,marker 1725),chromosome 10 open reading frame 67(C10orf67, marker 1726),chromosome 10 open reading frame 71(C10orf71,marker 1727),C10orf71 antisense RNA 1(C10orf71-AS1,marker 1728),chromosome 10 open reading frame 90(C10orf90 ,marker 1729),chromosome 10 open reading frame 90(C10orf90,marker 1730),chromosome 10 open reading frame 90(C10orf90,marker 1731),chromosome 10 open reading frame 91(C10orf91,marker 1732),chromosome 10 open reading frame 95 (C10orf95, marker 1733),chromosome 10 open reading frame 99(C10orf99,marker 1734),chromosome 10 open reading frame 99(C10orf99,marker 1735),chromosome 11 open reading frame 1(C11orf1,marker 1736),chromosome 11 open reading frame 16(C11orf16, marker 1737),chromosome 11 open reading frame 21(C11orf21,marker 1738),chromosome 11 open reading frame 21(C11orf21,marker 1739),chromosome 11 open reading frame 40(C11orf40,marker 1740),chromosome 11 open reading frame 42(C11orf42, marker 1741),chromosome 11 open reading frame 44(C11orf44,marker 1742),chromosome 11 open reading frame 45(C11orf45,marker 1743),chromosome 11 open reading frame 49(C11orf49,marker 1744), chromosome 11 open reading frame 53(C11orf53, marker 1745),chromosome 11 open reading frame 54(C11orf54, marker 1746),chromosome 11 open reading frame 57(C11orf57, marker 1747),chromosome 11 open reading frame 57(C11orf57, marker 1748 ),chromosome 11 open reading frame 58(C11orf58,marker 1749),chromosome 11 open reading frame 58(C11orf58,marker 1750),chromosome 11 open reading frame 63(C11orf63,marker 1751),chromosome 11 open reading frame 63(C11orf63, marker 1752),chromosome 11 open reading frame 65(C11orf65,marker 1753),chromosome 11 open reading frame 70(C11orf70,marker 1754),chromosome 11 open reading frame 70(C11orf70,marker 1755),chromosome 11 open reading frame 72( C11orf72, marker 1756),chromosome 11 open reading frame 85(C11orf85,marker 1757),chromosome 11 open reading frame 86(C11orf86,marker 1758),chromosome 11 open reading frame 87(C11orf87,marker 1759),chromosome 11 open reading frame 87(C11orf87, marker 1760),chromosome 11 open reading frame 87(C11orf87,marker 1761),chromosome 11 open reading frame 88(C11orf88,marker 1762),chromosome 11 open reading frame 94(C11orf94,marker 1763),chromosome 11 open reading frame 95(C11orf95, marker 1764),chromosome 11 open reading frame 97(C11orf97, marker 1765),chromosome 12 open reading frame 40(C12orf40,marker 1766),chromosome 12 open reading frame 40(C12orf40,marker 1767),chromosome 12 open reading frame 42(C12orf42, marker 1768),chromosome 12 open reading frame 42(C12orf42, marker 1769),chromosome 12 open reading frame 49(C12orf49, marker 1770),chromosome 12 open reading frame 49(C12orf49, marker 1771) ,chromosome 12 open reading frame 50(C12orf50,marker 1772),chromosome 12 open reading frame 54(C12orf54,marker 1773),chromosome 12 open reading frame 54(C12orf54,marker 1774),chromosome 12 open reading frame 54(C12orf54,marker 1775),chromosome 12 open reading frame 60(C12orf60,marker 1776),chromosome 12 open reading frame 65(C12orf65,marker 1777),chromosome 12 open reading frame 66(C12orf66,marker 1778),chromosome 12 open reading frame 74(C12orf74) ,marker 1779),chromosome 12 open reading frame 76(C12orf76,marker 1780),chromosome 12 open reading frame 77(C12orf77,marker 1781),chromosome 12 open reading frame 80(C12orf80,marker 1782),chromosome 12 open reading frame 80 (C12orf80, marker 1783),chromosome 14 open reading frame 1(C14orf1,marker 1784),chromosome 14 open reading frame 105(C14orf105,marker 1785),chromosome 14 open reading frame 105(C14orf105,marker 1786),chromosome 14 open reading frame 105(C14orf105, marker 1787),chromosome 14 open reading frame 159(C14orf159, marker 1788),chromosome 14 open reading frame 178(C14orf178, marker 1789),chromosome 14 open reading frame 180(C14orf180, marker 1790),chromosome 14 open reading frame 180(C14orf180, marker 1791),chromosome 14 open reading frame 39(C14orf39,marker 1792),chromosome 14 open reading frame 80(C14orf80,marker 1793),chromosome 14 open reading frame 93(C14orf93,marker 1794), chromosome 15 open reading frame 32(C15orf32, marker 1795),chromosome 15 open reading frame 39(C15orf39, marker 1796),chromosome 15 open reading frame 40(C15orf40, marker 1797),chromosome 15 open reading frame 41(C15orf41, marker 1798 ),chromosome 15 open reading frame 43(C15orf43,marker 1799),chromosome 15 open reading frame 48(C15orf48,marker 1800),chromosome 15 open reading frame 52(C15orf52,marker 1801),chromosome 15 open reading frame 54(C15orf54, marker 1802),chromosome 15 open reading frame 56(C15orf56,marker 1803),chromosome 15 open reading frame 57(C15orf57,marker 1804),chromosome 15 open reading frame 57(C15orf57,marker 1805),chromosome 15 open reading frame 59( C15orf59, marker 1806),chromosome 15 open reading frame 62(C15orf62,marker 1807),chromosome 15 open reading frame 62(C15orf62,marker 1808),chromosome 15 open reading frame 65(C15orf65,marker 1809),chromosome 16 open reading frame 13(C16orf13, marker 1810),chromosome 16 open reading frame 13(C16orf13,marker 1811),chromosome 16 open reading frame 45(C16orf45,marker 1812),chromosome 16 open reading frame 46(C16orf46,marker 1813),chromosome 16 open reading frame 52(C16orf52, marker 1814),chromosome 16 open reading frame 54 /// transmembrane protein C16orf54(C16orf54 /// LOC105369277, marker 1815),chromosome 16 open reading frame 62(C16orf62, marker 1816),chromosome 16 open reading frame 70(C16orf70, marker 1817),chromosome 16 open reading frame 70(C16orf70,marker 1818),chromosome 16 open reading frame 71(C16orf71,marker 1819),chromosome 16 open reading frame 78(C16orf78,marker 1820),chromosome 16 open reading frame 82(C16orf82, marker 1821),chromosome 16 open reading frame 87(C16orf87,marker 1822),chromosome 16 open reading frame 92(C16orf92,marker 1823),chromosome 16 open reading frame 95(C16orf95,marker 1824), chromosome 17 open reading frame 105(C17orf105, marker 1825),chromosome 17 open reading frame 47(C17orf47, marker 1826),chromosome 17 open reading frame 50(C17orf50, marker 1827),chromosome 17 open reading frame 51(C17orf51, marker 1828) ),chromosome 17 open reading frame 51(C17orf51,marker 1829),chromosome 17 open reading frame 51(C17orf51,marker 1830),chromosome 17 open reading frame 51(C17orf51,marker 1831),chromosome 17 open reading frame 53(C17orf53, marker 1832),chromosome 17 open reading frame 64(C17orf64,marker 1833),chromosome 17 open reading frame 67(C17orf67,marker 1834),chromosome 17 open reading frame 74(C17orf74,marker 1835),chromosome 17 open reading frame 77( C17orf77, marker 1836),chromosome 17 open reading frame 78(C17orf78,marker 1837),chromosome 17 open reading frame 89(C17orf89,marker 1838),chromosome 17 open reading frame 89(C17orf89,marker 1839),chromosome 17 open reading frame 98(C17orf98, marker 1840),chromosome 17 open reading frame 99(C17orf99,marker 1841),chromosome 18 open reading frame 12(C18orf12,marker 1842),chromosome 18 open reading frame 15(C18orf15,marker 1843),chromosome 18 open reading frame 21(C18orf21, marker 1844),chromosome 18 open reading frame 25(C18orf25, marker 1845),chromosome 18 open reading frame 25(C18orf25, marker 1846),chromosome 18 open reading frame 25(C18orf25, marker 1847),chromosome 18 open reading frame 42(C18orf42, marker 1848),chromosome 18 open reading frame 54(C18orf54, marker 1849),uncharacterized LOC497259 /// uncharacterized LOC102724470(C18orf61 /// LOC102724470,marker 1850),chromosome 18 open reading frame 8( C18orf8, marker 1851),chromosome 18 open reading frame 8(C18orf8,marker 1852),chromosome 19 open reading frame 12(C19orf12,marker 1853),chromosome 19 open reading frame 18(C19orf18,marker 1854),chromosome 19 open reading frame 25(C19orf25, marker 1855),chromosome 19 open reading frame 43(C19orf43,marker 1856),chromosome 19 open reading frame 44(C19orf44,marker 1857),chromosome 19 open reading frame 45(C19orf45,marker 1858),chromosome 19 open reading frame 45(C19orf45, marker 1859),chromosome 19 open reading frame 47(C19orf47, marker 1860),chromosome 19 open reading frame 47(C19orf47, marker 1861),chromosome 19 open reading frame 57(C19orf57, marker 1862),chromosome 19 open reading frame 73(C19orf73, marker 1863),chromosome 19 open reading frame 81(C19orf81, marker 1864),chromosome 19 open reading frame 84(C19orf84, marker 1865),C1GALT1 specific chaperone 1(C1GALT1C1,marker 1866),C1GALT1 -specific chaperone 1 like(C1GALT1C1L, marker 1867),complement component 1, q subcomponent, A chain(C1QA,marker 1868),complement component 1, q subcomponent, B chain(C1QB,marker 1869),complement component 1, q subcomponent , C chain(C1QC, marker 1870),complement component 1, q subcomponent-like 1(C1QL1,marker 1871),complement component 1, q subcomponent-like 1(C1QL1,marker 1872),C1q and tumor necrosis factor related protein 1 (C1QTNF1, marker 1873), C1QTNF1 antisense RNA 1 (C1QTNF1-AS1, marker 1874), C1q and tumor necrosis factor related protein 2 (C1QTNF2, marker 1875), C1q and tumor necrosis factor related protein 3 (C1QTNF3, marker 1876), C1q and tumor necrosis factor related protein 3(C1QTNF3, marker 1877),C1q and tumor necrosis factor related protein 4(C1QTNF4, marker 1878),C1q and tumor necrosis factor related protein 5 /// membrane frizzled-related protein(C1QTNF5 // / MFRP, marker 1879), C1q and tumor necrosis factor related protein 6 (C1QTNF6, marker 1880), C1q and tumor necrosis factor related protein 6 (C1QTNF6, marker 1881), C1q and tumor necrosis factor related protein 7 (C1QTNF7, marker 1882) ),C1q and tumor necrosis factor related protein 7(C1QTNF7, marker 1883),C1q and tumor necrosis factor related protein 9(C1QTNF9, marker 1884),C1RL antisense RNA 1(C1RL-AS1,marker 1885),C1RL antisense RNA 1( C1RL-AS1, Marker 1886), complement component 1, s subcomponent(C1S, Marker 1887), chromosome 1 open reading frame 100(C1orf100, Marker 1888), chromosome 1 open reading frame 101(C1orf101, Marker 1889), chromosome 1 open reading frame 101(C1orf101, marker 1890),chromosome 1 open
reading frame 105(C1orf105, marker 1891),chromosome 1 open reading frame 111(C1orf111, marker 1892),chromosome 1 open reading frame 115(C1orf115, marker 1893),chromosome 1 open reading frame 116(C1orf116, marker 1894),chromosome 1 open reading frame 116(C1orf116, marker 1895),chromosome 1 open reading frame 127(C1orf127,marker 1896),chromosome 1 open reading frame 132(C1orf132,marker 1897),chromosome 1 open reading frame 145(C1orf145,marker 1898) ,chromosome 1 open reading frame 145(C1orf145,marker 1899),chromosome 1 open reading frame 158(C1orf158,marker 1900),chromosome 1 open reading frame 162(C1orf162,marker 1901),chromosome 1 open reading frame 168(C1orf168,marker 1902),chromosome 1 open reading frame 168(C1orf168,marker 1903),chromosome 1 open reading frame 186(C1orf186,marker 1904),chromosome 1 open reading frame 186(C1orf186,marker 1905),chromosome 1 open reading frame 186 // / uncharacterized LOC100505650(C1orf186 /// LOC100505650,marker 1906),chromosome 1 open reading frame 194(C1orf194,marker 1907),chromosome 1 open reading frame 204(C1orf204,marker 1908),chromosome 1 open reading frame 21(C1orf21,marker 1909),chromosome 1 open reading frame 21(C1orf21,marker 1910),chromosome 1 open reading frame 220(C1orf220,marker 1911),chromosome 1 open reading frame 228(C1orf228,marker 1912),chromosome 1 open reading frame 228(C1orf228 ,marker 1913),chromosome 1 open reading frame 228(C1orf228,marker 1914),chromosome 1 open reading frame 228(C1orf228,marker 1915),chromosome 1 open reading frame 228(C1orf228,marker 1916),chromosome 1 open reading frame 234 (C1orf234, marker 1917),chromosome 1 open reading frame 27(C1orf27,marker 1918),chromosome 1 open reading frame 53(C1orf53,marker 1919),chromosome 1 open reading frame 56(C1orf56,marker 1920),chromosome 1 open reading frame 56(C1orf56, marker 1921),chromosome 1 open reading frame 61(C1orf61,marker 1922),chromosome 1 open reading frame 61(C1orf61,marker 1923),chromosome 1 open reading frame 61(C1orf61,marker 1924),chromosome 1 open reading frame 64(C1orf64, marker 1925),chromosome 1 open reading frame 68(C1orf68,marker 1926),chromosome 1 open reading frame 68(C1orf68,marker 1927),chromosome 1 open reading frame 87(C1orf87,marker 1928), chromosome 1 open reading frame 95(C1orf95, marker 1929),chromosome 1 open reading frame 95(C1orf95, marker 1930),complement component 2(C2, marker 1931),complement component 2(C2,marker 1932),chromosome 20 open reading frame 141(C20orf141, marker 1933),chromosome 20 open reading frame 144(C20orf144, marker 1934),C20orf166 antisense RNA 1(C20orf166-AS1,marker 1935),C20orf166 antisense RNA 1(C20orf166-AS1,marker 1936),chromo some 20 open reading frame 173(C20orf173, marker 1937),chromosome 20 open reading frame 181(C20orf181,marker 1938),chromosome 20 open reading frame 187(C20orf187,marker 1939),chromosome 20 open reading frame 195(C20orf195,marker 1940), chromosome 20 open reading frame 196(C20orf196, marker 1941),chromosome 20 open reading frame 197(C20orf197, marker 1942),chromosome 20 open reading frame 202(C20orf202, marker 1943),chromosome 20 open reading frame 202(C20orf202, marker 1944 ),chromosome 20 open reading frame 203(C20orf203,marker 1945),chromosome 20 open reading frame 203(C20orf203,marker 1946),chromosome 20 open reading frame 57 /// dual specificity phosphatase 15(C20orf57 /// DUSP15,marker 1947 ),chromosome 20 open reading frame 78(C20orf78,marker 1948),chromosome 20 open reading frame 85(C20orf85,marker 1949),chromosome 20 open reading frame 96(C20orf96,marker 1950),C21ORF116(marker 1951),chromosome 21 open reading frame 2(C21orf2, marker 1952),chromosome 21 open reading frame 2(C21orf2,marker 1953),chromosome 21 open reading frame 2(C21orf2,marker 1954),chromosome 21 open reading frame 2(C21orf2,marker 1955),chromosome 21 open reading frame 2(C21orf2, marker 1956),chromosome 21 open reading frame 58(C21orf58, marker 1957),chromosome 21 open reading frame 58(C21orf58, marker 1958),chromosome 21 open reading frame 58(C21orf58, marker 1959) ,chromosome 21 open reading frame 59(C21orf59,marker 1960),chromosome 21 open reading frame 62(C21orf62,marker 1961),chromosome 21 open reading frame 62(C21orf62,marker 1962),C21orf62 antisense RNA 1(C21orf62-AS1,marker 1963),C21orf62 antisense RNA 1(C21orf62-AS1, marker 1964),C21orf91 overlapping transcript 1(C21orf91-OT1,marker 1965),C21orf91 overlapping transcript 1(C21orf91-OT1,marker 1966),chromosome 22 open reading frame 15(C22orf15 ,marker 1967),chromosome 22 open reading frame 15(C22orf15,marker 1968),chromosome 22 open reading frame 23(C22orf23,marker 1969),chromosome 22 open reading frame 24(C22orf24,marker 1970),chromosome 22 open reading frame 31 (C22orf31, marker 1971),chromosome 22 open reading frame 34(C22orf34,marker 1972),chromosome 22 open reading frame 34(C22orf34,marker 1973),chromosome 22 open reading frame 42(C22orf42,marker 1974),chromosome 22 open reading frame 42(C22orf42, marker 1975),chromosome 22 open reading frame 46(C22orf46, marker 1976),C2CD2-like(C2CD2L,marker 1977),C2CD2-like(C2CD2L,marker 1978),C2 calcium-dependent domain containing 3( C2CD3, marker 1979),C2 calcium-dependent domain containing 4A(C2CD4A, marker 1980),C2 calcium-dependent domain containing 4B(C2CD4B, marker 1981),C2 calcium-dependent domain containing 4B(C2CD4B, marker 1982),chromosome 2 open reading frame 15(C2orf15, marker 1983),chromosome 2 open reading frame 27A(C2orf27A,marker 1984),chromosome 2 open reading frame 50(C2orf50,marker 1985),chromosome 2 open reading frame 54(C2orf54,marker 1986), chromosome 2 open reading frame 57(C2orf57, marker 1987),chromosome 2 open reading frame 61(C2orf61, marker 1988),chromosome 2 open reading frame 70(C2orf70,marker 1989),chromosome 2 open reading frame 71(C2orf71,marker 1990 ),chromosome 2 open reading frame 72(C2orf72,marker 1991),chromosome 2 open reading frame 73(C2orf73,marker 1992),chromosome 2 open reading frame 80(C2orf80,marker 1993),chromosome 2 open reading frame 82(C2orf82, marker 1994),chromosome 2 open reading frame 82(C2orf82,marker 1995),chromosome 2 open reading frame 83(C2orf83,marker 1996),chromosome 2 open reading frame 88(C2orf88,marker 1997),chromosome 2 open reading frame 88( C2orf88, marker 1998), complement component 3 (C3, marker 1999), complement component 3a receptor 1 (C3AR1, marker 2000), complement component 3 precursor pseudogene (C3P1, marker 2001), chromosome 3 open reading frame 14 (C3orf14, marker 2002),chromosome 3 open reading frame 20(C3orf20,marker 2003),chromosome 3 open reading frame 22(C3orf22,marker 2004),chromosome 3 open reading frame 30(C3orf30,marker 2005),chromosome 3 open reading frame 33(C3orf33) ,marker 2006),chromosome 3 open reading frame 35(C3orf35,marker 2007),chromosome 3 open reading frame 36(C3orf36,marker 2008),chromosome 3 open reading frame 49(C3orf49,marker 2009),chromosome 3 open reading frame 52 (C3orf52, marker 2010),chromosome 3 open reading frame 56(C3orf56,marker 2011),chromosome 3 open reading frame 58(C3orf58,marker 2012),chromosome 3 open reading frame 58(C3orf58,marker 2013),chromosome 3 open reading frame 62(C3orf62, marker 2014),chromosome 3 open reading frame 62(C3orf62,marker 2015),chromosome 3 open reading frame 67(C3orf67,marker 2016),chromosome 3 open reading frame 70(C3orf70,marker 2017),chromosome 3 open reading frame 79(C3orf79, marker 2018),chromosome 3 open reading frame 80(C3orf80,marker 2019),complement component 4A (Rodgers blood group) /// complement component 4B (Chido blood group) /// complement component 4B ( Chido blood group), copy 2(C4A /// C4B /// C4B_2, Marker 2020), complement component 4A (Rodgers blood group) /// complement component 4B (Chido blood group) /// complement component 4B (Chido blood group), copy 2(C4A /// C4B /// C4B_2, Marker 2021), complement component 4A (Rodgers blood group) /// complement component 4B (Chido blood group) /// complement component 4B (Chido blood group) , copy 2(C4A /// C4B /// C4B_2, marker 2022),complement component 4 binding protein, alpha(C4BPA,marker 2023),complement component 4 binding protein, beta(C4BPB,marker 2024),chromosome 4 open reading frame 17(C4orf17, marker 2025),chromosome 4 open reading frame 19(C4orf19,marker 2026),chromosome 4 open reading frame 22(C4orf22,marker 2027),chromosome 4 open reading frame 26(C4orf26,marker 2028),chromosome 4 open reading frame 27(C4orf27, marker 2029),chromosome 4 open reading frame 33(C4orf33,marker 2030),chromosome 4 open reading frame 33(C4orf33,marker 2031),chromosome 4 open reading frame 36(C4orf36,marker 2032), chromosome 4 open reading frame 45 (C4orf45, marker 2033), chromosome 4 open reading frame 47 (C4orf47, marker 2034), chromosome 4 open reading frame 47 (C4orf47, marker 2035), complement component 5a receptor 1 (C5AR1, marker 2036) ,complement component 5a receptor 2(C5AR2, marker 2037),chromosome 5 open reading frame 17(C5orf17,marker 2038),chromosome 5 open reading frame 22(C5orf22,marker 2039),chromosome 5 open reading frame 28(C5orf28,marker 2040) ),chromosome 5 open reading frame 42(C5orf42,marker 2041),chromosome 5 open reading frame 46(C5orf46,marker 2042),chromosome 5 open reading frame 47(C5orf47,marker 2043),chromosome 5 open reading frame 47(C5orf47, marker 2044),chromosome 5 open reading frame 49(C5orf49,marker 2045),chromosome 5 open reading frame 51(C5orf51,marker 2046),chromosome 5 open reading frame 56(C5orf56,marker 2047),chromosome 5 open reading frame 56( C5orf56, marker 2048),chromosome 5 open reading frame 56(C5orf56,marker 2049),chromosome 5 open reading frame 56(C5orf56,marker 2050),chromosome 5 open reading frame 58(C5orf58,marker 2051),chromosome 5 open reading frame 58(C5orf58, marker 2052),chromosome 5 open reading frame 58(C5orf58,marker 2053),chromosome 5 open reading frame 63(C5orf63,marker 2054),chromosome 5 open reading frame 63(C5orf63,marker 2055),chromosome 5 open reading frame 63(C5orf63, marker 2056),chromosome 5 open reading frame 63(C5orf63,marker 2057),chromosome 5 open reading frame 64(C5orf64,marker 2058),C5orf66 antisense RNA 1(C5orf66-AS1,marker 2059),complement component 6(C6, marker 2060),chromosome 6 open reading frame 10(C6orf10,marker 2061),chromosome 6 o
pen reading frame 118(C6orf118, marker 2062),chromosome 6 open reading frame 118(C6orf118,marker 2063),chromosome 6 open reading frame 15(C6orf15,marker 2064),chromosome 6 open reading frame 163(C6orf163,marker 2065), chromosome 6 open reading frame 163(C6orf163, marker 2066),chromosome 6 open reading frame 183 /// transmembrane protein FLJ37396(C6orf183 /// LOC100996634, marker 2067),chromosome 6 open reading frame 201(C6orf201, marker 2068),chromosome 6 open reading frame 223(C6orf223, marker 2069),chromosome 6 open reading frame 25(C6orf25,marker 2070),chromosome 6 open reading frame 52(C6orf52,marker 2071),chromosome 6 open reading frame 52(C6orf52,marker 2072) ,chromosome 6 open reading frame 52(C6orf52,marker 2073),chromosome 6 open reading frame 58(C6orf58,marker 2074),chromosome 6 open reading frame 58(C6orf58,marker 2075),chromosome 6 open reading frame 89(C6orf89,marker 2076),chromosome 6 open reading frame 99(C6orf99, marker 2077),complement component 7(C7,marker 2078),complement component 7(C7,marker 2079),chromosome 7 open reading frame 26(C7orf26,marker 2080),chromosome 7 open reading frame 33(C7orf33, marker 2081),chromosome 7 open reading frame 34(C7orf34,marker 2082),chromosome 7 open reading frame 34(C7orf34,marker 2083),chromosome 7 open reading frame 49(C7orf49,marker 2084) ,chromosome 7 open reading frame 50(C7orf50,marker 2085),chromosome 7 open reading frame 50(C7orf50,marker 2086),chromosome 7 open reading frame 61(C7orf61,marker 2087),chromosome 7 open reading frame 62(C7orf62,marker 2088),chromosome 7 open reading frame 69(C7orf69,marker 2089),chromosome 7 open reading frame 71(C7orf71,marker 2090),chromosome 7 open reading frame 73 /// uncharacterized LOC105375521 /// solute carrier family 13 (sodium/ sulfate symporter), member 4(C7orf73 /// LOC105375521 /// SLC13A4, marker 2091), chromosome 7 open reading frame 77(C7orf77, marker 2092), complement component 8, alpha polypeptide(C8A, marker 2093), complement component 8 , beta polypeptide(C8B, marker 2094),complement component 8, gamma polypeptide(C8G,marker 2095),chromosome 8 open reading frame 17(C8orf17,marker 2096),chromosome 8 open reading frame 22(C8orf22,marker 2097),chromosome 8 open reading frame 31(C8orf31, marker 2098),chromosome 8 open reading frame 34(C8orf34,marker 2099),chromosome 8 open reading frame 34(C8orf34,marker 2100),C8orf34 antisense RNA 1(C8orf34-AS1,marker 2101) ,chromosome 8 open reading frame 44(C8orf44,marker 2102),chromosome 8 open reading frame 46(C8orf46,marker 2103),chromosome 8 open reading frame 46(C8orf46,marker 2104),chromosome 8 open reading frame 46(C8orf46,marker 2105),chromosome 8 open reading frame 49(C8orf49,marker 2106),chromosome 8 open reading frame 58(C8orf58,marker 2107),chromosome 8 open reading frame 74(C8orf74,marker 2108),chromosome 8 open reading frame 74(C8orf74 ,marker 2109),complement component 9(C9,marker 2110),chromosome 9 open reading frame 131(C9orf131,marker 2111),C9orf135 antisense RNA 1 (head to head)(C9orf135-AS1,marker 2112),chromosome 9 open reading frame 152(C9orf152, marker 2113),chromosome 9 open reading frame 16(C9orf16, marker 2114),chromosome 9 open reading frame 163(C9orf163,marker 2115),chromosome 9 open reading frame 172(C9orf172,marker 2116),C9orf173 antisense RNA 1(C9orf173-AS1, marker 2117),C9orf173 antisense RNA 1 /// family with sequence similarity 166, member A(C9orf173-AS1 /// FAM166A, marker 2118),chromosome 9 open reading frame 24(C9orf24, marker 2119 ),chromosome 9 open reading frame 3(C9orf3, marker 2120),chromosome 9 open reading frame 3(C9orf3,marker 2121),chromosome 9 open reading frame 3(C9orf3,marker 2122),C9orf41 antisense RNA 1(C9orf41-AS1, marker 2123),chromosome 9 open reading frame 43(C9orf43,marker 2124),chromosome 9 open reading frame 47(C9orf47,marker 2125),chromosome 9 open reading frame 47(C9orf47,marker 2126),chromosome 9 open reading frame 50( C9orf50, marker 2127),chromosome 9 open reading frame 57(C9orf57,marker 2128),chromosome 9 open reading frame 62(C9orf62,marker 2129),chromosome 9 open reading frame 66(C9orf66,marker 2130),chromosome 9 open reading frame 66(C9orf66, marker 2131),chromosome 9 open reading frame 72(C9orf72,marker 2132),chromosome 9 open reading frame 84(C9orf84,marker 2133),chromosome 9 open reading frame 84(C9orf84,marker 2134),chromosome 9 open reading frame 85(C9orf85, marker 2135),chromosome 9 open reading frame 9(C9orf9,marker 2136),chromosome 9 open reading frame 9(C9orf9,marker 2137),carbonic anhydrase I(CA1,marker 2138),carbonic anhydrase I( CA1, marker 2139), carbonic anhydrase X (CA10, marker 2140), carbonic anhydrase X (CA10, marker 2141), carbonic anhydrase CA12, marker 2144), carbonic anhydrase XII (CA12, marker 2145), carbonic anhydrase VB, mitochondrial (CA5B, marker 2149), carbonic anhydrase VI (CA6, marker 2150), carbonic anhydrase VI (CA6, marker 2151), carbonic anhydrase VII (CA7, marker 2152), carbonic anhydrase VIII (CA8, marker 2153), carbonic anhydrase VIII (CA8, marker 2154), carbonic anhydrase IX (CA9, marker 2155), calcium binding protein 39-like (CAB39L, marker 2156), Cdk5 and Abl enzyme substrate 1 (CABLES1, marker 2157), calcium binding protein 1 (CABP1, marker 2158), calcium binding protein 1 (CABP1, marker 2159), calcium binding protein 1 (CABP1, marker 2160), calcium binding protein 2 (CABP2, marker 2161), calcium binding protein 4 (CABP4, marker 2162) ,calcium binding protein 4(CABP4, marker 2163),calcium binding protein 4(CABP4,marker 2164),calcium binding protein 5(CABP5,marker 2165),calcium binding protein 7(CABP7,marker 2166),calcium binding protein 7( CABP7, marker 2167), calcium-binding protein, spermatid-specific 1(CABS1, marker 2168), cache domain containing 1(CACHD1, marker 2169), calcium channel, voltage-dependent, P/Q type, alpha 1A subunit(CACNA1A , marker 2170),calcium channel, voltage-dependent, P/Q type, alpha 1A subunit(CACNA1A,marker 2171),calcium channel, voltage-dependent, P/Q type, alpha 1A subunit(CACNA1A,marker 2172),calcium channel, voltage-dependent, P/Q type, alpha 1A subunit(CACNA1A, marker 2173),calcium channel, voltage-dependent, N type, alpha 1B subunit(CACNA1B, marker 2174),calcium channel, voltage-dependent, N type , alpha 1B subunit(CACNA1B, marker 2175),calcium channel, voltage-dependent, L type, alpha 1C subunit(CACNA1C,marker 2176),calcium channel, voltage-dependent, L type, alpha 1C subunit(CACNA1C,marker 2177) ,calcium channel, voltage-dependent, L type, alpha 1C subunit(CACNA1C, marker 2178),calcium channel, voltage-dependent, L type, alpha 1C subunit(CACNA1C, marker 2179),calcium channel, voltage-dependent, L type , alpha 1D subunit(CACNA1D, marker 2180),calcium channel, voltage-dependent, L type, alpha 1D subunit(CACNA1D,marker 2181),calcium channel, voltage-dependent, L type, alpha 1D subunit(CACNA1D,marker 2182) ,calcium channel, voltage-dependent, L type, alpha 1D subunit(CACNA1D, marker 2183),calcium channel, voltage-dependent, R type, alpha 1E subunit(CACNA1E,marker 2184),calcium channel, voltage-dependent, R type , alpha 1E subunit(CACNA1E, marker 2185),calcium channel, voltage-dependent, R type, alpha 1E subunit(CACNA1E,marker 2186),calcium channel, voltage-dependent, R type, alpha 1E subunit(CACNA1E,marker 2187) ,calcium channel, voltage-dependent, R type, alpha 1E subunit(CACNA1E, marker 2188),calcium channel, voltage-dependent, R type, alpha 1E subunit(CACNA1E,marker 2189),calcium channel, voltage-dependent, L type , alpha 1F subunit(CACNA1F, marker 2190),calcium channel, voltage-dependent, T type, alpha 1G subunit(CACNA1G,marker 2191),calcium channel, voltage-dependent, T type, alpha 1G subunit(CACNA1G,marker 2192) ,calcium channel, voltage-dependent, T type, alpha 1G subunit(CACNA1G,marker 2193),calcium channel, voltage-dependent, T type, alpha 1G subunit(CACNA1G,marker 2194),calcium channel, voltage-dependent, T type , alpha 1G subunit(CACNA1G, marker 2195),CACNA1G antisense RNA 1(CACNA1G-AS1,marker 2196),calcium channel, voltage-dependent, T type, alpha 1H subunit(CACNA1H,marker 2197),calcium channel, voltage-dependent , T type, alpha 1H subunit(CACNA1H, marker 2198),calcium channel, voltage-dependent, T type, alpha 1I subunit(CACNA1I,marker 2199),calcium channel, voltage-dependent, T type, alpha 1I subunit(CACNA1I, marker 2200),calcium channel, voltage-dependent, T type, alpha 1I subunit(CACNA1I,marker 2201),calcium channel, voltage-dependent, L type, alpha 1S subunit(CACNA1S,marker 2202),calcium channel, voltage-dependent , alpha 2/delta subunit 1(CACNA2D1, marker 2203),calcium channel, voltage-dependent, alpha 2/delta subunit 4(CACNA2D4, marker 2204),calcium channel, voltage-dependent, alpha 2/delta subunit 4(CACNA2D4, marker 2205),calcium channel, voltage-dependent, beta 1 subunit(CACNB1,marker 2206),calcium channel, voltage-dependent, beta 1 subunit(CACNB1,marker 2207),calcium channel, voltage-dependent, beta 1 subunit(CACNB1 , marker 2208),calcium channel, voltage-dependent, beta 2 subunit(CACNB2,marker 2209),calcium channel, voltage-dependent, beta 2 subunit(CACNB2,marker 2210),calcium channel, voltage-dependent, beta 2 subunit( CACNB2, marker 2211), calcium channel, voltage-dependent, beta 2 subunit(CACNB2, marker 2212), calcium channel, voltage-dependent, beta 4 subunit(CACNB4, marker 2213), calcium channel, voltage-dependent, beta 4 subunit (CACNB4, marker 2214),calcium channel, voltage-dependent, gamma subunit 1(CACNG1, marker 2215),calcium channel, voltage-dependent, gamma subunit 2(CACNG2, marker 2216),calcium channel, voltage-dependent, gamma subunit 2(CACNG2, marker 2217),calcium channel, voltage-dependent, gamma subunit 3(CACNG3, marker 2218),calcium channel, voltage-dependent, gamma subunit 4(CACNG4, marker 2219),calcium channel, voltage-dependent, gamma subunit 4(CACNG4, marker 2220),calcium channel, voltage-dependent, gamma subunit 5(CACNG5, marker 2221),calcium channel, voltage-dependent, gamma subunit 5(CACNG5, marker 2222),calcium channel, voltage-dependent, gamma subunit 6(CACNG6, marker 2223),calcium cha
nnel, voltage-dependent, gamma subunit 7(CACNG7, marker 2224),calcium channel, voltage-dependent, gamma subunit 8(CACNG8, marker 2225),calcium channel, voltage-dependent, gamma subunit 8(CACNG8, marker 2226), calcium channel, voltage-dependent, gamma subunit 8 (CACNG8, marker 2227), cactin, spliceosome C complex subunit (CACTIN, marker 2228), cactin, spliceosome C complex subunit (CACTIN, marker 2229), CDK2-associated, cullin domain 1 (CACUL1, marker 2230),CDK2-associated, cullin domain 1(CACUL1, marker 2231),CDK2-associated, cullin domain 1(CACUL1, marker 2232),calcyclin binding protein(CACYBP,marker 2233),carbamoyl-phosphate synthetase 2 , aspartate transcarbamylase, and dihydroorotase(CAD, marker 2234),cell adhesion molecule 1(CADM1, marker 2235),cell adhesion molecule 1(CADM1, marker 2236),cell adhesion molecule 2(CADM2, marker 2237),cell adhesion molecule 2 (CADM2, marker 2238), cell adhesion molecule 2(CADM2, marker 2239), cell adhesion molecule 2(CADM2, marker 2240), CADM2 antisense RNA 1(CADM2-AS1, marker 2241), cell adhesion molecule 3(CADM3, marker 2242),cell adhesion molecule 3(CADM3, marker 2243),cell adhesion molecule 3(CADM3,marker 2244),CADM3 antisense RNA 1(CADM3-AS1,marker 2245),cell adhesion molecule 4(CADM4,marker 2246),cell adhesion molecule 4(CADM4, marker 2247), Ca++-dependent secretion activator(CADPS, marker 2248), Ca++-dependent secretion activator(CADPS, marker 2249), Ca++-dependent secretion activator(CADPS, marker 2250), cancer antigen 1( CAGE1, marker 2251), colon adenocarcinoma hypermethylated (non-protein coding) (CAHM, marker 2252), calcitonin-related polypeptide alpha (CALCA, marker 2253), calcitonin-related polypeptide alpha (CALCA, marker 2254), calcitonin-related polypeptide alpha (CALCA, marker 2255), calcium binding and coiled-coil domain 2 (CALCOCO2, marker 2256), calcium binding and coiled-coil domain 2 (CALCOCO2, marker 2257), calcium binding and coiled-coil domain 2 (CALCOCO2, marker 2258), calcitonin receptor (CALCR, marker 2259), calcitonin receptor (CALCR, marker 2260), calcitonin receptor like receptor (CALCRL, marker 2261), calcitonin receptor like receptor (CALCRL, marker 2262), calcitonin receptor like receptor (CALCRL, marker 2263), caldesmon 1 (CALD1, marker 2264), calcium homeostasis modulator 1 (CALHM1, marker 2265), calcium homeostasis modulator 3 (CALHM3, marker 2266), calmodulin 1 (phosphorylase kinase, delta) /// calmodulin 2 (phosphorylase kinase, delta)(CALM1 /// CALM2, marker 2267),calmodulin-like 3(CALML3,marker 2268),calmodulin-like 3(CALML3,marker 2269),calmodulin-like 4(CALML4,marker 2270),calmodulin- like 4(CALML4, marker 2271),calmodulin-like 5(CALML5,marker 2272),calmodulin-like 6(CALML6,marker 2273),calneuron 1(CALN1,marker 2274),calneuron 1(CALN1,marker 2275),calreticulin 3 (CALR3, marker 2276), calcyon neuron-specific vesicular protein (CALY, marker 2277), calcyon neuron-specific vesicular protein (CALY, marker 2278), calcium/calmodulin-dependent protein kinase I (CAMK1, marker 2279), calcium /calmodulin-dependent protein kinase ID (CAMK1D, marker 2280),calcium/calmodulin-dependent protein kinase IG (CAMK1G, marker 2281),calcium/calmodulin-dependent protein kinase IG (CAMK1G, marker 2282),calcium/calmodulin-dependent protein kinase II alpha (CAMK2A, marker 2283), calcium/calmodulin-dependent protein kinase II alpha (CAMK2A, marker 2284), calcium/calmodulin-dependent protein kinase II beta (CAMK2B, marker 2285), calcium/calmodulin-dependent protein kinase II beta(CAMK2B, marker 2286),calcium/calmodulin-dependent protein kinase II beta(CAMK2B,marker 2287),calcium/calmodulin-dependent protein kinase II beta(CAMK2B,marker 2288),calcium/calmodulin-dependent protein kinase II delta( CAMK2D, marker 2289), calcium/calmodulin-dependent protein kinase II gamma (CAMK2G, marker 2290), calcium/calmodulin-dependent protein kinase II gamma (CAMK2G, marker 2291), calcium/calmodulin-dependent protein kinase II inhibitor 2 (CAMK2N2 , marker 2292), calcium/calmodulin-dependent protein kinase IV (CAMK4, marker 2293), calcium/calmodulin-dependent protein kinase kinase 1, alpha (CAMKK1, marker 2294), calcium/calmodulin-dependent protein kinase kinase 2, beta( CAMKK2, marker 2295), calmodulin-lysine N-methyltransferase (CAMKMT, marker 2296), cathelicidin antimicrobial peptide (CAMP, marker 2297), calmodulin regulated spectrin-associated protein 1 (CAMSAP1, marker 2298), calmodulin regulated spectrin-associated protein 1 (CAMSAP1, marker 2299), calmodulin regulated spectrin-associated protein 1 (CAMSAP1, marker 2300), calmodulin binding transcription activator 1 (CAMTA1, marker 2301), cullin-associated and neddylation-dissociated 1 (CAND1, marker 2302), uncharacterized LOC100130460 (CAND1.11, marker 2303), cullin-associated and neddylation-dissociated 2 (putative) (CAND2, marker 2304), calnexin (CANX, marker 2305), calpain 10 (CAPN10, marker 2306), CAPN10 antisense RNA 1 (head to head) (CAPN10-AS1, marker 2307), calpain 11 (CAPN11, marker 2308), calpain 13 (CAPN13, marker 2309), calpain 13 (CAPN13, marker 2310), calpain 14 (CAPN14, marker 2311), calpain 15 (CAPN15, marker 2312), calpain 2, (m/II) large subunit(CAPN2, marker 2313), calpain 3(CAPN3, marker 2314),calpain 3(CAPN3, marker 2315),calpain 3(CAPN3, marker 2316) ,calpain 6(CAPN6, marker 2317),calpain 8(CAPN8,marker 2318),calpain 9(CAPN9,marker 2319),calpain 9(CAPN9,marker 2320),calpain, small subunit 2(CAPNS2,marker 2321),cell cycle associated protein 1(CAPRIN1, marker 2322), caprin family member 2(CAPRIN2, marker 2323),calcyphosine(CAPS,marker 2324),calcyphosine(CAPS,marker 2325),calcyphosine(CAPS,marker 2326),calcyphosine 2(CAPS2) , marker 2327), calcyphosine 2 (CAPS2, marker 2328), calcyphosine-like (CAPSL, marker 2329), capping protein (actin filament) muscle Z-line, alpha 1 (CAPZA1, marker 2330), capping protein (actin filament) muscle Z-line, alpha 2(CAPZA2, marker 2331), capping protein (actin filament) muscle Z-line, alpha 3(CAPZA3, marker 2332), capping protein (actin filament) muscle Z-line, beta(CAPZB, marker 2333),caspase recruitment domain family, member 10(CARD10,marker 2334),caspase recruitment domain family, member 10(CARD10,marker 2335),caspase recruitment domain family, member 11(CARD11,marker 2336),caspase recruitment domain family, member 14(CARD14, marker 2337),caspase recruitment domain family, member 14(CARD14,marker 2338),caspase recruitment domain family, member 14(CARD14,marker 2339),caspase recruitment domain family, member 14(CARD14,marker 2340) ,caspase recruitment domain family, member 14(CARD14, marker 2341),caspase recruitment domain family, member 14(CARD14,marker 2342),caspase recruitment domain family, member 16(CARD16,marker 2343),caspase recruitment domain family, member 16 (CARD16, marker 2344), caspase recruitment domain family, member 16 /// caspase 1(CARD16 /// CASP1, marker 2345), caspase recruitment domain family, member 18(CARD18, marker 2346), caspase recruitment domain family, member 19 (CARD19, marker 2347), caspase recruitment domain family, member 6 (CARD6, marker 2348), caspase recruitment domain family, member 8 (CARD8, marker 2349), CARD8 antisense RNA 1 (CARD8-AS1, marker 2350), CARD8 antisense RNA 1 (CARD8-AS1, marker 2351), caspase recruitment domain family, member 9 (CARD9, marker 2352), calcium responsive transcription factor (CARF, marker 2353), calcium responsive transcription factor (CARF, marker 2354), calcium regulated heat stable protein 1(CARHSP1, marker 2355),calcium regulated heat stable protein 1(CARHSP1, marker 2356),cardiac mesoderm enhancer-associated non-coding RNA(CARMN,marker 2357),cardiac mesoderm enhancer-associated non-coding RNA( CARMN, marker 2358), carnosine synthase 1(CARNS1, marker 2359),cysteinyl-tRNA synthetase(CARS, marker 2360),CARS antisense RNA 1(CARS-AS1, marker 2361),cysteinyl-tRNA synthetase 2, mitochondrial (putative) (CARS2, marker 2362),cysteinyl-tRNA synthetase 2, mitochondrial (putative)(CARS2, marker 2363),CART prepropeptide(CARTPT, marker 2364),cancer susceptibility candidate 1(CASC1, marker 2365),cancer susceptibility candidate 11 (non -protein coding)(CASC11, marker 2366), cancer susceptibility candidate 15 (non-protein coding)(CASC15, marker 2367), cancer susceptibility candidate 15 (non-protein coding)(CASC15, marker 2368), cancer susceptibility candidate 15 ( non-protein coding)(CASC15, marker 2369), cancer susceptibility candidate 16 (non-protein coding)(CASC16, marker 2370), cancer susceptibility candidate 17 (non-protein coding)(CASC17, marker 2371), cancer susceptibility candidate 18 (non-protein coding)(CASC18, marker 2372), cancer susceptibility candidate 2 (non-protein coding)(CASC2, marker 2373), cancer susceptibility candidate 2 (non-protein coding)(CASC2, marker 2374), cancer susceptibility candidate 2 (non-protein coding)(CASC2, marker 2375),cancer susceptibility candidate 2 (non-protein coding)(CASC2, marker 2376),cancer susceptibility candidate 2 (non-protein coding)(CASC2, marker 2377),cancer susceptibility candidate 22 (non-protein coding)(CASC22, marker 2378),cancer susceptibility candidate 23 (non-protein coding)(CASC23, marker 2379),cancer susceptibility candidate 4(CASC4, marker 2380),cancer susceptibility candidate 4(CASC4, marker 2381), cancer susceptibility candidate 5(CASC5, marker 2382), cancer susceptibility candidate 6 (non-protein coding)(CASC6, marker 2383),CAS1 domain containing 1(CASD1, marker 2384),CAS1 domain containing 1(CASD1, marker 2385), calcium/calmodulin-dependent serine protein kinase (MAGUK family)(CASK, marker 2386),CASK interacting protein 1(CASKIN1, marker 2387),CASK interacting protein 1(CASKIN1, marker 2388),CASK interacting protein 1( CASKIN1, marker 2389), caspase 1 (CASP1, marker 2390), caspase 1 (CASP1, marker 2391), caspase 1 (CASP1, marker 2392), caspase 1 (CASP1, marker 2393), caspase 1 (CASP1, marker 2394) ,caspase 10(CASP10, marker 2395),caspase 10(CASP10,marker 2396),caspase 10(CASP10,marker 2397),caspase 10(CASP10,marker 2398),caspase 12 (gene/pseudogene)(CASP12,marker 2399) , caspase 14 (CASP14, marker 2400), caspase 16, pseudogene (CASP16P, marker 2401), caspase 4 (CASP4, marker 2402), caspase 4 (CASP4, marker 2403), caspase 5 (CASP5, marker 2404), caspase 8 , apoptosis-related cysteine peptidase (CASP8, marker 2405), caspase 9 (CASP9, marker 2406), calsequestrin 1 (fast-twitch, skeletal muscle) (CASQ1, marker 2407), calsequestrin 2 (cardiac muscle)(
CASQ2, marker 2408),calcium-sensing receptor(CASR,marker 2409),calcium-sensing receptor(CASR,marker 2410),calcium-sensing receptor(CASR,marker 2411),calcium-sensing receptor(CASR,marker 2412), calcium-sensing receptor (CASR, marker 2413), Cas scaffolding protein family member 4 (CASS4, marker 2414), Cas scaffolding protein family member 4 (CASS4, marker 2415), calpastatin (CAST, marker 2416), calpastatin (CAST, marker 2417), castor zinc finger 1(CASZ1, marker 2418), castor zinc finger 1(CASZ1, marker 2419), castor zinc finger 1(CASZ1, marker 2420), castor zinc finger 1(CASZ1, marker 2421), catalase(CAT ,marker 2422),CATIP antisense RNA 1(CATIP-AS1,marker 2423),cation channel, sperm associated 2(CATSPER2,marker 2424),cation channel, sperm associated 2(CATSPER2,marker 2425),cation channel, sperm associated 2 /// cation channel, sperm associated 2 pseudogene 1(CATSPER2 /// CATSPER2P1, marker 2426), cation channel, sperm associated 3(CATSPER3, marker 2427), catsper channel auxiliary subunit beta(CATSPERB, marker 2428), catsper channel auxiliary subunit beta (CATSPERB, marker 2429), catsper channel auxiliary subunit delta (CATSPERD, marker 2430), catsper channel auxiliary subunit gamma (CATSPERG, marker 2431), catsper channel auxiliary subunit gamma (CATSPERG, marker 2432), catsper channel auxiliary subunit gamma (CATSPERG, marker 2433), uncharacterized LOC100506513 (CATX-1, marker 2434), uncharacterized LOC100506513 (CATX-1, marker 2435), caveolin 2 (CAV2, marker 2436), caveolin 3 (CAV3, marker 2437), calcium channel, voltage-dependent, beta subunit associated regulatory protein(CBARP, marker 2438),calcium channel, voltage-dependent, beta subunit associated regulatory protein(CBARP, marker 2439),calcium channel, voltage-dependent, beta subunit associated regulatory protein(CBARP, marker 2440), core-binding factor, runt domain, alpha subunit 2; translocated to, 2(CBFA2T2, marker 2441), core-binding factor, runt domain, alpha subunit 2; translocated to, 2(CBFA2T2, marker 2442), core-binding factor, runt domain, alpha subunit 2; translocated to, 3(CBFA2T3, marker 2443),Cbl proto-oncogene B, E3 ubiquitin protein ligase(CBLB, marker 2444),Cbl proto-oncogene C, E3 ubiquitin protein ligase (CBLC, marker 2445), Cbl proto-oncogene C, E3 ubiquitin protein ligase(CBLC, marker 2446), cerebellin 1 precursor(CBLN1, marker 2447), cerebellin 2 precursor(CBLN2, marker 2448), cerebellin 3 precursor(CBLN3, marker 2449), cerebellin 4 precursor (CBLN4, marker 2450), cerebellin 4 precursor (CBLN4, marker 2451), CBR3 antisense RNA 1 (CBR3-AS1, marker 2452), chromobox homolog 2 (CBX2, marker 2453), chromobox homolog 2 (CBX2, marker 2454), chromobox homolog 3 pseudogene 2 (CBX3P2, marker 2455), chromobox homolog 4 (CBX4, marker 2456), chromobox homolog 5 (CBX5, marker 2457), chromobox homolog 8 (CBX8, marker 2458), chibby homolog 1 (Drosophila)(CBY1, marker 2459), chibby homolog 3 (Drosophila)(CBY3, marker 2460), coiled-coil and C2 domain containing 1A(CC2D1A, marker 2461), coiled-coil and C2 domain containing 1A(CC2D1A ,marker 2462),coiled-coil and C2 domain containing 1B(CC2D1B,marker 2463),coiled-coil and C2 domain containing 2A(CC2D2A,marker 2464),coiled-coil and C2 domain containing 2A(CC2D2A,marker 2465), coiled-coil and C2 domain containing 2B(CC2D2B, marker 2466),coiled-coil and C2 domain containing 2B /// ENTPD1 antisense RNA 1 /// uncharacterized LOC105378440(CC2D2B /// ENTPD1-AS1 /// LOC105378440, marker 2467 ), cell cycle and apoptosis regulator 2(CCAR2, marker 2468), collagen and calcium binding EGF domains 1(CCBE1, marker 2469), collagen and calcium binding EGF domains 1(CCBE1, marker 2470), collagen and calcium binding EGF domains 1 (CCBE1, marker 2471), cysteine conjugate-beta lyase, cytoplasmic(CCBL1, marker 2472), coiled-coil domain containing 102B(CCDC102B, marker 2473), coiled-coil domain containing 103 /// family with sequence similarity 187, member A(CCDC103 /// FAM187A, marker 2474), coiled-coil domain containing 105(CCDC105, marker 2475), coiled-coil domain containing 110(CCDC110, marker 2476), coiled-coil domain containing 114(CCDC114, marker 2477) ,coiled-coil domain containing 116(CCDC116, marker 2478),coiled-coil domain containing 120(CCDC120, marker 2479),coiled-coil domain containing 120(CCDC120, marker 2480),coiled-coil domain containing 121(CCDC121, marker 2481), coiled-coil domain containing 122(CCDC122, marker 2482), coiled-coil domain containing 122(CCDC122, marker 2483), coiled-coil domain containing 125(CCDC125, marker 2484), coiled-coil domain containing 129(CCDC129 ,marker 2485),coiled-coil domain containing 129(CCDC129,marker 2486),coiled-coil domain containing 13(CCDC13,marker 2487),coiled-coil domain containing 13(CCDC13,marker 2488),CCDC13 antisense RNA 1(CCDC13 -AS1, marker 2489), coiled-coil domain containing 136 (CCDC136, marker 2490), coiled-coil domain containing 136 (CCDC136, marker 2491), coiled-coil domain containing 14 (CCDC14, marker 2492), coiled-coil domain containing 14(CCDC14, marker 2493), coiled-coil domain containing 140(CCDC140, marker 2494), coiled-coil domain containing 141(CCDC141, marker 2495), coiled-coil domain containing 142(CCDC142, marker 2496), coiled- coil domain containing 144A(CCDC144A, marker 2497), coiled-coil domain containing 144B (pseudogene)(CCDC144B, marker 2498), coiled-coil domain containing 144B (pseudogene)(CCDC144B, marker 2499), coiled-coil domain containing 144C, pseudogene (CCDC144CP, marker 2500), CCDC144NL ANTISENSE RNA 1 /// Uncharacterized Loc105369205 /// UNCHARACTERIZED LOC339260 (CCDC144NL-AS1 // // LOC105369205 /// LOC339260, Marker 2501), Coiled-Coil Domain Contening 146 (CCDC146, Marker 2502 ), coiled-coil domain containing 148(CCDC148, marker 2503), coiled-coil domain containing 148(CCDC148, marker 2504), CCDC148 antisense RNA 1(CCDC148-AS1, marker 2505), coiled-coil domain containing 149(CCDC149, marker 2506), coiled-coil domain containing 149(CCDC149, marker 2507), coiled-coil domain containing 149(CCDC149, marker 2508), coiled-coil domain containing 150(CCDC150, marker 2509), coiled-coil domain containing 153( CCDC153, marker 2510), coiled-coil domain containing 154 (CCDC154, marker 2511), coiled-coil domain containing 155 (CCDC155, marker 2512), coiled-coil domain containing 157 (CCDC157, marker 2513), coiled-coil domain containing 157(CCDC157, marker 2514), coiled-coil domain containing 158(CCDC158, marker 2515), coiled-coil domain containing 158(CCDC158, marker 2516), coiled-coil domain containing 159(CCDC159, marker 2517), coiled-coil domain containing 163, pseudogene(CCDC163P, marker 2518), coiled-coil domain containing 168(CCDC168, marker 2519), coiled-coil domain containing 168(CCDC168, marker 2520), coiled-coil domain containing 168(CCDC168, marker 2521) ,coiled-coil domain containing 169(CCDC169, marker 2522),coiled-coil domain containing 17(CCDC17, marker 2523),coiled-coil domain containing 170(CCDC170, marker 2524),coiled-coil domain containing 171(CCDC171, marker 2525), coiled-coil domain containing 171(CCDC171, marker 2526), coiled-coil domain containing 171(CCDC171, marker 2527), coiled-coil domain containing 171(CCDC171, marker 2528), coiled-coil domain containing 171(CCDC171 ,marker 2529),coiled-coil domain containing 171(CCDC171,marker 2530),coiled-coil domain containing 171(CCDC171,marker 2531),coiled-coil domain containing 173(CCDC173,marker 2532),coiled-coil domain containing 178 (CCDC178, marker 2533), coiled-coil domain containing 18(CCDC18, marker 2534), coiled-coil domain containing 180 /// LOC100499484-C9orf174 readthrough(CCDC180 /// LOC100499484-C9ORF174, marker 2535), coiled-coil domain containing 180 /// LOC100499484-C9orf174 readthrough(CCDC180 /// LOC100499484-C9ORF174, marker 2536), coiled-coil domain containing 181(CCDC181, marker 2537), coiled-coil domain containing 181(CCDC181, marker 2538), coiled- coil domain containing 182(CCDC182, marker 2539), coiled-coil domain containing 184(CCDC184, marker 2540), coiled-coil domain containing 185(CCDC185, marker 2541), coiled-coil domain containing 187(CCDC187, marker 2542), coiled-coil domain containing 187 (CCDC187, marker 2543), coiled-coil domain containing 189 (CCDC189, marker 2544), coiled-coil domain containing 190 (CCDC190, marker 2545), coiled-coil domain containing 24 (CCDC24, marker 2546) ), CCDC26 long non-coding RNA(CCDC26, marker 2547), coiled-coil domain containing 27(CCDC27, marker 2548), coiled-coil domain containing 28B(CCDC28B, marker 2549), coiled-coil domain containing 30(CCDC30, marker 2550), coiled-coil domain containing 30(CCDC30, marker 2551), coiled-coil domain containing 30 /// phosphopantothenoylcysteine synthetase(CCDC30 /// PPCS, marker 2552), coiled-coil domain containing 33(CCDC33, marker 2553 ), coiled-coil domain containing 34(CCDC34, marker 2554), coiled-coil domain containing 36(CCDC36, marker 2555), coiled-coil domain containing 36(CCDC36, marker 2556), coiled-coil domain containing 36(CCDC36, marker 2557),CCDC37 antisense RNA 1 (head to head)(CCDC37-AS1, marker 2558),CCDC37 antisense RNA 1 (head to head)(CCDC37-AS1, marker 2559),CCDC37 antisense RNA 1 (head to head)( CCDC37-AS1, marker 2560), coiled-coil domain containing 38(CCDC38, marker 2561), coiled-coil domain containing 39 /// uncharacterized LOC101928882(CCDC39 /// LOC101928882, marker 2562), coiled-coil domain containing 40( CCDC40, marker 2563), coiled-coil domain containing 40(CCDC40, marker 2564), coiled-coil domain containing 40(CCDC40, marker 2565), coiled-coil domain containing 40(CCDC40, marker 2566), coiled-coil domain containing 40(CCDC40, marker 2567), coiled-coil domain containing 42(CCDC42, marker 2568), coiled-coil domain containing 54(CCDC54, marker 2569), coiled-coil domain containing 57(CCDC57, marker 2570), coiled-coil domain containing 57(CCDC57, marker 2571), coiled-coil domain containing 57(CCDC57, marker 2572), coiled-coil domain containing 57(CCDC57, marker 2573), coiled-coil domain containing 57(CCDC57, marker 2574), coiled -coil domain containing 60(CCDC60, marker 2575),coiled-coil domain containing 61(CCDC61, marker 2576),coiled-coil domain containing 61(CCDC61, marker 2577),coiled-coil domain containing 62(CCDC62, marker 2578) ,coiled-coil domain containing 63(CCDC63, marker 2579),coiled-coil domain containing 64(CCDC64, marker 2580),coiled-coil domain containing 65(CCDC65, marker 2581),coiled-coil domain containing 65(CCDC65, marker 2582),coil
ed-coil domain containing 65(CCDC65, marker 2583), coiled-coil domain containing 66(CCDC66, marker 2584), coiled-coil domain containing 67(CCDC67, marker 2585), coiled-coil domain containing 67(CCDC67, marker 2586 ), coiled-coil domain containing 67(CCDC67, marker 2587), coiled-coil domain containing 67(CCDC67, marker 2588), coiled-coil domain containing 69(CCDC69, marker 2589), coiled-coil domain containing 7(CCDC7, marker 2590), coiled-coil domain containing 7(CCDC7, marker 2591), coiled-coil domain containing 7(CCDC7, marker 2592), coiled-coil domain containing 70(CCDC70, marker 2593), coiled-coil domain containing 71( CCDC71, marker 2594), coiled-coil domain containing 71-like(CCDC71L, marker 2595), coiled-coil domain containing 71-like(CCDC71L, marker 2596), coiled-coil domain containing 74B(CCDC74B, marker 2597), coiled -coil domain containing 78(CCDC78, marker 2598),coiled-coil domain containing 79(CCDC79, marker 2599),coiled-coil domain containing 80(CCDC80, marker 2600),coiled-coil domain containing 80 /// long intergenic non -protein coding RNA 1279(CCDC80 /// LINC01279, marker 2601), coiled-coil domain containing 82(CCDC82, marker 2602), coiled-coil domain containing 82(CCDC82, marker 2603), coiled-coil domain containing 83(CCDC83 ,marker 2604),coiled-coil domain containing 85A(CCDC85A,marker 2605),coiled-coil domain containing 85A(CCDC85A,marker 2606),coiled-coil domain containing 85A(CCDC85A,marker 2607),coiled-coil domain containing 85B (CCDC85B, marker 2608), coiled-coil domain containing 85B (CCDC85B, marker 2609), coiled-coil domain containing 87 (CCDC87, marker 2610), coiled-coil domain containing 88A (CCDC88A, marker 2611), coiled-coil domain containing 88B(CCDC88B, marker 2612), coiled-coil domain containing 88C /// uncharacterized LOC105370624(CCDC88C /// LOC105370624, marker 2613), coiled-coil domain containing 89(CCDC89, marker 2614), coiled-coil domain containing 90B (CCDC90B, marker 2615), coiled-coil domain containing 91 (CCDC91, marker 2616), coiled-coil domain containing 96 (CCDC96, marker 2617), coiled-coil domain containing 97 (CCDC97, marker 2618), ceramic carcimona expressed PCNA regulatory lncRNA (CCEPR, marker 2619), coiled-coil glutamate rich protein 1 (CCER1, marker 2620), calicin (CCIN, marker 2621), cholecystokinin A receptor (CCKAR, marker 2622), cholecystokinin A receptor (CCKAR, marker 2623) , cholecystokinin B receptor (CCKBR, marker 2624), chemokine (CC motif) ligand 1 (CCL1, marker 2625), chemokine (CC motif) ligand 11 (CCL11, marker 2626), chemokine (CC motif) ligand 13 (CCL13, marker 2627),chemokine (CC motif) ligand 13(CCL13, marker 2628),chemokine (CC motif) ligand 14 /// CCL15-CCL14 readthrough (NMD candidate)(CCL14 /// CCL15-CCL14, marker 2629),chemokine ( CC motif) ligand 15 /// CCL15-CCL14 readthrough (NMD candidate)(CCL15 /// CCL15-CCL14, marker 2630),chemokine (CC motif) ligand 16(CCL16, marker 2631),chemokine (CC motif) ligand 17 (CCL17, Marker 2632),chemokine (CC motif) ligand 18(CCL18,Marker 2633),chemokine (CC motif) ligand 18(CCL18,Marker 2634),chemokine (CC motif) ligand 19(CCL19,Marker 2635),chemokine (CC motif) ligand 20(CCL20, marker 2636),chemokine (CC motif) ligand 21(CCL21, marker 2637),chemokine (CC motif) ligand 22(CCL22, marker 2638),chemokine (CC motif) ligand 23(CCL23) , marker 2639), chemokine (CC motif) ligand 23 (CCL23, marker 2640), chemokine (CC motif) ligand 24 (CCL24, marker 2641), chemokine (CC motif) ligand 25 (CCL25, marker 2642), chemokine (CC motif) ligand 27(CCL27, marker 2643),chemokine (CC motif) ligand 28(CCL28, marker 2644),chemokine (CC motif) ligand 28(CCL28, marker 2645),chemokine (CC motif) ligand 28(CCL28, marker 2646),chemokine (CC motif) ligand 3 /// chemokine (CC motif) ligand 3-like 1 /// chemokine (CC motif) ligand 3-like 3(CCL3 /// CCL3L1 /// CCL3L3, marker 2647) ,chemokine (CC motif) ligand 4(CCL4, marker 2648),chemokine (CC motif) ligand 5(CCL5, marker 2649),chemokine (CC motif) ligand 5(CCL5, marker 2650),chemokine (CC motif) ligand 5 (CCL5, marker 2651),chemokine (CC motif) ligand 7(CCL7, marker 2652),chemokine (CC motif) ligand 8(CCL8, marker 2653),cyclin B2(CCNB2, marker 2654),cyclin B2(CCNB2, marker 2655), cyclin B3 (CCNB3, marker 2656), cyclin C (CCNC, marker 2657), cyclin D3 (CCND3, marker 2658), cyclin E1 (CCNE1, marker 2659), cyclin G2 (CCNG2, marker 2660), cyclin J (CCNJ, marker 2661), cyclin L1 (CCNL1, marker 2662), cyclin L1 (CCNL1, marker 2663), cyclin O (CCNO, marker 2664), CCNT2 antisense RNA 1 (CCNT2-AS1, marker 2665), cyclin Y( CCNY, marker 2666), cyclin Y-like 2, pseudogene (CCNYL2, marker 2667), centriolar coiled coil protein 110kDa (CCP110, marker 2668), chemokine (CC motif) receptor 1 (CCR1, marker 2669), chemokine (CC motif) ) receptor 10(CCR10, marker 2670),chemokine (CC motif) receptor 2(CCR2,marker 2671),chemokine (CC motif) receptor 2(CCR2,marker 2672),chemokine (CC motif) receptor 3(CCR3,marker 2673 ),chemokine (CC motif) receptor 4(CCR4,marker 2674),chemokine (CC motif) receptor 5 (gene/pseudogene)(CCR5,marker 2675),chemokine (CC motif) receptor 6(CCR6,marker 2676),chemokine (CC motif) receptor 7(CCR7, marker 2677),chemokine (CC motif) receptor 7(CCR7, marker 2678),chemokine (CC motif) receptor 8(CCR8, marker 2679),chemokine (CC motif) receptor 9(CCR9) , marker 2680), chemokine (CC motif) receptor-like 2 (CCRL2, marker 2681), centriole, cilia and spindle-associated protein (CCSAP, marker 2682), centriole, cilia and spindle-associated protein (CCSAP, marker 2683) ,centriole, cilia and spindle-associated protein(CCSAP, marker 2684),coiled-coil serine rich protein 1(CCSER1,marker 2685),coiled-coil serine rich protein 1(CCSER1,marker 2686),coiled-coil serine rich protein 2(CCSER2, marker 2687), chaperonin containing TCP1, subunit 8 (theta)(CCT8, marker 2688), chaperonin containing TCP1, subunit 8 (theta)-like 2(CCT8L2, marker 2689), CCZ1 homolog, vacuolar protein trafficking and biogenesis associated(CCZ1, marker 2690),CD101 molecule(CD101,marker 2691),CD101 molecule(CD101,marker 2692),CD109 molecule(CD109,marker 2693),CD14 molecule(CD14,marker 2694),CD160 molecule(CD160, marker 2695), CD163 molecule(CD163, marker 2696),CD163 molecule(CD163, marker 2697),CD163 molecule(CD163, marker 2698),CD163 molecule-like 1(CD163L1, marker 2699),CD177 molecule(CD177, marker 2700 ),CD180 molecule(CD180, marker 2701),CD19 molecule(CD19,marker 2702),CD1a molecule(CD1A,marker 2703),CD1b molecule(CD1B,marker 2704),CD1c molecule(CD1C,marker 2705),CD1d molecule( CD1D, marker 2706), CD1e molecule (CD1E, marker 2707), CD1e molecule (CD1E, marker 2708), CD2 molecule (CD2, marker 2709), CD200 receptor 1 (CD200R1, marker 2710), CD200 receptor 1 (CD200R1, marker 2711),CD207 molecule, langerin(CD207, marker 2712),CD209 molecule(CD209, marker 2713),CD209 molecule(CD209,marker 2714),CD209 molecule(CD209,marker 2715),CD22 molecule(CD22,marker 2716), CD22 molecule(CD22, marker 2717),CD22 molecule(CD22,marker 2718),CD226 molecule(CD226,marker 2719),CD244 molecule, natural killer cell receptor 2B4(CD244,marker 2720),CD244 molecule, natural killer cell receptor 2B4 (CD244, marker 2721), CD247 molecule(CD247, marker 2722),CD27 molecule(CD27, marker 2723),CD274 molecule(CD274, marker 2724),CD274 molecule(CD274, marker 2725),CD276 molecule(CD276, marker 2726 ),CD28 molecule(CD28, marker 2727),CD28 molecule(CD28,marker 2728),CD28 molecule(CD28,marker 2729),CD300a molecule(CD300A,marker 2730),CD300a molecule(CD300A,marker 2731),CD300a molecule( CD300A, marker 2732), CD300c molecule (CD300C, marker 2733), CD300 molecule-like family member b (CD300LB, marker 2734), CD300 molecule-like family member b (CD300LB, marker 2735), CD300 molecule-like family member f (CD300LF, marker 2736),CD300 molecule-like family member g(CD300LG,marker 2737),CD300 molecule-like family member g(CD300LG,marker 2738),CD300 molecule-like family member g(CD300LG,marker 2739),CD300 molecule-like family member g(CD300LG, marker 2740),CD33 molecule(CD33,marker 2741),CD34 molecule(CD34,marker 2742),CD36 molecule (thrombospondin receptor)(CD36,marker 2743),CD36 molecule (thrombospondin receptor) (CD36, marker 2744),CD36 molecule (thrombospondin receptor)(CD36, marker 2745),CD36 molecule (thrombospondin receptor)(CD36, marker 2746),CD36 molecule (thrombospondin receptor)(CD36, marker 2747),CD37 molecule(CD37 , marker 2748), CD37 molecule (CD37, marker 2749), CD38 molecule (CD38, marker 2750), CD3d molecule, delta (CD3-TCR complex) (CD3D, marker 2751), CD3e molecule, epsilon (CD3-TCR complex) (CD3E, marker 2752),CD3g molecule, gamma (CD3-TCR complex)(CD3G, marker 2753),CD4 molecule(CD4, marker 2754),CD4 molecule(CD4, marker 2755),CD40 molecule, TNF receptor superfamily member 5 (CD40, marker 2756),CD40 molecule, TNF receptor superfamily member 5(CD40, marker 2757),CD40 ligand(CD40LG, marker 2758),CD44 molecule (Indian blood group)(CD44,marker 2759),CD44 molecule (Indian blood group)(CD44, marker 2760),CD44 molecule (Indian blood group)(CD44,marker 2761),CD44 molecule (Indian blood group)(CD44,marker 2762),CD44 molecule (Indian blood group)(CD44,marker 2763) ,CD44 molecule (Indian blood group)(CD44, marker 2764),CD48 molecule(CD48, marker 2765),CD48 molecule(CD48,marker 2766),CD5 molecule(CD5,marker 2767),CD5 molecule(CD5,marker 2768) ,CD52 molecule(CD52, marker 2769),CD53 molecule(CD53,marker 2770),CD53 molecule(CD53,marker 2771),CD53 molecule(CD53,marker 2772),CD58 molecule(CD58,marker 2773),CD58 molecule(CD58 , marker 2774), CD59 molecule, complement regulatory protein(CD59, marker 2775), CD5 molecule-like(CD5L, marker 2776), CD6 molecule(CD6, marker 2777), CD6 molecule(CD6, marker 2778), CD6 molecule( CD6, marker 2779), CD6 molecule(CD6, marker 2780),CD6 molecule(CD6, marker 2781),CD6 molecule(CD6, marker 2782),CD6 molecule(CD6, marker 2783),CD68 molecule(CD68, marker 2784) ,CD69 molecule(CD69, marker 2785),CD7 molecule(CD7,marker 2786),CD7 molecule(CD7,marker 2787),CD72 molecule(CD72,marker 2788),CD74 molecule, major histocompatibility complex, class II invariant chain(CD74 , marker 2789), CD74 molecule, major histocompatibility complex, class II invariant chain (CD74, marker 2790), CD79a molecule, immunoglobulin-associated alpha (CD79A, marker 2791), CD79b molecule, immunoglobulin-associated beta (CD79B, marker 2792) ,CD79b molecule, immunoglobulin-associated beta(
CD79B, marker 2793), CD79b molecule, immunoglobulin-associated beta(CD79B, marker 2794),CD80 molecule(CD80, marker 2795),CD80 molecule(CD80, marker 2796),CD80 molecule(CD80, marker 2797),CD81 antisense RNA 1 (CD81-AS1, marker 2798), CD82 molecule (CD82, marker 2799), CD84 molecule (CD84, marker 2800), CD84 molecule (CD84, marker 2801), CD84 molecule (CD84, marker 2802), CD84 molecule (CD84 , marker 2803), CD84 molecule (CD84, marker 2804), CD84 molecule (CD84, marker 2805), CD84 molecule (CD84, marker 2806), CD84 molecule (CD84, marker 2807), CD86 molecule (CD86, marker 2808), CD86 molecule (CD86, marker 2809), CD86 molecule (CD86, marker 2810), CD8a molecule (CD8A, marker 2811), CD8b molecule (CD8B, marker 2812), CD8b molecule (CD8B, marker 2813), CD8b molecule (CD8B, marker 2814), CD8b molecule (CD8B, marker 2815), CD9 molecule (CD9, marker 2816), CD9 molecule (CD9, marker 2817), CD93 molecule (CD93, marker 2818), CD93 molecule (CD93, marker 2819), CD96 molecule(CD96, marker 2820),CD96 molecule(CD96, marker 2821),CD99 molecule-like 2(CD99L2, marker 2822),cytidine deaminase(CDA, marker 2823),cytidine and dCMP deaminase domain containing 1(CDADC1, marker 2824 ),codanin 1(CDAN1, marker 2825),cell division cycle 14A(CDC14A,marker 2826),cell division cycle 14A(CDC14A,marker 2827),cell division cycle 14A(CDC14A,marker 2828),cell division cycle 14A(CDC14A ,marker 2829),cell division cycle 14A(CDC14A,marker 2830),cell division cycle 14B(CDC14B,marker 2831),cell division cycle 14B(CDC14B,marker 2832),cell division cycle 14B(CDC14B,marker 2833),cell division cycle 14B(CDC14B, marker 2834),cell division cycle 14C(CDC14C,marker 2835),cell division cycle 20B(CDC20B,marker 2836),cell division cycle 20B(CDC20B,marker 2837),cell division cycle 20B(CDC20B, marker 2838), cell division cycle 20B (CDC20B, marker 2839), cell division cycle 20B (CDC20B, marker 2840), cell division cycle 25C (CDC25C, marker 2841), cell division cycle 34 (CDC34, marker 2842), cell division cycle 37 pseudogene 1(CDC37P1, marker 2843), cell division cycle 42(CDC42, marker 2844), cell division cycle 42(CDC42, marker 2845), CDC42 intronic transcript 1(CDC42-IT1, marker 2846), CDC42 binding protein kinase alpha (DMPK-like) (CDC42BPA, marker 2847), CDC42 binding protein kinase alpha (DMPK-like) (CDC42BPA, marker 2848), CDC42 binding protein kinase beta (DMPK-like) (CDC42BPB, marker 2849), CDC42 binding protein kinase gamma (DMPK-like) (CDC42BPG, marker 2850), CDC42 binding protein kinase gamma (DMPK-like) (CDC42BPG, marker 2851), CDC42 effector protein (Rho GTPase binding) 2 (CDC42EP2, marker 2852), CDC42 effector protein (Rho GTPase binding) 4 (CDC42EP4, marker 2853), CDC42 small effector 1 (CDC42SE1, marker 2854), CUB domain containing protein 1 (CDCP1, marker 2855), cadherin 11, type 2, OB-cadherin (osteoblast) (CDH11 , marker 2856), cadherin 11, type 2, OB-cadherin (osteoblast)(CDH11, marker 2857), cadherin 12, type 2 (N-cadherin 2)(CDH12, marker 2858), cadherin 15, type 1, M- cadherin (myotubule) (CDH15, marker 2859), cadherin 15, type 1, M-cadherin (myotubule) (CDH15, marker 2860), cadherin 16, KSP-cadherin (CDH16, marker 2861), cadherin 17, LI cadherin (liver -intestine) (CDH17, marker 2862), cadherin 18, type 2 (CDH18, marker 2863), cadherin 19, type 2 (CDH19, marker 2864), cadherin 19, type 2 (CDH19, marker 2865), cadherin 19, type 2 (CDH19, marker 2866), cadherin 20, type 2 (CDH20, marker 2867), cadherin 22, type 2 (CDH22, marker 2868), cadherin-related 23 (CDH23, marker 2869), cadherin-related 23 (CDH23, marker 2870), cadherin-related 23(CDH23, marker 2871), cadherin-related 23(CDH23, marker 2872), cadherin 24, type 2(CDH24, marker 2873), cadherin 26(CDH26, marker 2874), cadherin 26( CDH26, marker 2875), cadherin 26 (CDH26, marker 2876), cadherin 4, type 1, R-cadherin (retinal) (CDH4, marker 2877), cadherin 4, type 1, R-cadherin (retinal) (CDH4, marker 2878), cadherin 5, type 2 (vascular endothelium) (CDH5, marker 2879), cadherin 6, type 2, K-cadherin (fetal kidney) (CDH6, marker 2880), cadherin 7, type 2 (CDH7, marker 2881) ,cadherin 7, type 2(CDH7, marker 2882),cadherin 8, type 2(CDH8,marker 2883),cadherin 8, type 2(CDH8,marker 2884),cadherin 8, type 2(CDH8,marker 2885),cadherin 9, type 2 (T1-cadherin) (CDH9, marker 2886), cadherin-related family member 1 (CDHR1, marker 2887), cadherin-related family member 1 (CDHR1, marker 2888), cadherin-related family member 3 (CDHR3 , marker 2889), cadherin-related family member 3 (CDHR3, marker 2890), cadherin-related family member 5 (CDHR5, marker 2891), cadherin-related family member 5 (CDHR5, marker 2892), cadherin-related family member 5 (CDHR5, marker 2893), CDIPT antisense RNA 1 (head to head) (CDIPT-AS1, marker 2894), cyclin-dependent kinase 12 (CDK12, marker 2895), cyclin-dependent kinase 12 (CDK12, marker 2896), cyclin -dependent kinase 13 (CDK13, marker 2897), cyclin-dependent kinase 13 (CDK13, marker 2898), cyclin-dependent kinase 14 (CDK14, marker 2899), cyclin-dependent kinase 15 (CDK15, marker 2900), cyclin-dependent kinase 15 (CDK15, marker 2901), cyclin-dependent kinase 15 (CDK15, marker 2902), cyclin-dependent kinase 18 (CDK18, marker 2903), cyclin-dependent kinase 19 (CDK19, marker 2904), cyclin-dependent kinase 2 (CDK2, marker 2905), cyclin-dependent kinase 3 /// TEN1-CDK3 readthrough (NMD candidate)(CDK3 /// TEN1-CDK3, marker 2906), cyclin-dependent kinase 5, regulatory subunit 1 (p35)(CDK5R1 , marker 2907), cyclin-dependent kinase 5, regulatory subunit 2 (p39) (CDK5R2, marker 2908), CDK5 regulatory subunit associated protein 2 (CDK5RAP2, marker 2909), cyclin-dependent kinase 6 (CDK6, marker 2910), cyclin -dependent kinase 9(CDK9, marker 2911),CDK5 regulatory subunit associated protein 1-like 1(CDKAL1, marker 2912),CDK5 regulatory subunit associated protein 1-like 1(CDKAL1, marker 2913),cyclin-dependent kinase-like 1 (CDC2-related kinase)(CDKL1, marker 2914),cyclin-dependent kinase-like 1 (CDC2-related kinase)(CDKL1, marker 2915),cyclin-dependent kinase-like 1 (CDC2-related kinase)(CDKL1, marker 2916), cyclin-dependent kinase-like 2 (CDC2-related kinase) (CDKL2, marker 2917), cyclin-dependent kinase-like 2 (CDC2-related kinase) (CDKL2, marker 2918), cyclin-dependent kinase-like 3 (CDKL3, marker 2919), cyclin-dependent kinase-like 5 (CDKL5, marker 2920), cyclin-dependent kinase-like 5 (CDKL5, marker 2921), cyclin-dependent kinase inhibitor 2A (CDKN2A, marker 2922), cyclin- dependent kinase inhibitor 2A (CDKN2A, marker 2923), CDKN2A antisense RNA 1 (head to head) (CDKN2A-AS1, marker 2924), cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (CDKN2B, marker 2925), CDKN2B antisense RNA 1 (CDKN2B-AS1, marker 2926), cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (CDKN2C, marker 2927), cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (CDKN2C, marker 2928), cyclin -dependent kinase inhibitor 2D (p19, inhibits CDK4)(CDKN2D,marker 2929),cerebral dopamine neurotrophic factor(CDNF,marker 2930),cysteine dioxygenase type 1 /// uncharacterized LOC105379131(CDO1 /// LOC105379131,marker 2931),cell adhesion associated, oncogene regulated(CDON, marker 2932),cell adhesion associated, oncogene regulated(CDON, marker 2933),cerebellar degeneration related protein 1(CDR1,marker 2934),CMT1A duplicated region transcript 1(CDRT1,marker 2935),CMT1A duplicated region transcript 1(CDRT1, marker 2936),CMT1A duplicated region transcript 1(CDRT1, marker 2937),CMT1A duplicated region transcript 15(CDRT15, marker 2938),CMT1A duplicated region transcript 15-like 2(CDRT15L2, marker 2939), CDP-diacylglycerol synthase 1 (CDS1, marker 2940), CDP-diacylglycerol synthase 2 (CDS2, marker 2941), corneodesmosin (CDSN, marker 2942), corneodesmosin (CDSN, marker 2943), caudal type homeobox 1 (CDX1, marker 2944) ,caudal type homeobox 2(CDX2, marker 2945),caudal type homeobox 2(CDX2, marker 2946),chromodomain protein, Y-linked, 1(CDY1,marker 2947),chromodomain protein, Y-linked, 1 /// chromodomain protein, Y-linked, 1B /// chromodomain protein, Y-linked, 2A /// chromodomain protein, Y-linked, 2B(CDY1 /// CDY1B /// CDY2A /// CDY2B, marker 2948), carcinoembryonic antigen -related cell adhesion molecule 1 (biliary glycoprotein)(CEACAM1, marker 2949),carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)(CEACAM1, marker 2950),carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)(CEACAM1 , marker 2951), carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)(CEACAM1, marker 2952), carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)(CEACAM1, marker 2953), carcinoembryonic antigen-related cell adhesion molecule 21 (CEACAM21, marker 2954), carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3, marker 2955), carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3, marker 2956), carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3, marker 2957), carcinoembryonic antigen-related cell adhesion molecule 4(CEACAM4, marker 2958), carcinoembryonic antigen-related cell adhesion molecule 5(CEACAM5, marker 2959), carcinoembryonic antigen-related cell adhesion molecule 5(CEACAM5, marker 2960), carcinoembryonic antigen -related cell adhesion molecule 6 (non-specific cross reacting antigen) (CEACAM6, marker 2961), carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7, marker 2962), carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7, marker 2963) , carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7, marker 2964), carcinoembryonic antigen-related cell adhesion molecule 8 (CEACAM8, marker 2965), CCAAT/enhancer binding protein (C/EBP), delta (CEBPD, marker 2966), CCAAT/enhancer binding protein (C/EBP), epsilon (CEBPE, marker 2967), cat eye syndrome chromosome region, candidate 3 (non-protein coding) (CECR3, marker 2968), CECR5 antisense RNA 1 (CECR5-AS1, marker 2969), cat eye syndrome chromosome region, candidate 7 (non-protein coding) (CECR7, marker 2970), cat eye syndrome chromosome region, candidate 9 (non-protein coding) (CECR9, marker 2971), cat eye syndrome chromosome region , candidate 9 (non-protein coding)(CECR9, marker 2972),carboxyl ester lipase(CEL,marker 2973),carboxyl ester lipase(CEL,marker 2974),chymotrypsin-like elastase family, member 1(CELA1,marker 2975) ,chymotrypsin-like elastase family, member 2A /// chymotrypsin-like elastase family, member 2B(CELA2A /// CELA2B, marker 2976),chymotrypsin-lik
e elastase family, member 2A /// chymotrypsin-like elastase family, member 2B(CELA2A /// CELA2B, marker 2977),chymotrypsin-like elastase family, member 2B(CELA2B, marker 2978),chymotrypsin-like elastase family, member 3A (CELA3A, marker 2979), chymotrypsin-like elastase family, member 3A (CELA3A, marker 2980), chymotrypsin-like elastase family, member 3B (CELA3B, marker 2981), CUGBP, Elav-like family member 1 (CELF1, marker 2982),CUGBP, Elav-like family member 2(CELF2, marker 2983),CUGBP, Elav-like family member 2(CELF2, marker 2984),CUGBP, Elav-like family member 2(CELF2, marker 2985),CELF2 antisense RNA 1 (CELF2-AS1, marker 2986), CUGBP, Elav-like family member 3 (CELF3, marker 2987), CUGBP, Elav-like family member 3 (CELF3, marker 2988), CUGBP, Elav-like family member 4 ( CELF4, marker 2989), CUGBP, Elav-like family member 4 (CELF4, marker 2990), CUGBP, Elav-like family member 4 (CELF4, marker 2991), CUGBP, Elav-like family member 4 (CELF4, marker 2992) ,CUGBP, Elav-like family member 4(CELF4, marker 2993),CUGBP, Elav-like family member 6(CELF6, marker 2994),carboxyl ester lipase pseudogene(CELP,marker 2995),cadherin, EGF LAG seven-pass G -type receptor 1(CELSR1, marker 2996), cadherin, EGF LAG seven-pass G-type receptor 1(CELSR1, marker 2997), cell migration inducing protein, hyaluronan binding(CEMIP, marker 2998), cell migration inducing protein, hyaluronan binding (CEMIP, marker 2999), cementum protein 1 (CEMP1, marker 3000), centromere protein F (CENPF, marker 3001), centromere protein I (CENPI, marker 3002), centromere protein I (CENPI, marker 3003), centromere protein N (CENPN, marker 3004), centromere protein T (CENPT, marker 3005), centromere protein V (CENPV, marker 3006), centrosomal protein 104kDa (CEP104, marker 3007), centrosomal protein 112kDa (CEP112, marker 3008), centrosomal protein 112kDa (CEP112, marker 3009), centrosomal protein 126kDa (CEP126, marker 3010), centrosomal protein 126kDa (CEP126, marker 3011), centrosomal protein 126kDa (CEP126, marker 3012), centrosomal protein 135kDa (CEP135, marker 3013), centro somal protein 152kDa (CEP152, marker 3014), centrosomal protein 152kDa (CEP152, marker 3015), centrosomal protein 164kDa (CEP164, marker 3016), centrosomal protein 250kDa (CEP250, marker 3017), centrosomal protein 290kDa (CEP290, marker 3018), centro somal protein 295kDa (CEP295, marker 3019), centrosomal protein 295kDa (CEP295, marker 3020), centrosomal protein 41kDa (CEP41, marker 3021), centrosomal protein 41kDa (CEP41, marker 3022), centrosomal protein 41kDa (CEP41, marker 3023), centrosomal protein 41kDa (CEP41, marker 3024), centrosomal protein 44kDa (CEP44, marker 3025), centrosomal protein 57kDa-like 1 (CEP57L1, marker 3026), centrosomal protein 57kDa-like 1 (CEP57L1, marker 3027), centrosomal protein 57kDa-like 1 (CEP57L1, marker 3028), centrosomal protein 63kDa (CEP63, marker 3029), centrosomal protein 68kDa (CEP68, marker 3030), centrosomal protein 70kDa (CEP70, marker 3031), centrosomal protein 72kDa (CEP72, marker 3032), CEP83 antisense RNA 1 (head to head) (CEP83-AS1, marker 3033), centrosomal protein 85kDa-like (CEP85L, marker 3034), centrosomal protein 89kDa (CEP89, marker 3035), centrosomal protein 95kDa (CEP95, marker 3036), centrosomal protein 95kDa (CEP95, Marker 3037), choline/ethanolamine phosphotransferase 1 (CEPT1, Marker 3038), cerebral endothelial cell adhesion molecule (CERCAM, Marker 3039), cerebral endothelial cell adhesion molecule (CERCAM, Marker 3040), ceramide synthase 3 (CERS3, Marker 3041), ceramide synthase 3 (CERS3, marker 3042), ceramide synthase 5 (CERS5, marker 3043), ceramide synthase 6 (CERS6, marker 3044), carboxylesterase 1 /// carboxylesterase 1 pseudogene 1 (CES1 /// CES1P1, marker 3045), carboxylesterase 1 pseudogene 1 (CES1P1, marker 3046), carboxylesterase 3 (CES3, marker 3047), carboxylesterase 4A (CES4A, marker 3048), carboxylesterase 5A (CES5A, marker 3049), centrin 1 (CETN1, marker 3050), cholesteryl ester transfer protein, plasma (CETP, marker 3051), cilia and flagella associated protein 100 (CFAP100, marker 3052), cilia and flagella associated protein 100 (CFAP100, marker 3053), cilia and flagella associated protein 126 (CFAP126, marker 3054) ), cilia and flagella associated protein 157 (CFAP157, marker 3055), cilia and flagella associated protein 157 (CFAP157, marker 3056), cilia and flagella associated protein 157 (CFAP157, marker 3057), cilia and flagella associated protein 161 (CFAP161, marker 3058), cilia and flagella associated protein 206 (CFAP206, marker 3059), cilia and flagella associated protein 221 (CFAP221, marker 3060), cilia and flagella associated protein 221 (CFAP221, marker 3061), cilia and flagella associated protein 221( CFAP221, marker 3062), cilia and flagella associated protein 221 (CFAP221, marker 3063), cilia and flagella associated protein 43 (CFAP43, marker 3064), cilia and flagella associated protein 43 (CFAP43, marker 3065), cilia and flagella associated protein 43 (CFAP43, marker 3066), cilia and flagella associated protein 43 (CFAP43, marker 3067), cilia and flagella associated protein 44 (CFAP44, marker 3068), cilia and flagella associated protein 44 (CFAP44, marker 3069), cilia and flagella protein associated protein 45 (CFAP45, marker 3070), cilia and flagella associated protein 46 (CFAP46, marker 3071), cilia and flagella associated protein 46 (CFAP46, marker 3072), cilia and flagella associated protein 47 (CFAP47, marker 3073), cilia and flagella associated protein 47(CFAP47, marker 3074),cilia and flagella associated protein 47(CFAP47, marker 3075),cilia and flagella associated protein 52(CFAP52, marker 3076),cilia and flagella associated protein 52(CFAP52, marker 3077) ,cilia and flagella associated protein 53(CFAP53, marker 3078),cilia and flagella associated protein 53(CFAP53, marker 3079),cilia and flagella associated 54(CFAP54, marker 3080),cilia and flagella associated protein 57(CFAP57, marker 3081) ), cilia and flagella associated protein 58 (CFAP58, marker 3082), cilia and flagella associated protein 58 (CFAP58, marker 3083), cilia and flagella associated protein 61 (CFAP61, marker 3084), cilia and flagella associated protein 61 (CFAP61, marker 3085), cilia and flagella associated protein 61(CFAP61, marker 3086), cilia and flagella associated protein 65(CFAP65, marker 3087), cilia and flagella associated protein 65(CFAP65, marker 3088), cilia and flagella associated protein 65( CFAP65, marker 3089), cilia and flagella associated protein 69 (CFAP69, marker 3090), cilia and flagella associated protein 70 (CFAP70, marker 3091), cilia and flagella associated protein 70 (CFAP70, marker 3092), cilia and flagella associated protein 73 (CFAP73, marker 3093), cilia and flagella associated protein 74 (CFAP74, marker 3094), cilia and flagella associated protein 74 (CFAP74, marker 3095), cilia and flagella associated protein 74 (CFAP74, marker 3096), cilia and flagella associated protein 74 (CFAP74, marker 3097), cilia and flagella associated protein 97 (CFAP97, marker 3098), cilia and flagella associated protein 97 (CFAP97, marker 3099), cilia and flagella associated protein 99 (CFAP99, marker 3100), complement factor B(CFB, marker 3101),complement factor B(CFB, marker 3102),cripto, FRL-1, cryptic family 1(CFC1,marker 3103),cripto, FRL-1, cryptic family 1(CFC1,marker 3104) ,cripto, FRL-1, cryptic family 1 /// cripto, FRL-1, cryptic family 1B(CFC1 /// CFC1B, marker 3105),cripto, FRL-1, cryptic family 1B(CFC1B, marker 3106),complement factor D (adipsin)(CFD, marker 3107),complement factor H(CFH,marker 3108),complement factor H /// complement factor H-related 1(CFH /// CFHR1,marker 3109),complement factor H-related 2(CFHR2, marker 3110),complement factor H-related 3(CFHR3,marker 3111),complement factor H-related 3(CFHR3,marker 3112),complement factor H-related 4(CFHR4,marker 3113),complement factor H -related 5(CFHR5, marker 3114),complement factor I(CFI,marker 3115),complement factor I(CFI,marker 3116),cofilin 1 (non-muscle)(CFL1,marker 3117),cofilin 1 (non-muscle ) /// uncharacterized LOC101927853(CFL1 /// LOC101927853, Marker 3118), CASP8 and FADD like apoptosis regulator(CFLAR, Marker 3119), CASP8 and FADD like apoptosis regulator(CFLAR, Marker 3120), CASP8 and FADD like apoptosis regulator( CFLAR, marker 3121), CASP8 and FADD like apoptosis regulator(CFLAR, marker 3122), CFLAR antisense RNA 1(CFLAR-AS1, marker 3123), complement factor properdin(CFP, marker 3124), cystic fibrosis transmembrane conductance regulator(CFTR, marker 3125), cystic fibrosis transmembrane conductance regulator(CFTR, marker 3126), cystic fibrosis transmembrane conductance regulator(CFTR, marker 3127), cystic fibrosis transmembrane conductance regulator(CFTR, marker 3128), glycoprotein hormones, alpha polypeptide(CGA, marker 3129) ), glycoprotein hormones, alpha polypeptide(CGA, marker 3130), chorionic gonadotropin, beta polypeptide /// chorionic gonadotropin, beta polypeptide 5 /// chorionic gonadotropin, beta polypeptide 7(CGB /// CGB5 /// CGB7, marker 3131 ),cell growth regulator with EF-hand domain 1(CGREF1, marker 3132),neuropeptide Y receptor type 4-like /// neuropeptide Y receptor type 4 /// neuropeptide Y receptor Y4(CH17-360D5.1 /// LOC105379861 /// NPY4R, marker 3133), uncharacterized LOC102724558 /// uncharacterized LOC101927468(CH17-408M7.1 /// LOC101927468, marker 3134), putative uncharacterized protein C21orf125 /// long intergenic non-protein coding RNA 319(CH507-42P11 .6 /// LINC00319, marker 3135), uncharacterized LOC105372831 /// uncharacterized LOC105377139(CH507-9B2.8 /// LOC105377139, marker 3136), chondroadherin(CHAD, marker 3137), chondroadherin-like(CHADL, marker 3138) ,chromatin assembly factor 1, subunit A (p150)(CHAF1A, marker 3139),choline O-acetyltransferase(CHAT,marker 3140),coiled-coil-helix-coiled-coil-helix domain containing 3(CHCHD3,marker 3141), coiled-coil-helix , marker 3144), chromodomain helicase DNA binding protein 3 (CHD3, marker 3145), chromodomain helicase DNA binding protein 5 (CHD5, marker 3146), chromodomain helicase DNA binding protein 5 (CHD5, marker 3147), chromodomain helicase DNA binding protein 6 (CHD6, marker 3148), chromodomain helicase DNA binding protein 7 (CHD7, marker 3149), chromodomain helicase DNA binding protein 9 (CHD9, marker 3150), choline dehydrogenase (CHDH
, marker 3151), choline dehydrogenase (CHDH, marker 3152), choline dehydrogenase (CHDH, marker 3153), choline dehydrogenase (CHDH, marker 3154), choline dehydrogenase (CHDH, marker 3155), checkpoint kinase 1 (CHEK1, marker 3156) ,calcium homeostasis endoplasmic reticulum protein(CHERP,marker 3157),checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase /// uncharacterized LOC100128843(CHFR /// LOC100128843,marker 3158),chitinase 3-like 1 (cartilage glycoprotein- 39) (CHI3L1, marker 3159), chitinase 3-like 2 (CHI3L2, marker 3160), chitinase, acidic (CHIA, marker 3161), chitinase, acidic pseudogene 2 (CHIAP2, marker 3162), cysteine rich hydrophobic domain 1 (CHIC1) , marker 3163), cysteine rich hydrophobic domain 1 (CHIC1, marker 3164), chitinase 1 (chitotriosidase) (CHIT1, marker 3165), CHKB antisense RNA 1 (head to head) (CHKB-AS1, marker 3166), cell adhesion molecule L1-like (CHL1, marker 3167), cell adhesion molecule L1-like (CHL1, marker 3168), CHL1 antisense RNA 1 (CHL1-AS1, marker 3169), choroideremia-like (Rab escort protein 2) (CHML, marker 3170 ),choroideremia-like (Rab escort protein 2)(CHML, marker 3171),choroideremia-like (Rab escort protein 2)(CHML, marker 3172),chimerin 2(CHN2, marker 3173),chimerin 2 /// uncharacterized LOC101928168 (CHN2 /// LOC101928168, marker 3174), cysteine and histidine rich domain containing 1(CHORDC1, marker 3175), calcineurin-like EF-hand protein 2(CHP2, marker 3176), choline phosphotransferase 1(CHPT1, marker 3177), chordin (CHRD, marker 3178), chordin (CHRD, marker 3179), chordin-like 2 (CHRDL2, marker 3180), cholinergic receptor, muscarinic 1 (CHRM1, marker 3181), cholinergic receptor, muscarinic 2 (CHRM2, marker 3182) ,cholinergic receptor, muscarinic 3(CHRM3, marker 3183),cholinergic receptor, muscarinic 3(CHRM3,marker 3184),cholinergic receptor, muscarinic 3(CHRM3,marker 3185),cholinergic receptor, muscarinic 3(CHRM3,marker 3186),CHRM3 antisense RNA 2 (CHRM3-AS2, marker 3187), cholinergic receptor, muscarinic 4 (CHRM4, marker 3188), cholinergic receptor, muscarinic 5 (CHRM5, marker 3189), cholinergic receptor, nicotinic alpha 1 (CHRNA1, marker 3190), cholinergic receptor, nicotinic alpha 1(CHRNA1, marker 3191),cholinergic receptor, nicotinic alpha 10(CHRNA10, marker 3192),cholinergic receptor, nicotinic alpha 10(CHRNA10, marker 3193),cholinergic receptor, nicotinic alpha 10(CHRNA10, marker 3194) ,cholinergic receptor, nicotinic alpha 2(CHRNA2, marker 3195),cholinergic receptor, nicotinic alpha 3(CHRNA3, marker 3196),cholinergic receptor, nicotinic alpha 3(CHRNA3, marker 3197),cholinergic receptor, nicotinic alpha 4(CHRNA4, marker) 3198),cholinergic receptor, nicotinic alpha 4 /// uncharacterized LOC102723788(CHRNA4 /// LOC102723788, marker 3199),cholinergic receptor, nicotinic alpha 4 /// uncharacterized LOC102723788(CHRNA4 /// LOC102723788, marker 3200),cholinergic receptor, nicotinic alpha 4 /// uncharacterized LOC102723788(CHRNA4 /// LOC102723788, marker 3201), cholinergic receptor, nicotinic alpha 6(CHRNA6, marker 3202), cholinergic receptor, nicotinic beta 2(CHRNB2, marker 3203), cholinergic receptor, nicotinic beta 3(CHRNB3, Marker 3204), cholinergic receptor, nicotinic beta 3(CHRNB3, Marker 3205), cholinergic receptor, nicotinic beta 4(CHRNB4, Marker 3206), cholinergic receptor, nicotinic delta(CHRND, Marker 3207), cholinergic receptor, nicotinic epsilon (CHRNE, marker 3208), cholinergic receptor, nicotinic epsilon (CHRNE, marker 3209), cholinergic receptor, nicotinic gamma (CHRNG, marker 3210), carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 (CHST1, marker 3211), carbohydrate (keratan sulfate Gal-6) sulfotransferase 1(CHST1, marker 3212),carbohydrate (chondroitin 4) sulfotransferase 13(CHST13, marker 3213),carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15(CHST15, marker 3214) ,carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15(CHST15, marker 3215),carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2(CHST2, marker 3216),carbohydrate (chondroitin 6) sulfotransferase 3(CHST3 , marker 3217), chondroitin sulfate synthase 3 (CHSY3, marker 3218), churchill domain containing 1 (CHURC1, marker 3219), cytokine induced apoptosis inhibitor 1 (CIAPIN1, marker 3220), calcium and integrin binding family member 3 (CIB3, marker 3221),calcium and integrin binding family member 3(CIB3,marker 3222),calcium and integrin binding family member 4(CIB4,marker 3223),cell death-inducing DFFA-like effector a(CIDEA,marker 3224),cell death- inducing DFFA-like effector c (CIDEC, marker 3225), cell death-inducing DFFA-like effector c pseudogene (CIDECP, marker 3226), class II, major histocompatibility complex, transactivator (CIITA, marker 3227), class II, major histocompatibility complex, transactivator (CIITA, marker 3228), class II, major histocompatibility complex, transactivator (CIITA, marker 3229), cartilage intermediate layer protein, nucleotide pyrophosphohydrolase (CILP, marker 3230), cartilage intermediate layer protein 2 (CILP2, marker 3231) , cyclin-dependent kinase 2 interacting protein (CINP, marker 3232), CIRBP antisense RNA 1 (CIRBP-AS1, marker 3233), CIRBP antisense RNA 1 (CIRBP-AS1, marker 3234), CDGSH iron sulfur domain 2 (CISD2, marker 3235), CDGSH iron sulfur domain 3 (CISD3, marker 3236), cytokine inducible SH2-containing protein (CISH, marker 3237), citron rho-interacting serine/threonine kinase (CIT, marker 3238), Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 1(CITED1, marker 3239),Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2(CITED2, marker 3240),CDKN1A interacting zinc finger protein 1( CIZ1, marker 3241), cytoskeleton associated protein 2 (CKAP2, marker 3242), cytoskeleton associated protein 2 (CKAP2, marker 3243), cytoskeleton-associated protein 4 (CKAP4, marker 3244), creatine kinase, muscle (CKM, marker 3245) , creatine kinase, mitochondrial 2 (sarcomeric) (CKMT2, marker 3246), cytoplasmic linker associated protein 2 (CLASP2, marker 3247), Charcot-Leyden crystal galectin (CLC, marker 3248), chloride channel accessory 1 (CLCA1, marker 3249) ,chloride channel accessory 2(CLCA2, marker 3250),chloride channel accessory 2(CLCA2,marker 3251),chloride channel accessory 2(CLCA2,marker 3252),chloride channel accessory 2(CLCA2,marker 3253),chloride channel accessory 3, pseudogene (CLCA3P, marker 3254), chloride channel accessory 4 (CLCA4, marker 3255), chloride channel, voltage-sensitive 1 (CLCN1, marker 3256), chloride channel, voltage-sensitive 4 (CLCN4, marker 3257), chloride channel, voltage-sensitive 4(CLCN4, marker 3258),chloride channel, voltage-sensitive 5(CLCN5, marker 3259),chloride channel, voltage-sensitive 7(CLCN7, marker 3260),chloride channel, voltage-sensitive Ka /// chloride channel, voltage-sensitive Kb(CLCNKA /// CLCNKB,marker 3261),chloride channel, voltage-sensitive Kb(CLCNKB,marker 3262),chloride channel, voltage-sensitive Kb(CLCNKB,marker 3263),chloride channel, voltage- sensitive Kb(CLCNKB, marker 3264),claudin 1(CLDN1,marker 3265),claudin 10 /// uncharacterized LOC101927308(CLDN10 /// LOC101927308,marker 3266),CLDN10 antisense RNA 1(CLDN10-AS1,marker 3267),claudin 11 (CLDN11, marker 3268), claudin 11 /// uncharacterized LOC105374213 (CLDN11 /// LOC105374213, marker 3269), claudin 12 (CLDN12, marker 3270), claudin 14 (CLDN14, marker 3271), claudin 15 (CLDN15, marker 3272), claudin 16 (CLDN16, marker 3273), claudin 17 (CLDN17, marker 3274), claudin 18 (CLDN18, marker 3275), claudin 18 (CLDN18, marker 3276), claudin 18 (CLDN18, marker 3277), claudin 19 (CLDN19, marker 3278), claudin 2 (CLDN2, marker 3279), claudin 20 (CLDN20, marker 3280), claudin 23 (CLDN23, marker 3281), claudin 4 (CLDN4, marker 3282), claudin 5 (CLDN5, marker 3283) ), claudin 8 (CLDN8, marker 3284), claudin 9 (CLDN9, marker 3285), claudin domain containing 1 (CLDND1, marker 3286), claudin domain containing 1 (CLDND1, marker 3287), claudin domain containing 2 (CLDND2, marker 3288),C-type lectin domain family 10, member A(CLEC10A, marker 3289),C-type lectin domain family 11, member A(CLEC11A,marker 3290),C-type lectin domain family 12, member A(CLEC12A, marker 3291),C-type lectin domain family 12, member A(CLEC12A,marker 3292),C-type lectin domain family 12, member A(CLEC12A,marker 3293),C-type lectin domain family 12, member B(CLEC12B , marker 3294),C-type lectin domain family 12, member B(CLEC12B,marker 3295),C-type lectin domain family 14, member A(CLEC14A,marker 3296),C-type lectin domain family 16, member A( CLEC16A, marker 3297), C-type lectin domain family 18, member A /// C-type lectin domain family 18, member C(CLEC18A /// CLEC18C, marker 3298), C-type lectin domain family 1, member A (CLEC1A, marker 3299),C-type lectin domain family 1, member B(CLEC1B,marker 3300),C-type lectin domain family 2, member B(CLEC2B,marker 3301),C-type lectin domain family 2, member B (CLEC2B, marker 3302), C-type lectin domain family 2, member D (CLEC2D, marker 3303), C-type lectin domain family 2, member D (CLEC2D, marker 3304), C-type lectin domain family 2, member D (CLEC2D, marker 3305), C-type lectin domain family 2, member D (CLEC2D, marker 3306), C-type lectin domain family 2, member L (CLEC2L, marker 3307), C-type lectin domain family 3 , member A(CLEC3A, marker 3308),C-type lectin domain family 3, member B /// exosome component 7(CLEC3B /// EXOSC7, marker 3309),C-type lectin domain family 4, member A(CLEC4A, marker 3310),C-type lectin domain family 4, member A(CLEC4A,marker 3311),C-type lectin domain family 4, member C(CLEC4C,marker 3312),C-type lectin domain family 4, member C(CLEC4C ,marker 3313),C-type lectin domain family 4, member D(CLEC4D,marker 3314),C-type lectin domain family 4, member D(CLEC4D,marker 3315),C-type lectin domain family 4, member E( CLEC4E, marker 3316), C-type lectin domain family 4, member E (CLEC4E, marker 3317), C-type lectin domain family 4, member F (CLEC4F, marker 3318), C-type lectin domain family 4, member G (CLEC4G, marker 3319),C-type lectin domain family 4, member M(CLEC4M,marker 3320),C-type lectin domain family 4, member M(CLEC4M,marker 3321),C-type lectin domain family 5, member A (CLEC5A, marker 3322), C-type lectin domain family 7, member A (CLEC7A, marker 3323), C-type lectin domain family 7, member A (CLEC7A, marker 3324), C-type lectin domain family 7, member A (CLEC7A, marker 3325), C-type lectin domain family 7, memb
er A(CLEC7A, marker 3326),C-type lectin domain family 7, member A(CLEC7A,marker 3327),C-type lectin domain family 7, member A(CLEC7A,marker 3328),C-type lectin-like 1 (CLECL1, marker 3329), C-type lectin-like 1 (CLECL1, marker 3330), chloride intracellular channel 1 pseudogene 1 (CLIC1P1, marker 3331), chloride intracellular channel 2 (CLIC2, marker 3332), chloride intracellular channel 3 ( CLIC3, marker 3333), chloride intracellular channel 5(CLIC5, marker 3334), chloride intracellular channel 5(CLIC5, marker 3335), chloride intracellular channel 5(CLIC5, marker 3336), chloride intracellular channel 5(CLIC5, marker 3337), chloride intracellular channel 5 (CLIC5, marker 3338), chloride intracellular channel 6 (CLIC6, marker 3339), clathrin interactor 1 (CLINT1, marker 3340), CAP-GLY domain containing linker protein 1 (CLIP1, marker 3341), CAP-GLY domain containing linker protein 1 (CLIP1, marker 3342), CLIP1 antisense RNA 1 (CLIP1-AS1, marker 3343), CAP-GLY domain containing linker protein 3 (CLIP3, marker 3344), CAP-GLY domain containing linker protein family, member 4 (CLIP4, marker 3345), CDC like kinase 3 (CLK3, marker 3346), CDC like kinase 4 (CLK4, marker 3347), CDC like kinase 4 (CLK4, marker 3348), chronic lymphocytic leukemia up-regulated 1 // / uncharacterized LOC100507616(CLLU1 /// LOC100507616, marker 3349), chronic lymphocytic leukemia up-regulated 1 /// uncharacterized LOC100507616(CLLU1 /// LOC100507616, marker 3350), calmin (calponin-like, transmembrane)(CLMN, marker 3351 ),calmin (calponin-like, transmembrane)(CLMN,marker 3352),calmin (calponin-like, transmembrane)(CLMN,marker 3353),ceroid-lipofuscinosis, neuronal 6, late infantile, variant(CLN6,marker 3354), ceroid-lipofuscinosis, neuronal 6, late infantile, variant(CLN6, marker 3355),cytokine-dependent hematopoietic cell linker(CLNK, marker 3356),cytokine-dependent hematopoietic cell linker(CLNK, marker 3357),cytokine-dependent hematopoietic cell linker (CLNK, marker 3358), clock circadian regulator (CLOCK, marker 3359), cleavage and polyadenylation factor I subunit 1 (CLP1, marker 3360), ClpB homolog, mitochondrial AAA ATPase chaperonin (CLPB, marker 3361), colipase, pancreatic (CLPS , marker 3362), CLPTM1-like (CLPTM1L, marker 3363), clarin 1 (CLRN1, marker 3364), clarin 1 (CLRN1, marker 3365), clarin 1 (CLRN1, marker 3366), CLRN1 antisense RNA 1 (CLRN1-AS1 , marker 3367), clarin 3 (CLRN3, marker 3368), claspin (CLSPN, marker 3369), calsyntenin 2 (CLSTN2, marker 3370), CLSTN2 antisense RNA 1 (CLSTN2-AS1, marker 3371), clathrin, light chain A( CLTA, marker 3372), clathrin, light chain A (CLTA, marker 3373), clathrin, light chain B (CLTB, marker 3374), clathrin, heavy chain (Hc) (CLTC, marker 3375), clathrin, heavy chain (Hc ) (CLTC, marker 3376), clusterin (CLU, marker 3377), clusterin (CLU, marker 3378), clusterin associated protein 1 (CLUAP1, marker 3379), clustered mitochondria (cluA/CLU1) homolog pseudogene 3 (CLUHP3, marker 3380) ), clustered mitochondria (cluA/CLU1) homolog pseudogene 3 (CLUHP3, marker 3381), clusterin-like 1 (retinal) (CLUL1, marker 3382), clavesin 1 (CLVS1, marker 3383), clavesin 2 (CLVS2, marker 3384) ,citrate lyase beta like(CLYBL, marker 3385),citrate lyase beta like(CLYBL,marker 3386),CLYBL antisense RNA 1(CLYBL-AS1,marker 3387),CLYBL antisense RNA 2(CLYBL-AS2,marker 3388),CLYBL intronic transcript 1 (non-protein coding)(CLYBL-IT1 /// RP11-134O15.2, marker 3389),CLYBL intronic transcript 1 (non-protein coding) (CLYBL-IT1 /// RP11-134O15.2, marker 3390), chymase 1, mast cell (CMA1, marker 3391), cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene (CMAHP, marker 3392), cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene (CMAHP, marker 3393), cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene (CMAHP, marker 3394), cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene (CMAHP, marker 3395), cytidine monophosphate N-acetylneuraminic acid synthetase (CMAS, marker 3396), carboxymethylenebutenolidase homolog ( Pseudomonas)(CMBL, marker 3397),Cx(9)-C motif containing 4 /// mature T-cell proliferation 1(CMC4 /// MTCP1, marker 3398),c-Maf inducing protein /// uncharacterized LOC100129617(CMIP /// LOC100129617, marker 3399), chemerin chemokine-like receptor 1(CMKLR1, marker 3400), chemerin chemokine-like receptor 1(CMKLR1, marker 3401), chemerin chemokine-like receptor 1(CMKLR1, marker 3402), cytidine monophosphate (UMP-CMP) kinase 1, cytosolic(CMPK1, marker 3403),CKLF-like MARVEL transmembrane domain containing 1(CMTM1, marker 3404),CKLF-like MARVEL transmembrane domain containing 1(CMTM1, marker 3405),CKLF-like MARVEL transmembrane domain containing 2(CMTM2, marker 3406),CKLF-like MARVEL transmembrane domain containing 3(CMTM3, marker 3407),CKLF-like MARVEL transmembrane domain containing 6(CMTM6, marker 3408),cardiomyopathy associated 5(CMYA5, marker 3409) ,cyclic nucleotide binding domain containing 1(CNBD1, marker 3410),cyclic nucleotide binding domain containing 1(CNBD1, marker 3411),cyclic nucleotide binding domain containing 2(CNBD2, marker 3412),cyclic nucleotide binding domain containing 2(CNBD2, marker 3413),cyclic nucleotide binding domain containing 2(CNBD2, marker 3414),cyclic nucleotide binding domain containing 2(CNBD2, marker 3415),carnosine dipeptidase 1 (metallopeptidase M20 family)(CNDP1, marker 3416),CNDP dipeptidase 2 (metallopeptidase M20 family)(CNDP2, marker 3417),cyclic nucleotide gated channel alpha 1(CNGA1, marker 3418),cyclic nucleotide gated channel alpha 3(CNGA3, marker 3419),cyclic nucleotide gated channel alpha 4(CNGA4, marker 3420),cyclic nucleotide gated channel beta 1(CNGB1, marker 3421),cyclic nucleotide gated channel beta 1(CNGB1, marker 3422),cyclic nucleotide gated channel beta 1(CNGB1, marker 3423),cyclic nucleotide gated channel beta 3(CNGB3, marker 3424), cyclic nucleotide gated channel beta 3(CNGB3, marker 3425), cornichon family AMPA receptor auxiliary protein 2(CNIH2, marker 3426), cornichon family AMPA receptor auxiliary protein 4(CNIH4, marker 3427), connector enhancer of kinase suppressor of Ras 2( CNKSR2, Marker 3428), CNKSR family member 3 (CNKSR3, Marker 3429), CNKSR family member 3 (CNKSR3, Marker 3430), cyclin and CBS domain divalent metal cation transport mediator 1 (CNNM1, Marker 3431), cyclin and CBS domain divalent metal cation transport mediator 2 (CNNM2, marker 3432), cyclin and CBS domain divalent metal cation transport mediator 3 (CNNM3, marker 3433), CCR4-NOT transcription complex subunit 2 (CNOT2, marker 3434), CCR4-NOT transcription complex subunit 2 (CNOT2, marker 3435), CCR4-NOT transcription complex subunit 3 (CNOT3, marker 3436), CCR4-NOT transcription complex subunit 4 (CNOT4, marker 3437), CCR4-NOT transcription complex subunit 4 (CNOT4, marker 3438), CCR4 -NOT transcription complex subunit 6-like(CNOT6L, marker 3439),CCR4-NOT transcription complex subunit 6-like(CNOT6L, marker 3440),2',3'-cyclic nucleotide 3' phosphodiesterase(CNP, marker 3441),canopy FGF signaling regulator 1 (CNPY1, marker 3442), canopy FGF signaling regulator 2 (CNPY2, marker 3443), canopy FGF signaling regulator 3 (CNPY3, marker 3444), canopy FGF signaling regulator 4 (CNPY4, marker 3445), cannabinoid receptor 1 (brain) (CNR1, marker 3446), cannabinoid receptor 1 (brain) (CNR1, marker 3447), cannabinoid receptor 1 (brain) (CNR1, marker 3448), cannabinoid receptor 2 (CNR2, marker 3449), cyclin N-terminal domain containing 1(CNTD1, marker 3450),cyclin N-terminal domain containing 2(CNTD2, marker 3451),ciliary neurotrophic factor /// ZFP91-CNTF readthrough (NMD candidate)(CNTF /// ZFP91-CNTF, marker 3452) ,ciliary neurotrophic factor receptor(CNTFR, marker 3453),CNTFR antisense RNA 1(CNTFR-AS1, marker 3454),CNTFR antisense RNA 1(CNTFR-AS1, marker 3455),contactin 1(CNTN1, marker 3456),contactin 1( CNTN1, marker 3457), contactin 1(CNTN1, marker 3458), contactin 2 (axonal)(CNTN2, marker 3459), contactin 2 (axonal)(CNTN2, marker 3460), contactin 3 (plasmacytoma associated)(CNTN3, marker 3461) ), contactin 4 (CNTN4, marker 3462), contactin 5 (CNTN5, marker 3463), contactin 5 (CNTN5, marker 3464), contactin 6 (CNTN6, marker 3465), contactin associated protein-like 3 (CNTNAP3, marker 3466) ,contactin associated protein-like 3 /// contactin associated protein-like 3B /// contactin associated protein-like 3-like(CNTNAP3 /// CNTNAP3B /// LOC100289279,Marker 3467),contactin associated protein-like 4(CNTNAP4 ,marker 3468),contactin associated protein-like 4(CNTNAP4,marker 3469),contactin associated protein-like 4(CNTNAP4,marker 3470),contactin associated protein-like 4(CNTNAP4,marker 3471),contactin associated protein-like 5 (CNTNAP5, marker 3472), contactin associated protein-like 5(CNTNAP5, marker 3473), contactin associated protein-like 5(CNTNAP5, marker 3474), centrobin, centrosomal BRCA2 interacting protein(CNTROB, marker 3475), centrobin, centrosomal BRCA2 protein interacting (CNTROB, marker 3476), centrobin, centrosomal BRCA2 interacting protein (CNTROB, marker 3477), cytochrome c oxidase assembly factor 1 homolog (COA1, marker 3478), cytochrome c oxidase assembly factor 1 homolog (COA1, marker 3479), cytochrome c oxidase assembly factor 1 homolog(COA1, marker 3480),cytochrome c oxidase assembly factor 3(COA3, marker 3481),cordon-bleu WH2 repeat protein like 1(COBLL1, marker 3482),cordon-bleu WH2 repeat protein like 1 (COBLL1, marker 3483), cordon-bleu WH2 repeat protein like 1 (COBLL1, marker 3484), component of oligomeric golgi complex 1 (COG1, marker 3485), component of oligomeric golgi complex 2 (COG2, marker 3486), component of oligomeric golgi complex 3(COG3, marker 3487),component of oligomeric golgi complex 6(COG6, marker 3488),collagen, type X, alpha 1(COL10A1,marker 3489),collagen, type X, alpha 1(COL10A1,marker 3490) ),collagen, type XI, alpha 2(COL11A2,marker 3491),collagen, type XII, alpha 1(COL12A1,marker 3492),collagen, type XIV, alpha 1(COL14A1,marker 3493),collagen, type XIV, alpha 1(COL14A1, Marker 3494),collagen, type XV, alpha 1(COL15A1,Marker 3495),collagen, type XVII, alpha 1(COL17A1,Marker 3496),COL18A1 antisense RNA 1(COL18A1-AS1,Marker 3497),collagen , type XIX, alpha 1(COL19A1, marker 3498),collagen, type I, alpha 1(COL1A1,marker 3499),collagen, type XX, alpha 1(COL20A1,marker 3500),collagen, type XX, alpha 1(COL20A1 , marker 3501), collagen, type XXII, alpha 1(COL22A1, marker 3502), collagen, type XXIV, alpha 1(COL24
A1, marker 3503),collagen, type XXV, alpha 1(COL25A1,marker 3504),collagen, type XXV, alpha 1(COL25A1,marker 3505),collagen, type XXV, alpha 1(COL25A1,marker 3506),collagen, type XXVI, alpha 1(COL26A1, marker 3507),collagen, type XXVII, alpha 1(COL27A1, marker 3508),collagen, type XXVII, alpha 1(COL27A1,marker 3509),collagen, type XXVIII, alpha 1(COL28A1, marker 3510), collagen, type XXVIII, alpha 1(COL28A1, marker 3511), collagen, type III, alpha 1(COL3A1, marker 3512), collagen, type IV, alpha 3 (Goodpasture antigen)(COL4A3, marker 3513), collagen, type IV, alpha 3 (Goodpasture antigen)(COL4A3, marker 3514),collagen, type IV, alpha 3 (Goodpasture antigen)(COL4A3, marker 3515),collagen, type IV, alpha 3 (Goodpasture antigen)(COL4A3, marker 3516),collagen, type IV, alpha 3 (Goodpasture antigen)(COL4A3,marker 3517),collagen, type IV, alpha 3 (Goodpasture antigen)(COL4A3,marker 3518),collagen, type IV, alpha 3 (Goodpasture antigen )(COL4A3, marker 3519),collagen, type IV, alpha 4(COL4A4,marker 3520),collagen, type IV, alpha 4(COL4A4,marker 3521),collagen, type IV, alpha 4(COL4A4,marker 3522), collagen, type V, alpha 3(COL5A3, marker 3523),collagen, type VI, alpha 1(COL6A1, marker 3524),collagen, type VI, alpha 1(COL6A1,marker 3525),collagen, type VI, alpha 1( COL6A1, Marker 3526),collagen, type VI, alpha 1(COL6A1,Marker 3527),collagen, type VI, alpha 5(COL6A5,Marker 3528),collagen, type VI, alpha 5(COL6A5,Marker 3529),collagen, type VI, alpha 6(COL6A6, marker 3530),collagen, type VI, alpha 6(COL6A6,marker 3531),collagen, type VIII, alpha 1(COL8A1,marker 3532),collagen, type VIII, alpha 1(COL8A1, marker 3533),collagen, type VIII, alpha 2(COL8A2,marker 3534),collagen, type VIII, alpha 2(COL8A2,marker 3535),collagen, type IX, alpha 1(COL9A1,marker 3536),collagen, type IX , alpha 2 (COL9A2, marker 3537), colorectal cancer associated 1 (COLCA1, marker 3538), collectin sub-family member 10 (C-type lectin) (COLEC10, marker 3539), collectin subfamily member 11 (COLEC11, marker 3540) ,collectin sub-family member 12(COLEC12, marker 3541),collagen beta(1-O)galactosyltransferase 2(COLGALT2,marker 3542),COMM domain containing 10(COMMD10,marker 3543),COMM domain containing 10(COMMD10,marker 3544 ),COMM domain containing 4(COMMD4, marker 3545),COMM domain containing 5(COMMD5, marker 3546),COMM domain containing 6(COMMD6, marker 3547),cartilage oligomeric matrix protein(COMP,marker 3548),catechol-O- methyltransferase(COMT, marker 3549),catechol-O-methyltransferase(COMT,marker 3550),catechol-O-methyltransferase(COMT,marker 3551),catechol-O-methyltransferase(COMT,marker 3552),coatomer protein complex subunit alpha( COPA, marker 3553), coatomer protein complex subunit alpha (COPA, marker 3554), coatomer protein complex subunit beta 1 (COPB1, marker 3555), coatomer protein complex subunit beta 2 (beta prime) (COPB2, marker 3556), coatomer protein complex subunit epsilon (COPE, marker 3557), coatomer protein complex subunit gamma 2 (COPG2, marker 3558), COP9 signalosome subunit 4 (COPS4, marker 3559), COP9 signalosome subunit 7B (COPS7B, marker 3560), COP9 signalosome subunit 8( COPS8, marker 3561), coatomer protein complex subunit zeta 2 (COPZ2, marker 3562), coatomer protein complex subunit zeta 2 (COPZ2, marker 3563), coenzyme Q10B (COQ10B, marker 3564), coenzyme Q2 4-hydroxybenzoate polyprenyltransferase (COQ2, marker 3565), coenzyme Q9 (COQ9, marker 3566), corin, serine peptidase (CORIN, marker 3567), corin, serine peptidase (CORIN, marker 3568), corin, serine peptidase (CORIN, marker 3569), coronin, actin binding protein, 1B /// protein tyrosine phosphatase, receptor type, C-associated protein(CORO1B /// PTPRCAP, marker 3570), coronin 6 (CORO6, marker 3571), coronin 7 (CORO7, marker 3572), cortistatin (CORT, marker 3573), COX10 heme A:farnesyltransferase cytochrome c oxidase assembly factor(COX10, marker 3574),COX10 antisense RNA 1 /// uncharacterized LOC100506974(COX10-AS1 /// LOC100506974, marker 3575),COX14 cytochrome c oxidase assembly factor / // glycerol-3-phosphate dehydrogenase 1(COX14 /// GPD1, marker 3576),COX17 cytochrome c oxidase copper chaperone(COX17, marker 3577),COX18 cytochrome c oxidase assembly factor(COX18, marker 3578),COX19 cytochrome c oxidase assembly factor (COX19, marker 3579), cytochrome c oxidase subunit IV isoform 1 (COX4I1, marker 3580), cytochrome c oxidase subunit VIa polypeptide 1 (COX6A1, marker 3581), cytochrome c oxidase subunit VIa polypeptide 2 (COX6A2, marker 3582) ,cytochrome c oxidase subunit VIb polypeptide 2 (testis)(COX6B2, marker 3583),cytochrome c oxidase subunit VIc pseudogene 2(COX6CP2, marker 3584),cytochrome c oxidase subunit VIIb2(COX7B2, marker 3585),cytochrome c oxidase subunit VIIIC( COX8C, marker 3586), ceruloplasmin (ferroxidase) (CP, marker 3587), ceruloplasmin (ferroxidase) (CP, marker 3588), ceruloplasmin (ferroxidase) (CP, marker 3589), ceruloplasmin (ferroxidase) (CP, marker 3590), carboxypeptidase A1 (pancreatic) (CPA1, marker 3591), carboxypeptidase A2 (pancreatic) (CPA2, marker 3592), carboxypeptidase A3 (mast cell) (CPA3, marker 3593), carboxypeptidase A5 (CPA5, marker 3594), carboxypeptidase A6 (CPA6) , marker 3595), carboxypeptidase A6 (CPA6, marker 3596), carboxypeptidase B1 (tissue) (CPB1, marker 3597), carboxypeptidase B2 (plasma) (CPB2, marker 3598), carboxypeptidase D (CPD, marker 3599), CPEB1 antisense RNA 1 (CPEB1-AS1, marker 3600), CPEB1 antisense RNA 1 (CPEB1-AS1, marker 3601), cytoplasmic polyadenylation element binding protein 2 (CPEB2, marker 3602), cytoplasmic polyadenylation element binding protein 2 (CPEB2, marker 3603), CPEB2 antisense RNA 1 (head to head)(CPEB2-AS1, marker 3604),cytoplasmic polyadenylation element binding protein 3(CPEB3, marker 3605),cytoplasmic polyadenylation element binding protein 3(CPEB3, marker 3606),cytoplasmic polyadenylation element binding protein 3( CPEB3, marker 3607), cytoplasmic polyadenylation element binding protein 3 (CPEB3, marker 3608), cytoplasmic polyadenylation element binding protein 4 (CPEB4, marker 3609), cadherin-like and PC-esterase domain containing 1 (CPED1, marker 3610), cadherin -like and PC-esterase domain containing 1(CPED1, marker 3611), complexin 1(CPLX1, marker 3612), complexin 2(CPLX2, marker 3613), complexin 2(CPLX2, marker 3614), complexin 3(CPLX3, marker 3615) ),complexin 3(CPLX3, marker 3616),carboxypeptidase M(CPM,marker 3617),carboxypeptidase M(CPM,marker 3618),carboxypeptidase M(CPM,marker 3619),carboxypeptidase M(CPM,marker 3620),carboxypeptidase M( CPM, marker 3621), carboxypeptidase M (CPM, marker 3622), carboxypeptidase N, polypeptide 2 (CPN2, marker 3623), copine IV (CPNE4, marker 3624), copine V (CPNE5, marker 3625), copine V /// uncharacterized LOC100131043(CPNE5 /// LOC100131043, marker 3626),copine VI (neuronal)(CPNE6, marker 3627),copine VI (neuronal)(CPNE6, marker 3628),copine VII(CPNE7, marker 3629),copine VIII(CPNE8 , marker 3630), copine VIII (CPNE8, marker 3631), carboxypeptidase O (CPO, marker 3632), carboxypeptidase Q (CPQ, marker 3633), carboxypeptidase Q (CPQ, marker 3634), CPS1 intronic transcript 1 (CPS1-IT1, marker 3635), carnitine palmitoyltransferase 1A (liver)(CPT1A, marker 3636), CPX chromosome region, candidate 1(CPXCR1, marker 3637), CPX chromosome region, candidate 1(CPXCR1, marker 3638), carboxypeptidase X (M14 family), member 2(CPXM2, marker 3639),complement component (3b/4b) receptor 1 (Knops blood group)(CR1,marker 3640),complement component (3b/4b) receptor 1 (Knops blood group)(CR1,marker 3641) ,complement component (3b/4b) receptor 1 (Knops blood group)(CR1, marker 3642),complement component (3b/4b) receptor 1 (Knops blood group)(CR1, marker 3643),complement component (3b/4b) receptor 1 (Knops blood group) (CR1, marker 3644), complement component (3d/Epstein Barr virus) receptor 2 (CR2, marker 3645), cellular retinoic acid binding protein 1 (CRABP1, marker 3646), calcium release activated channel regulator 2A(CRACR2A, marker 3647),calcium release activated channel regulator 2A(CRACR2A,marker 3648),calcium release activated channel regulator 2A(CRACR2A,marker 3649),cramped chromatin regulator homolog 1(CRAMP1,marker 3650),carnitine O-acetyltransferase (CRAT, marker 3651),cervical cancer-associated transcript 37(CRAT37,marker 3652),crumbs family member 1, photoreceptor morphogenesis associated(CRB1,marker 3653),crumbs family member 1, photoreceptor morphogenesis associated(CRB1,marker 3654), crumbs family member 2(CRB2, marker 3655),cysteine rich C-terminal 1(CRCT1, marker 3656),cAMP responsive element binding protein 3-like 1(CREB3L1, marker 3657),cAMP responsive element binding protein 3-like 2( CREB3L2, marker 3658), cAMP responsive element binding protein 3-like 3 (CREB3L3, marker 3659), cAMP responsive element binding protein 5 (CREB5, marker 3660), CREB binding protein (CREBBP, marker 3661), CREB3 regulatory factor (CREBRF ,marker 3662),CREB/ATF bZIP transcription factor(CREBZF,marker 3663),CREB/ATF bZIP transcription factor(CREBZF,marker 3664),cellular repressor of E1A-stimulated genes 2(CREG2,marker 3665),cellular repressor of E1A -stimulated genes 2 (CREG2, marker 3666), cAMP responsive element modulator (CREM, marker 3667), corticotropin releasing hormone (CRH, marker 3668), corticotropin releasing hormone (CRH, marker 3669), corticotropin releasing hormone binding protein (CRHBP, marker 3670),corticotropin releasing hormone receptor 1 /// MGC57346-CRHR1 readthrough(CRHR1 /// MGC57346-CRHR1, marker 3671),corticotropin releasing hormone receptor 1 /// MGC57346-CRHR1 readthrough(CRHR1 /// MGC57346-CRHR1, marker 3672), corticotropin releasing hormone receptor 1 /// MGC57346-CRHR1 readthrough(CRHR1 /// MGC57346-CRHR1, marker 3673), CRHR1 intronic transcript 1 /// ADP-ribosylation factor pseudogene(CRHR1-IT1 /// MGC57346, marker 3674), CRHR1 intronic transcript 1 /// ADP-ribosylation factor pseudogene(CRHR1-IT1 /// MGC57346, marker 3675), corticotropin releasing hormone receptor 2(CRHR2, marker 3676), corticotropin releasing hormone receptor 2(CRHR2, marker 3677),cysteine-rich protein 1 (intestinal)(CRIP1, marker 3678),cysteine-rich protein 2(CRIP2, marker 3679),cysteine-rich secretory protein 1(CRISP1, marker 3680),cysteine-rich secretory protein 1( CRISP1, marker 3681), cysteine-rich secretory protein 2 (CRISP2, marker 3682), cysteine-rich secretory protein 3 (CRISP3, marker 3683), cysteine-rich secretory protein LCCL d
omain containing 2(CRISPLD2, marker 3684),cytokine receptor-like factor 2(CRLF2,marker 3685),cardiolipin synthase 1(CRLS1,marker 3686),cornulin(CRNN,marker 3687),ciliary rootlet coiled-coil, rootletin(CROCC) ,marker 3688),ciliary rootlet coiled-coil, rootletin pseudogene 2(CROCCP2,marker 3689),ciliary rootlet coiled-coil, rootletin pseudogene 3(CROCCP3,marker 3690),ciliary rootlet coiled-coil, rootletin pseudogene 3(CROCCP3,marker 3691), carnitine O-octanoyltransferase (CROT, marker 3692), C-reactive protein, pentraxin-related (CRP, marker 3693), C-reactive protein, pentraxin-related (CRP, marker 3694), cartilage acidic protein 1 (CRTAC1) , marker 3695), cartilage acidic protein 1(CRTAC1, marker 3696), cytotoxic and regulatory T-cell molecule(CRTAM, marker 3697), CREB regulated transcription coactivator 1(CRTC1, marker 3698), CREB regulated transcription coactivator 3(CRTC3, marker 3699), cone-rod homeobox(CRX, marker 3700), cone-rod homeobox(CRX, marker 3701), crystallin alpha A /// alpha-crystallin A chain(CRYAA /// LOC102724652, marker 3702), crystallin beta A1 (CRYBA1, marker 3703), crystallin beta A2 (CRYBA2, marker 3704), crystallin beta A4 (CRYBA4, marker 3705), crystallin beta B1 (CRYBB1, marker 3706), crystallin beta B2 (CRYBB2, marker 3707), crystallin beta B2 pseudogene 1 /// uncharacterized LOC105372965(CRYBB2P1 /// LOC105372965, marker 3708), crystallin beta B3(CRYBB3, marker 3709), crystallin gamma A(CRYGA, marker 3710), crystallin gamma B(CRYGB, marker 3711), crystallin gamma C (CRYGC, marker 3712), crystallin gamma N (CRYGN, marker 3713), crystallin gamma S (CRYGS, marker 3714), crystallin gamma S (CRYGS, marker 3715), crystallin lambda 1 (CRYL1, marker 3716), crystallin zeta like 1 (CRYZL1, marker 3717), cysteine sulfinic acid decarboxylase (CSAD, marker 3718), cysteine sulfinic acid decarboxylase (CSAD, marker 3719), CSAG family, member 3 (CSAG3, marker 3720), colony stimulating factor 1 (macrophage )(CSF1, marker 3721), colony stimulating factor 1 (macrophage)(CSF1, marker 3722), colony stimulating factor 1 (macrophage)(CSF1, marker 3723), colony stimulating factor 1 receptor(CSF1R, marker 3724), colony stimulating factor 2 (granulocyte-macrophage)(CSF2, marker 3725), colony stimulating factor 2 (granulocyte-macrophage)(CSF2, marker 3726), colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)(CSF2RA, marker 3727), colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) (CSF2RA, marker 3728), colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) (CSF2RA, marker 3729), colony stimulating factor 2 receptor, betagranul, low-affinity (cytocyte-macrophage) (CSF2RB, marker 3730), colony stimulating factor 3 (CSF3, marker 3731), colony stimulating factor 3 receptor (CSF3R, marker 3732), chondroitin sulfate N-acetylgalactosaminyltransferase 1(CSGALNACT1, marker 3733), chondroitin sulfate N-acetylgalactosaminyltransferase 2(CSGALNACT2, marker 3734), chorionic somatomammotropin hormone 1 (placental lactogen)(CSH1, marker 3735), chorionic somatomammotropin hormone 1 (placental lactogen) /// chorionic somatomammotropin in hormone 2 /// chorionic somatomammotropin hormone-like 1(CSH1 /// CSH2 /// CSHL1, marker 3736), chorionic somatomammotropin hormone 1 (placental lactogen) /// chorionic somatomammotropin hormone-like 1(CSH1 /// CSHL1, marker 3737),chorionic somatomammotropin hormone 1 (placental lactogen) /// chorionic somatomammotropin hormone-like 1(CSH1 /// CSHL1,marker 3738),chorionic somatomammotropin hormone 1 (placental lactogen) /// chorionic somatomammotropin hormone-like 1(CSH1 /// CSHL1, marker 3739), chorionic somatomammotropin hormone 1 (placental lactogen) /// chorionic somatomammotropin hormone-like 1 /// growth hormone 1 /// growth hormone 2(CSH1 /// CSHL1 /// GH1 // / GH2, marker 3740), chorionic somatomammotropin hormone 1 (placental lactogen) /// chorionic somatomammotropin hormone-like 1 /// growth hormone 1 /// growth hormone 2(CSH1 /// CSHL1 /// GH1 /// GH2 ,marker 3741),chorionic somatomammotropin hormone 2(CSH2,marker 3742),chorionic somatomammotropin hormone 2(CSH2,marker 3743),chorionic somatomammotropin hormone 2(CSH2,marker 3744),chorionic somatomammotropin hormone 2(CSH2,marker 3745),chorionic somatomammotropin hormone-like 1(CSHL1, marker 3746),chorionic somatomammotropin hormone-like 1(CSHL1, marker 3747),chorionic somatomammotropin hormone-like 1(CSHL1, marker 3748),chorionic somatomammotropin hormone-like 1(CSHL1, marker 3749) ,chorionic somatomammotropin hormone-like 1(CSHL1, marker 3750),CUB and Sushi multiple domains 1(CSMD1,marker 3751),CUB and Sushi multiple domains 1(CSMD1,marker 3752),CUB and Sushi multiple domains 1(CSMD1,marker 3753),CUB and Sushi multiple domains 1(CSMD1, marker 3754),CUB and Sushi multiple domains 1(CSMD1,marker 3755),CUB and Sushi multiple domains 2(CSMD2,marker 3756),CUB and Sushi multiple domains 2(CSMD2 ,marker 3757),CSMD2 antisense RNA 1(CSMD2-AS1,marker 3758),CUB and Sushi multiple domains 3(CSMD3,marker 3759),casein alpha s1(CSN1S1,marker 3760),casein alpha s2-like A, pseudogene( CSN1S2AP, marker 3761), casein beta (CSN2, marker 3762), casein kappa (CSN3, marker 3763), casein kinase 1, alpha 1 (CSNK1A1, marker 3764), casein kinase 1, alpha 1 pseudogene 1 (CSNK1A1P1, marker 3765) ), casein kinase 1, delta(CSNK1D, marker 3766), casein kinase 1, epsilon /// TPTE and PTEN homologous inositol lipid phosphatase pseudogene /// LOC400927-CSNK1E readthrough(CSNK1E /// LOC400927 /// LOC400927-CSNK1E, marker 3767), casein kinase 1, gamma 1 (CSNK1G1, marker 3768), CSNK1G2 antisense RNA 1 (CSNK1G2-AS1, marker 3769), casein kinase 1, gamma 3 (CSNK1G3, marker 3770), chondroitin sulfate proteoglycan 4 (CSPG4, marker 3771), chondroitin sulfate proteoglycan 4(CSPG4, marker 3772), chondroitin sulfate proteoglycan 4 pseudogene 1, Y-linked(CSPG4P1Y, marker 3773), chondroitin sulfate proteoglycan 4 pseudogene 5(CSPG4P5, marker 3774), centrosome and spindle pole associated protein 1(CSPP1, marker 3775),cysteine-serine-rich nuclear protein 3(CSRNP3, marker 3776),cysteine-serine-rich nuclear protein 3(CSRNP3, marker 3777),cysteine-serine-rich nuclear protein 3(CSRNP3, marker 3778), cysteine-serine-rich nuclear protein 3 (CSRNP3, marker 3779), cysteine and glycine-rich protein 3 (cardiac LIM protein) (CSRP3, marker 3780), cystatin 11 (CST11, marker 3781), cystatin 11( CST11, marker 3782), cystatin 13, pseudogene (CST13P, marker 3783), cystatin C (CST3, marker 3784), cystatin C (CST3, marker 3785), cystatin D (CST5, marker 3786), cystatin E/M (CST6) , marker 3787), cystatin F (leukocystatin) (CST7, marker 3788), cystatin 8 (cystatin-related epididymal specific) (CST8, marker 3789), cystatin 9 (testatin) (CST9, marker 3790), cystatin 9-like( CST9L, marker 3791), cystatin A (stefin A) (CSTA, marker 3792), cystatin B (stefin B) (CSTB, marker 3793), CSTF3 antisense RNA 1 (head to head) (CSTF3-AS1, marker 3794), cystatin-like 1(CSTL1, marker 3795), cancer/testis antigen family 45, member A1 /// cancer/testis antigen family 45, member A10 /// cancer/testis antigen family 45, member A2 /// cancer/testis antigen family 45, member A3 /// cancer/testis antigen family 45, member A4 /// cancer/testis antigen family 45, member A5 /// cancer/testis antigen family 45, member A6 /// cancer/testis antigen family 45, member A7 /// cancer/testis antigen family 45, member A8 /// cancer/testis antigen family 45, member A9(CT45A1 /// CT45A10 /// CT45A2 /// CT45A3 /// CT45A4 /// CT45A5 /// CT45A6 /// CT45A7 /// CT45A8 /// CT45A9, marker 3796), cancer/testis antigen family 45, member A1 /// cancer/testis antigen family 45, member A10 /// cancer/testis antigen family 45, member A2 /// cancer/testis antigen family 45, member A3 /// cancer/testis antigen family 45, member A4 /// cancer/testis antigen family 45, member A5 /// cancer/testis antigen family 45, member A6 /// cancer/testis antigen family 45, member A7 /// cancer/testis antigen family 45, member A8 /// cancer/testis antigen family 45, member A9(CT45A1 /// CT45A10 /// CT45A2 // / CT45A3 /// CT45A4 /// CT45A5 /// CT45A6 /// CT45A7 /// CT45A8 /// CT45A9, marker 3797), cancer/testis antigen family 47, member A1 /// cancer/testis antigen family 47, member A10 /// cancer/testis antigen family 47, member A11 /// cancer/testis antigen family 47, member A12 /// cancer/testis antigen family 47, member A2 /// cancer/testis antigen family 47, member A3 /// cancer/testis antigen family 47, member A4 /// cancer/testis antigen family 47, member A5 /// cancer/testis antigen family 47, member A6 /// cancer/testis antigen family 47, member A7 // / cancer/testis antigen family 47, member A8 /// cancer/testis antigen family 47, member A9(CT47A1 /// CT47A10 /// CT47A11 /// CT47A12 /// CT47A2 /// CT47A3 /// CT47A4 // / CT47A5 /// CT47A6 /// CT47A7 /// CT47A8 /// CT47A9, marker 3798), cancer/testis antigen 55 (CT55, marker 3799), cancer/testis antigen 62 (CT62, marker 3800), cancer/testis antigen 83(CT83, marker 3801), cancer/testis antigen 1A /// cancer/testis antigen 1B(CTAG1A /// CTAG1B, marker 3802), cancer/testis antigen 1A /// cancer/testis antigen 1B(CTAG1A // / CTAG1B, marker 3803), cancer/testis antigen 1A /// cancer/testis antigen 1B(CTAG1A /// CTAG1B, marker 3804), cancer/testis antigen 2(CTAG2, marker 3805), cancer/testis antigen 2(CTAG2 , marker 3806), cutaneous T-cell lymphoma-associated antigen 1 (CTAGE1, marker 3807), CTAGE family, member 11, pseudogene (CTAGE11P, marker 3808), CTAGE family, member 5 (CTAGE5, marker 3809), CTAGE family, member 5(CTAGE5, marker 3810), uncharacterized LOC101927096(CTB-113P19.1, marker 3811), uncharacterized LOC101927115(CTB-12O2.1, marker 3812), uncharacterized LOC101927115(CTB-12O2.1, marker 3813), uncharacterized LOC1053 79181 (CTB-49A3.2, Marker 3814), C-terminal binding protein 1 /// uncharacterized LOC101928588(CTBP1 /// LOC101928588, Marker 3815), CTBP1 antisense RNA (CTBP1-AS, Marker 3816), CTBP1 antisense RNA 2 ( head to head) (CTBP1-AS2, marker 3817), C-terminal binding protein 2 (CTBP2, marker 3818), CTS telomere maintenance complex component 1 (CTC1, marker 3819), CTS telomere maintenance complex component 1 (CTC1, marker 3820) ),CCCTC-binding factor (zinc finger protein)-like(CTCFL, marker 3821),uncharacterized LOC101929081(CTD-2194D22.4,marker 3822),uncharacterized LOC101929176(CTD-2297D10.2,marker 3823),un
characterized LOC101929472(CTD-2350J17.1, marker 3824), uncharacterized LOC101928857(CTD-3080P12.3, marker 3825), cardiotrophin 1(CTF1, marker 3826), CBP80/20-dependent translation initiation factor(CTIF, marker 3827), cytotoxic T-lymphocyte-associated protein 4(CTLA4, marker 3828),cytotoxic T-lymphocyte-associated protein 4(CTLA4, marker 3829),cytotoxic T-lymphocyte-associated protein 4(CTLA4, marker 3830),cytotoxic T-lymphocyte- protein associated 4 (CTLA4, marker 3831), cytotoxic T-lymphocyte-associated protein 4 (CTLA4, marker 3832), catenin (cadherin-associated protein), alpha 3 (CTNNA3, marker 3833), catenin (cadherin-associated protein), alpha 3(CTNNA3, marker 3834),catenin (cadherin-associated protein), alpha 3(CTNNA3, marker 3835),catenin (cadherin-associated protein), alpha 3(CTNNA3, marker 3836),catenin (cadherin-associated protein) , delta 2(CTNND2, marker 3837),cystinosin, lysosomal cystine transporter(CTNS, marker 3838),chymotrypsinogen B1 /// chymotrypsinogen B2(CTRB1 /// CTRB2, marker 3839),chymotrypsinogen B2(CTRB2, marker 3840),chymotrypsin C (caldecrin) (CTRC, marker 3841), chymotrypsin-like (CTRL, marker 3842), cathepsin F (CTSF, marker 3843), cathepsin G (CTSG, marker 3844), cathepsin L pseudogene 8 (CTSLP8, marker 3845), cathepsin S (CTSS, marker 3846), cathepsin S (CTSS, marker 3847), cathepsin S (CTSS, marker 3848), cathepsin W (CTSW, marker 3849), cathepsin Z (CTSZ, marker 3850), cortactin (CTTN, marker 3851),cytosolic thiouridylase subunit 2 homolog (S. pombe)(CTU2, marker 3852),cytosolic thiouridylase subunit 2 homolog (S. pombe)(CTU2, marker 3853),cytosolic thiouridylase subunit 2 homolog (S. pombe)(CTU2, marker 3854),cortexin 3(CTXN3,marker 3855),cortexin 3(CTXN3,marker 3856),cubilin (intrinsic factor-cobalamin receptor)(CUBN,marker 3857),CUE domain containing 1(CUEDC1,marker 3858),cullin 3 (CUL3, marker 3859), cullin 4A (CUL4A, marker 3860), cullin 5 (CUL5, marker 3861), cullin 7 (CUL7, marker 3862), cullin 9 (CUL9, marker 3863), cullin 9 (CUL9, marker 3864) ),cut-like homeobox 2(CUX2,marker 3865),CWF19-like 2, cell cycle control (S. pombe)(CWF19L2,marker 3866),CWF19-like 2, cell cycle control (S. pombe)(CWF19L2, marker 3867), cell wall biogenesis 43 C-terminal homolog(CWH43, marker 3868), cell wall biogenesis 43 C-terminal homolog(CWH43, marker 3869), chemokine (C-X3-C motif) ligand 1(CX3CL1, marker 3870) ),chemokine (C-X3-C motif) ligand 1(CX3CL1, marker 3871),chemokine (C-X3-C motif) receptor 1(CX3CR1, marker 3872),chemokine (C-X3-C motif) receptor 1( CX3CR1, marker 3873),chemokine (CXC motif) ligand 10(CXCL10, marker 3874),chemokine (CXC motif) ligand 11(CXCL11, marker 3875),chemokine (CXC motif) ligand 11(CXCL11, marker 3876),chemokine ( CXC motif) ligand 13(CXCL13, marker 3877),chemokine (CXC motif) ligand 14(CXCL14, marker 3878),chemokine (CXC motif) ligand 17(CXCL17, marker 3879),chemokine (CXC motif) ligand 2(CXCL2, marker 3880),chemokine (CXC motif) ligand 2(CXCL2,marker 3881),chemokine (CXC motif) ligand 5(CXCL5,marker 3882),chemokine (CXC motif) ligand 8(CXCL8,marker 3883),chemokine (CXC motif) ) ligand 8 (CXCL8, marker 3884), chemokine (CXC motif) ligand 9 (CXCL9, marker 3885), chemokine (CXC motif) receptor 1 (CXCR1, marker 3886), chemokine (CXC motif) receptor 2 (CXCR2, marker 3887) ),chemokine (CXC motif) receptor 3(CXCR3,marker 3888),chemokine (CXC motif) receptor 3(CXCR3,marker 3889),chemokine (CXC motif) receptor 5(CXCR5,marker 3890),chemokine (CXC motif) receptor 5(CXCR5, marker 3891),chemokine (CXC motif) receptor 6(CXCR6, marker 3892),chemokine (CXC motif) receptor 6(CXCR6, marker 3893),CXXC finger protein 1 pseudogene 1(CXXC1P1, marker 3894),chromosome X open reading frame 21(CXorf21, marker 3895),chromosome X open reading frame 36(CXorf36, marker 3896),chromosome X open reading frame 36(CXorf36, marker 3897),chromosome ,chromosome X open reading frame 36(CXorf36,marker 3899),chromosome X open reading frame 51A /// chromosome X open reading frame 51B(CXorf51A /// CXorf51B, marker 3901),chromosome X open reading frame 56(CXorf56, marker 3902),chromosome X open reading frame 57(CXorf57, marker 3903) ,chromosome X open reading frame 58(CXorf58, marker 3904),chromosome X open reading frame 65(CXorf65, marker 3905),chromosome lambda constant 1 (Mcg marker) /// immunoglobulin lambda constant 2 (Kern-Oz- marker) /// immunoglobulin lambda constant 3 (Kern-Oz+ marker) /// immunoglobulin lambda constant 7 /// immunoglobulin lambda joining 3 // / immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 1-44 /// immunoglobulin lambda variable 3-25 /// immunoglobulin lambda variable 4-3(CYAT1 /// IGLC1 /// IGLC2 /// IGLC3 // / IGLC7 /// IGLJ3 /// IGLL5 /// IGLV1-44 /// IGLV3-25 /// IGLV4-3, marker 3907), immunoglobulin lambda light chain-like /// immunoglobulin lambda constant 1 (Mcg marker) /// immunoglobulin lambda constant 2 (Kern-Oz- marker) /// immunoglobulin lambda constant 3 (Kern-Oz+ marker) /// immunoglobulin lambda constant 7 /// immunoglobulin lambda joining 3 /// immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 1-44 /// immunoglobulin lambda variable 3-25 /// immunoglobulin lambda variable 4-3 /// immunoglobulin lambda variable 7-43(CYAT1 /// IGLC1 /// IGLC2 /// IGLC3 /// IGLC7 /// IGLJ3 /// IGLL5 /// IGLV1-44 /// IGLV3-25 /// IGLV4-3 /// IGLV7-43, marker 3908), immunoglobulin lambda light chain-like /// immunoglobulin lambda constant 1 (Mcg marker) /// immunoglobulin lambda constant 2 (Kern-Oz- marker) /// immunoglobulin lambda constant 3 (Kern-Oz+ marker) /// immunoglobulin lambda joining 3 /// immunoglobulin lambda variable 1- 44 /// immunoglobulin lambda variable 3-25 /// immunoglobulin lambda variable 4-3(CYAT1 /// IGLC1 /// IGLC2 /// IGLC3 /// IGLJ3 /// IGLV1-44 /// IGLV3-25 / // IGLV4-3, marker 3909), immunoglobulin lambda light chain-like /// immunoglobulin lambda constant 1 (Mcg marker) /// immunoglobulin lambda constant 2 (Kern-Oz- marker) /// immunoglobulin lambda constant 3 (Kern -Oz+ marker) /// immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 1-44 /// immunoglobulin lambda variable 3-25 /// immunoglobulin lambda variable 4-3(CYAT1 /// IGLC1 /// IGLC2 /// IGLC3 /// IGLL5 /// IGLV1-44 /// IGLV3-25 /// IGLV4-3, marker 3910), immunoglobulin lambda light chain-like /// immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 3-1(CYAT1 /// IGLL5 /// IGLV3-1, marker 3911),cytochrome b561 family, member D2(CYB561D2, marker 3912),cytochrome b5 type A (microsomal)(CYB5A, marker 3913),cytochrome b5 reductase 1 (CYB5R1, marker 3914), cytochrome b5 reductase 4 (CYB5R4, marker 3915), cytochrome b5 reductase-like (CYB5RL, marker 3916), cytochrome b5 reductase-like (CYB5RL, marker 3917), cytochrome b-245, alpha polypeptide (CYBA, marker 3918), cytochrome b-245, beta polypeptide (CYBB, marker 3919), cytochrome b-245, beta polypeptide (CYBB, marker 3920), cytochrome b-245, beta polypeptide (CYBB, marker 3921) ,cytochrome b-245, beta polypeptide(CYBB, marker 3922),cytoglobin(CYGB, marker 3923),cylicin, basic protein of sperm head cytoskeleton 1(CYLC1,marker 3924),cylicin, basic protein of sperm head cytoskeleton 1(CYLC1) , marker 3925), cylicin, basic protein of sperm head cytoskeleton 1 (CYLC1, marker 3926), cylicin, basic protein of sperm head cytoskeleton 2 (CYLC2, marker 3927), cylindromatosis (turban tumor syndrome) (CYLD, marker 3928), cylindromatosis (turban tumor syndrome) (CYLD, marker 3929), cylindromatosis (turban tumor syndrome) (CYLD, marker 3930), chymosin pseudogene (CYMP, marker 3931), cytochrome P450, family 11, subfamily A, polypeptide 1 (CYP11A1, marker 3932),cytochrome P450, family 11, subfamily B, polypeptide 1(CYP11B1, marker 3933),cytochrome P450, family 11, subfamily B, polypeptide 1(CYP11B1, marker 3934),cytochrome P450, family 11, subfamily B, polypeptide 2 (CYP11B2, marker 3935),cytochrome P450, family 17, subfamily A, polypeptide 1(CYP17A1, marker 3936),cytochrome P450, family 17, subfamily A, polypeptide 1(CYP17A1, marker 3937),cytochrome P450, family 19, subfamily A, polypeptide 1(CYP19A1, marker 3938),cytochrome P450, family 19, subfamily A, polypeptide 1(CYP19A1, marker 3939),cytochrome P450, family 19, subfamily A, polypeptide 1(CYP19A1, marker 3940),cytochrome P450, family 19, subfamily A, polypeptide 1(CYP19A1, marker 3941),cytochrome P450, family 19, subfamily A, polypeptide 1(CYP19A1, marker 3942),cytochrome P450, family 19, subfamily A, polypeptide 1(CYP19A1, marker 3943) ,cytochrome P450, family 19, subfamily A, polypeptide 1(CYP19A1, marker 3944),cytochrome P450, family 1, subfamily A, polypeptide 2(CYP1A2, marker 3945),cytochrome P450, family 1, subfamily B, polypeptide 1(CYP1B1 ,marker 3946),CYP1B1 antisense RNA 1(CYP1B1-AS1,marker 3947),CYP1B1 antisense RNA 1(CYP1B1-AS1,marker 3948),cytochrome P450, family 21, subfamily A, polypeptide 1 pseudogene /// cytochrome P450, family 21, subfamily A, polypeptide 2(CYP21A1P /// CYP21A2, marker 3949), cytochrome P450, family 24, subfamily A, polypeptide 1(CYP24A1, marker 3950), cytochrome P450, family 26, subfamily B, polypeptide 1(CYP26B1, marker 3951), cytochrome P450, family 26, subfamily B, polypeptide 1(CYP26B1, marker 3952), cytochrome P450, family 27, subfamily B, polypeptide 1(CYP27B1, marker 3953), cytochrome P450, family 2, subfamily A, polypeptide 13(CYP2A13, marker 3954),cytochrome P450, family 2, subfamily A, polypeptide 6(CYP2A6, marker 3955),cytochrome P450, family 2, subfamily A, polypeptide 6(CYP2A6, marker 3956),cytochrome P450, family 2, subfamily A, polypeptide 6(CYP2A6, marker 3957),cytochrome P450, family 2, subfamily A, polypeptide 6(CYP2A6, marker 3958),cytochrome P450, family 2, subfamily A, polypeptide 7(CYP2A7, marker 3959),cytochrome P450 , family 2, subfamily A, polypeptide 7 /// cytochrome P450, family 2, subfamily A, polypeptide 7 pseudogene 1(CYP2A7 /// CYP2A7P1, marker 3960),cytochrome P450, family 2, subfamily A, polypeptide 7 pseudogene 1( CYP2A7P1,mer
car 3961),cytochrome P450, family 2, subfamily B, polypeptide 6(CYP2B6, marker 3962),cytochrome P450, family 2, subfamily B, polypeptide 6(CYP2B6, marker 3963),cytochrome P450, family 2, subfamily B, polypeptide 7, pseudogene (CYP2B7P, marker 3964), cytochrome P450, family 2, subfamily C, polypeptide 18 (CYP2C18, marker 3965), cytochrome P450, family 2, subfamily C, polypeptide 18 (CYP2C18, marker 3966), cytochrome P450, family 2, subfamily C, polypeptide 19(CYP2C19, marker 3967), cytochrome P450, family 2, subfamily C, polypeptide 8(CYP2C8, marker 3968), cytochrome P450, family 2, subfamily C, polypeptide 8(CYP2C8, marker 3969), cytochrome P450, family 2, subfamily C, polypeptide 9(CYP2C9, marker 3970),cytochrome P450, family 2, subfamily C, polypeptide 9(CYP2C9, marker 3971),cytochrome P450, family 2, subfamily C, polypeptide 9(CYP2C9, marker 3972), cytochrome P450, family 2, subfamily C, polypeptide 9(CYP2C9, marker 3973), cytochrome P450, family 2, subfamily C, polypeptide 9(CYP2C9, marker 3974), cytochrome P450, family 2, subfamily C, polypeptide 9(CYP2C9, marker 3975),cytochrome P450, family 2, subfamily C, polypeptide 9(CYP2C9, marker 3976),cytochrome P450, family 2, subfamily D, polypeptide 6(CYP2D6, marker 3977),cytochrome P450, family 2, subfamily D, polypeptide 6 /// cytochrome P450, family 2, subfamily D, polypeptide 7 (gene/pseudogene) /// cytochrome P450, family 2, subfamily D, polypeptide 6 pseudogene(CYP2D6 /// CYP2D7 /// LOC101929829, marker 3978), cytochrome P450, family 2, subfamily D, polypeptide 7 (gene/pseudogene)(CYP2D7, marker 3979), cytochrome P450, family 2, subfamily E, polypeptide 1(CYP2E1, marker 3980), cytochrome P450, family 2 , subfamily E, polypeptide 1(CYP2E1, marker 3981),cytochrome P450, family 2, subfamily E, polypeptide 1(CYP2E1, marker 3982),cytochrome P450, family 2, subfamily F, polypeptide 1(CYP2F1, marker 3983),cytochrome P450, family 2, subfamily J, polypeptide 2(CYP2J2, marker 3984),cytochrome P450, family 2, subfamily R, polypeptide 1(CYP2R1, marker 3985),cytochrome P450, family 2, subfamily T, polypeptide 1, pseudogene(CYP2T1P , marker 3986), cytochrome P450, family 2, subfamily U, polypeptide 1(CYP2U1, marker 3987), cytochrome P450, family 2, subfamily U, polypeptide 1(CYP2U1, marker 3988), cytochrome P450, family 2, subfamily W, polypeptide 1(CYP2W1, marker 3989),cytochrome P450, family 39, subfamily A, polypeptide 1(CYP39A1, marker 3990),cytochrome P450, family 39, subfamily A, polypeptide 1(CYP39A1, marker 3991),cytochrome P450, family 3 , subfamily A, polypeptide 4(CYP3A4, marker 3992),cytochrome P450, family 3, subfamily A, polypeptide 4(CYP3A4, marker 3993),cytochrome P450, family 3, subfamily A, polypeptide 4(CYP3A4, marker 3994),cytochrome P450, family 3, subfamily A, polypeptide 4(CYP3A4, marker 3995),cytochrome P450, family 3, subfamily A, polypeptide 43(CYP3A43, marker 3996),cytochrome P450, family 3, subfamily A, polypeptide 43(CYP3A43, marker 3997),cytochrome P450, family 3, subfamily A, polypeptide 43(CYP3A43, marker 3998),cytochrome P450, family 3, subfamily A, polypeptide 43(CYP3A43, marker 3999),cytochrome P450, family 3, subfamily A, polypeptide 5 (CYP3A5, marker 4000),cytochrome P450, family 3, subfamily A, polypeptide 5(CYP3A5, marker 4001),cytochrome P450, family 3, subfamily A, polypeptide 5(CYP3A5, marker 4002),cytochrome P450, family 3, subfamily A, polypeptide 5(CYP3A5, marker 4003),cytochrome P450, family 3, subfamily A, polypeptide 7(CYP3A7, marker 4004),cytochrome P450, family 3, subfamily A, polypeptide 7 /// CYP3A7-CYP3A51P readthrough(CYP3A7 / // CYP3A7-CYP3A51P, marker 4005), CYP3A7-CYP3A51P readthrough(CYP3A7-CYP3A51P, marker 4006), cytochrome P450, family 46, subfamily A, polypeptide 1(CYP46A1, marker 4007), cytochrome P450, family 4, subfamily A, polypeptide 11(CYP4A11, marker 4008), cytochrome P450, family 4, subfamily A, polypeptide 11(CYP4A11, marker 4009), cytochrome P450, family 4, subfamily A, polypeptide 11(CYP4A11, marker 4010), cytochrome P450, family 4 , subfamily A, polypeptide 11 /// cytochrome P450, family 4, subfamily A, polypeptide 22(CYP4A11 /// CYP4A22, marker 4011),cytochrome P450, family 4, subfamily A, polypeptide 11 /// cytochrome P450, family 4 , subfamily A, polypeptide 22(CYP4A11 /// CYP4A22, marker 4012),cytochrome P450, family 4, subfamily B, polypeptide 1(CYP4B1, marker 4013),cytochrome P450, family 4, subfamily B, polypeptide 1(CYP4B1, marker 4014),cytochrome P450, family 4, subfamily F, polypeptide 11(CYP4F11, marker 4015),cytochrome P450, family 4, subfamily F, polypeptide 12(CYP4F12, marker 4016),cytochrome P450, family 4, subfamily F, polypeptide 2 (CYP4F2, marker 4017),cytochrome P450, family 4, subfamily F, polypeptide 2 /// cytochrome P450, family 4, subfamily F, polypeptide 3(CYP4F2 /// CYP4F3, marker 4018),cytochrome P450, family 4, subfamily F, polypeptide 22(CYP4F22, marker 4019),cytochrome P450, family 4, subfamily F, polypeptide 29, pseudogene(CYP4F29P, marker 4020),cytochrome P450, family 4, subfamily F, polypeptide 3(CYP4F3, marker 4021),cytochrome P450, family 4, subfamily F, polypeptide 30, pseudogene(CYP4F30P, marker 4022),cytochrome P450, family 4, subfamily F, polypeptide 35, pseudogene(CYP4F35P, marker 4023),cytochrome P450, family 4, subfamily F, polypeptide 8 (CYP4F8, marker 4024),cytochrome P450, family 4, subfamily V, polypeptide 2(CYP4V2, marker 4025),cytochrome P450, family 4, subfamily V, polypeptide 2(CYP4V2, marker 4026),cytochrome P450, family 4, subfamily V, polypeptide 2 /// kallikrein B1(CYP4V2 /// KLKB1, marker 4027), cytochrome P450, family 4, subfamily V, polypeptide 2 /// kallikrein B1(CYP4V2 /// KLKB1, marker 4028), cytochrome P450, family 4, subfamily Z, polypeptide 1(CYP4Z1, marker 4029), cytochrome P450, family 4, subfamily Z, polypeptide 2, pseudogene(CYP4Z2P, marker 4030), CYP51A1 antisense RNA 1(CYP51A1-AS1, marker 4031), cytochrome P450 , family 7, subfamily A, polypeptide 1(CYP7A1, marker 4032),cytochrome P450, family 7, subfamily B, polypeptide 1(CYP7B1, marker 4033),cytochrome P450, family 8, subfamily B, polypeptide 1(CYP8B1, marker 4034 ),cystin 1(CYS1, marker 4035),cysteinyl leukotriene receptor 1(CYSLTR1,marker 4036),cysteinyl leukotriene receptor 1(CYSLTR1,marker 4037),cysteinyl leukotriene receptor 1(CYSLTR1,marker 4038),cysteinyl leukotriene receptor 2(CYSLTR2) , marker 4039), cysteine-rich tail protein 1 (CYSRT1, marker 4040), cytohesin 1 (CYTH1, marker 4041), cytohesin 2 (CYTH2, marker 4042), cytohesin 3 (CYTH3, marker 4043), cytohesin 3 (CYTH3, marker 4044), cytohesin 3 (CYTH3, marker 4045), cytohesin 4 (CYTH4, marker 4046), cytohesin 4 (CYTH4, marker 4047), cytohesin 4 (CYTH4, marker 4048), cytohesin 1 interacting protein (CYTIP, marker 4049) ,D21S2088E(D21S2088E,Marker 4050),D21S2088E(D21S2088E,Marker 4051),uncharacterized D21S2090E(D21S2090E,Marker 4052),dishevelled associated activator of morphogenesis 1(DAAM1,marker 4053),dishevelled associated activator of morphogenesis 2(DAAM2, marker 4054 ),Dab, reelin signal transducer, homolog 1 (Drosophila)(DAB1, marker 4055),DAB1 antisense RNA 1(DAB1-AS1, marker 4056),Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)(DAB2, marker 4057 ),Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)(DAB2, marker 4058),Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila)(DAB2, marker 4059),DAB2 interacting protein(DAB2IP, marker 4060), DAB2 interacting protein(DAB2IP, marker 4061),dishevelled-binding antagonist of beta-catenin 2(DACT2,marker 4062),dishevelled-binding antagonist of beta-catenin 3(DACT3,marker 4063),DACT3 antisense RNA 1(DACT3-AS1) , marker 4064), diacylglycerol lipase, alpha (DAGLA, marker 4065), DAN domain family member 5, BMP antagonist (DAND5, marker 4066), D-amino acid oxidase (DAO, marker 4067), D-amino acid oxidase activator (DAOA, marker 4068), D-amino acid oxidase activator (DAOA, marker 4069), DAOA antisense RNA 1 (DAOA-AS1, marker 4070), death associated protein 3 (DAP3, marker 4071), death-associated protein kinase 2 (DAPK2, marker 4072), death-associated protein kinase 2(DAPK2, marker 4073), death-associated protein kinase 3(DAPK3, marker 4074), death associated protein like 1(DAPL1, marker 4075), dual adapter of phosphotyrosine and 3-phosphoinositides(DAPP1, marker 4076), dual adapter of phosphotyrosine and 3-phosphoinositides(DAPP1, marker 4077), dual adapter of phosphotyrosine and 3-phosphoinositides(DAPP1, marker 4078), dual adapter of phosphotyrosine and 3-phosphoinositides(DAPP1 ,marker 4079),DARS antisense RNA 1(DARS-AS1,marker 4080),dynein assembly factor with WDR repeat domains 1(DAW1,marker 4081),deleted in azoospermia 1 /// deleted in azoospermia 2 /// deleted in azoospermia 3 /// deleted in azoospermia 4(DAZ1 /// DAZ2 /// DAZ3 /// DAZ4, marker 4082),deleted in azoospermia 1 /// deleted in azoospermia 2 /// deleted in azoospermia 3 /// deleted in azoospermia 4(DAZ1 /// DAZ2 /// DAZ3 /// DAZ4,marker 4083),deleted in azoospermia 1 /// deleted in azoospermia 2 /// deleted in azoospermia 3 /// deleted in azoospermia 4(DAZ1 // / DAZ2 /// DAZ3 /// DAZ4, marker 4084), deleted in azoospermia 1 /// deleted in azoospermia 2 /// deleted in azoospermia 3 /// deleted in azoospermia 4(DAZ1 /// DAZ2 /// DAZ3 /// DAZ4, Marker 4085), deleted in azoospermia 1 /// deleted in azoospermia 2 /// deleted in azoospermia 3 /// deleted in azoospermia 4(DAZ1 /// DAZ2 /// DAZ3 /// DAZ4, Marker 4086), deleted in azoospermia 1 /// deleted in azoospermia 2 /// deleted in azoospermia 3 /// deleted in azoospermia 4(DAZ1 /// DAZ2 /// DAZ3 /// DAZ4, Marker 4087), DAZ associated protein 2 (DAZAP2, marker 4088), D4Z4 binding element transcript (non-protein coding) /// double homeobox 3 /// double homeobox 4 /// double homeobox 4 like 1 /// double homeobox 4 like 10 /// double homeobox 4 like 11 /// double homeobox 4 like 12 /// double homeobox 4 like 13 /// double homeobox 4 like 14 /// double homeobox 4 like 15 /// double homeobox 4 like 2 /// double homeobox 4 like 20 /// double homeobox 4 like 21 /// double homeobox 4 like 22 /// double homeobox 4 like 23 /// double homeobox 4 like 24 /// double homeobox 4 like 25 /// double homeobox 4 like 3 /// double homeobox 4 like 4 /// double homeobox 4 like 5 /// double homeobox 4 like 6 /// double homeobox 4 like 7 /// double homeobox 4 like 8 /// dou
ble homeobox protein 4-like protein 4(DBET /// DUX3 /// DUX4 /// DUX4L1 /// DUX4L10 /// DUX4L11 /// DUX4L12 /// DUX4L13 /// DUX4L14 /// DUX4L15 /// DUX4L2 /// DUX4L20 /// DUX4L21 /// DUX4L22 /// DUX4L23 /// DUX4L24 /// DUX4L25 /// DUX4L3 /// DUX4L4 /// DUX4L5 /// DUX4L6 /// DUX4L7 /// DUX4L8 // / LOC100287823, Marker 4089), D4Z4 binding element transcript (non-protein coding) /// double homeobox 4 /// double homeobox 4 like 1 /// double homeobox 4 like 10 /// double homeobox 4 like 11 /// double homeobox 4 like 12 /// double homeobox 4 like 13 /// double homeobox 4 like 14 /// double homeobox 4 like 15 /// double homeobox 4 like 2 /// double homeobox 4 like 20 /// double homeobox 4 like 21 /// double homeobox 4 like 22 /// double homeobox 4 like 23 /// double homeobox 4 like 24 /// double homeobox 4 like 25 /// double homeobox 4 like 3 /// double homeobox 4 like 4 /// double homeobox 4 like 5 /// double homeobox 4 like 6 /// double homeobox 4 like 7 /// double homeobox 4 like 8(DBET /// DUX4 /// DUX4L1 /// DUX4L10 /// DUX4L11 /// DUX4L12 /// DUX4L13 /// DUX4L14 /// DUX4L15 /// DUX4L2 /// DUX4L20 /// DUX4L21 /// DUX4L22 /// DUX4L23 /// DUX4L24 /// DUX4L25 /// DUX4L3 / // DUX4L4 /// DUX4L5 /// DUX4L6 /// DUX4L7 /// DUX4L8, marker 4090), DBF4 zinc finger B(DBF4B, marker 4091), DBF4 zinc finger B(DBF4B, marker 4092), dopamine beta-hydroxylase (dopamine beta-monooxygenase) (DBH, marker 4093), dopamine beta-hydroxylase (dopamine beta-monooxygenase) (DBH, marker 4094), DBH antisense RNA 1 (DBH-AS1, marker 4095), diazepam binding inhibitor-like 5, pseudogene (DBIL5P, marker 4096), diazepam binding inhibitor-like 5 pseudogene 2 (DBIL5P2, marker 4097), D site of albumin promoter (albumin D-box) binding protein (DBP, marker 4098), dihydrolipoamide branched chain transacylase E2 (DBT , Marker 4099), DDB1 and CUL4 associated factor 13 (DCAF13, Marker 4100), DDB1 and CUL4 associated factor 13 (DCAF13, Marker 4101), DDB1 and CUL4 associated factor 15 (DCAF15, Marker 4102), DDB1 and CUL4 associated factor 16 (DCAF16, marker 4103),DDB1 and CUL4 associated factor 4(DCAF4,marker 4104),DDB1 and CUL4 associated factor 4-like 1(DCAF4L1,marker 4105),DDB1 and CUL4 associated factor 4-like 2(DCAF4L2,marker 4106 ),DDB1 and CUL4 associated factor 4-like 2(DCAF4L2, marker 4107),DDB1 and CUL4 associated factor 5(DCAF5, marker 4108),DDB1 and CUL4 associated factor 6(DCAF6, marker 4109),DDB1 and CUL4 associated factor 7 (DCAF7, marker 4110),DDB1 and CUL4 associated factor 7(DCAF7,marker 4111),DDB1 and CUL4 associated factor 8(DCAF8,marker 4112),DDB1 and CUL4 associated factor 8(DCAF8,marker 4113),DDB1 and CUL4 associated factor 8(DCAF8, marker 4114),DDB1 and CUL4 associated factor 8(DCAF8,marker 4115),DDB1 and CUL4 associated factor 8(DCAF8,marker 4116),DDB1 and CUL4 associated factor 8-like 2 /// uncharacterized locus FLJ32742 (DCAF8L2 /// FLJ32742, marker 4117), dephospho-CoA kinase domain containing(DCAKD, marker 4118), dendritic cell-associated nuclear protein /// TRAF-interacting protein with forkhead-associated domain, family member B(DCANP1 // / TIFAB, Marker 4119), discoidin, CUB and LCCL domain containing 2(DCBLD2, Marker 4120), DCC netrin 1 receptor(DCC, Marker 4121), DCC netrin 1 receptor(DCC, Marker 4122), dermcidin(DCD, Marker 4123) ),doublecortin domain containing 1 /// doublecortin domain containing 5(DCDC1 /// DCDC5, marker 4124),doublecortin domain containing 2(DCDC2, marker 4125),doublecortin domain containing 2B(DCDC2B, marker 4126),dachsous cadherin-related 1 (DCHS1, marker 4127), dachsous cadherin-related 2 (DCHS2, marker 4128), dachsous cadherin-related 2 (DCHS2, marker 4129), doublecortin-like kinase 1 (DCLK1, marker 4130), doublecortin-like kinase 1 ( DCLK1, marker 4131), doublecortin-like kinase 2 (DCLK2, marker 4132), doublecortin-like kinase 2 (DCLK2, marker 4133), doublecortin-like kinase 2 (DCLK2, marker 4134), doublecortin-like kinase 3 (DCLK3, marker 4135), DNA cross-link repair 1C (DCLRE1C, marker 4136), DNA cross-link repair 1C (DCLRE1C, marker 4137), decorin (DCN, marker 4138), decorin (DCN, marker 4139), decorin (DCN, marker 4140), decorin(DCN, marker 4141), decorin /// uncharacterized LOC101928584(DCN /// LOC101928584, marker 4142), decorin /// uncharacterized LOC101928584(DCN /// LOC101928584, marker 4143), DC-STAMP domain containing 1 (DCST1, marker 4144), DC-STAMP domain containing 2 (DCST2, marker 4145), dendrocyte expressed seven transmembrane protein (DCSTAMP, marker 4146), dopachrome tautomerase (DCT, marker 4147), dopachrome tautomerase (DCT, marker 4148) ), dopachrome tautomerase (DCT, marker 4149), dopachrome tautomerase (DCT, marker 4150), dynactin 1 (DCTN1, marker 4151), DCTN1 antisense RNA 1 (DCTN1-AS1, marker 4152), dynactin 2 (p50) (DCTN2, marker 4153), dynactin 2 (p50)(DCTN2, marker 4154), dynactin 4 (p62)(DCTN4, marker 4155), dynactin 5 (p25)(DCTN5, marker 4156), DCN1, defective in cullin neddylation 1, domain containing 1(DCUN1D1, Marker 4157),DCN1, defective in cullin neddylation 1, domain containing 1(DCUN1D1, Marker 4158),DCN1, defective in cullin neddylation 1, domain containing 5(DCUN1D5, Marker 4159),DET1 and DDB1 associated 1( DDA1, marker 4160), dopa decarboxylase (DDC, marker 4161), DDC antisense RNA 1 (DDC-AS1, marker 4162), DDHD domain containing 1 (DDHD1, marker 4163), DNA-damage inducible 1 homolog 1 (DDI1, marker 4164), DNA-damage inducible 1 homolog 2 (DDI2, marker 4165), dendrin (DDN, marker 4166), D-aspartate oxidase (DDO, marker 4167), D-aspartate oxidase (DDO, marker 4168), DDR1 antisense RNA 1 (head to head) (DDR1-AS1, marker 4169), DDR1 antisense RNA 1 (head to head) (DDR1-AS1, marker 4170), discoidin domain receptor tyrosine kinase 2 (DDR2, marker 4171), DEAD (Asp- Glu-Ala-Asp) box polypeptide 10 (DDX10, marker 4172), DDX11 antisense RNA 1 (DDX11-AS1, marker 4173), DEAD (Asp-Glu-Ala-Asp) box polypeptide 19A (DDX19A, marker 4174), DEAD (Asp-Glu-Ala-Asp) box polypeptide 19B(DDX19B, marker 4175),DEAD (Asp-Glu-Ala-Asp) box polypeptide 28(DDX28, marker 4176),DEAD (Asp-Glu-Ala-Asp) box polypeptide 31(DDX31, marker 4177),DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked(DDX3X, marker 4178),DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked (DDX3X, marker 4179),DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked(DDX3Y,marker 4180),DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked(DDX3Y , Marker 4181), DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked(DDX3Y, Marker 4182), DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked(DDX3Y, Marker 4183),DEAD (Asp-Glu-Ala-Asp) box polypeptide 4(DDX4, marker 4184),DEAD (Asp-Glu-Ala-Asp) box helicase 42(DDX42, marker 4185),DEAD (Asp-Glu-Ala -Asp) box polypeptide 43(DDX43, marker 4186),DEAD (Asp-Glu-Ala-Asp) box polypeptide 49(DDX49, marker 4187),DEAD (Asp-Glu-Ala-Asp) box polypeptide 50(DDX50, marker 4188),DEAD (Asp-Glu-Ala-Asp) box polypeptide 51(DDX51, marker 4189),DEAD (Asp-Glu-Ala-Asp) box polypeptide 51(DDX51, marker 4190),DEAD (Asp-Glu-Ala -Asp) box polypeptide 52(DDX52, marker 4191),DEAD (Asp-Glu-Ala-Asp) box polypeptide 53(DDX53, marker 4192),DEAD (Asp-Glu-Ala-Asp) box helicase 56(DDX56, marker 4193),DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like(DDX60L, marker 4194),DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like(DDX60L, marker 4195),DEAF1 transcription factor (DEAF1, marker 4196), deleted in esophageal cancer 1(1-Dec, marker 4197), DEF6 guanine nucleotide exchange factor(DEF6, marker 4198), DEF6 guanine nucleotide exchange factor(DEF6, marker 4199), defensin, alpha 1 / // defensin, alpha 1B /// defensin, alpha 3, neutrophil-specific(DEFA1 /// DEFA1B /// DEFA3, marker 4200), defensin, alpha 4, corticostatin(DEFA4, marker 4201), defensin, alpha 5, Paneth cell-specific(DEFA5, marker 4202), defensin, alpha 6, Paneth cell-specific(DEFA6, marker 4203), defensin, beta 1(DEFB1, marker 4204), defensin, beta 103A /// defensin, beta 103B( DEFB103A /// DEFB103B, marker 4205), defensin, beta 104A /// defensin, beta 104B(DEFB104A /// DEFB104B, marker 4206), defensin, beta 105A /// defensin, beta 105B(DEFB105A /// DEFB105B, marker 4207), defensin, beta 106A /// defensin, beta 106B(DEFB106A /// DEFB106B, marker 4208), defensin, beta 107A /// defensin, beta 107B(DEFB107A /// DEFB107B, marker 4209), defensin, beta 108B(DEFB108B, marker 4210),defensin, beta 114(DEFB114,marker 4211),defensin, beta 118(DEFB118,marker 4212),defensin, beta 119(DEFB119,marker 4213),defensin, beta 119(DEFB119,marker 4214),defensin, beta 121(DEFB121,marker 4215),defensin, beta 122 (pseudogene)(DEFB122,marker 4216),defensin, beta 123(DEFB123,marker 4217),defensin, beta 124(DEFB124,marker 4218), defensin, beta 125(DEFB125, marker 4219),defensin, beta 126(DEFB126,marker 4220),defensin, beta 126(DEFB126,marker 4221),defensin, beta 127(DEFB127,marker 4222),defensin, beta 129(DEFB129) , marker 4223), defensin, beta 132(DEFB132, marker 4224), defensin, beta 4A /// defensin, beta 4B(DEFB4A /// DEFB4B, marker 4225), defensin, theta 1 pseudogene /// defensin, theta 1 pseudogene 2(DEFT1P /// DEFT1P2, marker 4226), delta(4)-desaturase, sphingolipid 2(DEGS2, marker 4227), DENN/MADD domain containing 1B(DENND1B, marker 4228), DENN/MADD domain containing 1B(DENND1B , Marker 4229), DENN/MADD domain containing 1B(DENND1B, Marker 4230), DENN/MADD domain containing 1C(DENND1C, Marker 4231), DENN/MADD domain containing 2C(DENND2C, Marker 4232), DENN/MADD domain containing 2D (DENND2D, Marker 4233), DENN/MADD domain containing 2D(DENND2D, Marker 4234), DENN/MADD domain containing 3(DENND3, Marker 4235), DENN/MADD domain containing 3(DENND3, Marker 4236), DENN/MADD domain containing 4A(DENND4A, marker 4237),DENN/MADD domain containing 4C(DENND4C,marker 4238),DENN/MADD domain containing 5B(DENND5B,marker 4239),DENN/MADD domain containing 6B(DENND6B,marker 4240),DENN/ MADD domain containing 6B(DENND6B, marker 4241),DENN/MADD domain containing 6B(DENND6B, marker 4242),DEPDC1 antisense RNA 1(DEPDC1-AS1,marker 4243),DEP domain containing 4(DEPDC4,marker 4244),DEP domain containing 4 (DEPDC4, marker 4245), DEP domain containing MTOR-interacting protein (DEPTOR, marker 4246), derlin 1 (DERL1, marker 4247), derlin 3 (DERL3, marker 4248), derlin 3 (DERL3, marker 4249), desmin(DES, marker 4250),desmin(DES,marker 4251),desmin /// SPT20 homolog, SAGA complex component(DES /// SUPT20H,marker 4252),deafness, autosomal recessive 31(DFNB31,marker 4253),DiGeorge syndrome critical region gene 10 (non-protein codi
ng)(DGCR10, marker 4254),DiGeorge syndrome critical region gene 12 (non-protein coding)(DGCR12, marker 4255),DiGeorge syndrome critical region gene 12 (non-protein coding)(DGCR12, marker 4256),DiGeorge syndrome critical region gene 14(DGCR14, marker 4257),DiGeorge syndrome critical region gene 14(DGCR14, marker 4258),DiGeorge syndrome critical region gene 14(DGCR14,marker 4259),DiGeorge syndrome critical region gene 5 (non-protein coding)(DGCR5 , Marker 4260), DiGeorge syndrome critical region gene 5 (non-protein coding) (DGCR5, Marker 4261), DiGeorge syndrome critical region gene 5 (non-protein coding) (DGCR5, Marker 4262), DiGeorge syndrome critical region gene 5 ( non-protein coding)(DGCR5, marker 4263),DiGeorge syndrome critical region gene 5 (non-protein coding) /// uncharacterized LOC100287576(DGCR5 /// LOC100287576, marker 4264),DiGeorge syndrome critical region gene 6-like(DGCR6L , Marker 4265), DiGeorge syndrome critical region gene 7 (DGCR7, Marker 4266), DiGeorge syndrome critical region gene 7 (DGCR7, Marker 4267), DiGeorge syndrome critical region gene 9 (non-protein coding) (DGCR9, Marker 4268), diacylglycerol kinase alpha (DGKA, marker 4269), diacylglycerol kinase, beta 90kDa (DGKB, marker 4270), diacylglycerol kinase, beta 90kDa (DGKB, marker 4271), diacylglycerol kinase, epsilon 64kDa (DGKE, marker 4272), diacylglycerol kinase, epsilon 64kDa (DGKE, marker 4273), diacylglycerol kinase, epsilon 64kDa (DGKE, marker 4274), diacylglycerol kinase, epsilon 64kDa (DGKE, marker 4275), diacylglycerol kinase gamma (DGKG, marker 4276), diacylglycerol kinase gamma (DGKG, marker 4277) ),diacylglycerol kinase, eta(DGKH, marker 4278),diacylglycerol kinase, eta(DGKH,marker 4279),diacylglycerol kinase, iota(DGKI,marker 4280),diacylglycerol kinase, iota /// uncharacterized LOC100128727(DGKI /// LOC100128727 , marker 4281), diacylglycerol kinase theta(DGKQ, marker 4282), diacylglycerol kinase, zeta(DGKZ, marker 4283), deoxyguanosine kinase(DGUOK, marker 4284), dihydrodiol dehydrogenase (dimeric)(DHDH, marker 4285), deserthog( DHH, marker 4286), dihydroorotate dehydrogenase (quinone) (DHODH, marker 4287), dihydroorotate dehydrogenase (quinone) (DHODH, marker 4288), dehydrogenase/reductase (SDR family) member 12 (DHRS12, marker 4289), dehydrogenase/reductase ( SDR family) member 12 (DHRS12, marker 4290), dehydrogenase/reductase (SDR family) member 2 (DHRS2, marker 4291), DHRS4-AS1 (marker 4291), dehydrogenase/reductase (SDR family) member 7 (DHRS7, marker 4293) ), dehydrogenase/reductase (SDR family) member 7 (DHRS7, marker 4294), dehydrogenase/reductase (SDR family) member 7C (DHRS7C, marker 4295), dehydrogenase/reductase (SDR family) member 9 (DHRS9, marker 4296), dehydrogenase/reductase (SDR family) member 9(DHRS9, marker 4297),dehydrogenase/reductase (SDR family) member 9(DHRS9, marker 4298),DEAH (Asp-Glu-Ala-His) box helicase 30(DHX30, marker 4299) ), DEAH (Asp-Glu-Ala-His) box helicase 30 (DHX30, marker 4300), DEAH (Asp-Glu-Ala-His) box polypeptide 34 (DHX34, marker 4301), DEAH (Asp-Glu-Ala- His) box polypeptide 35(DHX35, marker 4302),DEAH (Asp-Glu-Ala-His) box polypeptide 36(DHX36, marker 4303),DEAH (Asp-Glu-Ala-Asp/His) box polypeptide 57(DHX57, marker 4304), DEXH (Asp-Glu-X-His) box polypeptide 58 (DHX58, marker 4305), DEAH (Asp-Glu-Ala-His) box polypeptide 8 (DHX8, marker 4306), diaphanous-related formin 1( DIAPH1, marker 4307), DIAPH2 antisense RNA 1 (DIAPH2-AS1, marker 4308), DIAPH2 antisense RNA 1 (DIAPH2-AS1, marker 4309), diaphanous-related formin 3 (DIAPH3, marker 4310), diaphanous-related formin 3( DIAPH3, marker 4311), DIAPH3 antisense RNA 1 (DIAPH3-AS1, marker 4312), DIAPH3 antisense RNA 1 (DIAPH3-AS1, marker 4313), DIAPH3 antisense RNA 1 (DIAPH3-AS1, marker 4314), dicer 1, ribonuclease type III (DICER1, marker 4315), dicer 1, ribonuclease type III (DICER1, marker 4316), dicer 1, ribonuclease type III (DICER1, marker 4317), DICER1 antisense RNA 1 (DICER1-AS1, marker 4318), DIM1 dimethyladenosine transferase 1 homolog (DIMT1, marker 4319), deiodinase, iodothyronine, type I (DIO1, marker 4320), deiodinase, iodothyronine, type II (DIO2, marker 4321), deiodinase, iodothyronine, type II (DIO2, marker 4322), deiodinase, iodothyronine, type II(DIO2, marker 4323),deiodinase, iodothyronine, type II(DIO2, marker 4324),deiodinase, iodothyronine, type II(DIO2, marker 4325),DIO2 antisense RNA 1(DIO2-AS1, marker 4326), DIO3 opposite strand/antisense RNA (head to head)(DIO3OS,marker 4327),DIO3 opposite strand/antisense RNA (head to head)(DIO3OS,marker 4328),DIO3 opposite strand/antisense RNA (head to head)(DIO3OS, marker 4329),disco-interacting protein 2 homolog A(DIP2A,marker 4330),disco-interacting protein 2 homolog A(DIP2A,marker 4331),disco-interacting protein 2 homolog A(DIP2A,marker 4332),disco-interacting protein 2 homolog A (DIP2A, marker 4333), disco-interacting protein 2 homolog A (DIP2A, marker 4334), disco-interacting protein 2 homolog B (DIP2B, marker 4335), disco-interacting protein 2 homolog B (DIP2B, marker 4336) ),DIRAS family, GTP-binding RAS-like 1(DIRAS1, marker 4337),DIRAS family, GTP-binding RAS-like 2(DIRAS2, marker 4338),DIRAS family, GTP-binding RAS-like 2(DIRAS2, marker 4339),DIRAS family, GTP-binding RAS-like 3(DIRAS3, marker 4340),disrupted in renal carcinoma 1(DIRC1,marker 4341),disrupted in renal carcinoma 3(DIRC3,marker 4342),DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease(DIS3, marker 4343),disrupted in schizophrenia 1(DISC1, marker 4344),disrupted in schizophrenia 1(DISC1, marker 4345),disrupted in schizophrenia 1(DISC1, marker 4346),disrupted in schizophrenia 1 /// TSNAX-DISC1 readthrough (NMD candidate)(DISC1 /// TSNAX-DISC1, marker 4347), disrupted in schizophrenia 1 /// TSNAX-DISC1 readthrough (NMD candidate)(DISC1 /// TSNAX-DISC1, marker 4348 ), dispatched homolog 2 (Drosophila)(DISP2, marker 4349), dispatched homolog 2 (Drosophila) /// proline/histidine/glycine-rich 1(DISP2 /// PHGR1, marker 4350), uncharacterized LOC26102(DKFZP434A062, marker 4351 ), uncharacterized LOC26102(DKFZP434A062, Marker 4352), uncharacterized LOC26077(DKFZP434H168, Marker 4353), uncharacterized LOC26070(DKFZP434K028, Marker 4354), uncharacterized LOC26082(DKFZP434L187, Marker 43 55),uncharacterized LOC26082(DKFZP434L187,Marker 4356),uncharacterized LOC26082 / // uncharacterized LOC105370751(DKFZP434L187 /// LOC105370751, marker 4357), uncharacterized protein DKFZp761C1711(DKFZP761C1711, marker 4358), uncharacterized protein DKFZp761C1711(DKFZP761C1711, marker 4 359), uncharacterized DKFZp434E1119(DKFZp434E1119, marker 4360), uncharacterized LOC93429(DKFZp434J0226, marker 4361), uncharacterized protein DKFZp434L192(DKFZp434L192, marker 4362), uncharacterized LOC401282(DKFZp451B082, marker 4363), uncharacterized LOC84237(DKFZp547J222, marker 4364), uncharacterized LOC84237(DKFZ p547J222, marker 4365), uncharacterized DKFZp779M0652(DKFZp779M0652, marker 4366), dickkopf WNT signaling pathway inhibitor 2 (DKK2, marker 4367), dickkopf WNT signaling pathway inhibitor 3 (DKK3, marker 4368), dickkopf WNT signaling pathway inhibitor 4 (DKK4, marker 4369), dickkopf-like 1 (DKKL1, marker 4370), DLC1 Rho GTPase activating protein(DLC1, marker 4371),DLC1 Rho GTPase activating protein(DLC1, marker 4372),DLC1 Rho GTPase activating protein(DLC1, marker 4373),deleted in lung and esophageal cancer 1(DLEC1,marker 4374),deleted in lung and esophageal cancer 1(DLEC1, marker 4375),deleted in lung and esophageal cancer 1(DLEC1, marker 4376),deleted in lymphocytic leukemia 2 (non-protein coding)(DLEU2, marker 4377),deleted in lymphocytic leukemia 2 (non-protein coding)(DLEU2, marker 4378),deleted in lymphocytic leukemia 2 (non-protein coding)(DLEU2,marker 4379),deleted in lymphocytic leukemia 2 (non-protein coding)(DLEU2,marker 4380),deleted in lymphocytic leukemia 2 (non-protein coding)(DLEU2, marker 4381),deleted in lymphocytic leukemia, 7(DLEU7,marker 4382),deleted in lymphocytic leukemia, 7(DLEU7,marker 4383),DLEU7 antisense RNA 1(DLEU7- AS1, marker 4384), discs, large homolog 1 (Drosophila)(DLG1, marker 4385), discs, large homolog 1 (Drosophila)(DLG1, marker 4386), DLG1 antisense RNA 1(DLG1-AS1, marker 4387), discs , large homolog 2 (Drosophila)(DLG2, marker 4388),discs, large homolog 2 (Drosophila)(DLG2, marker 4389),DLG3 antisense RNA 1(DLG3-AS1,marker 4390),discs, large homolog 4 (Drosophila) (DLG4, marker 4391), DLG5 antisense RNA 1 (DLG5-AS1, marker 4392), DLG5 antisense RNA 1 (DLG5-AS1, marker 4393), discs, large (Drosophila) homolog-associated protein 1 (DLGAP1, marker 4394) ,discs, large (Drosophila) homolog-associated protein 1(DLGAP1, marker 4395),discs, large (Drosophila) homolog-associated protein 1(DLGAP1, marker 4396),discs, large (Drosophila) homolog-associated protein 1(DLGAP1) , marker 4397), DLGAP1 antisense RNA 3(DLGAP1-AS3, marker 4398), discs, large (Drosophila) homolog-associated protein 2(DLGAP2, marker 4399), discs, large (Drosophila) homolog-associated protein 2(DLGAP2, marker 4400), DLGAP2 antisense RNA 1 (DLGAP2-AS1, marker 4401), discs, large (Drosophila) homolog-associated protein 3 (DLGAP3, marker 4402), DLGAP4 antisense RNA 1 (DLGAP4-AS1, marker 4403), delta- like 1 (Drosophila)(DLL1, marker 4404),delta-like 3 (Drosophila)(DLL3, marker 4405),delta-like 3 (Drosophila)(DLL3, marker 4406),delta-like 3 (Drosophila)(DLL3, marker 4407), delta-like 4 (Drosophila)(DLL4, marker 4408), distal-less homeobox 1(DLX1, marker 4409), distal-less homeobox 1(DLX1, marker 4410), distal-less homeobox 2(DLX2, marker 4411), distal-less homeobox 4 (DLX4, marker 4412), distal-less homeobox 4 (DLX4, marker 4413), distal-less homeobox 6 (DLX6, marker 4414), distal-less homeobox 6 (DLX6, marker 4415) ), distal-less homeobox 6 (DLX6, marker 4416), DLX6 antisense RNA 1 (DLX6-AS1, marker 4417), diencephalon/mesencephalon homeobox 1 (DMBX1, marker 4418), DNA meiotic recombinase 1 (DMC1, marker 4419), dystrophin (DMD, marker 4420), dystrophin (DMD, marker 4421), dimethylglycine dehydrogenase (DMGDH, marker 4422), dimethylglycine dehydrogenase (DMGDH, marker 4423), dentin matrix acidic phosphoprotein 1 (DMP1, marker 4424), dentin matrix acidic phosphoprotein 1 (DMP1, marker 4425), dystrophia myotonica-protein kinase (DMPK, marker 4426), doublesex and mab-3 related transcription factor 1 (DMRT1, marker 4427), doublesex and mab-3 related transcription factor 2 (DMRT2, marker 4428) ), doublesex and mab-3 related transcription factor
2(DMRT2, marker 4429), doublesex and mab-3 related transcription factor 3(DMRT3, marker 4430), DMRT-like family B with proline-rich C-terminal, 1(DMRTB1, marker 4431), DMRT-like family C1 /// DMRT-like family C1B(DMRTC1 /// DMRTC1B, marker 4432),DMRT-like family C1 /// DMRT-like family C1B(DMRTC1 /// DMRTC1B, marker 4433),DMRT-like family C2(DMRTC2 , marker 4434), dematin actin binding protein (DMTN, marker 4435), Dmx-like 2 (DMXL2, marker 4436), dynein, axonemal, assembly factor 1 (DNAAF1, marker 4437), dynein, axonemal, assembly factor 1 (DNAAF1 , marker 4438), dynein, axonemal, assembly factor 3(DNAAF3, marker 4439), dynein, axonemal, heavy chain 1(DNAH1, marker 4440), dynein, axonemal, heavy chain 1(DNAH1, marker 4441), dynein, axonemal , heavy chain 1(DNAH1, marker 4442),dynein, axonemal, heavy chain 1(DNAH1, marker 4443),dynein, axonemal, heavy chain 1(DNAH1, marker 4444),dynein, axonemal, heavy chain 1(DNAH1, marker 4445),dynein, axonemal, heavy chain 1(DNAH1,marker 4446),dynein, axonemal, heavy chain 1(DNAH1,marker 4447),dynein, axonemal, heavy chain 1(DNAH1,marker 4448),dynein, axonemal, heavy chain 1(DNAH1, marker 4449),dynein, axonemal, heavy chain 1(DNAH1,marker 4450),dynein, axonemal, heavy chain 1(DNAH1,marker 4451),dynein, axonemal, heavy chain 1(DNAH1,marker 4452) ,dynein, axonemal, heavy chain 10(DNAH10, marker 4453),dynein, axonemal, heavy chain 10(DNAH10, marker 4454),dynein, axonemal, heavy chain 10(DNAH10, marker 4455),dynein, axonemal, heavy chain 11 (DNAH11, marker 4456),dynein, axonemal, heavy chain 11(DNAH11,marker 4457),dynein, axonemal, heavy chain 11(DNAH11,marker 4458),dynein, axonemal, heavy chain 12(DNAH12,marker 4459),dynein , axonemal, heavy chain 12(DNAH12, marker 4460),dynein, axonemal, heavy chain 14(DNAH14, marker 4461),dynein, axonemal, heavy chain 14(DNAH14, marker 4462),dynein, axonemal, heavy chain 14(DNAH14 , marker 4463), dynein, axonemal, heavy chain 17(DNAH17, marker 4464), dynein, axonemal, heavy chain 17(DNAH17, marker 4465), DNAH17 antisense RNA 1(DNAH17-AS1, marker 4466), dynein, axonemal, heavy chain 2(DNAH2, marker 4467),dynein, axonemal, heavy chain 2(DNAH2,marker 4468),dynein, axonemal, heavy chain 3(DNAH3,marker 4469),dynein, axonemal, heavy chain 3(DNAH3,marker 4470 ),dynein, axonemal, heavy chain 3(DNAH3,marker 4471),dynein, axonemal, heavy chain 3(DNAH3,marker 4472),dynein, axonemal, heavy chain 5(DNAH5,marker 4473),dynein, axonemal, heavy chain 6(DNAH6, marker 4474), dynein, axonemal, heavy chain 6(DNAH6, marker 4475), dynein, axonemal, heavy chain 6(DNAH6, marker 4476), dynein, axonemal, heavy chain 6(DNAH6, marker 4477), dynein, axonemal, heavy chain 6(DNAH6, marker 4478),dynein, axonemal, heavy chain 6(DNAH6, marker 4479),dynein, axonemal, heavy chain 6(DNAH6, marker 4480),dynein, axonemal, heavy chain 7( DNAH7, marker 4481),dynein, axonemal, heavy chain 7(DNAH7,marker 4482),dynein, axonemal, heavy chain 7(DNAH7,marker 4483),dynein, axonemal, heavy chain 8(DNAH8,marker 4484),dynein, axonemal, heavy chain 9(DNAH9, marker 4485),dynein, axonemal, heavy chain 9(DNAH9, marker 4486),dynein, axonemal, heavy chain 9(DNAH9, marker 4487),dynein, axonemal, intermediate chain 1(DNAI1, marker 4488), dynein, axonemal, intermediate chain 2(DNAI2, marker 4489), dynein, axonemal, intermediate chain 2(DNAI2, marker 4490), DnaJ (Hsp40) homolog, subfamily A, member 4(DNAJA4, marker 4491), DnaJ (Hsp40) homolog, subfamily B, member 12(DNAJB12, marker 4492),DnaJ (Hsp40) homolog, subfamily B, member 13(DNAJB13, marker 4493),DnaJ (Hsp40) homolog, subfamily B, member 7(DNAJB7, Marker 4494), DnaJ (Hsp40) homolog, subfamily B, member 8 (DNAJB8, Marker 4495), DNAJB8 antisense RNA 1 (DNAJB8-AS1, Marker 4496), DnaJ (Hsp40) homolog, subfamily C, member 10 (DNAJC10, Marker 4497),DnaJ (Hsp40) homolog, subfamily C, member 12(DNAJC12, marker 4498),DnaJ (Hsp40) homolog, subfamily C, member 12(DNAJC12, marker 4499),DnaJ (Hsp40) homolog, subfamily C, member 13 (DNAJC13, marker 4500),DnaJ (Hsp40) homolog, subfamily C, member 16(DNAJC16, marker 4501),DnaJ (Hsp40) homolog, subfamily C, member 2(DNAJC2, marker 4502),DnaJ (Hsp40) homolog, subfamily C, member 21(DNAJC21, marker 4503),DnaJ (Hsp40) homolog, subfamily C, member 21(DNAJC21, marker 4504),DnaJ (Hsp40) homolog, subfamily C, member 21(DNAJC21, marker 4505),DnaJ (Hsp40 ) homolog, subfamily C, member 22(DNAJC22, marker 4506),DnaJ (Hsp40) homolog, subfamily C, member 22(DNAJC22, marker 4507),DnaJ (Hsp40) homolog, subfamily C, member 24(DNAJC24, marker 4508) ,DnaJ (Hsp40) homolog, subfamily C, member 27(DNAJC27, marker 4509),DnaJ (Hsp40) homolog, subfamily C, member 27(DNAJC27, marker 4510),DNAJC27 antisense RNA 1(DNAJC27-AS1, marker 4511), DnaJ (Hsp40) homolog, subfamily C, member 28(DNAJC28, marker 4512),DNAJC3 antisense RNA 1 (head to head)(DNAJC3-AS1, marker 4513),DnaJ (Hsp40) homolog, subfamily C, member 30(DNAJC30, marker 4514), DnaJ (Hsp40) homolog, subfamily C, member 4(DNAJC4, marker 4515), DnaJ (Hsp40) homolog, subfamily C, member 4(DNAJC4, marker 4516), DnaJ (Hsp40) homolog, subfamily C, member 4 (DNAJC4, marker 4517), DnaJ (Hsp40) homolog, subfamily C, member 5 beta (DNAJC5B, marker 4518), DnaJ (Hsp40) homolog, subfamily C, member 5 beta (DNAJC5B, marker 4519), DnaJ (Hsp40) homolog, subfamily C, member 5 gamma(DNAJC5G, marker 4520),DnaJ (Hsp40) homolog, subfamily C, member 6(DNAJC6, marker 4521),DNAJC9 antisense RNA 1(DNAJC9-AS1, marker 4522),dynein, axonemal, light chain 1 (DNAL1, marker 4523), dynein, axonemal, light chain 1 (DNAL1, marker 4524), deoxyribonuclease I (DNASE1, marker 4525), deoxyribonuclease I (DNASE1, marker 4526), deoxyribonuclease I (DNASE1, marker 4527) ,deoxyribonuclease I(DNASE1, marker 4528),deoxyribonuclease I(DNASE1,marker 4529),deoxyribonuclease I-like 2(DNASE1L2,marker 4530),deoxyribonuclease I-like 3(DNASE1L3,marker 4531),deoxyribonuclease I-like 3(DNASE1L3 , marker 4532), deoxyribonuclease II beta (DNASE2B, marker 4533), dynein heavy chain domain 1 (DNHD1, marker 4534), dynein heavy chain domain 1 (DNHD1, marker 4535), dynein heavy chain domain 1 (DNHD1, marker 4536) ,dynein heavy chain domain 1(DNHD1, marker 4537),dynamin 1(DNM1, marker 4538),dynamin 1-like(DNM1L, marker 4539),dynamin 1 pseudogene 35(DNM1P35, marker 4540),dynamin 1 pseudogene 41(DNM1P41 , marker 4541), dynamin 1 pseudogene 46 (DNM1P46, marker 4542), dynamin 2 (DNM2, marker 4543), dynamin 2 (DNM2, marker 4544), dynamin 3 (DNM3, marker 4545), DNM3 opposite strand/antisense RNA( DNM3OS, marker 4546), DNM3 opposite strand/antisense RNA (DNM3OS, marker 4547), dynamin binding protein (DNMBP, marker 4548), DNA (cytosine-5-)-methyltransferase 3-like (DNMT3L, marker 4549), aspartyl aminopeptidase (DNPEP, marker 4550), 2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (DNPH1, marker 4551), DNA nucleotidylexotransferase (DNTT, marker 4552), DNA nucleotidylexotransferase (DNTT, marker 4553), DNA nucleotidylexotransferase (DNTT, marker 4553) 4554),double C2-like domains, alpha(DOC2A, marker 4555),double C2-like domains, beta(DOC2B, marker 4556),double C2-like domains, beta(DOC2B, marker 4557),dedicator of cytokinesis 1( DOCK1, Marker 4558), dedicator of cytokinesis 1 (DOCK1, Marker 4559), dedicator of cytokinesis 10 (DOCK10, Marker 4560), dedicator of cytokinesis 10 (DOCK10, Marker 4561), dedicator of cytokinesis 2 (DOCK2, Marker 4562), dedicator of cytokinesis 4(DOCK4, marker 4563),dedicator of cytokinesis 4(DOCK4,marker 4564),DOCK4 antisense RNA 1(DOCK4-AS1,marker 4565),dedicator of cytokinesis 5(DOCK5,marker 4566),dedicator of cytokinesis 5 (DOCK5, marker 4567), dedicator of cytokinesis 5 (DOCK5, marker 4568), dedicator of cytokinesis 5 (DOCK5, marker 4569), dedicator of cytokinesis 5 (DOCK5, marker 4570), dedicator of cytokinesis 6 (DOCK6, marker 4571) ,dedicator of cytokinesis 7(DOCK7, marker 4572),dedicator of cytokinesis 8(DOCK8,marker 4573),dedicator of cytokinesis 8(DOCK8,marker 4574),dedicator of cytokinesis 8(DOCK8,marker 4575),dedicator of cytokinesis 9( DOCK9, Marker 4576), dedicator of cytokinesis 9 (DOCK9, Marker 4577), dedicator of cytokinesis 9 (DOCK9, Marker 4578), dedicator of cytokinesis 9 (DOCK9, Marker 4579), dedicator of cytokinesis 9 (DOCK9, Marker 4580), DOCK9 antisense RNA 2 (head to head) (DOCK9-AS2, marker 4581), deoxyhypusine hydroxylase/monooxygenase (DOHH, marker 4582), docking protein 2 (DOK2, marker 4583), docking protein 3 (DOK3, marker 4584), docking protein 3(DOK3, marker 4585), docking protein 6(DOK6, marker 4586), docking protein 6(DOK6, marker 4587), docking protein 6(DOK6, marker 4588), dopey family member 1(DOPEY1, marker 4589), dopey family member 1 (DOPEY1, marker 4590), dopey family member 2 (DOPEY2, marker 4591), DOT1-like histone H3K79 methyltransferase (DOT1L, marker 4592), diffuse panbronchiolitis critical region 1 (DPCR1, marker 4593), diffuse panbronchiolitis critical region 1 (DPCR1, marker 4594), dipeptidase 1 (renal) (DPEP1, marker 4595), dipeptidase 2 (DPEP2, marker 4596), dipeptidase 3 (DPEP3, marker 4597), D4, zinc and double PHD fingers family 1 (DPF1) , marker 4598),D4, zinc and double PHD fingers, family 3(DPF3,marker 4599),D4, zinc and double PHD fingers, family 3(DPF3,marker 4600),D4, zinc and double PHD fingers, family 3( DPF3, marker 4601), D4, zinc and double PHD fingers, family 3 (DPF3, marker 4602), diphthamide biosynthesis 3 pseudogene 1 (DPH3P1, marker 4603), diphthamine biosynthesis 6 (DPH6, marker 4604), DPH6 antisense RNA 1 ( head to head) (DPH6-AS1, marker 4605), DPP10 antisense RNA 3 (DPP10-AS3, marker 4606), dipeptidyl-peptidase 6 (DPP6, marker 4607), dipeptidyl-peptidase 6 (DPP6, marker 4608), dipeptidyl- peptidase 7 (DPP7, marker 4609), dipeptidyl-peptidase 9 (DPP9, marker 4610), dipeptidyl-peptidase 9 (DPP9, marker 4611), developmental pluripotency associated 4 (DPPA4, marker 4612), developmental pluripotency associated 5 (DPPA5, marker 4613), dermatopontin(DPT, marker 4614), dermatopontin(DPT, marker 4615), dermatopontin(DPT, marker 4616), dpy-19-like 1 (C. elegans)(DPY19L1, marker 4617), dpy-19-like 1 (C. elegans)(DPY19L1, marker 4618),dpy-19-like 1 (C. elegans)(DPY19L1, marker 4619),DPY19L1 pseudogene 1(DPY19L1P1,marker 4620),DPY19L2 pseudogene 2(DPY19L2P2,marker 4621) ,DPY19L2 pseudogene 3(DPY19L2P3,marker 4622),DPY19L2 pseudogene 4(DPY19L2P4,marker 4623),dihydropyrimidine dehydrogenase(DPYD,marker 4624),dihydropyrimidine dehydrogenase(DPYD,marker 4625),dihydropyrimid
ine dehydrogenase (DPYD, marker 4626), dihydropyrimidinase (DPYS, marker 4627), dihydropyrimidinase-like 3 (DPYSL3, marker 4628), dihydropyrimidinase-like 4 (DPYSL4, marker 4629), DEAQ box RNA-dependent ATPase 1 (DQX1, marker 4630),down-regulator of transcription 1(DR1,marker 4631),downregulated RNA in cancer, inhibitor of cell invasion and migration(DRAIC,marker 4632),downregulated RNA in cancer, inhibitor of cell invasion and migration(DRAIC,marker 4633) ), dynein regulatory complex subunit 1 (DRC1, marker 4634), dynein regulatory complex subunit 3 (DRC3, marker 4635), dynein regulatory complex subunit 3 (DRC3, marker 4636), dynein regulatory complex subunit 7 (DRC7, marker 4637), dopamine receptor D1 (DRD1, marker 4638), dopamine receptor D2 (DRD2, marker 4639), dopamine receptor D2 (DRD2, marker 4640), dopamine receptor D3 (DRD3, marker 4641), dopamine receptor D3 (DRD3, marker 4642), dopamine receptor D4 (DRD4, marker 4643), dopamine receptor D5 (DRD5, marker 4644), aspartate-rich 1 (DRICH1, marker 4645), aspartate-rich 1 (DRICH1, marker 4646), dystrophin related protein 2 (DRP2, marker 4647), dystrophin related protein 2 (DRP2, marker 4648), dystrophin related protein 2 (DRP2, marker 4649), desmocollin 1 (DSC1, marker 4650), desmocollin 2 (DSC2, marker 4651), desmocollin 3 (DSC3, marker 4652) ), desmocollin 3 (DSC3, marker 4653), Down syndrome cell adhesion molecule (DSCAM, marker 4654), Down syndrome cell adhesion molecule (DSCAM, marker 4655), Down syndrome cell adhesion molecule (DSCAM, marker 4656), DSCAM antisense RNA 1 (DSCAM-AS1, marker 4657), Down syndrome cell adhesion molecule like 1 (DSCAML1, marker 4658), Down syndrome cell adhesion molecule like 1 (DSCAML1, marker 4659), DNA replication and sister chromatid cohesion 1 (DSCC1, marker 4660) ),Down syndrome critical region 10 (non-protein coding)(DSCR10, marker 4661),Down syndrome critical region 4(DSCR4, marker 4662),Down syndrome critical region 8(DSCR8, marker 4663),Down syndrome critical region 9 ( non-protein coding) (DSCR9, marker 4664), dermatan sulfate epimerase (DSE, marker 4665), dermatan sulfate epimerase (DSE, marker 4666), dermatan sulfate epimerase-like (DSEL, marker 4667), desmoglein 1 (DSG1, marker 4668), DSG2 antisense RNA 1 (DSG2-AS1, marker 4669), desmoglein 3 (DSG3, marker 4670), desmoglein 3 (DSG3, marker 4671), desmoglein 4 (DSG4, marker 4672), dentin sialophosphoprotein (DSPP, marker 4673) ), dystonin (DST, marker 4674), dystonin (DST, marker 4675), dystonin (DST, marker 4676), dystonin (DST, marker 4677), dystonin (DST, marker 4678), dual serine/threonine and tyrosine protein kinase (DSTYK, marker 4679), D-tyrosyl-tRNA deacylase 1 (DTD1, marker 4680), death domain containing 1 (DTHD1, marker 4681), dystrobrevin, alpha (DTNA, marker 4682), dystrobrevin beta (DTNB, marker 4683) ,dystrobrevin beta(DTNB, marker 4684),dystrobrevin binding protein 1(DTNBP1, marker 4685),DTW domain containing 1(DTWD1,marker 4686),DTW domain containing 1(DTWD1,marker 4687),DTW domain containing 1(DTWD1, marker 4688), deltex 1, E3 ubiquitin ligase(DTX1, marker 4689), deltex 3, E3 ubiquitin ligase(DTX3, marker 4690), deltex 3, E3 ubiquitin ligase(DTX3, marker 4691), deltex 3, E3 ubiquitin ligase( DTX3, marker 4692), deltex 3, E3 ubiquitin ligase(DTX3, marker 4693), deoxythymidylate kinase(DTYMK, marker 4694), deoxythymidylate kinase(DTYMK, marker 4695), dual oxidase 1(DUOX1, marker 4696), dual oxidase 1 (DUOX1, marker 4697), dual oxidase 1(DUOX1, marker 4698), dual oxidase 2(DUOX2, marker 4699), dual oxidase maturation factor 1(DUOXA1, marker 4700), dual oxidase maturation factor 1(DUOXA1, marker 4701) ,dual oxidase maturation factor 2(DUOXA2, marker 4702),dihydrouridine synthase 3-like(DUS3L,marker 4703),dual specificity phosphatase 1(DUSP1,marker 4704),dual specificity phosphatase 1(DUSP1,marker 4705),dual specificity phosphatase 13 (DUSP13, marker 4706), dual specificity phosphatase 15 (DUSP15, marker 4707), dual specificity phosphatase 16 (DUSP16, marker 4708), dual specificity phosphatase 18 (DUSP18, marker 4709), dual specificity phosphatase 19 (DUSP19, marker 4710) ), dual specificity phosphatase 19 (DUSP19, marker 4711), dual specificity phosphatase 19 (DUSP19, marker 4712), dual specificity phosphatase 21 (DUSP21, marker 4713), dual specificity phosphatase 26 (putative) (DUSP26, marker 4714), dual specificity phosphatase 27 (putative)(DUSP27, marker 4715), dual specificity phosphatase 5 pseudogene 1 /// uncharacterized LOC105373132(DUSP5P1 /// LOC105373132, marker 4716), dual specificity phosphatase 7(DUSP7, marker 4717), dual specificity phosphatase 8 (DUSP8, marker 4718), dual specificity phosphatase 9(DUSP9, marker 4719), double homeobox 1(DUX1, marker 4720), double homeobox 1 /// double homeobox 3 /// double homeobox 5(DUX1 /// DUX3 / // DUX5, marker 4721), double homeobox A pseudogene 8 /// long intergenic non-protein coding RNA 1296(DUXAP8 /// LINC01296, marker 4722), double homeobox A pseudogene 8 /// long intergenic non-protein coding RNA 1296(DUXAP8 /// LINC01296, marker 4723), double homeobox A pseudogene 8 /// long intergenic non-protein coding RNA 1296(DUXAP8 /// LINC01296, marker 4724), DPY30 domain containing 1(DYDC1, marker 4725), dymeclin(DYM, marker 4726),dynein, cytoplasmic 1, heavy chain 1(DYNC1H1,marker 4727),dynein, cytoplasmic 1, heavy chain 1(DYNC1H1,marker 4728),dynein, cytoplasmic 1, heavy chain 1(DYNC1H1,marker 4729),dynein, cytoplasmic 1, heavy chain 1(DYNC1H1, marker 4730),dynein, cytoplasmic 1, intermediate chain 1(DYNC1I1, marker 4731),dynein, cytoplasmic 1, light intermediate chain 2(DYNC1LI2, marker 4732),dynein , cytoplasmic 2, heavy chain 1(DYNC2H1, marker 4733),dynein, cytoplasmic 2, light intermediate chain 1(DYNC2LI1, marker 4734),dynein, light chain, roadblock-type 1(DYNLRB1, marker 4735),dynein, light chain , roadblock-type 1(DYNLRB1, marker 4736),dynein, light chain, roadblock-type 1(DYNLRB1, marker 4737),dynein, light chain, roadblock-type 2(DYNLRB2, marker 4738),dual specificity tyrosine-(Y )-phosphorylation regulated kinase 1A(DYRK1A, marker 4739), dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1A(DYRK1A, marker 4740), dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1A(DYRK1A, marker 4741) ,dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1A(DYRK1A, marker 4742),dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1B(DYRK1B, marker 4743),dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1B (DYRK1B, marker 4744), dual specificity tyrosine-(Y)-phosphorylation regulated kinase 3 (DYRK3, marker 4745), double zinc ribbon and ankyrin repeat domains 1 (DZANK1, marker 4746), DNA binding protein with his-thr domain (Dbpht2, marker 4747), E2F transcription factor 2(E2F2, marker 4748), E2F transcription factor 2(E2F2, marker 4749), ELL associated factor 2(EAF2, marker 4750), ELL associated factor 2(EAF2, marker 4751) ,glutamyl-tRNA synthetase 2, mitochondrial(EARS2, marker 4752),early B-cell factor 1(EBF1,marker 4753),early B-cell factor 1(EBF1,marker 4754),early B-cell factor 1(EBF1, marker 4755), early B-cell factor 2(EBF2, marker 4756), early B-cell factor 2(EBF2, marker 4757), early B-cell factor 2(EBF2, marker 4758), early B-cell factor 3( EBF3, marker 4759), early B-cell factor 3(EBF3, marker 4760), early B-cell factor 3(EBF3, marker 4761), early B-cell factor 4(EBF4, marker 4762), Epstein-Barr virus induced 3 (EBI3, marker 4763), emopamil binding protein (sterol isomerase) (EBP, marker 4764), endothelin converting enzyme 2 (ECE2, marker 4765), endothelin converting enzyme-like 1 (ECEL1, marker 4766), extracellular matrix protein 2 , female organ and adipocyte specific(ECM2, marker 4767),extracellular matrix protein 2, female organ and adipocyte specific(ECM2, marker 4768),ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) pseudogene(ECRP, marker 4769), ectodysplasin A (EDA, marker 4770), ectodysplasin A (EDA, marker 4771), ectodysplasin A (EDA, marker 4772), ectodysplasin A (EDA, marker 4773), ectodysplasin A (EDA, marker 4774), ectodysplasin A2 receptor (EDA2R, marker 4775), EDAR-associated death domain (EDARADD, marker 4776), epididymal protein 3A (EDDM3A, marker 4777), epididymal protein 3A (EDDM3A, marker 4778), epididymal protein 3A (EDDM3A, marker 4779), epididymal protein 3B (EDDM3B, marker 4780), endothelin 2 (EDN2, marker 4781), endothelin 3 (EDN3, marker 4782), endothelin 3 (EDN3, marker 4783), EDNRB antisense RNA 1 (EDNRB-AS1, marker 4784), erythroid differentiation regulatory factor 1 (EDRF1, marker 4785), erythroid differentiation regulatory factor 1 (EDRF1, marker 4786), embryonic ectoderm development (EED, marker 4787), eukaryotic translation elongation factor 1 alpha 1 (EEF1A1, marker 4788), endonuclease/ exonuclease/phosphatase family domain containing 1(EEPD1, marker 4789),endonuclease/exonuclease/phosphatase family domain containing 1(EEPD1, marker 4790),endonuclease/exonuclease/phosphatase family domain containing 1(EEPD1, marker 4791),EF-hand calcium binding domain 1(EFCAB1, marker 4792),EF-hand calcium binding domain 1(EFCAB1, marker 4793),EF-hand calcium binding domain 1(EFCAB1, marker 4794),EF-hand calcium binding domain 11(EFCAB11, marker 4795 ),EF-hand calcium binding domain 12(EFCAB12, marker 4796),EF-hand calcium binding domain 13(EFCAB13, marker 4797),EF-hand calcium binding domain 13(EFCAB13, marker 4798),EF-hand calcium binding domain 13 (EFCAB13, marker 4799), EF-hand calcium binding domain 13 (EFCAB13, marker 4800), EF-hand calcium binding domain 13 (EFCAB13, marker 4801), EF-hand calcium binding domain 14 (EFCAB14, marker 4802), EF-hand calcium binding domain 14 /// uncharacterized LOC105378698(EFCAB14 /// LOC105378698, marker 4803),EF-hand calcium binding domain 2(EFCAB2, marker 4804),EF-hand calcium binding domain 3 /// uncharacterized LOC102724660( EFCAB3 /// LOC102724660, Marker 4805), EF-hand calcium binding domain 5 (EFCAB5, Marker 4806), EF-hand calcium binding domain 5 (EFCAB5, Marker 4807), EF-hand calcium binding domain 6 (EFCAB6, Marker 4808 ),EF-hand calcium binding domain 6(EFCAB6, marker 4809),EF-hand calcium binding domain 6(EFCAB6, marker 4810),EF-hand calcium binding domain 6(EFCAB6, marker 4811),EF-hand calcium binding domain 6 (EFCAB6, marker 4812), EF-hand calcium binding domain 6 (EFCAB6, marker 4813), EF-hand calcium binding domain 6 (EFCAB6, marker 4814), EF-hand and coiled-coil domain containing 1 (EFCC1, marker 4815),EF-hand and coile
d-coil domain containing 1 (EFCC1, marker 4816), EGF containing fibulin-like extracellular matrix protein 1 (EFEMP1, marker 4817), EF-hand domain family, member B (EFHB, marker 4818), EF-hand domain (C -terminal) containing 2(EFHC2, marker 4819),EF-hand domain family member D2(EFHD2, marker 4820),ephrin-A2(EFNA2,marker 4821),ephrin-A2(EFNA2,marker 4822),ephrin-A3( EFNA3, marker 4823), ephrin-A5 (EFNA5, marker 4824), ephrin-B1 (EFNB1, marker 4825), EFR3 homolog B (EFR3B, marker 4826), elongation factor Tu GTP binding domain containing 2 (EFTUD2, marker 4827) ,EGF-like and EMI domain containing 1, pseudogene(EGFEM1P, marker 4828),EGFLAM antisense RNA 2(EGFLAM-AS2, marker 4829),EGFLAM antisense RNA 2(EGFLAM-AS2, marker 4830),EGFLAM antisense RNA 4(EGFLAM -AS4, marker 4831), epidermal growth factor receptor(EGFR, marker 4832), epidermal growth factor receptor(EGFR, marker 4833), epidermal growth factor receptor(EGFR, marker 4834), epidermal growth factor receptor(EGFR, marker 4835) , epidermal growth factor receptor (EGFR, marker 4836), epidermal growth factor receptor (EGFR, marker 4837), egl-9 family hypoxia-inducible factor 1 (EGLN1, marker 4838), egl-9 family hypoxia-inducible factor 2 (EGLN2) , marker 4839), eosinophil granule ontogeny transcript (non-protein coding)(EGOT, marker 4840), eosinophil granule ontogeny transcript (non-protein coding)(EGOT, marker 4841), early growth response 4(EGR4, marker 4842), early growth response 4(EGR4, marker 4843), early growth response 4(EGR4, marker 4844),EH domain binding protein 1 like 1(EHBP1L1, marker 4845),EH domain binding protein 1 like 1(EHBP1L1, marker 4846), EH domain binding protein 1 like 1(EHBP1L1, marker 4847),EH domain binding protein 1 like 1(EHBP1L1, marker 4848),EH domain containing 3(EHD3, marker 4849),EH domain containing 4(EHD4, marker 4850), EH domain containing 4(EHD4, marker 4851),EH domain containing 4(EHD4, marker 4852),EH domain containing 4(EHD4, marker 4853),EH domain containing 4(EHD4, marker 4854),ets homologous factor(EHF, marker 4855), ets homologous factor(EHF, marker 4856), ets homologous factor(EHF, marker 4857), ets homologous factor(EHF, marker 4858), ets homologous factor(EHF, marker 4859), ets homologous factor(EHF, marker 4860), EHMT1 intronic transcript 1(EHMT1-IT1, marker 4861), euchromatic histone-lysine N-methyltransferase 2(EHMT2, marker 4862), EP300 interacting inhibitor of differentiation 3(EID3, marker 4863), eukaryotic translation initiation factor 1A , Y-linked(EIF1AY, marker 4864),eukaryotic translation initiation factor 1A, Y-linked(EIF1AY, marker 4865),eukaryotic translation initiation factor 1B(EIF1B, marker 4866),EIF1B antisense RNA 1(EIF1B-AS1, marker 4867 ),EIF1B antisense RNA 1(EIF1B-AS1, marker 4868),EIF1B antisense RNA 1(EIF1B-AS1,marker 4869),eukaryotic translation initiation factor 2-alpha kinase 3(EIF2AK3,marker 4870),eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa(EIF2B5, marker 4871),eukaryotic translation initiation factor 3, subunit B(EIF3B, marker 4872),eukaryotic translation initiation factor 3, subunit B(EIF3B, marker 4873),eukaryotic translation initiation factor 3, subunit C /// eukaryotic translation initiation factor 3, subunit C-like(EIF3C /// EIF3CL, marker 4874), eukaryotic translation initiation factor 3, subunit F(EIF3F, marker 4875), eukaryotic translation initiation factor 3, subunit F pseudogene 1( EIF3FP1, marker 4876), eukaryotic translation initiation factor 3, subunit K (EIF3K, marker 4877), eukaryotic translation initiation factor 3, subunit M (EIF3M, marker 4878), eukaryotic translation initiation factor 4A2 (EIF4A2, marker 4879), eukaryotic translation initiation factor 4E (EIF4E, marker 4880), eukaryotic translation initiation factor 4E (EIF4E, marker 4881), eukaryotic translation initiation factor 4E binding protein 2 (EIF4EBP2, marker 4882), eukaryotic translation initiation factor 4E nuclear import factor 1 (EIF4ENIF1, marker 4883),eukaryotic translation initiation factor 4 gamma, 2(EIF4G2, marker 4884),eukaryotic translation initiation factor 4 gamma, 3(EIF4G3, marker 4885),eukaryotic translation initiation factor 5A2(EIF5A2, marker 4886),elaC ribonuclease Z 1( ELAC1, marker 4887), elastase, neutrophil expressed (ELANE, marker 4888), ELAV like neuron-specific RNA binding protein 3 (ELAVL3, marker 4889), ELAV like neuron-specific RNA binding protein 3 (ELAVL3, marker 4890), ELAV like neuron-specific RNA binding protein 3(ELAVL3, marker 4891),ELAV like neuron-specific RNA binding protein 4(ELAVL4, marker 4892),ELAV like neuron-specific RNA binding protein 4(ELAVL4, marker 4893),E74-like factor 3 (ets domain transcription factor, epithelial-specific )(ELF3, marker 4894),E74-like factor 5 (ets domain transcription factor)(ELF5, marker 4895),E74-like factor 5 (ets domain transcription factor)(ELF5 , marker 4896), ELFN1 antisense RNA 1(ELFN1-AS1, marker 4897), extracellular leucine-rich repeat and fibronectin type III domain containing 2(ELFN2, marker 4898), extracellular leucine-rich repeat and fibronectin type III domain containing 2( ELFN2, marker 4899), extracellular leucine-rich repeat and fibronectin type III domain containing 2(ELFN2, marker 4900), extracellular leucine-rich repeat and fibronectin type III domain containing 2(ELFN2, marker 4901), ELK1, member of ETS oncogene family(ELK1, marker 4902),ELK4, ETS-domain protein (SRF accessory protein 1)(ELK4, marker 4903),ELK4, ETS-domain protein (SRF accessory protein 1)(ELK4, marker 4904),ELK4, ETS- domain protein (SRF accessory protein 1)(ELK4, marker 4905),ELK4, ETS-domain protein (SRF accessory protein 1)(ELK4, marker 4906),elongation factor RNA polymerase II(ELL, marker 4907),elongation factor RNA polymerase II(ELL, marker 4908), engulfment and cell motility 2(ELMO2, marker 4909), ELMO/CED-12 domain containing 1 /// uncharacterized LOC643923(ELMOD1 /// LOC643923, marker 4910), ELMO/CED-12 domain containing 2(ELMOD2, marker 4911),ELMO/CED-12 domain containing 2(ELMOD2, marker 4912),ELMO/CED-12 domain containing 3(ELMOD3, marker 4913),ELM2 and Myb/SANT-like domain containing 1( ELMSAN1, marker 4914), elastin (ELN, marker 4915), elastin (ELN, marker 4916), ELOVL2 antisense RNA 1 (ELOVL2-AS1, marker 4917), ELOVL fatty acid elongase 3 (ELOVL3, marker 4918), ELOVL fatty acid elongase 5 (ELOVL5, marker 4919), epididymal sperm binding protein 1 (ELSPBP1, marker 4920), embigin (EMB, marker 4921), ER membrane protein complex subunit 10 (EMC10, marker 4922), ER membrane protein complex subunit 3 (EMC3 ,marker 4923),endomucin(EMCN,marker 4924),endomucin(EMCN,marker 4925),endomucin(EMCN,marker 4926),essential meiotic structure-specific endonuclease subunit 2(EME2,marker 4927),EMI domain containing 1(EMID1 , marker 4928), elastin microfibril interfacer 1(EMILIN1, marker 4929), elastin microfibril interfacer 2(EMILIN2, marker 4930), echinoderm microtubule associated protein like 2(EML2, marker 4931), echinoderm microtubule associated protein like 2(EML2, marker 4932), EML2 antisense RNA 1 (EML2-AS1, marker 4933), EML2 antisense RNA 1 (EML2-AS1, marker 4934), echinoderm microtubule associated protein like 3 (EML3, marker 4935), echinoderm microtubule associated protein like 5 (EML5) , marker 4936), echinoderm microtubule associated protein like 5(EML5, marker 4937), echinoderm microtubule associated protein like 6(EML6, marker 4938), echinoderm microtubule associated protein like 6(EML6, marker 4939), epithelial membrane protein 1(EMP1) ,marker 4940),epithelial membrane protein 1(EMP1,marker 4941),epithelial membrane protein 1(EMP1,marker 4942),epithelial membrane protein 1(EMP1,marker 4943),epithelial membrane protein 2(EMP2,marker 4944),EMSY BRCA2-interacting transcriptional repressor(EMSY,marker 4945),empty spiracles homeobox 1(EMX1,marker 4946),EMX2 opposite strand/antisense RNA /// EMX2 opposite strand/antisense RNA(EMX2OS /// EMX2OS,marker 4947),engrailed homeobox 1(EN1, marker 4948),enabled homolog (Drosophila)(ENAH,marker 4949),enamelin(ENAM,marker 4950),enamelin(ENAM,marker 4951),endonuclease, polyU-specific(ENDOU,marker 4952),endonuclease V(ENDOV, marker 4953),endonuclease V(ENDOV,marker 4954),endonuclease V(ENDOV,marker 4955),endoglin(ENG,marker 4956),endoglin(ENG,marker 4957),enkurin, TRPC channel interacting protein(ENKUR ,marker 4958),enolase 1, (alpha)(ENO1,marker 4959),ENO1 antisense RNA 1(ENO1-AS1,marker 4960),enolase 3 (beta, muscle)(ENO3,marker 4961),enolase superfamily member 1( ENOSF1, marker 4962), ecto-NOX disulfide-thiol exchanger 1 (ENOX1, marker 4963), ecto-NOX disulfide-thiol exchanger 2 (ENOX2, marker 4964), ecto-NOX disulfide-thiol exchanger 2 (ENOX2, marker 4965) ,glutamyl aminopeptidase (aminopeptidase A)(ENPEP,marker 4966),ectonucleotide pyrophosphatase/phosphodiesterase 3(ENPP3,marker 4967),ectonucleotide pyrophosphatase/phosphodiesterase 3(ENPP3,marker 4968),ectonucleotide pyrophosphatase/phosphodiesterase 6(ENPP6,marker 4969), ectonucleotide pyrophosphatase/phosphodiesterase 7(ENPP7, marker 4970),ENTH domain containing 1(ENTHD1, marker 4971),ENTH domain containing 1(ENTHD1, marker 4972),ENTH domain containing 2(ENTHD2, marker 4973),ENTH domain containing 2( ENTHD2, marker 4974), ENTH domain containing 2(ENTHD2, marker 4975), ectonucleoside triphosphate diphosphohydrolase 1(ENTPD1, marker 4976), ectonucleoside triphosphate diphosphohydrolase 1(ENTPD1, marker 4977), ectonucleoside triphosphate diphosphohydrolase 1(ENTPD1, marker 4978), ENTPD1 antisense RNA 1 (ENTPD1-AS1, marker 4979), ectonucleoside triphosphate diphosphohydrolase 2 (ENTPD2, marker 4980), ectonucleoside triphosphate diphosphohydrolase 2 (ENTPD2, marker 4981), ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3, marker 4982), ectonucleoside triphosphate diphosphohydrolase 3 (ENTPD3, marker 4983), ENTPD3 antisense RNA 1 (ENTPD3-AS1, marker 4984), ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5, marker 4985), ectonucleoside triphosphate diphosphohydrolase 5 (ENTPD5, marker 4986), ectonucleoside triphosphate diphosphohydrolase 6 (putative)( ENTPD6, marker 4987), E1A binding protein p400 (EP400, marker 4988), EP400 N-terminal like (EP400NL, marker 4989), endothelial PAS domain protein 1 (EPAS1, marker 4990), erythrocyte membrane protein band 4.1 (EPB41, marker 4991), erythrocyte membrane protein band 4.1 (EPB41, marker 4992), erythrocyte membrane protein band 4.1 (EPB41, marker 4993)
,erythrocyte membrane protein band 4.1-like 1(EPB41L1, marker 4994),erythrocyte membrane protein band 4.1 like 4A(EPB41L4A, marker 4995),erythrocyte membrane protein band 4.1 like 4A(EPB41L4A, marker 4996),erythrocyte membrane protein band 4.1 like 4A(EPB41L4A, marker 4997),EPB41L4A antisense RNA 2 (head to head)(EPB41L4A-AS2,marker 4998),erythrocyte membrane protein band 4.1 like 4B(EPB41L4B,marker 4999),erythrocyte membrane protein band 4.1 like 4B(EPB41L4B, marker 5000), erythrocyte membrane protein band 4.1 like 4B (EPB41L4B, marker 5001), erythrocyte membrane protein band 4.2 (EPB42, marker 5002), ectopic P-granules autophagy protein 5 homolog (C. elegans) (EPG5, marker 5003), ectopic P-granules autophagy protein 5 homolog (C. elegans)(EPG5, marker 5004),ectopic P-granules autophagy protein 5 homolog (C. elegans)(EPG5, marker 5005),ectopic P-granules autophagy protein 5 homolog (C elegans) (EPG5, marker 5006), ectopic P-granules autophagy protein 5 homolog (C. elegans) (EPG5, marker 5007), EPH receptor A1 (EPHA1, marker 5008), EPHA1 antisense RNA 1 (EPHA1-AS1, marker 5009), EPH receptor A10 (EPHA10, marker 5010), EPH receptor A10 (EPHA10, marker 5011), EPH receptor A10 (EPHA10, marker 5012), EPH receptor A3 (EPHA3, marker 5013), EPH receptor A3 (EPHA3, marker 5014), EPH receptor A3 (EPHA3, marker 5015), EPH receptor A4 (EPHA4, marker 5016), EPH receptor A5 (EPHA5, marker 5017), EPH receptor A5 (EPHA5, marker 5018), EPH receptor A5 (EPHA5, marker 5019), EPHA5 antisense RNA 1 (EPHA5-AS1, marker 5020), EPH receptor A6 (EPHA6, marker 5021), EPH receptor A6 (EPHA6, marker 5022), EPH receptor A8 (EPHA8, marker 5023), EPH receptor B1 ( EPHB1, marker 5024), EPH receptor B2 (EPHB2, marker 5025), EPH receptor B2 (EPHB2, marker 5026), EPH receptor B2 /// transmembrane protein 60 (EPHB2 /// TMEM60, marker 5027), epoxide hydrolase 4( EPHX4, marker 5028), epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A, marker 5029), epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) (EPM2A, marker 5030), epsin 1 (EPN1, marker 5031),epsin 1(EPN1,marker 5032),epsin 2 /// EPN2 intronic transcript 1(EPN2 /// EPN2-IT1,marker 5033),EPN2 antisense RNA 1(EPN2-AS1,marker 5034),epsin 3( EPN3, marker 5035), epsin 3 (EPN3, marker 5036), erythropoietin (EPO, marker 5037), erythropoietin (EPO, marker 5038), erythropoietin receptor (EPOR, marker 5039), erythropoietin receptor (EPOR, marker 5040), epididymal peptidase inhibitor (EPPIN, marker 5041), epididymal peptidase inhibitor (EPPIN, marker 5042), epiplakin 1 (EPPK1, marker 5043), epiplakin 1 (EPPK1, marker 5044), epidermal growth factor receptor pathway substrate 15-like 1 (EPS15L1, marker 5045), epidermal growth factor receptor pathway substrate 15-like 1(EPS15L1, marker 5046), epidermal growth factor receptor pathway substrate 15-like 1(EPS15L1, marker 5047), epidermal growth factor receptor pathway substrate 15-like 1 // / uncharacterized LOC105372294(EPS15L1 /// LOC105372294, marker 5048), EPS8-like 1 (EPS8L1, marker 5049), EPS8-like 2 (EPS8L2, marker 5050), EPS8-like 3 (EPS8L3, marker 5051), epithelial stromal interaction 1 (breast) (EPSTI1, marker 5052), ethanolaminephosphotransferase 1 (EPT1, marker 5053), eosinophil peroxidase (EPX, marker 5054), epiphycan (EPYC, marker 5055), equatorin, sperm acrosome associated (EQTN, marker 5056), equatorin , sperm acrosome associated(EQTN, marker 5057),equatorin, sperm acrosome associated(EQTN, marker 5058),endoplasmic reticulum aminopeptidase 1(ERAP1, marker 5059),endoplasmic reticulum aminopeptidase 1(ERAP1, marker 5060),endoplasmic reticulum aminopeptidase 1 / // uncharacterized LOC101929747(ERAP1 /// LOC101929747, marker 5061), endoplasmic reticulum aminopeptidase 1 /// uncharacterized LOC101929747(ERAP1 /// LOC101929747, marker 5062), endoplasmic reticulum aminopeptidase 2(ERAP2, marker 5063) ,endoplasmic reticulum aminopeptidase 2 (ERAP2, marker 5064), endoplasmic reticulum aminopeptidase 2 (ERAP2, marker 5065), endoplasmic reticulum aminopeptidase 2 (ERAP2, marker 5066), endoplasmic reticulum aminopeptidase 2 (ERAP2, marker 5067), erb-b2 receptor tyrosine kinase 2 (ERBB2, marker 5068), erbb2 interacting protein(ERBB2IP, marker 5069),erb-b2 receptor tyrosine kinase 3(ERBB3, marker 5070),erb-b2 receptor tyrosine kinase 3(ERBB3, marker 5071),erb-b2 receptor tyrosine kinase 4( ERBB4, marker 5072), erb-b2 receptor tyrosine kinase 4 (ERBB4, marker 5073), erb-b2 receptor tyrosine kinase 4 (ERBB4, marker 5074), ELKS/RAB6-interacting/CAST family member 1 (ERC1, marker 5075) ,ERC2 intronic transcript 1(ERC2-IT1, marker 5076),excision repair cross-complementation group 4(ERCC4,marker 5077),excision repair cross-complementation group 6-like 2(ERCC6L2,marker 5078),excision repair cross-complementation group 6-like 2 (ERCC6L2, marker 5079), excision repair cross-complementation group 6-like 2 (ERCC6L2, marker 5080), excision repair cross-complementation group 8 (ERCC8, marker 5081), epiregulin (EREG, marker 5082) ,epiregulin(EREG,marker 5083),Ets2 repressor factor(ERF,marker 5084),v-ets avian erythroblastosis virus E26 oncogene homolog(ERG,marker 5085),v-ets avian erythroblastosis virus E26 oncogene homolog(ERG,marker 5086) ,v-ets avian erythroblastosis virus E26 oncogene homolog(ERG, marker 5087),v-ets avian erythroblastosis virus E26 oncogene homolog(ERG, marker 5088),endoplasmic reticulum-golgi intermediate compartment 1(ERGIC1, marker 5089),ERGIC and golgi 2(ERGIC2, marker 5090),ERGIC and golgi 3(ERGIC3,marker 5091),ERGIC and golgi 3(ERGIC3,marker 5092),ERI1 exoribonuclease family member 2(ERI2,marker 5093),ERI1 exoribonuclease family member 2(ERI2, marker 5094), glutamate rich 1(ERICH1, marker 5095), glutamate rich 1(ERICH1, marker 5096), glutamate rich 1(ERICH1, marker 5097), glutamate rich 1(ERICH1, marker 5098), glutamate rich 1(ERICH1, marker 5099), glutamate rich 1 (ERICH1, marker 5100), ERICH1 antisense RNA 1 (ERICH1-AS1, marker 5101), ERICH1 antisense RNA 1 (ERICH1-AS1, marker 5102), glutamate rich 3 (ERICH3, marker 5103), glutamate rich 3 (ERICH3, marker 5104), ERICH3 antisense RNA 1 (ERICH3-AS1, marker 5105), glutamate rich 4 (ERICH4, marker 5106), glutamate rich 6 (ERICH6, marker 5107), endoplasmic reticulum lectin 1 (ERLEC1, Marker 5108), ermin (ERMN, Marker 5109), endoplasmic reticulum to nucleus signaling 2 (ERN2, Marker 5110), endoplasmic reticulum to nucleus signaling 2 (ERN2, Marker 5111), endoplasmic reticulum oxidoreductase beta (ERO1B, Marker 5112), endoplasmic reticulum protein 44(ERP44, marker 5113), endogenous retrovirus group 3, member 1(ERV3-1, marker 5114), endogenous retrovirus group 3, member 2(ERV3-2, marker 5115), endogenous retrovirus group FH21, member 1( ERVFH21-1, marker 5116), endogenous retrovirus group FRD, member 1 (ERVFRD-1, marker 5117), endogenous retrovirus group H, member 3 (ERVH-3, marker 5118), endogenous retrovirus group H, member 6 (ERVH- 6, marker 5119), endogenous retrovirus group H, member 6(ERVH-6, marker 5120), endogenous retrovirus group K13, member 1(ERVK13-1, marker 5121), endogenous retrovirus group K13, member 1(ERVK13-1, marker 5122), endogenous retrovirus group K13, member 1(ERVK13-1, marker 5123), endogenous retrovirus group K3, member 2(ERVK3-2, marker 5124), endogenous retrovirus group MER61, member 1(ERVMER61-1, marker 5125) ), endogenous retrovirus group V, member 1(ERVV-1, marker 5126), endogenous retrovirus group W, member 1(ERVW-1, marker 5127), endogenous retrovirus group W, member 1(ERVW-1, marker 5128), endothelial cell adhesion molecule(ESAM, marker 5129), establishment of sister chromatid cohesion N-acetyltransferase 2(ESCO2, marker 5130), establishment of sister chromatid cohesion N-acetyltransferase 2(ESCO2, marker 5131), establishment of sister chromatid cohesion N- acetyltransferase 2 (ESCO2, marker 5132), esterase D (ESD, marker 5133), endothelial cell-specific molecule 1 (ESM1, marker 5134), espin (ESPN, marker 5135), espin (ESPN, marker 5136), espin (ESPN , marker 5137), espin(ESPN, marker 5138), espin /// espin pseudogene(ESPN /// ESPNP, marker 5139), espin-like(ESPNL, marker 5140), espin-like(ESPNL, marker 5141), estrogen receptor 1 (ESR1, marker 5142), estrogen receptor 1 (ESR1, marker 5143), estrogen receptor 1 (ESR1, marker 5144), estrogen receptor 1 (ESR1, marker 5145), estrogen receptor 1 (ESR1, marker 5146), estrogen receptor 1 (ESR1, marker 5147), estrogen receptor 1 (ESR1, marker 5148), estrogen receptor 1 (ESR1, marker 5149), estrogen receptor 1 (ESR1, marker 5150), estrogen receptor 2 (ER beta) (ESR2, marker 5151), estrogen receptor 2 (ER beta) (ESR2, marker 5152), estrogen receptor 2 (ER beta) (ESR2, marker 5153), estrogen receptor 2 (ER beta) (ESR2, marker 5154), estrogen receptor 2 ( ER beta) (ESR2, marker 5155), estrogen receptor 2 (ER beta) (ESR2, marker 5156), estrogen-related receptor beta (ESRRB, marker 5157), estrogen-related receptor beta (ESRRB, marker 5158), estrogen- related receptor beta (ESRRB, marker 5159), ESX homeobox 1 (ESX1, marker 5160), extended synaptotagmin-like protein 3 (ESYT3, marker 5161), extended synaptotagmin-like protein 3 (ESYT3, marker 5162), ethanolamine-phosphate phospho -lyase(ETNPPL, marker 5163), v-ets avian erythroblastosis virus E26 oncogene homolog 2(ETS2, marker 5164), ets variant 2(ETV2, marker 5165), ets variant 3(ETV3, marker 5166), ets variant 5( ETV5, marker 5167), ets variant 6 (ETV6, marker 5168), ets variant 7 (ETV7, marker 5169), ets variant 7 (ETV7, marker 5170), eva-1 homolog B (C. elegans) (EVA1B, marker 5171), eva-1 homolog C (C. elegans) (EVA1C, marker 5172), Ellis van Creveld protein (EVC, marker 5173), Ellis van Creveld protein (EVC, marker 5174), Ellis van Creveld protein (EVC, marker 5174) 5175), Ellis van Creveld syndrome 2 (EVC2, marker 5176), ecotropic viral integration site 2A (EVI2A, marker 5177), ecotropic viral integration site 2B (EVI2B, marker 5178), ecotropic viral integration site 5 (EVI5, marker 5179) ,ecotropic viral integration site 5(EVI5, marker 5180),ecotropic viral integration site 5-like(EVI5L,marker 5181),ecotropic viral integration site 5-like(EVI5L,marker 5182),ecotropic viral integration site 5-like(EVI5L ,marker 5183),ecotropic viral integration site 5-like(EVI5L,marker 5184),envoplakin(EVPL,marker 5185),envoplakin-like(EVPLL,marker 5186),even-skipped homeobox 1(EVX1,marker 5187),even -skipped homeobox 1(EVX1, marker 5188), Ewing sarcoma associated transcript 1(EWSAT1, marker 5189), exonuclease 3'-5' domain containing 1(EXD1, marker 5190), exon
uclease 3'-5' domain containing 3(EXD3, marker 5191),exonuclease 5(EXO5, marker 5192),exocyst complex component 3(EXOC3,marker 5193),EXOC3 antisense RNA 1(EXOC3-AS1,marker 5194),exocyst complex component 3-like 1(EXOC3L1, marker 5195),exocyst complex component 3-like 4(EXOC3L4, marker 5196),exocyst complex component 3-like 4(EXOC3L4, marker 5197),exocyst complex component 4(EXOC4, marker 5198) ), exocyst complex component 6 (EXOC6, marker 5199), exocyst complex component 6B (EXOC6B, marker 5200), exocyst complex component 7 (EXOC7, marker 5201), endo/exonuclease (5'-3'), endonuclease G-like (EXOG, Marker 5202), endo/exonuclease (5'-3'), endonuclease G-like(EXOG, Marker 5203), exosome component 1(EXOSC1, Marker 5204), exosome component 1(EXOSC1, Marker 5205), exosome component 10 (EXOSC10, marker 5206), exosome component 2 (EXOSC2, marker 5207), exosome component 3 (EXOSC3, marker 5208), exophilin 5 (EXPH5, marker 5209), exososin-like glycosyltransferase 1 (EXTL1, marker 5210), EXTL3 antisense RNA 1 (EXTL3-AS1, marker 5211), EYA transcriptional coactivator and phosphatase 1 (EYA1, marker 5212), EYA transcriptional coactivator and phosphatase 3 (EYA3, marker 5213), EYA transcriptional coactivator and phosphatase 3 (EYA3, marker 5214) ),EYA transcriptional coactivator and phosphatase 4(EYA4, marker 5215),EYA transcriptional coactivator and phosphatase 4(EYA4, marker 5216),EYA transcriptional coactivator and phosphatase 4(EYA4, marker 5217),eyes shut homolog (Drosophila)(EYS, marker 5218), enhancer of zeste 1 polycomb repressive complex 2 subunit(EZH1, marker 5219), enhancer of zeste 1 polycomb repressive complex 2 subunit(EZH1, marker 5220), coagulation factor X(F10, marker 5221), coagulation factor XI( F11, marker 5222), coagulation factor XI(F11, marker 5223), coagulation factor XI(F11, marker 5224), coagulation factor // LOC102723888, marker 5226), coagulation factor XII (Hageman factor)(F12, marker 5227), coagulation factor XIII, A1 polypeptide(F13A1, marker 5228), coagulation factor XIII, B polypeptide(F13B, marker 5229), coagulation factor II (thrombin)(F2, marker 5230),coagulation factor II (thrombin) receptor-like 2(F2RL2, marker 5231),coagulation factor II (thrombin) receptor-like 2(F2RL2, marker 5232),coagulation factor II (thrombin ) receptor-like 3(F2RL3, marker 5233),coagulation factor V (proaccelerin, labile factor)(F5, marker 5234),coagulation factor V (proaccelerin, labile factor)(F5, marker 5235),coagulation factor V (proaccelerin, labile factor) (F5, marker 5236), coagulation factor VII (serum prothrombin conversion accelerator) (F7, marker 5237), coagulation factor VII (serum prothrombin conversion accelerator) (F7, marker 5238), coagulation factor IX (F9, marker 5239) ), fatty acid 2-hydroxylase(FA2H, marker 5240), Fanconi anemia core complex associated protein 100(FAAP100, marker 5241), Fanconi anemia core complex associated protein 20(FAAP20, marker 5242), Fanconi anemia core complex associated protein 20( FAAP20, marker 5243), Fanconi anemia core complex associated protein 20 (FAAP20, marker 5244), Fanconi anemia core complex associated protein 20 (FAAP20, marker 5245), Fanconi anemia core complex associated protein 20 (FAAP20, marker 5246), fatty acid binding protein 1, liver(FABP1, marker 5247),fatty acid binding protein 1, liver(FABP1, marker 5248),fatty acid binding protein 2, intestinal(FABP2, marker 5249),fatty acid binding protein 3, muscle and heart( FABP3, marker 5250), fatty acid binding protein 3, pseudogene 2(FABP3P2, marker 5251), fatty acid binding protein 4, adipocyte(FABP4, marker 5252), fatty acid binding protein 4, adipocyte(FABP4, marker 5253), fatty acid binding protein 6, ileal(FABP6, marker 5254),fatty acid binding protein 6, ileal(FABP6, marker 5255),fatty acid binding protein 6, ileal(FABP6, marker 5256),fatty acid binding protein 7, brain(FABP7 , marker 5257), fatty acid desaturase 2(FADS2, marker 5258), Fas (TNFRSF6) associated factor 1(FAF1, marker 5259), fumarylacetoacetate hydrolase (fumarylacetoacetase)(FAH, marker 5260), fumarylacetoacetate hydrolase domain containing 2A(FAHD2A, marker 5261), fumarylacetoacetate hydrolase domain containing 2A /// fumarylacetoacetate hydrolase domain containing 2B /// fumarylacetoacetate hydrolase domain containing 2C, pseudogene(FAHD2A /// FAHD2B /// FAHD2CP, marker 5262), fumarylacetoacetate hydrolase domain containing 2B /// fumarylacetoacetate hydrolase domain containing 2C, pseudogene(FAHD2B /// FAHD2CP, marker 5263),fumarylacetoacetate hydrolase domain containing 2C, pseudogene(FAHD2CP, marker 5264),Fas apoptotic inhibitory molecule 2(FAIM2, marker 5265),Fas apoptotic inhibitory molecule 2( FAIM2, marker 5266),family with sequence similarity 102, member A(FAM102A,marker 5267),family with sequence similarity 104, member B(FAM104B,marker 5268),family with sequence similarity 105, member A(FAM105A,marker 5269) ,family with sequence similarity 106, member A(FAM106A,marker 5270),family with sequence similarity 107, member A(FAM107A,marker 5271),family with sequence similarity 107, member A(FAM107A,marker 5272),family with sequence similarity 110, member B(FAM110B, marker 5273),family with sequence similarity 110, member D(FAM110D,marker 5274),family with sequence similarity 111, member A(FAM111A,marker 5275),family with sequence similarity 117, member B( FAM117B, marker 5276),family with sequence similarity 118, member B(FAM118B,marker 5277),family with sequence similarity 120A(FAM120A,marker 5278),family with sequence similarity 120A(FAM120A,marker 5279),family with sequence similarity 120A (FAM120A, marker 5280),family with sequence similarity 120A(FAM120A,marker 5281),family with sequence similarity 120A(FAM120A,marker 5282),family with sequence similarity 120A opposite strand(FAM120AOS,marker 5283),family with sequence similarity 120A opposite strand(FAM120AOS, marker 5284),family with sequence similarity 122C(FAM122C,marker 5285),family with sequence similarity 122C(FAM122C,marker 5286),family with sequence similarity 124 member A(FAM124A,marker 5287),family with sequence similarity 126, member A(FAM126A, marker 5288),family with sequence similarity 129, member C(FAM129C,marker 5289),family with sequence similarity 129, member C(FAM129C,marker 5290),family with sequence similarity 129, member C (FAM129C, marker 5291),family with sequence similarity 131, member A(FAM131A,marker 5292),family with sequence similarity 131, member A(FAM131A,marker 5293),family with sequence similarity 131, member C(FAM131C,marker 5294 ),family with sequence similarity 132, member A(FAM132A,marker 5295),family with sequence similarity 132, member B /// high mobility group AT-hook 1(FAM132B /// HMGA1,marker 5296),family with sequence similarity 134, member B(FAM134B, marker 5297),family with sequence similarity 134, member B(FAM134B,marker 5298),family with sequence similarity 135, member A(FAM135A,marker 5299),family with sequence similarity 135, member B( FAM135B, marker 5300), family with sequence similarity 135, member B(FAM135B, marker 5301), family with sequence similarity 135, member B(FAM135B, marker 5302), family with sequence similarity 138, member A /// family with sequence similarity 138, member B /// family with sequence similarity 138, member C /// family with sequence similarity 138, member E /// family with sequence similarity 138, member F(FAM138A /// FAM138B /// FAM138C // / FAM138E /// FAM138F, marker 5303),FAM13A antisense RNA 1(FAM13A-AS1, marker 5304),FAM13A antisense RNA 1(FAM13A-AS1, marker 5305),family with sequence similarity 13, member C(FAM13C,marker 5306) ),family with sequence similarity 149, member A(FAM149A,marker 5307),family with sequence similarity 149, member B1(FAM149B1,marker 5308),family with sequence similarity 151, member A(FAM151A,marker 5309),family with sequence similarity 153, member A(FAM153A,marker 5310),family with sequence similarity 153, member A /// family with sequence similarity 153, member B /// family with sequence similarity 153, member C, pseudogene /// uncharacterized LOC100507387 / // uncharacterized LOC105377751(FAM153A /// FAM153B /// FAM153C /// LOC100507387 /// LOC105377751, marker 5311), family with sequence similarity 153, member A /// family with sequence similarity 153, member B /// uncharacterized LOC100507387 /// uncharacterized LOC105377751(FAM153A /// FAM153B /// LOC100507387 /// LOC105377751, marker 5312), family with sequence similarity 153, member B /// uncharacterized LOC100507387 /// uncharacterized LOC105377751(FAM 153B /// LOC100507387 / // LOC105377751, marker 5313), family with sequence similarity 153, member B /// uncharacterized LOC100507387 /// uncharacterized LOC105377751(FAM153B /// LOC100507387 /// LOC105377751, marker 5314), FAM155A intronic transcript 1(FAM155 A-IT1, marker 5315),family with sequence similarity 159, member A(FAM159A,marker 5316),family with sequence similarity 159, member A(FAM159A,marker 5317),family with sequence similarity 160, member A1(FAM160A1,marker 5318),family with sequence similarity 160, member B1(FAM160B1, marker 5319),family with sequence similarity 160, member B2(FAM160B2,marker 5320),family with sequence similarity 160, member B2(FAM160B2,marker 5321),family with sequence similarity 161, member A(FAM161A, marker 5322),family with sequence similarity 161, member B(FAM161B,marker 5323),family with sequence similarity 162, member A(FAM162A,marker 5324),family with sequence similarity 163, member A(FAM163A, marker 5325),family with sequence similarity 163, member A(FAM163A,marker 5326),family with sequence similarity 163, member A(FAM163A,marker 5327),family with sequence similarity 163, member B(FAM163B,marker 5328),family with sequence similarity 166, member A(FAM166A, marker 5329),family with sequence similarity 166, member A(FAM166A,marker 5330),family with sequence similarity 166, member B(FAM166B,marker 5331),family with sequence similarity 167, member A(FAM167A, marker 5332),FAM167A antisense RNA 1(FAM167A-AS1,marker 5333),family with sequence similarity 167, member B(FAM167B,marker 5334),family with sequence similarity 169, member B(FAM169B,marker 5335 ),family with sequence similarity 170, member A(FAM170A,marker 5336),family
with sequence similarity 170, member B(FAM170B, marker 5337),FAM170B antisense RNA 1(FAM170B-AS1,marker 5338),FAM170B antisense RNA 1(FAM170B-AS1,marker 5339),FAM170B antisense RNA 1(FAM170B-AS1,marker 5340),family with sequence similarity 171, member A2(FAM171A2,marker 5341),family with sequence similarity 171, member B(FAM171B,marker 5342),family with sequence similarity 173, member B(FAM173B,marker 5343),family with sequence similarity 178, member B(FAM178B, marker 5344),family with sequence similarity 179, member A(FAM179A,marker 5345),family with sequence similarity 181, member A(FAM181A,marker 5346),FAM181A antisense RNA 1(FAM181A- AS1, marker 5347),family with sequence similarity 181, member B(FAM181B,marker 5348),family with sequence similarity 181, member B(FAM181B,marker 5349),family with sequence similarity 181, member B(FAM181B,marker 5350) ,family with sequence similarity 182, member A(FAM182A,marker 5351),family with sequence similarity 182, member A /// family with sequence similarity 182, member B(FAM182A /// FAM182B,marker 5352),family with sequence similarity 182, member B(FAM182B, marker 5353),family with sequence similarity 182, member B(FAM182B,marker 5354),family with sequence similarity 183, member C, pseudogene(FAM183CP,marker 5355),family with sequence similarity 184, member B(FAM184B, marker 5356),family with sequence similarity 185, member A(FAM185A,marker 5357),family with sequence similarity 186, member A(FAM186A,marker 5358),family with sequence similarity 186, member A(FAM186A,marker 5359),family with sequence similarity 186, member B(FAM186B,marker 5360),family with sequence similarity 187, member B(FAM187B,marker 5361),family with sequence similarity 188, member B /// INMT-FAM188B readthrough (NMD candidate)(FAM188B /// INMT-FAM188B, marker 5362),family with sequence similarity 189, member B(FAM189B,marker 5363),family with sequence similarity 196, member A(FAM196A,marker 5364),family with sequence similarity 196 , member B(FAM196B,marker 5365),family with sequence similarity 19 (chemokine (CC motif)-like), member A1(FAM19A1,marker 5366),family with sequence similarity 19 (chemokine (CC motif)-like), member A2(FAM19A2, marker 5367),family with sequence similarity 19 (chemokine (CC motif)-like), member A5(FAM19A5,marker 5368),family with sequence similarity 19 (chemokine (CC motif)-like), member A5( FAM19A5, marker 5369), family with sequence similarity 19 (chemokine (CC motif)-like), member A5(FAM19A5, marker 5370), family with sequence similarity 200, member A(FAM200A, marker 5371), family with sequence similarity 201 , member A(FAM201A,marker 5372),family with sequence similarity 201, member B /// uncharacterized LOC105376060(FAM201B /// LOC105376060,marker 5373),family with sequence similarity 205, member A(FAM205A,marker 5374),family with sequence similarity 205, member A /// transmembrane protein C9orf144B pseudogene(FAM205A /// FAM205BP, marker 5375),transmembrane protein C9orf144B pseudogene(FAM205BP, marker 5376),transmembrane protein C9orf144B pseudogene(FAM205BP, marker 5377),family with sequence similarity 205, member C(FAM205C, marker 5378),family with sequence similarity 208, member A(FAM208A,marker 5379),family with sequence similarity 208, member B(FAM208B,marker 5380),family with sequence similarity 208, member B (FAM208B, marker 5381),family with sequence similarity 209, member A(FAM209A,marker 5382),family with sequence similarity 209, member B(FAM209B,marker 5383),family with sequence similarity 20, member A(FAM20A,marker 5384 ),family with sequence similarity 20, member A(FAM20A,marker 5385),family with sequence similarity 20, member C(FAM20C,marker 5386),family with sequence similarity 20, member C(FAM20C,marker 5387),family with sequence similarity 20, member C(FAM20C,marker 5388),family with sequence similarity 212, member A(FAM212A,marker 5389),family with sequence similarity 212, member B /// uncharacterized LOC101928718(FAM212B /// LOC101928718,marker 5390) ,family with sequence similarity 212, member B /// uncharacterized LOC101928718(FAM212B /// LOC101928718, marker 5391),family with sequence similarity 212, member B /// uncharacterized LOC101928718(FAM212B /// LOC101928718, marker 5392),family with sequence similarity 214, member A(FAM214A, marker 5393),family with sequence similarity 215, member A (non-protein coding)(FAM215A,marker 5394),family with sequence similarity 216, member B(FAM216B,marker 5395), family with sequence similarity 217, member A(FAM217A, marker 5396),family with sequence similarity 217, member A(FAM217A,marker 5397),family with sequence similarity 218, member A(FAM218A,marker 5398),family with sequence similarity 218 , member A(FAM218A, marker 5399),family with sequence similarity 21, member A pseudogene(FAM21EP,marker 5400),family with sequence similarity 221, member B(FAM221B,marker 5401),family with sequence similarity 222, member A( FAM222A, marker 5402),FAM222A antisense RNA 1(FAM222A-AS1,marker 5403),family with sequence similarity 223, member A (non-protein coding) /// family with sequence similarity 223, member B (non-protein coding) (FAM223A /// FAM223B, marker 5404),family with sequence similarity 223, member B (non-protein coding)(FAM223B, marker 5405),family with sequence similarity 224, member A (non-protein coding)(FAM224A, marker 5406),family with sequence similarity 224, member A (non-protein coding) /// family with sequence similarity 224, member B (non-protein coding)(FAM224A /// FAM224B,marker 5407),family with sequence similarity 224 , member A (non-protein coding) /// family with sequence similarity 224, member B (non-protein coding)(FAM224A /// FAM224B, marker 5408),family with sequence similarity 225, member A (non-protein coding ) /// family with sequence similarity 225, member B (non-protein coding)(FAM225A /// FAM225B, marker 5409), family with sequence similarity 227, member B(FAM227B, marker 5410), family with sequence similarity 227, member B(FAM227B, marker 5411),family with sequence similarity 228, member A(FAM228A,marker 5412),family with sequence similarity 229, member A(FAM229A,marker 5413),family with sequence similarity 229, member A(FAM229A, marker 5414), family with sequence similarity 230, member B (non-protein coding) /// putative uncharacterized protein LOC388882 /// putative uncharacterized protein LOC388882 /// uncharacterized LOC105372856 /// putative uncharacterized protein ENSP00000383309 /// putative uncharacterized protein LOC388882 /// uncharacterized LOC729461(FAM230B /// LOC100996415 /// LOC105369215 /// LOC105372856 /// LOC105379519 /// LOC105379550 /// LOC729461, marker 5415), family with sequence similarity 230, member C (FAM230C, marker 5416 ),family with sequence similarity 231, member D /// uncharacterized LOC388692(FAM231D /// LOC388692,marker 5417),family with sequence similarity 231, member D /// uncharacterized LOC388692(FAM231D /// LOC388692,marker 5418), family with sequence similarity 234, member B(FAM234B, marker 5419),family with sequence similarity 234, member B(FAM234B,marker 5420),family with sequence similarity 24, member A(FAM24A,marker 5421),family with sequence similarity 24 , member B(FAM24B,marker 5422),family with sequence similarity 26, member D(FAM26D,marker 5423),family with sequence similarity 26, member E(FAM26E,marker 5424),family with sequence similarity 26, member E(FAM26E ,marker 5425),family with sequence similarity 26, member F(FAM26F,marker 5426),family with sequence similarity 26, member F(FAM26F,marker 5427),family with sequence similarity 26, member F(FAM26F,marker 5428), family with sequence similarity 27, member B /// family with sequence similarity 27, member C /// uncharacterized LOC102725186 /// uncharacterized LOC105379444(FAM27B /// FAM27C /// LOC102725186 /// LOC105379444, marker 5429),family with sequence similarity 27, member E2 /// family with sequence similarity 27, member E3(FAM27E2 /// FAM27E3,marker 5430),family with sequence similarity 3, member B(FAM3B,marker 5431),family with sequence similarity 3, member C(FAM3C, marker 5432),family with sequence similarity 3, member C(FAM3C,marker 5433),family with sequence similarity 3, member D(FAM3D,marker 5434),family with sequence similarity 41, member A, Y-linked 1 /// family with sequence similarity 41, member A, Y-linked 2(FAM41AY1 /// FAM41AY2, marker 5435),family with sequence similarity 43, member A(FAM43A,marker 5436),family with sequence similarity 43, member B(FAM43B, marker 5437),family with sequence similarity 45, member A(FAM45A,marker 5438),family with sequence similarity 45, member A(FAM45A,marker 5439),family with sequence similarity 46, member A(FAM46A,marker 5440),family with sequence similarity 46, member C(FAM46C,marker 5441),family with sequence similarity 46, member D(FAM46D,marker 5442),family with sequence similarity 47, member A(FAM47A,marker 5443),family with sequence similarity 47, member B(FAM47B, marker 5444),family with sequence similarity 47, member C(FAM47C,marker 5445),family with sequence similarity 47, member E(FAM47E,marker 5446),family with sequence similarity 49, member A(FAM49A, marker 5447),family with sequence similarity 49, member B(FAM49B,marker 5448),family with sequence similarity 53, member A(FAM53A,marker 5449),family with sequence similarity 53, member A(FAM53A,marker 5450),family with sequence similarity 53, member B(FAM53B,marker 5451),FAM53B antisense RNA 1(FAM53B-AS1,marker 5452),FAM53B antisense RNA 1(FAM53B-AS1,marker 5453),family with sequence similarity 57, member B(FAM57B, marker 5454),family with sequence similarity 65, member A(FAM65A,marker 5455),family with sequence similarity 65, member C(FAM65C,marker 5456),family with sequence similarity 65, member C(FAM65C, marker 5457),family with sequence similarity 66, member C(FAM66C,marker 5458),family with sequence similarity 66, member C(FAM66C,marker 5459),family with sequence similarity 66, member C(FAM66C,marker 5460),family with sequence similarity 66, member D(FAM66D, marker 5461),family with sequence similarity 69, member A(FAM69A,marker 5462),family with sequence similarity 71, member A(FAM71A,marker 5463),family with sequence similarity 71,
member A(FAM71A, marker 5464),family with sequence similarity 71, member A(FAM71A,marker 5465),family with sequence similarity 71, member B(FAM71B,marker 5466),family with sequence similarity 71, member B(FAM71B, marker 5467),family with sequence similarity 71, member B(FAM71B,marker 5468),family with sequence similarity 71, member C(FAM71C,marker 5469),family with sequence similarity 71, member D(FAM71D,marker 5470),family with sequence similarity 71, member E2(FAM71E2, marker 5471),family with sequence similarity 71, member E2(FAM71E2,marker 5472),family with sequence similarity 71, member F2(FAM71F2,marker 5473),family with sequence similarity 78, member A(FAM78A, marker 5474),family with sequence similarity 78, member B(FAM78B,marker 5475),family with sequence similarity 81, member A(FAM81A,marker 5476),family with sequence similarity 81, member A(FAM81A, marker 5477),family with sequence similarity 81, member B(FAM81B,marker 5478),family with sequence similarity 83, member A(FAM83A,marker 5479),family with sequence similarity 83, member A(FAM83A,marker 5480),family with sequence similarity 83, member A(FAM83A, marker 5481),family with sequence similarity 83, member B(FAM83B,marker 5482),family with sequence similarity 83, member C(FAM83C,marker 5483),family with sequence similarity 83, member C (FAM83C, marker 5484), FAM83C antisense RNA 1 (FAM83C-AS1, marker 5485), family with sequence similarity 83, member E (FAM83E, marker 5486), family with sequence similarity 83, member H (FAM83H, marker 5487 ),family with sequence similarity 84, member A(FAM84A,marker 5488),family with sequence similarity 84, member A(FAM84A,marker 5489),family with sequence similarity 84, member A(FAM84A,marker 5490),family with sequence similarity 84, member A /// uncharacterized LOC653602(FAM84A /// LOC653602, marker 5491),family with sequence similarity 86, member A pseudogene(FAM86B3P, marker 5492),family with sequence similarity 86, member A pseudogene(FAM86B3P, marker 5493),family with sequence similarity 86, member A pseudogene(FAM86B3P,marker 5494),family with sequence similarity 86, member A pseudogene(FAM86B3P,marker 5495),family with sequence similarity 86, member A pseudogene /// family with sequence similarity 90, member A1 /// family with sequence similarity 90, member A2 pseudogene(FAM86B3P /// FAM90A1 /// FAM90A2P, marker 5496),family with sequence similarity 87, member A /// family with sequence similarity 87, member B(FAM87A /// FAM87B, marker 5497), family with sequence similarity 87, member A /// family with sequence similarity 87, member B(FAM87A /// FAM87B, marker 5498), family with sequence similarity 90, member A1 (FAM90A1, marker 5499), family with sequence similarity 92, member A1(FAM92A1, marker 5500), family with sequence similarity 95, member A(FAM95A, marker 5501), family with sequence similarity 95, member B1 /// coiled- coiled-coil domain-containing protein 29-like /// coiled-coil domain-containing protein 29-like(FAM95B1 /// LOC101060026 /// LOC105379252, marker 5502), family with similarity sequence 98, member A(FAM98A, marker 5503) ,family with sequence similarity 98, member B(FAM98B,marker 5504),family with sequence similarity 99, member B (non-protein coding)(FAM99B,marker 5505),family with sequence similarity 9, member A(FAM9A,marker 5506 ),family with sequence similarity 9, member B(FAM9B,marker 5507),family with sequence similarity 9, member B(FAM9B,marker 5508),family with sequence similarity 9, member C(FAM9C,marker 5509),FANCD2/FANCI -associated nuclease 1 (FAN1, marker 5510), Fanconi anemia complementation group C (FANCC, marker 5511), Fanconi anemia complementation group C (FANCC, marker 5512), Fanconi anemia complementation group D2 (FANCD2, marker 5513), Fanconi anemia complementation group D2 (FANCD2, marker 5514), FANCD2 opposite strand (FANCD2OS, marker 5515), Fanconi anemia complementation group M (FANCM, marker 5516), fibroblast activation protein alpha (FAP, marker 5517), fatty acyl-CoA reductase 2 (FAR2) ,marker 5518),FERM, ARH/RhoGEF and pleckstrin domain protein 1(FARP1,marker 5519),FERM, ARH/RhoGEF and pleckstrin domain protein 1(FARP1,marker 5520),FERM, ARH/RhoGEF and pleckstrin domain protein 2( FARP2, marker 5521), FERM, ARH/RhoGEF and pleckstrin domain protein 2 (FARP2, marker 5522), FERM, ARH/RhoGEF and pleckstrin domain protein 2 (FARP2, marker 5523), phenylalanyl-tRNA synthetase 2, mitochondrial (FARS2, marker 5524), phenylalanyl-tRNA synthetase beta subunit (FARSB, marker 5525), Fas cell surface death receptor (FAS, marker 5526), FAS antisense RNA 1 (FAS-AS1, marker 5527), Fas ligand (TNF superfamily, member 6 )(FASLG, marker 5528),Fas ligand (TNF superfamily, member 6)(FASLG, marker 5529),fatty acid synthase(FASN,marker 5530),FAT atypical cadherin 2(FAT2,marker 5531),FAT atypical cadherin 3( FAT3, marker 5532), fetal and adult testis expressed 1(FATE1, marker 5533), failed axon connections homolog(FAXC, marker 5534), Fas (TNFRSF6) binding factor 1(FBF1, marker 5535), fibrillarin-like 1(FBLL1 , marker 5536), fibulin 1 (FBLN1, marker 5537), fibulin 1 (FBLN1, marker 5538), fibrillin 1 (FBN1, marker 5539), fibrillin 2 (FBN2, marker 5540), fructose-1,6-bisphosphatase 1( FBP1, marker 5541), fructose-1,6-bisphosphatase 2 (FBP2, marker 5542), fibrosin (FBRS, marker 5543), fibrosin-like 1 (FBRSL1, marker 5544), fibrosin-like 1 (FBRSL1, marker 5545) ,F-box and leucine-rich repeat protein 12(FBXL12, marker 5546),F-box and leucine-rich repeat protein 13(FBXL13, marker 5547),F-box and leucine-rich repeat protein 13(FBXL13, marker 5548 ),F-box and leucine-rich repeat protein 14(FBXL14, marker 5549),F-box and leucine-rich repeat protein 14(FBXL14, marker 5550),F-box and leucine-rich repeat protein 16(FBXL16, marker 5551),F-box and leucine-rich repeat protein 17(FBXL17, marker 5552),F-box and leucine-rich repeat protein 17(FBXL17, marker 5553),F-box and leucine-rich repeat protein 18(FBXL18, Marker 5554), F-box and leucine-rich repeat protein 18 (FBXL18, Marker 5555), F-box and leucine-rich repeat protein 18 (FBXL18, Marker 5556), FBXL19 antisense RNA 1 (head to head) (FBXL19- AS1, marker 5557), F-box and leucine-rich repeat protein 20 (FBXL20, marker 5558), F-box and leucine-rich repeat protein 20 (FBXL20, marker 5559), F-box and leucine-rich repeat protein 21 (gene/pseudogene)(FBXL21, marker 5560),F-box and leucine-rich repeat protein 21 (gene/pseudogene)(FBXL21, marker 5561),F-box and leucine-rich repeat protein 21 (gene/pseudogene)( FBXL21, marker 5562), F-box and leucine-rich repeat protein 22 (FBXL22, marker 5563), F-box and leucine-rich repeat protein 3 (FBXL3, marker 5564), F-box and leucine-rich repeat protein 6 (FBXL6, marker 5565), F-box and leucine-rich repeat protein 8 (FBXL8, marker 5566), F-box protein 10 (FBXO10, marker 5567), F-box protein 10 (FBXO10, marker 5568), F- box protein 10(FBXO10, marker 5569),F-box protein 11(FBXO11, marker 5570),F-box protein, helicase, 18(FBXO18, marker 5571),F-box protein 2(FBXO2, marker 5572),F -box protein 21 (FBXO21, marker 5573), F-box protein 22 (FBXO22, marker 5574), F-box protein 24 (FBXO24, marker 5575), F-box protein 24 (FBXO24, marker 5576), F-box protein 27 (FBXO27, marker 5577), F-box protein 28 (FBXO28, marker 5578), F-box protein 3 (FBXO3, marker 5579), F-box protein 3 (FBXO3, marker 5580), F-box protein 3 (FBXO3, marker 5581),F-box protein 32(FBXO32, marker 5582),F-box protein 32(FBXO32, marker 5583),F-box protein 32(FBXO32, marker 5584),F-box protein 32(FBXO32 , marker 5585), F-box protein 32 (FBXO32, marker 5586), F-box protein 32 (FBXO32, marker 5587), F-box protein 32 (FBXO32, marker 5588), F-box protein 36 (FBXO36, marker 5589), F-box protein 39 (FBXO39, marker 5590), F-box protein 4 (FBXO4, marker 5591), F-box protein 4 (FBXO4, marker 5592), F-box protein 40 (FBXO40, marker 5593) ,F-box protein 40(FBXO40, marker 5594),F-box protein 41(FBXO41, marker 5595),F-box protein 41(FBXO41,marker 5596),F-box protein 42(FBXO42,marker 5597),F -box protein 43 (FBXO43, marker 5598), F-box protein 44 (FBXO44, marker 5599), F-box protein 44 (FBXO44, marker 5600), F-box protein 9 (FBXO9, marker 5601), F-box protein 9(FBXO9, marker 5602),F-box and WD repeat domain containing 10(FBXW10, marker 5603),F-box and WD repeat domain containing 12(FBXW12, marker 5604),F-box and WD repeat domain containing 2 (FBXW2, marker 5605),F-box and WD repeat domain containing 2(FBXW2, marker 5606),F-box and WD repeat domain containing 4 pseudogene 1(FBXW4P1, marker 5607),F-box and WD repeat domain containing 7 , E3 ubiquitin protein ligase(FBXW7, marker 5608),Fc receptor, IgA, IgM, high affinity(FCAMR, marker 5609),Fc fragment of IgA receptor(FCAR, marker 5610),Fc fragment of IgA receptor(FCAR, marker 5611) ),Fc fragment of IgA receptor(FCAR, marker 5612),Fc fragment of IgA receptor(FCAR,marker 5613),Fc fragment of IgA receptor(FCAR,marker 5614),Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide(FCER1A, marker 5615), Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide(FCER1A, marker 5616), Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide(FCER1G, marker 5617) ,Fc fragment of IgE, low affinity II, receptor for (CD23)(FCER2, marker 5618),Fc fragment of IgE, low affinity II, receptor for (CD23)(FCER2, marker 5619),Fc fragment of IgG binding protein( Fc fragment of IgG, high affinity Ia, receptor (CD64)(FCGR1A, marker 5621), Fc fragment of IgG, high affinity Ia, receptor (CD64) /// Fc fragment of IgG, high affinity Ic , receptor (CD64), pseudogene(FCGR1A /// FCGR1C, marker 5622),Fc fragment of IgG, high affinity Ib, receptor (CD64)(FCGR1B, marker 5623),Fc fragment of IgG, low affinity IIa, receptor (CD32 )(FCGR2A, marker 5624), Fc fragment of IgG, low affinity IIa, receptor (CD32) /// Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)(FCGR2A /// FCGR2C, Marker 5625), Fc fragment of IgG, low affinity IIa, receptor (CD32) /// Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)(FCGR2A /// FCGR2C, Marker 5626), Fc fragment of IgG, low affinity IIb, receptor (CD32)(FCGR2B, marker 5627),Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)(FCGR2C, marker 5628),Fc fragment of IgG , low affinity IIc, receptor for (CD32) (gene/pseudogene)(FCGR2C, marker 5629),Fc fragment of IgG, low affinity IIc
, receptor for (CD32) (gene/pseudogene)(FCGR2C, marker 5630),Fc fragment of IgG, low affinity IIIa, receptor (CD16a) /// Fc fragment of IgG, low affinity IIIb, receptor (CD16b)(FCGR3A / // FCGR3B, marker 5631), Fc fragment of IgG, low affinity IIIb, receptor (CD16b)(FCGR3B, marker 5632), FCH domain only 2(FCHO2, marker 5633), FCH and double SH3 domains 1(FCHSD1, marker 5634 ),FCH and double SH3 domains 1(FCHSD1, marker 5635),FCH and double SH3 domains 2(FCHSD2, marker 5636),Fc fragment of IgM receptor(FCMR,marker 5637),Fc fragment of IgM receptor(FCMR,marker 5638 ), ficolin (collagen/fibrinogen domain containing) 1 (FCN1, marker 5639), ficolin (collagen/fibrinogen domain containing lectin) 2 (FCN2, marker 5640), ficolin (collagen/fibrinogen domain containing lectin) 2 (FCN2, marker 5641) ), ficolin (collagen/fibrinogen domain containing lectin) 2 (FCN2, marker 5642), ficolin (collagen/fibrinogen domain containing) 3 (FCN3, marker 5643), Fc receptor-like 1 (FCRL1, marker 5644), Fc receptor- like 1(FCRL1, marker 5645),Fc receptor-like 2(FCRL2, marker 5646),Fc receptor-like 2(FCRL2, marker 5647),Fc receptor-like 2(FCRL2, marker 5648),Fc receptor-like 2 (FCRL2, marker 5649), Fc receptor-like 2 (FCRL2, marker 5650), Fc receptor-like 3 (FCRL3, marker 5651), Fc receptor-like 3 (FCRL3, marker 5652), Fc receptor-like 4 (FCRL4 , marker 5653), Fc receptor-like 4 (FCRL4, marker 5654), Fc receptor-like 4 (FCRL4, marker 5655), Fc receptor-like 5 (FCRL5, marker 5656), Fc receptor-like 5 (FCRL5, marker 5657), Fc receptor-like 5 (FCRL5, marker 5658), Fc receptor-like 5 (FCRL5, marker 5659), Fc receptor-like 5 (FCRL5, marker 5660), Fc receptor-like A (FCRLA, marker 5661) , Fc receptor-like A (FCRLA, marker 5662), Fc receptor-like A (FCRLA, marker 5663), Fc receptor-like B (FCRLB, marker 5664), follicular dendritic cell secreted protein (FDCSP, marker 5665), ferrochelatase (FECH, marker 5666), fem-1 homolog a (C. elegans) (FEM1A, marker 5667), FOXF1 adjacent non-coding developmental regulatory RNA (FENDRR, marker 5668), FOXF1 adjacent non-coding developmental regulatory RNA (FENDRR, marker 5669),fer-1-like family member 4, pseudogene (functional)(FER1L4,marker 5670),fer-1-like family member 4, pseudogene (functional)(FER1L4,marker 5671),fer-1-like family member 5 (FER1L5, marker 5672), FER1L6 antisense RNA 1 (FER1L6-AS1, marker 5673), Fer3-like bHLH transcription factor (FERD3L, marker 5674), fermitin family member 1 (FERMT1, marker 5675), fermitin family member 3 (FERMT3, marker 5676), FES proto-oncogene, tyrosine kinase (FES, marker 5677), fetuin B (FETUB, marker 5678), FEV (ETS oncogene family) (FEV, marker 5679), fasciculation and elongation protein zeta 2 ( zygin II) (FEZ2, marker 5680), fasciculation and elongation protein zeta 2 (zygin II) (FEZ2, marker 5681), FEZ family zinc finger 2 (FEZF2, marker 5682), free fatty acid receptor 1 (FFAR1, marker 5683) ,free fatty acid receptor 1(FFAR1, marker 5684),free fatty acid receptor 2(FFAR2, marker 5685),free fatty acid receptor 3 /// G protein-coupled receptor 42 (gene/pseudogene)(FFAR3 /// GPR42 ,marker 5686),free fatty acid receptor 4(FFAR4,marker 5687),fibrinogen alpha chain(FGA,marker 5688),FYVE, RhoGEF and PH domain containing 2(FGD2,marker 5689),FYVE, RhoGEF and PH domain containing 2 (FGD2, marker 5690),FYVE, RhoGEF and PH domain containing 2(FGD2, marker 5691),FYVE, RhoGEF and PH domain containing 2(FGD2, marker 5692),FYVE, RhoGEF and PH domain containing 3(FGD3, marker 5693) ),FYVE, RhoGEF and PH domain containing 3(FGD3, marker 5694),FYVE, RhoGEF and PH domain containing 4(FGD4, marker 5695),FGD5 antisense RNA 1(FGD5-AS1, marker 5696),FYVE, RhoGEF and PH domain containing 6(FGD6, marker 5697),FYVE, RhoGEF and PH domain containing 6(FGD6, marker 5698),fibroblast growth factor 1 (acidic)(FGF1, marker 5699),fibroblast growth factor 1 (acidic)(FGF1, marker 5700), fibroblast growth factor 1 (acidic) (FGF1, marker 5701), fibroblast growth factor 10 (FGF10, marker 5702), FGF10 antisense RNA 1 (FGF10-AS1, marker 5703), fibroblast growth factor 11 (FGF11, marker 5704) ), fibroblast growth factor 12 (FGF12, marker 5705), fibroblast growth factor 13 /// long intergenic non-protein coding RNA 889 (FGF13 /// LINC00889, marker 5706), fibroblast growth factor 14 (FGF14, marker 5707), fibroblast growth factor 14 (FGF14, marker 5708), fibroblast growth factor 14 (FGF14, marker 5709), fibroblast growth factor 14 (FGF14, marker 5710), fibroblast growth factor 14 (FGF14, marker 5711), FGF14 antisense RNA 2 (FGF14 -AS2, marker 5712), FGF14 intronic transcript 1 (FGF14-IT1, marker 5713), fibroblast growth factor 16 (FGF16, marker 5714), fibroblast growth factor 17 (FGF17, marker 5715), fibroblast growth factor 18 (FGF18, marker 5716), fibroblast growth factor 18 (FGF18, marker 5717), fibroblast growth factor 18 (FGF18, marker 5718), fibroblast growth factor 18 (FGF18, marker 5719), fibroblast growth factor 18 (FGF18, marker 5720), fibroblast growth factor 20 (FGF20, marker 5721), fibroblast growth factor 21 (FGF21, marker 5722), fibroblast growth factor 22 (FGF22, marker 5723), fibroblast growth factor 22 (FGF22, marker 5724), fibroblast growth factor 22 (FGF22, marker 5725) ), fibroblast growth factor 23 (FGF23, marker 5726), fibroblast growth factor 3 (FGF3, marker 5727), fibroblast growth factor 4 (FGF4, marker 5728), fibroblast growth factor 5 (FGF5, marker 5729), fibroblast growth factor 5 (FGF5, marker 5730), fibroblast growth factor 5 (FGF5, marker 5731), fibroblast growth factor 6 (FGF6, marker 5732), fibroblast growth factor 7 (FGF7, marker 5733), fibroblast growth factor 7 (FGF7, marker 5734) ,fibroblast growth factor 7(FGF7, marker 5735),fibroblast growth factor 7 /// fibroblast growth factor 7 pseudogene /// keratinocyte growth factor-like protein 2(FGF7 /// KGFLP1 /// KGFLP2, marker 5736),fibroblast growth factor 8 (androgen-induced) (FGF8, marker 5737), fibroblast growth factor 9 (FGF9, marker 5738), fibroblast growth factor binding protein 1 (FGFBP1, marker 5739), fibroblast growth factor binding protein 2 (FGFBP2, marker 5740) ), FGFR1 oncogene partner(FGFR1OP, marker 5741), FGFR1 oncogene partner(FGFR1OP, marker 5742), FGFR1 oncogene partner 2(FGFR1OP2, marker 5743), FGFR1 oncogene partner 2(FGFR1OP2, marker 5744), fibroblast growth factor receptor 2( FGFR2, marker 5745),fibroblast growth factor receptor 2(FGFR2, marker 5746),fibroblast growth factor receptor 2(FGFR2, marker 5747),fibroblast growth factor receptor 2(FGFR2, marker 5748),fibroblast growth factor receptor 2(FGFR2, Marker 5749), fibroblast growth factor receptor 2 (FGFR2, Marker 5750), fibroblast growth factor receptor 2 (FGFR2, Marker 5751), fibroblast growth factor receptor 4 (FGFR4, Marker 5752), fibroblast growth factor receptor-like 1 (FGFRL1, Marker 5753), FGGY carbohydrate kinase domain containing(FGGY, Marker 5754), fibrinogen like 1(FGL1, Marker 5755), fibrinogen-like 2(FGL2, Marker 5756), fibrinogen-like 2(FGL2, Marker 5757), FGR proto -oncogene, Src family tyrosine kinase(FGR, marker 5758),forkhead-associated (FHA) phosphopeptide binding domain 1(FHAD1, marker 5759),forkhead-associated (FHA) phosphopeptide binding domain 1(FHAD1, marker 5760),forkhead- associated (FHA) phosphopeptide binding domain 1(FHAD1, marker 5761),forkhead-associated (FHA) phosphopeptide binding domain 1(FHAD1, marker 5762),forkhead-associated (FHA) phosphopeptide binding domain 1(FHAD1, marker 5763),four and a half LIM domains 5(FHL5, marker 5764),four and a half LIM domains 5(FHL5, marker 5765),four and a half LIM domains 5(FHL5, marker 5766),fibrinogen C domain containing 1(FIBCD1, marker 5767), fibrinogen C domain containing 1(FIBCD1, marker 5768), fin bud initiation factor homolog (zebrafish)(FIBIN, marker 5769), c-fos induced growth factor (vascular endothelial growth factor D) /// PIR-FIGF readthrough (FIGF /// PIR-FIGF, marker 5770), folliculogenesis specific bHLH transcription factor (FIGLA, marker 5771), filamin A interacting protein 1 (FILIP1, marker 5772), filamin A interacting protein 1 (FILIP1, marker 5773), filamin A interacting protein 1-like(FILIP1L, marker 5774), fat storage-inducing transmembrane protein 1(FITM1, marker 5775), fat storage-inducing transmembrane protein 2(FITM2, marker 5776), fat storage-inducing transmembrane protein 2(FITM2 , marker 5777), FK506 binding protein 15 (FKBP15, marker 5778), FK506 binding protein 15 (FKBP15, marker 5779), FK506 binding protein 15 (FKBP15, marker 5780), FK506 binding protein 3 (FKBP3, marker 5781), FK506 binding protein 4 (FKBP4, marker 5782), FK506 binding protein 4 (FKBP4, marker 5783), FK506 binding protein 6 (FKBP6, marker 5784), FK506 binding protein 7 (FKBP7, marker 5785), FK506 binding protein 8 (FKBP8, marker 5786), FK506 binding protein 8 (FKBP8, marker 5787), FKSG29 (FKSG29, marker 5788), folliculin (FLCN, marker 5789), folliculin (FLCN, marker 5790), folliculin (FLCN, marker 5791), filaggrin (FLG ,marker 5792),FLG antisense RNA 1(FLG-AS1,marker 5793),FLG antisense RNA 1(FLG-AS1,marker 5794),filaggrin family member 2(FLG2,marker 5795),Fli-1 proto-oncogene, ETS transcription factor(FLI1, marker 5796),Fli-1 proto-oncogene, ETS transcription factor(FLI1, marker 5797),Fli-1 proto-oncogene, ETS transcription factor(FLI1, marker 5798),Fli-1 proto-oncogene, ETS transcription factor(FLI1, marker 5799), uncharacterized protein FLJ10038 /// GA binding protein transcription factor, beta subunit 1(FLJ10038 /// GABPB1, marker 5800), uncharacterized protein FLJ10038 /// GA binding protein transcription factor, beta subunit 1(FLJ10038 /// GABPB1, marker 5801), uncharacterized LOC388439(FLJ12120, marker 5802), uncharacterized LOC440101(FLJ12825, marker 5803), uncharacterized LOC79857(FLJ13224, marker 5804), uncharacterized LOC246318(FLJ1377 3, Marker 5805), uncharacterized LOC641928 (FLJ16734, marker 5806), uncharacterized LOC100192386 (FLJ16779, marker 5807), uncharacterized LOC90024 (FLJ20021, marker 5808), uncharacterized FLJ20712 (FLJ20712, marker 5809), uncharacterized protein FLJ21369 (FLJ21369, marker 581 0), uncharacterized LOC400512(FLJ21408, marker 5811), uncharacterized LOC400512(FLJ21408, marker 5812), uncharacterized LOC401081(FLJ22763, marker 5813), uncharacterized protein FLJ23519 /// ribonuclease/angiogenin inhibitor 1(FLJ23519 /// RNH1, marker 5814), uncharacterized protein FLJ23867 /// qui escin Q6 sulfhydryl oxidase 1 (FLJ23867 /// QSOX1, marker 5815), MAP/microtubule affinity-regulating kinase 1 pseudogene (FLJ25758, marker 5816), FLJ26850
protein (FLJ26850, marker 5817), uncharacterized protein FLJ31356 (FLJ31356, marker 582), uncharacterized protein FLJ30679 (FLJ30679, marker 5819), uncharacterized LOC441072 (FLJ31104, marker 5820) 1),uncharacterized protein FLJ31713( FLJ31713, marker 5822), uncharacterized LOC440137 (FLJ31945, marker 5823), uncharacterized protein FLJ32154 (FLJ32154, marker 5824), uncharacterized LOC643977 (FLJ32255, marker 5825), uncharacterized LOC643977 (FLJ32255, marker 5826) ,FLJ33360 protein(FLJ33360, marker 5827 ), uncharacterized LOC285150 (FLJ33534, marker 5828), uncharacterized FLJ34503 (FLJ34503, marker 5829), uncharacterized protein FLJ35700 (FLJ35700, marker 5830), FLJ35816 protein (FLJ35816, marker 5831), uncharacterized LOC645524 (FLJ36 840, marker 5832), uncharacterized LOC399821 (FLJ37035, marker 5833), uncharacterized LOC399821(FLJ37035, marker 5834), uncharacterized LOC399821(FLJ37035, marker 5835), trigger transposable element derived 2 pseudogene(FLJ37201, marker 5836), uncharacterized LOC729614(FLJ37453, marker 5837 ),uncharacterized LOC729614( FLJ37453, marker 5838), uncharacterized LOC642691 /// uncharacterized LOC105371215 /// uncharacterized LOC105379432(FLJ37786 /// LOC105371215 /// LOC105379432, marker 5839), uncharacterized LOC651430(FLJ38576, marker 5 840), uncharacterized protein FLJ38773(FLJ38773, marker 5841 ), uncharacterized FLJ40288 (FLJ40288, marker 5842), uncharacterized LOC440200 (FLJ41170, marker 5843), uncharacterized LOC441441 (FLJ41455, marker 5844), uncharacterized LOC400999 (FLJ42351, marker 5845), uncharacterized LOC729220 (FL J45513, marker 5846), uncharacterized LOC440918( FLJ46875, marker 5847), FLJ90680 protein (FLJ90680, marker 5848), flotillin 1 (FLOT1, marker 5849), fibronectin leucine rich transmembrane protein 1 (FLRT1, marker 5850), fibronectin leucine rich transmembrane protein 2 (FLRT2, marker 5851), fms-related tyrosine kinase 1 (FLT1, marker 5852), fms-related tyrosine kinase 3 (FLT3, marker 5853), fms-related tyrosine kinase 3 ligand (FLT3LG, marker 5854), fms-related tyrosine kinase 3 ligand (FLT3LG, marker 5855), fms-related tyrosine kinase 4 (FLT4, marker 5856), fms-related tyrosine kinase 4 (FLT4, marker 5857), fms-related tyrosine kinase 4 (FLT4, marker 5858), feline leukemia virus subgroup C cellular receptor family, member 2(FLVCR2, marker 5859),formin 1(FMN1,marker 5860),formin 1(FMN1,marker 5861),formin 1(FMN1,marker 5862),formin 2(FMN2,marker 5863),formin 2( FMN2, Marker 5864), formin 2 (FMN2, Marker 5865), formin like 1 (FMNL1, Marker 5866), formin like 1 (FMNL1, Marker 5867), formin like 2 (FMNL2, Marker 5868), formin like 3 (FMNL3) ,marker 5869),formin like 3(FMNL3,marker 5870),formin like 3(FMNL3,marker 5871),formin like 3(FMNL3,marker 5872),flavin containing monooxygenase 1(FMO1,marker 5873),flavin containing monooxygenase 2 (FMO2, marker 5874), flavin containing monooxygenase 2(FMO2, marker 5875),flavin containing monooxygenase 3(FMO3, marker 5876),flavin containing monooxygenase 3(FMO3, marker 5877),flavin containing monooxygenase 5(FMO5, marker 5878) ,flavin containing monooxygenase 5(FMO5, marker 5879),flavin containing monooxygenase 5(FMO5, marker 5880),flavin containing monooxygenase 5(FMO5, marker 5881),flavin containing monooxygenase 6 pseudogene(FMO6P, marker 5882),flavin containing monooxygenase 9 pseudogene(FMO9P, marker 5883),fragile 5887),fibronectin type III domain containing 1(FNDC1, marker 5888),fibronectin type III domain containing 3A(FNDC3A, marker 5889),fibronectin type III domain containing 3B(FNDC3B, marker 5890),fibronectin type III domain containing 4(FNDC4 ,marker 5891),fibronectin type III domain containing 5(FNDC5,marker 5892),fibronectin type III domain containing 7(FNDC7,marker 5893),fibronectin type III domain containing 8(FNDC8,marker 5894),fibronectin type III domain containing 9 (FNDC9, marker 5895), folliculin interacting protein 1(FNIP1, marker 5896), folliculin interacting protein 1(FNIP1, marker 5897), folliculin interacting protein 1(FNIP1, marker 5898), folliculin interacting protein 2(FNIP2, marker 5899) , farnesyltransferase, CAAX box, alpha (FNTA, marker 5900), farnesyltransferase, CAAX box, beta (FNTB, marker 5901), focadhesin (FOCAD, marker 5902), folate hydrolase (prostate-specific membrane antigen) 1 (FOLH1, marker 5903) ),folate hydrolase (prostate-specific membrane antigen) 1 /// folate hydrolase 1B(FOLH1 /// FOLH1B, marker 5904),folate hydrolase (prostate-specific membrane antigen) 1 /// folate hydrolase 1B(FOLH1 /// FOLH1B, marker 5905), folate hydrolase (prostate-specific membrane antigen) 1 /// folate hydrolase 1B(FOLH1 /// FOLH1B, marker 5906), folate hydrolase 1B(FOLH1B, marker 5907), folate receptor 2 (fetal)( FOLR2, marker 5908), folate receptor 2 (fetal) (FOLR2, marker 5909), folate receptor 3 (gamma) (FOLR3, marker 5910), FBJ murine osteosarcoma viral oncogene homolog B (FOSB, marker 5911), FOS-like antigen 2 (FOSL2, marker 5912), FOS-like antigen 2 (FOSL2, marker 5913), forkhead box A1 (FOXA1, marker 5914), forkhead box A1 (FOXA1, marker 5915), forkhead box A2 (FOXA2, marker 5916), forkhead box B1 (FOXB1, marker 5917), forkhead box C2 (FOXC2, marker 5918), FOXC1 upstream transcript (non-protein coding) (FOXCUT, marker 5919), forkhead box D2 (FOXD2, marker 5920), FOXD2 antisense RNA 1 (head to head)(FOXD2-AS1, marker 5921), FOXD2 antisense RNA 1 (head to head)(FOXD2-AS1, marker 5922), forkhead box D3(FOXD3, marker 5923), forkhead box D3(FOXD3, marker 5924 ),forkhead box D4(FOXD4,marker 5925),forkhead box D4 /// forkhead box D4-like 1(FOXD4 /// FOXD4L1,marker 5926),forkhead box E1(FOXE1,marker 5927),forkhead box E1(FOXE1 , marker 5928), forkhead box E3 (FOXE3, marker 5929), forkhead box F1 (FOXF1, marker 5930), forkhead box F2 (FOXF2, marker 5931), forkhead box I1 (FOXI1, marker 5932), forkhead box J1 (FOXJ1 , marker 5933), forkhead box J2(FOXJ2, marker 5934), forkhead box K1(FOXK1, marker 5935), forkhead box K1(FOXK1, marker 5936), forkhead box K1(FOXK1, marker 5937), forkhead box K2(FOXK2 , marker 5938), forkhead box L1(FOXL1, marker 5939), forkhead box L1(FOXL1, marker 5940), forkhead box N1(FOXN1, marker 5941), forkhead box N1(FOXN1, marker 5942), forkhead box N2(FOXN2 , marker 5943), forkhead box N3 (FOXN3, marker 5944), forkhead box N3 (FOXN3, marker 5945), FOXN3 antisense RNA 1 (FOXN3-AS1, marker 5946), FOXN3 antisense RNA 2 (FOXN3-AS2, marker 5947) ,forkhead box N4(FOXN4, marker 5948),forkhead box N4(FOXN4, marker 5949),forkhead box N4(FOXN4, marker 5950),forkhead box O1(FOXO1, marker 5951),forkhead box O3(FOXO3, marker 5952) ,forkhead box O3 /// forkhead box O3B pseudogene(FOXO3 /// FOXO3B, marker 5953), forkhead box P1(FOXP1, marker 5954), forkhead box P1(FOXP1, marker 5955), forkhead box P1(FOXP1, marker 5956 ), forkhead box P1 (FOXP1, marker 5957), FOXP1 antisense RNA 1 (FOXP1-AS1, marker 5958), forkhead box P2 (FOXP2, marker 5959), forkhead box P2 (FOXP2, marker 5960), forkhead box P2 (FOXP2 , marker 5961), forkhead box P2(FOXP2, marker 5962), forkhead box P2(FOXP2, marker 5963), forkhead box P2(FOXP2, marker 5964), forkhead box P2(FOXP2, marker 5965), forkhead box P2(FOXP2 , marker 5966), forkhead box P2 (FOXP2, marker 5967), forkhead box P3 (FOXP3, marker 5968), forkhead box P3 (FOXP3, marker 5969), forkhead box P3 (FOXP3, marker 5970), forkhead box P4 (FOXP4 , marker 5971), FOXP4 antisense RNA 1 (FOXP4-AS1, marker 5972), forkhead box R1 (FOXR1, marker 5973), forkhead box R2 (FOXR2, marker 5974), FAD-dependent oxidoreductase domain containing 2 (FOXRED2, marker 5975) ), forkhead box S1(FOXS1, marker 5976), FPGT-TNNI3K readthrough /// TNNI3 interacting kinase(FPGT-TNNI3K /// TNNI3K, marker 5977), formyl peptide receptor 1(FPR1, marker 5978), formyl peptide receptor 1 (FPR1, marker 5979), formyl peptide receptor 2(FPR2, marker 5980), formyl peptide receptor 2(FPR2, marker 5981), formyl peptide receptor 3(FPR3, marker 5982), formyl peptide receptor 3(FPR3, marker 5983) ,fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1(FRA10AC1, marker 5984),Fraser extracellular matrix complex subunit 1(FRAS1, marker 5985) , FRAS1 related extracellular matrix 1 (FREM1, marker 5986), FRAS1 related extracellular matrix 1 (FREM1, marker 5987), FRAS1 related extracellular matrix 3 (FREM3, marker 5988), FSHD region gene 1 /// FSHD region gene 1 family member B, pseudogene /// FSHD region gene 1 family member C, pseudogene /// FSHD region gene 1 family member E, pseudogene /// uncharacterized LOC101930531 /// protein FRG1B(FRG1 /// FRG1BP /// FRG1CP /// FRG1EP /// LOC101930531 /// LOC102724813, marker 5989), FSHD region gene 1 family member B, pseudogene(FRG1BP, marker 5990),FSHD region gene 1 family member B, pseudogene(FRG1BP, marker 5991),FSHD region gene 1 family member E, pseudogene(FRG1EP, marker 5992),FSHD region gene 1 family member E, pseudogene /// FSHD region gene 1 family member J, pseudogene /// uncharacterized LOC101930531 /// protein FRG1B-like(FRG1EP /// FRG1JP /// LOC101930531 /// LOC105376057, marker 5993), FSHD region gene 1 family member J, pseudogene (FRG1JP, marker 5994), FSHD region gene 2 family, member E, pseudogene (FRG2EP, marker 5995), fyn-related Src family tyrosine kinase (FRK, marker 5996), fyn-related Src family tyrosine kinase (FRK, marker 5997), FERM domain containing 1 (FRMD1, marker 5998), FERM domain containing 3 (FRMD3, marker 5999), FERM domain containing 3(FRMD3, marker 6000),FERM domain containing 4A(FRMD4A,marker 6001),FERM domain containing 4A /// uncharacterized LOC105376424(FRMD4A /// LOC105376424, marker 6002),FERM domain containing 4A /// uncharacterized LOC105376424(FRMD4A /// LOC105376424, Marker 6003), FERM domain containing 4B(FRMD4B, Marker 6004), FERM domain containing 4B(FRMD4B, Marker 6005), FRMD6 antisense RNA 1(FRMD6-AS1, Marker 6006), FERM domain containing 7(FRMD7 , marker 6007), FERM domain containing 8 (FRMD8, marker 6008), FERM domain containing 8 (FRMD8, marker 6009), FERM domain containing 8 pseudogene 1 (FRMD8P1, marker 6010), FERM and PDZ domain containing 1 (FRMPD1, marker 6011),FERM and PDZ domain containing 2 /// FERM and PDZ domain containing 2B, pseudogene(FRMPD2 /// FRMPD2B, marker 6012),FERM and PDZ domain containing 4(FRMPD4, marker 6013),FERM and PDZ domain co
ntaining 4(FRMPD4, marker 6014),ferric-chelate reductase 1(FRRS1,marker 6015),ferric-chelate reductase 1-like(FRRS1L,marker 6016),ferric-chelate reductase 1-like(FRRS1L,marker 6017),fibroblast growth factor receptor substrate 3 (FRS3, marker 6018), FRY microtubule binding protein (FRY, marker 6019), FRY microtubule binding protein (FRY, marker 6020), FRY antisense RNA 1 (FRY-AS1, marker 6021), FRY like transcription coactivator (FRYL, marker 6022), FRY like transcription coactivator (FRYL, marker 6023), frizzled-related protein (FRZB, marker 6024), frizzled-related protein (FRZB, marker 6025), fibrous sheath CABYR binding protein (FSCB, marker 6026), fascin actin-bundling protein 2, retinal (FSCN2, marker 6027), fascin actin-bundling protein 3, testicular (FSCN3, marker 6028), fibronectin type III and SPRY domain containing 1-like (FSD1L, marker 6029), fibronectin type III and SPRY domain containing 2 (FSD2, marker 6030), follicle stimulating hormone, beta polypeptide (FSHB, marker 6031), follicle stimulating hormone receptor (FSHR, marker 6032), fibrous sheath interacting protein 1 (FSIP1, marker 6033) ,fibrous sheath interacting protein 1(FSIP1, marker 6034),fibrous sheath interacting protein 2(FSIP2, marker 6035),follistatin-like 4(FSTL4, marker 6036),follistatin-like 4(FSTL4, marker 6037),follistatin-like 4 (FSTL4, marker 6038), Follistatin-Like 5 (FSTL5, marker 6039), Formidoyltransferase Cyclodeaminase (FTCD, marker 6040), FormimidoyltransFerase Cyclod EAMINASE (FTCD, marker 6041), Formidoyltransferase Cyclodeaminase (FTCD, marker 6042), Formimidoyltransferase Cyclodeaminase (FTCD) , Marker 6043), formiminotransferase cyclodeaminase N-terminal like(FTCDNL1, Marker 6044), formiminotransferase cyclodeaminase N-terminal like(FTCDNL1, Marker 6045), ferritin, heavy polypeptide-like 17(FTHL17, Marker 6046), fucosidase, alpha-L - 1, tissue(FUCA1, marker 6047), FUN14 domain containing 2(FUNDC2, marker 6048), fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)(FUT3, marker 6049), fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)(FUT3, marker 6050),fucosyltransferase 5 (alpha (1,3) fucosyltransferase)(FUT5, marker 6051),fucosyltransferase 6 (alpha (1,3) fucosyltransferase)( FUT6, marker 6052),fucosyltransferase 6 (alpha (1,3) fucosyltransferase)(FUT6, marker 6053),fucosyltransferase 6 (alpha (1,3) fucosyltransferase)(FUT6, marker 6054),fucosyltransferase 6 (alpha (1,3) ) fucosyltransferase)(FUT6, marker 6055),fucosyltransferase 6 (alpha (1,3) fucosyltransferase)(FUT6, marker 6056),fucosyltransferase 7 (alpha (1,3) fucosyltransferase)(FUT7, marker 6057),fucosyltransferase 7 (alpha (1,3) fucosyltransferase)(FUT7, marker 6058),fucosyltransferase 9 (alpha (1,3) fucosyltransferase)(FUT9, marker 6059),fucosyltransferase 9 (alpha (1,3) fucosyltransferase)(FUT9, marker 6060), fragile (FXYD2, marker 6064),FXYD domain containing ion transport regulator 2 /// FXYD domain containing ion transport regulator 6 /// FXYD6-FXYD2 readthrough(FXYD2 /// FXYD6 /// FXYD6-FXYD2, marker 6065),FXYD domain containing ion transport regulator 3(FXYD3, marker 6066),FXYD domain containing ion transport regulator 4(FXYD4, marker 6067),FXYD domain containing ion transport regulator 5 /// uncharacterized LOC100127972(FXYD5 /// LOC100127972, marker 6068),FYN binding protein(FYB, marker 6069),FYN binding protein(FYB,marker 6070),FYN binding protein(FYB,marker 6071),FYN binding protein(FYB,marker 6072),FYN binding protein(FYB,marker 6073),frizzled class receptor 1 (FZD1, marker 6074), frizzled class receptor 1 (FZD1, marker 6075), frizzled class receptor 10 (FZD10, marker 6076), FZD10 antisense RNA 1 (head to head) (FZD10-AS1, marker 6077), FZD10 antisense RNA 1 (head to head)(FZD10-AS1, marker 6078), frizzled class receptor 4(FZD4, marker 6079), frizzled class receptor 9(FZD9, marker 6080), fizzy/cell division cycle 20 related 1(FZR1 , marker 6081), glucose-6-phosphatase, catalytic subunit(G6PC, marker 6082),glucose-6-phosphatase, catalytic subunit(G6PC, marker 6083),glucose-6-phosphatase, catalytic, 2(G6PC2, marker 6084) , GRB2-associated binding protein 1 (GAB1, marker 6085), GRB2-associated binding protein 1 (GAB1, marker 6086), GRB2-associated binding protein 1 (GAB1, marker 6087), GRB2-associated binding protein 3 (GAB3, marker 6088), GRB2-associated binding protein 3 (GAB3, marker 6089), GRB2-associated binding protein family, member 4 (GAB4, marker 6090), GABA(A) receptors associated protein like 3, pseudogene (GABARAPL3, marker 6091), gamma-aminobutyric acid (GABA) B receptor, 2(GABBR2, marker 6092),gamma-aminobutyric acid (GABA) B receptor, 2(GABBR2, marker 6093),GABPB1 antisense RNA 1(GABPB1-AS1, marker 6094),gamma -aminobutyric acid (GABA) A receptor, alpha 1(GABRA1, marker 6095),gamma-aminobutyric acid (GABA) A receptor, alpha 1(GABRA1, marker 6096),gamma-aminobutyric acid (GABA) A receptor, alpha 2( GABRA2, marker 6097), gamma-aminobutyric acid (GABA) A receptor, alpha 2(GABRA2, marker 6098), gamma-aminobutyric acid (GABA) A receptor, alpha 2(GABRA2, marker 6099), gamma-aminobutyric acid (GABA ) A receptor, alpha 2(GABRA2, marker 6100),gamma-aminobutyric acid (GABA) A receptor, alpha 2(GABRA2, marker 6101),gamma-aminobutyric acid (GABA) A receptor, alpha 3(GABRA3, marker 6102) ,gamma-aminobutyric acid (GABA) A receptor, alpha 4(GABRA4, marker 6103),gamma-aminobutyric acid (GABA) A receptor, alpha 4(GABRA4, marker 6104),gamma-aminobutyric acid (GABA) A receptor, alpha 6(GABRA6, marker 6105), gamma-aminobutyric acid (GABA) A receptor, beta 1(GABRB1, marker 6106), gamma-aminobutyric acid (GABA) A receptor, beta 1(GABRB1, marker 6107), gamma-aminobutyric acid (GABA) A receptor, beta 2(GABRB2, marker 6108),gamma-aminobutyric acid (GABA) A receptor, beta 2(GABRB2, marker 6109),gamma-aminobutyric acid (GABA) A receptor, beta 2(GABRB2, marker 6110),gamma-aminobutyric acid (GABA) A receptor, beta 3(GABRB3, marker 6111),gamma-aminobutyric acid (GABA) A receptor, beta 3(GABRB3, marker 6112),gamma-aminobutyric acid (GABA) A receptor , delta(GABRD, marker 6113), gamma-aminobutyric acid (GABA) A receptor, delta(GABRD, marker 6114), gamma-aminobutyric acid (GABA) A receptor, epsilon(GABRE, marker 6115), gamma-aminobutyric acid ( GABA) A receptor, gamma 1(GABRG1, marker 6116),gamma-aminobutyric acid (GABA) A receptor, gamma 1(GABRG1, marker 6117),gamma-aminobutyric acid (GABA) A receptor, gamma 2(GABRG2, marker 6118 ),gamma-aminobutyric acid (GABA) A receptor, gamma 2(GABRG2, marker 6119),gamma-aminobutyric acid (GABA) A receptor, gamma 3(GABRG3, marker 6120),gamma-aminobutyric acid (GABA) A receptor, gamma 3 (GABRG3, marker 6121), GABRG3 antisense RNA 1 (GABRG3-AS1, marker 6122), gamma-aminobutyric acid (GABA) A receptor, theta (GABRQ, marker 6123), gamma-aminobutyric acid (GABA) A receptor, rho 1 (GABRR1, marker 6124), gamma-aminobutyric acid (GABA) A receptor, rho 2 (GABRR2, marker 6125), gamma-aminobutyric acid (GABA) A receptor, rho 3 (gene/pseudogene) (GABRR3, marker 6126) ), glutamate decarboxylase 2 (GAD2, marker 6127), glutamate decarboxylase 2 (GAD2, marker 6128), glutamate decarboxylase 2 (GAD2, marker 6129), glutamate decarboxylase 2 (GAD2, marker 6130), glutamate decarboxylase 2 (GAD2, marker 6131) ), growth arrest and DNA-damage-inducible, beta (GADD45B, marker 6132), growth arrest and DNA-damage-inducible, gamma interacting protein 1 (GADD45GIP1, marker 6133), glutamate decarboxylase like 1 (GADL1, marker 6134), FGF-2 activity-associated protein 2 (GAFA2, marker 6135), FGF-2 activity-associated protein 3 (GAFA3, marker 6136), G antigen 1 (GAGE1, marker 6137), G antigen 1 /// G antigen 12B / // G antigen 12C /// G antigen 12D /// G antigen 12E /// G antigen 12F /// G antigen 12G /// G antigen 12H /// G antigen 12I /// G antigen 12J /// G antigen 13 /// G antigen 2A /// G antigen 2B /// G antigen 2C /// G antigen 2D /// G antigen 2E /// G antigen 4 /// G antigen 5 /// G antigen 6 /// G antigen 7 /// G antigen 8(GAGE1 /// GAGE12B /// GAGE12C /// GAGE12D /// GAGE12E /// GAGE12F /// GAGE12G /// GAGE12H /// GAGE12I /// GAGE12J /// GAGE13 /// GAGE2A /// GAGE2B /// GAGE2C /// GAGE2D /// GAGE2E /// GAGE4 /// GAGE5 /// GAGE6 /// GAGE7 /// GAGE8, marker 6138), G antigen 1 /// G antigen 12D /// G antigen 12F /// G antigen 12G /// G antigen 12I /// G antigen 12J /// G antigen 13 /// G antigen 2A /// G antigen 2B /// G antigen 2C /// G antigen 2D /// G antigen 2E /// G antigen 3 /// G antigen 4 /// G antigen 5 /// G antigen 6 /// G antigen 7 / // G antigen 8(GAGE1 /// GAGE12D /// GAGE12F /// GAGE12G /// GAGE12I /// GAGE12J /// GAGE13 /// GAGE2A /// GAGE2B /// GAGE2C /// GAGE2D /// GAGE2E /// GAGE3 /// GAGE4 /// GAGE5 /// GAGE6 /// GAGE7 /// GAGE8, marker 6139),G antigen 1 /// G antigen 12D /// G antigen 12F /// G antigen 12G /// G antigen 12I /// G antigen 12J /// G antigen 13 /// G antigen 2B /// G antigen 2D /// G antigen 2E /// G antigen 4 /// G antigen 5 / // G antigen 6 /// G antigen 7(GAGE1 /// GAGE12D /// GAGE12F /// GAGE12G /// GAGE12I /// GAGE12J /// GAGE13 /// GAGE2B /// GAGE2D /// GAGE2E / // GAGE4 /// GAGE5 /// GAGE6 /// GAGE7, marker 6140),G antigen 12B /// G antigen 12C /// G antigen 12D /// G antigen 12E /// G antigen 12F /// G antigen 12G /// G antigen 12H /// G antigen 12I /// G antigen 2A /// G antigen 2C /// G antigen 2D /// G antigen 2E /// G antigen 4 /// G antigen 5 /// G antigen 6 /// G antigen 7 /// G antigen 8(GAGE12B /// GAGE12C /// GAGE12D /// GAGE12E /// GAGE12F /// GAGE12G /// GAGE12H /// GAGE12I / // GAGE2A /// GAGE2C /// GAGE2D /// GAGE2E /// GAGE4 /// GAGE5 /// GAGE6 /// GAGE7 /// GAGE8, marker 6141),G antigen 12D /// G antigen 12F / // G antigen 12G /// G antigen 12I /// G antigen 2D /// G antigen 2E /// G antigen 4 /// G antigen 5 /// G antigen 6 /// G antigen 7(GAGE12D / // GAGE12F /// GAGE12G /// GAGE12I /// GAGE2D /// GAGE2E /// GAGE4 /// GAGE5 /// GAGE6 /// GAGE7, marker 6142), G antigen 3(GAGE3, marker 6143), galactose-3-O-sulfotransferase 1 (GAL3ST1, marker 6144), galactose-3-O-sulfotransferase 2 (GAL3ST2, marker 6145), galactokinase 1 (GALK1, marker 6146), galactosamine (N-acetyl)-6-sulfat
ase(GALNS, marker 6147), polypeptide N-acetylgalactosaminyltransferase 10 (GALNT10, marker 6148), polypeptide N-acetylgalactosaminyltransferase 13 (GALNT13, marker 6149), polypeptide N-acetylgalactosaminyltransferase 14 (GALNT14, marker 6150), polypeptide N-acetylgal actosaminyltransferase 15( GALNT15, marker 6151), polypeptide N-acetylgalactosaminyltransferase 15 (GALNT15, marker 6152), polypeptide N-acetylgalactosaminyltransferase 15 (GALNT15, marker 6153), polypeptide N-acetylgalactosaminyltransferase 16 (GALNT16, marker 6154), polypeptide N-acetylgalact osaminyltransferase 16(GALNT16, marker 6155), polypeptide N-acetylgalactosaminyltransferase 18 /// uncharacterized LOC105376551(GALNT18 /// LOC105376551, marker 6156), polypeptide N-acetylgalactosaminyltransferase 2(GALNT2, marker 6157), polypeptide N-acetylgalactosaminyltransferase 3(GAL NT3, marker 6158), polypeptide N-acetylgalactosaminyltransferase 4 /// POC1B-GALNT4 readthrough(GALNT4 /// POC1B-GALNT4, marker 6159), polypeptide N-acetylgalactosaminyltransferase 5(GALNT5, marker 6160), polypeptide N-acetylgalactosaminyltransferase 5(GALNT5, marker 6161), polypeptide N -acetylgalactosaminyltransferase 5(GALNT5, marker 6162),polypeptide N-acetylgalactosaminyltransferase 5(GALNT5, marker 6163),polypeptide N-acetylgalactosaminyltransferase 5(GALNT5, marker 6164),polypeptide N-acetylgalactosaminyltransferase 8 /// potassium channel, voltage gated shaker related subfamily A, member 6(GALNT8 /// KCNA6, marker 6165), polypeptide N-acetylgalactosaminyltransferase 8 /// potassium channel, voltage gated shaker related subfamily A, member 6(GALNT8 /// KCNA6, marker 6166), polypeptide N-acetylgalactosaminyltransferase 8 /// potassium channel, voltage gated shaker related subfamily A, member 6(GALNT8 /// KCNA6, marker 6167), polypeptide N-acetylgalactosaminyltransferase 9(GALNT9, marker 6168), polypeptide N-acetylgalactosaminyltransferase-like 5(GALNTL5, marker 6169), polypeptide N-acetylgalactosaminyltransferase-like 6 (GALNTL6, marker 6170), galanin-like peptide (GALP, marker 6171), galanin receptor 1 (GALR1, marker 6172), galanin receptor 2 (GALR2, marker 6173), galanin receptor 3(GALR3, marker 6174), galactose-1-phosphate uridylyltransferase(GALT, marker 6175), galactose-1-phosphate uridylyltransferase(GALT, marker 6176), glucosidase, alpha; neutral C(GANC, marker 6177), glucosidase, alpha ; neutral C (GANC, marker 6178), growth associated protein 43 (GAP43, marker 6179), glyceraldehyde-3-phosphate dehydrogenase, spermatogenic (GAPDHS, marker 6180), gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA (GAPLINC, marker 6181), GRB2-binding adapter protein, transmembrane (GAPT, marker 6182), GTPase activating Rap/RanGAP domain-like 3 (GARNL3, marker 6183), GTPase activating Rap/RanGAP domain-like 3 (GARNL3, marker 6184), GTPase activating Rap/RanGAP domain-like 3 (GARNL3, marker 6185), phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase (GART, marker 6186), GAS1 adjacent regulatory RNA (GAS1RR, marker 6187), GAS1 adjacent regulatory RNA( GAS1RR, marker 6188), growth arrest-specific 2 (GAS2, marker 6189), growth arrest-specific 2 like 1 (GAS2L1, marker 6190), growth arrest-specific 2 like 2 (GAS2L2, marker 6191), GAS5 antisense RNA 1 (GAS5-AS1, marker 6192),GAS6 antisense RNA 1(GAS6-AS1,marker 6193),GAS6 antisense RNA 1(GAS6-AS1,marker 6194),growth arrest-specific 7(GAS7,marker 6195),GAS8 antisense RNA 1 (GAS8-AS1, marker 6196), gastrin (GAST, marker 6197), GATA binding protein 1 (globin transcription factor 1) (GATA1, marker 6198), GATA2 antisense RNA 1 (GATA2-AS1, marker 6199), GATA2 antisense RNA 1 (GATA2-AS1, marker 6200), GATA3 antisense RNA 1 (GATA3-AS1, marker 6201), GATA3 antisense RNA 1 (GATA3-AS1, marker 6202), GATA binding protein 4 (GATA4, marker 6203), GATA binding protein 4 (GATA4, marker 6204), GATA binding protein 4 (GATA4, marker 6205), GATA binding protein 4 (GATA4, marker 6206), GATA binding protein 4 (GATA4, marker 6207), GATA binding protein 5 (GATA5, marker 6208), GATA binding protein 5 (GATA5, marker 6209), GATA binding protein 6 (GATA6, marker 6210), GATA zinc finger domain containing 1 (GATAD1, marker 6211), GATA zinc finger domain containing 2A (GATAD2A, marker 6212) ,GATA zinc finger domain containing 2A(GATAD2A, marker 6213),glycine amidinotransferase (L-arginine:glycine amidinotransferase)(GATM, marker 6214),glycine amidinotransferase (L-arginine:glycine amidinotransferase)(GATM, marker 6215),glycine amidinotransferase GATM , stromal antigen 3 opposite strand(GATS,marker 6219),glucosidase, beta, acid /// glucosidase, beta, acid pseudogene 1 /// glucosylceramidase-like(GBA /// GBAP1 /// LOC100510710,marker 6220),glucosidase , beta, acid 3 (gene/pseudogene)(GBA3, marker 6221),glucosidase, beta, acid 3 (gene/pseudogene)(GBA3, marker 6222),guanylate binding protein 1, interferon-inducible(GBP1, marker 6223), guanylate binding protein 1, interferon-inducible(GBP1, marker 6224),guanylate binding protein 1, interferon-inducible(GBP1, marker 6225),guanylate binding protein 1, interferon-inducible(GBP1, marker 6226),guanylate binding protein 1, interferon-inducible pseudogene 1 (GBP1P1, marker 6227), guanylate binding protein 2, interferon-inducible (GBP2, marker 6228), guanylate binding protein 2, interferon-inducible (GBP2, marker 6229), guanylate binding protein 3 (GBP3, marker 6230), guanylate binding protein 4 (GBP4, marker 6231), guanylate binding protein 4 (GBP4, marker 6232), guanylate binding protein 5 (GBP5, marker 6233), guanylate binding protein 5 (GBP5, marker 6234), guanylate binding protein family, member 6(GBP6, marker 6235),guanylate binding protein family, member 6(GBP6, marker 6236),gastrulation brain homeobox 1(GBX1,marker 6237),gastrulation brain homeobox 2(GBX2,marker 6238),group-specific component (vitamin D binding protein)(GC, marker 6239),GRIP and coiled-coil domain containing 1(GCC1, marker 6240),GRIP and coiled-coil domain containing 1(GCC1, marker 6241),GRIP and coiled-coil domain containing 2(GCC2, marker 6242),GCC2 antisense RNA 1(GCC2-AS1,marker 6243),GCC2 antisense RNA 1 /// uncharacterized LOC105373540 /// plasminogen-like B1 /// plasminogen-like B2(GCC2-AS1 / // LOC105373540 /// PLGLB1 /// PLGLB2, marker 6244), glucagon (GCG, marker 6245), glucagon receptor (GCGR, marker 6246), glucokinase (hexokinase 4) (GCK, marker 6247), glucokinase (hexokinase 4) regulator(GCKR, marker 6248), glutamate-cysteine ligase, catalytic subunit(GCLC, marker 6249), glial cells missing homolog 1 (Drosophila)(GCM1, marker 6250), glial cells missing homolog 2 (Drosophila)(GCM2, marker 6251 ),glucosaminyl (N-acetyl) transferase 3, mucin type(GCNT3, marker 6252),glucosaminyl (N-acetyl) transferase 4, core 2(GCNT4, marker 6253),glucosaminyl (N-acetyl) transferase family member 7(GCNT7) , marker 6254), glucosaminyl (N-acetyl) transferase family member 7 (GCNT7, marker 6255), germinal center-associated, signaling and motility (GCSAM, marker 6256), germinal center-associated, signaling and motility-like (GCSAML, marker 6257), GCSAML antisense RNA 1 (GCSAML-AS1, marker 6258), guanine deaminase (GDA, marker 6259), guanine deaminase (GDA, marker 6260), growth differentiation factor 10 (GDF10, marker 6261), growth differentiation factor 11 (GDF11, marker 6262), growth differentiation factor 11 (GDF11, marker 6263), growth differentiation factor 15 (GDF15, marker 6264), growth differentiation factor 15 (GDF15, marker 6265), growth differentiation factor 2 (GDF2, marker 6266) ,growth differentiation factor 5(GDF5, marker 6267),growth differentiation factor 9(GDF9,marker 6268),glial cell derived neurotrophic factor(GDNF,marker 6269),glycerophosphodiester phosphodiesterase domain containing 1(GDPD1,marker 6270),glycerophosphodiester phosphodiesterase domain containing 1(GDPD1, marker 6271), glycerophosphodiester phosphodiesterase domain containing 3(GDPD3, marker 6272), GDP-D-glucose phosphorylase 1(GDPGP1, marker 6273), gem nuclear organelle associated protein 7(GEMIN7, marker 6274), golgi to ER traffic protein 4 (GET4, marker 6275), golgi to ER traffic protein 4 (GET4, marker 6276), glial fibrillary acidic protein (GFAP, marker 6277), glial fibrillary acidic protein (GFAP, marker 6278), growth factor, augmenter of liver regeneration(GFER, marker 6279),growth factor independent 1 transcription repressor(GFI1, marker 6280),growth factor independent 1B transcription repressor(GFI1B,marker 6281),growth factor independent 1B transcription repressor(GFI1B,marker 6282),G elongation factor, mitochondrial 1(GFM1, marker 6283),G elongation factor, mitochondrial 1(GFM1, marker 6284),glucose-fructose oxidoreductase domain containing 1(GFOD1, marker 6285),GDNF family receptor alpha 1(GFRA1, marker 6286) ,GDNF family receptor alpha 2(GFRA2, marker 6287),GDNF family receptor alpha 2(GFRA2,marker 6288),GDNF family receptor alpha 3(GFRA3,marker 6289),GDNF family receptor alpha 3(GFRA3,marker 6290),GDNF family receptor alpha 4(GFRA4, marker 6291),GDNF family receptor alpha 4(GFRA4, marker 6292),golgi-associated, gamma adaptin ear containing, ARF binding protein 1(GGA1, marker 6293),golgi-associated, gamma adaptin ear containing, ARF binding protein 2(GGA2, marker 6294), golgi-associated, gamma adaptin ear containing, ARF binding protein 2(GGA2, marker 6295), gamma-glutamylamine cyclotransferase(GGACT, marker 6296), gamma-glutamylamine cyclotransferase // / uncharacterized LOC100507654(GGACT /// LOC100507654, marker 6297), gametogenetin(GGN, marker 6298), gametogenetin(GGN, marker 6299), gametogenetin binding protein 2(GGNBP2, marker 6300), gametogenetin binding protein 2(GGNBP2, marker 6301) ),gamma-glutamyltransferase 1 /// gamma-glutamyltransferase 2 /// gamma-glutamyltransferase 3 pseudogene /// gamma-glutamyltransferase 8 pseudogene /// gamma-glutamyltransferase light chain 1 /// gamma-glutamyltransferase light chain 2 /// inactive gamma-glutamyltranspeptidase 2-like /// inactive gamma-glutamyltranspeptidase 2(GGT1 /// GGT2 /// GGT3P /// GGT8P /// GGTLC1 /// GGTLC2 /// LOC102724197 /// LOC102724823, Marker 6302), gamma-glutamyltransfer
rase 5 (GGT5, marker 6303), gamma-glutamyltransferase 6 (GGT6, marker 6304), gamma-glutamyltransferase 7 (GGT7, marker 6305), glycoprotein, alpha-galactosyltransferase 1 pseudogene (GGTA1P, marker 6306), gamma-glutamyltransferase light chain 2(GGTLC2, marker 6307),growth hormone 1(GH1,marker 6308),growth hormone 1(GH1,marker 6309),growth hormone 1(GH1,marker 6310),growth hormone 1(GH1,marker 6311),growth hormone 2 (GH2, marker 6312), growth hormone 2 (GH2, marker 6313), GH3 domain containing (GHDC, marker 6314), gastric carcinoma proliferation enhancing transcript 1 (GHET1, marker 6315), growth hormone releasing hormone (GHRH, marker 6316) ),growth hormone releasing hormone receptor(GHRHR, marker 6317),growth hormone releasing hormone receptor(GHRHR,marker 6318),growth hormone releasing hormone receptor(GHRHR,marker 6319),ghrelin/obestatin prepropeptide(GHRL,marker 6320),ghrelin /obestatin prepropeptide(GHRL, marker 6321),ghrelin opposite strand/antisense RNA(GHRLOS, marker 6322),growth hormone secretagogue receptor(GHSR,marker 6323),growth hormone secretagogue receptor(GHSR,marker 6324),growth hormone secretagogue receptor( GHSR, marker 6325), gastric intrinsic factor (vitamin B synthesis) (GIF, marker 6326), GRB10 interacting GYF protein 1 (GIGYF1, marker 6327), GRB10 interacting GYF protein 2 (GIGYF2, marker 6328), GTPase, IMAP family member 1(GIMAP1, marker 6329),GTPase, IMAP family member 1(GIMAP1, marker 6330),GTPase, IMAP family member 1(GIMAP1, marker 6331),GTPase, IMAP family member 1(GIMAP1, marker 6332),GTPase, IMAP family member 1(GIMAP1, marker 6333), GIMAP1-GIMAP5 readthrough /// GTPase, IMAP family member 5(GIMAP1-GIMAP5 /// GIMAP5, marker 6334), GTPase, IMAP family member 2(GIMAP2, marker 6335), GTPase , IMAP family member 4(GIMAP4, marker 6336),GTPase, IMAP family member 5(GIMAP5, marker 6337),GTPase, IMAP family member 6(GIMAP6, marker 6338),GTPase, IMAP family member 6(GIMAP6, marker 6339) ,GTPase, IMAP family member 7(GIMAP7, marker 6340),GTPase, IMAP family member 8(GIMAP8, marker 6341),GTPase, IMAP family member 8(GIMAP8, marker 6342),GINS complex subunit 2 (Psf2 homolog)(GINS2 , marker 6343), GINS complex subunit 4 (Sld5 homolog) (GINS4, marker 6344), GINS complex subunit 4 (Sld5 homolog) (GINS4, marker 6345), gastric inhibitory polypeptide(GIP, marker 6346), GIPC PDZ domain containing family , member 2(GIPC2, marker 6347),GIPC PDZ domain containing family, member 2(GIPC2, marker 6348),GIPC PDZ domain containing family, member 3(GIPC3, marker 6349),GIPC PDZ domain containing family, member 3(GIPC3 , marker 6350), gastric inhibitory polypeptide receptor (GIPR, marker 6351), gastric inhibitory polypeptide receptor (GIPR, marker 6352), G protein-coupled receptor kinase interacting ArfGAP 2 (GIT2, marker 6353), G protein-coupled receptor kinase interacting ArfGAP 2 (GIT2, marker 6354), G protein-coupled receptor kinase interacting ArfGAP 2 (GIT2, marker 6355), G protein-coupled receptor kinase interacting ArfGAP 2 (GIT2, marker 6356), gap junction protein alpha 10 (GJA10, marker 6357), gap junction protein alpha 3 (GJA3, marker 6358), gap junction protein alpha 3 (GJA3, marker 6359), gap junction protein alpha 4 (GJA4, marker 6360), gap junction protein alpha 4 (GJA4, marker 6361) ,gap junction protein alpha 5(GJA5, marker 6362),gap junction protein alpha 5(GJA5,marker 6363),gap junction protein alpha 8(GJA8,marker 6364),gap junction protein alpha 9 /// GJA9-MYCBP readthrough( GJA9 /// GJA9-MYCBP, marker 6365), gap junction protein beta 1(GJB1, marker 6366), gap junction protein beta 3(GJB3, marker 6367), gap junction protein beta 3(GJB3, marker 6368), gap junction protein beta 3 (GJB3, marker 6369), gap junction protein beta 4 (GJB4, marker 6370), gap junction protein beta 5 (GJB5, marker 6371), gap junction protein beta 6 (GJB6, marker 6372), gap junction protein gamma 2 (GJC2, marker 6373), gap junction protein gamma 2 (GJC2, marker 6374), gap junction protein delta 2 (GJD2, marker 6375), gap junction protein delta 3 (GJD3, marker 6376), gap junction protein delta 3( GJD3, marker 6377), gap junction protein delta 4 (GJD4, marker 6378), glycerol kinase 2 (GK2, marker 6379), glycerol kinase 5 (putative) (GK5, marker 6380), glycerol kinase 5 (putative) (GK5, marker 6381), G kinase anchoring protein 1 (GKAP1, marker 6382), gastrokine 1 (GKN1, marker 6383), gastrokine 2 (GKN2, marker 6384), galactosidase beta 1 like (GLB1L, marker 6385), galactosidase beta 1 like 3 (GLB1L3, marker 6386), glucocorticoid induced 1 (GLCCI1, marker 6387), gliomedin (GLDN, marker 6388), GLE1 RNA export mediator (GLE1, marker 6389), GLI family zinc finger 2 (GLI2, marker 6390), GLI family zinc finger 4(GLI4, marker 6391),GLI family zinc finger 4(GLI4,marker 6392),GLI family zinc finger 4 /// ZFP41 zinc finger protein(GLI4 /// ZFP41,marker 6393),GLIS family zinc finger 1 (GLIS1, marker 6394), GLIS3 antisense RNA 1 (GLIS3-AS1, marker 6395), glyoxalase domain containing 5 (GLOD5, marker 6396), glyoxalase domain containing 5 (GLOD5, marker 6397), glucagon-like peptide 1 receptor (GLP1R , marker 6398), glucagon-like peptide 1 receptor (GLP1R, marker 6399), glucagon-like peptide 1 receptor (GLP1R, marker 6400), glucagon-like peptide 1 receptor (GLP1R, marker 6401), glucagon-like peptide 1 receptor (GLP1R, marker 6402), glucagon-like peptide 2 receptor (GLP2R, marker 6403), glycine receptor alpha 1 (GLRA1, marker 6404), glycine receptor alpha 2 (GLRA2, marker 6405), glycine receptor alpha 3 (GLRA3, marker 6406), glycine receptor alpha 3 (GLRA3, marker 6407), glycine receptor alpha 3 (GLRA3, marker 6408), glycine receptor beta (GLRB, marker 6409), glutaredoxin 3 (GLRX3, marker 6410), glutaminase (GLS, marker 6411) ),glutaminase(GLS,marker 6412),glutaminase(GLS,marker 6413),glutaminase(GLS,marker 6414),glutaminase 2 (liver, mitochondrial)(GLS2,marker 6415),glutaminase 2 (liver, mitochondrial)(GLS2, marker 6416), glycosyltransferase 1 domain containing 1 (GLT1D1, marker 6417), glycolipid transfer protein domain containing 2 (GLTPD2, marker 6418), glioma tumor suppressor candidate region gene 2 (GLTSCR2, marker 6419), glutamate dehydrogenase 2 (GLUD2, marker 6420), glutamate-ammonia ligase (GLUL, marker 6421), glycine-N-acyltransferase (GLYAT, marker 6422), glycine-N-acyltransferase (GLYAT, marker 6423), glycine-N-acyltransferase (GLYAT, marker 6424), glycine-N-acyltransferase-like 1(GLYATL1, marker 6425),glycine-N-acyltransferase-like 1 /// uncharacterized LOC100287413(GLYATL1 /// LOC100287413, marker 6426),glycine-N-acyltransferase-like 2(GLYATL2, marker 6427), glycerate kinase (GLYCTK, marker 6428), GLYCTK antisense RNA 1 (GLYCTK-AS1, marker 6429), GM2 ganglioside activator (GM2A, marker 6430), GDP-mannose 4,6-dehydratase (GMDS, marker 6431) ,GMDS antisense RNA 1 (head to head)(GMDS-AS1, marker 6432),GMDS antisense RNA 1 (head to head)(GMDS-AS1,marker 6433),glucocorticoid modulatory element binding protein 1(GMEB1,marker 6434), glia maturation factor, gamma (GMFG, marker 6435), GEM interacting protein (GMIP, marker 6436), glycosylphosphatidylinositol anchored molecule like (GML, marker 6437), geminin coiled-coil domain containing (GMNC, marker 6438), guanine nucleotide binding protein (G protein), alpha 13 (GNA13, marker 6439), GNA14 antisense RNA 1 (GNA14-AS1, marker 6440), guanine nucleotide binding protein (G protein), alpha 15 (Gq class) (GNA15, marker 6441), guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O(GNAO1, marker 6442),guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O(GNAO1, marker 6443),guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O(GNAO1, marker 6444), GNAS complex locus(GNAS, marker 6445), GNAS complex locus(GNAS, marker 6446), guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1(GNAT1, marker 6447),guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 1(GNAT1, marker 6448),guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2(GNAT2, marker 6449),guanine nucleotide binding protein, alpha transducing 3(GNAT3, marker 6450),guanine nucleotide binding protein (G protein), beta polypeptide 1-like(GNB1L, marker 6451),guanine nucleotide binding protein (G protein), beta 5(GNB5, marker 6452),guanine nucleotide binding protein (G protein), gamma 11(GNG11, marker 6453),guanine nucleotide binding protein (G protein), gamma 13(GNG13, marker 6454),guanine nucleotide binding protein (G protein), gamma 2(GNG2, marker 6455),guanine nucleotide binding protein (G protein), gamma 2(GNG2, marker 6456),guanine nucleotide binding protein (G protein), gamma 4(GNG4, marker 6457),guanine nucleotide binding protein (G protein), gamma 7 (GNG7, marker 6458), guanine nucleotide binding protein (G protein), gamma 8(GNG8, marker 6459), guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1(GNGT1, marker 6460), guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 (GNGT2, marker 6461), guanine nucleotide binding protein-like 1 (GNL1, marker 6462), guanine nucleotide binding protein-like 1 (GNL1, marker 6463), granulysin (GNLY, marker 6464), granulysin (GNLY, marker 6465), glycine N-methyltransferase (GNMT, marker 6466), N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits (GNPTAB, marker 6467), gonadotropin releasing hormone 1 (GNRH1, marker 6468), gonadotropin releasing hormone 1 (GNRH1, marker 6469), gonadotropin releasing hormone 2 (GNRH2, marker 6470), gonadotropin releasing hormone 2 /// protein tyrosine phosphatase, receptor type, A (GNRH2 /// PTPRA, marker 6471) ,gonadotropin releasing hormone receptor(GNRHR, marker 6472),gonadotropin releasing hormone receptor(GNRHR,marker 6473),gonadotropin releasing hormone receptor(GNRHR,marker 6474),gonadotropin releasing hormone receptor 2, pseudogene(GNRHR2,marker 6475),golgin A2 pseudogene 2, Y-linked /// golgin A2 pseudogene 3, Y-linked(GOLGA2P2Y /// GOLGA2P3Y, marker 6476), golgin A2 pseudogene 5(GOLGA2P5, marker 6477), golgin A2 pseudogene 5(GOLGA2P5, marker 6478), golgin A3(GOLGA3, marker 6479),golgin A6 family, member A(GOLGA6A,marker 6480),golgin A6 family, member A /// golgin A6 family, member B /// golgin A6 family, member D(GOLGA6A // / GOLGA6B /// GOLGA6D, marker 6481), golgin A6 family-like 1 /// golgin A6 family-li
ke 22 /// golgin A6 family-like 6(GOLGA6L1 /// GOLGA6L22 /// GOLGA6L6, marker 6482), golgin A6 family-like 1 /// golgin A6 family-like 22 /// golgin A6 family-like 6 (GOLGA6L1 /// GOLGA6L22 /// GOLGA6L6, marker 6483),golgin A6 family-like 2(GOLGA6L2, marker 6484),golgin A7 family, member B(GOLGA7B, marker 6485),golgin A8 family, member I, pseudogene( GOLGA8IP, marker 6486), golgi integral membrane protein 4 (GOLIM4, marker 6487), golgi membrane protein 1 (GOLM1, marker 6488), golgi transport 1A (GOLT1A, marker 6489), golgi-associated PDZ and coiled-coil motif containing( GOPC, marker 6490), golgi-associated PDZ and coiled-coil motif containing(GOPC, marker 6491), golgi reassembly stacking protein 1(GORASP1, marker 6492),golgi SNAP receptor complex member 1(GOSR1, marker 6493),golgi SNAP receptor complex member 2 (GOSR2, marker 6494), glutamic-oxaloacetic transaminase 1-like 1 (GOT1L1, marker 6495), glutamic-oxaloacetic transaminase 1-like 1 (GOT1L1, marker 6496), glycoprotein Ib (platelet), alpha polypeptide( GP1BA, marker 6497), glycoprotein Ib (platelet), beta polypeptide /// septin 5 /// SEPT5-GP1BB readthrough(GP1BB /// SEPT5 /// SEPT5-GP1BB, marker 6498), glycoprotein 2 (zymogen granule membrane) (GP2, marker 6499), glycoprotein 2 (zymogen granule membrane) (GP2, marker 6500), glycoprotein 2 (zymogen granule membrane) (GP2, marker 6501), glycoprotein 2 (zymogen granule membrane) (GP2, marker 6502), glycoprotein V (platelet)(GP5, marker 6503), glycoprotein V (platelet)(GP5, marker 6504), glycoprotein VI (platelet)(GP6, marker 6505), glycoprotein IX (platelet)(GP9, marker 6506), glycoprotein A33 ( transmembrane) (GPA33, marker 6507), glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT2, marker 6508), glycerol-3-phosphate acyltransferase 4 (GPAT4, marker 6509), G-patch domain containing 11 (GPATCH11, marker 6510) ),G-patch domain containing 2 like(GPATCH2L,marker 6511),G-patch domain containing 2 like(GPATCH2L,marker 6512),G-patch domain containing 4(GPATCH4,marker 6513),G-patch domain containing 4( GPATCH4, marker 6514), G protein-coupled bile acid receptor 1 (GPBAR1, marker 6515), glypican 1 (GPC1, marker 6516), glypican 5 (GPC5, marker 6517), glycerol-3-phosphate dehydrogenase 1 (GPD1, marker 6518), glycerol-3-phosphate dehydrogenase 1 (GPD1, marker 6519), glycerol-3-phosphate dehydrogenase 1 (GPD1, marker 6520), G protein-coupled estrogen receptor 1 (GPER1, marker 6521), G protein-coupled estrogen receptor 1 (GPER1, marker 6522), glycoprotein hormone alpha 2 (GPHA2, marker 6523), glycoprotein hormone beta 5 (GPHB5, marker 6524), glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 (GPIHBP1, marker 6525), glycosylphosphatidylinositol specific phospholipase D1 (GPLD1, marker 6526), glycosylphosphatidylinositol specific phospholipase D1 (GPLD1, marker 6527), glycosylphosphatidylinositol specific phospholipase D1 (GPLD1, marker 6528), glycosylphosphatidylinositol specific phospholipase D1 (GPLD1, marker 6529), glycosylphosphatidylinositol specific phospholipase D1(GPLD1, marker 6530) , glycoprotein M6A (GPM6A, marker 6531), glycoprotein (transmembrane) nmb (GPNMB, marker 6532), G protein-coupled receptor 1 (GPR1, marker 6533), GPR1 antisense RNA (GPR1-AS, marker 6534), G protein- coupled receptor 101(GPR101, marker 6535),G protein-coupled receptor 107(GPR107, marker 6536),G protein-coupled receptor 107(GPR107, marker 6537),G protein-coupled receptor 12(GPR12, marker 6538),G protein-coupled receptor 12(GPR12, marker 6539),G protein-coupled receptor 132(GPR132, marker 6540),G protein-coupled receptor 132(GPR132, marker 6541),G protein-coupled receptor 135(GPR135, marker 6542) ,G protein-coupled receptor 135(GPR135, marker 6543),G protein-coupled receptor 135(GPR135, marker 6544),G protein-coupled receptor 137(GPR137, marker 6545),G protein-coupled receptor 141(GPR141, marker 6546), G protein-coupled receptor 146 (GPR146, marker 6547), G protein-coupled receptor 15 (GPR15, marker 6548), G protein-coupled receptor 150 (GPR150, marker 6549), G protein-coupled receptor 153 (GPR153) , marker 6550), G protein-coupled receptor 155 (GPR155, marker 6551), G protein-coupled receptor 155 (GPR155, marker 6552), G protein-coupled receptor 155 (GPR155, marker 6553), G protein-coupled receptor 156 (GPR156, marker 6554), G protein-coupled receptor 157 (GPR157, marker 6555), G protein-coupled receptor 158 (GPR158, marker 6556), G protein-coupled receptor 162 (GPR162, marker 6557), G protein-coupled receptor 17(GPR17, marker 6558),G protein-coupled receptor 17(GPR17, marker 6559),G protein-coupled receptor 171(GPR171, marker 6560),G protein-coupled receptor 173(GPR173, marker 6561),G protein -coupled receptor 173 (GPR173, marker 6562), G protein-coupled receptor 174 (GPR174, marker 6563), G protein-coupled receptor 18 (GPR18, marker 6564), G protein-coupled receptor 180 (GPR180, marker 6565), G protein-coupled receptor 180(GPR180, marker 6566),G protein-coupled receptor 180(GPR180, marker 6567),G protein-coupled receptor 182(GPR182, marker 6568),G protein-coupled receptor 182(GPR182, marker 6569) ), G protein-coupled receptor 183 (GPR183, marker 6570), G protein-coupled receptor 20 (GPR20, marker 6571), G protein-coupled receptor 21 /// RAB GTPase activating protein 1 (GPR21 /// RABGAP1, marker 6572),G protein-coupled receptor 21 /// RAB GTPase activating protein 1(GPR21 /// RABGAP1, marker 6573),G protein-coupled receptor 22(GPR22, marker 6574),G protein-coupled receptor 22(GPR22, marker 6575), G protein-coupled receptor 25 (GPR25, marker 6576), G protein-coupled receptor 26 (GPR26, marker 6577), G protein-coupled receptor 26 (GPR26, marker 6578), G protein-coupled receptor 26 ( GPR26, marker 6579), G protein-coupled receptor 3 (GPR3, marker 6580), G protein-coupled receptor 31 (GPR31, marker 6581), G protein-coupled receptor 32 (GPR32, marker 6582), G protein-coupled receptor 34 (GPR34, marker 6583), G protein-coupled receptor 35 (GPR35, marker 6584), G protein-coupled receptor 37 (endothelin receptor type B-like) (GPR37, marker 6585), G protein-coupled receptor 37 like 1 (GPR37L1, marker 6586),G protein-coupled receptor 37 like 1(GPR37L1, marker 6587),G protein-coupled receptor 37 like 1 /// uncharacterized LOC284570(GPR37L1 /// LOC284570,marker 6588),G protein-coupled receptor 39(GPR39, marker 6589),G protein-coupled receptor 39(GPR39, marker 6590),G protein-coupled receptor 39(GPR39, marker 6591),G protein-coupled receptor 4(GPR4, marker 6592),G protein -coupled receptor 4 (GPR4, marker 6593), G protein-coupled receptor 45 (GPR45, marker 6594), G protein-coupled receptor 50 (GPR50, marker 6595), G protein-coupled receptor 52 (GPR52, marker 6596), G protein-coupled receptor 55 (GPR55, marker 6597), G protein-coupled receptor 55 (GPR55, marker 6598), G protein-coupled receptor 6 (GPR6, marker 6599), G protein-coupled receptor 61 (GPR61, marker 6600) ),G protein-coupled receptor 62(GPR62, marker 6601),G protein-coupled receptor 65(GPR65, marker 6602),G protein-coupled receptor 68(GPR68, marker 6603),G protein-coupled receptor 68(GPR68, marker 6604), G protein-coupled receptor 75 (GPR75, marker 6605), G protein-coupled receptor 78 (GPR78, marker 6606), G protein-coupled receptor 82 (GPR82, marker 6607), G protein-coupled receptor 82 ( GPR82, marker 6608), G protein-coupled receptor 82 (GPR82, marker 6609), G protein-coupled receptor 83 (GPR83, marker 6610), G protein-coupled receptor 84 (GPR84, marker 6611), G protein-coupled receptor 85 (GPR85, marker 6612), G protein-coupled receptor 85 (GPR85, marker 6613), G protein-coupled receptor 88 (GPR88, marker 6614), G protein-coupled receptor 89B (GPR89B, marker 6615), G protein- coupled receptor, class C, group 5, member A(GPRC5A, marker 6616),G protein-coupled receptor, class C, group 5, member B(GPRC5B, marker 6617),G protein-coupled receptor, class C, group 5 , member C(GPRC5C, marker 6618),G protein-coupled receptor, class C, group 5, member D(GPRC5D, marker 6619),G protein-coupled receptor, class C, group 5, member D(GPRC5D, marker 6620 ),G protein-coupled receptor, class C, group 6, member A(GPRC6A, marker 6621),G protein regulated inducer of neurite outgrowth 1(GPRIN1,marker 6622),G protein regulated inducer of neurite outgrowth 1(GPRIN1,marker 6623), G protein regulated inducer of neurite outgrowth 2(GPRIN2, marker 6624),GPRIN family member 3(GPRIN3, marker 6625),GPRIN family member 3(GPRIN3, marker 6626),GPRIN family member 3(GPRIN3, marker 6627) ,GPRIN family member 3(GPRIN3, marker 6628),GPRIN family member 3(GPRIN3, marker 6629),G-protein signaling modulator 1(GPSM1, marker 6630),glutamic-pyruvate transaminase (alanine aminotransferase)(GPT,marker 6631) ,glutathione peroxidase 2(GPX2, marker 6632),glutathione peroxidase 5(GPX5, marker 6633),glutathione peroxidase 5(GPX5, marker 6634),GRAM domain containing 1C(GRAMD1C,marker 6635),GRAM domain containing 3(GRAMD3,marker 6636),GRAM domain containing 4(GRAMD4, marker 6637),GRAM domain containing 4(GRAMD4, marker 6638),GRB2-related adapter protein /// GRB2-related adapter protein-like(GRAP /// GRAPL, marker 6639) ,GRB2-related adapter protein /// GRB2-related adapter protein-like(GRAP /// GRAPL, marker 6640),GRB2-related adapter protein 2(GRAP2, marker 6641),GRB2-related adapter protein-like(GRAPL, marker 6642), GRB2-related adapter protein-like (GRAPL, marker 6643), GRB2-related adapter protein-like (GRAPL, marker 6644), GRB2-related adapter protein-like (GRAPL, marker 6645), GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein (GRASP, marker 6646), GRP1-associated scaffold protein opposite strand (GRASPOS, marker 6647), growth factor receptor bound protein 2 (GRB2, marker 6648), growth regulation by estrogen in breast cancer 1 (GREB1, marker 6649), growth regulation by estrogen in breast cancer 1(GREB1, marker 6650), gremlin 2, DAN family BMP antagonist(GREM2, marker 6651), gremlin 2, DAN family BMP antagonist(GREM2, marker 6652), gremlin 2, DAN family BMP antagonist(GREM2, marker 6653),glutamate receptor, ionotropic, AMPA 1(GRIA1, marker 6654),glutamate receptor, ionotropic, AMPA 1(GRIA1, marker 6655),glutamate receptor, ionotropic, AMPA 2( GRIA2, marker 6656), glutamate receptor, ionotropic, AMPA 2 (GRIA2, marker 6657), glutamate receptor, ionotropic, AMPA 2 (GRIA2, marker 6658), glutamate receptor, ionotropic, AMPA 3 (GRIA3, marker 6659), glutamate receptor , ionotropic, AMPA 3(GRIA3, marker 6660),glutamate rece
ptor, ionotropic, AMPA 3(GRIA3, marker 6661),glutamate receptor, ionotropic, AMPA 3(GRIA3, marker 6662),glutamate receptor, ionotropic, AMPA 4(GRIA4, marker 6663),glutamate receptor, ionotropic, AMPA 4(GRIA4) , marker 6664), glutamate receptor, ionotropic, AMPA 4 (GRIA4, marker 6665), glutamate receptor, ionotropic, delta 1 (GRID1, marker 6666), glutamate receptor, ionotropic, delta 1 (GRID1, marker 6667), glutamate receptor, ionotropic, delta 1 (GRID1, marker 6668), GRID1 antisense RNA 1 (GRID1-AS1, marker 6669), glutamate receptor, ionotropic, delta 2 (GRID2, marker 6670), glutamate receptor, ionotropic, kainate 1 (GRIK1, marker 6671) ),glutamate receptor, ionotropic, kainate 1(GRIK1, marker 6672),glutamate receptor, ionotropic, kainate 1(GRIK1, marker 6673),GRIK1 antisense RNA 1(GRIK1-AS1,marker 6674),GRIK1 antisense RNA 2(GRIK1- AS2, marker 6675), glutamate receptor, ionotropic, kainate 2(GRIK2, marker 6676),glutamate receptor, ionotropic, kainate 2(GRIK2, marker 6677),glutamate receptor, ionotropic, kainate 2(GRIK2, marker 6678),glutamate receptor , ionotropic, kainate 2(GRIK2, marker 6679),glutamate receptor, ionotropic, kainate 2(GRIK2, marker 6680),glutamate receptor, ionotropic, kainate 2(GRIK2, marker 6681),glutamate receptor, ionotropic, kainate 3(GRIK3, marker 6682), glutamate receptor, ionotropic, kainate 3(GRIK3, marker 6683),glutamate receptor, ionotropic, kainate 4(GRIK4, marker 6684),glutamate receptor, ionotropic, kainate 5(GRIK5, marker 6685),glutamate receptor, ionotropic , kainate 5 (GRIK5, marker 6686), glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1, marker 6687), glutamate receptor, ionotropic, N-methyl D-aspartate 1 (GRIN1, marker 6688), glutamate receptor , ionotropic, N-methyl D-aspartate 1(GRIN1, marker 6689),glutamate receptor, ionotropic, N-methyl D-aspartate 1(GRIN1, marker 6690),glutamate receptor, ionotropic, N-methyl D-aspartate 1(GRIN1 , Marker 6691), glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A, Marker 6692), glutamate receptor, ionotropic, N-methyl D-aspartate 2A (GRIN2A, Marker 6693), glutamate receptor, ionotropic, N- methyl D-aspartate 2A (GRIN2A, marker 6694), glutamate receptor, ionotropic, N-methyl D-aspartate 2B (GRIN2B, marker 6695), glutamate receptor, ionotropic, N-methyl D-aspartate 2B (GRIN2B, marker 6696), glutamate receptor, ionotropic, N-methyl D-aspartate 2B(GRIN2B, marker 6697),glutamate receptor, ionotropic, N-methyl D-aspartate 2C(GRIN2C, marker 6698),glutamate receptor, ionotropic, N-methyl D-aspartate 2C (GRIN2C, marker 6699), glutamate receptor, ionotropic, N-methyl D-aspartate 2D (GRIN2D, marker 6700), glutamate receptor, ionotropic, N-methyl-D-aspartate 3A (GRIN3A, marker 6701), glutamate receptor, ionotropic , N-methyl-D-aspartate 3A (GRIN3A, marker 6702), glutamate receptor, ionotropic, N-methyl-D-aspartate 3B (GRIN3B, marker 6703), glutamate receptor interacting protein 1 (GRIP1, marker 6704), glutamate receptor protein interacting 2 (GRIP2, marker 6705), G protein-coupled receptor kinase 1 (GRK1, marker 6706), G protein-coupled receptor kinase 4 (GRK4, marker 6707), G protein-coupled receptor kinase 4 (GRK4, marker 6708) ),G protein-coupled receptor kinase 4(GRK4, marker 6709),G protein-coupled receptor kinase 4(GRK4, marker 6710),G protein-coupled receptor kinase 5(GRK5, marker 6711),G protein-coupled receptor kinase 6 (GRK6, marker 6712), G protein-coupled receptor kinase 7 (GRK7, marker 6713), glutamate receptor, metabotropic 1 (GRM1, marker 6714), glutamate receptor, metabotropic 1 (GRM1, marker 6715), glutamate receptor, metabotropic 1 (GRM1, marker 6716), glutamate receptor, metabotropic 2 (GRM2, marker 6717), glutamate receptor, metabotropic 2 (GRM2, marker 6718), glutamate receptor, metabotropic 4 (GRM4, marker 6719), glutamate receptor, metabotropic 5 ( GRM5, marker 6720), glutamate receptor, metabotropic 5(GRM5, marker 6721),glutamate receptor, metabotropic 5(GRM5, marker 6722),glutamate receptor, metabotropic 6(GRM6, marker 6723),glutamate receptor, metabotropic 7(GRM7, marker 6724), glutamate receptor, metabotropic 7 (GRM7, marker 6725), glutamate receptor, metabotropic 7 (GRM7, marker 6726), glutamate receptor, metabotropic 8 (GRM8, marker 6727), glutamate receptor, metabotropic 8 (GRM8, marker 6728) ), glutamate receptor, metabotropic 8 (GRM8, marker 6729), gastrin-releasing peptide (GRP, marker 6730), GRTP1 antisense RNA 1 (GRTP1-AS1, marker 6731), GRTP1 antisense RNA 1 (GRTP1-AS1, marker 6732) ,uncharacterized LOC100652791(GS1-24F4.2, marker 6733),transmembrane protein 225-like(GS1-259H13.2,marker 6734),microtubule-associated protein 1 light chain 3 beta pseudogene(GS1-279B7.1,marker 6735) ,unknown transcript(GS1-600G8.3, marker 6736),gamma-secretase activating protein(GSAP,marker 6737),gamma-secretase activating protein(GSAP,marker 6738),goosecoid homeobox(GSC,marker 6739),goosecoid homeobox 2 (GSC2, marker 6740), gasdermin B (GSDMB, marker 6741), gasdermin B (GSDMB, marker 6742), gasdermin B (GSDMB, marker 6743), Gse1 coiled-coil protein (GSE1, marker 6744), germ cell associated 1 (GSG1, marker 6745), GSG1-like (GSG1L, marker 6746), glycogen synthase kinase 3 alpha (GSK3A, marker 6747), glycogen synthase kinase 3 beta (GSK3B, marker 6748), glycogen synthase kinase 3 beta (GSK3B, marker 6749), gelsolin (GSN, marker 6750), gelsolin (GSN, marker 6751), gelsolin (GSN, marker 6752), gelsolin (GSN, marker 6753), GSN antisense RNA 1 (GSN-AS1, marker 6754), glutathione S -transferase alpha 3 (GSTA3, marker 6755), glutathione S-transferase mu 4 (GSTM4, marker 6756), glutathione S-transferase mu 4 (GSTM4, marker 6757), glutathione S-transferase mu 5 (GSTM5, marker 6758), glutathione S-transferase omega 2(GSTO2, marker 6759),glutathione S-transferase theta 1(GSTT1, marker 6760),glutathione S-transferase theta 1(GSTT1, marker 6761),glutathione S-transferase theta pseudogene 1 /// glutathione S-transferase theta pseudogene 2(GSTTP1 /// GSTTP2, marker 6762),GS homeobox 1(GSX1, marker 6763),GS homeobox 1(GSX1, marker 6764),GS homeobox 2(GSX2, marker 6765),glycosyltransferase like domain containing 1(GTDC1, marker 6766), glycosyltransferase like domain containing 1(GTDC1, marker 6767), general transcription factor IIA 1-like(GTF2A1L, marker 6768), general transcription factor IIA 1-like /// STON1-GTF2A1L readthrough( GTF2A1L /// STON1-GTF2A1L, marker 6769), general transcription factor IIA 2 (GTF2A2, marker 6770), general transcription factor IIH subunit 1 (GTF2H1, marker 6771), general transcription factor IIH subunit 5 (GTF2H5, marker 6772), general transcription factor IIH subunit 5(GTF2H5, marker 6773), general transcription factor IIH subunit 5(GTF2H5, marker 6774), GTF2I repeat domain containing 2 /// GTF2I repeat domain containing 2B(GTF2IRD2 /// GTF2IRD2B, marker 6775), GTF2I repeat domain containing 2 /// GTF2I repeat domain containing 2B(GTF2IRD2 /// GTF2IRD2B, marker 6776), GTF3C2 antisense RNA 1(GTF3C2-AS1, marker 6777), GTF3C2 antisense RNA 1(GTF3C2-AS1, marker 6778), general transcription factor IIIC subunit 3 (GTF3C3, marker 6779), GTP binding protein 1 (GTPBP1, marker 6780), GTP binding protein 1 (GTPBP1, marker 6781), GTP binding protein 1 (GTPBP1, marker 6782), GTP binding protein 1 (GTPBP1, marker 6783),GTP-binding protein 10 (putative)(GTPBP10, marker 6784),GTP-binding protein 10 (putative) /// uncharacterized LOC101927446(GTPBP10 /// LOC101927446, marker 6785),GTP-binding protein 10 (putative) /// uncharacterized LOC101927446(GTPBP10 /// LOC101927446, marker 6786), GTP-binding protein 10 (putative) /// uncharacterized LOC101927446(GTPBP10 /// LOC101927446, marker 6787), GTP binding protein 2(GTPBP2 , marker 6788), G-2 and S-phase expressed 1(GTSE1, marker 6789), GTSE1 antisense RNA 1 (head to head)(GTSE1-AS1, marker 6790), gametocyte specific factor 1(GTSF1, marker 6791), gametocyte specific factor 1-like(GTSF1L, marker 6792),gametocyte specific factor 1-like(GTSF1L, marker 6793),guanylate cyclase activator 1A (retina)(GUCA1A,marker 6794),guanylate cyclase activator 1B (retina)(GUCA1B, marker 6795), guanylate cyclase activator 1C (GUCA1C, marker 6796), guanylate cyclase activator 1C (GUCA1C, marker 6797), guanylate cyclase activator 1C (GUCA1C, marker 6798), guanylate cyclase activator 2A (guanylin) (GUCA2A, marker 6799) ,guanylate cyclase activator 2B (uroguanylin)(GUCA2B,marker 6800),guanylate cyclase 1, soluble, alpha 2(GUCY1A2,marker 6801),guanylate cyclase 1, soluble, alpha 2(GUCY1A2,marker 6802),guanylate cyclase 1, soluble , alpha 2(GUCY1A2, marker 6803),guanylate cyclase 1, soluble, alpha 2(GUCY1A2, marker 6804),guanylate cyclase 1, soluble, alpha 2(GUCY1A2, marker 6805),guanylate cyclase 1, soluble, alpha 3(GUCY1A3 ,marker 6806),guanylate cyclase 1, soluble, alpha 3(GUCY1A3,marker 6807),guanylate cyclase 1, soluble, alpha 3(GUCY1A3,marker 6808),guanylate cyclase 1, soluble, beta 2 (pseudogene)(GUCY1B2,marker 6809), guanylate cyclase 2C (GUCY2C, marker 6810), guanylate cyclase 2D, membrane (retina-specific) (GUCY2D, marker 6811), guanylate cyclase 2F, retinal (GUCY2F, marker 6812), guanylate kinase 1 (GUK1, marker 6813) ),GULP, engulfment adapter PTB domain containing 1(GULP1, marker 6814),glucuronidase, beta(GUSB, marker 6815),glucuronidase, beta pseudogene 1(GUSBP1, marker 6816),glucuronidase, beta pseudogene 1(GUSBP1, marker 6817) ,glucuronidase, beta pseudogene 1(GUSBP1, marker 6818),glucuronidase, beta pseudogene 11(GUSBP11, marker 6819),glucuronidase, beta pseudogene 11(GUSBP11, marker 6820),glucuronidase, beta pseudogene 2(GUSBP2, marker 6821),glucuronidase , beta pseudogene 5(GUSBP5, marker 6822),GTPase, very large interferon inducible pseudogene 1(GVINP1, marker 6823),GTPase, very large interferon inducible pseudogene 1(GVINP1, marker 6824),GVQW motif containing 1(GVQW1, marker 6825) ), GVQW motif containing 2(GVQW2, marker 6826), glycophorin A (MNS blood group)(GYPA, marker 6827), glycophorin A (MNS blood group)(GYPA, marker 6828), glycophorin A (MNS blood group)(GYPA , marker 6829), glycophorin A (MNS blood group) (GYPA, marker 6830), glycophorin A (MNS blood group) (GYPA, marker 6831), glycophorin A (MNS blood group) /// glycophorin B (MNS blood group) (GYPA /// GYPB, Marker 6832), glycophorin B (MNS blood group) (GYPB, Marker 6833), glycophorin B (MNS blood group) (GYPB, Marker 6834), glycophorin B (MNS blood group) (GYPB, Marker 6835), glycophorin E (MNS blood group) (GYPE, marker 6836), glycophorin E (MNS b
blood group) (GYPE, marker 6837), glycophorin E (MNS blood group) (GYPE, marker 6838), glycogen synthase 2 (liver) (GYS2, marker 6839), GDNF-inducible zinc finger protein 1 (GZF1, marker 6840) , granzyme A (GZMA, marker 6841), granzyme B (GZMB, marker 6842), granzyme H (GZMH, marker 6843), granzyme K (GZMK, marker 6844), granzyme M (GZMM, marker 6845), H19, imprinted maternally expressed transcript (non-protein coding) /// uncharacterized LOC102724852(H19 /// LOC102724852, marker 6846),H19, imprinted maternally expressed transcript (non-protein coding) /// uncharacterized LOC102724852(H19 /// LOC102724852, marker 6847 ),H1 histone family, member N, testis-specific(H1FNT,marker 6848),H1 histone family, member N, testis-specific(H1FNT,marker 6849),H1 histone family, member N, testis-specific(H1FNT,marker 6850),H1 histone family, member O, oocyte-specific(H1FOO, marker 6851),H2A histone family, member B1 /// H2A histone family, member B2 /// H2A histone family, member B3(H2AFB1 /// H2AFB2 /// H2AFB3, marker 6852), H2A histone family, member J(H2AFJ, marker 6853), H2A histone family, member J(H2AFJ, marker 6854), H2A histone family, member Y(H2AFY, marker 6855), H2A histone family, member Y(H2AFY, marker 6856),H2B histone family, member M(H2BFM, marker 6857),H2B histone family, member X, pseudogene /// H2B histone family, member M pseudogene(H2BFXP /// LOC100101478, marker 6858),hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)(H6PD, marker 6859),hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)(H6PD, marker 6860),hexose-6-phosphate dehydrogenase (glucose 1 -dehydrogenase) (H6PD, marker 6861), 3-hydroxyanthranilate 3,4-dioxygenase (HAAO, marker 6862), B1 for mucin (HAB1, marker 6863), B1 for mucin (HAB1, marker 6864), hyaluronan binding protein 2( HABP2, marker 6865), hyaluronan binding protein 4 (HABP4, marker 6866), 3-hydroxyacyl-CoA dehydratase 1 (HACD1, marker 6867), 3-hydroxyacyl-CoA dehydratase 4 (HACD4, marker 6868), HOXD antisense growth-associated long non-coding RNA (HAGLR, marker 6869), HOXD antisense growth-associated long non-coding RNA (HAGLR, marker 6870), HOXD antisense growth-associated long non-coding RNA (HAGLR, marker 6871), HAGLR opposite strand ( non-protein coding) (HAGLROS, marker 6872), histidine ammonia-lyase (HAL, marker 6873), histidine ammonia-lyase (HAL, marker 6874), histidine ammonia-lyase (HAL, marker 6875), hepcidin antimicrobial peptide (HAMP) , marker 6876), heart and neural crest derivatives expressed 2(HAND2, marker 6877), HAND2 antisense RNA 1 (head to head)(HAND2-AS1, marker 6878), HAND2 antisense RNA 1 (head to head)(HAND2-AS1 ,marker 6879),hydroxyacid oxidase (glycolate oxidase) 1(HAO1,marker 6880),hydroxyacid oxidase 2 (long chain)(HAO2,marker 6881),hydroxyacid oxidase 2 (long chain)(HAO2,marker 6882),huntingtin-associated protein 1 (HAP1, marker 6883), huntingtin-associated protein 1 (HAP1, marker 6884), hyaluronan and proteoglycan link protein 2 (HAPLN2, marker 6885), highly accelerated region 1A (non-protein coding) (HAR1A, marker 6886) ,hyaluronan synthase 1(HAS1,marker 6887),hyaluronan synthase 3 /// UTP4 small subunit (SSU) processome component(HAS3 /// UTP4,marker 6888),hepatitis A virus cellular receptor 1(HAVCR1,marker 6889),hepatitis A virus cellular receptor 1 pseudogene 1 (HAVCR1P1, marker 6890), hepatitis A virus cellular receptor 2 (HAVCR2, marker 6891), hepatitis A virus cellular receptor 2 (HAVCR2, marker 6892), hepatitis A virus cellular receptor 2 (HAVCR2, marker 6893), hepatitis A virus cellular receptor 2 (HAVCR2, marker 6894), HCLS1 associated protein X-1 (HAX1, marker 6895), hemoglobin, alpha 1 /// hemoglobin, alpha 2 (HBA1 /// HBA2, marker 6896) ,hemoglobin, alpha 1 /// hemoglobin, alpha 2(HBA1 /// HBA2, marker 6897),hemoglobin, alpha 1 /// hemoglobin, alpha 2(HBA1 /// HBA2, marker 6898),hemoglobin, alpha 2( HBA2, marker 6899), hemoglobin, beta (HBB, marker 6900), hemoglobin, beta (HBB, marker 6901), hemoglobin, beta (HBB, marker 6902), hemoglobin, beta pseudogene 1 (HBBP1, marker 6903), hypophosphatemic bone disease /// hemoglobin, delta(HBD /// HBD, marker 6904), hemoglobin, epsilon 1(HBE1, marker 6905), hemoglobin, epsilon 1(HBE1, marker 6906), heparin-binding EGF-like growth factor(HBEGF , marker 6907), heparin-binding EGF-like growth factor(HBEGF, marker 6908), hemoglobin, gamma A /// hemoglobin, gamma G(HBG1 /// HBG2, marker 6909), hemoglobin, gamma G(HBG2, marker 6910), hemoglobin, mu (HBM, marker 6911), HMG-box transcription factor 1 (HBP1, marker 6912), HMG-box transcription factor 1 (HBP1, marker 6913), hemoglobin, theta 1 (HBQ1, marker 6914), HBS1-like translational GTPase (HBS1L, marker 6915), HBS1-like translational GTPase (HBS1L, marker 6916), hemoglobin, zeta (HBZ, marker 6917), hydroxycarboxylic acid receptor 1 (HCAR1, marker 6918), hydroxycarboxylic acid receptor 3 ( HCAR3, marker 6919), hepatocellular carcinoma associated transcript 5 (non-protein coding)(HCCAT5, marker 6920), host cell factor C1(HCFC1, marker 6921), host cell factor C1(HCFC1, marker 6922), host cell factor C2 (HCFC2, marker 6923), host cell factor C2 (HCFC2, marker 6924), HLA complex group 18 (non-protein coding) (HCG18, marker 6925), HLA complex group 22 (HCG22, marker 6926), HLA complex group 26 (non-protein coding)(HCG26, marker 6927),HLA complex group 27 (non-protein coding)(HCG27, marker 6928),HLA complex group 4 (non-protein coding)(HCG4, marker 6929),HLA complex group 4B (non-protein coding) (HCG4B, marker 6930), HLA complex group 9 (non-protein coding) (HCG9, marker 6931), HCK proto-oncogene, Src family tyrosine kinase (HCK, marker 6932), hematopoietic cell- specific Lyn substrate 1(HCLS1, marker 6933),hyperpolarization activated cyclic nucleotide gated potassium channel 1(HCN1,marker 6934),hyperpolarization activated cyclic nucleotide gated potassium channel 1(HCN1,marker 6935),hyperpolarization activated cyclic nucleotide gated potassium channel 2( HCN2, marker 6936), hyperpolarization activated cyclic nucleotide gated potassium channel 2(HCN2, marker 6937), HLA complex P5 (non-protein coding)(HCP5, marker 6938), HLA complex P5B (non-protein coding)(HCP5B, marker 6939), hepatocellular carcinoma-related HCRP1 (HCRP1, marker 6940), hypocretin (orexin) neuropeptide precursor (HCRT, marker 6941), hypocretin (orexin) receptor 1 (HCRTR1, marker 6942), hypocretin (orexin) receptor 2 (HCRTR2, marker 6943), hematopoietic cell signal transducer (HCST, marker 6944), histone deacetylase 10 (HDAC10, marker 6945), histone deacetylase 10 (HDAC10, marker 6946), histone deacetylase 4 (HDAC4, marker 6947), histone deacetylase 5 (HDAC5) ,marker 6948),histone deacetylase 6(HDAC6,marker 6949),histone deacetylase 7(HDAC7,marker 6950),histone deacetylase 9(HDAC9,marker 6951),histone deacetylase 9(HDAC9,marker 6952),histone deacetylase 9(HDAC9 ,marker 6953),histidine decarboxylase(HDC,marker 6954),high density lipoprotein binding protein(HDLBP,marker 6955),HEAT repeat containing 1(HEATR1,marker 6956),HEAT repeat containing 4(HEATR4,marker 6957),HEAT repeat containing 5B(HEATR5B, marker 6958), HEAT repeat containing 9(HEATR9, marker 6959), heme binding protein 2(HEBP2, marker 6960), hdc homolog, cell cycle regulator(HECA, marker 6961), hdc homolog, cell cycle regulator (HECA, marker 6962), HECT domain containing E3 ubiquitin protein ligase 1(HECTD1, marker 6963), HECT domain containing E3 ubiquitin protein ligase 2(HECTD2, marker 6964), HECT domain containing E3 ubiquitin protein ligase 2(HECTD2, marker 6965) ),HECT domain containing E3 ubiquitin protein ligase 4(HECTD4, marker 6966),HECT domain containing E3 ubiquitin protein ligase 4(HECTD4, marker 6967),HECT domain containing E3 ubiquitin protein ligase 4(HECTD4, marker 6968),HECT domain containing E3 ubiquitin protein ligase 4(HECTD4, marker 6969),HECT domain containing E3 ubiquitin protein ligase 4(HECTD4, marker 6970),HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1(HECW1, marker 6971),HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1(HECW1, marker 6972),HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1(HECW1, marker 6973),HECW1 intronic transcript 1(HECW1-IT1, marker 6974),HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2(HECW2, marker 6975),HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2(HECW2, marker 6976),helicase (DNA) B(HELB, marker 6977),helicase (DNA ) B(HELB, marker 6978), helicase, lymphoid-specific(HELLS, marker 6979), helicase, POLQ-like(HELQ, marker 6980), helicase, POLQ-like(HELQ, marker 6981), helicase with zinc finger( HELZ, Marker 6982), helicase with zinc finger 2, transcriptional coactivator(HELZ2, Marker 6983), helicase with zinc finger 2, transcriptional coactivator(HELZ2, Marker 6984), hemogen(HEMGN, Marker 6985), hemogen(HEMGN, Marker 6986) ), HemK methyltransferase family member 1 (HEMK1, marker 6987), HemK methyltransferase family member 1 (HEMK1, marker 6988), hepatic and glial cell adhesion molecule (HEPACAM, marker 6989), HEPACAM family member 2 (HEPACAM2, marker 6990), hephaestin(HEPH, marker 6991),HECT and RLD domain containing E3 ubiquitin protein ligase family member 1(HERC1, marker 6992),HECT and RLD domain containing E3 ubiquitin protein ligase family member 1(HERC1, marker 6993),HECT and RLD domain containing E3 ubiquitin protein ligase 2(HERC2, marker 6994),HECT and RLD domain containing E3 ubiquitin protein ligase 2 /// hect domain and RLD 2 pseudogene 10(HERC2 /// HERC2P10, marker 6995),hect domain and RLD 2 pseudogene 3(HERC2P3, marker 6996), hect domain and RLD 2 pseudogene 5 /// hect domain and RLD 2 pseudogene 8(HERC2P5 /// HERC2P8, marker 6997), hect domain and RLD 2 pseudogene 7(HERC2P7, marker 6998), hect domain and RLD 2 pseudogene 7(HERC2P7, marker 6999),hect domain and RLD 2 pseudogene 7(HERC2P7, marker 7000),HECT and RLD domain containing E3 ubiquitin protein ligase 3 /// uncharacterized LOC101929134(HERC3 /// LOC101929134, Marker 7001), HECT and RLD domain containing E3 ubiquitin protein ligase 3 /// uncharacterized LOC101929134(HERC3 /// LOC101929134, Marker 7002), HECT and RLD domain containing E3 ubiquitin protein ligase 4(HERC4, Marker 7003), HECT and RLD domain containing E3 ubiquitin protein ligase 4(HERC4, marker 7004),HECT and RLD domain containing E3 ubiquitin protein ligase family member 6(HERC6, marker 7005), homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like
domain member 1(HERPUD1, marker 7006),hes family bHLH transcription factor 1(HES1,marker 7007),hes family bHLH transcription factor 2(HES2,marker 7008),hes family bHLH transcription factor 2(HES2,marker 7009),hes family bHLH transcription factor 2 (HES2, marker 7010), hes family bHLH transcription factor 6 (HES6, marker 7011), hes family bHLH transcription factor 7 (HES7, marker 7012), hexosaminidase A (alpha polypeptide) (HEXA, marker 7013) ,hexosaminidase A (alpha polypeptide)(HEXA, marker 7014),HEXA antisense RNA 1(HEXA-AS1, marker 7015),hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing(HEXDC, marker 7016),hes-related family bHLH transcription factor with YRPW motif-like(HEYL, marker 7017), hemochromatosis(HFE, marker 7018), hemochromatosis(HFE, marker 7019), hemochromatosis(HFE, marker 7020), hemochromatosis(HFE, marker 7021), hemochromatosis(HFE, marker 7022), hemochromatosis(HFE, marker 7023), hemochromatosis(HFE, marker 7024), hemochromatosis(HFE, marker 7025), hemochromatosis(HFE, marker 7026), hemochromatosis(HFE, marker 7027), hemochromatosis(HFE, marker 7028) ), hemochromatosis(HFE, marker 7029), hemochromatosis(HFE, marker 7030), hemochromatosis(HFE, marker 7031), hemochromatosis(HFE, marker 7032), hemochromatosis type 2 (juvenile)(HFE2, marker 7033), HFM1, ATP -dependent DNA helicase homolog (HFM1, marker 7034), HFM1, ATP-dependent DNA helicase homolog (HFM1, marker 7035), uncharacterized LOC100128124 (HGC6.3, marker 7036), homogentisate 1,2-dioxygenase (HGD, marker 7037) ,homogentisate 1,2-dioxygenase(HGD, marker 7038),homogentisate 1,2-dioxygenase(HGD,marker 7039),homogentisate 1,2-dioxygenase(HGD,marker 7040),hepatocyte growth factor (hepapoietin A; scatter factor) (HGF, marker 7041),hepatocyte growth factor (hepapoietin A; scatter factor)(HGF, marker 7042),hepatocyte growth factor (hepapoietin A; scatter factor)(HGF, marker 7043),hepatocyte growth factor (hepapoietin A; scatter factor) ) (HGF, marker 7044), hepatocyte growth factor (hepapoietin A; scatter factor) (HGF, marker 7045), HGF activator (HGFAC, marker 7046), hepatocyte growth factor-regulated tyrosine kinase substrate (HGS, marker 7047), heparan -alpha-glucosaminide N-acetyltransferase(HGSNAT, marker 7048),heparan-alpha-glucosaminide N-acetyltransferase(HGSNAT, marker 7049),heparan-alpha-glucosaminide N-acetyltransferase(HGSNAT, marker 7050),heparan-alpha-glucosaminide N -acetyltransferase(HGSNAT, marker 7051),hedgehog acyltransferase-like(HHATL,marker 7052),hematopoietically expressed homeobox(HHEX,marker 7053),hematopoietically expressed homeobox(HHEX,marker 7054),hedgehog interacting protein(HHIP,marker 7055), hedgehog interacting protein(HHIP, marker 7056),hedgehog interacting protein(HHIP,marker 7057),hedgehog interacting protein(HHIP,marker 7058),HHIP-like 1(HHIPL1,marker 7059),HHIP-like 1(HHIPL1,marker 7060 ),HHIP-like 2(HHIPL2, marker 7061),HERV-H LTR-associating 1(HHLA1,marker 7062),HERV-H LTR-associating 1(HHLA1,marker 7063),HERV-H LTR-associating 2(HHLA2 , Marker 7064), HERV-H LTR-associating 2 (HHLA2, Marker 7065), HERV-H LTR-associating 2 (HHLA2, Marker 7066), HERV-H LTR-associating 3 (HHLA3, Marker 7067), hypermethylated in cancer 1(HIC1, marker 7068), hypermethylated in cancer 1(HIC1, marker 7069), hypermethylated in cancer 1(HIC1, marker 7070), hypermethylated in cancer 2(HIC2, marker 7071), HID1 domain containing(HID1, marker 7072) ,hypoxia inducible factor 3, alpha subunit(HIF3A, marker 7073),hypoxia inducible factor 3, alpha subunit(HIF3A,marker 7074),hypoxia inducible factor 3, alpha subunit(HIF3A,marker 7075),hypoxia inducible factor 3, alpha subunit (HIF3A, marker 7076), hypoxia inducible factor 3, alpha subunit(HIF3A, marker 7077), HIG1 hypoxia inducible domain family, member 1B(HIGD1B, marker 7078), histone linker H1 domain, spermatid-specific 1, pseudogene(HILS1, marker 7079), histidine triad nucleotide binding protein 3(HINT3, marker 7080), huntingtin interacting protein 1(HIP1, marker 7081), huntingtin interacting protein 1 related(HIP1R, marker 7082), homeodomain interacting protein kinase 1(HIPK1, marker 7083) ), homeodomain interacting protein kinase 1 (HIPK1, marker 7084), HIPK1 antisense RNA 1 (HIPK1-AS1, marker 7085), HIPK1 antisense RNA 1 (HIPK1-AS1, marker 7086), homeodomain interacting protein kinase 2 (HIPK2, marker 7087) ),homeodomain interacting protein kinase 2(HIPK2, marker 7088),homeodomain interacting protein kinase 2(HIPK2,marker 7089),homeodomain interacting protein kinase 2(HIPK2,marker 7090),homeodomain interacting protein kinase 3(HIPK3,marker 7091), homeodomain interacting protein kinase 3(HIPK3, marker 7092),homeodomain interacting protein kinase 4(HIPK4, marker 7093),histone cell cycle regulator(HIRA,marker 7094),HIRA interacting protein 3(HIRIP3,marker 7095),histone cluster 1, H1b(HIST1H1B, marker 7096),histone cluster 1, H1t(HIST1H1T,marker 7097),histone cluster 1, H1t(HIST1H1T,marker 7098),histone cluster 1, H2ab(HIST1H2AB,marker 7099),histone cluster 1, H2ad / // histone cluster 1, H3d(HIST1H2AD /// HIST1H3D, marker 7100), histone cluster 1, H2ak(HIST1H2AK, marker 7101), histone cluster 1, H2ak(HIST1H2AK, marker 7102), histone cluster 1, H2al(HIST1H2AL, marker 7103), histone cluster 1, H2a, pseudogene 4(HIST1H2APS4, marker 7104), histone cluster 1, H2ba(HIST1H2BA, marker 7105), histone cluster 1, H2bb(HIST1H2BB, marker 7106), histone cluster 1, H2bc(HIST1H2BC ,marker 7107),histone cluster 1, H2bc(HIST1H2BC,marker 7108),histone cluster 1, H2bg(HIST1H2BG,marker 7109),histone cluster 1, H2bj /// uncharacterized LOC105374995(HIST1H2BJ /// LOC105374995,marker 7110), histone cluster 1, H2bl(HIST1H2BL, marker 7111),histone cluster 1, H2bm(HIST1H2BM, marker 7112),histone cluster 1, H2bn(HIST1H2BN,marker 7113),histone cluster 1, H2bo(HIST1H2BO,marker 7114),histone cluster 1, H3a (HIST1H3A, marker 7115), histone cluster 1, H3b (HIST1H3B, marker 7116), histone cluster 1, H3c (HIST1H3C, marker 7117), histone cluster 1, H3e (HIST1H3E, marker 7118), histone cluster 1, H3f(HIST1H3F, marker 7119),histone cluster 1, H3h(HIST1H3H,marker 7120),histone cluster 1, H3i(HIST1H3I,marker 7121),histone cluster 1, H3j(HIST1H3J,marker 7122),histone cluster 1, H4a( HIST1H4A, marker 7123), hisstone cluster 1, H4b (HIST1H4B, marker 7124), histone cluster 1, H4d (HIST1H4D, marker 7125), histone cluster 1, H4f (HIST1H4F, marker 7126), hisstone cluster 1, H4g (HIST1H4G, marker 7127),histone cluster 1, H4h(HIST1H4H,marker 7128),histone cluster 1, H4h(HIST1H4H,marker 7129),histone cluster 1, H4h /// uncharacterized LOC105374985(HIST1H4H /// LOC105374985,marker 7130),histone cluster 1, H4i (HIST1H4I, marker 7131), histone cluster 1, H4l (HIST1H4L, marker 7132), histone cluster 1, H4, pseudogene 1 (HIST1H4PS1, marker 7133), histone cluster 3, H3 (HIST3H3, marker 7134), human immunodeficiency virus type I enhancer binding protein 1(HIVEP1, marker 7135),human immunodeficiency virus type I enhancer binding protein 1(HIVEP1, marker 7136),human immunodeficiency virus type I enhancer binding protein 2(HIVEP2, marker 7137),human immunodeficiency virus type I enhancer binding protein 3(HIVEP3, marker 7138),human immunodeficiency virus type I enhancer binding protein 3(HIVEP3,marker 7139),human immunodeficiency virus type I enhancer binding protein 3(HIVEP3,marker 7140),hexokinase 3 (white cell)(HK3, marker 7141), hexokinase domain containing 1(HKDC1, marker 7142), hexokinase domain containing 1(HKDC1, marker 7143), hexokinase domain containing 1(HKDC1, marker 7144), hexokinase domain containing 1(HKDC1, marker 7144) 7145), HKR1, GLI-Kruppel zinc finger family member (HKR1, marker 7146), HKR1, GLI-Kruppel zinc finger family member (HKR1, marker 7147), major histocompatibility complex, class II, DM beta (HLA-DMB, marker 7148), major histocompatibility complex, class II, DO alpha (HLA-DOA, marker 7149), major histocompatibility complex, class II, DO alpha (HLA-DOA, marker 7150), major histocompatibility complex, class II, DO beta (HLA -DOB, marker 7151), major histocompatibility complex, class II, DO beta(HLA-DOB, marker 7152), major histocompatibility complex, class II, DP alpha 1(HLA-DPA1, marker 7153), major histocompatibility complex, class II , DP alpha 1(HLA-DPA1, marker 7154), major histocompatibility complex, class II, DP alpha 2 (pseudogene)(HLA-DPA2, marker 7155), major histocompatibility complex, class II, DP beta 1(HLA-DPB1, marker 7156), major histocompatibility complex, class II, DQ alpha 1(HLA-DQA1, marker 7157), major histocompatibility complex, class II, DQ alpha 1(HLA-DQA1, marker 7158), major histocompatibility complex, class II, DQ alpha 1(HLA-DQA1, marker 7159), major histocompatibility complex, class II, DQ alpha 1 /// major histocompatibility complex, class II, DQ alpha 2(HLA-DQA1 /// HLA-DQA2, marker 7160), major histocompatibility complex, class II, DQ beta 1(HLA-DQB1, marker 7161),major histocompatibility complex, class II, DQ beta 1(HLA-DQB1, marker 7162),major histocompatibility complex, class II, DQ beta 1(HLA- DQB1, marker 7163), major histocompatibility complex, class II, DQ beta 1 /// major histocompatibility complex, class II, DQ beta 2(HLA-DQB1 /// HLA-DQB2, marker 7164), major histocompatibility complex, class II , DQ beta 1 /// major histocompatibility complex, class II, DR beta 1 /// major histocompatibility complex, class II, DR beta 2 (pseudogene) /// major histocompatibility complex, class II, DR beta 3 /// major histocompatibility complex, class II, DR beta 4 /// major histocompatibility complex, class II, DR beta 5 /// major histocompatibility complex, class II, DR beta 6 (pseudogene) /// major histocompatibility complex, class II, DR beta 7 (pseudogene) /// major histocompatibility complex, class II, DR beta 8 (pseudogene) /// HLA class II histocompatibility antigen, DRB1-7 beta chain(HLA-DQB1 /// HLA-DRB1 /// HLA-DRB2 /// HLA-DRB3 /// HLA-DRB4 /// HLA-DRB5 /// HLA-DRB6 /// HLA-DRB7 /// HLA-DRB8 /// LOC105369230, marker 7165), major histocompatibility complex, class II, DQ beta 2 (HLA-DQB2, marker 7166), major histocompatibility complex, class II, DR alpha (HLA-DRA, marker 7167), major histocompatibility complex, class II, DR alpha (HLA-DRA, marker 7168), major histocompatibility complex, class II, DR beta 1 /// major histocompatibility complex, class II, DR beta 3 /// major histocompatibility complex, class II, DR beta 4
/// major histocompatibility complex, class II, DR beta 5 /// HLA class II histocompatibility antigen, DRB1-7 beta chain(HLA-DRB1 /// HLA-DRB3 /// HLA-DRB4 /// HLA-DRB5 / // LOC105369230, marker 7169), major histocompatibility complex, class II, DR beta 4(HLA-DRB4, marker 7170), major histocompatibility complex, class II, DR beta 4(HLA-DRB4, marker 7171), major histocompatibility complex, class II, DR beta 6 (pseudogene) (HLA-DRB6, marker 7172), major histocompatibility complex, class I, F (HLA-F, marker 7173), HLA-F antisense RNA 1 (HLA-F-AS1, marker 7174) ), hepatic leukemia factor (HLF, marker 7175), hepatic leukemia factor (HLF, marker 7176), hepatic leukemia factor (HLF, marker 7177), H2.0-like homeobox (HLX, marker 7178), histocompatibility (minor) 13 (HM13, Marker 7179), histocompatibility (minor) 13 (HM13, Marker 7180), histocompatibility (minor) 13 (HM13, Marker 7181), homeobox containing 1 (HMBOX1, Marker 7182), hemicentin 2 (HMCN2, Marker 7183), hemicentin 2 (HMCN2, marker 7184), hemicentin 2 (HMCN2, marker 7185), high mobility group 20B (HMG20B, marker 7186), high mobility group AT-hook 2 (HMGA2, marker 7187), high mobility group AT-hook 2 (HMGA2, marker 7188),high mobility group AT-hook 2(HMGA2,marker 7189),high mobility group AT-hook 2(HMGA2,marker 7190),high mobility group AT-hook 2(HMGA2,marker 7191),high mobility group AT-hook 2(HMGA2, marker 7192),high mobility group AT-hook 2(HMGA2,marker 7193),high mobility group box 2(HMGB2,marker 7194),high mobility group box 3 pseudogene 30(HMGB3P30,marker 7195),high mobility group box 4(HMGB4,marker 7196),3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1(HMGCLL1,marker 7197),3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1(HMGCLL1 , Marker 7198), 3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1 (HMGCLL1, Marker 7199), 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) (HMGCS2, Marker 7200), 3-hydroxy- 3-methylglutaryl-CoA synthase 2 (mitochondrial) (HMGCS2, marker 7201), high mobility group nucleosomal binding domain 2 pseudogene 46 (HMGN2P46, marker 7202), HMGN3 antisense RNA 1 (HMGN3-AS1, marker 7203), HMGN3 antisense RNA 1 (HMGN3-AS1, marker 7204), high mobility group nucleosome binding domain 5 (HMGN5, marker 7205), histocompatibility (minor) HA-1 (HMHA1, marker 7206), histocompatibility (minor) HB-1 (HMHB1, marker 7207) ,HMP19 protein(HMP19, marker 7208),H6 family homeobox 1(HMX1,marker 7209),H6 family homeobox 2(HMX2,marker 7210),head and neck cancer-associated transcript 21(HNCAT21,marker 7211),HNF1 homeobox A (HNF1A, marker 7212), HNF1 homeobox B (HNF1B, marker 7213), HNF1 homeobox B (HNF1B, marker 7214), hepatocyte nuclear factor 4, alpha (HNF4A, marker 7215), hepatocyte nuclear factor 4, alpha (HNF4A, marker 7216),hepatocyte nuclear factor 4, alpha(HNF4A, marker 7217),hepatocyte nuclear factor 4, alpha(HNF4A, marker 7218),hepatocyte nuclear factor 4, alpha(HNF4A, marker 7219),HNF4A antisense RNA 1(HNF4A-AS1 ,marker 7220),hepatocyte nuclear factor 4, gamma(HNF4G,marker 7221),hepatocyte nuclear factor 4, gamma(HNF4G,marker 7222),histamine N-methyltransferase(HNMT,marker 7223),histamine N-methyltransferase(HNMT,marker 7224), histamine N-methyltransferase (HNMT, marker 7225), heterogeneous nuclear ribonucleoprotein A2/B1 (HNRNPA2B1, marker 7226), heterogeneous nuclear ribonucleoprotein C (C1/C2) (HNRNPC, marker 7227), heterogeneous nuclear ribonucleoprotein D (HNRNPD, marker 7228), heterogeneous nuclear ribonucleoprotein D (HNRNPD, marker 7229), heterogeneous nuclear ribonucleoprotein D like (HNRNPDL, marker 7230), heterogeneous nuclear ribonucleoprotein L-like (HNRNPLL, marker 7231), heterogeneous nuclear ribonucleoprotein M (HNRNPM, marker 7232) ,heterogeneous nuclear ribonucleoprotein M(HNRNPM, marker 7233),heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A)(HNRNPU, marker 7234),4-hydroxy-2-oxoglutarate aldolase 1(HOGA1, marker 7235),hook microtubule-tethering protein 3(HOOK3, marker 7236),HOP homeobox(HOPX, marker 7237),HOP homeobox(HOPX, marker 7238),HOP homeobox(HOPX, marker 7239),HORMA domain containing 1(HORMAD1,marker 7240),HORMA domain containing 2 (HORMAD2, marker 7241),HORMA domain containing 2(HORMAD2, marker 7242),HOX transcript antisense RNA(HOTAIR, marker 7243),HOXA transcript antisense RNA, myeloid-specific 1(HOTAIRM1, marker 7244),HOXA transcript antisense RNA, myeloid-specific 1(HOTAIRM1, marker 7245),H19 opposite tumor suppressor(HOTS,marker 7246),H19 opposite tumor suppressor(HOTS,marker 7247),HOXA distal transcript antisense RNA(HOTTIP,marker 7248),HOXA distal transcript antisense RNA (HOTTIP, marker 7249),HOXA distal transcript antisense RNA(HOTTIP,marker 7250),HOXA cluster antisense RNA 2(HOXA-AS2,marker 7251),HOXA cluster antisense RNA 2(HOXA-AS2,marker 7252),HOXA cluster antisense RNA 2 (HOXA-AS2, marker 7253), HOXA cluster antisense RNA 3 (HOXA-AS3, marker 7254), homeobox A1 (HOXA1, marker 7255), homeobox A10 (HOXA10, marker 7256), homeobox A10 (HOXA10, marker 7257) ),HOXA10 antisense RNA(HOXA10-AS,marker 7258),HOXA10-HOXA9 readthrough /// homeobox A9(HOXA10-HOXA9 /// HOXA9,marker 7259),HOXA10-HOXA9 readthrough /// homeobox A9(HOXA10-HOXA9 / // HOXA9, marker 7260), homeobox A11 (HOXA11, marker 7261), homeobox A11 (HOXA11, marker 7262), HOXA11 antisense RNA (HOXA11-AS, marker 7263), HOXA11 antisense RNA (HOXA11-AS, marker 7264), homeobox A13(HOXA13, marker 7265),homeobox A13(HOXA13,marker 7266),homeobox A13(HOXA13,marker 7267),homeobox A2(HOXA2,marker 7268),homeobox A3(HOXA3,marker 7269),homeobox A3(HOXA3, marker 7270), homeobox A4 (HOXA4, marker 7271), homeobox A5 (HOXA5, marker 7272), homeobox A6 (HOXA6, marker 7273), homeobox A7 (HOXA7, marker 7274), homeobox A7 (HOXA7, marker 7275), HOXB cluster antisense RNA 1(HOXB-AS1, marker 7276),HOXB cluster antisense RNA 1(HOXB-AS1, marker 7277),HOXB cluster antisense RNA 3(HOXB-AS3, marker 7278),HOXB cluster antisense RNA 3(HOXB-AS3 ,marker 7279),HOXB cluster antisense RNA 3(HOXB-AS3,marker 7280),HOXB cluster antisense RNA 3(HOXB-AS3,marker 7281),HOXB cluster antisense RNA 3(HOXB-AS3,marker 7282),homeobox B1( HOXB1, marker 7283), homeobox B1 (HOXB1, marker 7284), homeobox B13 (HOXB13, marker 7285), homeobox B13 (HOXB13, marker 7286), homeobox B3 (HOXB3, marker 7287), homeobox B4 (HOXB4, marker 7288) ,homeobox B5(HOXB5, marker 7289),homeobox B6(HOXB6,marker 7290),homeobox B6(HOXB6,marker 7291),homeobox B7(HOXB7,marker 7292),homeobox B7(HOXB7,marker 7293),homeobox B7(HOXB7 ,marker 7294),homeobox B8(HOXB8,marker 7295),homeobox B8(HOXB8,marker 7296),homeobox B8(HOXB8,marker 7297),homeobox B9(HOXB9,marker 7298),homeobox B9(HOXB9,marker 7299), HOXC cluster antisense RNA 3 (HOXC-AS3, marker 7300), homeobox C10 (HOXC10, marker 7301), homeobox C12 (HOXC12, marker 7302), homeobox C13 (HOXC13, marker 7303), homeobox C4 (HOXC4, marker 7304), homeobox C5 (HOXC5, marker 7305), homeobox C6 (HOXC6, marker 7306), homeobox C8 (HOXC8, marker 7307), homeobox C9 (HOXC9, marker 7308), HOXD cluster antisense RNA 2 (HOXD-AS2, marker 7309), homeobox D1 (HOXD1, marker 7310), homeobox D1 /// microRNA 7704 (HOXD1 /// MIR7704, marker 7311), homeobox D10 (HOXD10, marker 7312), homeobox D10 (HOXD10, marker 7313), homeobox D10 (HOXD10, marker 7314),homeobox D11(HOXD11,marker 7315),homeobox D12(HOXD12,marker 7316),homeobox D13(HOXD13,marker 7317),homeobox D13(HOXD13,marker 7318),homeobox D13(HOXD13,marker 7319),homeobox D3 /// homeobox D4(HOXD3 /// HOXD4, marker 7320), homeobox D3 /// homeobox D4(HOXD3 /// HOXD4, marker 7321), homeobox D3 /// homeobox D4(HOXD3 /// HOXD4, marker 7322), homeobox D4 (HOXD4, marker 7323), homeobox D8 (HOXD8, marker 7324), homeobox D9 (HOXD9, marker 7325), haptoglobin (HP, marker 7326), haptoglobin /// haptoglobin-related protein (HP // / HPR, marker 7327), uncharacterized LOC100652929 (HP09025, marker 7328), hippocalcin (HPCA, marker 7329), hippocalcin like 4 (HPCAL4, marker 7330), hippocalcin like 4 (HPCAL4, marker 7331), 4-hydroxyphenylpyruvate dioxygenase (HPD , marker 7332), hematopoietic prostaglandin D synthase (HPGDS, marker 7333), haptoglobin-related protein (HPR, marker 7334), hypoxanthine phosphoribosyltransferase 1 (HPRT1, marker 7335), Hermansky-Pudlak syndrome 1 (HPS1, marker 7336), Hermansky -Pudlak syndrome 1 (HPS1, marker 7337), Hermansky-Pudlak syndrome 4 (HPS4, marker 7338), Hermansky-Pudlak syndrome 6 (HPS6, marker 7339), heparanase (HPSE, marker 7340), heparanase 2 (inactive) (HPSE2 ,marker 7341),Helicobacter pylori responsive 1 (non-protein coding)(HPYR1,marker 7342),Helicobacter pylori responsive 1 (non-protein coding)(HPYR1,marker 7343),hair growth associated(HR,marker 7344),hair growth associated(HR, marker 7345),HRAS-like suppressor 2(HRASLS2,marker 7346),HRAS-like suppressor 2(HRASLS2,marker 7347),HRAS-like suppressor 2(HRASLS2,marker 7348),HRAS-like suppressor family , member 5 (HRASLS5, marker 7349), heart tissue-associated transcript 13 (HRAT13, marker 7350), histidine rich calcium binding protein (HRC, marker 7351), histidine rich carboxyl terminus 1 (HRCT1, marker 7352), histidine-rich glycoprotein (HRG, marker 7353), histidine-rich glycoprotein (HRG, marker 7354), histamine receptor H1 (HRH1, marker 7355), histamine receptor H1 (HRH1, marker 7356), histamine receptor H2 (HRH2, marker 7357), histamine receptor H2 (HRH2, marker 7358), histamine receptor H3 (HRH3, marker 7359), histamine receptor H3 (HRH3, marker 7360), histamine receptor H4 (HRH4, marker 7361), histamine receptor H4 (HRH4, marker 7362), harakiri , BCL2 interacting protein(HRK, marker 7363),harakiri, BCL2 interacting protein /// uncharacterized LOC283454(HRK /// LOC283454, marker 7364),HCLS1 binding protein 3(HS1BP3, marker 7365),HCLS1 binding protein 3(HS1BP3, marker 7366), HCLS1 binding protein 3 (HS1BP3, marker 7367), heparan sulfate 2-O-sulfotransferase 1 (HS2ST1, marker 7368), heparan sulfate (glucosamine) 3-O-sulfotransferase 1 (HS3ST1, marker 7369), heparan sulfate (glucosamine) 3-O-sulfotransferase 1(HS3ST1, marker 7370),heparan sulfate (glucosamine) 3-O-sulfotransferase 1(HS3ST1, marker 7371),heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1(HS3ST3B1, marker 7372) ), heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 (HS3ST3B1, marker 7373), heparan sulfate (glucosamine) 3-O-sulfotransferase 6 (HS3ST6, marker 7374), heparan sulfate 6-O-sulfotransferase 1 (HS6ST1, marker 7375), heparan sulfate 6-O-sulfotransferase 3(HS6ST3, marker 7376), heparan sulfate 6-O-sulfotransfer
ase 3(HS6ST3, marker 7377), heparan sulfate 6-O-sulfotransferase 3(HS6ST3, marker 7378), heparan sulfate 6-O-sulfotransferase 3(HS6ST3, marker 7379), heat shock factor binding protein 1-like 1(HSBP1L1 , marker 7380), hydroxysteroid (11-beta) dehydrogenase 1 (HSD11B1, marker 7381), hydroxysteroid (17-beta) dehydrogenase 12 (HSD17B12, marker 7382), hydroxysteroid (17-beta) dehydrogenase 12 (HSD17B12, marker 7383), hydroxysteroid (17-beta) dehydrogenase 12(HSD17B12, marker 7384),hydroxysteroid (17-beta) dehydrogenase 14(HSD17B14, marker 7385),hydroxysteroid (17-beta) dehydrogenase 2(HSD17B2, marker 7386),hydroxysteroid (17-beta) ) dehydrogenase 3 (HSD17B3, marker 7387), hydroxysteroid (17-beta) dehydrogenase 4 (HSD17B4, marker 7388), hydroxysteroid (17-beta) dehydrogenase 7 pseudogene 2 (HSD17B7P2, marker 7389), hydroxy-delta-5-steroid dehydrogenase , 3 beta- and steroid delta-isomerase 1 (HSD3B1, marker 7390), hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 (HSD3B1, marker 7391), hydroxy-delta-5-steroid dehydrogenase , 3 beta- and steroid delta-isomerase 2(HSD3B2, marker 7392), hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7(HSD3B7, marker 7393), hydroxysteroid dehydrogenase like 2(HSDL2, marker 7394), heat shock transcription factor 1(HSF1, marker 7395), heat shock transcription factor 2 binding protein /// uncharacterized LOC105379490(HSF2BP /// LOC105379490, marker 7396), heat shock transcription factor 4(HSF4, marker 7397), heat shock transcription factor family member 5(HSF5, marker 7398),heat shock transcription factor family, X-linked 1 /// heat shock transcription factor family, X-linked 2(HSFX1 /// HSFX2, marker 7399),heat shock transcription factor, Y-linked 1 /// heat shock transcription factor, Y-linked 2(HSFY1 /// HSFY2, marker 7400),heat shock transcription factor, Y-linked 1 /// heat shock transcription factor, Y-linked 2(HSFY1 /// HSFY2, marker 7401), hematopoietic SH2 domain containing(HSH2D, marker 7402), heat shock 70kDa protein 12A(HSPA12A, marker 7403), heat shock 70kD protein 12B(HSPA12B, marker 7404), heat shock 70kD protein 12B (HSPA12B, marker 7405), heat shock 70kDa protein 1B (HSPA1B, marker 7406), heat shock 70kDa protein 1-like (HSPA1L, marker 7407), heat shock 70kDa protein 6 (HSP70B') (HSPA6, marker 7408) ,heat shock 70kDa protein 6 (HSP70B')(HSPA6, marker 7409),heat shock 70kDa protein 9 (mortalin)(HSPA9,marker 7410),heat shock 27kDa protein 2(HSPB2,marker 7411),heat shock 27kDa protein 3( HSPB3, marker 7412), heat shock protein, alpha-crystallin-related, B6(HSPB6, marker 7413), heat shock protein, alpha-crystallin-related, B6(HSPB6, marker 7414), heat shock 27kDa protein family, member 7 (cardiovascular)(HSPB7, marker 7415), heat shock 27kDa protein family, member 7 (cardiovascular)(HSPB7, marker 7416), heat shock 22kDa protein 8(HSPB8, marker 7417), heat shock protein, alpha-crystallin-related, B9 (HSPB9, marker 7418), uncharacterized LOC100286989 (HSPC081, marker 7419), uncharacterized LOC105372274 (HSPC102, marker 7420), uncharacterized LOC101928612 (HSPC324, marker 7421), heat shock 60kDa protein 1 (chaperonin) (HSPD1, marker 74 22), heat shock 60kDa protein 1 (chaperonin) (HSPD1, marker 7423), HIV-1 Tat interactive protein 2 (HTATIP2, marker 7424), HIV-1 Tat specific factor 1 pseudogene 2 (HTATSF1P2, marker 7425), hisstatin 1 (HTN1, marker 7426), hisstatin 3 (HTN3, marker 7427), 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled (HTR1A, marker 7428), 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled (HTR1B, marker 7429),5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled(HTR1E, marker 7430),5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled(HTR1F, marker 7431),5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled(HTR2A, marker 7432),5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled(HTR2A, marker 7433),5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled(HTR2A, marker 7434),5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled(HTR2B, marker 7435),5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled(HTR2C, marker 7436),5-hydroxytryptamine (serotonin) receptor 3A, ionotropic(HTR3A, marker 7437),5-hydroxytryptamine (serotonin) receptor 3B, ionotropic(HTR3B, marker 7438),5-hydroxytryptamine (serotonin) receptor 3C, ionotropic(HTR3C, marker 7439),5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled(HTR4, marker 7440),5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled(HTR4, marker 7441),5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled(HTR5A, marker 7442),5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled(HTR6, marker 7443),5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled(HTR6, marker 7444),5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled(HTR7, marker 7445),5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled /// 5-hydroxytryptamine (serotonin) receptor 7 pseudogene 1(HTR7 /// HTR7P1, marker 7446) ,5-hydroxytryptamine (serotonin) receptor 7 pseudogene 1(HTR7P1, marker 7447),HtrA serine peptidase 3(HTRA3, marker 7448),HtrA serine peptidase 4(HTRA4, marker 7449),hormonally up-regulated Neu-associated kinase(HUNK , marker 7450), HUS1 checkpoint clamp component(HUS1, marker 7451), HUS1 checkpoint clamp component B(HUS1B, marker 7452), HUS1 checkpoint clamp component B(HUS1B, marker 7453), HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase (HUWE1, marker 7454), HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase (HUWE1, marker 7455), hyaluronoglucosaminidase 1 (HYAL1, marker 7456), hyaluronoglucosaminidase 3 (HYAL3, marker 7457), hyaluronoglucosaminidase 4 (HYAL4, marker 7458), hyaluronoglucosaminidase pseudogene 1 (HYALP1, marker 7459), HYDIN, axonemal central pair apparatus protein (HYDIN, marker 7460), HYDIN, axonemal central pair apparatus protein (HYDIN, marker 7461), HYDIN, axonemal central pair apparatus protein(HYDIN, marker 7462),HYDIN, axonemal central pair apparatus protein(HYDIN, marker 7463),HYDIN, axonemal central pair apparatus protein /// HYDIN2, axonemal central pair apparatus protein (pseudogene)(HYDIN /// HYDIN2, marker 7464), HYDIN2, axonemal central pair apparatus protein (pseudogene) (HYDIN2, marker 7465), HYDIN2, axonemal central pair apparatus protein (pseudogene) (HYDIN2, marker 7466), hydroxylysine kinase (HYKK, marker 7467), hydatidiform mole associated and imprinted (non-protein coding)(HYMAI, marker 7468), huntingtin interacting protein M(HYPM, marker 7469), islet amyloid polypeptide(IAPP, marker 7470), IBA57 homolog, iron-sulfur cluster assembly(IBA57, marker 7471) ,IBA57 homolog, iron-sulfur cluster assembly(IBA57, marker 7472),IBA57 antisense RNA 1 (head to head)(IBA57-AS1, marker 7473),integrin-binding sialoprotein(IBSP, marker 7474),integrin-binding sialoprotein( IBSP, marker 7475), inhibitor of Bruton agammaglobulinemia tyrosine kinase(IBTK, marker 7476), islet cell autoantigen 1(ICA1, marker 7477), islet cell autoantigen 1(ICA1, marker 7478), islet cell autoantigen 1(ICA1, marker 7479) ),islet cell autoantigen 1 like(ICA1L, marker 7480),islet cell autoantigen 1 like(ICA1L,marker 7481),islet cell autoantigen 1 like(ICA1L,marker 7482),intercellular adhesion molecule 1(ICAM1,marker 7483),intercellular adhesion molecule 2(ICAM2, marker 7484), intercellular adhesion molecule 2(ICAM2, marker 7485), intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)(ICAM4, marker 7486), intercellular adhesion molecule 5(ICAM5, marker 7487), interactor of little elongation complex ELL subunit 2 (ICE2, marker 7488), intestinal cell (MAK-like) kinase (ICK, marker 7489), isoprenylcysteine carboxyl methyltransferase (ICMT, marker 7490), inducible T-cell co-stimulator (ICOS, marker 7491), inducible T-cell co-stimulator ligand /// ICOS ligand(ICOSLG /// LOC102723996, marker 7492), inducible T-cell co-stimulator ligand /// ICOS ligand(ICOSLG /// LOC102723996, marker 7493 ),inducible T-cell co-stimulator ligand /// ICOS ligand(ICOSLG /// LOC102723996, marker 7494),inducible T-cell co-stimulator ligand /// ICOS ligand(ICOSLG /// LOC102723996, marker 7495), ID2 antisense RNA 1 (head to head)(ID2-AS1, marker 7496),ID2 antisense RNA 1 (head to head)(ID2-AS1, marker 7497),inhibitor of DNA binding 2B, dominant negative helix-loop-helix protein (pseudogene) (ID2B, marker 7498), inhibitor of DNA binding 4, dominant negative helix-loop-helix protein (ID4, marker 7499), isocitrate dehydrogenase 1 (NADP+) (IDH1, marker 7500), IDH1 antisense RNA 1 (IDH1 -AS1, marker 7501), isocitrate dehydrogenase 3 (NAD+) alpha (IDH3A, marker 7502), isopentenyl-diphosphate delta isomerase 2 (IDI2, marker 7503), idnK, gluconokinase homolog (E. coli) (IDNK, marker 7504), idnK, gluconokinase homolog (E. coli) (IDNK, marker 7505), indoleamine 2,3-dioxygenase 2 (IDO2, marker 7506), iduronate 2-sulfatase (IDS, marker 7507), iduronate 2-sulfatase (IDS, marker 7508) ), iduronate 2-sulfatase(IDS, marker 7509), iduronate 2-sulfatase(IDS, marker 7510), iduronidase, alpha-L-(IDUA, marker 7511), iduronidase, alpha-L-(IDUA, marker 7512), iduronidase, alpha-L-(IDUA, marker 7513), interferon, alpha-inducible protein 27(IFI27, marker 7514), interferon-induced protein 35(IFI35, marker 7515), interferon-induced protein 44(IFI44, marker 7516) ,interferon-induced protein 44(IFI44, marker 7517),interferon-induced protein 44-like(IFI44L, marker 7518),interferon induced, with helicase C domain 1(IFIH1,marker 7519),interferon induced, with helicase C domain 1 (IFIH1, marker 7520), interferon induced, with helicase C domain 1(IFIH1, marker 7521), interferon-induced protein with tetratricopeptide repeats 2(IFIT2, marker 7522), interferon-induced protein with tetratricopeptide repeats 2(IFIT2, marker 7523) ),interferon-induced protein with tetratricopeptide repeats 3(IFIT3, marker 7524),interferon-induced protein with tetratricopeptide repeats 3(IFIT3, marker 7525),interferon-induced protein with tetratricopeptide repeats 5(IFIT5, marker 7526),interferon induced transmembrane protein 10 (IFITM10, marker 7527), interferon induced transmembrane protein 10 (IFITM10, marker 7528), interferon induced transmembrane protein 10 (IFITM10, marker 7529), interferon, alpha 1 (IFNA1, marker 7530), interferon, alpha 10 (IFNA10) , marker 7531), interferon, alpha 13(IF
NA13, marker 7532), interferon, alpha 14 (IFNA14, marker 7533), interferon, alpha 16 (IFNA16, marker 7534), interferon, alpha 17 (IFNA17, marker 7535), interferon, alpha 2 (IFNA2, marker 7536), interferon, alpha 21 (IFNA21, marker 7537), interferon, alpha 4 (IFNA4, marker 7538), interferon, alpha 5 (IFNA5, marker 7539), interferon, alpha 6 (IFNA6, marker 7540), interferon, alpha 7 (IFNA7) , marker 7541), interferon, alpha 8(IFNA8, marker 7542), interferon (alpha, beta and omega) receptor 1(IFNAR1, marker 7543), interferon, beta 1, fibroblast(IFNB1, marker 7544), interferon, epsilon( IFNE, marker 7545), interferon, gamma (IFNG, marker 7546), interferon gamma receptor 1 (IFNGR1, marker 7547), interferon, kappa (IFNK, marker 7548), interferon, lambda 1 (IFNL1, marker 7549), interferon, lambda 2 (IFNL2, marker 7550), interferon, lambda 2 /// interferon, lambda 3 (IFNL2 /// IFNL3, marker 7551), interferon, lambda receptor 1 (IFNLR1, marker 7552), interferon, omega 1 (IFNW1, marker 7553), intraflagellar transport 122 (IFT122, marker 7554), intraflagellar transport 140 (IFT140, marker 7555), intraflagellar transport 140 (IFT140, marker 7556), intraflagellar transport 27 (IFT27, marker 7557), intraflagellar transport 57 (IFT57, marker 7558), intraflagellar transport 74 (IFT74, marker 7559), intraflagellar transport 74 (IFT74, marker 7560), intraflagellar transport 80 (IFT80, marker 7561), intraflagellar transport 80 (IFT80, marker 7562), intraflagellar transport 81 (IFT81, marker 7563), insulin-like growth factor 1 (somatomedin C) (IGF1, marker 7564), insulin-like growth factor 1 (somatomedin C) (IGF1, marker 7565), insulin-like growth factor 1 (somatomedin C) (IGF1 , marker 7566), insulin-like growth factor 1 (somatomedin C) (IGF1, marker 7567), insulin-like growth factor 1 (somatomedin C) (IGF1, marker 7568), insulin-like growth factor 1 receptor (IGF1R, marker 7569),insulin-like growth factor 2 /// INS-IGF2 readthrough(IGF2 /// INS-IGF2,marker 7570),insulin-like growth factor 2 /// INS-IGF2 readthrough(IGF2 /// INS-IGF2 , marker 7571), IGF2 antisense RNA (IGF2-AS, marker 7572), IGF2BP2 antisense RNA 1 (IGF2BP2-AS1, marker 7573), IGF2BP2 antisense RNA 1 (IGF2BP2-AS1, marker 7574), IGF2BP2 antisense RNA 1 (IGF2BP2- AS1, marker 7575), IGF2BP2 antisense RNA 1 (IGF2BP2-AS1, marker 7576), insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3, marker 7577), insulin-like growth factor 2 receptor (IGF2R, marker 7578), insulin-like growth factor binding protein, acid labile subunit(IGFALS, marker 7579),insulin like growth factor binding protein 1(IGFBP1, marker 7580),insulin like growth factor binding protein 1(IGFBP1, marker 7581),insulin like growth factor binding protein 5 (IGFBP5, marker 7582), insulin like growth factor binding protein 7 (IGFBP7, marker 7583), IGFBP7 antisense RNA 1 (IGFBP7-AS1, marker 7584), IGF like family member 1 (IGFL1, marker 7585), IGF like family member 2(IGFL2, marker 7586),immunoglobulin-like and fibronectin type III domain containing 1(IGFN1,marker 7587),immunoglobulin-like and fibronectin type III domain containing 1(IGFN1,marker 7588),immunoglobulin heavy locus(IGH , marker 7589), immunoglobulin heavy locus(IGH, marker 7590), immunoglobulin heavy locus(IGH, marker 7591), immunoglobulin heavy locus /// immunoglobulin constant heavy alpha 1 /// immunoglobulin heavy constant alpha 2 (A2m marker)(IGH /// IGHA1 /// IGHA2, marker 7592), immunoglobulin heavy locus /// immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy constant alpha 2 (A2m marker) /// immunoglobulin heavy constant delta /// immunoglobulin heavy diversity 3 -3 /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 2 (G2m marker) /// immunoglobulin heavy constant gamma 3 (G3m marker) /// immunoglobulin heavy joining 5 /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-21 /// immunoglobulin heavy variable 3-48 /// immunoglobulin heavy variable 3-71 (pseudogene) /// immunoglobulin heavy variable 4-31(IGH /// IGHA1 /// IGHA2 /// IGHD /// IGHD3-3 /// IGHG1 /// IGHG2 /// IGHG3 /// IGHJ5 /// IGHM /// IGHV3-21 /// IGHV3-48 /// IGHV3-71 / // IGHV4-31, marker 7593), immunoglobulin heavy locus /// immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy constant alpha 2 (A2m marker) /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 4 (G4m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 4-31 /// immunoglobulin heavy variable 4-39 /// putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 (IGH /// IGHA1 /// IGHA2 /// IGHG1 /// IGHG4 /// IGHM /// IGHV4-31 /// IGHV4-39 /// LOC102723407, Marker 7594), immunoglobulin heavy locus /// immunoglobulin heavy constant alpha 2 (A2m marker) /// immunoglobulin heavy constant delta /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy variable 4-31 /// immunoglobulin heavy variable 4-61 /// putative V -set and immunoglobulin domain-containing-like protein IGHV4OR15-8(IGH /// IGHA2 /// IGHD /// IGHG1 /// IGHV4-31 /// IGHV4-61 /// LOC102723407, marker 7595), immunoglobulin heavy locus /// src kinase associated phosphoprotein 2(IGH /// SKAP2, marker 7596), immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy constant alpha 2 (A2m marker) /// immunoglobulin heavy constant gamma 1 (G1m marker) / // immunoglobulin heavy constant gamma 3 (G3m marker) /// immunoglobulin heavy joining 4 /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-23 /// immunoglobulin heavy variable 4-31 /// immunoglobulin kappa locus / // zinc finger, CW type with PWWP domain 2(IGHA1 /// IGHA2 /// IGHG1 /// IGHG3 /// IGHJ4 /// IGHM /// IGHV3-23 /// IGHV4-31 /// IGK / // ZCWPW2, marker 7597), immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy constant delta /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 2 (G2m marker) /// immunoglobulin heavy constant gamma 3 (G3m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-30 /// immunoglobulin heavy variable 3-33 /// immunoglobulin heavy variable 4-31(IGHA1 /// IGHD /// IGHG1 /// IGHG2 /// IGHG3 /// IGHM /// IGHV3-30 /// IGHV3-33 /// IGHV4-31, marker 7598), immunoglobulin heavy constant alpha 1 /// immunoglobulin constant heavy delta /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 3 (G3m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-21 /// immunoglobulin heavy variable 3-48 /// immunoglobulin heavy variable 3-71 (pseudogene) /// immunoglobulin heavy variable 4-31(IGHA1 /// IGHD /// IGHG1 /// IGHG3 /// IGHM /// IGHV3-21 /// IGHV3-48 /// IGHV3-71 /// IGHV4-31, marker 7599), immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 3 (G3m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 1-69 /// immunoglobulin heavy variable 1-69-2(IGHA1 /// IGHG1 /// IGHG3 /// IGHM /// IGHV1-69 /// IGHV1-69-2, marker 7600),immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 3 (G3m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-11 (gene /pseudogene) /// immunoglobulin heavy variable 4-31(IGHA1 /// IGHG1 /// IGHG3 /// IGHM /// IGHV3-11 /// IGHV4-31, marker 7601), immunoglobulin heavy constant alpha 1 // / immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 3 (G3m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-30 /// immunoglobulin heavy variable 3-33 /// immunoglobulin heavy variable 4-31(IGHA1 /// IGHG1 /// IGHG3 /// IGHM /// IGHV3-30 /// IGHV3-33 /// IGHV4-31, marker 7602), immunoglobulin heavy constant alpha 1 // / immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-20(IGHA1 /// IGHG1 /// IGHM /// IGHV3-20, marker 7603),immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-23 /// immunoglobulin heavy variable 4-31 /// immunoglobulin kappa locus /// zinc finger , CW type with PWWP domain 2(IGHA1 /// IGHG1 /// IGHM /// IGHV3-23 /// IGHV4-31 /// IGK /// ZCWPW2, marker 7604), immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-38 (non-functional)(IGHA1 /// IGHG1 /// IGHM /// IGHV3-38, marker 7605) ,immunoglobulin heavy constant alpha 1 /// immunoglobulin heavy variable 2-5 /// immunoglobulin heavy variable 4-31(IGHA1 /// IGHV2-5 /// IGHV4-31, marker 7606),immunoglobulin heavy constant alpha 1 // / immunoglobulin heavy variable 2-5 /// immunoglobulin heavy variable 4-31(IGHA1 /// IGHV2-5 /// IGHV4-31, marker 7607), immunoglobulin heavy constant delta(IGHD, marker 7608), immunoglobulin heavy constant delta (IGHD, marker 7609), immunoglobulin heavy constant delta(IGHD, marker 7610), immunoglobulin heavy constant delta(IGHD, marker 7611), immunoglobulin heavy constant delta(IGHD, marker 7612), immunoglobulin heavy diversity 3-16(IGHD3-16 , marker 7613), immunoglobulin heavy constant epsilon(IGHE, marker 7614), immunoglobulin heavy constant epsilon /// immunoglobulin heavy constant epsilon P1 (pseudogene)(IGHE /// IGHEP1, marker 7615), immunoglobulin constant heavy gamma 1 (G1m marker )(IGHG1, marker 7616), immunoglobulin heavy constant gamma 1 (G1m marker)(IGHG1, marker 7617), immunoglobulin heavy constant gamma 1 (G1m marker)(IGHG1, marker 7618), immunoglobulin heavy constant gamma 1 (G1m marker)( IGHG1, marker 7619), immunoglobulin heavy constant gamma 1 (G1m marker)(IGHG1, marker 7620), immunoglobulin heavy constant gamma 1 (G1m marker)(IGHG1, marker 7621), immunoglobulin constant heavy gamma 1 (G1m marker)(IGHG1, marker 7622), immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy constant gamma 3 (G3m marker) /// immunoglobulin heavy constant mu /// immunoglobulin heavy variable 4-31(IGHG1 /// IGHG3 /// IGHM /// IGHV4-31, marker 7623), immunoglobulin heavy constant gamma 1 (G1m marker) /// im
munoglobulin heavy constant mu(IGHG1 /// IGHM, marker 7624),immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy variable 3-13 /// immunoglobulin heavy variable 4-31(IGHG1 /// IGHV3-13 /// IGHV4-31, marker 7625), immunoglobulin heavy constant gamma 1 (G1m marker) /// immunoglobulin heavy variable 5-51(IGHG1 /// IGHV5-51, marker 7626), immunoglobulin heavy constant gamma 1 (G1m marker ) /// src kinase associated phosphoprotein 2(IGHG1 /// SKAP2, marker 7627), immunoglobulin heavy constant mu(IGHM, marker 7628), immunoglobulin heavy constant mu(IGHM, marker 7629), immunoglobulin heavy constant mu(IGHM, marker 7630), immunoglobulin heavy constant mu /// immunoglobulin heavy variable 1-69 /// immunoglobulin heavy variable 1-69-2(IGHM /// IGHV1-69 /// IGHV1-69-2, marker 7631), immunoglobulin heavy constant mu /// immunoglobulin heavy variable 3-30 /// immunoglobulin heavy variable 3-33(IGHM /// IGHV3-30 /// IGHV3-33, marker 7632), immunoglobulin mu binding protein 2(IGHMBP2, marker 7633) ,immunoglobulin heavy variable 1-69(IGHV1-69, marker 7634),immunoglobulin heavy variable 1-69(IGHV1-69,marker 7635),immunoglobulin heavy variable 1-69(IGHV1-69,marker 7636),immunoglobulin heavy variable 3 -47 (pseudogene)(IGHV3-47, marker 7637),immunoglobulin heavy variable 3-48(IGHV3-48,marker 7638),immunoglobulin heavy variable 3-53 /// immunoglobulin heavy variable 3-66 /// immunoglobulin heavy variable 3-72(IGHV3-53 /// IGHV3-66 /// IGHV3-72, marker 7639), immunoglobulin heavy variable 3-54 (pseudogene)(IGHV3-54, marker 7640), immunoglobulin heavy variable 3-72(IGHV3 -72, marker 7641), immunoglobulin heavy variable 3-73(IGHV3-73, marker 7642), immunoglobulin heavy variable 5-78 (pseudogene) /// microRNA 5195(IGHV5-78 /// MIR5195, marker 7643), immunoglobulin heavy variable 7-81 (non-functional) (IGHV7-81, marker 7644), IgA-inducing protein (IGIP, marker 7645), immunoglobulin kappa locus (IGK, marker 7646), immunoglobulin kappa locus (IGK, marker 7647), immunoglobulin kappa locus /// immunoglobulin kappa constant /// immunoglobulin kappa joining 3 /// immunoglobulin kappa variable 1-33 /// immunoglobulin kappa variable 1D-33 /// immunoglobulin kappa variable 2-29 (gene/pseudogene) // / immunoglobulin kappa variable 3D-15 (gene/pseudogene)(IGK /// IGKC /// IGKJ3 /// IGKV1-33 /// IGKV1D-33 /// IGKV2-29 /// IGKV3D-15, marker 7648) ,immunoglobulin kappa locus /// immunoglobulin kappa constant /// immunoglobulin kappa variable 1-5 /// immunoglobulin kappa variable 2-24(IGK /// IGKC /// IGKV1-5 /// IGKV2-24, marker 7649) ,immunoglobulin kappa locus /// immunoglobulin kappa constant /// immunoglobulin kappa variable 1-5 /// immunoglobulin kappa variable 2-24(IGK /// IGKC /// IGKV1-5 /// IGKV2-24, marker 7650) ,immunoglobulin kappa locus /// immunoglobulin kappa constant /// immunoglobulin kappa variable 1-5 /// immunoglobulin kappa variable 2-28 /// immunoglobulin kappa variable 2D-28(IGK /// IGKC /// IGKV1-5 / // IGKV2-28 /// IGKV2D-28, marker 7651), immunoglobulin kappa constant(IGKC, marker 7652), immunoglobulin kappa constant(IGKC, marker 7653), immunoglobulin kappa constant(IGKC, marker 7654), immunoglobulin kappa constant( IGKC, marker 7655), immunoglobulin kappa constant(IGKC, marker 7656), immunoglobulin kappa variable 1-17(IGKV1-17, marker 7657), immunoglobulin kappa variable 1-37 (non-functional) /// immunoglobulin kappa variable 1D- 37 (non-functional)(IGKV1-37 /// IGKV1D-37, marker 7658), immunoglobulin kappa variable 1-39 (gene/pseudogene) /// immunoglobulin kappa variable 1D-39(IGKV1-39 /// IGKV1D- 39, marker 7659), immunoglobulin kappa variable 1-5 (IGKV1-5, marker 7660), immunoglobulin kappa variable 1D-8 (IGKV1D-8, marker 7661), immunoglobulin kappa variable 1/OR2-108 (non-functional)( IGKV1OR2-108, marker 7662), immunoglobulin kappa variable 2-28 /// immunoglobulin kappa variable 2D-28 (IGKV2-28 /// IGKV2D-28, marker 7663), immunoglobulin kappa variable 4-1 (IGKV4-1, marker 7664),immunoglobulin lambda constant 1 (Mcg marker)(IGLC1,marker 7665),immunoglobulin lambda constant 1 (Mcg marker)(IGLC1,marker 7666),immunoglobulin lambda constant 1 (Mcg marker)(IGLC1,marker 7667),immunoglobulin lambda constant 1 (Mcg marker) /// immunoglobulin lambda joining 3(IGLC1 /// IGLJ3, marker 7668),immunoglobulin lambda constant 1 (Mcg marker) /// immunoglobulin lambda joining 3 /// immunoglobulin lambda-like polypeptide 5 // / immunoglobulin lambda variable 3-21(IGLC1 /// IGLJ3 /// IGLL5 /// IGLV3-21, marker 7669), immunoglobulin lambda joining 3(IGLJ3, marker 7670), immunoglobulin lambda joining 3(IGLJ3, marker 7671), immunoglobulin lambda joining 3(IGLJ3, marker 7672),immunoglobulin lambda joining 3(IGLJ3, marker 7673),immunoglobulin lambda joining 3(IGLJ3, marker 7674),immunoglobulin lambda joining 3 /// immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 3-19(IGLJ3 /// IGLL5 /// IGLV3-19, marker 7675), immunoglobulin lambda joining 3 /// immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 3-19(IGLJ3 /// IGLL5 /// IGLV3-19, marker 7676), immunoglobulin lambda-like polypeptide 1 (IGLL1, marker 7677), immunoglobulin lambda-like polypeptide 3, pseudogene (IGLL3P, marker 7678), immunoglobulin lambda-like polypeptide 5 (IGLL5, marker 7679) ),immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 1-40 /// immunoglobulin lambda variable 1-44 /// immunoglobulin lambda variable 1-50 (non-functional)(IGLL5 /// IGLV1-40 // / IGLV1-44 /// IGLV1-50, marker 7680), immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 2-5 (pseudogene)(IGLL5 /// IGLV2-5, marker 7681), immunoglobulin lambda-like polypeptide 5 /// immunoglobulin lambda variable 6-57(IGLL5 /// IGLV6-57, marker 7682), immunoglobulin lambda variable 2-14 (IGLV2-14, marker 7683), immunoglobulin lambda variable 3-10 (IGLV3-10, marker 7684), immunoglobulin lambda variable 3-25 (IGLV3-25, marker 7685), immunoglobulin lambda variable 4-3 (IGLV4-3, marker 7686), immunoglobulin lambda variable 4-60 (IGLV4-60, marker 7687), immunoglobulin lambda variable 9-49(IGLV9-49, marker 7688),immunoglobulin lambda variable cluster(IGLV@,marker 7689),immunoglobulin lambda variable cluster(IGLV@,marker 7690),immunoglobulin lambda variable (I)-70 (pseudogene)( IGLVI-70, marker 7691), immunoglobulin lambda variable (IV)/OR22-1 (pseudogene)(IGLVIVOR22-1, marker 7692), immunoglobulin lambda variable (IV)/OR22-2 (pseudogene)(IGLVIVOR22-2, marker 7693 ), immunoglobulin superfamily, member 10 (IGSF10, marker 7694), immunoglobulin superfamily, member 11 (IGSF11, marker 7695), IGSF11 antisense RNA 1 (IGSF11-AS1, marker 7696), immunoglobulin superfamily, member 22 (IGSF22, marker 7697) ,immunoglobulin superfamily, member 3(IGSF3, marker 7698),immunoglobulin superfamily, member 3(IGSF3, marker 7699),immunoglobulin superfamily, member 3(IGSF3, marker 7700),immunoglobulin superfamily, member 5(IGSF5, marker 7701),immunoglobulin superfamily, member 6(IGSF6, marker 7702),immunoglobulin superfamily, member 6(IGSF6, marker 7703),immunoglobulin superfamily, member 9B(IGSF9B,marker 7704),immunoglobulin superfamily, member 9B(IGSF9B,marker 7705),indian hedgehog( IHH, marker 7706), indian hedgehog (IHH, marker 7707), inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein (IKBKAP, marker 7708), IKAROS family zinc finger 1 (IKZF1, marker 7709) ,IKAROS family zinc finger 1(IKZF1, marker 7710),IKAROS family zinc finger 1(IKZF1, marker 7711),IKAROS family zinc finger 1(IKZF1, marker 7712),IKAROS family zinc finger 1(IKZF1, marker 7713),IKAROS family zinc finger 1(IKZF1, marker 7714),IKAROS family zinc finger 1(IKZF1, marker 7715),IKAROS family zinc finger 2(IKZF2, marker 7716),IKAROS family zinc finger 2(IKZF2, marker 7717),IKAROS family zinc finger finger 3 (IKZF3, marker 7718), IKAROS family zinc finger 3 (IKZF3, marker 7719), IKAROS family zinc finger 3 (IKZF3, marker 7720), IKAROS family zinc finger 4 (IKZF4, marker 7721), interleukin 10 (IL10, marker 7722), interleukin 10 receptor, alpha(IL10RA, marker 7723), IL10RB antisense RNA 1 (head to head)(IL10RB-AS1, marker 7724), IL10RB antisense RNA 1 (head to head)(IL10RB-AS1, marker 7725 ), interleukin 11 (IL11, marker 7726), interleukin 12A (IL12A, marker 7727), IL12A antisense RNA 1 (IL12A-AS1, marker 7728), interleukin 12B (IL12B, marker 7729), interleukin 12 receptor, beta 1 (IL12RB1 , marker 7730), interleukin 12 receptor, beta 1 (IL12RB1, marker 7731), interleukin 12 receptor, beta 1 (IL12RB1, marker 7732), interleukin 12 receptor, beta 2 (IL12RB2, marker 7733), interleukin 13 (IL13, marker 7734), interleukin 13 receptor, alpha 2 (IL13RA2, marker 7735), interleukin 15 (IL15, marker 7736), interleukin 15 receptor, alpha (IL15RA, marker 7737), interleukin 16 (IL16, marker 7738), interleukin 16 (IL16) , marker 7739), interleukin 16 (IL16, marker 7740), interleukin 17A (IL17A, marker 7741), interleukin 17A (IL17A, marker 7742), interleukin 17B (IL17B, marker 7743), interleukin 17C (IL17C, marker 7744), interleukin 17F (IL17F, marker 7745), interleukin 17 receptor A (IL17RA, marker 7746), interleukin 17 receptor C (IL17RC, marker 7747), interleukin 17 receptor C (IL17RC, marker 7748), interleukin 17 receptor E (IL17RE, marker 7749), interleukin 17 receptor E (IL17RE, marker 7750), interleukin 18 (IL18, marker 7751), interleukin 18 binding protein (IL18BP, marker 7752), interleukin 18 binding protein (IL18BP, marker 7753), interleukin 18 binding protein( IL18BP, marker 7754), interleukin 18 receptor 1 (IL18R1, marker 7755), interleukin 18 receptor accessory protein (IL18RAP, marker 7756), interleukin 19 (IL19, marker 7757), interleukin 1 alpha (IL1A, marker 7758), interleukin 1 beta(IL1B, marker 7759), interleukin 1 family, member 10 (theta)(IL1F10, marker 7760), interleukin 1 receptor, type I(IL1R1, marker 7761), interleukin 1 receptor, type I(IL1R1, marker 7762), interleukin 1 receptor, type II(IL1R2, marker 7763),interleukin 1 receptor, type II(IL1R2, marker 7764),interleukin 1 receptor accessory protein(IL1RAP, marker 7765),interleukin 1 receptor accessory protein-like 1(IL1RAPL1, marker 7766), interleukin 1 receptor accessory protein-like 1 (IL1RAPL1, marker 7767), interleukin 1 receptor accessory protein-like 2 (IL1RAPL2, marker 7768), interleukin 1 receptor-like 1 (IL1RL1, marker 7769), interleukin 1 receptor- like 1(IL1RL1, marker 7770), interl
eukin 1 receptor-like 1(IL1RL1, marker 7771), interleukin 1 receptor-like 1(IL1RL1, marker 7772), interleukin 1 receptor-like 2(IL1RL2, marker 7773), interleukin 1 receptor antagonist(IL1RN, marker 7774), interleukin 1 receptor antagonist (IL1RN, marker 7775), interleukin 1 receptor antagonist (IL1RN, marker 7776), interleukin 1 receptor antagonist (IL1RN, marker 7777), interleukin 1 receptor antagonist (IL1RN, marker 7778), interleukin 2 (IL2, marker) 7779), interleukin 20 (IL20, marker 7780), interleukin 20 receptor, alpha (IL20RA, marker 7781), interleukin 20 receptor, alpha (IL20RA, marker 7782), interleukin 20 receptor, alpha (IL20RA, marker 7783), interleukin 20 receptor beta (IL20RB, marker 7784), interleukin 21 (IL21, marker 7785), interleukin 21 receptor (IL21R, marker 7786), interleukin 21 receptor (IL21R, marker 7787), interleukin 21 receptor (IL21R, marker 7788), IL21R antisense RNA 1 (IL21R-AS1, marker 7789), interleukin 22 (IL22, marker 7790), interleukin 22 (IL22, marker 7791), interleukin 22 receptor, alpha 1 (IL22RA1, marker 7792), interleukin 22 receptor, alpha 2 (IL22RA2) , marker 7793), interleukin 23, alpha subunit p19(IL23A, marker 7794), interleukin 23, alpha subunit p19(IL23A, marker 7795), interleukin 23 receptor(IL23R, marker 7796), interleukin 23 receptor(IL23R, marker 7797) , interleukin 24 (IL24, marker 7798), interleukin 25 (IL25, marker 7799), interleukin 26 (IL26, marker 7800), interleukin 27 (IL27, marker 7801), interleukin 27 receptor, alpha /// relaxin 3 (IL27RA / // RLN3, marker 7802), interleukin 2 receptor, alpha(IL2RA, marker 7803), interleukin 2 receptor, alpha(IL2RA, marker 7804), interleukin 2 receptor, gamma(IL2RG, marker 7805), interleukin 3(IL3, marker 7806), interleukin 31 receptor A (IL31RA, marker 7807), interleukin 31 receptor A (IL31RA, marker 7808), interleukin 31 receptor A (IL31RA, marker 7809), interleukin 33 (IL33, marker 7810), interleukin 34 (IL34, marker 7811), interleukin 36, alpha(IL36A, marker 7812), interleukin 36, beta(IL36B, marker 7813), interleukin 36, beta(IL36B, marker 7814), interleukin 36, gamma(IL36G, marker 7815), interleukin 36 receptor antagonist (IL36RN, marker 7816), interleukin 37 (IL37, marker 7817), interleukin 37 (IL37, marker 7818), interleukin 3 receptor, alpha (low affinity) (IL3RA, marker 7819), interleukin 4 (IL4, marker 7820) ), interleukin 4 (IL4, marker 7821), interleukin 4 induced 1 (IL4I1, marker 7822), interleukin 4 induced 1 /// nucleoporin 62kDa (IL4I1 /// NUP62, marker 7823), interleukin 5 (IL5, marker 7824) ,interleukin 5 receptor, alpha(IL5RA, marker 7825),interleukin 5 receptor, alpha(IL5RA, marker 7826),interleukin 5 receptor, alpha(IL5RA, marker 7827),interleukin 5 receptor, alpha(IL5RA, marker 7828),interleukin 6 receptor (IL6R, marker 7829), interleukin 6 receptor (IL6R, marker 7830), interleukin 6 signal transducer (IL6ST, marker 7831), interleukin 6 signal transducer (IL6ST, marker 7832), interleukin 6 signal transducer (IL6ST, marker 7833) ), interleukin 7 (IL7, marker 7834), interleukin 7 (IL7, marker 7835), interleukin 7 receptor (IL7R, marker 7836), interleukin 7 receptor (IL7R, marker 7837), interleukin 9 (IL9, marker 7838), interleukin 9 receptor (IL9R, marker 7839), interleukin 9 receptor (IL9R, marker 7840), immunoglobulin-like domain containing receptor 1 (ILDR1, marker 7841), immunoglobulin-like domain containing receptor 1 (ILDR1, marker 7842), immunoglobulin-like domain containing receptor 2(ILDR2, marker 7843), ilvB (bacterial acetolactate synthase)-like(ILVBL, marker 7844), inner mitochondrial membrane peptidase subunit 2(IMMP2L, marker 7845), inositol monophosphatase domain containing 1(IMPAD1, marker 7846) , inositol monophosphatase domain containing 1(IMPAD1, marker 7847), interphotoreceptor matrix proteoglycan 1(IMPG1, marker 7848), interphotoreceptor matrix proteoglycan 2(IMPG2, marker 7849), interphotoreceptor matrix proteoglycan 2(IMPG2, marker 7850), InaD-like ( Drosophila) (INADL, marker 7851), InaD-like (Drosophila) (INADL, marker 7852), InaD-like (Drosophila) (INADL, marker 7853), inactivation escape 1 (non-protein coding) (INE1, marker 7854) ,inverted formin, FH2 and WH2 domain containing(INF2, marker 7855),inverted formin, FH2 and WH2 domain containing(INF2, marker 7856),inhibitor of growth family member 2(ING2, marker 7857),inhibitor of growth family member 3 (ING3, marker 7858), inhibitor of growth family member 5 (ING5, marker 7859), inhibitor of growth family, X-linked, pseudogene (INGX, marker 7860), inhibitor alpha (INHA, marker 7861), inhibitor beta A( INHBA, marker 7862),inhibin beta A(INHBA,marker 7863),INHBA antisense RNA 1(INHBA-AS1,marker 7864),INHBA antisense RNA 1(INHBA-AS1,marker 7865),inhibin beta B(INHBB,marker 7866) ),inhibin beta C(INHBC, marker 7867),INTS3 and NABP interacting protein(INIP,marker 7868),indolethylamine N-methyltransferase(INMT,marker 7869),INO80 complex subunit B /// INO80B-WBP1 readthrough (NMD candidate) (INO80B /// INO80B-WBP1, marker 7870), INO80 complex subunit B /// INO80B-WBP1 readthrough (NMD candidate)(INO80B /// INO80B-WBP1, marker 7871), INO80 complex subunit D(INO80D, marker 7872 ), INO80 complex subunit D (INO80D, marker 7873), inositol polyphosphate-4-phosphatase type IA (INPP4A, marker 7874), inositol polyphosphate-4-phosphatase type II B (INPP4B, marker 7875), inositol polyphosphate-4-phosphatase type II B (INPP4B, marker 7876), inositol polyphosphate-4-phosphatase type II B (INPP4B, marker 7877), inositol polyphosphate-5-phosphatase B (INPP5B, marker 7878), inositol polyphosphate-5-phosphatase D (INPP5D, marker 7879), inositol polyphosphate-5-phosphatase D (INPP5D, marker 7880), inositol polyphosphate-5-phosphatase J (INPP5J, marker 7881), insulin (INS, marker 7882), inscuteable homolog (Drosophila) (INSC, marker 7883) ),insulin-like 3 (Leydig cell)(INSL3,marker 7884),insulin-like 3 (Leydig cell)(INSL3,marker 7885),insulin-like 4 (placenta)(INSL4,marker 7886),insulin-like 5 (INSL5, marker 7887), insulin-like 6 (INSL6, marker 7888), insulinoma-associated 2 (INSM2, marker 7889), insulin receptor-related receptor (INSRR, marker 7890), integrator complex subunit 1 (INTS1, marker 7891 ),integrator complex subunit 10(INTS10, marker 7892),integrator complex subunit 4(INTS4,marker 7893),integrator complex subunit 4(INTS4,marker 7894),integrator complex subunit 4(INTS4,marker 7895),integrator complex subunit 4 pseudogene 1 (INTS4P1, marker 7896), integrator complex subunit 6 (INTS6, marker 7897), INTS6 antisense RNA 1 (INTS6-AS1, marker 7898), INTS6 antisense RNA 1 (INTS6-AS1, marker 7899), integrator complex subunit 9 (INTS9, marker 7900), inversin (INVS, marker 7901), inversin (INVS, marker 7902), inositol hexakisphosphate kinase 3 (IP6K3, marker 7903), interaction protein for cytohesin exchange factors 1 (IPCEF1, marker 7904), inositol polyphosphate multikinase (IPMK, marker 7905), importin 11 (IPO11, marker 7906), importin 11 /// leucine rich repeat containing 70 (IPO11 /// LRRC70, marker 7907), importin 5 pseudogene 1 (IPO5P1, marker 7908), importin 5 pseudogene 1 (IPO5P1, marker 7909), IPO9 antisense RNA 1 (IPO9-AS1, marker 7910), intracisternal A particle-promoted polypeptide (IPP, marker 7911), intracisternal A particle-promoted polypeptide (IPP, marker 7912), inositol 1,3,4,5,6-pentakisphosphate 2-kinase(IPPK, marker 7913),IQ motif containing with AAA domain 1(IQCA1, marker 7914),IQ motif containing with AAA domain 1(IQCA1, marker 7915),IQ motif containing with AAA domain 1 (IQCA1, marker 7916), IQ motif containing C (IQCC, marker 7917), IQ motif containing D (IQCD, marker 7918), IQ motif containing E (IQCE, marker 7919), IQ motif containing F1 (IQCF1, marker 7920),IQ motif containing F1(IQCF1, marker 7921),IQ motif containing F2(IQCF2, marker 7922),IQ motif containing F3(IQCF3, marker 7923),IQ motif containing F3 /// IQ motif containing F5 pseudogene(IQCF3 /// IQCF4, marker 7924),IQ motif containing F5 pseudogene(IQCF4, marker 7925),IQ motif containing F5(IQCF5, marker 7926),IQCF5 antisense RNA 1(IQCF5-AS1, marker 7927),IQ motif containing F6(IQCF6, marker 7928),IQ motif containing G(IQCG, marker 7929),IQ motif containing H(IQCH,marker 7930),IQ motif containing H(IQCH,marker 7931),IQ motif containing H(IQCH, Marker 7932), IQ motif containing H(IQCH, Marker 7933), IQ motif containing H(IQCH, Marker 7934), IQ motif containing H(IQCH, Marker 7935), IQCH antisense RNA 1(IQCH-AS1, Marker 7936), IQCJ-SCHIP1 readthrough antisense RNA 1(IQCJ-SCHIP1-AS1, marker 7937), IQ motif containing K(IQCK, marker 7938), IQ motif containing K(IQCK, marker 7939), IQ motif containing GTPase activating protein 2(IQGAP2, IQ motif containing GTPase activating protein 3(IQGAP3, marker 7941),IQ motif containing GTPase activating protein 3(IQGAP3, marker 7942),IQ motif containing GTPase activating protein 3(IQGAP3, marker 7943),IQ motif and Sec7 domain 2(IQSEC2, marker 7944),IQ motif and Sec7 domain 2(IQSEC2, marker 7945),IQ motif and Sec7 domain 2(IQSEC2, marker 7946),IQ motif and Sec7 domain 3(IQSEC3, marker 7947),IQ motif and Sec7 domain 3(IQSEC3, marker 7948),IQ motif and Sec7 domain 3(IQSEC3, marker 7949),IQ motif and Sec7 domain 3(IQSEC3, marker 7950),IQ motif and ubiquitin domain containing(IQUB, marker 7951), interleukin 1 receptor associated kinase 2(IRAK2, marker 7952),interleukin 1 receptor associated kinase 2(IRAK2, marker 7953),interleukin 1 receptor associated kinase 2(IRAK2, marker 7954),interleukin 1 receptor associated kinase 3(IRAK3, marker 7955 ), interleukin 1 receptor associated kinase 3 (IRAK3, marker 7956), interleukin 1 receptor associated kinase 3 (IRAK3, marker 7957), interleukin 1 receptor associated kinase 4 (IRAK4, marker 7958), iron responsive element binding protein 2 (IREB2, marker 7959), interferon regulatory factor 1 (IRF1, marker 7960), interferon regulatory factor 2 binding protein 1 (IRF2BP1, marker 7961), interferon regulatory factor 2 binding protein 2 (IRF2BP2, marker 7962), interferon regulatory factor 4 (IRF4, marker 7963), interferon regulatory factor 4 (IRF4, marker 7964), interferon regulatory factor 5 (IRF5, marker 7965), interferon regulatory factor 5 (IRF5, marker 7966), interferon regulatory factor 5 (IRF5, marker 7967), interferon regulatory factor 6 (IRF6, marker 7968), immunoresponsive 1 homolog (mouse) (IRG1, marker 7969), immunity-related GTPase family, cinema (IRGC, marker 7970), immunity-related GTPase family, M (IRGM, marker 7971), immunity-related GTPase family, Q(IRGQ, marker 7972),immuni
ty-related GTPase family, Q(IRGQ, marker 7973), iroquois homeobox 4(IRX4, marker 7974), interferon stimulated exonuclease gene 20kDa(ISG20, marker 7975), interferon stimulated exonuclease gene 20kDa like 2(ISG20L2, marker 7976), immunoglobulin superfamily containing leucine-rich repeat(ISLR, marker 7977),immunoglobulin superfamily containing leucine-rich repeat 2(ISLR2, marker 7978),isthmin 1, angiogenesis inhibitor(ISM1, marker 7979),isthmin 1, angiogenesis inhibitor(ISM1, marker 7980), ISM1 antisense RNA 1 (ISM1-AS1, marker 7981), isthmin 2 (ISM2, marker 7982), ISPD antisense RNA 1 (ISPD-AS1, marker 7983), ISPD antisense RNA 1 (ISPD-AS1, marker 7984) , intestine-specific homeobox (ISX, marker 7985), ISY1 splicing factor homolog (ISY1, marker 7986), inositol-3-phosphate synthase 1 (ISYNA1, marker 7987), inositol-3-phosphate synthase 1 (ISYNA1, marker 7988) ,inositol-3-phosphate synthase 1(ISYNA1, marker 7989),itchy E3 ubiquitin protein ligase(ITCH,marker 7990),integrin alpha FG-GAP repeat containing 1(ITFG1,marker 7991),integrin alpha FG-GAP repeat containing 2 /// uncharacterized LOC100507424(ITFG2 /// LOC100507424, marker 7992), integrin alpha FG-GAP repeat containing 2 /// uncharacterized LOC100507424(ITFG2 /// LOC100507424, marker 7993), integrin alpha 1(ITGA1, marker 7994), integrin alpha 1(ITGA1, marker 7995),integrin alpha 10(ITGA10,marker 7996),integrin alpha 11(ITGA11,marker 7997),integrin alpha 11(ITGA11,marker 7998),integrin alpha 2b(ITGA2B,marker 7999), integrin alpha 2b(ITGA2B, marker 8000),integrin alpha 2b(ITGA2B,marker 8001),integrin alpha 4(ITGA4,marker 8002),integrin alpha 4(ITGA4,marker 8003),integrin alpha 4(ITGA4,marker 8004), integrin alpha 8(ITGA8, marker 8005),integrin alpha 8(ITGA8,marker 8006),integrin alpha 8(ITGA8,marker 8007),integrin alpha 8(ITGA8,marker 8008),integrin alpha 9(ITGA9,marker 8009), integrin alpha 9 (ITGA9, marker 8010), integrin alpha 9 (ITGA9, marker 8011), ITGA9 antisense RNA 1 (ITGA9-AS1, marker 8012), integrin alpha D (ITGAD, marker 8013), integrin alpha L (ITGAL, marker 8014), integrin alpha L (ITGAL, marker 8015), integrin, alpha M (complement component 3 receptor 3 subunit) (ITGAM, marker 8016), integrin alpha X (ITGAX, marker 8017), integrin alpha X (ITGAX, marker 8018) ),integrin beta 1(ITGB1,marker 8019),integrin beta 1(ITGB1,marker 8020),integrin beta 1(ITGB1,marker 8021),integrin beta 1 /// integrin beta 1 pseudogene 1(ITGB1 /// ITGB1P1, marker 8022), integrin beta 1 binding protein 1 (ITGB1BP1, marker 8023), integrin beta 1 binding protein (melusin) 2 (ITGB1BP2, marker 8024), integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) (ITGB2, marker 8025),integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)(ITGB2,marker 8026),integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)(ITGB2,marker 8027),ITGB2 antisense RNA 1 (ITGB2-AS1, marker 8028), ITGB2 antisense RNA 1 (ITGB2-AS1, marker 8029), integrin beta 3 (ITGB3, marker 8030), integrin beta 3 (ITGB3, marker 8031), integrin beta 3 (ITGB3, marker 8032) ),integrin beta 3(ITGB3,marker 8033),integrin beta 3(ITGB3,marker 8034),integrin beta 3(ITGB3,marker 8035),integrin beta 3(ITGB3,marker 8036),integrin beta 4(ITGB4,marker 8037) ),integrin beta 4(ITGB4,marker 8038),integrin beta 4(ITGB4,marker 8039),integrin beta 4(ITGB4,marker 8040),integrin beta 4(ITGB4,marker 8041),integrin beta 6 /// uncharacterized LOC100505984 (ITGB6 ///loc100505984, marker 8042), Integrin Beta 6 /// Uncharacterized Loc100505984 (ITGB6 /// Loc100505984, Marker 8043), Integrin Beta 6 /// Unchar Acterized Loc100505984 (ITGB6 /// LOC100505984, Marker 8044), Integrin beta 7(ITGB7, marker 8045),integrin beta 8(ITGB8,marker 8046),integrin beta 8(ITGB8,marker 8047),integrin beta 8(ITGB8,marker 8048),integrin beta 8(ITGB8,marker 8049),integrin beta like 1(ITGBL1, marker 8050),integrin beta like 1(ITGBL1,marker 8051),integrin beta like 1(ITGBL1,marker 8052),integrin beta like 1(ITGBL1,marker 8053),integrin beta like 1(ITGBL1, marker 8054), inter-alpha-trypsin inhibitor heavy chain 1 (ITIH1, marker 8055), inter-alpha-trypsin inhibitor heavy chain 2 (ITIH2, marker 8056), inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3, marker 8057) ),inter-alpha-trypsin inhibitor heavy chain family, member 4(ITIH4, marker 8058),inter-alpha-trypsin inhibitor heavy chain family, member 4(ITIH4, marker 8059),inter-alpha-trypsin inhibitor heavy chain family, member 4(ITIH4, marker 8060), inter-alpha-trypsin inhibitor heavy chain family, member 4(ITIH4, marker 8061), inter-alpha-trypsin inhibitor heavy chain family, member 5(ITIH5, marker 8062), inter-alpha -trypsin inhibitor heavy chain family, member 6 (ITIH6, marker 8063), IL2-inducible T-cell kinase (ITK, marker 8064), intelectin 1 (galactofuranose binding) (ITLN1, marker 8065), inositol-tetrakisphosphate 1-kinase( ITPK1, marker 8066), inositol-tetrakisphosphate 1-kinase (ITPK1, marker 8067), ITPK1 antisense RNA 1 (ITPK1-AS1, marker 8068), ITPK1 antisense RNA 1 (ITPK1-AS1, marker 8069), inositol-trisphosphate 3- kinase A (ITPKA, marker 8070), inositol-trisphosphate 3-kinase B (ITPKB, marker 8071), inositol-trisphosphate 3-kinase B (ITPKB, marker 8072), inositol-trisphosphate 3-kinase B (ITPKB, marker 8073) , inositol-trisphosphate 3-kinase B (ITPKB, marker 8074), ITPKB intronic transcript 1 (ITPKB-IT1, marker 8075), inositol 1,4,5-trisphosphate receptor, type 1 (ITPR1, marker 8076), inositol 1, 4,5-trisphosphate receptor, type 1 (ITPR1, marker 8077), ITPR1 antisense RNA 1 (head to head) (ITPR1-AS1, marker 8078), inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2, marker 8079), inositol 1,4,5-trisphosphate receptor, type 3 (ITPR3, marker 8080), inositol 1,4,5-trisphosphate receptor, type 3 (ITPR3, marker 8081), inositol 1,4,5-trisphosphate receptor protein interacting(ITPRIP, marker 8082), inositol 1,4,5-trisphosphate receptor interacting protein-like 2(ITPRIPL2, marker 8083), inositol 1,4,5-trisphosphate receptor interacting protein-like 2(ITPRIPL2, marker 8084) ,intersectin 1(ITSN1,marker 8085),intersectin 1(ITSN1,marker 8086),intersectin 1(ITSN1,marker 8087),intersectin 1(ITSN1,marker 8088),intersectin 1(ITSN1,marker 8089),intersectin 2(ITSN2) , marker 8090), isovaleryl-CoA dehydrogenase (IVD, marker 8091), involucrin (IVL, marker 8092), influenza virus NS1A binding protein (IVNS1ABP, marker 8093), IWS1 homolog (S. cerevisiae) (IWS1, marker 8094), iodotyrosine deiodinase (IYD, marker 8095), izumo sperm-egg fusion 1 (IZUMO1, marker 8096), IZUMO family member 2 (IZUMO2, marker 8097), IZUMO family member 4 (IZUMO4, marker 8098), IZUMO family member 4 (IZUMO4) , marker 8099), immunoglobulin kappa chain complex (Igk, marker 8100), jade family PHD finger 2 (JADE2, marker 8101), jagged 1 (JAG1, marker 8102), jagged 1 (JAG1, marker 8103), jagged 2 (JAG2 , Marker 8104), Janus kinase 1 (JAK1, Marker 8105), Janus kinase 1 (JAK1, Marker 8106), Janus kinase 2 (JAK2, Marker 8107), Janus kinase 2 (JAK2, Marker 8108), Janus kinase 3 (JAK3 , Marker 8109), Janus kinase 3(JAK3, Marker 8110), janus kinase and microtubule interacting protein 1(JAKMIP1, Marker 8111), janus kinase and microtubule interacting protein 2(JAKMIP2, Marker 8112), Janus kinase and microtubule interacting protein 3 (JAKMIP3, marker 8113), jumonji, AT rich interactive domain 2 (JARID2, marker 8114), JARID2 antisense RNA 1 (JARID2-AS1, marker 8115), JAZF1 antisense RNA 1 (JAZF1-AS1, marker 8116), joining chain of multimeric IgA and IgM(JCHAIN, marker 8117), Jun dimerization protein 2(JDP2, marker 8118), jumonji domain containing 1C(JMJD1C, marker 8119), jumonji domain containing 1C(JMJD1C, marker 8120), JMJD1C antisense RNA 1(JMJD1C -AS1, marker 8121), jumonji domain containing 6(JMJD6, marker 8122),jumonji domain containing 6(JMJD6, marker 8123),JMJD7-PLA2G4B readthrough /// phospholipase A2, group IVB (cytosolic)(JMJD7-PLA2G4B // / PLA2G4B, marker 8124), Josephin domain containing 2(JOSD2, marker 8125), junctophilin 2(JPH2, marker 8126), junctophilin 2(JPH2, marker 8127), junctophilin 3(JPH3, marker 8128), junctophilin 3(JPH3, marker 8129), junctophilin 3 (JPH3, marker 8130), Jrk helix-turn-helix protein (JRK, marker 8131), Jrk helix-turn-helix protein (JRK, marker 8132), Jrk helix-turn-helix protein (JRK ,marker 8133),JRK-like(JRKL,marker 8134),junctional sarcoplasmic reticulum protein 1 /// uncharacterized LOC105372240(JSRP1 /// LOC105372240,marker 8135),jun D proto-oncogene(JUND,marker 8136),kidney associated antigen 1(KAAG1, marker 8137),kalirin, RhoGEF kinase(KALRN, marker 8138),kalirin, RhoGEF kinase(KALRN, marker 8139),kalirin, RhoGEF kinase(KALRN, marker 8140),kalirin, RhoGEF kinase(KALRN, marker 8141), kalirin, RhoGEF kinase(KALRN, marker 8142),KN motif and ankyrin repeat domains 1(KANK1, marker 8143),KN motif and ankyrin repeat domains 1(KANK1, marker 8144),KN motif and ankyrin repeat domains 1( KANK1, marker 8145), KN motif and ankyrin repeat domains 2(KANK2, marker 8146), KN motif and ankyrin repeat domains 2(KANK2, marker 8147), KN motif and ankyrin repeat domains 3(KANK3, marker 8148), KANSL1 antisense RNA 1 (KANSL1-AS1, marker 8149), KAT8 regulatory NSL complex subunit 3 (KANSL3, marker 8150), KAT8 regulatory NSL complex subunit 3 (KANSL3, marker 8151), KAT8 regulatory NSL complex subunit 3 (KANSL3, marker 8152), K(lysine) acetyltransferase 6A (KAT6A, marker 8153), K(lysine) acetyltransferase 6B (KAT6B, marker 8154), K(lysine) acetyltransferase 8 (KAT8, marker 8155), katanin p60 subunit A-like 2 (KATNAL2, marker 8156), katanin p80 (WD repeat containing) subunit B 1 (KATNB1, marker 8157), Kazal-type serine peptidase inhibitor domain 1 (KAZALD1, marker 8158), Kazal-type serine peptidase inhibitor domain 1 (KAZALD1, marker 8159), Kazal-type serine peptidase inhibitor domain 1 (KAZALD1, marker 8160), kazrin, periplakin interacting protein (KAZN, marker 8161), kelch repeat and BTB (POZ) domain containing 12 (KBTBD12, marker 8162), renal clear cell carcinoma-associated transcript 333(KCCAT333, marker 8163), potassium channel modulatory factor 1(KCMF1, marker 8164), potassium channel, voltage gated shaker related subfamily A, member 1(KCNA1, marker 8165), potassium channel, voltage gated shaker related subfamily A, member 1(KCNA1, marker 8166), potassium channel, voltage gated shaker related subfamily A, member 10(KCNA10, marker 8167), potassium channel, voltage gated shaker related subfamily A, member 2(KCNA2, marker 8168), potassium channel
, voltage gated shaker related subfamily A, member 2(KCNA2,marker 8169),potassium channel, voltage gated shaker related subfamily A, member 3(KCNA3,marker 8170),potassium channel, voltage gated shaker related subfamily A, member 4(KCNA4 , marker 8171), potassium channel, voltage gated shaker related subfamily A, member 5(KCNA5, marker 8172), potassium channel, voltage gated shaker related subfamily A, member 7(KCNA7, marker 8173), potassium channel, voltage gated subfamily A regulatory beta subunit 1(KCNAB1, marker 8174),potassium channel, voltage gated subfamily A regulatory beta subunit 1(KCNAB1,marker 8175),potassium channel, voltage gated subfamily A regulatory beta subunit 1(KCNAB1,marker 8176),potassium channel, voltage gated subfamily A regulatory beta subunit 2(KCNAB2, marker 8177), potassium channel, voltage gated subfamily A regulatory beta subunit 3(KCNAB3, marker 8178), potassium channel, voltage gated Shab related subfamily B, member 1(KCNB1, marker 8179 ),potassium channel, voltage gated Shab related subfamily B, member 1(KCNB1,marker 8180),potassium channel, voltage gated Shab related subfamily B, member 1(KCNB1,marker 8181),potassium channel, voltage gated Shab related subfamily B, member 1(KCNB1, marker 8182), potassium channel, voltage gated Shab related subfamily B, member 2(KCNB2, marker 8183), potassium channel, voltage gated Shab related subfamily B, member 2(KCNB2, marker 8184), potassium channel, voltage gated Shaw related subfamily C, member 1(KCNC1,marker 8185),potassium channel, voltage gated Shaw related subfamily C, member 1(KCNC1,marker 8186),potassium channel, voltage gated Shaw related subfamily C, member 2(KCNC2, marker 8187), potassium channel, voltage gated Shaw related subfamily C, member 2(KCNC2, marker 8188), potassium channel, voltage gated Shaw related subfamily C, member 3(KCNC3, marker 8189), potassium channel, voltage gated Shaw related subfamily C, member 3(KCNC3,marker 8190),potassium channel, voltage gated Shaw related subfamily C, member 3(KCNC3,marker 8191),potassium channel, voltage gated Shaw related subfamily C, member 4(KCNC4,marker 8192),potassium channel, voltage gated Shaw related subfamily C, member 4(KCNC4,marker 8193),potassium channel, voltage gated Shaw related subfamily C, member 4(KCNC4,marker 8194),potassium channel, voltage gated Shal related subfamily D, member 3( KCND3, marker 8195), potassium channel, voltage gated Shal related subfamily D, member 3(KCND3, marker 8196), potassium channel, voltage gated Shal related subfamily D, member 3(KCND3, marker 8197), potassium channel, voltage gated Shal related subfamily D, member 3(KCND3, marker 8198), potassium channel, voltage gated subfamily E regulatory beta subunit 1 /// putative uncharacterized protein LOC388820(KCNE1 /// LOC102723475, marker 8199), potassium channel, voltage gated subfamily E regulatory beta subunit 1 /// putative uncharacterized protein LOC388820(KCNE1 /// LOC102723475, marker 8200), potassium channel, voltage gated subfamily E regulatory beta subunit 2(KCNE2, marker 8201), potassium channel, voltage gated subfamily E regulatory beta subunit 3 (KCNE3, Marker 8202), potassium channel, voltage gated subfamily E regulatory beta subunit 4(KCNE4, Marker 8203), potassium channel, voltage gated subfamily E regulatory beta subunit 4(KCNE4, Marker 8204), potassium channel, voltage gated subfamily E regulatory beta subunit 4(KCNE4, marker 8205), potassium channel, voltage gated modifier subfamily F, member 1(KCNF1, marker 8206), potassium channel, voltage gated modifier subfamily G, member 1(KCNG1, marker 8207), potassium channel, voltage gated modifier subfamily G, member 2(KCNG2, marker 8208), potassium channel, voltage gated modifier subfamily G, member 3(KCNG3, marker 8209), potassium channel, voltage gated modifier subfamily G, member 4(KCNG4, marker 8210) ,potassium channel, voltage gated eag related subfamily H, member 1(KCNH1,marker 8211),potassium channel, voltage gated eag related subfamily H, member 4(KCNH4,marker 8212),potassium channel, voltage gated eag related subfamily H, member 5(KCNH5, marker 8213), potassium channel, voltage gated eag related subfamily H, member 5(KCNH5, marker 8214), potassium channel, voltage gated eag related subfamily H, member 5(KCNH5, marker 8215), potassium channel, voltage gated eag related subfamily H, member 6(KCNH6, marker 8216), potassium channel, voltage gated eag related subfamily H, member 6(KCNH6, marker 8217), potassium channel, voltage gated eag related subfamily H, member 6(KCNH6, marker 8218),potassium channel, voltage gated eag related subfamily H, member 7(KCNH7,marker 8219),potassium channel, voltage gated eag related subfamily H, member 7(KCNH7,marker 8220),potassium channel, voltage gated eag related subfamily H , member 8(KCNH8, marker 8221),Kv channel interacting protein 1(KCNIP1, marker 8222),Kv channel interacting protein 2(KCNIP2,marker 8223),Kv channel interacting protein 2(KCNIP2,marker 8224),Kv channel interacting protein 2 (KCNIP2, marker 8225), KCNIP2 antisense RNA 1 (KCNIP2-AS1, marker 8226), Kv channel interacting protein 3, calsenilin (KCNIP3, marker 8227), Kv channel interacting protein 3, calsenilin (KCNIP3, marker 8228), Kv channel interacting protein 3, calsenilin(KCNIP3, marker 8229),Kv channel interacting protein 3, calsenilin(KCNIP3, marker 8230),Kv channel interacting protein 3, calsenilin(KCNIP3, marker 8231),Kv channel interacting protein 4(KCNIP4, marker 8232), potassium channel, inwardly rectifying subfamily J, member 1(KCNJ1, marker 8233), potassium channel, inwardly rectifying subfamily J, member 1(KCNJ1, marker 8234), potassium channel, inwardly rectifying subfamily J, member 10(KCNJ10, marker 8235), potassium channel, inwardly rectifying subfamily J, member 10(KCNJ10, marker 8236), potassium channel, inwardly rectifying subfamily J, member 11(KCNJ11, marker 8237), potassium channel, inwardly rectifying subfamily J, member 12(KCNJ12 , marker 8238), potassium channel, inwardly rectifying subfamily J, member 12(KCNJ12, marker 8239), potassium channel, inwardly rectifying subfamily J, member 12 /// potassium channel, inwardly rectifying subfamily J, member 18(KCNJ12 /// KCNJ18, marker 8240), potassium channel, inwardly rectifying subfamily J, member 12 /// potassium channel, inwardly rectifying subfamily J, member 18(KCNJ12 /// KCNJ18, marker 8241), potassium channel, inwardly rectifying subfamily J, member 13 (KCNJ13, marker 8242), potassium channel, inwardly rectifying subfamily J, member 13(KCNJ13, marker 8243), potassium channel, inwardly rectifying subfamily J, member 14(KCNJ14, marker 8244), potassium channel, inwardly rectifying subfamily J, member 15(KCNJ15, marker 8245), potassium channel, inwardly rectifying subfamily J, member 15(KCNJ15, marker 8246), potassium channel, inwardly rectifying subfamily J, member 15(KCNJ15, marker 8247), potassium channel, inwardly rectifying subfamily J, member 15(KCNJ15, marker 8248), potassium channel, inwardly rectifying subfamily J, member 15(KCNJ15, marker 8249), potassium channel, inwardly rectifying subfamily J, member 16(KCNJ16, marker 8250), KCNJ2 antisense RNA 1 (head to head)(KCNJ2-AS1, marker 8251), potassium channel, inwardly rectifying subfamily J, member 3(KCNJ3, marker 8252), potassium channel, inwardly rectifying subfamily J, member 3(KCNJ3, marker 8253), potassium channel, inwardly rectifying subfamily J, member 3(KCNJ3, marker 8254), potassium channel, inwardly rectifying subfamily J, member 4(KCNJ4, marker 8255), potassium channel, inwardly rectifying subfamily J, member 5(KCNJ5, marker 8256), potassium channel, inwardly rectifying subfamily J, member 5(KCNJ5, marker 8257), potassium channel, inwardly rectifying subfamily J, member 5(KCNJ5, marker 8258), potassium channel, inwardly rectifying subfamily J, member 5(KCNJ5, marker 8259), potassium channel, inwardly rectifying subfamily J, member 5(KCNJ5, marker 8260), potassium channel, inwardly rectifying subfamily J, member 5(KCNJ5, marker 8261), potassium channel, inwardly rectifying subfamily J, member 6(KCNJ6, marker 8262), potassium channel , inwardly rectifying subfamily J, member 6(KCNJ6, marker 8263), potassium channel, inwardly rectifying subfamily J, member 8(KCNJ8, marker 8264), potassium channel, inwardly rectifying subfamily J, member 8(KCNJ8, marker 8265), potassium channel, inwardly rectifying subfamily J, member 9(KCNJ9, marker 8266), potassium channel, inwardly rectifying subfamily J, member 9(KCNJ9, marker 8267), potassium channel, two pore domain subfamily K, member 1(KCNK1, marker 8268) ,potassium channel, two pore domain subfamily K, member 1(KCNK1,marker 8269),potassium channel, two pore domain subfamily K, member 10(KCNK10,marker 8270),potassium channel, two pore domain subfamily K, member 10(KCNK10 , marker 8271), potassium channel, two pore domain subfamily K, member 13(KCNK13, marker 8272), potassium channel, two pore domain subfamily K, member 15(KCNK15, marker 8273), potassium channel, two pore domain subfamily K, member 15(KCNK15, marker 8274), potassium channel, two pore domain subfamily K, member 16(KCNK16, marker 8275), potassium channel, two pore domain subfamily K, member 2(KCNK2, marker 8276), potassium channel, two pore domain subfamily K, member 3(KCNK3, marker 8277), potassium channel, two pore domain subfamily K, member 3(KCNK3, marker 8278), potassium channel, two pore domain subfamily K, member 3(KCNK3, marker 8279), potassium channel, two pore domain subfamily K, member 4(KCNK4, marker 8280), potassium channel, two pore domain subfamily K, member 7(KCNK7, marker 8281), potassium channel, two pore domain subfamily K, member 7(KCNK7, marker 8282), potassium channel, two pore domain subfamily K, member 7(KCNK7, marker 8283), potassium channel, two pore domain subfamily K, member 9(KCNK9, marker 8284), potassium channel, two pore domain subfamily K, member 9 (KCNK9, marker 8285), potassium channel, calcium activated large conductance subfamily M alpha, member 1(KCNMA1, marker 8286), potassium channel, calcium activated large conductance subfamily M alpha, member 1(KCNMA1, marker 8287), potassium channel, calcium activated large conductance subfamily M alpha, member 1(KCNMA1, marker 8288), KCNMA1 antisense RNA 1(KCNMA1-AS1, marker 8289), potassium channel subfamily M regulator
y beta subunit 1 (KCNMB1, marker 8290), potassium channel subfamily M regulatory beta subunit 2 (KCNMB2, marker 8291), potassium channel subfamily M regulatory beta subunit 2 (KCNMB2, marker 8292), KCNMB2 antisense RNA 1 (KCNMB2-AS1, marker 8293), potassium activated intermediate/small conductance subfamily N alpha, member 1(KCNN1, marker 8294), potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3(KCNN3, marker 8295), potassium channel , calcium activated intermediate/small conductance subfamily N alpha, member 3(KCNN3,marker 8296),potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3(KCNN3,marker 8297),potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3(KCNN3, marker 8298), potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4(KCNN4, marker 8299), potassium channel, voltage gated KQT-like subfamily Q, member 1( KCNQ1, marker 8300), potassium channel, voltage gated KQT-like subfamily Q, member 1(KCNQ1, marker 8301), KCNQ1 antisense RNA 1(KCNQ1-AS1, marker 8302), KCNQ1 downstream neighbor (non-protein coding)(KCNQ1DN ,marker 8303),KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)(KCNQ1OT1,marker 8304),KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)(KCNQ1OT1,marker 8305),KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)(KCNQ1OT1, marker 8306), KCNQ1 opposite strand/antisense transcript 1 (non-protein coding)(KCNQ1OT1, marker 8307), potassium channel, voltage gated KQT-like subfamily Q, member 2(KCNQ2 , marker 8308), potassium channel, voltage gated KQT-like subfamily Q, member 2(KCNQ2, marker 8309), potassium channel, voltage gated KQT-like subfamily Q, member 3(KCNQ3, marker 8310), potassium channel, voltage gated KQT-like subfamily Q, member 3(KCNQ3, marker 8311), potassium channel, voltage gated KQT-like subfamily Q, member 3(KCNQ3, marker 8312), potassium channel, voltage gated KQT-like subfamily Q, member 4(KCNQ4 , marker 8313), potassium channel, voltage gated KQT-like subfamily Q, member 5(KCNQ5, marker 8314), potassium channel, voltage gated KQT-like subfamily Q, member 5(KCNQ5, marker 8315), potassium channel regulator(KCNRG , marker 8316), potassium channel regulator /// tripartite motif containing 13(KCNRG /// TRIM13, marker 8317), potassium voltage-gated channel, modifier subfamily S, member 2(KCNS2, marker 8318), potassium voltage-gated channel , modifier subfamily S, member 2(KCNS2, marker 8319), potassium voltage-gated channel, modifier subfamily S, member 2(KCNS2, marker 8320), potassium channel, sodium activated subfamily T, member 1(KCNT1, marker 8321), potassium channel, sodium activated subfamily T, member 1(KCNT1, marker 8322),potassium channel, sodium activated subfamily T, member 1(KCNT1,marker 8323),potassium channel, subfamily U, member 1(KCNU1,marker 8324),potassium channel, voltage gated modifier subfamily V, member 1(KCNV1,marker 8325),potassium channel, voltage gated modifier subfamily V, member 1(KCNV1,marker 8326),potassium channel, voltage gated modifier subfamily V, member 2(KCNV2,marker 8327), kielin/chordin-like protein(KCP, marker 8328), kielin/chordin-like protein(KCP, marker 8329), potassium channel tetramerization domain containing 1(KCTD1, marker 8330), potassium channel tetramerization domain containing 1(KCTD1 , marker 8331), potassium channel tetramerization domain containing 15(KCTD15, marker 8332), potassium channel tetramerization domain containing 16(KCTD16, marker 8333), potassium channel tetramerization domain containing 16(KCTD16, marker 8334), potassium channel tetramerization domain containing 17 (KCTD17, Marker 8335), potassium channel tetramerization domain containing 19(KCTD19, Marker 8336), potassium channel tetramerization domain containing 4(KCTD4, Marker 8337), potassium channel tetramerization domain containing 4(KCTD4, Marker 8338), potassium channel tetramerization domain containing 5 (KCTD5, marker 8339), potassium channel tetramerization domain containing 7 (KCTD7, marker 8340), lysine (K)-specific demethylase 1B (KDM1B, marker 8341), lysine (K)-specific demethylase 3A (KDM3A, marker 8342) ), lysine (K)-specific demethylase 4B (KDM4B, marker 8343), lysine (K)-specific demethylase 4B (KDM4B, marker 8344), lysine (K)-specific demethylase 4B (KDM4B, marker 8345), lysine (K )-specific demethylase 4B /// FLJ00291 protein(KDM4B /// LOC100507022, marker 8346), lysine (K)-specific demethylase 4C (KDM4C, marker 8347), lysine (K)-specific demethylase 4C (KDM4C, marker 8348) ,lysine (K)-specific demethylase 4D (KDM4D, marker 8349), lysine (K)-specific demethylase 4D (KDM4D, marker 8350), lysine (K)-specific demethylase 5A (KDM5A, marker 8351), lysine (K) -specific demethylase 5B (KDM5B, marker 8352), lysine (K)-specific demethylase 5D (KDM5D, marker 8353), lysine (K)-specific demethylase 6B (KDM6B, marker 8354), lysine (K)-specific demethylase 6B ( KDM6B, marker 8355), lysine (K)-specific demethylase 8 (KDM8, marker 8356), lysine (K)-specific demethylase 8 (KDM8, marker 8357), lysine (K)-specific demethylase 8 (KDM8, marker 8358) , 3-ketodihydrosphingosine reductase (KDSR, marker 8359), Kell blood group, metallo-endopeptidase (KEL, marker 8360), keratocan (KERA, marker 8361), keratinocyte growth factor-like protein 2 (KGFLP2, marker 8362), KH homology domain containing 1(KHDC1, marker 8363),KH homology domain containing 1-like(KHDC1L, marker 8364),KH domain containing 3-like, subcortical maternal complex member(KHDC3L, marker 8365),KH domain containing, RNA binding, signal transduction associated 3 (KHDRBS3, marker 8366), ketohexokinase (KHK, marker 8367), KH-type splicing regulatory protein (KHSRP, marker 8368), KIAA0087 (KIAA0087, marker 8369), KIAA0125 (KIAA0125, marker 8370), KIAA0125 (KIAA0125) , marker 8371), KIAA0141 (KIAA0141, marker 8372), KIAA0319 (KIAA0319, marker 8373), KIAA0408 (KIAA0408, marker 8374), KIAA0430 (KIAA0430, marker 8375), uncharacterized LOC57235 (KIAA0485, marker 8376), uncharacterized LOC57235(KIAA0485 , marker 8377), uncharacterized LOC57242 (KIAA0509, marker 8378), KIAA0513 (KIAA0513, marker 8379), KIAA0513 (KIAA0513, marker 8380), KIAA0754 (KIAA0754, marker 8381), KIAA0754 /// microtubule-actin crosslinking factor 1 (KIAA07) 54 /// MACF1, marker 8382), KIAA0754 /// microtubule-actin crosslinking factor 1(KIAA0754 /// MACF1, marker 8383), KIAA0825(KIAA0825, marker 8384), KIAA0825(KIAA0825, marker 8385), KIAA1024(KIAA1024, Marker 8386), KIAA1107 (KIAA1107, Marker 8387), KIAA1109 (KIAA1109, Marker 8388), KIAA1109 (KIAA1109, Marker 8389), KIAA1109 (KIAA1109, Marker 8390), KIAA1109 (KIAA1109, Marker 8391), KIAA1109 (KIAA 1109, marker 8392 ), KIAA1161 (KIAA1161, marker 8393), KIAA1210 (KIAA1210, marker 8394), KIAA1211 (KIAA1211, marker 8395), KIAA1211-LIKE (KIAA1211L, marker 8396) , KIAA1211-LIKE (KIAA1211L, marker 8397), KIAA1211-LIKE ( KIAA1211L, marker 8398), KIAA1217 (KIAA1217, marker 8399), KIAA1217 (KIAA1217, marker 8400), KIAA1217 (KIAA1217, marker 8401), KIAA1257 (KIAA1257, marker 8402), KIAA1257 /// uncharacterized LOC100132731 (KIAA1257 /// LOC100132731 , marker 8403), KIAA1324(KIAA1324, marker 8404), KIAA1324(KIAA1324, marker 8405), KIAA1324(KIAA1324, marker 8406), KIAA1328(KIAA1328, marker 8407), KIAA1429(KIAA1429, marker 8408), KIAA1456(KI AA1456, marker 8409), KIAA1456(KIAA1456, marker 8410), KIAA1456(KIAA1456, marker 8411), KIAA1456(KIAA1456, marker 8412), KIAA1462(KIAA1462, marker 8413), KIAA1462(KIAA1462, marker 8414), KIAA1549-like(KI AA1549L, marker 8415), KIAA1614 (KIAA1614, marker 8416), KIAA1614 antisense RNA 1 /// syntaxin 6 (KIAA1614-AS1 /// STX6, marker 8417), KIAA1652 protein (KIAA1652, marker 8418), KIAA1652 protein (KIAA1652, marker 8419) ,KIAA1654 protein(KIAA1654, marker 8420),KIAA1654 protein(KIAA1654,marker 8421),KIAA1656 protein /// ring finger protein 215(KIAA1656 /// RNF215,marker 8422),KIAA1656 protein /// ring finger protein 215(KIAA1656 /// RNF215, marker 8423), KIAA1671 (KIAA1671, marker 8424), KIAA1671 (KIAA1671, marker 8425), KIAA1683 (KIAA1683, marker 8426), KIAA1683 (KIAA1683, marker 8427), KIAA1755 (KIAA1755, marker 8428), KIAA 1755 (KIAA1755, marker 8429), KIAA1841 (KIAA1841, marker 8430), KIAA2012 (KIAA2012, marker 8431), KIAA2022 (KIAA2022, marker 8432), KIAA2022 (KIAA2022, marker 8433), KIAA2022 (KIAA2022, marker 8434), KIAA 2026(KIAA2026 , marker 8435), kinase D-interacting substrate 220kDa (KIDINS220, marker 8436), kinase D-interacting substrate 220kDa (KIDINS220, marker 8437), kinase D-interacting substrate 220kDa (KIDINS220, marker 8438), kinesin family member 12 (KIF12) , marker 8439), kinesin family member 17 (KIF17, marker 8440), kinesin family member 19 (KIF19, marker 8441), kinesin family member 19 (KIF19, marker 8442), kinesin family member 1A (KIF1A, marker 8443), kinesin family member 1B (KIF1B, marker 8444), kinesin family member 20B (KIF20B, marker 8445), kinesin family member 20B (KIF20B, marker 8446), kinesin family member 24 (KIF24, marker 8447), kinesin family member 25 (KIF25, marker 8448), kinesin family member 25 (KIF25, marker 8449), KIF25 antisense RNA 1 (KIF25-AS1, marker 8450), KIF25 antisense RNA 1 (KIF25-AS1, marker 8451), KIF25 antisense RNA 1 (KIF25-AS1, marker 8452), kinesin family member 26B (KIF26B, marker 8453), kinesin family member 26B (KIF26B, marker 8454), kinesin family member 27 (KIF27, marker 8455), kinesin heavy chain member 2A (KIF2A, marker 8456), kinesin family member 2B (KIF2B, marker 8457), kinesin family member 5A (KIF5A, marker 8458), kinesin family member 5A (KIF5A, marker 8459), kinesin family member 5A (KIF5A, marker 8460), kinesin family member 6 (KIF6, marker 8461), kinesin family member 6(KIF6, marker 8462), kinesin family member 6(KIF6, marker 8463), kinesin family member 6(KIF6, marker 8464), kinesin family member 6(KIF6, marker 8465), kinesin family member 9 (KIF9, marker 8466), KIF9 antisense RNA 1 (KIF9-AS1, marker 8467), kinesin family member C3 (KIFC3, marker 8468), kinesin family member C3 (KIFC3, marker 8469), Kin17 DNA and RNA binding protein (KIN, marker 8470), killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 /// killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 /// killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 /// killer cell immunoglobulin-like receptor, two domains, pseudogene 1 /// killer cell immunoglobulin-like
receptor, two domains, short cytoplasmic tail, 1 /// killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2 /// killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 /// killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 /// killer cell immunoglobulin-like receptor 2DL2 /// killer cell immunoglobulin-like receptor 2DS1 /// killer cell immunoglobulin-like receptor 2DS1(KIR2DL1 /// KIR2DL2 /// KIR2DL3 /// KIR2DP1 /// KIR2DS1 /// KIR2DS2 /// KIR2DS4 /// KIR3DL1 /// LOC105379645 /// LOC105379650 /// LOC105379662, marker 8471), killer cell immunoglobulin-like receptor, two domains , long cytoplasmic tail, 1 /// killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 /// killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 /// killer cell immunoglobulin-like receptor 2DL2(KIR2DL1 /// KIR2DL2 /// KIR2DL3 /// LOC105379645, marker 8472), killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 /// killer cell immunoglobulin-like receptor 2DL2(KIR2DL2 // / LOC105379645, marker 8473), killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3(KIR2DL3, marker 8474), killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4(KIR2DL4, marker 8475) ,killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4(KIR2DL4, marker 8476),killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4(KIR2DL4, marker 8477),killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5A /// killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 5B(KIR2DL5A /// KIR2DL5B, marker 8478),killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 /// killer cell immunoglobulin-like receptor 2DS1 /// killer cell immunoglobulin-like receptor 2DS1(KIR2DS1 /// LOC105379650 /// LOC105379662, marker 8479), killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2(KIR2DS2, marker 8480),killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 3 /// killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5 /// killer cell immunoglobulin -like receptor 2DS3 allele 0020101 /// killer cell immunoglobulin-like receptor 2DS3(KIR2DS3 /// KIR2DS5 /// LOC102725023 /// LOC105369139, marker 8481), killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4 (KIR2DS4, marker 8482),killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 4(KIR2DS4,marker 8483),killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5(KIR2DS5,marker 8484) ,killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1(KIR3DL1,marker 8485),killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 /// killer cell immunoglobulin-like receptor, three domains , long cytoplasmic tail, 2(KIR3DL1 /// KIR3DL2, marker 8486),killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 /// killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL1 /// KIR3DL2, marker 8487), killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 /// killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2(KIR3DL1 /// KIR3DL2 ,marker 8488),killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2(KIR3DL2,marker 8489),killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 3(KIR3DL3,marker 8490),killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1(KIR3DS1, marker 8491),killer cell immunoglobulin-like receptor, three domains, X1(KIR3DX1, marker 8492),killer cell immunoglobulin-like receptor, three domains, X1 (KIR3DX1, Marker 8493),kin of IRRE like (Drosophila)(KIRREL, Marker 8494),kin of IRRE like 2 (Drosophila)(KIRREL2, Marker 8495),kin of IRRE like 3 (Drosophila)(KIRREL3, Marker 8496) ,KIRREL3 antisense RNA 2(KIRREL3-AS2, marker 8497),KIRREL3 antisense RNA 3(KIRREL3-AS3, marker 8498),KiSS-1 metastasis-suppressor(KISS1,marker 8499),KIT ligand(KITLG,marker 8500),KIT ligand (KITLG, marker 8501), KIT ligand (KITLG, marker 8502), KIZ antisense RNA 1 (KIZ-AS1, marker 8503), KIZ antisense RNA 1 (KIZ-AS1, marker 8504), klotho (KL, marker 8505) , klotho beta (KLB, marker 8506), klotho beta (KLB, marker 8507), kinesin light chain 1 (KLC1, marker 8508), kinesin light chain 3 (KLC3, marker 8509), kinesin light chain 3 (KLC3, marker 8510) ), kinesin light chain 4 (KLC4, marker 8511), Kruppel-like factor 1 (erythroid) (KLF1, marker 8512), Kruppel-like factor 11 (KLF11, marker 8513), Kruppel-like factor 12 (KLF12, marker 8514 ), Kruppel-like factor 12 (KLF12, marker 8515), Kruppel-like factor 12 (KLF12, marker 8516), Kruppel-like factor 12 (KLF12, marker 8517), Kruppel-like factor 13 (KLF13, marker 8518), Kruppel-like factor 13 /// proline-rich protein HaeIII subfamily 1-like(KLF13 /// LOC105370939, marker 8519), Kruppel-like factor 14(KLF14, marker 8520), Kruppel-like factor 14(KLF14, marker 8521 ), Kruppel-like factor 17 (KLF17, marker 8522), Kruppel-like factor 18 (KLF18, marker 8523), Kruppel-like factor 2 (KLF2, marker 8524), Kruppel-like factor 2 (KLF2, marker 8525), KLF3 antisense RNA 1 (KLF3-AS1, marker 8526), KLF3 antisense RNA 1 (KLF3-AS1, marker 8527), Kruppel-like factor 4 (gut) (KLF4, marker 8528), Kruppel-like factor 9 (KLF9, marker 8529), Kruppel-like factor 9 (KLF9, marker 8530), Kruppel-like factor 9 (KLF9, marker 8531), Kruppel-like factor 9 (KLF9, marker 8532), Kruppel-like factor 9 (KLF9, marker 8533) ,kelch domain containing 1(KLHDC1, marker 8534),kelch domain containing 1(KLHDC1,marker 8535),kelch domain containing 10(KLHDC10,marker 8536),kelch domain containing 4(KLHDC4,marker 8537),kelch domain containing 4 / // uncharacterized LOC105371397(KLHDC4 /// LOC105371397, marker 8538), kelch domain containing 7B(KLHDC7B, marker 8539), kelch domain containing 7B(KLHDC7B, marker 8540), kelch-like family member 1(KLHL1, marker 8541), kelch-like family member 1(KLHL1, marker 8542),kelch-like family member 10(KLHL10, marker 8543),kelch-like family member 10(KLHL10, marker 8544),kelch-like family member 11(KLHL11, marker 8545 ),kelch-like family member 14(KLHL14, marker 8546),kelch-like family member 14(KLHL14, marker 8547),kelch-like family member 17(KLHL17, marker 8548),kelch-like family member 18(KLHL18, marker 8549), kelch-like family member 20 (KLHL20, marker 8550), kelch-like family member 22 (KLHL22, marker 8551), kelch-like family member 22 (KLHL22, marker 8552), kelch-like family member 23 / // phosphatase, orphan 2 /// PHOSPHO2-KLHL23 readthrough(KLHL23 /// PHOSPHO2 /// PHOSPHO2-KLHL23, marker 8553), kelch-like family member 23 /// PHOSPHO2-KLHL23 readthrough(KLHL23 /// PHOSPHO2- KLHL23, marker 8554), kelch-like family member 24 (KLHL24, marker 8555), kelch-like family member 28 (KLHL28, marker 8556), kelch-like family member 29 (KLHL29, marker 8557), kelch-like family member 29 (KLHL29, marker 8558), kelch-like family member 29 (KLHL29, marker 8559), kelch-like family member 3 (KLHL3, marker 8560), KLHL30 antisense RNA 1 /// uncharacterized LOC105369287 (KLHL30-AS1 /// LOC105369287, marker 8561), kelch-like family member 31 (KLHL31, marker 8562), kelch-like family member 31 (KLHL31, marker 8563), kelch-like family member 32 (KLHL32, marker 8564), kelch-like family member 34 (KLHL34, marker 8565), kelch-like family member 34 (KLHL34, marker 8566), kelch-like family member 35 (KLHL35, marker 8567), kelch-like family member 35 (KLHL35, marker 8568), kelch-like family member 35 (KLHL35, marker 8569), kelch-like family member 36 (KLHL36, marker 8570), kelch-like family member 40 (KLHL40, marker 8571), kelch-like family member 41 (KLHL41, marker 8572), kelch -like family member 41(KLHL41, marker 8573),kelch-like family member 5(KLHL5, marker 8574),kelch-like family member 6(KLHL6, marker 8575),kelch-like family member 6(KLHL6, marker 8576) ,kelch-like family member 6(KLHL6, marker 8577),kelch-like family member 6(KLHL6, marker 8578),kelch-like family member 8(KLHL8, marker 8579),kelch-like family member 9(KLHL9, marker 8580), kelch-like family member 9 (KLHL9, marker 8581), kallikrein 1 (KLK1, marker 8582), kallikrein related peptidase 10 (KLK10, marker 8583), kallikrein related peptidase 10 (KLK10, marker 8584), kallikrein related peptidase 11 (KLK11, marker 8585), kallikrein related peptidase 12 (KLK12, marker 8586), kallikrein related peptidase 12 (KLK12, marker 8587), kallikrein related peptidase 13 (KLK13, marker 8588), kallikrein related peptidase 13 (KLK13, marker 8589 ), kallikrein related peptidase 14 (KLK14, marker 8590), kallikrein related peptidase 15 (KLK15, marker 8591), kallikrein related peptidase 15 (KLK15, marker 8592), kallikrein related peptidase 15 (KLK15, marker 8593), kallikrein related peptidase 15 (KLK15, marker 8594), kallikrein related peptidase 2 (KLK2, marker 8595), kallikrein related peptidase 2 (KLK2, marker 8596), kallikrein related peptidase 2 (KLK2, marker 8597), kallikrein related peptidase 2 (KLK2, marker 8598) ,kallikrein related peptidase 3(KLK3, marker 8599),kallikrein related peptidase 3(KLK3, marker 8600),kallikrein related peptidase 4(KLK4, marker 8601),kallikrein related peptidase 4(KLK4, marker 8602),kallikrein related peptidase 4( KLK4, marker 8603), kallikrein related peptidase 4 (KLK4, marker 8604), kallikrein related peptidase 4 (KLK4, marker 8605), kallikrein related peptidase 5 (KLK5, marker 8606), kallikrein related peptidase 6 (KLK6, marker 8607), kallikrein related peptidase 7(KLK7, marker 8608),kallikrein related peptidase 7(KLK7, marker 8609),kallikrein related peptidase 8(KLK8, marker 8610),kallikrein related peptidase 8 /// kallikrein related peptidase 9(KLK8 /// KLK9 , marker 8611), killin, p53-regulated DNA replication inhibitor (KLLN, marker 8612), killer cell lectin-like receptor subfamily A pseudogene 1 (KLRAP1, marker 8613), killer cell lectin-like receptor subfamily B, member 1 (KLRB1 , marker 8614), killer cell lectin-like receptor subfamily C, member 1 /// killer cell lectin-like receptor subfamily C, member 2(KLRC1 /// KLRC2, marker 8615), killer cell lectin-like receptor subfamily C, member 3(KLRC3, marker 8616),kil
ler cell lectin-like receptor subfamily C, member 4(KLRC4, marker 8617),KLRC4-KLRK1 readthrough /// killer cell lectin-like receptor subfamily K, member 1(KLRC4-KLRK1 /// KLRK1, marker 8618),KLRC4 -KLRK1 readthrough /// killer cell lectin-like receptor subfamily K, member 1(KLRC4-KLRK1 /// KLRK1, marker 8619),killer cell lectin-like receptor subfamily D, member 1(KLRD1, marker 8620),killer cell lectin-like receptor subfamily D, member 1(KLRD1, marker 8621),killer cell lectin-like receptor subfamily D, member 1(KLRD1, marker 8622),killer cell lectin-like receptor subfamily F, member 1(KLRF1, marker 8623 ),kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)(KMO, marker 8624),kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)(KMO, marker 8625),kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)(KMO, marker 8626), lysine (K)-specific methyltransferase 2A (KMT2A, marker 8627), lysine (K)-specific methyltransferase 2A (KMT2A, marker 8628), lysine (K)-specific methyltransferase 2A (KMT2A, marker 8629), lysine ( K)-specific methyltransferase 2B (KMT2B, marker 8630), lysine (K)-specific methyltransferase 2B (KMT2B, marker 8631), lysine (K)-specific methyltransferase 2C (KMT2C, marker 8632), lysine (K)-specific methyltransferase 2C (KMT2C, marker 8633), lysine (K)-specific methyltransferase 2D (KMT2D, marker 8634), lysine (K)-specific methyltransferase 2D (KMT2D, marker 8635), lysine (K)-specific methyltransferase 2D (KMT2D, marker 8636), KMT2E antisense RNA 1 (head to head) (KMT2E-AS1, marker 8637), lysine (K)-specific methyltransferase 5C (KMT5C, marker 8638), kinocilin (KNCN, marker 8639), kinase non-catalytic C- lobe domain (KIND) containing 1(KNDC1, marker 8640),kinase non-catalytic C-lobe domain (KIND) containing 1(KNDC1, marker 8641),kininogen 1(KNG1, marker 8642),kininogen 1(KNG1, marker 8643 ), kininogen 1 (KNG1, marker 8644), karyopherin alpha 4 (importin alpha 3) (KPNA4, marker 8645), Kirsten rat sarcoma viral oncogene homolog (KRAS, marker 8646), Kirsten rat sarcoma viral oncogene homolog (KRAS, marker 8647) ), Kirsten rat sarcoma viral oncogene homolog(KRAS, marker 8648),KRAB-A domain containing 2(KRBA2, marker 8649),KRAB box domain containing 1(KRBOX1, marker 8650),KRBOX1 antisense RNA 1(KRBOX1-AS1, marker 8651),kringle containing transmembrane protein 1(KREMEN1, marker 8652),kringle containing transmembrane protein 1(KREMEN1, marker 8653),kringle containing transmembrane protein 1(KREMEN1, marker 8654),kringle containing transmembrane protein 1(KREMEN1, marker 8655) ,kringle containing transmembrane protein 2(KREMEN2, marker 8656),KRR1, small subunit (SSU) processome component, homolog (yeast)(KRR1,marker 8657),KRR1, small subunit (SSU) processome component, homolog (yeast)(KRR1 ,marker 8658),KRR1, small subunit (SSU) processome component, homolog (yeast)(KRR1,marker 8659),keratin 1, type II(KRT1,marker 8660),keratin 12, type I(KRT12,marker 8661), keratin 13, type I(KRT13, marker 8662),keratin 14, type I(KRT14, marker 8663),keratin 15, type I(KRT15, marker 8664),keratin 16, type I(KRT16, marker 8665),keratin 17 pseudogene 5 (KRT17P5, marker 8666), keratin 19, type I (KRT19, marker 8667), keratin 19 pseudogene 2 (KRT19P2, marker 8668), keratin 19 pseudogene 2 (KRT19P2, marker 8669), keratin 2, type II (KRT2 , marker 8670), keratin 20, type I (KRT20, marker 8671), keratin 222, type II (KRT222, marker 8672), keratin 222, type II (KRT222, marker 8673), keratin 223 pseudogene (KRT223P, marker 8674) ,keratin 23, type I(KRT23,marker 8675),keratin 24, type I(KRT24,marker 8676),keratin 25, type I(KRT25,marker 8677),keratin 27, type I(KRT27,marker 8678),keratin 3, type II (KRT3, marker 8679), keratin 31, type I (KRT31, marker 8680), keratin 32, type I (KRT32, marker 8681), keratin 33A, type I (KRT33A, marker 8682), keratin 33B, type I(KRT33B, marker 8683),keratin 34, type I /// keratin, type I cuticular Ha4(KRT34 /// LOC100653049, marker 8684),keratin 35, type I(KRT35, marker 8685),keratin 36, type I(KRT36, marker 8686),keratin 37, type I(KRT37, marker 8687),keratin 38, type I(KRT38, marker 8688),keratin 4, type II(KRT4, marker 8689),keratin 4, type II( KRT4, marker 8690), keratin 40, type I(KRT40, marker 8691),keratin 40, type I(KRT40, marker 8692),keratin 5, type II(KRT5, marker 8693),keratin 6A, type II(KRT6A, marker 8694), keratin 6A, type II /// keratin 6B, type II /// keratin 6C, type II(KRT6A /// KRT6B /// KRT6C, marker 8695), keratin 6B, type II(KRT6B, marker 8696 ),keratin 7, type II(KRT7, marker 8697),keratin 71, type II(KRT71,marker 8698),keratin 72, type II(KRT72,marker 8699),keratin 73, type II(KRT73,marker 8700), keratin 73, type II(KRT73, marker 8701),keratin 74, type II(KRT74, marker 8702),keratin 74, type II(KRT74, marker 8703),keratin 75, type II(KRT75, marker 8704),keratin 76 , type II(KRT76, marker 8705),keratin 77, type II(KRT77,marker 8706),keratin 78, type II(KRT78,marker 8707),keratin 78, type II(KRT78,marker 8708),keratin 79, type II (KRT79, marker 8709), keratin 80, type II (KRT80, marker 8710), keratin 81, type II (KRT81, marker 8711), keratin 82, type II (KRT82, marker 8712), keratin 83, type II( KRT83, marker 8713), keratin 84, type II (KRT84, marker 8714), keratin 85, type II (KRT85, marker 8715), keratin 86, type II (KRT86, marker 8716), keratin 8 pseudogene 11 (KRT8P11, marker 8717), keratin 9, type I (KRT9, marker 8718), keratin associated protein 1-1 (KRTAP1-1, marker 8719), keratin associated protein 1-3 (KRTAP1-3, marker 8720), keratin associated protein 1- 3 (KRTAP1-3, marker 8721), keratin associated protein 1-5 (KRTAP1-5, marker 8722), keratin associated protein 10-11 (KRTAP10-11, marker 8723), keratin associated protein 10-12 (KRTAP10-12 , marker 8724), keratin associated protein 11-1 (KRTAP11-1, marker 8725), keratin associated protein 13-1 (KRTAP13-1, marker 8726), keratin associated protein 17-1 (KRTAP17-1, marker 8727), keratin associated protein 19-1 (KRTAP19-1, marker 8728), keratin associated protein 19-3 (KRTAP19-3, marker 8729), keratin associated protein 2-1 (KRTAP2-1, marker 8730), keratin associated protein 2- 2 (KRTAP2-2, marker 8731), keratin associated protein 2-3 (KRTAP2-3, marker 8732), keratin associated protein 2-4 (KRTAP2-4, marker 8733), keratin associated protein 3-1 (KRTAP3-1) , marker 8734), keratin associated protein 3-2 (KRTAP3-2, marker 8735), keratin associated protein 3-3 (KRTAP3-3, marker 8736), keratin associated protein 4-1 (KRTAP4-1, marker 8737), keratin associated protein 4-11 (KRTAP4-11, marker 8738), keratin associated protein 4-12 (KRTAP4-12, marker 8739), keratin associated protein 4-2 (KRTAP4-2, marker 8740), keratin associated protein 4- 3 (KRTAP4-3, marker 8741), keratin associated protein 4-4 (KRTAP4-4, marker 8742), keratin associated protein 4-5 (KRTAP4-5, marker 8743), keratin associated protein 4-6 (KRTAP4-6 ,marker 8744),keratin associated protein 4-7 /// keratin-associated protein 4-7(KRTAP4-7 /// LOC100996750,marker 8745),keratin associated protein 4-8(KRTAP4-8,marker 8746),keratin protein associated protein 4-9(KRTAP4-9, marker 8747),keratin associated protein 5-2(KRTAP5-2, marker 8748),keratin associated protein 5-8(KRTAP5-8, marker 8749),keratin associated protein 5-9 (KRTAP5-9, marker 8750), KRTAP5-1/KRTAP5-2 antisense RNA 1 (KRTAP5-AS1, marker 8751), KRTAP5-1/KRTAP5-2 antisense RNA 1 (KRTAP5-AS1, marker 8752), keratin associated protein 7-1 (gene/pseudogene)(KRTAP7-1, marker 8753), keratin associated protein 8-1(KRTAP8-1, marker 8754), keratin associated protein 9-2 /// keratin associated protein 9-8(KRTAP9- 2 /// KRTAP9-8, marker 8755), keratin associated protein 9-3 (KRTAP9-3, marker 8756), keratin associated protein 9-4 (KRTAP9-4, marker 8757), keratin associated protein 9-8 (KRTAP9 -8, Marker 8758), keratin associated protein 9-9 (KRTAP9-9, Marker 8759), keratinocyte differentiation-associated protein (KRTDAP, Marker 8760), Kinase suppressor of ras 1 (KSR1, Marker 8761), Kinase suppressor of ras 1(KSR1, marker 8762),kinase suppressor of ras 1(KSR1, marker 8763),kinase suppressor of ras 2(KSR2, marker 8764),kinase suppressor of ras 2(KSR2, marker 8765),KxDL motif containing 1(KXD1 , marker 8766), KxDL motif containing 1(KXD1, marker 8767), kyphoscoliosis peptidase(KY, marker 8768), kyphoscoliosis peptidase(KY, marker 8769), kyphoscoliosis peptidase(KY, marker 8770), kyphoscoliosis peptidase(KY, marker 8771) ), kynureninase (KYNU, marker 8772), kynureninase (KYNU, marker 8773), kynureninase (KYNU, marker 8774), L1 cell adhesion molecule (L1CAM, marker 8775), L-2-hydroxyglutarate dehydrogenase (L2HGDH, marker 8776), l(3)mbt-like 1 (Drosophila)(L3MBTL1, marker 8777),l(3)mbt-like 1 (Drosophila)(L3MBTL1, marker 8778),l(3)mbt-like 1 (Drosophila)(L3MBTL1, marker 8779), l(3)mbt-like 4 (Drosophila)(L3MBTL4, marker 8780), l(3)mbt-like 4 (Drosophila)(L3MBTL4, marker 8781), L3MBTL4 antisense RNA 1(L3MBTL4-AS1, marker 8782), laccase (multicopper oxidoreductase) domain containing 1(LACC1, marker 8783), laccase (multicopper oxidoreductase) domain containing 1(LACC1, marker 8784), lactation elevated 1(LACE1, marker 8785), lactation elevated 1(LACE1, marker 8782) 8786), lacritin (LACRT, marker 8787), LACTB2 antisense RNA 1 (LACTB2-AS1, marker 8788), lymphocyte-activation gene 3 (LAG3, marker 8789), leukocyte-associated immunoglobulin-like receptor 1 (LAIR1, marker 8790) , leukocyte-associated immunoglobulin-like receptor 1 (LAIR1, marker 8791), leukocyte-associated immunoglobulin-like receptor 2 (LAIR2, marker 8792), lactalbumin, alpha- (LALBA, marker 8793), laminin, alpha 1 (LAMA1, marker 8794), laminin, alpha 2(LAMA2, marker 8795), laminin, alpha 2(LAMA2, marker 8796), laminin, alpha 2(LAMA2, marker 8797), laminin, alpha 2(LAMA2, marker 8798), laminin, alpha 3(LAMA3, marker 8799), laminin, alpha 3(LAMA3, marker 8800), laminin, alpha 3(LAMA3, marker 8801), laminin, alpha 3(LAMA3, marker 8802), laminin, alpha 3(LAMA3, marker 8803 ), laminin, alpha 3(LAMA3, marker 8804), laminin, alpha 4(LAMA4, marker 8805), laminin, alpha 4(LAMA4, marker 8806), laminin, alpha 4(LAMA4, marker 8807), laminin, alpha 4 (LAMA4, marker 8808), laminin, alpha 4 (LAMA4, marker 8809), LAMA5 antisense RNA 1 (LAMA5-AS1, marker 8810), laminin, beta 2 pseudogene 1 (LAMB2P1, marker 8811), laminin, beta 3 (LAMB3) , marker 8812), laminin, beta 4 (LAMB4, marker 8813), laminin, beta 4 (LAMB4, marker 8814), laminin, beta 4 (LAMB4, marker 8815), laminin, gamma 2 (LAMC2, marker 8816), laminin , gamma 3(LAMC3, marker 8817), lysosomal-associated membrane p
rotein 3 (LAMP3, marker 8818), LAMTOR5 antisense RNA 1 (LAMTOR5-AS1, marker 8819), LanC lantibiotic synthetase component C-like 2 (bacterial) (LANCL2, marker 8820), LanC lantibiotic synthetase component C-like 3 (bacterial )(LANCL3, marker 8821), lysosomal protein transmembrane 5(LAPTM5, marker 8822), lysosomal protein transmembrane 5(LAPTM5, marker 8823), like-glycosyltransferase(LARGE, marker 8824), LARGE antisense RNA 1(LARGE-AS1, marker 8825), LARGE antisense RNA 1(LARGE-AS1, marker 8826), LARGE antisense RNA 1(LARGE-AS1, marker 8827), LARGE antisense RNA 1(LARGE-AS1, marker 8828), La ribonucleoprotein domain family, member 1( LARP1, marker 8829), La ribonucleoprotein domain family, member 1B (LARP1B, marker 8830), La ribonucleoprotein domain family, member 4B (LARP4B, marker 8831), La ribonucleoprotein domain family, member 4B (LARP4B, marker 8832), La ribonucleoprotein domain family, member 6(LARP6, marker 8833), LAS1-like, ribosome biogenesis factor(LAS1L, marker 8834), linker for activation of T-cells(LAT, marker 8835), linker for activation of T-cells(LAT, marker 8836), linker for activation of T-cells family member 2(LAT2, marker 8837), linker for activation of T-cells family member 2(LAT2, marker 8838), large tumor suppressor kinase 1(LATS1, marker 8839), large tumor suppressor kinase 1(LATS1, marker 8840),large tumor suppressor kinase 1(LATS1, marker 8841),large tumor suppressor kinase 2(LATS2,marker 8842),large tumor suppressor kinase 2(LATS2,marker 8843),lymphocyte transmembrane adapter 1 (LAX1, marker 8844), layilin (LAYN, marker 8845), layilin (LAYN, marker 8846), lipopolysaccharide binding protein (LBP, marker 8847), lipopolysaccharide binding protein (LBP, marker 8848), ladybird homeobox 1 (LBX1) , marker 8849), LBX1 antisense RNA 1 (head to head) (LBX1-AS1, marker 8850), Leber congenital amaurosis 5 (LCA5, marker 8851), Leber congenital amaurosis 5-like (LCA5L, marker 8852), lung cancer associated lncRNA 1 (LCAL1, marker 8853), lecithin-cholesterol acyltransferase (LCAT, marker 8854), late cornified envelope 1B (LCE1B, marker 8855), late cornified envelope 2B (LCE2B, marker 8856), late cornified envelope 3D (LCE3D, marker 8857), LCMT1 antisense RNA 2 (LCMT1-AS2, marker 8858), LCMT1 antisense RNA 2 (LCMT1-AS2, marker 8859), leucine carboxyl methyltransferase 2 (LCMT2, marker 8860), lipocalin 1 (LCN1, marker 8861), lipocalin 10 (LCN10, marker 8862), lipocalin 12 (LCN12, marker 8863), lipocalin 15 (LCN15, marker 8864), lipocalin 2 (LCN2, marker 8865), lipocalin 6 (LCN6, marker 8866), lipocalin 8 (LCN8, marker 8867), lipocalin 8 (LCN8, marker 8868), lipocalin-like 1 (LCNL1, marker 8869), lipocalin-like 1 (LCNL1, marker 8870), lymphocyte cytosolic protein 2 (LCP2, marker 8871), lymphocyte cytosolic protein 2( LCP2, marker 8872), lymphocyte cytosolic protein 2(LCP2, marker 8873), lymphocyte cytosolic protein 2(LCP2, marker 8874), lymphocyte cytosolic protein 2(LCP2, marker 8875), lymphocyte cytosolic protein 2(LCP2, marker 8876), lactase (LCT, marker 8877), lactase-like (LCTL, marker 8878), LIM domain binding 2 (LDB2, marker 8879), LIM domain binding 3 (LDB3, marker 8880), LIM domain binding 3 (LDB3, marker 8881) ,LIM domain binding 3(LDB3, marker 8882),LIM domain binding 3(LDB3, marker 8883),LIM domain binding 3(LDB3, marker 8884),lactate dehydrogenase A-like 6A(LDHAL6A,marker 8885),lactate dehydrogenase A -like 6B (LDHAL6B, marker 8886), lactate dehydrogenase C (LDHC, marker 8887), lactate dehydrogenase D (LDHD, marker 8888), low density lipoprotein receptor (LDLR, marker 8889), low density lipoprotein receptor (LDLR, marker 8890) ),low density lipoprotein receptor class A domain containing 4(LDLRAD4, marker 8891),low density lipoprotein receptor class A domain containing 4(LDLRAD4, marker 8892),low density lipoprotein receptor class A domain containing 4(LDLRAD4, marker 8893), low density lipoprotein receptor class A domain containing 4 (LDLRAD4, marker 8894), LDLRAD4 antisense RNA 1 (LDLRAD4-AS1, marker 8895), leukocyte cell-derived chemotaxin 2 (LECT2, marker 8896), lymphoid enhancer-binding factor 1 (LEF1) , marker 8897), lymphoid enhancer-binding factor 1 (LEF1, marker 8898), LEF1 antisense RNA 1 (LEF1-AS1, marker 8899), LEF1 antisense RNA 1 (LEF1-AS1, marker 8900), leucine, glutamate and lysine rich 1 (LEKR1, marker 8901), leucine, glutamate and lysine rich 1 (LEKR1, marker 8902), late cornified envelope-like proline-rich 1 (LELP1, marker 8903), LEMD1 antisense RNA 1 (LEMD1-AS1, marker 8904) ,LEMD1 antisense RNA 1 (LEMD1-AS1, marker 8905), lens epithelial protein (LENEP, marker 8906), leukocyte receptor cluster (LRC) member 1 (LENG1, marker 8907), leukocyte receptor cluster (LRC) member 9 (LENG9, marker 8908), leptin (LEP, marker 8909), leptin receptor (LEPR, marker 8910), leptin receptor (LEPR, marker 8911), leptin receptor (LEPR, marker 8912), leptin receptor /// leptin receptor overlapping transcript (LEPR /// LEPROT, marker 8913), leptin receptor overlapping transcript(LEPROT, marker 8914), leucine zipper-EF-hand containing transmembrane protein 1(LETM1, marker 8915), leucine zipper-EF-hand containing transmembrane protein 2(LETM2, marker 8916), leucine zipper-EF-hand containing transmembrane protein 2(LETM2, marker 8917), lymphocyte expansion molecule(LEXM, marker 8918), lectin, galactoside-binding, soluble, 12(LGALS12, marker 8919), lectin, galactoside -binding, soluble, 13(LGALS13, marker 8920), lectin, galactoside-binding, soluble, 14(LGALS14, marker 8921), lectin, galactoside-binding, soluble, 2(LGALS2, marker 8922), lectin, galactoside-binding , soluble, 3(LGALS3, marker 8923), lectin, galactoside-binding, soluble, 4(LGALS4, marker 8924), lectin, galactoside-binding, soluble, 7 /// lectin, galactoside-binding, soluble, 7B(LGALS7 /// LGALS7B, marker 8925), lectin, galactoside-binding, soluble, 8(LGALS8, marker 8926), LGALS8 antisense RNA 1(LGALS8-AS1, marker 8927), lectin, galactoside-binding, soluble, 9(LGALS9, marker 8928), leucine-rich repeat LGI family, member 3(LGI3, marker 8929),leucine-rich repeat LGI family, member 4(LGI4, marker 8930),leucine-rich repeat LGI family, member 4(LGI4, marker 8931) ),leucine-rich repeat containing G protein-coupled receptor 4(LGR4, marker 8932),leucine-rich repeat containing G protein-coupled receptor 4(LGR4, marker 8933),leucine-rich repeat containing G protein-coupled receptor 5( LGR5, marker 8934), leucine-rich repeat containing G protein-coupled receptor 6 (LGR6, marker 8935), lengthsin, lens protein with glutamine synthetase domain (LGSN, marker 8936), luteinizing hormone beta polypeptide (LHB, marker 8937), luteinizing hormone/choriogonadotropin receptor (LHCGR, marker 8938), lipoma HMGIC fusion partner-like 3 (LHFPL3, marker 8939), LHFPL3 antisense RNA 1 (LHFPL3-AS1, marker 8940), LHFPL3 antisense RNA 1 (LHFPL3-AS1, marker 8941) ),LHFPL3 antisense RNA 1 /// uncharacterized LOC105375436(LHFPL3-AS1 /// LOC105375436, marker 8942),LHFPL3 antisense RNA 2(LHFPL3-AS2, marker 8943),lipoma HMGIC fusion partner-like 5(LHFPL5, marker 8944) ,LIM homeobox 1(LHX1, marker 8945),LIM homeobox 3(LHX3, marker 8946),LIM homeobox 4(LHX4, marker 8947),LIM homeobox 4(LHX4, marker 8948),LIM homeobox 4(LHX4, marker 8949) ,LIM homeobox 6(LHX6, marker 8950),LIM homeobox 8(LHX8, marker 8951),LIM homeobox 9(LHX9, marker 8952),LIM homeobox 9(LHX9, marker 8953),LIM homeobox 9(LHX9, marker 8954) ,LIM homeobox 9 (LHX9, marker 8955), leukemia inhibitory factor receptor alpha (LIFR, marker 8956), LIFR antisense RNA 1 (LIFR-AS1, marker 8957), ligase III, DNA, ATP-dependent (LIG3, marker 8958) ,leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1(LILRA1, marker 8959),leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1(LILRA1, marker 8960),leukocyte immunoglobulin- like receptor, subfamily A (with TM domain), member 2(LILRA2, marker 8961),leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2(LILRA2, marker 8962),leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2(LILRA2, marker 8963),leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2(LILRA2, marker 8964),leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3(LILRA3, marker 8965), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 4(LILRA4, marker 8966), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5(LILRA5, marker 8967), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5(LILRA5, marker 8968), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5(LILRA5, marker 8969), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5(LILRA5, marker 8970), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3(LILRA6 /// LILRB2 /// LILRB3, marker 8971), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin- like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3(LILRA6 /// LILRB2 /// LILRB3 /// LOC102725015 /// LOC102725029 /// LOC102725031 /// LOC102725034 /// LOC102725035, marker 8972), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3(LILRA6 /// LILRB2 /// LILRB3 /// LOC102725015 /// LOC10272502
9 /// LOC102725031 /// LOC102725034 /// LOC102725035, marker 8973), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3(LILRA6 /// LILRB2 /// LILRB3 /// LOC102725015 /// LOC102725029 /// LOC102725031 /// LOC102725034 /// LOC102725035, marker 8974), leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 /// leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3 /// leukocyte immunoglobulin-like receptor subfamily B member 3(LILRA6 /// LILRB2 /// LILRB3 / // LOC102725015 /// LOC102725029 /// LOC102725031 /// LOC102725034 /// LOC102725035, marker 8975), leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1(LILRB1, marker 8976), leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1(LILRB1, marker 8977),leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1(LILRB1, marker 8978),leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2(LILRB2, marker 8979),leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2(LILRB2, marker 8980),leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4(LILRB4, marker 8981),leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 4(LILRB4, marker 8982),leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5(LILRB5, marker 8983), leukocyte immunoglobulin-like receptor pseudogene 2(LILRP2, marker 8984), lens intrinsic membrane protein 2(LIM2, marker 8985), LIM and calponin homology domains 1(LIMCH1, marker 8986),LIM domains containing 1(LIMD1, marker 8987),LIM domains containing 1(LIMD1, marker 8988),LIMD1 antisense RNA 1(LIMD1-AS1, marker 8989),Lck interacting transmembrane adapter 1(LIME1, marker 8990),LIM domain kinase 1(LIMK1, marker 8991),LIM and senescent cell antigen-like domains 1(LIMS1, marker 8992),LIM and senescent cell antigen-like domains 1 /// LIM and senescent cell antigen-like domains 3 /// LIM and senescent cell antigen-like domains 3-like(LIMS1 /// LIMS3 /// LIMS3L, marker 8993),LIMS3-LOC440895 readthrough /// glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast) pseudogene /// two pore channel 3 pseudogene /// two pore channel 3 pseudogene(LIMS3-LOC440895 /// LOC100288570 /// LOC100507334 /// LOC440895, marker 8994),LIM and senescent cell antigen-like domains 3 -like(LIMS3L, marker 8995),lin-37 DREAM MuvB core complex component(LIN37,marker 8996),lin-54 DREAM MuvB core complex component(LIN54,marker 8997),lin-7 homolog A (C. elegans)( LIN7A, marker 8998), lin-9 DREAM MuvB core complex component (LIN9, marker 8999), lin-9 DREAM MuvB core complex component (LIN9, marker 9000), long intergenic non-protein coding RNA, p53 induced transcript (LINC- PINT, marker 9001), long intergenic non-protein coding RNA, p53 induced transcript(LINC-PINT, marker 9002), long intergenic non-protein coding RNA, p53 induced transcript(LINC-PINT, marker 9003), long intergenic non- protein coding RNA 28(LINC00028, marker 9004),long intergenic non-protein coding RNA 29(LINC00029,marker 9005),long intergenic non-protein coding RNA 32(LINC00032,marker 9006),long intergenic non-protein coding RNA 32( LINC00032, Marker 9007), long intergenic non-protein coding RNA 32 (LINC00032, Marker 9008), long intergenic non-protein coding RNA 32 (LINC00032, Marker 9009), long intergenic non-protein coding RNA 51 (LINC00051, Marker 9010) ,long intergenic non-protein coding RNA 92(LINC00092, marker 9011),long intergenic non-protein coding RNA 102(LINC00102, marker 9012),long intergenic non-protein coding RNA 106(LINC00106, marker 9013),long intergenic non- protein coding RNA 112(LINC00112, marker 9014),long intergenic non-protein coding RNA 113(LINC00113, marker 9015),long intergenic non-protein coding RNA 158(LINC00158, marker 9016),long intergenic non-protein coding RNA 161( LINC00161, Marker 9017), long intergenic non-protein coding RNA 161 (LINC00161, Marker 9018), long intergenic non-protein coding RNA 162 (LINC00162, Marker 9019), long intergenic non-protein coding RNA 163 (LINC00163, Marker 9020) ,long intergenic non-protein coding RNA 165(LINC00165, marker 9021),long intergenic non-protein coding RNA 167(LINC00167, marker 9022),long intergenic non-protein coding RNA 173(LINC00173, marker 9023),long intergenic non- protein coding RNA 174(LINC00174, marker 9024),long intergenic non-protein coding RNA 176(LINC00176, marker 9025),long intergenic non-protein coding RNA 184(LINC00184, marker 9026),long intergenic non-protein coding RNA 184( LINC00184, marker 9027), long intergenic non-protein coding RNA 189 (LINC00189, marker 9028), long intergenic non-protein coding RNA 202-1 (LINC00202-1, marker 9029), long intergenic non-protein coding RNA 202-2 (LINC00202-2, Marker 9030),long intergenic non-protein coding RNA 202-2(LINC00202-2,Marker 9031),long intergenic non-protein coding RNA 205(LINC00205,Marker 9032),long intergenic non-protein coding RNA 208 (LINC00208, marker 9033), long intergenic non-protein coding RNA 210 (LINC00210, marker 9034), long intergenic non-protein coding RNA 221 (LINC00221, marker 9035), long intergenic non-protein coding RNA 226 (LINC00226, marker 9036),long intergenic non-protein coding RNA 238(LINC00238,marker 9037),long intergenic non-protein coding RNA 240(LINC00240,marker 9038),long intergenic non-protein coding RNA 242(LINC00242,marker 9039),long intergenic non-protein coding RNA 244(LINC00244, marker 9040),long intergenic non-protein coding RNA 260(LINC00260,marker 9041),long intergenic non-protein coding RNA 265(LINC00265,marker 9042),long intergenic non-protein coding RNA 265(LINC00265, marker 9043), long intergenic non-protein coding RNA 266-1 /// long intergenic non-protein coding RNA 1347 /// uncharacterized LOC101927097 /// uncharacterized LOC102723917 /// uncharacterized LOC102723928 /// uncharacterized LOC105371423 / // uncharacterized LOC105376332 /// uncharacterized LOC105378582 /// uncharacterized LOC105379690 /// uncharacterized LOC728323 /// protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2(LINC00266-1 /// LINC01347 /// LOC101927097 /// LOC102723917 /// LOC102723928 /// LOC105371423 /// LOC105376332 /// LOC105378582 /// LOC105379690 /// LOC728323 /// PCMTD2, marker 9044), long intergenic non-protein coding RNA 269(LINC00269 , marker 9045 ),long intergenic non-protein coding RNA 271(LINC00271,marker 9046),long intergenic non-protein coding RNA 276(LINC00276,marker 9047),long intergenic non-protein coding RNA 280(LINC00280,marker 9048),long intergenic non -protein coding RNA 282(LINC00282, marker 9049),long intergenic non-protein coding RNA 284(LINC00284,marker 9050),long intergenic non-protein coding RNA 290(LINC00290,marker 9051),long intergenic non-protein coding RNA 293 (LINC00293, Marker 9052), long intergenic non-protein coding RNA 298 (LINC00298, Marker 9053), long intergenic non-protein coding RNA 299 /// long intergenic non-protein coding RNA 299 (LINC00299 /// LINC00299, Marker 9054 ),long intergenic non-protein coding RNA 301(LINC00301,marker 9055),long intergenic non-protein coding RNA 301(LINC00301,marker 9056),long intergenic non-protein coding RNA 301(LINC00301,marker 9057),long intergenic non -protein coding RNA 302(LINC00302, marker 9058),long intergenic non-protein coding RNA 302(LINC00302,marker 9059),long intergenic non-protein coding RNA 304(LINC00304,marker 9060),long intergenic non-protein coding RNA 304 (LINC00304, marker 9061), long intergenic non-protein coding RNA 304 (LINC00304, marker 9062), long intergenic non-protein coding RNA 305 (LINC00305, marker 9063), long intergenic non-protein coding RNA 307 (LINC00307, marker 9064) ),long intergenic non-protein coding RNA 308(LINC00308,marker 9065),long intergenic non-protein coding RNA 308(LINC00308,marker 9066),long intergenic non-protein coding RNA 309(LINC00309,marker 9067),long intergenic non -protein coding RNA 310 (LINC00310, marker 9068), long intergenic non-protein coding RNA 311 (LINC00311, marker 9069), long intergenic non-protein coding RNA 312 (LINC00312, marker 9070), long intergenic non-protein coding RNA 313 (LINC00313, Marker 9071), long intergenic non-protein coding RNA 313 (LINC00313, Marker 9072), long intergenic non-protein coding RNA 314 (LINC00314, Marker 9073), long intergenic non-protein coding RNA 315 (LINC00315, Marker 9074) ),long intergenic non-protein coding RNA 317(LINC00317,marker 9075),long intergenic non-protein coding RNA 320(LINC00320,marker 9076),long intergenic non-protein coding RNA 320(LINC00320,marker 9077),long intergenic non -protein coding RNA 323(LINC00323, marker 9078),long intergenic non-protein coding RNA 324(LINC00324, marker 9079),long intergenic non-protein coding RNA 326(LINC00326, marker 9080),long intergenic non-protein coding RNA 327 (LINC00327, Marker 9081), long intergenic non-protein coding RNA 328 (LINC00328, Marker 9082), long intergenic non-protein coding RNA 330 (LINC00330, Marker 9083), long intergenic non-protein coding RNA 334 (LINC00334, Marker 9084) ),long intergenic non-protein coding RNA 334(LINC00334,marker 9085),long intergenic non-protein coding RNA 334(LINC00334,marker 9086),long intergenic non-protein coding RNA 337(LINC00337,marker 9087),long intergenic non -protein coding RNA 342(LINC00342, marker 9
088),long intergenic non-protein coding RNA 342(LINC00342,marker 9089),long intergenic non-protein coding RNA 343(LINC00343,marker 9090),long intergenic non-protein coding RNA 347(LINC00347,marker 9091),long intergenic non-protein coding RNA 348(LINC00348, marker 9092),long intergenic non-protein coding RNA 354(LINC00354, marker 9093),long intergenic non-protein coding RNA 354(LINC00354, marker 9094),long intergenic non-protein coding RNA 358 (LINC00358, marker 9095), long intergenic non-protein coding RNA 382 (LINC00382, marker 9096), long intergenic non-protein coding RNA 396 (LINC00396, marker 9097), long intergenic non-protein coding RNA 403 (LINC00403, marker 9098),long intergenic non-protein coding RNA 408(LINC00408,marker 9099),long intergenic non-protein coding RNA 408(LINC00408,marker 9100),long intergenic non-protein coding RNA 410(LINC00410,marker 9101),long intergenic non-protein coding RNA 421(LINC00421, marker 9102),long intergenic non-protein coding RNA 423(LINC00423, marker 9103),long intergenic non-protein coding RNA 424(LINC00424, marker 9104),long intergenic non-protein coding RNA 437(LINC00437, Marker 9105), long intergenic non-protein coding RNA 441(LINC00441, Marker 9106), long intergenic non-protein coding RNA 441(LINC00441, Marker 9107), long intergenic non-protein coding RNA 445(LINC00445, Marker 9108),long intergenic non-protein coding RNA 452(LINC00452,marker 9109),long intergenic non-protein coding RNA 454(LINC00454,marker 9110),long intergenic non-protein coding RNA 458(LINC00458,marker 9111),long intergenic non-protein coding RNA 460(LINC00460, marker 9112),long intergenic non-protein coding RNA 460(LINC00460, marker 9113),long intergenic non-protein coding RNA 462(LINC00462, marker 9114),long intergenic non-protein coding RNA 463 (LINC00463, marker 9115), long intergenic non-protein coding RNA 466 (LINC00466, marker 9116), long intergenic non-protein coding RNA 470 (LINC00470, marker 9117), long intergenic non-protein coding RNA 470 /// long intergenic non-protein coding RNA 470(LINC00470 /// LINC00470, marker 9118),long intergenic non-protein coding RNA 470 /// long intergenic non-protein coding RNA 470(LINC00470 /// LINC00470, marker 9119),long intergenic non-protein coding RNA 470 /// long intergenic non-protein coding RNA 470(LINC00470 /// LINC00470, marker 9120),long intergenic non-protein coding RNA 471(LINC00471, marker 9121),long intergenic non-protein coding RNA 472(LINC00472, Marker 9122), long intergenic non-protein coding RNA 473(LINC00473, Marker 9123), long intergenic non-protein coding RNA 474(LINC00474, Marker 9124), long intergenic non-protein coding RNA 474(LINC00474, Marker 9125),long intergenic non-protein coding RNA 475(LINC00475,marker 9126),long intergenic non-protein coding RNA 475 /// long intergenic non-protein coding RNA 475(LINC00475 /// LINC00475,marker 9127),long intergenic non-protein coding RNA 475 /// long intergenic non-protein coding RNA 475(LINC00475 /// LINC00475, marker 9128),long intergenic non-protein coding RNA 476(LINC00476, marker 9129),long intergenic non-protein coding RNA 476 (LINC00476, marker 9130), long intergenic non-protein coding RNA 477 (LINC00477, marker 9131), long intergenic non-protein coding RNA 479 (LINC00479, marker 9132), long intergenic non-protein coding RNA 482 (LINC00482, marker 9133),long intergenic non-protein coding RNA 483(LINC00483,marker 9134),long intergenic non-protein coding RNA 485(LINC00485,marker 9135),long intergenic non-protein coding RNA 486(LINC00486,marker 9136),long intergenic non-protein coding RNA 486(LINC00486, marker 9137),long intergenic non-protein coding RNA 486(LINC00486, marker 9138),long intergenic non-protein coding RNA 487(LINC00487, marker 9139),long intergenic non-protein coding RNA 488 (LINC00488, marker 9140), long intergenic non-protein coding RNA 491 (LINC00491, marker 9141), long intergenic non-protein coding RNA 491 (LINC00491, marker 9142), long intergenic non-protein coding RNA 494 (LINC00494, marker 9143),long intergenic non-protein coding RNA 504(LINC00504,marker 9144),long intergenic non-protein coding RNA 507(LINC00507,marker 9145),long intergenic non-protein coding RNA 508(LINC00508,marker 9146),long intergenic non-protein coding RNA 511 /// long intergenic non-protein coding RNA 673(LINC00511 /// LINC00673, marker 9147),long intergenic non-protein coding RNA 514(LINC00514, marker 9148),long intergenic non-protein coding RNA 515 (LINC00515, marker 9149), long intergenic non-protein coding RNA 518 (LINC00518, marker 9150), long intergenic non-protein coding RNA 518 (LINC00518, marker 9151), long intergenic non-protein coding RNA 520 (LINC00520, marker 9152),long intergenic non-protein coding RNA 521(LINC00521,marker 9153),long intergenic non-protein coding RNA 521(LINC00521,marker 9154),long intergenic non-protein coding RNA 521(LINC00521,marker 9155),long intergenic non-protein coding RNA 523(LINC00523, marker 9156),long intergenic non-protein coding RNA 525(LINC00525, marker 9157),long intergenic non-protein coding RNA 527(LINC00527, marker 9158),long intergenic non-protein coding RNA 527 (LINC00527, marker 9159), long intergenic non-protein coding RNA 528 (LINC00528, marker 9160), long intergenic non-protein coding RNA 529 (LINC00529, marker 9161), long intergenic non-protein coding RNA 535 (LINC00535, marker 9162),long intergenic non-protein coding RNA 535(LINC00535,marker 9163),long intergenic non-protein coding RNA 536(LINC00536,marker 9164),long intergenic non-protein coding RNA 537(LINC00537,marker 9165),long intergenic non-protein coding RNA 537(LINC00537, marker 9166),long intergenic non-protein coding RNA 543(LINC00543, marker 9167),long intergenic non-protein coding RNA 544(LINC00544, marker 9168),long intergenic non-protein coding RNA 550 (LINC00550, marker 9169), long intergenic non-protein coding RNA 551 (LINC00551, marker 9170), long intergenic non-protein coding RNA 555 (LINC00555, marker 9171), long intergenic non-protein coding RNA 556 (LINC00556, marker 9172),long intergenic non-protein coding RNA 557(LINC00557,marker 9173),long intergenic non-protein coding RNA 558(LINC00558,marker 9174),long intergenic non-protein coding RNA 559(LINC00559,marker 9175),long intergenic non-protein coding RNA 560 (LINC00560, marker 9176), long intergenic non-protein coding RNA 561 (LINC00561, marker 9177), long intergenic non-protein coding RNA 563 (LINC00563, marker 9178), long intergenic non-protein coding RNA 564 (LINC00564, marker 9179), long intergenic non-protein coding RNA 565 (LINC00565, marker 9180), long intergenic non-protein coding RNA 566 (LINC00566, marker 9181), long intergenic non-protein coding RNA 567 (LINC00567, marker 9182),long intergenic non-protein coding RNA 572(LINC00572,marker 9183),long intergenic non-protein coding RNA 574(LINC00574,marker 9184),long intergenic non-protein coding RNA 577(LINC00577,marker 9185),long intergenic non-protein coding RNA 582(LINC00582, marker 9186),long intergenic non-protein coding RNA 587(LINC00587, marker 9187),long intergenic non-protein coding RNA 588(LINC00588, marker 9188),long intergenic non-protein coding RNA 589(LINC00589, Marker 9189), long intergenic non-protein coding RNA 592(LINC00592, Marker 9190), long intergenic non-protein coding RNA 593(LINC00593, Marker 9191), long intergenic non-protein coding RNA 593(LINC00593, Marker 9192),long intergenic non-protein coding RNA 595(LINC00595,marker 9193),long intergenic non-protein coding RNA 598(LINC00598,marker 9194),long intergenic non-protein coding RNA 598(LINC00598,marker 9195),long intergenic non-protein coding RNA 598(LINC00598, marker 9196),long intergenic non-protein coding RNA 605(LINC00605, marker 9197),long intergenic non-protein coding RNA 606(LINC00606, marker 9198),long intergenic non-protein coding RNA 606 (LINC00606, marker 9199), long intergenic non-protein coding RNA 607 (LINC00607, marker 9200), long intergenic non-protein coding RNA 608 (LINC00608, marker 9201), long intergenic non-protein coding RNA 608 (LINC00608, marker 9202),long intergenic non-protein coding RNA 610(LINC00610,marker 9203),long intergenic non-protein coding RNA 612(LINC00612,marker 9204),long intergenic non-protein coding RNA 615(LINC00615,marker 9205),long intergenic non-protein coding RNA 616 (LINC00616, marker 9206), long intergenic non-protein coding RNA 619 (LINC00619, marker 9207), long intergenic non-protein coding RNA 620 (LINC00620, marker 9208), long intergenic non-protein coding RNA 622 (LINC00622, marker 9209), long intergenic non-protein coding RNA 624 (LINC00624, marker 9210), long intergenic non-protein coding RNA 626 (LINC00626, marker 9211), long intergenic non-protein coding RNA 628 (LINC00628, marker 9212),long intergenic non-protein coding RNA 628(LINC00628,marker 9213),long intergenic non-protein coding RNA 629(LINC00629,marker 9214),long intergenic non-protein coding RNA 630(LINC00630,marker 9215),long intergenic non-protein coding RNA 632(LINC00632, marker 9216),long intergenic non-protein coding RNA 635(LINC00635, marker 9217),long intergenic non-protein coding RNA 636(LINC00636, marker 9218),long intergenic non-protein coding RNA 639 (LINC00639, marker 9219), long intergenic non-protein coding RNA 641 (LINC00641, marker 9220), long intergenic non-protein coding RNA 642 (LINC00642, marker 9221), long intergenic non-protein coding RNA 642 (LINC00642, marker 9222),long intergenic non-protein coding RNA 642(LINC00642,marker 9223),long intergenic non-protein coding RNA 643(LINC00643,marker 9224),long intergenic non-protein coding RNA 643(LINC00643,marker 9225),long intergenic non-protein coding RNA 644 (LINC00644, marker 9226), long intergenic non-protein coding RNA 645 (LINC00645, marker 9227), long intergenic non-protein coding RNA 652 (LINC00652, marker 9228), long intergenic non-protein coding RNA 654 (LINC00654, marker 9229), long intergenic non-protein coding RNA 654 /// uncharacterized LOC643406 (LINC00654 /// LOC643406, marker 9230), long intergenic non-protein coding RNA 656 (LINC00656, marker 9231), long intergenic non -protein coding RNA 658(LINC00658, marker 9232),long intergenic non-protein coding RNA 659(LINC00659, marker 9233),long intergenic non-protein coding RNA 661(LINC00661, marker 9234),long intergenic non-protein coding RNA 661 (L
INC00661, Marker 9235), long intergenic non-protein coding RNA 662 (LINC00662, Marker 9236), long intergenic non-protein coding RNA 662 (LINC00662, Marker 9237), long intergenic non-protein coding RNA 662 (LINC00662, Marker 9238) ,long intergenic non-protein coding RNA 662(LINC00662, marker 9239),long intergenic non-protein coding RNA 663(LINC00663, marker 9240),long intergenic non-protein coding RNA 664(LINC00664, marker 9241),long intergenic non- protein coding RNA 664(LINC00664, marker 9242),long intergenic non-protein coding RNA 664(LINC00664, marker 9243),long intergenic non-protein coding RNA 665(LINC00665, marker 9244),long intergenic non-protein coding RNA 665( LINC00665, marker 9245), long intergenic non-protein coding RNA 668 (LINC00668, marker 9246), long intergenic non-protein coding RNA 671 (LINC00671, marker 9247), long intergenic non-protein coding RNA 671 (LINC00671, marker 9248) ,long intergenic non-protein coding RNA 673(LINC00673, marker 9249),long intergenic non-protein coding RNA 674(LINC00674, marker 9250),long intergenic non-protein coding RNA 674(LINC00674, marker 9251),long intergenic non- protein coding RNA 675(LINC00675, marker 9252),long intergenic non-protein coding RNA 675(LINC00675, marker 9253),long intergenic non-protein coding RNA 680(LINC00680, marker 9254),long intergenic non-protein coding RNA 682( LINC00682, marker 9255), long intergenic non-protein coding RNA 684 /// long intergenic non-protein coding RNA 684 (LINC00684 /// LOC100132304, marker 9256), long intergenic non-protein coding RNA 687 (LINC00687, marker 9257) ,long intergenic non-protein coding RNA 689(LINC00689, marker 9258),long intergenic non-protein coding RNA 689(LINC00689, marker 9259),long intergenic non-protein coding RNA 689(LINC00689, marker 9260),long intergenic non- protein coding RNA 689(LINC00689, marker 9261),long intergenic non-protein coding RNA 689(LINC00689, marker 9262),long intergenic non-protein coding RNA 690(LINC00690, marker 9263),long intergenic non-protein coding RNA 691( LINC00691, marker 9264), long intergenic non-protein coding RNA 692 (LINC00692, marker 9265), long intergenic non-protein coding RNA 692 (LINC00692, marker 9266), long intergenic non-protein coding RNA 700 (LINC00700, marker 9267) ,long intergenic non-protein coding RNA 703(LINC00703, marker 9268),long intergenic non-protein coding RNA 705(LINC00705, marker 9269),long intergenic non-protein coding RNA 708(LINC00708, marker 9270),long intergenic non- protein coding RNA 710(LINC00710, marker 9271),long intergenic non-protein coding RNA 824(LINC00824, marker 9272),long intergenic non-protein coding RNA 824(LINC00824, marker 9273),long intergenic non-protein coding RNA 836( LINC00836, marker 9274), long intergenic non-protein coding RNA 837 (LINC00837, marker 9275), long intergenic non-protein coding RNA 838 (LINC00838, marker 9276), long intergenic non-protein coding RNA 839 (LINC00839, marker 9277) ,long intergenic non-protein coding RNA 841(LINC00841, marker 9278),long intergenic non-protein coding RNA 844(LINC00844, marker 9279),long intergenic non-protein coding RNA 845(LINC00845, marker 9280),long intergenic non- protein coding RNA 851(LINC00851, marker 9281),long intergenic non-protein coding RNA 852(LINC00852, marker 9282),long intergenic non-protein coding RNA 853(LINC00853, marker 9283),long intergenic non-protein coding RNA 856( LINC00856, marker 9284), long intergenic non-protein coding RNA 857 (LINC00857, marker 9285), long intergenic non-protein coding RNA 858 (LINC00858, marker 9286), long intergenic non-protein coding RNA 862 (LINC00862, marker 9287) ,long intergenic non-protein coding RNA 865(LINC00865, marker 9288),long intergenic non-protein coding RNA 867(LINC00867, marker 9289),long intergenic non-protein coding RNA 868(LINC00868, marker 9290),long intergenic non- protein coding RNA 869(LINC00869, marker 9291),long intergenic non-protein coding RNA 869(LINC00869, marker 9292),long intergenic non-protein coding RNA 870(LINC00870, marker 9293),long intergenic non-protein coding RNA 877( LINC00877, marker 9294), long intergenic non-protein coding RNA 879 (LINC00879, marker 9295), long intergenic non-protein coding RNA 880 (LINC00880, marker 9296), long intergenic non-protein coding RNA 881 (LINC00881, marker 9297) ,long intergenic non-protein coding RNA 882(LINC00882, marker 9298),long intergenic non-protein coding RNA 884(LINC00884, marker 9299),long intergenic non-protein coding RNA 884(LINC00884, marker 9300),long intergenic non- protein coding RNA 886(LINC00886, marker 9301),long intergenic non-protein coding RNA 887(LINC00887, marker 9302),long intergenic non-protein coding RNA 892(LINC00892, marker 9303),long intergenic non-protein coding RNA 893( LINC00893, marker 9304), long intergenic non-protein coding RNA 893 /// long intergenic non-protein coding RNA 894(LINC00893 /// LINC00894, marker 9305), long intergenic non-protein coding RNA 894(LINC00894, marker 9306) ,long intergenic non-protein coding RNA 894(LINC00894, marker 9307),long intergenic non-protein coding RNA 895(LINC00895, marker 9308),long intergenic non-protein coding RNA 896(LINC00896, marker 9309),long intergenic non- protein coding RNA 899(LINC00899, marker 9310),long intergenic non-protein coding RNA 899(LINC00899, marker 9311),long intergenic non-protein coding RNA 900(LINC00900, marker 9312),long intergenic non-protein coding RNA 901( LINC00901, Marker 9313), long intergenic non-protein coding RNA 905 (LINC00905, Marker 9314), long intergenic non-protein coding RNA 906 (LINC00906, Marker 9315), long intergenic non-protein coding RNA 907 (LINC00907, Marker 9316) ,long intergenic non-protein coding RNA 907(LINC00907, marker 9317),long intergenic non-protein coding RNA 907(LINC00907, marker 9318),long intergenic non-protein coding RNA 908(LINC00908, marker 9319),long intergenic non- protein coding RNA 908(LINC00908, marker 9320),long intergenic non-protein coding RNA 908(LINC00908, marker 9321),long intergenic non-protein coding RNA 910(LINC00910, marker 9322),long intergenic non-protein coding RNA 910( LINC00910, Marker 9323), long intergenic non-protein coding RNA 911 (LINC00911, Marker 9324), long intergenic non-protein coding RNA 917 (LINC00917, Marker 9325), long intergenic non-protein coding RNA 919 (LINC00919, Marker 9326) ,long intergenic non-protein coding RNA 920(LINC00920, marker 9327),long intergenic non-protein coding RNA 921(LINC00921, marker 9328),long intergenic non-protein coding RNA 922(LINC00922, marker 9329),long intergenic non- protein coding RNA 923(LINC00923, marker 9330),long intergenic non-protein coding RNA 924(LINC00924, marker 9331),long intergenic non-protein coding RNA 926(LINC00926, marker 9332),long intergenic non-protein coding RNA 927( LINC00927, Marker 9333), long intergenic non-protein coding RNA 927 (LINC00927, Marker 9334), long intergenic non-protein coding RNA 928 (LINC00928, Marker 9335), long intergenic non-protein coding RNA 929 (LINC00929, Marker 9336) ,long intergenic non-protein coding RNA 930(LINC00930, marker 9337),long intergenic non-protein coding RNA 933(LINC00933, marker 9338),long intergenic non-protein coding RNA 934(LINC00934, marker 9339),long intergenic non- protein coding RNA 935(LINC00935, marker 9340),long intergenic non-protein coding RNA 937(LINC00937, marker 9341),long intergenic non-protein coding RNA 938(LINC00938, marker 9342),long intergenic non-protein coding RNA 939( LINC00939, marker 9343), long intergenic non-protein coding RNA 942(LINC00942, marker 9344), long intergenic non-protein coding RNA 942(LINC00942, marker 9345), long intergenic non-protein coding RNA 943(LINC00943, marker 9346) ,long intergenic non-protein coding RNA 944(LINC00944, marker 9347),long intergenic non-protein coding RNA 944(LINC00944, marker 9348),long intergenic non-protein coding RNA 944(LINC00944, marker 9349),long intergenic non- protein coding RNA 944(LINC00944, marker 9350),long intergenic non-protein coding RNA 950(LINC00950, marker 9351),long intergenic non-protein coding RNA 954(LINC00954, marker 9352),long intergenic non-protein coding RNA 955( LINC00955, marker 9353), long intergenic non-protein coding RNA 957(LINC00957, marker 9354), long intergenic non-protein coding RNA 957(LINC00957, marker 9355), long intergenic non-protein coding RNA 957(LINC00957, marker 9356) ,long intergenic non-protein coding RNA 957(LINC00957, marker 9357),long intergenic non-protein coding RNA 958(LINC00958, marker 9358),long intergenic non-protein coding RNA 959(LINC00959, marker 9359),long intergenic non- protein coding RNA 960(LINC00960, marker 9360),long intergenic non-protein coding RNA 961(LINC00961, marker 9361),long intergenic non-protein coding RNA 963(LINC00963, marker 9362),long intergenic non-protein coding RNA 963( LINC00963, marker 9363), long intergenic non-protein coding RNA 964 /// uncharacterized LOC105375742(LINC00964 /// LOC105375742, marker 9364), long intergenic non-protein coding RNA 964 /// zinc finger protein 572(LINC00964 /// ZNF572, marker 9365), long intergenic non-protein coding RNA 967 (LINC00967, marker 9366), long intergenic non-protein coding RNA 968 (LINC00968, marker 9367), long intergenic non-protein coding RNA 969 (LINC00969, marker 9368) ,long intergenic non-protein coding RNA 969(LINC00969, marker 9369),long intergenic non-protein coding RNA 970(LINC00970, marker 9370),long intergenic non-protein coding RNA 982(LINC00982, marker 9371),long intergenic non- protein coding RNA 982(LINC00982, marker 9372),long intergenic non-protein coding RNA 982(LINC00982, marker 9373),long intergenic non-protein coding RNA 982(LINC00982, marker 9374),long intergenic non-protein coding RNA 993( LINC00993, marker 9375), long intergenic non-protein coding RNA 996(LINC00996, marker 9376), long intergenic non-protein coding RNA 997(LINC00997, marker 9377), long intergenic non-protein coding RNA 997(LINC00997, marker 9378) ,long intergenic non-protein coding RNA 997(LINC00997, marker 9379),long intergenic non-protein coding RNA 1004(LINC01004, marker 9380),long intergenic non-protein coding RNA 1004(LINC01004, marker 9381),long intergenic non- protein coding RNA 1006 (LINC01006, marker 9382), long intergenic non-protein coding RNA 1007 (LINC01007, marker 9383), long intergenic non-protein coding RNA 1010 (LINC01010, marker 9384), long intergenic
non-protein coding RNA 1012(LINC01012, marker 9385),long intergenic non-protein coding RNA 1013(LINC01013, marker 9386),long intergenic non-protein coding RNA 1013(LINC01013, marker 9387),long intergenic non-protein coding RNA 1015(LINC01015, marker 9388),long intergenic non-protein coding RNA 1016(LINC01016,marker 9389),long intergenic non-protein coding RNA 1016(LINC01016,marker 9390),long intergenic non-protein coding RNA 1016(LINC01016,marker 9391),long intergenic non-protein coding RNA 1018(LINC01018,marker 9392),long intergenic non-protein coding RNA 1019(LINC01019,marker 9393),long intergenic non-protein coding RNA 1020(LINC01020,marker 9394),long intergenic non-protein coding RNA 1020(LINC01020, marker 9395),long intergenic non-protein coding RNA 1023(LINC01023, marker 9396),long intergenic non-protein coding RNA 1029(LINC01029, marker 9397),long intergenic non-protein coding RNA 1049(LINC01049, Marker 9398), long intergenic non-protein coding RNA 1056(LINC01056, Marker 9399), long intergenic non-protein coding RNA 1056(LINC01056, Marker 9400), long intergenic non-protein coding RNA 1057(LINC01057, Marker 9401),long intergenic non-protein coding RNA 1069(LINC01069,marker 9402),long intergenic non-protein coding RNA 1082(LINC01082,marker 9403),long intergenic non-protein coding RNA 1085(LINC01085,marker 9404),long intergenic non-protein coding RNA 1087(LINC01087, marker 9405),long intergenic non-protein coding RNA 1088(LINC01088, marker 9406),long intergenic non-protein coding RNA 1089(LINC01089, marker 9407),long intergenic non-protein coding RNA 1091(LINC01091, Marker 9408), long intergenic non-protein coding RNA 1091(LINC01091, Marker 9409), long intergenic non-protein coding RNA 1093(LINC01093, Marker 9410), long intergenic non-protein coding RNA 1094(LINC01094, Marker 9411),long intergenic non-protein coding RNA 1095(LINC01095,marker 9412),long intergenic non-protein coding RNA 1096(LINC01096,marker 9413),long intergenic non-protein coding RNA 1097(LINC01097,marker 9414),long intergenic non-protein coding RNA 1098(LINC01098, marker 9415),long intergenic non-protein coding RNA 1101(LINC01101, marker 9416),long intergenic non-protein coding RNA 1102(LINC01102, marker 9417),long intergenic non-protein coding RNA 1103 (LINC01103, marker 9418), long intergenic non-protein coding RNA 1104 (LINC01104, marker 9419), long intergenic non-protein coding RNA 1105 (LINC01105, marker 9420), long intergenic non-protein coding RNA 1105 (LINC01105, marker 9421),long intergenic non-protein coding RNA 1105(LINC01105,marker 9422),long intergenic non-protein coding RNA 1105(LINC01105,marker 9423),long intergenic non-protein coding RNA 1106(LINC01106,marker 9424),long intergenic non-protein coding RNA 1106 /// long intergenic non-protein coding RNA 1123(LINC01106 /// LINC01123, marker 9425),long intergenic non-protein coding RNA 1107(LINC01107, marker 9426),long intergenic non-protein coding RNA 1111 (LINC01111, marker 9427), long intergenic non-protein coding RNA 1114 (LINC01114, marker 9428), long intergenic non-protein coding RNA 1115 (LINC01115, marker 9429), long intergenic non-protein coding RNA 1116 (LINC01116, marker 9430),long intergenic non-protein coding RNA 1118(LINC01118,marker 9431),long intergenic non-protein coding RNA 1119(LINC01119,marker 9432),long intergenic non-protein coding RNA 1120(LINC01120,marker 9433),long intergenic non-protein coding RNA 1120(LINC01120, marker 9434),long intergenic non-protein coding RNA 1121(LINC01121, marker 9435),long intergenic non-protein coding RNA 1122(LINC01122, marker 9436),long intergenic non-protein coding RNA 1122(LINC01122, Marker 9437), long intergenic non-protein coding RNA 1125(LINC01125, Marker 9438), long intergenic non-protein coding RNA 1126(LINC01126, Marker 9439), long intergenic non-protein coding RNA 1127(LINC01127, Marker 9440),long intergenic non-protein coding RNA 1128(LINC01128,marker 9441),long intergenic non-protein coding RNA 1128(LINC01128,marker 9442),long intergenic non-protein coding RNA 1128(LINC01128,marker 9443),long intergenic non-protein coding RNA 1128(LINC01128, marker 9444),long intergenic non-protein coding RNA 1128(LINC01128, marker 9445),long intergenic non-protein coding RNA 1133(LINC01133, marker 9446),long intergenic non-protein coding RNA 1133(LINC01133, Marker 9447), long intergenic non-protein coding RNA 1134(LINC01134, Marker 9448), long intergenic non-protein coding RNA 1134(LINC01134, Marker 9449), long intergenic non-protein coding RNA 1136(LINC01136, Marker 9450),long intergenic non-protein coding RNA 1137(LINC01137,marker 9451),long intergenic non-protein coding RNA 1138(LINC01138,marker 9452),long intergenic non-protein coding RNA 1138(LINC01138,marker 9453),long intergenic non-protein coding RNA 1139(LINC01139, marker 9454),long intergenic non-protein coding RNA 1140(LINC01140, marker 9455),long intergenic non-protein coding RNA 1140(LINC01140, marker 9456),long intergenic non-protein coding RNA 1141(LINC01141, Marker 9457), long intergenic non-protein coding RNA 1142(LINC01142, Marker 9458), long intergenic non-protein coding RNA 1144(LINC01144, Marker 9459), long intergenic non-protein coding RNA 1146(LINC01146, Marker 9460),long intergenic non-protein coding RNA 1153(LINC01153,marker 9461),long intergenic non-protein coding RNA 1158(LINC01158,marker 9462),long intergenic non-protein coding RNA 1159(LINC01159,marker 9463),long intergenic non-protein coding RNA 1165(LINC01165, marker 9464),long intergenic non-protein coding RNA 1169(LINC01169, marker 9465),long intergenic non-protein coding RNA 1180(LINC01180, marker 9466),long intergenic non-protein coding RNA 1181(LINC01181, marker 9467),long intergenic non-protein coding RNA 1184(LINC01184,marker 9468),long intergenic non-protein coding RNA 1184(LINC01184,marker 9469),long intergenic non-protein coding RNA 1184 /// uncharacterized LOC105379165(LINC01184 /// LOC105379165, marker 9470), long intergenic non-protein coding RNA 1184 /// uncharacterized LOC105379165(LINC01184 /// LOC105379165, marker 9471), long intergenic non-protein coding RNA 1186(LINC01186, marker 9 472) ,long intergenic non-protein coding RNA 1187(LINC01187, marker 9473),long intergenic non-protein coding RNA 1187(LINC01187, marker 9474),long intergenic non-protein coding RNA 1191(LINC01191, marker 9475),long intergenic non- protein coding RNA 1191(LINC01191, marker 9476),long intergenic non-protein coding RNA 1191(LINC01191, marker 9477),long intergenic non-protein coding RNA 1192(LINC01192, marker 9478),long intergenic non-protein coding RNA 1192( LINC01192, marker 9479), long intergenic non-protein coding RNA 1197 /// uncharacterized LOC105370994(LINC01197 /// LOC105370994, marker 9480), long intergenic non-protein coding RNA 1198 /// uncharacterized LOC102723968(LINC01198 /// LOC10272396 8, marker 9481), long intergenic non-protein coding RNA 1204 (LINC01204, marker 9482), long intergenic non-protein coding RNA 1206 (LINC01206, marker 9483), long intergenic non-protein coding RNA 1206 (LINC01206, marker 9484), long intergenic non-protein coding RNA 1207(LINC01207, marker 9485),long intergenic non-protein coding RNA 1208(LINC01208, marker 9486),long intergenic non-protein coding RNA 1209(LINC01209, marker 9487),long intergenic non-protein coding RNA 1210(LINC01210, marker 9488),long intergenic non-protein coding RNA 1210(LINC01210,marker 9489),long intergenic non-protein coding RNA 1212(LINC01212,marker 9490),long intergenic non-protein coding RNA 1213(LINC01213, marker 9491), long intergenic non-protein coding RNA 1214 (LINC01214, marker 9492), long intergenic non-protein coding RNA 1215 (LINC01215, marker 9493), long intergenic non-protein coding RNA 1220 (LINC01220, marker 9494), long intergenic non-protein coding RNA 1222(LINC01222, marker 9495),long intergenic non-protein coding RNA 1225(LINC01225, marker 9496),long intergenic non-protein coding RNA 1225(LINC01225, marker 9497),long intergenic non-protein coding RNA 1226(LINC01226, marker 9498),long intergenic non-protein coding RNA 1227(LINC01227,marker 9499),long intergenic non-protein coding RNA 1231(LINC01231,marker 9500),long intergenic non-protein coding RNA 1233(LINC01233, marker 9501), long intergenic non-protein coding RNA 1234 (LINC01234, marker 9502), long intergenic non-protein coding RNA 1241 (LINC01241, marker 9503), long intergenic non-protein coding RNA 1242 (LINC01242, marker 9504), long intergenic non-protein coding RNA 1243(LINC01243, marker 9505), long intergenic non-protein coding RNA 1246 /// MIR7515 host gene(LINC01246 /// MIR7515HG, marker 9506), long intergenic non-protein coding RNA 1252(LINC01252, marker 9507), long intergenic non-protein coding RNA 1254(LINC01254, marker 9508), long intergenic non-protein coding RNA 1255(LINC01255, marker 9509), long intergenic non-protein coding RNA 1257(LINC01257, marker 9510), long intergenic non-protein coding RNA 1260(LINC01260, marker 9511),long intergenic non-protein coding RNA 1260(LINC01260, marker 9512),long intergenic non-protein coding RNA 1267(LINC01267, marker 9513),long intergenic non-protein coding RNA 1268(LINC01268, marker 9514),long intergenic non-protein coding RNA 1270(LINC01270,marker 9515),long intergenic non-protein coding RNA 1271(LINC01271,marker 9516),long intergenic non-protein coding RNA 1272(LINC01272, marker 9517), long intergenic non-protein coding RNA 1278 (LINC01278, marker 9518), long intergenic non-protein coding RNA 1281 (LINC01281, marker 9519), long intergenic non-protein coding RNA 1282 (LINC01282, marker 9520), long intergenic non-protein coding RNA 1289(LINC01289, marker 9521),long intergenic non-protein coding RNA 1293(LINC01293, marker 9522),long intergenic non-protein coding RNA 1296(LINC01296, marker 9523),long intergenic non-protein coding RNA 1297(LINC01297, Marker 9524),long intergenic non-protein coding RNA 1300(LINC01300, Marker 9525),long intergenic non-protein coding RNA 1304(LINC01304, Marker 9526),long intergenic non-protein coding RNA 1305(LINC01305, marker 9527), long intergenic non-protein coding RNA 1310 (LINC01310, marker 9528), long intergenic non-protein coding RNA 1312 (LINC01312, marker 9529), long intergenic non-protein coding RNA 1312 (LINC01312, marker 9530), long intergenic non-protein cod
ing RNA 1314(LINC01314, marker 9531),long intergenic non-protein coding RNA 1314(LINC01314,marker 9532),long intergenic non-protein coding RNA 1314(LINC01314,marker 9533),long intergenic non-protein coding RNA 1330(LINC01330 ,marker 9534),long intergenic non-protein coding RNA 1330(LINC01330,marker 9535),long intergenic non-protein coding RNA 1333(LINC01333,marker 9536),long intergenic non-protein coding RNA 1339(LINC01339,marker 9537), long intergenic non-protein coding RNA 1341(LINC01341, marker 9538),long intergenic non-protein coding RNA 1342(LINC01342, marker 9539),long intergenic non-protein coding RNA 1343(LINC01343, marker 9540),long intergenic non-protein coding RNA 1346(LINC01346, marker 9541), long intergenic non-protein coding RNA 1347(LINC01347, marker 9542), long intergenic non-protein coding RNA 1348(LINC01348, marker 9543), long intergenic non-protein coding RNA 1350(LINC01350 ,marker 9544),long intergenic non-protein coding RNA 1351(LINC01351,marker 9545),long intergenic non-protein coding RNA 1352(LINC01352,marker 9546),long intergenic non-protein coding RNA 1352(LINC01352,marker 9547), long intergenic non-protein coding RNA 1354(LINC01354, marker 9548),long intergenic non-protein coding RNA 1355(LINC01355, marker 9549),long intergenic non-protein coding RNA 1359(LINC01359, marker 9550),long intergenic non-protein coding RNA 1360(LINC01360, marker 9551),long intergenic non-protein coding RNA 1360(LINC01360,marker 9552),long intergenic non-protein coding RNA 1360(LINC01360,marker 9553),long intergenic non-protein coding RNA 1361(LINC01361 ,marker 9554),long intergenic non-protein coding RNA 1361(LINC01361,marker 9555),long intergenic non-protein coding RNA 1362(LINC01362,marker 9556),long intergenic non-protein coding RNA 1364(LINC01364,marker 9557), long intergenic non-protein coding RNA 1365(LINC01365, marker 9558),long intergenic non-protein coding RNA 1366(LINC01366, marker 9559),long intergenic non-protein coding RNA 1366(LINC01366, marker 9560),long intergenic non-protein coding RNA 1393(LINC01393, marker 9561),long intergenic non-protein coding RNA 1395(LINC01395, marker 9562),long intergenic non-protein coding RNA 1398(LINC01398, marker 9563),long intergenic non-protein coding RNA 1410(LINC01410 ,marker 9564),long intergenic non-protein coding RNA 1410 /// uncharacterized LOC105379818(LINC01410 /// LOC105379818,marker 9565),long intergenic non-protein coding RNA 1416(LINC01416,marker 9566),long intergenic non-protein coding RNA 1419(LINC01419, marker 9567),long intergenic non-protein coding RNA 1424(LINC01424,marker 9568),long intergenic non-protein coding RNA 1425(LINC01425,marker 9569),long intergenic non-protein coding RNA 1426(LINC01426, marker 9570), long intergenic non-protein coding RNA 1428 (LINC01428, marker 9571), long intergenic non-protein coding RNA 1431 (LINC01431, marker 9572), long intergenic non-protein coding RNA 1432 (LINC01432, marker 9573), long intergenic non-protein coding RNA 1442(LINC01442, marker 9574),long intergenic non-protein coding RNA 1448(LINC01448, marker 9575),long intergenic non-protein coding RNA 1449(LINC01449, marker 9576),long intergenic non-protein coding RNA 1465(LINC01465, marker 9577),long intergenic non-protein coding RNA 1467(LINC01467, marker 9578),long intergenic non-protein coding RNA 1468(LINC01468, marker 9579),long intergenic non-protein coding RNA 1477(LINC01477, marker 9580), long intergenic non-protein coding RNA 1482 (LINC01482, marker 9581), long intergenic non-protein coding RNA 1487 (LINC01487, marker 9582), long intergenic non-protein coding RNA 1490 (LINC01490, marker 9583), long intergenic non-protein coding RNA 1492(LINC01492, marker 9584),long intergenic non-protein coding RNA 1494(LINC01494, marker 9585),long intergenic non-protein coding RNA 1500(LINC01500, marker 9586),long intergenic non-protein coding RNA 1504(LINC01504, marker 9587),long intergenic non-protein coding RNA 1505(LINC01505, marker 9588),long intergenic non-protein coding RNA 1505(LINC01505, marker 9589),long intergenic non-protein coding RNA 1511(LINC01511, marker 9590), long intergenic non-protein coding RNA 1512 (LINC01512, marker 9591), long intergenic non-protein coding RNA 1514 (LINC01514, marker 9592), long intergenic non-protein coding RNA 1516 (LINC01516, marker 9593), long intergenic non-protein coding RNA 1520(LINC01520, marker 9594),long intergenic non-protein coding RNA 1521(LINC01521, marker 9595),long intergenic non-protein coding RNA 1523(LINC01523, marker 9596),long intergenic non-protein coding RNA 1525(LINC01525, marker 9597),long intergenic non-protein coding RNA 1526(LINC01526, marker 9598),long intergenic non-protein coding RNA 1527(LINC01527, marker 9599),long intergenic non-protein coding RNA 1530(LINC01530, marker 9600), long intergenic non-protein coding RNA 1532 (LINC01532, marker 9601), long intergenic non-protein coding RNA 1533 (LINC01533, marker 9602), long intergenic non-protein coding RNA 1535 (LINC01535, marker 9603), long intergenic non-protein coding RNA 1537(LINC01537, marker 9604),long intergenic non-protein coding RNA 1538(LINC01538, marker 9605),long intergenic non-protein coding RNA 1539(LINC01539, marker 9606),long intergenic non-protein coding RNA 1541(LINC01541, Marker 9607),long intergenic non-protein coding RNA 1545(LINC01545, Marker 9608),long intergenic non-protein coding RNA 1547(LINC01547, Marker 9609),long intergenic non-protein coding RNA 1547(LINC01547, marker 9610), long intergenic non-protein coding RNA 1549(LINC01549, marker 9611), long intergenic non-protein coding RNA 1550(LINC01550, marker 9612), long intergenic non-protein coding RNA 1550(LINC01550, marker 9613), long intergenic non-protein coding RNA 1550(LINC01550, marker 9614),long intergenic non-protein coding RNA 1551(LINC01551, marker 9615),long intergenic non-protein coding RNA 1553(LINC01553, marker 9616),long intergenic non-protein coding RNA 1554(LINC01554, marker 9617),long intergenic non-protein coding RNA 1555(LINC01555, marker 9618),long intergenic non-protein coding RNA 1558(LINC01558, marker 9619),long intergenic non-protein coding RNA 1558(LINC01558, marker 9620), long intergenic non-protein coding RNA 1561 (LINC01561, marker 9621), long intergenic non-protein coding RNA 1563 (LINC01563, marker 9622), long intergenic non-protein coding RNA 1565 (LINC01565, marker 9623), long intergenic non-protein coding RNA 1566(LINC01566, marker 9624),long intergenic non-protein coding RNA 1568(LINC01568, marker 9625),long intergenic non-protein coding RNA 1568(LINC01568, marker 9626),long intergenic non-protein coding RNA 1569(LINC01569, marker 9627),long intergenic non-protein coding RNA 1578(LINC01578, marker 9628),long intergenic non-protein coding RNA 1579 /// uncharacterized LOC105369203(LINC01579 /// LOC105369203, marker 9629),long intergenic non-protein coding RNA 1580(LINC01580, marker 9630),long intergenic non-protein coding RNA 1581(LINC01581, marker 9631),long intergenic non-protein coding RNA 1583(LINC01583, marker 9632),long intergenic non-protein coding RNA 1585(LINC01585, marker 9633), long intergenic non-protein coding RNA 1587(LINC01587, marker 9634), long intergenic non-protein coding RNA 1588(LINC01588, marker 9635), long intergenic non-protein coding RNA 1588(LINC01588, marker 9636),long intergenic non-protein coding RNA 1588(LINC01588, marker 9637),long intergenic non-protein coding RNA 1588(LINC01588, marker 9638),long intergenic non-protein coding RNA 1590 /// small integral membrane protein 8( LINC01590 /// SMIM8, marker 9639), long intergenic non-protein coding RNA 1590 /// small integral membrane protein 8(LINC01590 /// SMIM8, marker 9640), long intergenic non-protein coding RNA 1592(LINC01592, marker 9641 ),long intergenic non-protein coding RNA 1599(LINC01599,marker 9642),long intergenic non-protein coding RNA 1600(LINC01600,marker 9643),long intergenic non-protein coding RNA 1607(LINC01607,marker 9644),long intergenic non -protein coding RNA 1607(LINC01607, marker 9645),long intergenic non-protein coding RNA 1613(LINC01613, marker 9646),long intergenic non-protein coding RNA 1614(LINC01614, marker 9647),long intergenic non-protein coding RNA 1616 (LINC01616, marker 9648), long intergenic non-protein coding RNA 1618 (LINC01618, marker 9649), long intergenic non-protein coding RNA 1619 (LINC01619, marker 9650), long intergenic non-protein coding RNA 1620 (LINC01620, marker 9651) ),long intergenic non-protein coding RNA 1620(LINC01620,marker 9652),long intergenic non-protein coding RNA 1620(LINC01620,marker 9653),long intergenic non-protein coding RNA 1622(LINC01622,marker 9654),LINGO1 antisense RNA 1(LINGO1-AS1, marker 9655), LINGO1 antisense RNA 2(LINGO1-AS2, marker 9656), leucine rich repeat and Ig domain containing 2(LINGO2, marker 9657), leucine rich repeat and Ig domain containing 2(LINGO2, marker 9658), lines homolog 1(LINS1, marker 9659), lipase A, lysosomal acid, cholesterol esterase /// uncharacterized LOC101926887(LIPA /// LOC101926887, marker 9660), lipase, hepatic(LIPC, marker 9661), lipase, hormone -sensitive(LIPE, marker 9662), lipase, hormone-sensitive(LIPE, marker 9663), LIPE antisense RNA 1 /// uncharacterized LOC101930071(LIPE-AS1 /// LOC101930071, marker 9664), LIPE antisense RNA 1 /// uncharacterized LOC101930071(LIPE-AS1 /// LOC101930071, marker 9665), lipase, gastric(LIPF, marker 9666), lipase, member H(LIPH, marker 9667), lipase, member H(LIPH, marker 9668), lipase, member I(LIPI, marker 9669), lipase, family member J(LIPJ, marker 9670), lipase, family member J(LIPJ, marker 9671), lipase, family member J(LIPJ, marker 9672), lipase, family member J( LIPJ, marker 9673), lipopolysaccharide-induced TNF factor(LITAF, marker 9674), LKAAEAR motif containing 1(LKAAEAR1, marker 9675), uncharacterized LOC100128594(LL0XNC01-116E7.2, marker 9676), uncharacterized LOC648691(LL22NC03-63E9.3 ,marker 9677),uncharacterized LOC101927722(LL22NC03-75H12.2,marker 9678),lethal giant larvae homolog 1 (Drosophila)(LLGL1,marker 9679),LLP homolog, long-term synaptic facilitation (Aplysia)(LLPH,marker 9680) ,lectin, mannose-binding, 1 like(LMAN1L, marker 9681),lectin, mannose-binding 2(LMAN2, marker 9682),limb development membrane protein 1(LMBR1, marker 9683),LMBR1 domain containing 1(LMBRD1, marker 9684 ),LMBR1 dom
ain containing 2(LMBRD2, marker 9685), LMBR1 domain containing 2(LMBRD2, marker 9686), LIM and cysteine-rich domains 1(LMCD1, marker 9687), lipase maturation factor 1(LMF1, marker 9688), lipase maturation factor 1 (LMF1, marker 9689), lipase maturation factor 1 (LMF1, marker 9690), lipase maturation factor 1 (LMF1, marker 9691), leishmanolysin-like (metallopeptidase M8 family) (LMLN, marker 9692), leishmanolysin-like (metallopeptidase M8 family) (LMLN, marker 9693), lamin A/C (LMNA, marker 9694), lamin tail domain containing 1 (LMNTD1, marker 9695), lamin tail domain containing 2 (LMNTD2, marker 9696), LIM domain only 2 (rhombotin -like 1)(LMO2, marker 9697),LIM domain only 3 (rhombotin-like 2)(LMO3, marker 9698),LIM domain only 3 (rhombotin-like 2)(LMO3, marker 9699),LIM domain only 3 ( rhombotin-like 2)(LMO3, marker 9700),LIM domain only 4(LMO4, marker 9701),LIM domain 7(LMO7, marker 9702),LIM domain 7(LMO7, marker 9703),LIM domain 7(LMO7, marker 9704), LMO7 downstream neighbor(LMO7DN, marker 9705), leiomodin 1 (smooth muscle)(LMOD1, marker 9706), leiomodin 1 (smooth muscle)(LMOD1, marker 9707), leiomodin 2 (cardiac)(LMOD2, marker 9708) , leiomodin 3 (fetal) (LMOD3, marker 9709), leiomodin 3 (fetal) (LMOD3, marker 9710), leiomodin 3 (fetal) (LMOD3, marker 9711), lemur tyrosine kinase 2 (LMTK2, marker 9712), lemur tyrosine kinase 2 (LMTK2, marker 9713), lemur tyrosine kinase 3 (LMTK3, marker 9714), LIM homeobox transcription factor 1, alpha (LMX1A, marker 9715), LIM homeobox transcription factor 1, beta (LMX1B, marker 9716), leucyl/ cystinyl aminopeptidase(LNPEP, marker 9717), leucyl/cystinyl aminopeptidase(LNPEP, marker 9718), leucyl/cystinyl aminopeptidase(LNPEP, marker 9719), uncharacterized LOC100049716(LOC100049716, marker 9720), uncharacterized LOC100049716(LOC100 049716, Marker 9721), FK506 binding protein 6, 36kDa pseudogene /// FK506 binding protein 6, 36kDa pseudogene(LOC100101148 /// LOC541473, marker 9722), uncharacterized LOC100126784(LOC100126784, marker 9723), uncharacterized LOC100126784(LOC100126784, marker 97 24),uncharacterized LOC100126784(LOC100126784, marker 9725), KIAA1191 pseudogene(LOC100127938, marker 9726), uncharacterized LOC100127940(LOC100127940, marker 9727), uncharacterized LOC100127955 /// uncharacterized LOC100128374(LOC100127955 /// LOC100128374 , marker 9728), uncharacterized LOC100127974(LOC100127974, marker 9729), uncharacterized LOC100128079(LOC100128079, marker 9730), uncharacterized LOC100128079(LOC100128079, marker 9731), putative ubiquitin-conjugating enzyme E2Q2-like protein(LOC100128108, marker 9732), four and a half LIM domains 1 pseudogene(LOC100128164, Marker 9733), PNAS- 19(LOC100128185, marker 9734), uncharacterized LOC100128198(LOC100128198, marker 9735), uncharacterized LOC100128239(LOC100128239, marker 9736), uncharacterized LOC100128281(LOC100128281, marker 9737),un characterized LOC100128281(LOC100128281, marker 9738), uncharacterized LOC100128288(LOC100128288, marker 9739), uncharacterized LOC100128325(LOC100128325, marker 9740), uncharacterized LOC100128398 /// uncharacterized LOC100288490(LOC100128398 /// LOC100288490, marker 9741), uncharacterized LOC100128398 /// uncharacterized LOC100288490(LOC100128398 /// LOC100288490, marker 9742), uncharacterized LOC100128554 (LOC100128554, marker 9743), LMNE6487(LOC100128644, marker 9744), INM04(LOC100128751, marker 9745), uncharacterized LOC100128840(LOC100128840, marker 9746), connexin(LOC100128922, marker 9747), uncharacterized LOC100128988(LOC100128988, marker 9748), uncharacterized LOC100128988(LOC100128988, marker 9749), uncharacterized LOC100128993(LOC100128993, marker 9750), uncharacterized LOC100129029(LOC100129029, marker 9751), uncharacterized LOC100129034(LOC100129034, marker 9752), uncharacterized LOC100129069(LOC100129069, marker 9753), serine/arginine repetitive matrix protein 2-like(LOC100129098, marker 9754), uncharacterized LOC100129112(LOC100129112, marker 9755), uncharacterized LOC100129129(LOC100129129, marker 9756), uncharacterized LOC100129175(LOC100129175, marker 9757), PRO2866(LOC100129198, marker 9758), uncharacterized LOC100129380(LOC100129380, marker 9759), uncharacterized LOC100129447(LOC100129447, marker 9760), uncharacterized LOC100129455(LOC100129455, marker 9761), uncharacterized LOC100129455(LOC100129455, marker 9762), uncharacterized LOC100129476( LOC100129476, marker 9763), uncharacterized LOC100129518 /// superoxide dismutase 2, mitochondrial (LOC100129518 /// SOD2, marker 9764), uncharacterized LOC100129603(LOC100129603, marker 9765), uncharacterized LOC100129620(LOC100129620, marker 9766), uncharacterized LOC100129884(LOC100129884, marker 9767) ,uncharacterized LOC100129917(LOC100129917, marker 9768), lectin, galactoside -binding, soluble, 14 pseudogene(LOC100129935, marker 9769), uncharacterized LOC100129973(LOC100129973, marker 9770), uncharacterized LOC100130078(LOC100130078, marker 9771), uncharacterized LOC100130111(LOC100130111, marker 9772), uncharacterized LOC100130111(LOC100130111, marker 9773), LP2209(LOC100130232, marker 9774), uncharacterized LOC100130264(LOC100130264, marker 9775), uncharacterized LOC100130268(LOC100130268, marker 9776), uncharacterized LOC100130278(LOC100130278, marker 9777 ), uncharacterized LOC100130285(LOC100130285, marker 9778), POTE ankyrin domain family, member F pseudogene(LOC100130331, marker 9779),uncharacterized LOC100130357(LOC100130357,marker 9780),uncharacterized LOC100130370(LOC100130370,marker 9781),uncharacterized LOC100130370(LOC100130370,marker 9782),un characterized LOC100130417(LOC100130417, marker 9783), uncharacterized LOC100130417(LOC100130417, marker 9784), uncharacterized LOC100130429 /// uncharacterized LOC105374584(LOC100130429 /// LOC105374584, marker 9785), uncharacterized LOC100130452(LOC100130452, marker 9786), uncharacterized LOC100130456(LOC100 130456, marker 9787), uncharacterized LOC100130458(LOC100130458, marker 9788), uncharacterized LOC100130476(LOC100130476, marker 9789), uncharacterized LOC100130502(LOC100130502, marker 9790), uncharacterized LOC100130548(LOC100130548, marker 9791), uncharacterized LOC100130642 /// uncharacterized LOC10537 4584(LOC100130642 /// LOC105374584, Marker 9792), uncharacterized LOC100130654(LOC100130654, Marker 9793), uncharacterized LOC100130691(LOC100130691, marker 9794), uncharacterized LOC100130705(LOC100130705, marker 9795), uncharacterized LOC100130744(LOC100130744, marker 9796), uncharacterized LOC100130815(LOC 100130815, marker 9797), uncharacterized LOC100130856 /// persephin(LOC100130856 /// PSPN, marker 9798), uncharacterized LOC100130950 (LOC100130950, marker 9799), uncharacterized LOC100130950 (LOC100130950, marker 9800), ADAM metallopeptidase domain 3A-like (LOC100130964, marker 9801), uncharacterized LOC100130992 (LOC100130992, marker 9802), uncharacterized LOC100131053(LOC100131053 , marker 9803), uncharacterized LOC100131170(LOC100131170, marker 9804), uncharacterized LOC100131180(LOC100131180, marker 9805), uncharacterized LOC100131303(LOC100131303, marker 9806), RAD52 motif containing 1 pseudogene(LOC10 0131347, marker 9807), uncharacterized LOC100131496(LOC100131496, marker 9808),PRO2122(LOC100131508,Marker 9809),uncharacterized LOC100131510(LOC100131510,Marker 9810),uncharacterized LOC100131532(LOC100131532,Marker 9811),uncharacterized LOC100131581(LOC100131581 , marker 9812), uncharacterized LOC100131655(LOC100131655, marker 9813), uncharacterized LOC100131662( LOC100131662, marker 9814), uncharacterized LOC100131756(LOC100131756, marker 9815), uncharacterized LOC100131763(LOC100131763, marker 9816), uncharacterized LOC100131860(LOC100131860, marker 9817), uncharacterized LOC100131864(LOC100131864, marker 9818), uncharacterized LOC100132005(LOC100132005, marker 9819) ,phosphodiesterase 4D interacting protein pseudogene(LOC100132057, marker 9820),uncharacterized LOC100132077(LOC100132077,marker 9821),uncharacterized LOC100132078(LOC100132078,marker 9822),uncharacterized LOC100132167(LOC10013216 7, marker 9823), uncharacterized LOC100132207(LOC100132207, marker 9824), uncharacterized LOC100132249(LOC100132249, marker 9825), uncharacterized LOC100132319(LOC100132319, marker 9826), uncharacterized LOC100132356(LOC100132356, marker 9827), PRO0419(LOC100132661, marker 9828), uncharacter ized LOC100132686(LOC100132686, marker 9829), uncharacterized LOC100132735(LOC100132735, marker 9830 ), uncharacterized LOC100133039(LOC100133039, marker 9831), uncharacterized LOC100133131(LOC100133131, marker 9832), uncharacterized LOC100133461(LOC100133461, marker 9833), uncharacterized LOC100133669(LOC10013 3669, marker 9834), uncharacterized LOC100133920(LOC100133920, marker 9835), uncharacterized LOC100133920 / // monofunctional C1-tetrahydrofolate synthase, mitochondrial-like /// monofunctional C1-tetrahydrofolate synthase, mitochondrial-like /// monofunctional C1-tetrahydrofolate synthase, mitochondrial-like /// uncharacterized LOC286297(LOC100133920 /// LOC100996643 /// LOC101928195 /// LOC102724580 /// LOC286297, marker 9836), uncharacterized LOC100133920 /// monofunctional C1-tetrahydrofolate synthase, mitochondrial-like /// monofunctional C1-tetrahydrofolate synthase, mitochondrial-like /// monofunctional C1-tetrahydrofolate synthase, mitochondrial- like /// uncharacterized LOC286297(LOC100133920 /// LOC100996643 /// LOC101928195 /// LOC102724580 /// LOC286297, marker 9837), uncharacterized LOC100133985(LOC100133985, marker 9838), uncharacterized LOC10 0134040(LOC100134040, marker 9839), uncharacterized LOC100134317 / // uncharacterized LOC284412(LOC100134317 /// LOC284412, marker 9840), uncharacterized LOC100134368(LOC100134368, marker 9841), uncharacterized LOC100134445 /// WAS protein family homolog 1 pseudogene /// WAS protein family homolog 2-like /// WAS protein family homolog 1 /// WAS protein family homolog 2 pseudogene /// WAS protein family homolog 3 pseudogene /// WAS protein family homolog 5 pseudogene /// WAS protein family homolog 7 pseudogene(LOC100134445 /// LOC100288778 /// LOC102723897 / // WASH1 /// WASH2P /// WASH3P /// WASH5P /// WASH7P, marker 9842), uncharacterized LOC100134822(LOC100134822, marker 9843), uncharacterized LOC100134937(LOC100134937, marker 9844), uncharacterized LOC100147773(LOC1001 47773, marker 9845) ,tektin 4 pseudogene /// maFF-interacting protein /// MAFF interacting protein (pseudogene) /// tektin 4 pseudogene 2(LOC100233156 /// LOC10537955
4 /// MAFIP /// TEKT4P2, marker 9846),tektin 4 pseudogene /// maFF-interacting protein /// MAFF interacting protein (pseudogene) /// tektin 4 pseudogene 2(LOC100233156 /// LOC105379554 /// MAFIP /// TEKT4P2, marker 9847), tektin 4 pseudogene /// MAFF interacting protein (pseudogene) /// tektin 4 pseudogene 2(LOC100233156 /// MAFIP /// TEKT4P2, marker 9848), uncharacterized LOC100240728(LOC100240728, marker 9849 ), uncharacterized LOC100240728(LOC100240728, marker 9850), uncharacterized LOC100240734(LOC100240734, marker 9851), uncharacterized LOC100240735 /// uncharacterized LOC101928906 /// uncharacterized LOC102723678(LOC100240 735 /// LOC101928906 /// LOC102723678, marker 9852), uncharacterized LOC100268168( LOC100268168, marker 9853), uncharacterized LOC100270804(LOC100270804, marker 9854), uncharacterized LOC100271832(LOC100271832, marker 9855), uncharacterized LOC100272217(LOC100272217, marker 9856), uncharacterized LOC100272217(LOC100272217, marker 9857), DnaJ (Hsp40) homolog, subfamily B , member 3 pseudogene(LOC100286922, marker 9858), uncharacterized LOC100286925(LOC100286925, marker 9859), uncharacterized LOC100287015(LOC100287015, marker 9860), uncharacterized LOC100287210(LOC100287210, marker 986 1),uncharacterized LOC100287221 /// uncharacterized LOC105371401(LOC100287221 /// LOC105371401, Marker 9862), cytokine receptor CRL2(LOC100287290, Marker 9863), cytokine receptor CRL2(LOC100287290, Marker 9864), uncharacterized LOC100287387(LOC100287387, Marker 9865), uncharacterized LOC100287525(LOC 100287525, marker 9866), uncharacterized LOC100287590(LOC100287590, marker 9867), uncharacterized LOC100287704(LOC100287704, marker 9868), uncharacterized LOC100287704 /// uncharacterized LOC100287834(LOC100287704 /// LOC100287834, marker 9869), uncharacterized LOC100287728 /// zinc finger protein 75D(LOC100287728 /// ZNF75D, marker 9870), uncharacterized LOC100287728 /// zinc finger protein 75D(LOC100287728 /// ZNF75D, marker 9871), uncharacterized LOC100287808(LOC100287808, marker 9872), uncharacterized LOC100287877(LOC100287877, marker 9873), uncharacterized LOC10 0288123(LOC100288123, marker 9874), uncharacterized LOC100288181( LOC100288181, marker 9875), uncharacterized LOC100288238(LOC100288238, marker 9876), uncharacterized LOC100288310(LOC100288310, marker 9877), glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast) pseudogene(LOC100288570, marker 9878), cutaneous T-cell lymphoma-associated antigen 1 pseudogene(LOC100288590, marker 9879), ankyrin repeat domain 20 family, member A2 pseudogene(LOC100288656, marker 9880), uncharacterized LOC100288721(LOC100288721, marker 9881), uncharacterized LOC100288798(LOC100288798, marker 9882), un characterized LOC100288893 /// trafficking protein particle complex 12(LOC100288893 /// TRAPPC12, marker 9883), POTE ankyrin domain family member D-like(LOC100288966, marker 9884), uncharacterized LOC100289045(LOC100289045, marker 9885), uncharacterized LOC100289058(LOC100289058, marker 98 86),uncharacterized LOC100289061(LOC100289061 , marker 9887), uncharacterized LOC100289094(LOC100289094, marker 9888), uncharacterized LOC100289230(LOC100289230, marker 9889), cytoskeleton associated protein 2-like pseudogene /// uncharacterized LOC105369219(LOC100289473 /// LOC105 369219, marker 9890), uncharacterized LOC100289495(LOC100289495 ,marker 9891),immunoglobin superfamily, member 21 pseudogene(LOC100289518,marker 9892),immunoglobin superfamily, member 21 pseudogene(LOC100289518,marker 9893),serologically defined breast cancer antigen NY-BR-40(LOC100291666,marker 9894),serine/ arginine repetitive matrix protein 3-like(LOC100293704, marker 9895), uncharacterized LOC100294145(LOC100294145, marker 9896), uncharacterized LOC100294362(LOC100294362, marker 9897), uncharacterized LOC100379224(LOC100379224, marker 9898), zinc finger protein 772 pseudogene (LOC100419741, marker 9899), thyroid hormone receptor interactor 11 pseudogene (LOC100421171, marker 9900), MAP/microtubule affinity-regulating kinase 2 pseudogene (LOC100421494, marker 9901), P antigen family, member 5 (prostate associated) pseudogene /// P antigen family, member 5 (prostate associated)(LOC100421746 /// PAGE5, marker 9902), eukaryotic translation initiation factor 3, subunit J pseudogene(LOC100422212, marker 9903), proteasome activator subunit 3 pseudogene(LOC100422526, marker 9904), uncharacterized LOC100422737(LOC10042273 7, marker 9905), uncharacterized LOC100422737(LOC100422737, marker 9906), uncharacterized LOC100422781(LOC100422781, marker 9907), uncharacterized LOC100499194(LOC100499194, marker 9908), uncharacterized LOC100499489( LOC100499489, marker 9909), uncharacterized LOC100499489(LOC100499489, marker 9910), uncharacterized LOC100505478(LOC100505478, marker 9911), uncharacterized LOC100505498(LOC100505498, marker 9912), uncharacterized LOC100505498(LOC100505498, marker 9913), uncharacterized LOC100505498 /// testis expressed 41 (non-protein coding)(LOC100505498 /// TEX41, marker 9914) ,uncharacterized LOC100505515(LOC100505515, marker 9915),uncharacterized LOC100505530(LOC100505530,marker 9916),uncharacterized LOC100505534(LOC100505534,marker 9917),uncharacterized LOC100505555 /// zinc finger protein 8 46(LOC100505555 /// ZNF846, marker 9918), uncharacterized LOC100505564 (LOC100505564, marker 9919), uncharacterized LOC100505570(LOC100505570, marker 9920), uncharacterized LOC100505609(LOC100505609, marker 9921), uncharacterized LOC100505609(LOC100505609, marker 9922), uncharacterized LOC100505622(LOC100505622, marker 9923), uncharacterized LOC100505635(LOC100505635, marker 9924 ), uncharacterized LOC100505658(LOC100505658, marker 9925), uncharacterized LOC100505664(LOC100505664, marker 9926), uncharacterized LOC100505666(LOC100505666, marker 9927), uncharacterized LOC100505685(LOC10050 5685, marker 9928), uncharacterized LOC100505711(LOC100505711, marker 9929), uncharacterized LOC100505716( LOC100505716, marker 9930), uncharacterized LOC100505727(LOC100505727, marker 9931), uncharacterized LOC100505774(LOC100505774, marker 9932), uncharacterized LOC100505782(LOC100505782, marker 9933), uncharacterized LOC100505784(LOC100505784, marker 9934), myosin heavy chain IB-like(LOC100505797 , marker 9935), uncharacterized LOC100505817(LOC100505817, marker 9936), uncharacterized LOC100505824(LOC100505824, marker 9937), zinc finger protein 474-like(LOC100505841, marker 9938), uncharacterized LOC100505851(LOC10 0505851, marker 9939), uncharacterized LOC100505851(LOC100505851, marker 9940), uncharacterized LOC100505853(LOC100505853, marker 9941), uncharacterized LOC100505874(LOC100505874, marker 9942), uncharacterized LOC100505878(LOC100505878, marker 9943), uncharacterized LOC100505912( LOC100505912, marker 9944), uncharacterized LOC100505915(LOC100505915, marker 9945), uncharacterized LOC100505918(LOC100505918, marker 9946), uncharacterized LOC100505920(LOC100505920, marker 9947), uncharacterized LOC100505942(LOC100505942, marker 9948), uncharacterized LOC100505978(LOC100505978, marker 9949), uncharacterized LOC100505985(LOC100505985, marker 9950), uncharacterized LOC100506016(LOC100506016, marker 9951), uncharacterized LOC100506022(LOC100506022, marker 9952), uncharacterized LOC100506047(LOC100506047, marker 9953), uncharacterized LOC100506071(LOC100506071, marker 9954), uncharacterized LOC100506082(LOC 100506082, marker 9955), uncharacterized LOC100506083(LOC100506083, marker 9956), uncharacterized LOC100506113 (LOC100506113, marker 9957), uncharacterized LOC100506114(LOC100506114, marker 9958), uncharacterized LOC100506122(LOC100506122, marker 9959), uncharacterized LOC100506125(LOC100506125, marker 9960), putative uncharacter ized protein FLJ37770-like (LOC100506127, marker 9961), putative uncharacterized protein FLJ37770-like(LOC100506127, marker 9962), uncharacterized LOC100506142(LOC100506142, marker 9963), uncharacterized LOC100506142(LOC100506142, marker 9964), uncharacterized LOC100506175(LOC100506175, marker 9 965), uncharacterized LOC100506207(LOC100506207, marker 9966), uncharacterized LOC100506207(LOC100506207 ,marker 9967),uncharacterized LOC100506236(LOC100506236,marker 9968),uncharacterized LOC100506258(LOC100506258,marker 9969),uncharacterized LOC100506258(LOC100506258,marker 9970),uncharacterized LOC100506271 (LOC100506271, marker 9971), uncharacterized LOC100506272(LOC100506272, marker 9972), uncharacterized LOC100506274(LOC100506274, marker 9973), uncharacterized LOC100506274(LOC100506274, marker 9974), uncharacterized LOC100506282(LOC100506282, marker 9975), uncharacterized LOC100506282(LOC1005062 82, marker 9976), uncharacterized LOC100506286(LOC100506286, marker 9977), uncharacterized LOC100506289(LOC100506289, marker 9978), uncharacterized LOC100506314(LOC100506314, marker 9979), uncharacterized LOC100506314(LOC100506314, marker 9980), uncharacterized LOC100506319(LOC100506319, marker 9981), uncharacterized LOC100506331( LOC100506331, marker 9982), uncharacterized LOC100506368(LOC100506368, marker 9983), uncharacterized LOC100506371(LOC100506371, marker 9984), uncharacterized LOC100506374(LOC100506374, marker 9985), uncharacterized LOC100506388(LOC100506388, marker 9986), uncharacterized LOC100506403 /// uncharacterized LOC10192 8269 /// runt-related transcription factor 1(LOC100506403 /// LOC101928269 // / RUNX1, marker 9987), uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9988), uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9989) ,uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9990),uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9991),uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9992),uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9993),uncharacterized LOC100506403 /// runt-related transcription factor 1 (LOC100506403 /// RUNX1, marker 9994), uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9995), uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1 , marker 9996), uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker
9997), uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9998), uncharacterized LOC100506403 /// runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 9999), uncharacterized LOC100506403 / // runt-related transcription factor 1(LOC100506403 /// RUNX1, marker 10000), uncharacterized LOC100506406(LOC100506406, marker 10001), uncharacterized LOC100506411(LOC100506411, marker 10002), uncharacterized LOC100506446(LOC100 506446, marker 10003), uncharacterized LOC100506459 // / uncharacterized LOC105378922(LOC100506459 /// LOC105378922, marker 10004), uncharacterized LOC100506470(LOC100506470, marker 10005), uncharacterized LOC100506472(LOC100506472, marker 10006), uncharacterized LOC1 00506472(LOC100506472, marker 10007), uncharacterized LOC100506476(LOC100506476, marker 10008), uncharacterized LOC100506489(LOC100506489, marker 10009), uncharacterized LOC100506497(LOC100506497, marker 10010), uncharacterized LOC100506497(LOC100506497, marker 10011), uncharacterized LOC100506498(LOC1005 06498, marker 10012), uncharacterized LOC100506504(LOC100506504, marker 10013), uncharacterized LOC100506526(LOC100506526, marker 10014), uncharacterized LOC100506530(LOC100506530, marker 10015), uncharacterized LOC100506557(LOC100506557, marker 10016), uncharacterized LOC100506563(LOC100506563, marker 10017), uncharacterized LOC100506 571(LOC100506571, marker 10018), uncharacterized LOC100506585(LOC100506585, marker 10019), uncharacterized LOC100506606(LOC100506606, marker 10020), uncharacterized LOC100506639(LOC100506639, marker 10021), uncharacterized LOC100506667(LOC100506667, marker 10022), uncharacterized LOC100506675(LOC1005066 75, marker 10023), uncharacterized LOC100506675(LOC100506675, marker 10024), uncharacterized LOC100506679(LOC100506679, marker 10025), uncharacterized LOC100506699(LOC100506699, marker 10026), uncharacterized LOC100506725(LOC100506725, marker 10027), uncharacterized LOC100506731(LOC100506731, marker 10028), uncharacterized LOC1005067 90(LOC100506790, marker 10029), uncharacterized LOC100506813 /// uncharacterized LOC105373076(LOC100506813 // / LOC105373076, marker 10030), uncharacterized LOC100506844(LOC100506844, marker 10031), uncharacterized LOC100506851(LOC100506851, marker 10032), uncharacterized LOC100506858(LOC100506858, marker 10033) ,uncharacterized LOC100506860(LOC100506860, marker 10034),uncharacterized LOC100506860(LOC100506860, marker 10035 ), uncharacterized LOC100506885(LOC100506885, marker 10036), uncharacterized LOC100506895(LOC100506895, marker 10037), uncharacterized LOC100506929(LOC100506929, marker 10038), uncharacterized LOC100506999(LOC10 0506999, marker 10039), uncharacterized LOC100507006(LOC100507006, marker 10040), uncharacterized LOC100507053( LOC100507053, marker 10041), uncharacterized LOC100507053(LOC100507053, marker 10042), uncharacterized LOC100507065 /// uncharacterized LOC105369187(LOC100507065 /// LOC105369187, marker 10043), uncharacterized LOC 100507073(LOC100507073, marker 10044), uncharacterized LOC100507103(LOC100507103, marker 10045) ,uncharacterized LOC100507140(LOC100507140,Marker 10046),uncharacterized LOC100507194(LOC100507194,Marker 10047),uncharacterized LOC100507201(LOC100507201,Marker 10048),uncharacterized LOC100507221 /// uncharacter ized LOC105369266(LOC100507221 /// LOC105369266, marker 10049), uncharacterized LOC100507250(LOC100507250 ,marker 10050),uncharacterized LOC100507277(LOC100507277,marker 10051),uncharacterized LOC100507283(LOC100507283,marker 10052),uncharacterized LOC100507283(LOC100507283,marker 10053),uncharacterized LOC10050 7291(LOC100507291, marker 10054), uncharacterized LOC100507311(LOC100507311, marker 10055), uncharacterized LOC100507330(LOC100507330, marker 10056), uncharacterized LOC100507336(LOC100507336, marker 10057), uncharacterized LOC100507351(LOC100507351, marker 10058), uncharacterized LOC100507377(LOC1005 07377, marker 10059), uncharacterized LOC100507384(LOC100507384, marker 10060), uncharacterized LOC100507388(LOC100507388, marker 10061), uncharacterized LOC100507389(LOC100507389, marker 10062), uncharacterized LOC100507389(LOC100507389, marker 10063), uncharacterized LOC100507391(LOC100507391, marker 10064), uncharacterized LOC100507 395(LOC100507395, marker 10065), uncharacterized LOC100507403(LOC100507403, marker 10066), uncharacterized LOC100507431(LOC100507431, Marker 10067), uncharacterized LOC100507443(LOC100507443, Marker 10068), uncharacterized LOC100507461(LOC100507461, Marker 10069), uncharacterized LOC100507468(LOC1005074 68, marker 10070), uncharacterized LOC100507477(LOC100507477, marker 10071), uncharacterized LOC100507477(LOC100507477, marker 10072),uncharacterized LOC100507480(LOC100507480,Marker 10073),uncharacterized LOC100507494(LOC100507494,Marker 10074),uncharacterized LOC100507494(LOC100507494,Marker 10075),uncharacterized LOC1005075 06(LOC100507506, marker 10076), uncharacterized LOC100507513(LOC100507513, marker 10077), uncharacterized LOC100507516 (LOC100507516, marker 10078), uncharacterized LOC100507516(LOC100507516, marker 10079), uncharacterized LOC100507534(LOC100507534, marker 10080), uncharacterized LOC100507537(LOC100507537, marker 10081), uncharacterized LOC100507547 /// proline-rich transmembrane protein 1(LOC100507547 /// PRRT1, marker 10082), uncharacterized LOC100507547 /// proline-rich transmembrane protein 1(LOC100507547 /// PRRT1, marker 10083), uncharacterized LOC100507547 /// proline-rich transmembrane protein 1(LOC100507547 /// PRRT1, marker 10084), uncharacterized LOC100507557(LOC100507557, marker 10085), uncharacterized LOC100507560(LOC100507560, marker 10086), uncharacterized LOC100507562(LOC100507562, marker 10087), uncharacterized LOC100507564(LOC1005 07564, marker 10088), uncharacterized LOC100507577 /// lon peptidase 2, peroxisomal /// siah E3 ubiquitin protein ligase 1(LOC100507577 /// LONP2 /// SIAH1, marker 10089), uncharacterized LOC100507600(LOC100507600, marker 10090), uncharacterized LOC100507634(LOC100507634, marker 10091), uncharacterized LOC10050 7634(LOC100507634, marker 10092), uncharacterized LOC100507642( LOC100507642, marker 10093), uncharacterized LOC100507654(LOC100507654, marker 10094), uncharacterized LOC100507654(LOC100507654, marker 10095), uncharacterized LOC100508046 /// uncharacterized LOC101929572 /// POTE H antisense RNA 1(LOC100508046 /// LOC101929572 /// POTEH-AS1 ,marker 10096),uncharacterized LOC100508631(LOC100508631,marker 10097),uncharacterized LOC100509303(LOC100509303,marker 10098),uncharacterized LOC100509814(LOC100509814,marker 10099),LOC100289561 -PRKRIP1 readthrough(LOC100630923, marker 10100), uncharacterized 100631378(LOC100631378, marker 10101 ),uncharacterized 100631378(LOC100631378,Marker 10102),uncharacterized LOC100652768(LOC100652768,Marker 10103),uncharacterized LOC100652911(LOC100652911,Marker 10104),uncharacterized LOC100652999(LOC100 652999, marker 10105), uncharacterized LOC100653233(LOC100653233, marker 10106), uncharacterized LOC100996246( LOC100996246, marker 10107), uncharacterized LOC100996251(LOC100996251, marker 10108), uncharacterized LOC100996255(LOC100996255, marker 10109), uncharacterized LOC100996263(LOC100996263, marker 10110), uncharacterized LOC100996286(LOC100996286, marker 10111), uncharacterized LOC100996325(LOC100996325, marker 10112) ,uncharacterized LOC100996342(LOC100996342, marker 10113),uncharacterized LOC100996345(LOC100996345,marker 10114),uncharacterized LOC100996385(LOC100996385,marker 10115),uncharacterized LOC100996385 /// chromosome alignment -maintaining phosphoprotein 1-like /// uncharacterized LOC105379685(LOC100996385 // / LOC105377772 /// LOC105379685, marker 10116), uncharacterized LOC100996404(LOC100996404, marker 10117), uncharacterized LOC100996419(LOC100996419, marker 10118), uncharacterized LOC100996419(LOC1009 96419, marker 10119), uncharacterized LOC100996455(LOC100996455, marker 10120), uncharacterized LOC100996506( LOC100996506, marker 10121), uncharacterized LOC100996506(LOC100996506, marker 10122), uncharacterized LOC100996549(LOC100996549, marker 10123), uncharacterized LOC100996583(LOC100996583, marker 10124), uncharacterized LOC100996624(LOC100996624, marker 10125),uncharacterized LOC100996654(LOC100996654, marker 10126) ,uncharacterized LOC100996671(LOC100996671, marker 10127),uncharacterized LOC100996681(LOC100996681,marker 10128),CAVP-target protein-like /// SPEG complex locus(LOC100996693 /// SPEG,marker 10129),CAVP-target protein-like // / SPEG complex locus(LOC100996693 /// SPEG,marker 10130),uncharacterized LOC100996694(LOC100996694,marker 10131),phosphodiesterase 4D interacting protein-like(LOC100996724,marker 10132),phosphodiesterase 4D interacting protein-like /// phosphodiesterase 4D interacting protein -like /// phosphodiesterase 4D interacting protein(LOC100996724 /// LOC653513 /// PDE4DIP, marker 10133),phosphodiesterase 4D interacting protein-like /// phosphodiesterase 4D interacting protein(LOC100996724 /// PDE4DIP, marker 10134),phosphodiesterase 4D protein interacting-like /// phosphodiesterase 4D protein(LOC100996724 /// PDE4DIP,marker 10135),uncharacterized LOC100996741 /// uncharacterized LOC105371224 /// uncharacterized LOC105371420 /// uncharacterized LOC388692(LOC100996741 /// LOC10537 1224 /// LOC105371420 / // LOC388692, marker 10136), uncharacterized LOC100996756(LOC100996756, marker 10137), uncharacterized LOC100996902(LOC100996902, marker 10138), uncharacterized LOC101059948(LOC101059948, marker 10139), uncharacter ized LOC101060019(LOC101060019, Marker 10140), uncharacterized LOC101060091(LOC101060091, Marker 10141),uncharacterized LOC101060157(LOC101060157,Marker 10142),uncharacterized LOC101060179 /// PR domain containing 11(LOC101060179 /// PRDM11,Marker 10143),nuclear pore complex-interacting protein family member B4-like /// nuclear pore complex- protein interacting family member B5-like interacting /// nuclear pore complex protein pseudogene /// nuclear pore complex interacting protein family, member A2 /// nuclear pore complex interacting protein family, member B11 /// nuclear pore complex interacting protein family, member B1, pseudogene /// nuclear pore complex interacting protein family, member B3 /// nuclear pore complex interacting protein family, member B4 /// nuclear pore complex interacting protein family
ly, member B5(LOC101060275 /// LOC105369248 /// LOC613037 /// NPIPA2 /// NPIPB11 /// NPIPB1P /// NPIPB3 /// NPIPB4 /// NPIPB5, marker 10144), putative uncharacterized SMG1-like protein / // uncharacterized LOC105371127 /// SMG1 phosphatidylinositol 3-kinase-related kinase /// SMG1 pseudogene 1 /// SMG1 pseudogene 2 /// SMG1 pseudogene 3 /// SMG1 pseudogene 5(LOC101060386 /// LOC105371127 /// SMG1 / // smg1p1 /// smg1p2 /// smg1p3 //// smg1p5, marker 10145), UNCHARACTERIZED LOC101060400 (LOC101060400, Marker 10146), UNCHARACTERIZED LOC1060400 (LOC 101060400, marker 10147), Polycystin-1-Like /// Polycystin-1- like /// NPIP-like protein 1 /// nuclear pore complex interacting protein family, member A1 /// nuclear pore complex interacting protein family, member A2 /// nuclear pore complex protein family, member A3 /// nuclear pore complex interacting protein family, member A5 /// nuclear pore complex protein family, member A7 /// nuclear pore complex interacting protein family, member A8 /// polycystic kidney disease 1 (autosomal dominant) /// polycystic kidney disease 1 ( autosomal dominant) pseudogene 1 /// polycystic kidney disease 1 (autosomal dominant) pseudogene 5(LOC101060429 /// LOC101930013 /// LOC102724993 /// NPIPA1 /// NPIPA2 /// NPIPA3 /// NPIPA5 /// NPIPA7 // / NPIPA8 /// PKD1 /// PKD1P1 /// PKD1P5, marker 10148), DNA-directed RNA polymerase III subunit RPC5 /// polymerase (RNA) III (DNA directed) polypeptide E (80kD)(LOC101060521 /// POLR3E ,marker 10149),uncharacterized LOC101060553(LOC101060553,marker 10150),uncharacterized LOC101559451(LOC101559451,marker 10151),uncharacterized LOC101593348(LOC101593348,marker 10152),uncharacterized LOC10180 5491 /// transmembrane protein 247(LOC101805491 /// TMEM247, marker 10153) ,uncharacterized LOC101805491 /// transmembrane protein 247(LOC101805491 /// TMEM247, marker 10154), uncharacterized LOC101926892(LOC101926892, marker 10155), uncharacterized LOC101926907(LOC101926907, marker 10156) ,uncharacterized LOC101926913(LOC101926913,marker 10157),uncharacterized LOC101926913( LOC101926913, marker 10158), uncharacterized LOC101926915(LOC101926915, marker 10159), uncharacterized LOC101926934(LOC101926934, marker 10160), uncharacterized LOC101926942(LOC101926942, marker 10161), uncharacterized LOC101926943(LOC101926943, marker 10162), uncharacterized LOC101926944(LOC101926944, marker 10163) ,uncharacterized LOC101926948(LOC101926948,Marker 10164),uncharacterized LOC101926951(LOC101926951,Marker 10165),uncharacterized LOC101926959(LOC101926959,Marker 10166),uncharacterized LOC101926960(LOC10 1926960, Marker 10167), uncharacterized LOC101926962(LOC101926962, Marker 10168), uncharacterized LOC101926963(LOC101926963 , marker 10169), uncharacterized LOC101926969(LOC101926969, marker 10170), uncharacterized LOC101926975(LOC101926975, marker 10171), putative uncharacterized protein FLJ43826(LOC101926984, marker 10172), uncharacterized LOC101926 997(LOC101926997, Marker 10173), uncharacterized LOC101927018(LOC101927018, Marker 10174 ), uncharacterized LOC101927020(LOC101927020, marker 10175), uncharacterized LOC101927021(LOC101927021, marker 10176), uncharacterized LOC101927027(LOC101927027, marker 10177), uncharacterized LOC101927038(LOC10 1927038, marker 10178), uncharacterized LOC101927040(LOC101927040, marker 10179), uncharacterized LOC101927043( LOC101927043, marker 10180), uncharacterized LOC101927043(LOC101927043, marker 10181), uncharacterized LOC101927044(LOC101927044, marker 10182), uncharacterized LOC101927051(LOC101927051, marker 10183), uncharacterized LOC101927051(LOC101927051, marker 10184),uncharacterized LOC101927051(LOC101927051, marker 10185) ,uncharacterized LOC101927055 /// TTN antisense RNA 1(LOC101927055 /// TTN-AS1, marker 10186), uncharacterized LOC101927057 /// oligodendrocyte myelin glycoprotein(LOC101927057 /// OMG, marker 10187), uncharacterized LOC101927058(LOC10 1927058, marker 10188) ,uncharacterized LOC101927059(LOC101927059,Marker 10189),uncharacterized LOC101927066(LOC101927066,Marker 10190),uncharacterized LOC101927069(LOC101927069,Marker 10191),uncharacterized LOC101927079(LOC10 1927079, marker 10192), uncharacterized LOC101927079 /// olfactory receptor 4N4 /// olfactory receptor 4N4 /// uncharacterized LOC727924 /// olfactory receptor, family 4, subfamily N, member 4(LOC101927079 /// LOC102723532 /// LOC105369274 /// LOC727924 /// OR4N4, marker 10193), uncharacterized LOC101927079 /// olfactory receptor 4N4 /// uncharacterized LOC727924(LOC101927079 /// LOC102723532 /// LOC727924, marker 10194), uncharacterized LOC101927079 /// uncharacterized LOC727924 /// olfactory receptor, family 4, subfamily N, member 4(LOC101927079 /// LOC7 27924 // LOC1 01927098(LOC101927098, Marker 10199), uncharacterized LOC101927121(LOC101927121, Marker 10200 ), uncharacterized LOC101927121(LOC101927121, marker 10201), uncharacterized LOC101927123(LOC101927123, marker 10202), uncharacterized LOC101927124(LOC101927124, marker 10203), uncharacterized LOC101927126(LOC10 1927126, marker 10204), uncharacterized LOC101927131(LOC101927131, marker 10205), uncharacterized LOC101927138( LOC101927138, marker 10206), uncharacterized LOC101927157(LOC101927157, marker 10207), uncharacterized LOC101927159(LOC101927159, marker 10208), uncharacterized LOC101927164(LOC101927164, marker 10209), uncharacterized LOC101927165(LOC101927165, marker 10210), uncharacterized LOC101927166(LOC101927166, marker 10211) ,uncharacterized LOC101927181(LOC101927181,Marker 10212),uncharacterized LOC101927196(LOC101927196,Marker 10213),uncharacterized LOC101927204(LOC101927204,Marker 10214),uncharacterized LOC101927210(LOC10 1927210, Marker 10215), uncharacterized LOC101927211(LOC101927211, Marker 10216), uncharacterized LOC101927228(LOC101927228 ,marker 10217),uncharacterized LOC101927237(LOC101927237,marker 10218),uncharacterized LOC101927244(LOC101927244,marker 10219),uncharacterized LOC101927248(LOC101927248,marker 10220),uncharacterized LOC10192 7253(LOC101927253, marker 10221), uncharacterized LOC101927254(LOC101927254, marker 10222), uncharacterized LOC101927256(LOC101927256, marker 10223), uncharacterized LOC101927257(LOC101927257, marker 10224), uncharacterized LOC101927263(LOC101927263, marker 10225), uncharacterized LOC101927268 /// uncharacterized LOC102724851 /// uncharacterized LOC105374994(LOC101927268 /// LOC102724851 /// LOC105374994, marker 10226), uncharacterized LOC101927268 /// uncharacterized LOC102724851 /// uncharacterized LOC105374994(LOC101927268 /// LOC102724851 /// LOC105374994, marker 10227), uncharacterized LOC101927272(LOC10192 7272, Marker 10228), uncharacterized LOC101927274(LOC101927274, Marker 10229), uncharacterized LOC101927278(LOC101927278, Marker 10230), uncharacterized LOC101927282(LOC101927282, Marker 10231), uncharacterized LOC101927286(LOC101927286, Marker 10232), uncharacterized LOC101927292(LOC1019272 92, marker 10233), uncharacterized LOC101927305(LOC101927305, marker 10234), uncharacterized LOC101927310(LOC101927310, marker 10235),uncharacterized LOC101927313(LOC101927313,Marker 10236),uncharacterized LOC101927314(LOC101927314,Marker 10237),uncharacterized LOC101927330(LOC101927330,Marker 10238),uncharacterized LOC1019273 31(LOC101927331, marker 10239), uncharacterized LOC101927339(LOC101927339, marker 10240), uncharacterized LOC101927340 (LOC101927340, marker 10241), uncharacterized LOC101927342(LOC101927342, marker 10242), uncharacterized LOC101927346(LOC101927346, marker 10243), uncharacterized LOC101927348(LOC101927348, marker 10244), uncharacterized LOC101927358(LOC101927358, marker 10245), uncharacterized LOC101927359(LOC101927359, marker 10246 ), uncharacterized LOC101927362(LOC101927362, marker 10247), uncharacterized LOC101927363(LOC101927363, marker 10248), uncharacterized LOC101927365(LOC101927365, marker 10249), uncharacterized LOC101927377(LOC10 1927377, marker 10250), uncharacterized LOC101927377(LOC101927377, marker 10251), uncharacterized LOC101927379( LOC101927379, marker 10252), uncharacterized LOC101927391(LOC101927391, marker 10253), uncharacterized proline-rich protein-like(LOC101927402, marker 10254), uncharacterized LOC101927406(LOC101927406, marker 10255), uncharacterized LOC101927410(LOC101927410, marker 10256),uncharacterized LOC101927411( LOC101927411, marker 10257), uncharacterized LOC101927416(LOC101927416, marker 10258), uncharacterized LOC101927417(LOC101927417, marker 10259), uncharacterized LOC101927424 /// uncharacterized LOC101929800 /// uncharacter ized LOC440896(LOC101927424 /// LOC101929800 /// LOC440896, Marker 10260) ,uncharacterized LOC101927432(LOC101927432,Marker 10261),uncharacterized LOC101927438(LOC101927438,Marker 10262),uncharacterized LOC101927447(LOC101927447,Marker 10263),uncharacterized LOC101927450(LOC10 1927450, marker 10264), uncharacterized LOC101927460(LOC101927460, marker 10265), uncharacterized LOC101927467(LOC101927467 ,marker 10266),uncharacterized LOC101927479(LOC101927479,marker 10267),uncharacterized LOC101927482(LOC101927482,marker 10268),uncharacterized LOC101927490(LOC101927490,marker 10269),uncharacterized LOC10192 7494(LOC101927494, marker 10270), uncharacterized LOC101927495(LOC101927495, marker 10271), uncharacterized LOC101927499(LOC101927499, marker 10272), uncharacterized LOC101927502(LOC101927502, marker 10273), collagen alpha-1(III) chain-like(LOC101927503, marker 10274), uncharacterized LOC101927513(LOC101927 513, Marker 10275), uncharacterized LOC101927516(LOC101927516, Marker 10276),uncharacterized LOC101927516(LOC101927516,Marker 10277),uncharacterized LOC101927523(LOC101927523,Marker 10278),uncharacterized LOC101927526(LOC101927526,Marker 10279),uncharacterized LOC1019275 31(LOC101927531, marker 10280), uncharacterized LOC101927533 /// uncharacterized LOC440867(LOC101927533 // / LOC440867, marker 10281), uncharacterized LOC101927534(LOC101927534, marker 10282), uncharacterized LOC101927539(LOC101927539, marker 10283), uncharacterized LOC101927543(LOC101927543, marker 10284), uncharacter ized LOC101927550(LOC101927550, marker 10285), uncharacterized LOC101927552 /// uncharacterized LOC102
724057(LOC101927552 /// LOC102724057, marker 10286), uncharacterized LOC101927553(LOC101927553, marker 10287), uncharacterized LOC101927560 /// uncharacterized LOC101927587(LOC101927560 /// LOC101 927587, marker 10288), dynamin-1-like /// uncharacterized LOC101928042 / // uncharacterized LOC102725021(LOC101927579 /// LOC101928042 /// LOC102725021, Marker 10289), uncharacterized LOC101927588(LOC101927588, Marker 10290), uncharacterized LOC101927592(LOC101927592, Marker 10291), uncharacterized LOC101927603(LOC101927603, Marker 10292), uncharacterized LOC101927604(LOC101927604 ,marker 10293),uncharacterized LOC101927606(LOC101927606,marker 10294),uncharacterized LOC101927606(LOC101927606,marker 10295),uncharacterized LOC101927608(LOC101927608,marker 10296),uncharacterized LOC10192 7609(LOC101927609, Marker 10297), uncharacterized LOC101927610(LOC101927610, Marker 10298), uncharacterized LOC101927610(LOC101927610, marker 10299), uncharacterized LOC101927616(LOC101927616, marker 10300), uncharacterized LOC101927620(LOC101927620, marker 10301), uncharacterized LOC101927623(LOC1019 27623, marker 10302), uncharacterized LOC101927636(LOC101927636, marker 10303), uncharacterized LOC101927640(LOC101927640, marker 10304), uncharacterized LOC101927641(LOC101927641, marker 10305), uncharacterized LOC101927647(LOC101927647, marker 10306), uncharacterized LOC101927648(LOC101927648, marker 10307), uncharacterized LOC101927 650(LOC101927650, marker 10308), uncharacterized LOC101927651(LOC101927651, marker 10309), uncharacterized LOC101927653(LOC101927653, marker 10310), uncharacterized LOC101927657(LOC101927657, marker 10311), uncharacterized LOC101927660(LOC101927660, marker 10312), heat shock transcription factor, X-linked-like /// heat shock transcription factor, X-linked- like( LOC101927685 /// LOC101928917, marker 10313), uncharacterized LOC101927690(LOC101927690, marker 10314), uncharacterized LOC101927701(LOC101927701, marker 10315), uncharacterized LOC101927709(LOC10192 7709, marker 10316), uncharacterized LOC101927723(LOC101927723, marker 10317), uncharacterized LOC101927735(LOC101927735 , marker 10318), uncharacterized LOC101927752(LOC101927752, marker 10319), uncharacterized LOC101927759 /// NAD(P)H dehydrogenase, quinone 2(LOC101927759 /// NQO2, marker 10320), uncharacterized LOC101927760(LOC1019 27760, marker 10321), uncharacterized LOC101927766 (LOC101927766, marker 10322), uncharacterized LOC101927768(LOC101927768, marker 10323), uncharacterized LOC101927769(LOC101927769, marker 10324), uncharacterized LOC101927770(LOC101927770, marker 10325), uncharacterized LOC101927787(LOC101927787, marker 10326), uncharacterized LOC101927790(LOC101927790, marker 10327 ), uncharacterized LOC101927798(LOC101927798, marker 10328), uncharacterized LOC101927798(LOC101927798, marker 10329), uncharacterized LOC101927809(LOC101927809, marker 10330), uncharacterized LOC101927811(LOC10 1927811, marker 10331), uncharacterized LOC101927814(LOC101927814, marker 10332), uncharacterized LOC101927814( LOC101927814, marker 10333), uncharacterized LOC101927815(LOC101927815, marker 10334), uncharacterized LOC101927829(LOC101927829, marker 10335), uncharacterized LOC101927830 /// TMLHE antisense RNA 1(LOC1019278 30 /// TMLHE-AS1, marker 10336), uncharacterized LOC101927837(LOC101927837 ,marker 10337),uncharacterized LOC101927839(LOC101927839,marker 10338),uncharacterized LOC101927843(LOC101927843,marker 10339),uncharacterized LOC101927849(LOC101927849,marker 10340),uncharacterized LOC10192 7851(LOC101927851, marker 10341), uncharacterized LOC101927851(LOC101927851, marker 10342), uncharacterized LOC101927851(LOC101927851, marker 10343), uncharacterized LOC101927865(LOC101927865, marker 10344), uncharacterized LOC101927869(LOC101927869, marker 10345), uncharacterized LOC101927870(LOC1019 27870, marker 10346), uncharacterized LOC101927870(LOC101927870, marker 10347), uncharacterized LOC101927876(LOC101927876, marker 10348), uncharacterized LOC101927877(LOC101927877, marker 10349), uncharacterized LOC101927884(LOC101927884, marker 10350), uncharacterized LOC101927901(LOC101927901, marker 10351), uncharacterized LOC101927 907(LOC101927907, Marker 10352), uncharacterized LOC101927910(LOC101927910, Marker 10353), uncharacterized LOC101927914(LOC101927914, Marker 10354), uncharacterized LOC101927934(LOC101927934, Marker 10355), uncharacterized LOC101927943(LOC101927943, Marker 10356), uncharacterized LOC101927948(LOC1019279 48, marker 10357), uncharacterized LOC101927950(LOC101927950, marker 10358), uncharacterized LOC101927958(LOC101927958, marker 10359), uncharacterized LOC101927967(LOC101927967, marker 10360), uncharacterized LOC101927972(LOC101927972, marker 10361), uncharacterized LOC101928000(LOC101928000, marker 10362), uncharacterized LOC1019280 02(LOC101928002, marker 10363), uncharacterized LOC101928009(LOC101928009, marker 10364), uncharacterized LOC101928012 (LOC101928012, marker 10365), uncharacterized LOC101928014(LOC101928014, marker 10366), uncharacterized LOC101928020(LOC101928020, marker 10367), uncharacterized LOC101928026(LOC101928026, marker 10368), uncharacterized LOC101928031(LOC101928031, marker 10369), uncharacterized LOC101928035(LOC101928035, marker 10370 ), uncharacterized LOC101928043(LOC101928043, marker 10371), uncharacterized LOC101928045(LOC101928045, marker 10372), uncharacterized LOC101928047(LOC101928047, marker 10373), uncharacterized LOC101928052(LOC10 1928052, marker 10374), uncharacterized LOC101928068(LOC101928068, marker 10375), uncharacterized LOC101928068( LOC101928068, marker 10376), uncharacterized LOC101928069(LOC101928069, marker 10377), uncharacterized LOC101928087(LOC101928087, marker 10378), uncharacterized LOC101928098(LOC101928098, marker 10379), uncharacterized LOC101928100(LOC101928100, marker 10380), uncharacterized LOC101928101(LOC101928101, marker 10381) ,uncharacterized LOC101928107(LOC101928107,Marker 10382),uncharacterized LOC101928111(LOC101928111,Marker 10383),collagen alpha-1(I) chain-like(LOC101928120,Marker 10384),uncharacterized LOC101928123(LOC1019 28123, marker 10385), uncharacterized LOC101928123(LOC101928123, marker 10386), uncharacterized LOC101928132(LOC101928132, marker 10387), uncharacterized LOC101928134(LOC101928134, marker 10388), uncharacterized LOC101928135(LOC101928135, marker 10389), uncharacterized LOC101928 139(LOC101928139, marker 10390), uncharacterized LOC101928140(LOC101928140, marker 10391), uncharacterized LOC101928144(LOC101928144, marker 10392), uncharacterized LOC101928152(LOC101928152, marker 10393), uncharacterized LOC101928160 /// zinc finger protein 707(LOC101928160 /// ZNF707, marker 10394), uncharacterized LOC10 1928161(LOC101928161, marker 10395), uncharacterized LOC101928162(LOC101928162 ,marker 10396),uncharacterized LOC101928167(LOC101928167,marker 10397),uncharacterized LOC101928173(LOC101928173,marker 10398),uncharacterized LOC101928182(LOC101928182,marker 10399),uncharacterized LOC10192 8185(LOC101928185, marker 10400), uncharacterized LOC101928188 /// uncharacterized LOC105371401(LOC101928188 /// LOC105371401, marker 10401), uncharacterized LOC101928191(LOC101928191, marker 10402), uncharacterized LOC101928196(LOC101928196, marker 10403), uncharacterized LOC101928201(LOC101928201, marker 10404 ), uncharacterized LOC101928205(LOC101928205, Marker 10405), uncharacterized LOC101928207(LOC101928207, LOC 101928222, Marker 10409), uncharacterized LOC101928225(LOC101928225, Marker 10410), uncharacterized LOC101928227(LOC101928227, Marker 10411), uncharacterized LOC101928230(LOC101928230, Marker 10412), uncharacterized LOC101928236(LOC101928236, Marker 10413), uncharacterized LOC101928236(LOC1019282 36, marker 10414), uncharacterized LOC101928238 /// olfactory receptor, family 7, subfamily D, member 2(LOC101928238 /// OR7D2, Marker 10415), uncharacterized LOC101928238 /// olfactory receptor, family 7, subfamily D, member 2(LOC101928238 /// OR7D2, Marker 10416), uncharacterized LOC101928238 /// olfactory receptor, family 7, subfamily D, member 2(LOC101928238 /// OR7D2, marker 10417), uncharacterized LOC101928251(LOC101928251, marker 10418), uncharacterized LOC101928255(LOC101928255, marker 10419), uncharacterized LOC101928259(LOC10192 8259, Marker 10420), uncharacterized LOC101928263(LOC101928263, Marker 10421 ), uncharacterized LOC101928263(LOC101928263, marker 10422), uncharacterized LOC101928271(LOC101928271, marker 10423), uncharacterized LOC101928273(LOC101928273, marker 10424), uncharacterized LOC101928277(LOC10 1928277, marker 10425), uncharacterized LOC101928278(LOC101928278, marker 10426), uncharacterized LOC101928280( LOC101928280, marker 10427), uncharacterized LOC101928283(LOC101928283, marker 10428), uncharacterized LOC101928284(LOC101928284, marker 10429), uncharacterized LOC101928288(LOC101928288, marker 10430), uncharacterized LOC101928291(LOC101928291, marker 10431), uncharacterized LOC101928298(LOC101928298, marker 10432) ,uncharacterized LOC101928303(LOC101928303,Marker 10433),uncharacterized LOC101928304(LOC101928304,Marker 10434),uncharacterized LOC101928306(LOC101928306,Marker 10435),uncharacterized LOC101928307(LOC10 1928307, marker 10436), uncharacterized LOC101928307(LOC101928307, marker 10437), uncharacterized LOC101928309(LOC101928309 ,marker 10438),uncharacterized LOC101928314(LOC101928314,marker 10439),uncharacterized LOC101928314(LOC101928314,marker 10440),uncharacterized LOC101928317(LOC101928317,marker 10441),uncharacterized LOC10192 8323(LOC101928323, marker 10442), uncharacterized LOC101928324(LOC101928324, marker 10443), uncharacterized LOC101928326(LOC101928326, marker 10444), uncharacterized LOC101928327(LOC101928327, marker 10445), uncharacterized LOC101928327(LOC101928327, marker 10446), uncharacterized LOC101928333(LOC1019 28333, marker 10447), uncharacterized LOC101928335(LOC101928335, marker 10448), uncharacterized LOC101928343(LOC101928343, marker 10449), uncharacterized LOC101928370(LOC101928370, marker 10450), uncharacterized LOC101928371(LOC101928371, marker 10451), uncharacterized LOC101928373(LOC101928373, marker 10452), uncharacterized LOC101928 386(LOC101928386, marker 10453), uncharacterized LOC1019
28389(LOC101928389, marker 10454), uncharacterized LOC101928401(LOC101928401, marker 10455), uncharacterized LOC101928403(LOC101928403, marker 10456), uncharacterized LOC101928405(LOC101928405, marker 1 0457), uncharacterized LOC101928409(LOC101928409, Marker 10458), uncharacterized LOC101928417(LOC101928417, Marker 10459),uncharacterized LOC101928418(LOC101928418,Marker 10460),uncharacterized LOC101928419(LOC101928419,Marker 10461),uncharacterized LOC101928424(LOC101928424,Marker 10462),uncharacterized LOC1019284 29(LOC101928429, marker 10463), arabinogalactan protein 1-like(LOC101928433, marker 10464) ,arabinogalactan protein 1-like(LOC101928433, marker 10465),uncharacterized LOC101928435(LOC101928435,marker 10466),uncharacterized LOC101928443(LOC101928443,marker 10467),uncharacterized LOC101928446(LOC10192) 8446, marker 10468), uncharacterized LOC101928449(LOC101928449, marker 10469), uncharacterized LOC101928460(LOC101928460, Marker 10470), uncharacterized LOC101928461(LOC101928461, Marker 10471), uncharacterized LOC101928462(LOC101928462, Marker 10472), uncharacterized LOC101928475(LOC1019284 75, marker 10473), uncharacterized LOC101928476(LOC101928476, marker 10474), uncharacterized LOC101928478(LOC101928478, marker 10475), uncharacterized LOC101928487(LOC101928487, marker 10476), uncharacterized LOC101928491(LOC101928491, marker 10477), uncharacterized LOC101928495(LOC101928495, marker 10478), uncharacterized LOC1019285 04(LOC101928504, marker 10479), uncharacterized LOC101928505(LOC101928505, marker 10480), uncharacterized LOC101928510 (LOC101928510, marker 10481), uncharacterized LOC101928516(LOC101928516, marker 10482), uncharacterized LOC101928519(LOC101928519, marker 10483), uncharacterized LOC101928521(LOC101928521, marker 10484), uncharacterized LOC101928524 /// pre-mRNA processing factor 18(LOC101928524 /// LOC10 1928535(LOC101928535, marker 10489), uncharacterized LOC101928539(LOC101928539, marker 10490) ,uncharacterized LOC101928551(LOC101928551,Marker 10491),uncharacterized LOC101928551(LOC101928551,Marker 10492),uncharacterized LOC101928551(LOC101928551,Marker 10493),uncharacterized LOC101928553(LOC10 1928553, Marker 10494), uncharacterized LOC101928554(LOC101928554, Marker 10495), uncharacterized LOC101928557(LOC101928557 , marker 10496), uncharacterized LOC101928560(LOC101928560, marker 10497), uncharacterized LOC101928565(LOC101928565, marker 10498), uncharacterized LOC101928574 /// zinc finger protein 44(LOC101928574 /// ZNF44, marker 104 99), uncharacterized LOC101928580(LOC101928580, Marker 10500 ), uncharacterized LOC101928583(LOC101928583, marker 10501), uncharacterized LOC101928583(LOC101928583, marker 10502), uncharacterized LOC101928590(LOC101928590, marker 10503), uncharacterized LOC101928595(LOC10 1928595, marker 10504), uncharacterized LOC101928597(LOC101928597, marker 10505), uncharacterized LOC101928602( LOC101928602, marker 10506), uncharacterized LOC101928614(LOC101928614, marker 10507), uncharacterized LOC101928617(LOC101928617, marker 10508), uncharacterized LOC101928618(LOC101928618, marker 10509), uncharacterized LOC101928622(LOC101928622, marker 10510), uncharacterized LOC101928626(LOC101928626, marker 10511) ,uncharacterized LOC101928631(LOC101928631,Marker 10512),uncharacterized LOC101928632(LOC101928632,Marker 10513),uncharacterized LOC101928651(LOC101928651,Marker 10514),uncharacterized LOC101928651(LOC10 1928651, Marker 10515), uncharacterized LOC101928651(LOC101928651, Marker 10516), uncharacterized LOC101928658(LOC101928658 ,marker 10517),uncharacterized LOC101928658(LOC101928658,marker 10518),uncharacterized LOC101928658(LOC101928658,marker 10519),uncharacterized LOC101928658(LOC101928658,marker 10520),uncharacterized LOC10192 8661(LOC101928661, marker 10521), uncharacterized LOC101928663(LOC101928663, marker 10522), uncharacterized LOC101928668(LOC101928668, marker 10523), uncharacterized LOC101928669 /// uncharacterized LOC101930100 /// uncharacterized LOC644450(LOC101928669 /// LOC101930100 /// LOC644450, marker 10524), uncharacter ized LOC101928669 /// uncharacterized LOC105379521 /// uncharacterized LOC105379854 // / uncharacterized LOC644450(LOC101928669 /// LOC105379521 /// LOC105379854 /// LOC644450, marker 10525), uncharacterized LOC101928682(LOC101928682, marker 10526), uncharacterized LOC101928682(LOC1019 28682, Marker 10527), uncharacterized LOC101928694(LOC101928694, Marker 10528), uncharacterized LOC101928697(LOC101928697, Marker 10529), uncharacterized LOC101928700(LOC101928700, Marker 10530), uncharacterized LOC101928707(LOC101928707, Marker 10531), uncharacterized LOC101928708(LOC1019287 08, marker 10532), uncharacterized LOC101928710(LOC101928710, marker 10533), uncharacterized LOC101928716(LOC101928716, marker 10534),uncharacterized LOC101928727(LOC101928727,Marker 10535),collagen alpha-1(III) chain-like(LOC101928728,Marker 10536),collagen alpha-1(III) chain-like(LOC101928728,Marker 10537),collagen alpha-1 (III) chain-like(LOC101928728, marker 10538), uncharacterized LOC101928730(LOC101928730, marker 10539), uncharacterized LOC101928731(LOC101928731, marker 10540), uncharacterized LOC101928739(LOC101928739, marker 1 0541),uncharacterized LOC101928741(LOC101928741,Marker 10542),uncharacterized LOC101928748(LOC101928748, Marker 10543), uncharacterized LOC101928751(LOC101928751, Marker 10544), uncharacterized LOC101928760(LOC101928760, Marker 10545), uncharacterized LOC101928762(LOC1019287 62, Marker 10546), uncharacterized LOC101928778(LOC101928778, Marker 10547), uncharacterized LOC101928792 /// Prader -Willi region non-protein coding RNA 1(LOC101928792 /// PWRN1, marker 10548), uncharacterized LOC101928797(LOC101928797, marker 10549), uncharacterized LOC101928809(LOC101928809, marker 10550), uncharacterized LOC101928813(LOC1 01928813, marker 10551), uncharacterized LOC101928817( LOC101928817, marker 10552), uncharacterized LOC101928817(LOC101928817, marker 10553), uncharacterized LOC101928820(LOC101928820, marker 10554), uncharacterized LOC101928823(LOC101928823, marker 10555), uncharacterized LOC101928833(LOC101928833, marker 10556), uncharacterized LOC101928834(LOC101928834, marker 10557) ,uncharacterized LOC101928837(LOC101928837,Marker 10558),collagen alpha-1(II) chain-like(LOC101928841,Marker 10559),collagen alpha-1(II) chain-like(LOC101928841,Marker 10560),uncharacterized LOC101928844(LOC101928 844, marker 10561), uncharacterized LOC101928845(LOC101928845, marker 10562), uncharacterized LOC101928847(LOC101928847, marker 10563), uncharacterized LOC101928850(LOC101928850, marker 10564), uncharacterized LOC1019288 51(LOC101928851, marker 10565), uncharacterized LOC101928858(LOC101928858, marker 10566), uncharacterized LOC101928861 (LOC101928861, marker 10567), uncharacterized LOC101928865(LOC101928865, marker 10568), uncharacterized LOC101928877(LOC101928877, marker 10569), uncharacterized LOC101928881(LOC101928881, marker 10570), uncharacterized LOC101928886(LOC101928886, marker 10571), uncharacterized LOC101928893(LOC101928893, marker 10572 ), uncharacterized LOC101928894(LOC101928894, marker 10573), uncharacterized LOC101928896(LOC101928896, marker 10574), uncharacterized LOC101928896(LOC101928896, marker 10575), uncharacterized LOC101928902(LOC10 1928902, marker 10576), uncharacterized LOC101928902(LOC101928902, marker 10577), uncharacterized LOC101928907( LOC101928907, marker 10578), uncharacterized LOC101928907(LOC101928907, marker 10579), uncharacterized LOC101928909(LOC101928909, marker 10580), uncharacterized LOC101928933(LOC101928933, marker 10581), uncharacterized LOC101928937(LOC101928937, marker 10582), uncharacterized LOC101928940(LOC101928940, marker 10583) ,uncharacterized LOC101928943(LOC101928943,Marker 10584),uncharacterized LOC101928957(LOC101928957,Marker 10585),uncharacterized LOC101928961(LOC101928961,Marker 10586),uncharacterized LOC101928973(LOC10 1928973, marker 10587), uncharacterized LOC101928973(LOC101928973, marker 10588), uncharacterized LOC101928978(LOC101928978 ,marker 10589),uncharacterized LOC101928982(LOC101928982,marker 10590),uncharacterized LOC101928985(LOC101928985,marker 10591),uncharacterized LOC101928988(LOC101928988,marker 10592),uncharacterized LOC10192 8995(LOC101928995, marker 10593), uncharacterized LOC101929002(LOC101929002, marker 10594), uncharacterized LOC101929004(LOC101929004, marker 10595), uncharacterized LOC101929007(LOC101929007, marker 10596), uncharacterized LOC101929019(LOC101929019, marker 10597), uncharacterized LOC101929034(LOC1019 29034, marker 10598), uncharacterized LOC101929050(LOC101929050, marker 10599), uncharacterized LOC101929060 /// mesoderm induction early response 1, family member 2(LOC101929060 /// MIER2, marker 10600), uncharacterized LOC101929064(LOC101929064, marker 10601), uncharacterized LOC101929072 /// uncharacterized LOC285835(LOC101929072 /// LOC285835, Marker 10602), uncharacterized LOC101929073( LOC101929073, marker 10603), uncharacterized LOC101929073(LOC101929073, marker 10604), uncharacterized LOC101929076(LOC101929076, marker 10605), uncharacterized LOC101929084(LOC101929084, marker 10606), uncharacterized LOC101929109(LOC101929109, marker 10607), uncharacterized LOC101929114(LOC101929114, marker 10608) ,uncharacterized LOC101929116(LOC101929116,Marker 10609),uncharacterized LOC101929122(LOC101929122,Marker 10610),uncharacterized LOC101929123(LOC101929123,Marker 10611),uncharacterized LOC101929125(LOC10 1929125, marker 10612), uncharacterized LOC101929133(LOC101929133, marker 10613), uncharacterized LOC101929143(LOC101929143 ,marker 10614),uncharacterized LOC101929144(LOC101929144,marker 10615),uncharacterized LOC101929147(LOC101929147,marker 10616),uncharacterized LOC101929148(LOC101929148,marker 10617),uncharacterized LOC10192 9148(LOC101929148, marker 10618), uncharacterized LOC101929151(LOC101929151, marker 10619), uncharacterized LOC101929153(LOC101929153, marker 10620), uncharacterized LOC101929154(LOC101929154, marker 10621), uncharacterized LOC101929164(LOC101929164, marker 10622), uncharacterized LOC101929165(LOC1019 29165, Marker 10623), uncharacterized LOC101929172(LOC101929172, Marker 10624), uncha
characterized LOC101929174(LOC101929174, marker 10625), uncharacterized LOC101929180(LOC101929180, marker 10626), uncharacterized LOC101929181(LOC101929181, marker 10627), uncharacterized LOC101929208(LOC101 929208, marker 10628), uncharacterized LOC101929210(LOC101929210, marker 10629), uncharacterized LOC101929224(LOC101929224, marker 10630), uncharacterized LOC101929229(LOC101929229, marker 10631), uncharacterized LOC101929241(LOC101929241, marker 10632), uncharacterized LOC101929248(LOC101929248, marker 10633), uncharacterized LOC101929 255(LOC101929255, marker 10634), uncharacterized LOC101929260(LOC101929260, marker 10635), uncharacterized LOC101929261(LOC101929261, marker 10636), uncharacterized LOC101929268(LOC101929268, marker 10637), uncharacterized LOC101929269(LOC101929269, marker 10638), uncharacterized LOC101929272(LOC1019292 72, marker 10639), uncharacterized LOC101929279(LOC101929279, marker 10640), uncharacterized LOC101929284(LOC101929284, marker 10641), uncharacterized LOC101929288(LOC101929288, marker 10642), uncharacterized LOC101929289(LOC101929289, marker 10643), uncharacterized LOC101929297(LOC101929297, marker 10644), uncharacterized LOC1019293 12(LOC101929312, marker 10645), uncharacterized LOC101929315(LOC101929315, marker 10646), uncharacterized LOC101929319 (LOC101929319, marker 10647), uncharacterized LOC101929325(LOC101929325, marker 10648), uncharacterized LOC101929340(LOC101929340, marker 10649), uncharacterized LOC101929341(LOC101929341, marker 10650), uncharacterized LOC101929372(LOC101929372, marker 10651), uncharacterized LOC101929378(LOC101929378, marker 10652 ), uncharacterized LOC101929384(LOC101929384, marker 10653), uncharacterized LOC101929398(LOC101929398, marker 10654), uncharacterized LOC101929406(LOC101929406, marker 10655), uncharacterized LOC101929413(LOC10 1929413, marker 10656), uncharacterized LOC101929441(LOC101929441, marker 10657), uncharacterized LOC101929450( LOC101929450, marker 10658), uncharacterized LOC101929450(LOC101929450, marker 10659), uncharacterized LOC101929454(LOC101929454, marker 10660), uncharacterized LOC101929459(LOC101929459, marker 10661), uncharacterized LOC101929460(LOC101929460, marker 10662), uncharacterized LOC101929464(LOC101929464, marker 10663) ,uncharacterized LOC101929465(LOC101929465,Marker 10664),uncharacterized LOC101929473(LOC101929473,Marker 10665),uncharacterized LOC101929475(LOC101929475,Marker 10666),uncharacterized LOC101929480(LOC10 1929480, marker 10667), uncharacterized LOC101929486(LOC101929486, marker 10668), uncharacterized LOC101929488(LOC101929488 ,marker 10669),uncharacterized LOC101929497(LOC101929497,marker 10670),uncharacterized LOC101929497(LOC101929497,marker 10671),uncharacterized LOC101929504(LOC101929504,marker 10672),uncharacterized LOC10192 9505(LOC101929505, marker 10673), uncharacterized LOC101929511(LOC101929511, marker 10674), uncharacterized LOC101929512(LOC101929512, marker 10675), uncharacterized LOC101929517(LOC101929517, marker 10676), uncharacterized LOC101929524(LOC101929524, marker 10677), uncharacterized LOC101929526(LOC1019 29526, marker 10678), uncharacterized LOC101929528(LOC101929528, marker 10679), uncharacterized LOC101929529(LOC101929529, marker 10680), atherin-like(LOC101929536, marker 10681), uncharacterized LOC101929538(LOC101929538, marker 10682), uncharacterized LOC101929549(LOC101929549, marker 10683), uncharacterized LOC101929550(LOC1019 29550, Marker 10684), uncharacterized LOC101929552(LOC101929552, Marker 10685), uncharacterized LOC101929570(LOC101929570, marker 10686), uncharacterized LOC101929584(LOC101929584, marker 10687), uncharacterized LOC101929586(LOC101929586, marker 10688), uncharacterized LOC101929592(LOC1019 29592, marker 10689), putative POM121-like protein 1-like /// putative POM121- like protein 1-like /// putative POM121-like protein 1-like /// putative POM121-like protein 1-like /// putative POM121-like protein 1-like /// POM121 membrane glycoprotein (rat) pseudogene // / NLR family, apoptosis inhibitory protein pseudogene /// putative POM121-like protein 1-like(LOC101929599 /// LOC101929812 /// LOC102724994 /// LOC102724995 /// LOC105369229 /// LOC441081 /// LOC643784 /// LOC728093, marker 10690), uncharacterized LOC101929605 /// protein phosphatase 2, regulatory subunit B'', beta pseudogene(LOC101929605 /// LOC390705, marker 10691), uncharacterized LOC101929607(LOC101929607, marker 10692), uncharacterized LOC101929607 (LOC101929607, marker 10693), uncharacterized LOC101929609(LOC101929609, marker 10694), uncharacterized LOC101929621(LOC101929621, marker 10695), uncharacterized LOC101929622(LOC101929622, marker 10696), uncharacterized LOC101929628(LOC1019 29628, Marker 10697), uncharacterized LOC101929631(LOC101929631, Marker 10698), uncharacterized LOC101929645(LOC101929645, marker 10699), uncharacterized LOC101929657(LOC101929657, marker 10700), uncharacterized LOC101929660(LOC101929660, marker 10701), uncharacterized LOC101929662(LOC101929662, marker 10702), uncharacterized LOC101929 680(LOC101929680, marker 10703), uncharacterized LOC101929681(LOC101929681, marker 10704), uncharacterized LOC101929694(LOC101929694, marker 10705), uncharacterized LOC101929705(LOC101929705, marker 10706), uncharacterized LOC101929709(LOC101929709, marker 10707), uncharacterized LOC101929713(LOC1019297 13, marker 10708), uncharacterized LOC101929713(LOC101929713, marker 10709), uncharacterized LOC101929715(LOC101929715, marker 10710), uncharacterized LOC101929717(LOC101929717, marker 10711), uncharacterized LOC101929718(LOC101929718, marker 10712), uncharacterized LOC101929719(LOC101929719, marker 10713), uncharacterized LOC1019297 26(LOC101929726, marker 10714), uncharacterized LOC101929728 /// solute carrier family 35, member E4(LOC101929728 /// SLC35E4, marker 10715), putative POM121-like protein 1 /// putative POM121-like protein 1 /// putative POM121-like protein 1 /// uncharacterized LOC102725072 /// putative POM121-like protein 1 -like /// POM121 transmembrane nucleoporin-like 10, pseudogene /// POM121 transmembrane nucleoporin-like 1, pseudogene /// POM121 transmembrane nucleoporin-like 3, pseudogene /// POM121 transmembrane nucleoporin-like 4 pseudogene /// POM121 transmembrane nucleoporin-like 7 /// POM121 transmembrane nucleoporin-like 8 pseudogene /// POM121 transmembrane nucleoporin-like 9, pseudogene(LOC101929738 /// LOC102724151 /// LOC102724728 /// LOC102725072 /// LOC727983 /// POM1 21L10P /// POM121L1P /// POM121L3P /// POM121L4P /// POM121L7 /// POM121L8P /// POM121L9P, marker 10716), putative POM121-like protein 1 /// putative POM121-like protein 1 /// putative POM121-like protein 1 /// putative POM121-like protein 1-like /// POM121 transmembrane nucleoporin-like 10, pseudogene /// POM121 transmembrane nucleoporin-like 1, pseudogene /// POM121 transmembrane nucleoporin-like 3, pseudogene /// POM121 transmembrane nucleoporin -like 4 pseudogene /// pom121 Transmembrane Nucleoporin-Like 7 /// POM121 Transmembrane Nucleoporin-Like 8 pseudogene /// POM121 Transmembrane Nucleopo Rin-Like 9, pseudogene (LOC101929738 /// LOC102724151 /// LOC102724728 /// LOC727983 // / POM121L10P /// POM121L1P /// POM121L3P /// POM121L4P /// POM121L7 /// POM121L8P /// POM121L9P, marker 10717), putative POM121-like protein 1 /// putative POM121-like protein 1 /// putative POM121-like protein 1 /// putative POM121-like protein 1-like /// POM121 transmembrane nucleoporin-like 10, pseudogene /// POM121 transmembrane nucleoporin-like 1, pseudogene /// POM121 transmembrane nucleoporin-like 4 pseudogene // / POM121 transmembrane nucleoporin-like 7 /// POM121 transmembrane nucleoporin-like 8 pseudogene /// POM121 transmembrane nucleoporin-like 9, pseudogene(LOC101929738 /// LOC102724151 /// LOC102724728 /// LOC727983 /// POM121L 10P /// POM121L1P /// POM121L4P /// POM121L7 /// POM121L8P /// POM121L9P, marker 10718), uncharacterized LOC101929741(LOC101929741, marker 10719), uncharacterized LOC101929745(LOC101929745, marker 10720), transcription initiation factor TFI ID subunit 4-like(LOC101929748, marker 10721), uncharacterized LOC101929752(LOC101929752, marker 10722), uncharacterized LOC101929759(LOC101929759, marker 10723), uncharacterized LOC101929762(LOC101929762, marker 10724), uncharacterized LOC101929 774(LOC101929774, marker 10725), uncharacterized LOC101929774 /// uncharacterized LOC105376844(LOC101929774 / // LOC105376844, marker 10726), uncharacterized LOC101929777 /// wingless-type MMTV integration site family, member 3(LOC101929777 /// WNT3, marker 10727), uncharacterized LOC101929800 /// uncharacterized LOC440896(LOC101929800 /// LOC4408 96, marker 10728 ),uncharacterized LOC101929800 /// uncharacterized LOC440896 /// phosphoglucomutase 5(LOC101929800 /// LOC440896 /// PGM5, marker 10729), uncharacterized LOC101929872(LOC101929872, marker 10730), uncharacterized LOC10192989 7(LOC101929897, marker 10731), uncharacterized LOC101929902( LOC101929902, marker 10732), uncharacterized LOC101929926(LOC101929926, marker 10733), uncharacterized LOC101929947(LOC101929947, marker 10734), uncharacterized LOC101929963(LOC101929963, marker 10735), uncharacterized LOC101929964(LOC101929964, marker 10736),uncharacterized LOC101929964(LOC101929964, marker 10737) ,uncharacterized LOC101929977(LOC101929977,Marker 10738),uncharacterized LOC101929988(LOC101929988,Marker 10739),lipopolysaccharide-induced tumor necrosis factor-alpha factor-like(LOC101929989,Marker 10740),uncharacterized LOC10193 0026 /// uncharacterized LOC105379811(LOC101930026 /// LOC105379811 ,marker 10741),uncharacterized LOC101930028(LOC101930028,marker 10742),uncharacterized LOC101930067(LOC101930067,marker 10743),uncharacterized LOC101930081(LOC101930081,marker 10744),uncharacterized LOC10193 0112(LOC101930112, marker 10745), uncharacterized LOC101930114(LOC101930114, marker 10746), von Willebrand factor A domain-containing protein 3A /// von Willebrand factor A domain containing 3A(LOC101930115 /// VWA3A, marker 10747),von Willebrand factor A domain-containing protein 3A /// von Willebrand factor A domain containing 3A( LOC101930115 /// VWA3A, marker 10748), uncharacterized LOC101930120(LOC101930120, marker 10749), uncharacterized LOC101930149(LOC101930149, marker 10750), uncharacterized LOC101930164(LOC101930164, marker 1 0751), RNA polymerase II transcription factor SIII subunit A3-like
/// RNA polymerase II transcription factor SIII subunit A3-like /// RNA polymerase II transcription factor SIII subunit A3-like /// RNA polymerase II transcription factor SIII subunit A3-like /// transcription elongation factor B polypeptide 3C (elongin A3) /// transcription elongation factor B polypeptide 3C-like /// transcription elongation factor B polypeptide 3C-like 2(LOC101930165 /// LOC101930171 /// LOC102725060 /// LOC105369241 /// TCEB3C /// TCEB3CL /// TCEB3CL2, marker 10752), uncharacterized LOC101930370(LOC101930370, marker 10753), uncharacterized LOC101930370(LOC101930370, marker 10754), uncharacterized LOC101930370(LOC101930370, marker 10755), uncharacterized LOC 101930421(LOC101930421, Marker 10756), uncharacterized LOC101930421(LOC101930421, Marker 10757) ,uncharacterized LOC101930452(LOC101930452,Marker 10758),uncharacterized LOC101930531(LOC101930531,Marker 10759),testis expressed 28 pseudogene /// testis expressed 28(LOC102030688 /// TEX28,Marker 10760),uncharacterized LOC10246 7079(LOC102467079, marker 10761), uncharacterized LOC102546226(LOC102546226, Marker 10762), uncharacterized LOC102546294(LOC102546294, Marker 10763), uncharacterized LOC102546299(LOC102546299, Marker 10764), uncharacterized LOC102546299(LOC1025462 99, marker 10765), uncharacterized LOC102546299(LOC102546299, marker 10766), uncharacterized LOC102723335(LOC102723335, marker 10767),uncharacterized LOC102723364(LOC102723364,Marker 10768),uncharacterized LOC102723380 /// uncharacterized LOC102724370(LOC102723380 /// LOC102724370,Marker 10769),ankyrin repeat domain-containing protein 20B-like // / ankyrin repeat domain-containing protein 20B- like /// uncharacterized LOC105379516 /// uncharacterized LOC105379552(LOC102723382 /// LOC102723891 /// LOC105379516 /// LOC105379552, marker 10770), uncharacterized LOC102723409(LOC102723409, marker 107 71),uncharacterized LOC102723448(LOC102723448,Marker 10772),uncharacterized LOC102723468 (LOC102723468, marker 10773), uncharacterized LOC102723493(LOC102723493, marker 10774), uncharacterized LOC102723506 /// uncharacterized protein, clone pT-Adv JuaX22(LOC102723506 /// ORF1, marker 10775), uncharacterized LOC1027235 17 /// SOX9 antisense RNA 1( LOC102723517 /// SOX9-AS1, marker 10776), uncharacterized LOC102723517 /// SOX9 antisense RNA 1(LOC102723517 /// SOX9-AS1, marker 10777), uncharacterized LOC102723526(LOC102723526, marker 10778), uncharacterized LOC10 2723600(LOC102723600, Marker 10779 ),uncharacterized LOC102723645(LOC102723645,marker 10780),uncharacterized LOC102723648(LOC102723648,marker 10781),uncharacterized LOC102723648(LOC102723648,marker 10782),TP53-target gene 3 protein /// TP53-target gene 3 protein /// TP53 target 3 /// TP53 target 3B /// TP53 target 3C /// TP53 target 3D /// TP53 target 3 family member E /// TP53 target 3 family member F(LOC102723655 /// LOC102723713 /// TP53TG3 /// TP53TG3B /// TP53TG3C /// TP53TG3D /// TP53TG3E /// TP53TG3F, marker 10783), uncharacterized LOC102723657(LOC102723657, marker 10784), basic proline-rich protein-like(LOC102723665, marker 10785), uncharacterized LOC102723678 (LOC102723678, Marker 10786), uncharacterized LOC102723692(LOC102723692, marker 10787), uncharacterized LOC102723694(LOC102723694, marker 10788), uncharacterized LOC102723694(LOC102723694, marker 10789), uncharacterized LOC1027237 01(LOC102723701, marker 10790), uncharacterized LOC102723704(LOC102723704, marker 10791), uncharacterized LOC102723722 /// uncharacterized LOC102725017(LOC102723722 /// LOC102725017, marker 10792), uncharacterized LOC102723722 /// uncharacterized LOC102725017 /// NDUFA6 antisense RNA 1 (head to head)(LOC102723722 /// LOC102725017 /// NDUFA6-AS1, Marker 10793 ), uncharacterized LOC102723757(LOC102723757, marker 10794), uncharacterized LOC102723757(LOC102723757, marker 10795), uncharacterized LOC102723779(LOC102723779, marker 10796), uncharacterized LOC102723786(LOC10 2723786, marker 10797), uncharacterized LOC102723809(LOC102723809, marker 10798), uncharacterized LOC102723831( LOC102723831, marker 10799), uncharacterized LOC102723847(LOC102723847, marker 10800), uncharacterized LOC102723886(LOC102723886, marker 10801), uncharacterized LOC102723904(LOC102723904, marker 10802), uncharacterized LOC102723908 /// uncharacterized LOC105379852(LOC102723908 /// LOC105379852, Marker 10803) ,uncharacterized LOC102723924(LOC102723924,Marker 10804),uncharacterized LOC102723927(LOC102723927,Marker 10805),uncharacterized LOC102723927(LOC102723927,Marker 10806),uncharacterized LOC102723932(LOC10 2723932, marker 10807), uncharacterized LOC102724009(LOC102724009, marker 10808), uncharacterized LOC102724030(LOC102724030 , marker 10809), proline-rich receptor-like protein kinase PERK13(LOC102724064, marker 10810), uncharacterized LOC102724100(LOC102724100, marker 10811), uncharacterized LOC102724156(LOC102724156, marker 10812), periodic tryptophan protein 2 homolog /// PWP2 periodic tryptophan protein homolog (yeast)(LOC102724159 /// PWP2, marker 10813), uncharacterized LOC102724162(LOC102724162, marker 10814), uncharacterized LOC102724165(LOC102724165, marker 10815), uncharacterized LOC102724229 /// RAS p21 protein activator 4(LOC102724229 /// RASA4 , marker 10816), uncharacterized LOC102724229 /// RAS p21 protein activator 4 /// RAS p21 protein activator 4B /// RAS p21 protein activator 4C, pseudogene(LOC102724229 /// RASA4 /// RASA4B /// RASA4CP, marker 10817 ),uncharacterized LOC102724252(LOC102724252,marker 10818),uncharacterized LOC102724252(LOC102724252,marker 10819),uncharacterized LOC102724275 /// uncharacterized LOC102724356 /// uncharacterized LOC102725134 /// uncharacterized LOC105369228(LOC102724275 /// LOC102724356 /// LOC102725134 /// LOC105369228, marker 10820), uncharacterized LOC102724312(LOC102724312, marker 10821), uncharacterized LOC102724312(LOC102724312, marker 10822), uncharacterized LOC102724323(LOC102724323, marker 10823), uncharacterized LOC102724352(LOC102724352, marker 10824),uncharacterized LOC102724382(LOC102724382, marker 10825) ,uncharacterized LOC102724404(LOC102724404,Marker 10826),uncharacterized LOC102724418(LOC102724418,Marker 10827),uncharacterized LOC102724434(LOC102724434,Marker 10828),uncharacterized LOC102724449(LOC10 2724449, marker 10829), uncharacterized LOC102724470(LOC102724470, marker 10830), synaptotagmin-15 / / synaptotagmin 724528 /// phosphatidylinositol glycan anchor biosynthesis class C(LOC102724528 /// PIGC, marker 10834), uncharacterized LOC102724542(LOC102724542, marker 10835), uncharacterized LOC102724551(LOC102724551, marker 10836), uncharacterized LOC102724587(LOC10272 4587, marker 10837), uncharacterized LOC102724593(LOC102724593, marker 10838) ,uncharacterized LOC102724593(LOC102724593,Marker 10839),uncharacterized LOC102724612(LOC102724612,Marker 10840),uncharacterized LOC102724634(LOC102724634,Marker 10841),uncharacterized LOC102724634(LOC10 2724634, marker 10842), uncharacterized LOC102724638(LOC102724638, marker 10843), uncharacterized LOC102724698(LOC102724698 ,marker 10844),uncharacterized LOC102724699(LOC102724699,marker 10845),uncharacterized LOC102724703(LOC102724703,marker 10846),uncharacterized LOC102724714(LOC102724714,marker 10847),uncharacterized LOC10272 4782(LOC102724782, marker 10848), uncharacterized LOC102724814(LOC102724814, marker 10849), uncharacterized LOC102724814(LOC102724814, marker 10850), uncharacterized LOC102724859(LOC102724859, marker 10851), uncharacterized LOC102724927(LOC102724927, marker 10852), uncharacterized LOC102724929(LOC1027 24929, marker 10853), uncharacterized LOC102724938(LOC102724938, marker 10854), uncharacterized LOC102724965(LOC102724965, marker 10855),pyridoxal-dependent decarboxylase domain-containing protein 1 /// pyridoxal-dependent decarboxylase domain containing 1(LOC102724985 /// PDXDC1, marker 10856),pyridoxal-dependent decarboxylase domain-containing protein 1 /// pyridoxal-dependent decarboxylase domain containing 1(LOC102724985 /// PDXDC1, marker 10857),pyridoxal-dependent decarboxylase domain-containing protein 1 /// pyridoxal-dependent decarboxylase domain containing 1(LOC102724985 /// PDXDC1, marker 10858),pyridoxal-dependent decarboxylase domain- containing protein 1 /// pyridoxal-dependent decarboxylase domain containing 1 /// pyridoxal-dependent decarboxylase domain containing 2, pseudogene(LOC102724985 /// PDXDC1 /// PDXDC2P, marker 10859), serine/threonine-protein phosphatase 2A regulatory subunit B '' Subunit Beta /// Protein Phosphatase 2, Regulatory Subunit B ', Beta (LOC102725016 /// PPP2R3B, Marker 10860) 2 (LOC102725022, marker 10861), UNCHARACTERIZED LOC102725072 /// POM121 Transmembrane Nucleoporin-Like 1, pseudogene /// POM121 transmembrane nucleoporin-like 8 pseudogene /// POM121 transmembrane nucleoporin-like 9, pseudogene(LOC102725072 /// POM121L1P /// POM121L8P /// POM121L9P, marker 10862), uncharacterized LOC102725108(LOC1027251 08, Marker 10863), uncharacterized LOC102725108(LOC102725108, marker 10864), uncharacterized LOC102725116(LOC102725116, marker 10865), uncharacterized LOC102725116(LOC102725116, marker 10866), rho guanine nucleotide exchange factor 5-like /// OR2A1 antisense RNA 1 /// olfactory receptor, family 2 , subfamily A, member 20 pseudogene /// olfactory receptor, family 2, subfamily A, member 9 pseudogene(LOC102725117 /// OR2A1-AS1 /// OR2A20P /// OR2A9P, marker 10867), uncharacterized LOC102725126(LOC102725126, marker 10868 ),uncharacterized LOC102725126 /// uncharacterized LOC286272(LOC102725126 /// LOC286272, marker 10869), uncharacterized LOC102725140(LOC102725140, marker 10870), uncharacterized LOC102725200(LOC102725200, marker 10 871),uncharacterized LOC102725228 /// uncharacterized LOC440149(LOC102725228 /// LOC440149, marker 10872), uncharacterized LOC102800447(LOC102800447, marker 10873), uncharacterized LOC105274304(LOC105274304, marker 10874), endogenous retrovirus group K member 25 Env polyprotein-like(LOC105369153, marker 10875), uncharacterized LOC105369167(LOC105369167, marker 10876), uncharacterized LOC105369167(LOC105369167, marker 10877), uncharacterized LOC105369167(LOC105369167, marker 10878
),uncharacterized LOC105369192(LOC105369192,marker 10879),uncharacterized LOC105369192(LOC105369192,marker 10880),putative neuroblastoma breakpoint family member 6-like protein(LOC105369199,marker 10881),uncharacterized LOC105369211 /// zinc finger protein 627(LOC105369211 /// ZNF627, marker 10882), uncharacterized LOC105369213(LOC105369213, marker 10883), structure-specific endonuclease subunit SLX1-like /// SLX1 homolog A, structure-specific endonuclease subunit /// SLX1A-SULT1A3 readthrough (NMD candidate) /// SLX1 homolog B, structure-specific endonuclease subunit /// SLX1B-SULT1A4 readthrough (NMD candidate)(LOC105369236 /// SLX1A /// SLX1A-SULT1A3 /// SLX1B /// SLX1B-SULT1A4,marker 10884),sperm protein associated with the nucleus on the X chromosome B/F /// SPANX family, member B1(LOC105369237 /// SPANXB1, marker 10885), leukosialin /// quinolinate phosphoribosyltransferase /// sialophorin(LOC105369261 /// QPRT /// SPN, marker 10886), tyrosine-protein phosphatase non-receptor type 20 /// protein tyrosine phosphatase, non-receptor type 20(LOC105369264 /// PTPN20, marker 10887), uncharacterized LOC105369268 /// uncharacterized LOC105376051(LOC105369268 /// LOC105376051, marker 10888), protein SSX4-like /// synovial sarcoma, X breakpoint 4 /// synovial sarcoma, LOC105369341(LOC105369341, marker 10891), uncharacterized LOC105369387(LOC105369387, marker 10892), uncharacterized LOC105369434(LOC105369434, marker 10893), uncharacterized LOC105369499(LOC1053694 99, marker 10894), uncharacterized LOC105369507(LOC105369507, marker 10895), uncharacterized LOC105369514(LOC105369514, marker 10896), uncharacterized LOC105369523 /// USP2 antisense RNA 1 (head to head)(LOC105369523 /// USP2-AS1, Marker 10897), uncharacterized LOC105369541(LOC105369541, Marker 10898), uncharacterized LOC105369553(LOC105369 553, marker 10899), uncharacterized LOC105369569 (LOC105369569, marker 10900), uncharacterized LOC105369595(LOC105369595, marker 10901), uncharacterized LOC105369600 /// WNK lysine deficient protein kinase 1(LOC105369600 /// WNK1, marker 10902), uncharacterized LOC105369602( LOC105369602, marker 10903), uncharacterized LOC105369609( LOC105369609, marker 10904), uncharacterized LOC105369635(LOC105369635, marker 10905), uncharacterized LOC105369645(LOC105369645, marker 10906), uncharacterized LOC105369662(LOC105369662, marker 10907), uncharacterized LOC105369665(LOC105369665, marker 10908), uncharacterized LOC105369671(LOC105369671, marker 10909) ,uncharacterized LOC105369705(LOC105369705,Marker 10910),uncharacterized LOC105369739(LOC105369739,Marker 10911),uncharacterized LOC105369746(LOC105369746,Marker 10912),uncharacterized LOC105369748(LOC10 5369748, Marker 10913), uncharacterized LOC105369779(LOC105369779, Marker 10914), uncharacterized LOC105369816(LOC105369816 ,marker 10915),uncharacterized LOC105369820(LOC105369820,marker 10916),uncharacterized LOC105369860(LOC105369860,marker 10917),uncharacterized LOC105369889(LOC105369889,marker 10918),uncharacterized LOC10536 9890(LOC105369890, marker 10919), uncharacterized LOC105369922(LOC105369922, marker 10920), uncharacterized LOC105369957(LOC105369957, marker 10921), uncharacterized LOC105369974(LOC105369974, marker 10922), uncharacterized LOC105369974(LOC105369974, marker 10923), uncharacterized LOC105370027(LOC1053 70027, marker 10924), uncharacterized LOC105370059(LOC105370059, marker 10925), uncharacterized LOC105370078(LOC105370078, marker 10926), uncharacterized LOC105370178(LOC105370178, marker 10927), uncharacterized LOC105370178(LOC105370178, marker 10928), uncharacterized LOC105370201(LOC105370201, marker 10929), uncharacterized LOC105370 291(LOC105370291, Marker 10930), uncharacterized LOC105370361(LOC105370361, Marker 10931), uncharacterized LOC105370361(LOC105370361, marker 10932), uncharacterized LOC105370424(LOC105370424, marker 10933), uncharacterized LOC105370431(LOC105370431, marker 10934), uncharacterized LOC105370474(LOC1053704 74, marker 10935), uncharacterized LOC105370475(LOC105370475, marker 10936), uncharacterized LOC105370478(LOC105370478, marker 10937),uncharacterized LOC105370479(LOC105370479,Marker 10938),uncharacterized LOC105370523(LOC105370523,Marker 10939),uncharacterized LOC105370549(LOC105370549,Marker 10940),uncharacterized LOC1053705 69(LOC105370569, marker 10941), uncharacterized LOC105370580(LOC105370580, marker 10942), uncharacterized LOC105370606 (LOC105370606, marker 10943), uncharacterized LOC105370612(LOC105370612, marker 10944), uncharacterized LOC105370613(LOC105370613, marker 10945), uncharacterized LOC105370622(LOC105370622, marker 10946), uncharacterized LOC105370629(LOC105370629, marker 10947), uncharacterized LOC105370629(LOC105370629, marker 10948 ), uncharacterized LOC105370630(LOC105370630, marker 10949), uncharacterized LOC105370638(LOC105370638, marker 10950), uncharacterized LOC105370642(LOC105370642, marker 10951), uncharacterized LOC105370687(LOC10 5370687, marker 10952), uncharacterized LOC105370697(LOC105370697, marker 10953), uncharacterized LOC105370720( LOC105370720, marker 10954), uncharacterized LOC105370737(LOC105370737, marker 10955), uncharacterized LOC105370746(LOC105370746, marker 10956), uncharacterized LOC105370752(LOC105370752, marker 10957), uncharacterized LOC105370752(LOC105370752, marker 10958), uncharacterized LOC105370792(LOC105370792, marker 10959) ,uncharacterized LOC105370792(LOC105370792,Marker 10960),uncharacterized LOC105370809(LOC105370809,Marker 10961),uncharacterized LOC105370812(LOC105370812,Marker 10962),uncharacterized LOC105370818 /// tro pomodulin 3 (ubiquitous)(LOC105370818 /// TMOD3, marker 10963), uncharacterized LOC105370829(LOC105370829, Marker 10964), uncharacterized LOC105370832(LOC105370832, Marker 10965), uncharacterized LOC105370834(LOC105370834, Marker 10966), uncharacterized LOC105370890(LOC1053708 90, marker 10967), uncharacterized LOC105370907(LOC105370907, marker 10968), uncharacterized LOC105370914(LOC105370914, marker 10969),uncharacterized LOC105370941(LOC105370941,Marker 10970),probable lysosomal cobalamin transporter(LOC105370945,Marker 10971),probable lysosomal cobalamin transporter(LOC105370945,Marker 10972),probable lysosomal cobalamin transporter(LOC105370945, marker 10973), uncharacterized LOC105370962(LOC105370962, marker 10974), uncharacterized LOC105370963(LOC105370963, marker 10975), uncharacterized LOC105370977(LOC105370977, marker 10976), uncharacterized LOC105370978(LOC105370978, marker 10977), uncharacterized LOC105370 997(LOC105370997, marker 10978), uncharacterized LOC105371038(LOC105371038, marker 10979), uncharacterized LOC105371046(LOC105371046, Marker 10980), uncharacterized LOC105371074(LOC105371074, Marker 10981), uncharacterized LOC105371074(LOC105371074, Marker 10982), uncharacterized LOC105371079(LOC1053710 79, marker 10983), uncharacterized LOC105371171(LOC105371171, marker 10984), uncharacterized LOC105371226(LOC105371226, marker 10985), uncharacterized LOC105371232(LOC105371232, marker 10986), uncharacterized LOC105371264(LOC105371264, marker 10987), uncharacterized LOC105371290(LOC105371290, marker 10988), uncharacterized LOC1053713 52(LOC105371352, Marker 10989), SH3 domain-binding protein 1-like(LOC105371371, marker 10990), uncharacterized LOC105371374(LOC105371374, marker 10991), uncharacterized LOC105371413(LOC105371413, marker 10992), keratin-associated protein 5-2-like(LOC105371414, marker 10993), uncharacterized LOC10537143 2(LOC105371432, marker 10994), uncharacterized LOC105371450( LOC105371450, marker 10995), uncharacterized LOC105371453(LOC105371453, marker 10996), uncharacterized LOC105371472(LOC105371472, marker 10997), breakpoint cluster region protein-like(LOC105371478, marker 10998), uncharacterized LOC10 5371485(LOC105371485, marker 10999), uncharacterized LOC105371491(LOC105371491 ,marker 11000),uncharacterized LOC105371501(LOC105371501,marker 11001),uncharacterized LOC105371508(LOC105371508,marker 11002),uncharacterized LOC105371561(LOC105371561,marker 11003),uncharacterized LOC10537 1600(LOC105371600, marker 11004), uncharacterized LOC105371602(LOC105371602, marker 11005), uncharacterized LOC105371622(LOC105371622, marker 11006), uncharacterized LOC105371622(LOC105371622, marker 11007), uncharacterized LOC105371672(LOC105371672, marker 11008), uncharacterized LOC105371691(LOC1053 71691, marker 11009), uncharacterized LOC105371693(LOC105371693, marker 11010), uncharacterized LOC105371703(LOC105371703, marker 11011), uncharacterized LOC105371708(LOC105371708, marker 11012), uncharacterized LOC105371734(LOC105371734, marker 11013), uncharacterized LOC105371763(LOC105371763, marker 11014), uncharacterized LOC105371 772(LOC105371772, marker 11015), uncharacterized LOC105371798(LOC105371798, marker 11016), uncharacterized LOC105371809(LOC105371809, Marker 11017), uncharacterized LOC105371839(LOC105371839, Marker 11018), uncharacterized LOC105371919(LOC105371919, Marker 11019), uncharacterized LOC105371920(LOC1053719 20, marker 11020), uncharacterized LOC105371923(LOC105371923, marker 11021), uncharacterized LOC105371932(LOC105371932, marker 11022),uncharacterized LOC105371967(LOC105371967,Marker 11023),uncharacterized LOC105372024(LOC105372024,Marker 11024),uncharacterized LOC105372069(LOC105372069,Marker 11025),uncharacterized LOC1053720 98(LOC105372098, marker 11026), uncharacterized LOC105372147(LOC105372147, marker 11027), uncharacterized LOC105372179 (LOC105372179, marker 11028), uncharacterized LOC105372217(LOC105372217, marker 11029), uncharacterized LOC105372237(LOC105372237, marker 11030), uncharacterized LOC105372239(LOC105372239, marker 11031), uncharacterized LOC105372255 /// regulatory factor X, 2 (influences HLA class II expression )(LOC105372255 /// RFX2, marker 11032), uncharacterized LOC105372257(LOC105372257, marker 11033), uncharacterized LOC105372297(LOC105372297, marker 11034), uncharacterized LOC105372327(LOC105372327, marker 1 1035), uncharacterized LOC105372366(LOC105372366, marker 11036), uncharacterized LOC105372394 (LOC105372394, marker 11037), uncharacterized LOC105372404(LOC105372404, marker 11038), uncharacterized LOC105372410(LOC105372410, marker 11039), uncharacterized LOC105372433(LOC105372433, marker 11040), uncharacter
ized LOC105372482(LOC105372482, marker 11041), uncharacterized LOC105372483(LOC105372483, marker 11042), uncharacterized LOC105372485(LOC105372485, marker 11043), uncharacterized LOC105372520(LOC10537 2520, marker 11044), uncharacterized LOC105372547(LOC105372547, marker 11045), uncharacterized LOC105372602(LOC105372602, marker 11046), uncharacterized LOC105372637(LOC105372637, marker 11047), uncharacterized LOC105372640(LOC105372640, marker 11048), uncharacterized LOC105372691 /// NF-kappaB interacting long non-coding RNA(LOC105372691 /// NKILA , marker 11049), uncharacterized LOC105372695( LOC105372695, Marker 11050), uncharacterized LOC105372733(LOC105372733, Marker 11051), uncharacterized LOC105372742(LOC105372742, Marker 11052), uncharacterized LOC105372742 /// uncharacterized LOC150005(LOC10537 2742 /// LOC150005, marker 11053), uncharacterized LOC105372761(LOC105372761, marker 11054) ,uncharacterized LOC105372762(LOC105372762, marker 11055),uncharacterized LOC105372779(LOC105372779,marker 11056),uncharacterized LOC105372819(LOC105372819,marker 11057),uncharacterized protein C21orf124 /// pyridox al (pyridoxine, vitamin B6) kinase(LOC105372824 /// PDXK, marker 11058),uncharacterized LOC105372835(LOC105372835,Marker 11059),uncharacterized LOC105372835(LOC105372835,Marker 11060),uncharacterized LOC105372876(LOC105372876,Marker 11061),uncharacterized LOC1053728 76(LOC105372876, marker 11062), uncharacterized LOC105372881(LOC105372881, marker 11063), uncharacterized LOC105372953 (LOC105372953, marker 11064), uncharacterized LOC105372969(LOC105372969, marker 11065), uncharacterized LOC105372989(LOC105372989, marker 11066), uncharacterized LOC105372989(LOC105372989, marker 11067), uncharacterized LOC105372991(LOC105372991, marker 11068), uncharacterized LOC105373065(LOC105373065, marker 11069 ), uncharacterized LOC105373085(LOC105373085, marker 11070), uncharacterized LOC105373098(LOC105373098, marker 11071), uncharacterized LOC105373113(LOC105373113, marker 11072), uncharacterized LOC105373113(LOC10 5373113, marker 11073), uncharacterized LOC105373150(LOC105373150, marker 11074), uncharacterized LOC105373170( LOC105373170, marker 11075), uncharacterized LOC105373223(LOC105373223, marker 11076), uncharacterized LOC105373225(LOC105373225, marker 11077), uncharacterized LOC105373319(LOC105373319, marker 11078), uncharacterized LOC105373334(LOC105373334, marker 11079), uncharacterized LOC105373418(LOC105373418, marker 11080) ,uncharacterized LOC105373430 /// MIR3681 host gene(LOC105373430 /// MIR3681HG, marker 11081), uncharacterized LOC105373434(LOC105373434, marker 11082), uncharacterized LOC105373460(LOC105373460, marker 11083) ,uncharacterized LOC105373495(LOC105373495, marker 11084),uncharacterized LOC105373547 / // uncharacterized LOC105373552(LOC105373547 /// LOC105373552, marker 11085), uncharacterized LOC105373554(LOC105373554, marker 11086), uncharacterized LOC105373618(LOC105373618, marker 11087), uncharacterized LOC1 05373660(LOC105373660, marker 11088), uncharacterized LOC105373714(LOC105373714, marker 11089) ,uncharacterized LOC105373738(LOC105373738,Marker 11090),uncharacterized LOC105373738(LOC105373738,Marker 11091),uncharacterized LOC105373754(LOC105373754,Marker 11092),uncharacterized LOC105373764(LOC10 5373764, marker 11093), uncharacterized LOC105373801(LOC105373801, marker 11094), uncharacterized LOC105373860(LOC105373860 ,marker 11095),uncharacterized LOC105373876(LOC105373876,marker 11096),uncharacterized LOC105373942(LOC105373942,marker 11097),uncharacterized LOC105373958(LOC105373958,marker 11098),uncharacterized LOC10537 3991(LOC105373991, marker 11099), uncharacterized LOC105374030(LOC105374030, marker 11100), uncharacterized LOC105374042(LOC105374042, marker 11101), uncharacterized LOC105374089(LOC105374089, marker 11102), uncharacterized LOC105374118(LOC105374118, marker 11103), uncharacterized LOC105374240(LOC1053 74240, marker 11104), uncharacterized LOC105374258(LOC105374258, marker 11105), uncharacterized LOC105374258(LOC105374258, marker 11106), uncharacterized LOC105374290(LOC105374290, marker 11107), uncharacterized LOC105374325(LOC105374325, marker 11108), uncharacterized LOC105374336(LOC105374336, marker 11109), uncharacterized LOC105374 374(LOC105374374, marker 11110), uncharacterized LOC105374419(LOC105374419, marker 11111), uncharacterized LOC105374423(LOC105374423, Marker 11112), uncharacterized LOC105374428(LOC105374428, Marker 11113), uncharacterized LOC105374583(LOC105374583, Marker 11114), uncharacterized LOC105374587(LOC1053745 87, marker 11115), uncharacterized LOC105374621(LOC105374621, marker 11116), uncharacterized LOC105374629(LOC105374629, marker 11117), uncharacterized LOC105374648(LOC105374648, marker 11118), uncharacterized LOC105374676(LOC105374676, marker 11119), uncharacterized LOC105374690(LOC105374690, marker 11120), spidroin-2-like(LOC105 374693, marker 11121), uncharacterized LOC105374738(LOC105374738, marker 11122) ,uncharacterized LOC105374763(LOC105374763,Marker 11123),uncharacterized LOC105374768(LOC105374768,Marker 11124),uncharacterized LOC105374775(LOC105374775,Marker 11125),uncharacterized LOC105374779 /// RAB 1A, member RAS oncogene family(LOC105374779 /// RAB1A, marker 11126), uncharacterized LOC105374809(LOC105374809, marker 11127), uncharacterized LOC105374809(LOC105374809, marker 11128), uncharacterized LOC105374836 /// TraB domain containing 2A(LOC105374836 /// TRABD2A, marker 11129), uncharacterized LOC105374869(LOC105374869, marker 11130),uncharacterized LOC105374872( LOC105374872, marker 11131), uncharacterized LOC105374877(LOC105374877, marker 11132), uncharacterized LOC105374888(LOC105374888, marker 11133), uncharacterized LOC105374895(LOC105374895, marker 11134), uncharacterized LOC105374928(LOC105374928, marker 11135),uncharacterized LOC105374928(LOC105374928, marker 11136) ,uncharacterized LOC105374937(LOC105374937,Marker 11137),uncharacterized LOC105374947(LOC105374947,Marker 11138),uncharacterized LOC105374953(LOC105374953,Marker 11139),uncharacterized LOC105374984(LOC10 5374984, Marker 11140), uncharacterized LOC105374989(LOC105374989, Marker 11141), uncharacterized LOC105375026(LOC105375026 ,marker 11142),uncharacterized LOC105375038(LOC105375038,marker 11143),uncharacterized LOC105375061(LOC105375061,marker 11144),uncharacterized LOC105375075(LOC105375075,marker 11145),uncharacterized LOC10537 5089(LOC105375089, marker 11146), uncharacterized LOC105375105(LOC105375105, marker 11147), TRIO and F-actin-binding protein-like(LOC105375116, marker 11148), uncharacterized LOC105375153(LOC105375153, marker 11149), uncharacterized LOC105375172(LOC105375172, marker 11150), uncharacterized LOC105375201(LOC105375 201, Marker 11151), uncharacterized LOC105375206(LOC105375206, Marker 11152),uncharacterized LOC105375218(LOC105375218,Marker 11153),uncharacterized LOC105375240(LOC105375240,Marker 11154),uncharacterized LOC105375253(LOC105375253,Marker 11155),uncharacterized LOC1053752 73(LOC105375273, Marker 11156), uncharacterized LOC105375282(LOC105375282, Marker 11157), uroplakin- 3b /// uroplakin 3B(LOC105375355 /// UPK3B, marker 11158), uncharacterized LOC105375361(LOC105375361, marker 11159), uncharacterized LOC105375382(LOC105375382, marker 11160), uncharacterized LOC105375427(LOC 105375427, Marker 11161), uncharacterized LOC105375483(LOC105375483, Marker 11162), uncharacterized LOC105375492(LOC105375492, marker 11163), uncharacterized LOC105375509(LOC105375509, marker 11164), uncharacterized LOC105375531(LOC105375531, marker 11165), uncharacterized LOC1053755 31(LOC105375531, marker 11166), uncharacterized LOC105375547(LOC105375547, marker 11167), uncharacterized LOC105375571 (LOC105375571, marker 11168), uncharacterized LOC105375582(LOC105375582, marker 11169), uncharacterized LOC105375602(LOC105375602, marker 11170), basic salivary proline-rich protein 2-like(LOC105375620, marker 11171), bas ic salivary proline-rich protein 2-like (LOC105375620, marker 11172), uncharacterized LOC105375624(LOC105375624, marker 11173), uncharacterized LOC105375640(LOC105375640, marker 11174), uncharacterized LOC105375650(LOC105375650, marker 11175), uncharacterized LOC105375677(LOC105375677, marker 11176), uncharacterized LOC105375679(LOC105375679, marker 11177 ), uncharacterized LOC105375707(LOC105375707, marker 11178), uncharacterized LOC105375769(LOC105375769, marker 11179), uncharacterized LOC105375771(LOC105375771, marker 11180), uncharacterized LOC105375773(LOC10 5375773, marker 11181), uncharacterized LOC105375785(LOC105375785, marker 11182), uncharacterized LOC105375839( LOC105375839, marker 11183), uncharacterized LOC105375839(LOC105375839, marker 11184), uncharacterized LOC105375848 /// proenkephalin(LOC105375848 /// PENK, marker 11185), uncharacterized LOC105375875(LOC1053758 75, marker 11186), uncharacterized LOC105375978 /// zinc finger, DHHC -type containing 21(LOC105375978 /// ZDHHC21, marker 11187), uncharacterized LOC105376023(LOC105376023, marker 11188), uncharacterized LOC105376031(LOC105376031, marker 11189), uncharacterized LOC105376037(LOC10537 6037, marker 11190), uncharacterized LOC105376064 /// uncharacterized LOC105379438 / // uncharacterized LOC105379447(LOC105376064 /// LOC105379438 /// LOC105379447, marker 11191), uncharacterized LOC105376066(LOC105376066, marker 11192), uncharacterized LOC105376072(LOC105376072, marker 11193), uncharacterized LOC105376081(LOC105376081, marker 11194), uncharacterized LOC105376100(LOC105376100 ,marker 11195),uncharacterized LOC105376132(LOC105376132,marker 11196),uncharacterized LOC105376139(LOC105376139,marker 11197),uncharacterized LOC105376196(LOC105376196,marker 11198),uncharacterized LOC10537 6226(LOC105376226, Marker 11199), uncharacterized LOC105376230(LOC105376230, Marker 11200), uncharacterized LOC105376236(LOC105376236, marker 11201), uncharacterized LOC105376256(LOC105376256, marker 11202), uncharacterized LOC105376285(LOC105376285, marker 11203), uncharacterized LOC105376287(LOC1053 76287, marker 11204), uncharacterized LOC105376301(LOC105376301, marker 11205), uncharacterized LOC105376323(LOC105376323, marker 11206), uncharacterized LOC105376323(LOC105376323, marker 11207), uncharacterized LOC105376360(LOC105376360, marker 11208), uncharacterized LOC105376379(LOC105376379, marker 11209), endogenous retrovirus group K member 7 En v polyprotein-like(LOC10537
6387, marker 11210), uncharacterized LOC105376427(LOC105376427, marker 11211), uncharacterized LOC105376439(LOC105376439, marker 11212), uncharacterized LOC105376486 /// uncharacterized LOC338620(LOC105376486 /// LOC338620, marker 11213), uncharacterized LOC105376489(LOC105376489, marker 11214) ,uncharacterized LOC105376512 /// toll interacting protein(LOC105376512 /// TOLLIP, marker 11215), uncharacterized LOC105376530(LOC105376530, marker 11216), uncharacterized LOC105376586(LOC105376586, marker 11217), uncharacterized LOC10 5376606(LOC105376606, marker 11218),collagen alpha- 2(I) chain-like(LOC105376684, marker 11219), uncharacterized LOC105376703(LOC105376703, marker 11220), uncharacterized LOC105376717(LOC105376717, marker 11221), uncharacterized LOC105376768 /// cancer/testis antigen 75(LOC 105376768 /// LOC440934, Marker 11222), uncharacterized LOC105376790(LOC105376790, marker 11223), uncharacterized LOC105376798 /// ZFP3 zinc finger protein(LOC105376798 /// ZFP3, marker 11224), uncharacterized LOC105376944(LOC105376944, marker 11225) ,uncharacterized LOC105376944(LOC105376944, marker 11226), uncharacterized LOC105376948 /// ssu-2 homolog (C. elegans)(LOC105376948 /// SSUH2, marker 11227), uncharacterized LOC105376975(LOC105376975, marker 11228), uncharacterized LOC105376997(LOC105376997, marker 1122 9),uncharacterized LOC105377076 /// zinc finger protein 589(LOC105377076 /// ZNF589, marker 11230), uncharacterized LOC105377085(LOC105377085, marker 11231), uncharacterized LOC105377105(LOC105377105, marker 11232), uncharacterized LOC105377108(LOC105377 108, Marker 11233), uncharacterized LOC105377108(LOC105377108, Marker 11234), transcription initiation factor TFIID subunit 4-like /// uncharacterized LOC401068(LOC105377135 /// LOC401068, marker 11235), uncharacterized LOC105377143(LOC105377143, marker 11236), zinc finger protein Rlf-like(LOC105377200, marker 11237), zinc finger protein Rlf - like(LOC105377200, marker 11238), uncharacterized LOC105377223(LOC105377223, marker 11239), uncharacterized LOC105377245(LOC105377245, marker 11240), uncharacterized LOC105377276(LOC105377276, marker 11241) ,uncharacterized LOC105377320(LOC105377320,Marker 11242),uncharacterized LOC105377323(LOC105377323,Marker 11243), uncharacterized LOC105377335(LOC105377335, marker 11244), uncharacterized LOC105377371(LOC105377371, marker 11245), uncharacterized LOC105377391(LOC105377391, marker 11246), uncharacterized LOC1053773 99(LOC105377399, marker 11247), uncharacterized LOC105377421(LOC105377421, marker 11248), uncharacterized LOC105377436 (LOC105377436, marker 11249), uncharacterized LOC105377441(LOC105377441, marker 11250), uncharacterized LOC105377443(LOC105377443, marker 11251), uncharacterized LOC105377450 /// N(alpha)-acetyltransferase 15, NatA auxiliary subunit(LOC105377450 /// NAA15, marker 11252 ),uncharacterized LOC105377450 /// N(alpha)-acetyltransferase 15, NatA auxiliary subunit(LOC105377450 /// NAA15, marker 11253), uncharacterized LOC105377458(LOC105377458, marker 11254), uncharacterized LOC105377468(LOC1053 77468, marker 11255), uncharacterized LOC105377485( LOC105377485, marker 11256), uncharacterized LOC105377486(LOC105377486, marker 11257), uncharacterized LOC105377591 /// sorting nexin 25(LOC105377591 /// SNX25, marker 11258), uncharacterized LOC105377656(LOC1 05377656, Marker 11259), uncharacterized LOC105377663(LOC105377663, Marker 11260 ), uncharacterized LOC105377690(LOC105377690, marker 11261), uncharacterized LOC105377730(LOC105377730, marker 11262), uncharacterized LOC105377750(LOC105377750, marker 11263), uncharacterized LOC105377776(LOC10 5377776, marker 11264), uncharacterized LOC105377782 /// uncharacterized LOC286087(LOC105377782 /// LOC286087, marker 11265), uncharacterized LOC105377809(LOC105377809, marker 11266), uncharacterized LOC105377809(LOC105377809, marker 11267), uncharacterized LOC105377832(LOC105377832, marker 11268), uncharacterized LOC105377832(LOC105377832, Marker 11269), uncharacterized LOC105377844(LOC105377844, Marker 11270) ,uncharacterized LOC105377866(LOC105377866,Marker 11271),uncharacterized LOC105377924(LOC105377924,Marker 11272),uncharacterized LOC105377925(LOC105377925,Marker 11273),uncharacterized LOC105377938(LOC10 5377938, marker 11274), uncharacterized LOC105377993(LOC105377993, marker 11275), uncharacterized LOC105378011(LOC105378011 ,marker 11276),uncharacterized LOC105378044(LOC105378044,marker 11277),uncharacterized LOC105378052(LOC105378052,marker 11278),uncharacterized LOC105378067(LOC105378067,marker 11279),uncharacterized LOC10537 8074(LOC105378074, marker 11280), uncharacterized LOC105378130(LOC105378130, marker 11281), uncharacterized LOC105378136(LOC105378136, marker 11282), uncharacterized LOC105378138(LOC105378138, marker 11283), uncharacterized LOC105378146 /// uncharacterized LOC340178(LOC105378146 /// LOC340178, marker 1128 4),uncharacterized LOC105378171 /// uncharacterized LOC105378174(LOC105378171 /// LOC105378174, marker 11285), uncharacterized LOC105378195(LOC105378195, marker 11286), uncharacterized LOC105378231(LOC105378231, marker 11287), uncharacterized LOC105378276(LOC105378276, marker 11288), uncharacterized LOC105378 286(LOC105378286, marker 11289), uncharacterized LOC105378289 /// uncharacterized LOC105378296 /// uncharacterized LOC105378410(LOC105378289 /// LOC105378296 /// LOC105378410, marker 11290), uncharacterized LOC105378311(LOC105378311, marker 11291), uncharacterized LOC105378349(LOC105378349, marker 1 1292), uncharacterized LOC105378363(LOC105378363, marker 11293), uncharacterized LOC105378367(LOC105378367, marker 11294), uncharacterized LOC105378382(LOC105378382, marker 11295), uncharacterized LOC105378382(LOC105378382, marker 11296), uncharacterized LOC105378419(LOC105378419, marker 11297), uncharacterized LOC1053784 70(LOC105378470, marker 11298), uncharacterized LOC105378515(LOC105378515, marker 11299), uncharacterized LOC105378538 (LOC105378538, marker 11300), uncharacterized LOC105378588(LOC105378588, marker 11301), uncharacterized LOC105378589(LOC105378589, marker 11302), uncharacterized LOC105378589(LOC105378589, marker 11303), uncharacterized protein FLJ14100(LOC105378592, marker 11304), uncharacterized LOC105378596 /// uncharacterized LOC115110(LOC105378596 /// LOC115110, Marker 11305), uncharacterized LOC105378597(LOC105378597, Marker 11306), uncharacterized LOC105378604(LOC105378604, Marker 11307), uncharacterized LOC105378635(LOC 105378635, marker 11308), uncharacterized LOC105378688(LOC105378688, marker 11309), uncharacterized LOC105378689 (LOC105378689, marker 11310), uncharacterized LOC105378696(LOC105378696, marker 11311), uncharacterized LOC105378702(LOC105378702, marker 11312), uncharacterized LOC105378726(LOC105378726, marker 11313), uncharacterized LOC105378730(LOC105378730, marker 11314), uncharacterized LOC105378739(LOC105378739, marker 11315 ), uncharacterized LOC105378749(LOC105378749, marker 11316), uncharacterized LOC105378749(LOC105378749, marker 11317), uncharacterized LOC105378749(LOC105378749, marker 11318), uncharacterized LOC105378753(LOC10 5378753, marker 11319), uncharacterized LOC105378789(LOC105378789, marker 11320), uncharacterized LOC105378828( LOC105378828, marker 11321), uncharacterized LOC105378943(LOC105378943, marker 11322), uncharacterized LOC105378997(LOC105378997, marker 11323), uncharacterized LOC105379071(LOC105379071, marker 11324), uncharacterized LOC105379143(LOC105379143, marker 11325), uncharacterized LOC105379178(LOC105379178, marker 11326) ,uncharacterized LOC105379232(LOC105379232, marker 11327),uncharacterized LOC105379250(LOC105379250,marker 11328),uncharacterized LOC105379250(LOC105379250,marker 11329),uncharacterized LOC105379273 /// anky rin interacting repeat domain 57 pseudogene /// MAFF protein (pseudogene) /// tektin 4 pseudogene 2(LOC105379273 /// LOC389834 /// MAFIP /// TEKT4P2, marker 11330), uncharacterized LOC105379341(LOC105379341, marker 11331), uncharacterized LOC105379341(LOC105379341, marker 11332), uncharacterized LOC105379348(LOC105379348, marker 11333), uncharacterized LOC105379385(LOC105379385, marker 11334), uncharacterized LOC105379448(LOC105379448, marker 11335), uncharacterized LOC105379477(LOC105379477, marker 11336), uncharacterized LOC105379524(LOC1053 79524, marker 11337), uncharacterized LOC105379555(LOC105379555, marker 11338), uncharacterized LOC105379627(LOC105379627, marker 11339), uncharacterized LOC105379661(LOC105379661, marker 11340), uncharacterized LOC105379685 /// uncharacterized LOC401220(LOC105379685 /// LOC401220, marker 11341), uncharacterized LOC105379699 /// leucine rich repeat and fibronectin type III domain containing 2(LOC105379699 // / LRFN2, marker 11342), uncharacterized LOC105379703(LOC105379703, marker 11343), CASP-like protein 4A1(LOC105379704, marker 11344), CASP-like protein 4A1(LOC105379704, marker 11345), uncharacterized LOC105379742(LOC 105379742, marker 11346), uncharacterized LOC105379752(LOC105379752, marker 11347), uncharacterized LOC105379807(LOC105379807, marker 11348), uncharacterized LOC105379809(LOC105379809, marker 11349), uncharacterized LOC105379878(LOC1053798 78, marker 11350), uncharacterized LOC106699570(LOC106699570, marker 11351), uncharacterized protein LOC113230(LOC113230, marker 11352), uncharacterized LOC115110(LOC115110, marker 11353), uncharacterized protein BC008131(LOC142937, marker 11354), uncharacterized LOC143188 /// vesicle transport through interaction with t-SNAREs 1A(LOC143188 /// VTI1A, marker 11355), uncharacterized LOC145474 (LOC145474, marker 11356), uncharacterized LOC145678(LOC145678, marker 11357), uncharacterized LOC145694(LOC145694, marker 11358), uncharacterized LOC145783 /// zinc finger protein 280D(LOC145783 /// ZNF280D, marker 11359), uncharacterized LOC145783 /// zinc finger protein 280D(LOC145783 /// ZNF280D, marker 11360), uncharacterized LOC145783 /// zinc finger protein 280D(LOC145783 /// ZNF280D, marker 11361), uncharacterized LOC145845(LOC145845, marker 11362), uncharacterized LOC145945(LOC14 5945, marker 11363), uncharacterized LOC146513(LOC146513, marker 11364), uncharacterized LOC146795(LOC146795, marker 11365), Rho GTPase activating protein 27 pseudogene(LOC146880, marker 11366), Rho GTPase activating protein 27 pseudogene(LOC146880, marker 113) 67),uncharacterized LOC147004( LOC147004, marker 11368), uncharacterized LOC147791(LOC147791, marker 11369), un
characterized LOC148696(LOC148696, marker 11370), uncharacterized LOC149351(LOC149351, marker 11371), uncharacterized LOC149373(LOC149373, marker 11372), uncharacterized LOC149703(LOC149703, marker 11373), homeobox protein cut-like 1(LOC1 50051, marker 11374), uncharacterized LOC150596(LOC150596, marker 11375), uncharacterized LOC150596(LOC150596, marker 11376), uncharacterized LOC151121(LOC151121, marker 11377), uncharacterized LOC151174(LOC151174, marker 11378), uncharacterized LOC151484(LOC 151484, Marker 11379), uncharacterized LOC151657(LOC151657, Marker 11380), putative uncharacterized protein LOC151760(LOC151760, marker 11381), putative uncharacterized protein LOC151760(LOC151760, marker 11382), uncharacterized LOC152225(LOC152225, marker 11383), uncharacterized LOC152274(LOC152274, marker 113 84), uncharacterized LOC153577(LOC153577, marker 11385 ), uncharacterized LOC153682(LOC153682, marker 11386), uncharacterized LOC153684(LOC153684, marker 11387), uncharacterized LOC153811 /// ring finger protein 130(LOC153811 /// RNF130, marker 11388), uncharacterized LOC153910(LOC153910, Marker 11389),family with sequence similarity 115, member C pseudogene(LOC154761,marker 11390),family with sequence similarity 115, member C pseudogene /// TRPM8 channel-associated factor 2 /// TRPM8 channel-associated factor 2 pseudogene 1(LOC154761 /// TCAF2 /// TCAF2P1, marker 11391), AI894139 pseudogene /// zinc finger family member 783(LOC155060 /// ZNF783, marker 11392), AI894139 pseudogene /// zinc finger family member 783(LOC155060 /// ZNF783, marker 11393) ,uncharacterized LOC157273(LOC157273, marker 11394),uncharacterized LOC157503 /// X-linked Kx blood group related 4(LOC157503 /// ,marker 11397), uncharacterized LOC157860(LOC157860, marker 11398), uncharacterized LOC157931(LOC157931, marker 11399), uncharacterized LOC158434(LOC158434, marker 11400), uncharacterized LOC162137(LOC162137, marker 11401), dihydr ofolate reductase pseudogene (LOC1720, marker 11402), uncharacterized LOC200609(LOC200609, marker 11403), uncharacterized LOC200772(LOC200772, marker 11404), uncharacterized LOC200830(LOC200830, marker 11405), SUMO-interacting motifs containing 1 pseudogene(LOC202181, marker 11406), uncharacterized LOC219690 (LOC219690, marker 11407), dedicator of cytokinesis 1 pseudogene(LOC220077, marker 11408), uncharacterized LOC221122(LOC221122, marker 11409), uncharacterized LOC221122(LOC221122, marker 11410), uncharacterized LOC221814(LOC221814, marker 11411), uncharacterized LOC221946(LOC2 21946, marker 11412), uncharacterized LOC253573( LOC253573, marker 11413), uncharacterized LOC253805(LOC253805, marker 11414), uncharacterized LOC254028(LOC254028, marker 11415), uncharacterized LOC254896 /// tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain(LOC254896 /// TNF RSF10C, marker 11416), uncharacterized LOC255177(LOC255177, marker 11417), uncharacterized LOC255654(LOC255654, marker 11418), uncharacterized LOC257152(LOC257152, marker 11419), uncharacterized LOC257396(LOC257396, marker 11420), anti -CNG alpha 1 cation channel translation product- like(LOC280665, marker 11421), uncharacterized LOC283038(LOC283038, marker 11422), uncharacterized LOC283045(LOC283045, marker 11423), uncharacterized LOC283075(LOC283075, marker 11424), uncharacterized LOC283075(LOC283075, marker11425), uncharacterized LOC283112(LOC283112, marker 11426),uncharacterized LOC283140(LOC283140,Marker 11427),uncharacterized LOC283177(LOC283177,Marker 11428),uncharacterized LOC283177(LOC283177,Marker 11429),uncharacterized LOC283194(LOC283194,Marker 11430),uncharacter ized LOC283214(LOC283214, marker 11431), uncharacterized LOC283335 (LOC283335, marker 11432), uncharacterized LOC283352(LOC283352, marker 11433), uncharacterized LOC283352(LOC283352, marker 11434), uncharacterized LOC283387(LOC283387, marker 11435), uncharacterized LOC283435(LOC283435, marker 11436), uncharacterized LOC283454(LOC283454, marker 11437 ), uncharacterized LOC283482(LOC283482, marker 11438), uncharacterized LOC283484(LOC283484, marker 11439), uncharacterized LOC283484(LOC283484, marker 11440), uncharacterized LOC283516(LOC283516, marker 11441), uncharacterized LOC283 585(LOC283585, marker 11442), uncharacterized LOC283588 / // ribosomal protein S6 kinase, 90kDa, polypeptide 5(LOC283588 /// RPS6KA5, marker 11443), uncharacterized LOC283665(LOC283665, marker 11444), uncharacterized LOC283674(LOC283674, marker 11445), uncharacterized LOC283674(LOC283674, marker 1 1446),uncharacterized LOC283713 /// OTU deubiquitinase 7A(LOC283713 /// OTUD7A, marker 11447), uncharacterized LOC283731(LOC283731, marker 11448), uncharacterized LOC283737(LOC283737, marker 11449), uncharacterized LOC283745(LOC283745, marker 1 1450),uncharacterized LOC283745(LOC283745, marker 11451), FSHD region gene 1 pseudogene(LOC283788, marker 11452),FSHD region gene 1 pseudogene(LOC283788, marker 11453),FSHD region gene 1 pseudogene(LOC283788, marker 11454),FSHD region gene 1 pseudogene(LOC283788, marker 11455 ), FSHD region gene 1 pseudogene(LOC283788, marker 11456), uncharacterized LOC283856(LOC283856, marker 11457), uncharacterized LOC283861(LOC283861, marker 11458), uncharacterized LOC283887(LOC283887, marker 11459), uncharacterized LOC283887 (LOC283887, marker 11460), pyruvate dehydrogenase phosphatase regulatory subunit pseudogene /// pyruvate dehydrogenase phosphatase regulatory subunit(LOC283922 /// PDPR, marker 11461), uncharacterized LOC284009 /// methyltransferase like 16(LOC284009 /// METTL16, marker 11462), uncharacterized LOC284014(LOC2840 14, marker 11463),uncharacterized LOC284080(LOC284080,marker 11464),uncharacterized LOC284080(LOC284080,marker 11465),uncharacterized LOC284240(LOC284240,marker 11466),uncharacterized LOC284263(LOC284263,marker 11467),uncharacter ized LOC284294(LOC284294, marker 11468),solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 pseudogene(LOC284379, marker 11469), uncharacterized LOC284395(LOC284395, marker 11470), uncharacterized LOC284454(LOC284454, marker 11471), uncharacterized LOC284561(LOC284561, marker 11472) ,uncharacterized LOC284561(LOC284561, marker 11473), uncharacterized LOC284578(LOC284578, marker 11474), uncharacterized LOC284600(LOC284600, marker 11475), uncharacterized LOC284630 /// tetratricopeptide repeat domain 34(LOC284630 /// TTC34, marker 114 76),uncharacterized LOC284632(LOC284632 , marker 11477), uncharacterized LOC284648(LOC284648, marker 11478), uncharacterized LOC284661(LOC284661, marker 11479), uncharacterized LOC284661(LOC284661, marker 11480), uncharacterized LOC284669(LOC284669, marker 11481), uncharacterized LOC284669(LOC284669, marker 11482), uncharacterized LOC284788(LOC284788, marker 11483), uncharacterized LOC284798(LOC284798, marker 11484), uncharacterized LOC284825(LOC284825, marker 11485), uncharacterized LOC284865(LOC284865, marker 11486), uncharacterized LOC28489 8(LOC284898, marker 11487), uncharacterized LOC284912(LOC284912, marker 11488), uncharacterized LOC284930(LOC284930, marker 11489), uncharacterized LOC284930(LOC284930, marker 11490), uncharacterized LOC284933(LOC284933, marker 11491), uncharacterized LOC284950(LOC284950, marker 11492), un characterized LOC285000(LOC285000, marker 11493), uncharacterized LOC285043(LOC285043, marker 11494), uncharacterized LOC285095(LOC285095, marker 11495), uncharacterized FLJ38379(LOC285097, marker 11496), uncharacterized FLJ38379(LOC285097, marker 11497), uncharacterized LOC285147(LOC28 5147, Marker 11498), uncharacterized LOC285147(LOC285147, Marker 11499),uncharacterized LOC285181(LOC285181,Marker 11500),uncharacterized LOC285191(LOC285191,Marker 11501),uncharacterized LOC285300(LOC285300,Marker 11502),uncharacterized LOC285389(LOC285389,Marker 11503),uncharacter ized LOC285422(LOC285422, marker 11504), uncharacterized LOC285423 (LOC285423, marker 11505), uncharacterized LOC285500(LOC285500, marker 11506), uncharacterized LOC285556(LOC285556, marker 11507), uncharacterized LOC285593(LOC285593, marker 11508), uncharacterized LOC285593(LOC285593, marker 11509), uncharacterized LOC285627(LOC285627, marker 11510 ),MIR146A host gene(LOC285628, marker 11511),MIR146A host gene(LOC285628, marker 11512),uncharacterized LOC285638(LOC285638,marker 11513),uncharacterized LOC285692(LOC285692,marker 11514),uncharacterized LOC285692(LOC2 85692, marker 11515), uncharacterized LOC285696(LOC285696, marker 11516), uncharacterized LOC285766(LOC285766, marker 11517), uncharacterized LOC285819(LOC285819, marker 11518), uncharacterized LOC285847(LOC285847, marker 11519), uncharacterized LOC285847(LOC 285847, Marker 11520), uncharacterized LOC285847(LOC285847, Marker 11521), uncharacterized LOC285857(LOC285857, marker 11522), uncharacterized LOC285889(LOC285889, marker 11523), uncharacterized LOC285957(LOC285957, marker 11524), uncharacterized LOC286058(LOC286058, marker 11525), tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain pseudogene(LOC286059, marker 11526), tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain pseudogene(LOC286059, marker 11527), uncharacterized LOC286068(LOC286068, marker 11528), uncharacterized LOC286071(LOC286071, marker 11 529) ,uncharacterized LOC286083(LOC286083, marker 11530),uncharacterized LOC286114(LOC286114,marker 11531),uncharacterized LOC286114(LOC286114,marker 11532),uncharacterized LOC286121(LOC286121,marker 11533),uncharacterized LOC286 177(LOC286177, marker 11534), uncharacterized LOC286178(LOC286178 , marker 11535), uncharacterized LOC286238(LOC286238, marker 11536), uncharacterized LOC286359(LOC286359, marker 11537), uncharacterized LOC286359(LOC286359, marker 11538), uncharacterized LOC286382(LOC286382, marker 11539), uncharacterized LOC286437(LOC286437, marker 11540), V-set and immunoglobulin domain-containing protein 10-like(LOC338667, marker 11541),uncharacterized LOC338694(LOC338694,marker 11542),epididymal protein pseudogene(LOC338963,marker 11543),uncharacterized LOC339166 /// WSC domain containing 1(LOC339166 / // WSCD1, marker 11544), uncharacterized LOC339298(LOC339298, marker 11545), cytosolic thiouridylase subunit 1 homolog (S. pombe) pseudogene(LOC339352, marker 11546), uncharacterized LOC339468
(LOC339468, marker 11547), uncharacterized LOC339539(LOC339539, marker 11548), uncharacterized LOC339568(LOC339568, marker 11549), uncharacterized LOC339593(LOC339593, marker 11550), uncharacterized LOC339622(LOC339622, marker 11551), uncharacterized LOC339666(LOC339666, marker 11552 ), uncharacterized LOC339685(LOC339685, marker 11553), uncharacterized LOC339807(LOC339807, marker 11554), uncharacterized LOC339862(LOC339862, marker 11555), uncharacterized LOC339874(LOC339874, marker 11556), uncharacterized LOC339 874(LOC339874, marker 11557), uncharacterized LOC339975( LOC339975, marker 11558), uncharacterized LOC339978(LOC339978, marker 11559), uncharacterized LOC339988(LOC339988, marker 11560), uncharacterized LOC339988(LOC339988, marker 11561), uncharacterized LOC340017(LOC340017, marker 11562), uncharacterized LOC340074(LOC340074, marker 11563) ,uncharacterized LOC340090(LOC340090, marker 11564),uncharacterized LOC340107(LOC340107,marker 11565),uncharacterized LOC340107(LOC340107,marker 11566),uncharacterized LOC340184(LOC340184,marker 11567),uncharacterized LOC340 340(LOC340340, marker 11568), uncharacterized LOC340357(LOC340357 , marker 11569), uncharacterized LOC340581(LOC340581, marker 11570), NmrA-like family domain containing 1 pseudogene(LOC344887, marker 11571), uncharacterized LOC349160(LOC349160, marker 11572), C-type lectin domain family 2, member D pseudogene( LOC374443, marker 11573), C-type lectin domain family 2, member D pseudogene(LOC374443, marker 11574), uncharacterized LOC374890(LOC374890, marker 11575), uncharacterized LOC375196(LOC375196, marker 11576), uncharacterized LOC388456(LOC3884 56, marker 11577) ,uncharacterized LOC388692(LOC388692, marker 11578),uncharacterized LOC388692(LOC388692,marker 11579),uncharacterized LOC388780(LOC388780,marker 11580),uncharacterized LOC388882(LOC388882,marker 11581),uncharacterized LOC388 942(LOC388942, marker 11582), uncharacterized LOC389199(LOC389199 ,marker 11583),uncharacterized LOC389247(LOC389247,marker 11584),uncharacterized LOC389332(LOC389332,marker 11585),uncharacterized LOC389641(LOC389641,marker 11586),ankyrin repeat domain 57 pseudogene(LOC389834,marker 11587),an kyrin repeat domain 57 pseudogene( LOC389834, marker 11588), ankyrin repeat domain 57 pseudogene(LOC389834, marker 11589), ankyrin repeat domain 57 pseudogene(LOC389834, marker 11590), uncharacterized LOC399716(LOC399716, marker 11591), uncharacterized LOC399884(LOC399884, marker 11) 592),uncharacterized LOC399900 (LOC399900, marker 11593), uncharacterized LOC399900(LOC399900, marker 11594), uncharacterized LOC400499(LOC400499, marker 11595), uncharacterized LOC400541(LOC400541, marker 11596), uncharacterized LOC400548(LOC400548, marker 11597), uncharacterized LOC400568(LOC400568, marker 11598 ),uncharacterized LOC400590(LOC400590,marker 11599),uncharacterized LOC400590(LOC400590,marker 11600),uncharacterized LOC400620(LOC400620,marker 11601),uncharacterized LOC400620(LOC400620,marker 11602),uncharacterized LOC400 622(LOC400622, marker 11603), uncharacterized LOC400627( LOC400627, Marker 11604), uncharacterized LOC400627(LOC400627, Marker 11605), uncharacterized LOC400655(LOC400655, Marker 11606), uncharacterized LOC400655(LOC400655, Marker 11607), uncharacterized LOC400748(LOC400748, Marker 11608), uncharacterized LOC400756(LOC400756, marker 11609) ,uncharacterized LOC400768 /// neuroblastoma breakpoint family, member 6(LOC400768 /// NBPF6, marker 11610), uncharacterized LOC400794(LOC400794, marker 11611), uncharacterized LOC400794(LOC400794, marker 11612), uncharacterized LOC400794(LOC4007 94, marker 11613), uncharacterized LOC400940(LOC400940, marker 11614), uncharacterized LOC400940(LOC400940, marker 11615), uncharacterized LOC400958(LOC400958, marker 11616), uncharacterized LOC400965(LOC400965, marker 11617), uncharacterized LOC40105 2(LOC401052, marker 11618), uncharacterized LOC401098(LOC401098, marker 11619), uncharacterized LOC401134(LOC401134, marker 11620), uncharacterized LOC401134(LOC401134, marker 11621), uncharacterized LOC401176(LOC401176, marker 11622), zinc finger protein ZIC 5(LOC401261, marker 11623), uncharacterized LOC401312(LOC401312, marker 11624 ),uncharacterized LOC401320(LOC401320,marker 11625),uncharacterized LOC401320(LOC401320,marker 11626),uncharacterized LOC401320(LOC401320,marker 11627),uncharacterized LOC401320(LOC401320,marker 11628),uncharacterized LOC401 320(LOC401320, marker 11629), uncharacterized LOC401324( LOC401324, Marker 11630), uncharacterized LOC401442(LOC401442, Marker 11631), uncharacterized LOC401463(LOC401463, Marker 11632), uncharacterized LOC401463(LOC401463, Marker 11633), uncharacterized LOC401585(LOC401585, Marker 11634), putative uncharacterized protein MGC39545(LOC403312, marker 11635), uncharacterized LOC403323(LOC403323, marker 11636), uncharacterized LOC414300(LOC414300, marker 11637), uncharacterized LOC439933(LOC439933, marker 11638), uncharacterized LOC439933(LOC439933, marker 11639), uncharacter ized LOC439938(LOC439938, marker 11640), uncharacterized LOC439951 (LOC439951, marker 11641), uncharacterized LOC440028(LOC440028, marker 11642), uncharacterized LOC440028(LOC440028, marker 11643), uncharacterized LOC440117(LOC440117, marker 11644), uncharacterized LOC440173(LOC440173, marker 11645), uncharacterized LOC440330(LOC440330, marker 11646 ), uncharacterized LOC440346(LOC440346, marker 11647), uncharacterized LOC440570(LOC440570, marker 11648), uncharacterized LOC440602(LOC440602, marker 11649), uncharacterized LOC440704(LOC440704, marker 11650), proline dehydrogenase (oxi dase) 1 pseudogene(LOC440792, marker 11651 ), proline dehydrogenase (oxidase) 1 pseudogene(LOC440792, marker 11652), uncharacterized LOC440864 /// mutS homolog 6(LOC440864 /// MSH6, marker 11653), uncharacterized LOC440982 /// Zic family member 1(LOC440982 /// ZIC1 ,marker 11654),uncharacterized LOC441025(LOC441025,marker 11655),uncharacterized LOC441052(LOC441052,marker 11656),uncharacterized LOC441086(LOC441086,marker 11657),zinc finger CCCH-type domain-containing-like /// zinc finger CCCH-type containing 11A(LOC441155 /// ZC3H11A, marker 11658), uncharacterized LOC441178(LOC441178, marker 11659), uncharacterized LOC441178(LOC441178, marker 11660), uncharacterized LOC441179(LOC441179, marker 11661), uncharacterized LOC44 1204(LOC441204, marker 11662), uncharacterized LOC441204(LOC441204, marker 11663), uncharacterized LOC441204(LOC441204, marker 11664), uncharacterized LOC441204(LOC441204, marker 11665), uncharacterized LOC441242(LOC441242, marker 11666), PMS1 homolog 2, mismatch repair system component pseudogene /// PMS1 homolog 2 , mismatch repair system component pseudogene 1 /// PMS1 homolog 2, mismatch repair system component pseudogene 10 /// PMS1 homolog 2, mismatch repair system component pseudogene 5 /// PMS1 homolog 2, mismatch repair system component pseudogene 6(LOC441259 // / PMS2P1 /// PMS2P10 /// PMS2P5 /// PMS2P6, marker 11667), prothymosin, alpha pseudogene (LOC441454, marker 11668), septin 7 pseudogene (LOC441601, marker 11669), zinc finger protein 91 pseudogene (LOC441666, marker 11670) ),zinc finger protein 91 pseudogene(LOC441666, marker 11671),uncharacterized LOC442028(LOC442028,marker 11672),uncharacterized LOC497256(LOC497256,marker 11673),uncharacterized LOC51145(LOC51145,marker 11674),uncharacterized LOC541472( LOC541472, marker 11675), uncharacterized LOC550113 /// UBA6 antisense RNA 1 (head to head)(LOC550113 /// UBA6-AS1, marker 11676), uncharacterized LOC553103(LOC553103, marker 11677), uncharacterized LOC55338(LOC55338, marker 11678), uncharacterized LOC55338(LOC5533 8, marker 11679), uncharacterized LOC55338(LOC55338, marker 11680), uncharacterized LOC55338(LOC55338, marker 11681), uncharacterized LOC554174(LOC554174, marker 11682), leucine carboxyl methyltransferase 1 pseudogene(LOC554206, marker 11683), leucine carboxyl methyltransferase 1 pseudogene(LOC554206 ,marker 11684),uncharacterized LOC554207(LOC554207,marker 11685),uncharacterized gastric protein ZA52P(LOC57399,marker 11686),uncharacterized LOC574538(LOC574538,marker 11687),uncharacterized LOC613266(LOC613266,marker 11688),un characterized LOC619427(LOC619427, Marker 11689 ),uncharacterized LOC642426(LOC642426,marker 11690),uncharacterized LOC642620(LOC642620,marker 11691),uncharacterized LOC642696(LOC642696,marker 11692),uncharacterized LOC642852(LOC642852,marker 11693),Ras homolog enriched in brain pseudogene(LOC642862, marker 11694) ,uncharacterized LOC643072(LOC643072, marker 11695),centrosomal protein 192kDa pseudogene(LOC643201,marker 11696),centrosomal protein 192kDa pseudogene(LOC643201,marker 11697),centrosomal protein 192kDa pseudogene(LOC643201,marker 11698),uncharacter ized LOC643355(LOC643355, Marker 11699 ), uncharacterized LOC643549(LOC643549, marker 11700), hCG2019139(LOC643659, marker 11701), platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa) pseudogene(LOC643711, marker 11702), platelet-activating factor acetylhydrolase 1b , catalytic subunit 2 (30kDa) pseudogene (LOC643711, marker 11703), platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa) pseudogene (LOC643711, marker 11704), caspase 4, apoptosis-related cysteine peptidase pseudogene (LOC643733, marker 11705), caspase 4 , apoptosis-related cysteine peptidase pseudogene(LOC643733, marker 11706),uncharacterized LOC644090(LOC644090,marker 11707),uncharacterized LOC644090(LOC644090,marker 11708),uncharacterized LOC644135(LOC644135,marker 11709),uncharacterized LOC64 4794(LOC644794, marker 11710), uncharacterized LOC644852(LOC644852, marker 11711), uncharacterized LOC645188(LOC645188, marker 11712), PP565(LOC645261, marker 11713), uncharacterized LOC645321(LOC645321, marker 11714), uncharacterized LOC645485(LOC6454 85, Marker 11715), uncharacterized LOC645513(LOC645513, Marker 11716),uncharacterized LOC645513(LOC645513,Marker 11717),uncharacterized LOC645513(LOC645513,Marker 11718),uncharacterized LOC645513(LOC645513,Marker 11719),uncharacterized LOC645513(LOC645513,Marker 11720),uncharacter ized LOC645984(LOC645984, marker 11721), uncharacterized LOC646014 (LOC646014, marker 11722), uncharacterized LOC646241(LOC646241, marker 11723), uncharacterized LOC646241(LOC646241, marker 11724), hCG1654703(LOC646268, marker 11725), hCG1654703(LOC646268, marker 1172 6),uncharacterized LOC646383(LOC646383, marker
11727), uncharacterized LOC646482(LOC646482, marker 11728), uncharacterized LOC646484(LOC646484, marker 11729), uncharacterized LOC646522(LOC646522, marker 11730), uncharacterized LOC646588(LOC646588, marker 11731), uncharacter ized LOC646626(LOC646626, marker 11732), uncharacterized LOC646736 (LOC646736, marker 11733), uncharacterized LOC646743 /// uncharacterized LOC150527(LOC646743 /// TISP43, marker 11734), uncharacterized LOC646762(LOC646762, marker 11735), uncharacterized LOC646778(LOC646778, marker 11736), uncharacter ized LOC647070(LOC647070, Marker 11737 ), uncharacterized LOC647323(LOC647323, marker 11738), uncharacterized LOC648987(LOC648987, marker 11739), potassium channel tetramerization domain containing 5 pseudogene(LOC652276, marker 11740), uncharacterized LOC652993(LOC652993, marker 11741), uncharacterized LOC6 53160(LOC653160, marker 11742 ), uncharacterized LOC653581(LOC653581, marker 11743), otoancorin pseudogene /// otoancorin(LOC653786 /// OTOA, marker 11744), lymphocyte-specific protein 1 pseudogene(LOC654342, marker 11745), uncharacterized LOC654841(LOC654841, marker 11746), uncharacterized LOC692247(LOC692247, marker 11747), uncharacterized LOC692247(LOC692247, marker 11748), uncharacterized LOC727820(LOC727820, marker 11749), uncharacterized LOC727916(LOC727916, marker 11750), uncharacterized LOC72794 4(LOC727944, marker 11751),chromosome X open reading frame 56 pseudogene(LOC728024, marker 11752),hCG1813624(LOC728040,marker 11753),hCG2003663(LOC728061,marker 11754),uncharacterized LOC728073(LOC728073,marker 11755),uncharacterized LOC728084(LOC728084, Marker 11756), uncharacterized LOC728095(LOC728095, Marker 11757 ), uncharacterized LOC728099(LOC728099, marker 11758), uncharacterized LOC728099(LOC728099, marker 11759), uncharacterized LOC728114(LOC728114, marker 11760), uncharacterized LOC728175(LOC728175, marker 11761), uncharacterized LOC728 175(LOC728175, marker 11762), uncharacterized LOC728196( LOC728196, Marker 11763), uncharacterized LOC728283(LOC728283, Marker 11764), hCG1795091(LOC728327, Marker 11765), uncharacterized LOC728353(LOC728353, Marker 11766), uncharacterized LOC728353(LOC728353, Marker 11 767), uncharacterized LOC728445(LOC728445, marker 11768), uncharacterized LOC728485(LOC728485, marker 11769), programmed cell death 6 pseudogene(LOC728613, marker 11770), programmed cell death 6 pseudogene /// programmed cell death 6(LOC728613 /// PDCD6, marker 11771), programmed cell death 6 pseudogene / // programmed cell death 6(LOC728613 /// PDCD6, marker 11772), uncharacterized LOC728705(LOC728705, marker 11773), uncharacterized LOC728730(LOC728730, marker 11774), uncharacterized LOC728730(LOC728730, marker 11775), zinc finger protein pseudogene(LOC7 28743 , marker 11776), zinc finger protein pseudogene(LOC728743, marker 11777), uncharacterized LOC728805(LOC728805, marker 11778), uncharacterized LOC728868(LOC728868, marker 11779), uncharacterized LOC729083(LOC729083, marker 11780), hCG173 2469(LOC729164, marker 11781) ,uncharacterized LOC729173(LOC729173, marker 11782),uncharacterized LOC729224(LOC729224,marker 11783),uncharacterized LOC729291(LOC729291,marker 11784),uncharacterized LOC729291(LOC729291,marker 11785),uncharacterized LOC729 296(LOC729296, marker 11786), uncharacterized LOC729296 // / MIR646 host gene(LOC729296 /// MIR646HG, marker 11787), uncharacterized LOC729307(LOC729307, marker 11788), uncharacterized LOC729506(LOC729506, marker 11789), spidroin-2(LOC729652, marker 11790), uncharacterized LOC729683 (LOC729683, Marker 11791 ), uncharacterized LOC729732 (LOC729732, marker 11792), hCG1994895 (LOC729866, marker 11793), serine/arginine repetitive matrix protein 1 (LOC729870, marker 11794), uncharacterized LOC729887 (LOC729887, marker 11795), uncharacterized LOC72996 6 /// phosphodiesterase 4C, cAMP-specific(LOC729966 /// PDE4C, marker 11796), uncharacterized LOC729966 /// phosphodiesterase 4C, cAMP-specific(LOC729966 /// PDE4C, marker 11797), hCG2028352-like(LOC729970, marker 11798), quinone oxidoreductase-like protein 2 pseudogene(LOC730102, marker 11799), uncharacterized LOC730202(LOC730202, marker 11800), uncharacterized LOC730961(LOC730961, marker 11801), uncharacterized LOC731157(LOC731157, marker 11802), uncharacterized LOC780529(LOC780 529, marker 11803), uncharacterized LOC79160(LOC79160 , marker 11804), uncharacterized LOC79999(LOC79999, marker 11805), uncharacterized LOC84214(LOC84214, marker 11806), uncharacterized LOC84843(LOC84843, marker 11807), uncharacterized LOC90246(LOC90246, marker 11808), uncharacterized LOC902 46(LOC90246, marker 11809), uncharacterized LOC91450(LOC91450, marker 11810), uncharacterized LOC93444(LOC93444, marker 11811), uncharacterized LOC93463(LOC93463, marker 11812), loss of heterozygosity, 12, chromosomal region 2 (non-protein coding)(LOH12CR2, marker 11813), lon peptidase 2, peroxisomal(LONP2, marker 11814),LON peptidase N-terminal domain and ring finger 1(LONRF1, marker 11815),LON peptidase N-terminal domain and ring finger 2(LONRF2, marker 11816),LON peptidase N-terminal domain and ring finger 3(LONRF3, marker 11817), loricrin(LOR, marker 11818), lysyl oxidase(LOX, marker 11819), lipoxygenase homology domains 1(LOXHD1, marker 11820), lysyl oxidase-like 2(LOXL2, marker 11821) ), lysyl oxidase-like 2(LOXL2, marker 11822), lysyl oxidase-like 2(LOXL2, marker 11823), lysyl oxidase-like 4(LOXL4, marker 11824), lysyl oxidase-like 4(LOXL4, marker 11825), lipoprotein, Lp(a)(LPA,marker 11826),lipoprotein, Lp(a) /// plasminogen(LPA /// PLG,marker 11827),lipoprotein, Lp(a)-like 2, pseudogene(LPAL2,marker 11828 ),lipoprotein, Lp(a)-like 2, pseudogene(LPAL2, marker 11829),lysophosphatidic acid receptor 5(LPAR5,marker 11830),lysophosphatidic acid receptor 5(LPAR5,marker 11831),lysophosphatidic acid receptor 6(LPAR6,marker 11832), lysophosphatidylcholine acyltransferase 2(LPCAT2, marker 11833), lysophosphatidylcholine acyltransferase 2(LPCAT2, marker 11834), lysophosphatidylcholine acyltransferase 4(LPCAT4, marker 11835), lysophosphatidylcholine acyltransferase 4(LPCAT 4, marker 11836), lipin 3(LPIN3, marker 11837) ), lactoperoxidase (LPO, marker 11838), LIM domain containing preferred translocation partner in lipoma (LPP, marker 11839), LIM domain containing preferred translocation partner in lipoma (LPP, marker 11840), LPP antisense RNA 2 (LPP-AS2, marker 11841), leupaxin (LPXN, marker 11842), leucine-rich repeats and calponin homology (CH) domain containing 1 (LRCH1, marker 11843), leucine-rich repeats and calponin homology (CH) domain containing 3 (LRCH3, marker 11844) ,leucine-rich repeats and calponin homology (CH) domain containing 3(LRCH3, marker 11845),leucine-rich repeats and calponin homology (CH) domain containing 4(LRCH4, marker 11846),leucine-rich repeats and calponin homology (CH ) domain containing 4(LRCH4, marker 11847), leucine rich repeat and fibronectin type III domain containing 1(LRFN1, marker 11848), leucine rich repeat and fibronectin type III domain containing 2(LRFN2, marker 11849), leucine rich repeat and fibronectin type III domain containing 4(LRFN4, marker 11850), leucine-rich alpha-2-glycoprotein 1(LRG1, marker 11851), leucine-rich repeats and guanylate kinase domain containing(LRGUK, marker 11852), leucine-rich repeats and immunoglobulin -like domains 1(LRIG1, marker 11853),leucine-rich repeats and immunoglobulin-like domains 1(LRIG1, marker 11854),leucine-rich repeats and immunoglobulin-like domains 2(LRIG2, marker 11855),leucine-rich repeats and immunoglobulin-like domains 2(LRIG2, marker 11856), leucine-rich repeat, immunoglobulin-like and transmembrane domains 1(LRIT1, marker 11857), lymphoid-restricted membrane protein(LRMP, marker 11858), lymphoid-restricted membrane protein(LRMP , marker 11859), LDL receptor related protein 1 (LRP1, marker 11860), LDL receptor related protein 1 (LRP1, marker 11861), LDL receptor related protein 10 (LRP10, marker 11862), LDL receptor related protein 11 (LRP11, marker 11863), LDL receptor related protein 1B (LRP1B, marker 11864), LRP2 binding protein (LRP2BP, marker 11865), LDL receptor related protein 3 (LRP3, marker 11866), LDL receptor related protein 5 (LRP5, marker 11867), LDL receptor related protein 5 like (LRP5L, marker 11868), leucine rich repeat containing 1 (LRRC1, marker 11869), leucine rich repeat containing 10B (LRRC10B, marker 11870), leucine rich repeat containing 15 (LRRC15, marker 11871), leucine rich repeat containing 15(LRRC15, marker 11872), leucine rich repeat containing 16A(LRRC16A, marker 11873), leucine rich repeat containing 16A(LRRC16A, marker 11874), leucine rich repeat containing 16B(LRRC16B, marker 11875), leucine rich repeat containing 17 (LRRC17, marker 11876), leucine rich repeat containing 18 (LRRC18, marker 11877), leucine rich repeat containing 19 (LRRC19, marker 11878), LRRC2 antisense RNA 1 (LRRC2-AS1, marker 11879), leucine rich repeat containing 23 (LRRC23, marker 11880), leucine rich repeat containing 25(LRRC25, marker 11881), leucine rich repeat containing 27(LRRC27, marker 11882), leucine rich repeat containing 27(LRRC27, marker 11883), leucine rich repeat containing 27(LRRC27) , marker 11884), leucine rich repeat containing 27(LRRC27, marker 11885), leucine rich repeat containing 28(LRRC28, marker 11886), leucine rich repeat containing 28(LRRC28, marker 11887), leucine rich repeat containing 29(LRRC29, marker 11888), leucine rich repeat containing 3(LRRC3, marker 11889), leucine rich repeat containing 3(LRRC3, marker 11890), leucine rich repeat containing 31(LRRC31, marker 11891), leucine rich repeat containing 32(LRRC32, marker 11892) ,leucine rich repeat containing 36(LRRC36, marker 11893),leucine rich repeat containing 37A /// leucine rich repeat containing 37A /// leucine rich repeat containing 37, member A2(LRRC37A /// LRRC37A /// LRRC37A2,marker 11894 ), leucine rich repeat containing 37, member A16, pseudogene(LRRC37A16P, marker 11895), leucine rich repeat containing 37, member A2 /// leucine rich repeat containing 37, member A3(LRRC37A2 /// LRRC37A3, marker 11896), leucine rich repeat containing 37, member A3(LRRC37A3, marker 11897), leucine rich repeat containing 37, member A5, pseudogene(LRRC37A5P, marker 11898), leucine rich repeat containing 37, member A5, pseudogene(LRRC37A5P, marker 11899), leucine rich repeat containing 37, member A7, pseudogene(LRRC37A7P, marker 11900),leucine rich repeat containing 37, member A7, pseudogene(LRRC37A7P
, marker 11901), leucine rich repeat containing 37, member A8, pseudogene(LRRC37A8P, marker 11902), leucine rich repeat containing 37B pseudogene 1(LRRC37BP1, marker 11903), leucine rich repeat containing 38(LRRC38, marker 11904), leucine rich repeat containing 39(LRRC39, marker 11905), leucine rich repeat containing 39(LRRC39, marker 11906), leucine rich repeat containing 3C(LRRC3C, marker 11907), leucine rich repeat containing 41(LRRC41, marker 11908), leucine rich repeat containing 41(LRRC41, marker 11909), leucine rich repeat containing 43(LRRC43, marker 11910), leucine rich repeat containing 43(LRRC43, marker 11911), leucine rich repeat containing 43(LRRC43, marker 11912), leucine rich repeat containing 46( LRRC46, marker 11913), leucine rich repeat containing 46(LRRC46, marker 11914), leucine rich repeat containing 4B(LRRC4B, marker 11915), leucine rich repeat containing 4C(LRRC4C, marker 11916), leucine rich repeat containing 52(LRRC52, marker 11917), leucine rich repeat containing 55(LRRC55, marker 11918), leucine rich repeat containing 56(LRRC56, marker 11919), leucine rich repeat containing 57(LRRC57, marker 11920), leucine rich repeat containing 59(LRRC59, marker 11921) ), leucine rich repeat containing 59 (LRRC59, marker 11922), leucine rich repeat containing 6 (LRRC6, marker 11923), leucine rich repeat containing 63 (LRRC63, marker 11924), leucine rich repeat containing 66 (LRRC66, marker 11925), leucine rich repeat containing 69(LRRC69, marker 11926),leucine rich repeat containing 7(LRRC7, marker 11927),leucine rich repeat containing 7(LRRC7, marker 11928),leucine rich repeat containing 7(LRRC7, marker 11929),leucine rich repeat containing 7(LRRC7, marker 11930), leucine rich repeat containing 71(LRRC71, marker 11931), leucine rich repeat containing 72(LRRC72, marker 11932), leucine rich repeat containing 73(LRRC73, marker 11933), leucine rich repeat containing 74A(LRRC74A, marker 11934), leucine rich repeat containing 74A(LRRC74A, marker 11935), leucine rich repeat containing 74A(LRRC74A, marker 11936), leucine rich repeat containing 74B(LRRC74B, marker 11937), LRRC75A antisense RNA 1(LRRC75A -AS1, marker 11938), LRRC75A antisense RNA 1 (LRRC75A-AS1, marker 11939), leucine rich repeat containing 75B (LRRC75B, marker 11940), leucine rich repeat containing 8 family, member B (LRRC8B, marker 11941), leucine rich repeat containing 8 family, member C(LRRC8C, marker 11942),leucine rich repeat containing 8 family, member C(LRRC8C, marker 11943),leucine rich repeat containing 8 family, member E(LRRC8E, marker 11944),leucine rich repeat containing 8 family, member E(LRRC8E, marker 11945), leucine-rich repeats and death domain containing 1(LRRD1, marker 11946), leucine rich repeat (in FLII) interacting protein 1(LRRFIP1, marker 11947), leucine rich repeat (in FLII) interacting protein 1(LRRFIP1, marker 11948), leucine rich repeat (in FLII) interacting protein 1(LRRFIP1, marker 11949), leucine rich repeat (in FLII) interacting protein 2(LRRFIP2, marker 11950), leucine rich repeat ( in FLII) interacting protein 2(LRRFIP2, marker 11951), leucine rich repeat (in FLII) interacting protein 2(LRRFIP2, marker 11952), leucine-rich repeats and IQ motif containing 1(LRRIQ1, marker 11953), leucine-rich repeats and IQ motif containing 3(LRRIQ3, marker 11954),leucine-rich repeats and IQ motif containing 3(LRRIQ3, marker 11955),leucine-rich repeat kinase 1(LRRK1, marker 11956),leucine-rich repeat kinase 1(LRRK1, marker 11957), leucine-rich repeat kinase 2(LRRK2, marker 11958), leucine rich repeat neuronal 1(LRRN1, marker 11959), leucine rich repeat neuronal 2(LRRN2, marker 11960), leucine rich repeat neuronal 2(LRRN2, marker 11961), LRRN4 C-terminal like (LRRN4CL, marker 11962), leucine rich repeat transmembrane neuronal 2 (LRRTM2, marker 11963), leucine-rich repeats and transmembrane domains 1 (LRTM1, marker 11964), leucine-rich repeats and transmembrane domains 1 (LRTM1, marker 11965), leucine-rich repeats and transmembrane domains 2 (LRTM2, marker 11966), leucine rich transmembrane and O-methyltransferase domain containing (LRTOMT, marker 11967), limbic system-associated membrane protein (LSAMP, marker 11968) ),limbic system-associated membrane protein(LSAMP, marker 11969),limbic system-associated membrane protein(LSAMP, marker 11970),limbic system-associated membrane protein(LSAMP, marker 11971),uncharacterized LOC101926903(LSAMP-AS1,marker 11972 ),LSM11, U7 small nuclear RNA associated(LSM11, marker 11973),LSM family member 14B(LSM14B,marker 11974),LSM family member 14B(LSM14B,marker 11975),leucine-rich single-pass membrane protein 1(LSMEM1, marker 11976), leucine-rich single-pass membrane protein 1 (LSMEM1, marker 11977), leucine-rich single-pass membrane protein 2 (LSMEM2, marker 11978), lymphocyte-specific protein 1 (LSP1, marker 11979), lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)(LSS, marker 11980), leukocyte specific transcript 1(LST1, marker 11981), leukocyte specific transcript 1(LST1, marker 11982), leukocyte specific transcript 1(LST1, marker 11983), leukocyte specific transcript 1(LST1, marker 11984), leukocyte specific transcript 1(LST1, marker 11985), leukocyte specific transcript 1(LST1, marker 11986), lymphotoxin alpha (LTA, marker 11987), lymphotoxin beta (TNF superfamily, member 3 ) (LTB, marker 11988), leukotriene B4 receptor (LTB4R, marker 11989), leukotriene B4 receptor (LTB4R, marker 11990), leukotriene B4 receptor 2 (LTB4R2, marker 11991), latent transforming growth factor beta binding protein 3 (LTBP3, marker 11992), latent transforming growth factor beta binding protein 3 (LTBP3, marker 11993), latent transforming growth factor beta binding protein 3 (LTBP3, marker 11994), latent transforming growth factor beta binding protein 4 (LTBP4, marker 11995), lymphotoxin beta receptor (TNFR superfamily, member 3)(LTBR, marker 11996),lymphotoxin beta receptor (TNFR superfamily, member 3)(LTBR, marker 11997),lymphotoxin beta receptor (TNFR superfamily, member 3)(LTBR, marker 11998), lymphotoxin beta receptor (TNFR superfamily, member 3) (LTBR, marker 11999), leukotriene C4 synthase (LTC4S, marker 12000), lactotransferrin (LTF, marker 12001), leukocyte receptor tyrosine kinase (LTK, marker 12002), leukocyte receptor tyrosine kinase (LTK, marker 12003), listerin E3 ubiquitin protein ligase 1 (LTN1, marker 12004), LTV1 ribosome biogenesis factor (LTV1, marker 12005), LUC7-like (LUC7L, marker 12006), lumican (LUM, marker 12007), leukemia -associated non-coding IGF1R activator RNA 1(LUNAR1, marker 12008), leucine rich adapter protein 1-like(LURAP1L, marker 12009), LURAP1L antisense RNA 1(LURAP1L-AS1, marker 12010), leucine zipper protein 1(LUZP1, marker 12011), leucine zipper protein 2 (LUZP2, marker 12012), leucine zipper protein 4 (LUZP4, marker 12013), liver cancer-associated transcript 1 (LVCAT1, marker 12014), laeverin (LVRN, marker 12015), lymphocyte antigen 6 complex, locus D(LY6D, marker 12016),lymphocyte antigen 6 complex, locus G5C(LY6G5C,marker 12017),lymphocyte antigen 6 complex, locus G6C(LY6G6C,marker 12018),lymphocyte antigen 6 complex, locus G6D(LY6G6D,marker 12019), lymphocyte antigen 6 complex, locus G6D /// lymphocyte antigen 6 complex, locus G6F(LY6G6D /// LY6G6F, marker 12020), lymphocyte antigen 6 complex, locus G6E (pseudogene)(LY6G6E, marker 12021), lymphocyte antigen 6 complex, locus H (LY6H, marker 12022), lymphocyte antigen 6 complex, locus K (LY6K, marker 12023), lymphocyte antigen 6 complex, locus K (LY6K, marker 12024), lymphocyte antigen 75 (LY75, marker 12025), lymphocyte antigen 86(LY86, marker 12026),LY86 antisense RNA 1(LY86-AS1,marker 12027),LY86 antisense RNA 1(LY86-AS1,marker 12028),LY86 antisense RNA 1(LY86-AS1,marker 12029),lymphocyte antigen 9(LY9, marker 12030), lymphocyte antigen 9(LY9, marker 12031), lymphocyte antigen 9(LY9, marker 12032), lymphocyte antigen 96(LY96, marker 12033), lysozyme G-like 1(LYG1, marker 12034) ,lysozyme G-like 2(LYG2, marker 12035),lymphoblastic leukemia associated hematopoiesis regulator 1(LYL1,marker 12036),Ly6/neurotoxin 1(LYNX1,marker 12037),Ly6/neurotoxin 1(LYNX1,marker 12038),LY6/ PLAUR domain containing 3(LYPD3, marker 12039),LY6/PLAUR domain containing 4(LYPD4, marker 12040),LY6/PLAUR domain containing 4(LYPD4, marker 12041),LY6/PLAUR domain containing 5(LYPD5, marker 12042), LY6/PLAUR domain containing 6(LYPD6, marker 12043),LY6/PLAUR domain containing 8(LYPD8, marker 12044),LY6/PLAUR domain containing 8(LYPD8, marker 12045),LYR motif containing 2(LYRM2, marker 12046), LYRM4 antisense RNA 1(LYRM4-AS1, marker 12047),LYRM4 antisense RNA 1(LYRM4-AS1, marker 12048),LYR motif containing 9(LYRM9, marker 12049),lysosomal trafficking regulator(LYST, marker 12050),lysosomal trafficking regulator (LYST, marker 12051), lysosomal trafficking regulator(LYST, marker 12052), lymphatic vessel endothelial hyaluronan receptor 1(LYVE1, marker 12053), lymphatic vessel endothelial hyaluronan receptor 1(LYVE1, marker 12054), lysozyme(LYZ, marker 12055) ,lysozyme(LYZ,marker 12056),lysozyme-like 1(LYZL1,marker 12057),lysozyme-like 1 /// lysozyme-like 2(LYZL1 /// LYZL2,marker 12058),lysozyme-like 4(LYZL4,marker 12059), lysozyme-like 6(LYZL6, marker 12060), leucine zipper transcription factor like 1(LZTFL1, marker 12061), leucine zipper transcription factor like 1(LZTFL1, marker 12062), leucine zipper, putative tumor suppressor 1(LZTS1, marker 12063), leucine zipper, putative tumor suppressor 1(LZTS1, marker 12064), leucine zipper, putative tumor suppressor 1(LZTS1, marker 12065), leucine zipper, putative tumor suppressor 1(LZTS1, marker 12066), leucine zipper, putative tumor suppressor 1 (LZTS1, marker 12067), LZTS1 antisense RNA 1 (LZTS1-AS1, marker 12068), leucine zipper, putative tumor suppressor 2 (LZTS2, marker 12069), meiosis 1 associated protein (M1AP, marker 12070), meiosis 1 protein associated(M1AP, marker 12071),meiosis 1 associated protein(M1AP, marker 12072),meiosis 1 associated protein(M1AP, marker 12073),MYCBP-associated, testis expressed 1(MAATS1,marker 12074),MYCBP-associated, testis expressed 1(MAATS1, marker 12075),MYCBP-associated, testis expressed 1(MAATS1, marker 12076),MYCBP-associated, testis expressed 1(MAATS1, marker 12077),mab-21-like 1 (C. elegans) // / microRNA 548f-5(MAB21L1 /// MIR548F5, marker 12078), mab-21-like 2 (C. elegans)(MAB21L2, marker 12079), mab-21-like 3 (C. elegans)(MAB21L3, marker 12080 ), metastasis
associated in colon cancer 1(MACC1, marker 12081),MACRO domain containing 1(MACROD1, marker 12082),MACRO domain containing 2(MACROD2, marker 12083),MACRO domain containing 2(MACROD2, marker 12084),MACRO domain containing 2( MACROD2, marker 12085), MACROD2 antisense RNA 1 (MACROD2-AS1, marker 12086), maelstrom spermatogenic transposon silencer (MAEL, marker 12087), v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog (MAF, marker 12088), v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog(MAF, marker 12089),v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog(MAF,marker 12090),v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G(MAFG,marker 12091),v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K (MAFK, marker 12092), myelin associated glycoprotein(MAG, marker 12093), myelin associated glycoprotein(MAG, marker 12094), MAGE family member A1(MAGEA1, marker 12095), MAGE family member A10(MAGEA10, marker 12096), MAGEA10 -MAGEA5 readthrough /// MAGE family member A5(MAGEA10-MAGEA5 /// MAGEA5, marker 12097), MAGEA10-MAGEA5 readthrough /// MAGE family member A5(MAGEA10-MAGEA5 /// MAGEA5, marker 12098), MAGE family member A11 (MAGEA11, marker 12099), MAGE family member A3 (MAGEA3, marker 12100), MAGE family member A4 (MAGEA4, marker 12101), MAGE family member A6 (MAGEA6, marker 12102), MAGE family member A8 (MAGEA8, marker 12103) ),MAGE family member A9 /// MAGE family member A9B(MAGEA9 /// MAGEA9B, marker 12104), MAGE family member B1(MAGEB1, marker 12105), MAGE family member B18(MAGEB18, marker 12106), MAGE family member B2 (MAGEB2, marker 12107), MAGE family member B3 (MAGEB3, marker 12108), MAGE family member B4 (MAGEB4, marker 12109), MAGE family member B4 (MAGEB4, marker 12110), MAGE family member B6 (MAGEB6, marker 12111) ,MAGE family member C1(MAGEC1, marker 12112),MAGE family member C2(MAGEC2, marker 12113),MAGE family member C2(MAGEC2, marker 12114),MAGE family member C3(MAGEC3, marker 12115),MAGE family member E2( MAGEE2, marker 12116), membrane associated guanylate kinase, WW and PDZ domain containing 1(MAGI1, marker 12117), membrane associated guanylate kinase, WW and PDZ domain containing 1(MAGI1, marker 12118), membrane associated guanylate kinase, WW and PDZ domain containing 1(MAGI1, marker 12119),membrane associated guanylate kinase, WW and PDZ domain containing 1(MAGI1, marker 12120),MAGI1 intronic transcript 1(MAGI1-IT1, marker 12121),membrane associated guanylate kinase, WW and PDZ domain containing 2 (MAGI2, marker 12122), MAGI2 antisense RNA 2 (MAGI2-AS2, marker 12123), MAGI2 antisense RNA 3 (MAGI2-AS3, marker 12124), MAGI2 antisense RNA 3 (MAGI2-AS3, marker 12125), MAGI2 intronic transcript 1(MAGI2-IT1, marker 12126), membrane associated guanylate kinase, WW and PDZ domain containing 3(MAGI3, marker 12127), MAGI family member, X-linked(MAGIX, marker 12128), MAGI family member, X-linked (MAGIX, marker 12129), MAGI family member, X-linked(MAGIX, marker 12130), MAGI family member, X-linked(MAGIX, marker 12131), MAGI family member, X-linked(MAGIX, marker 12132), germ cell-associated kinase (MAK, marker 12133), male germ cell-associated kinase (MAK, marker 12134), mal, T-cell differentiation protein (MAL, marker 12135), MAM and LDL receptor class A domain containing 1 (MALRD1 , Marker 12136), MALT1 paracaspase(MALT1, Marker 12137), MAMDC2 antisense RNA 1(MAMDC2-AS1, Marker 12138), MAMDC2 antisense RNA 1(MAMDC2-AS1, Marker 12139), MAM domain containing 4(MAMDC4, Marker 12140) ,mastermind-like transcriptional coactivator 2(MAML2,marker 12141),mastermind-like transcriptional coactivator 3(MAML3,marker 12142),mastermind-like transcriptional coactivator 3(MAML3,marker 12143),mastermind-like domain containing 1(MAMLD1,marker 12144), mannosidase, alpha, class 1A, member 2(MAN1A2, marker 12145), mannosidase, alpha, class 1A, member 2(MAN1A2, marker 12146), mannosidase, alpha, class 2A, member 2(MAN2A2, marker 12147) ,mannosidase, alpha, class 2C, member 1(MAN2C1, marker 12148),mannosidase, alpha, class 2C, member 1(MAN2C1, marker 12149),mannosidase, endo-alpha(MANEA, marker 12150),mannosidase, endo-alpha (MANEA, marker 12151), monoamine oxidase A (MAOA, marker 12152), monoamine oxidase B (MAOB, marker 12153), monoamine oxidase B (MAOB, marker 12154), microtubule-associated protein 10 (MAP10, marker 12155), microtubule protein associated 1A (MAP1A, marker 12156), microtubule associated protein 1A (MAP1A, marker 12157), microtubule-associated protein 1 light chain 3 beta 2 (MAP1LC3B2, marker 12158), mitogen-activated protein kinase kinase 2 (MAP2K2, marker 12159) ), mitogen-activated protein kinase kinase 5 (MAP2K5, marker 12160), mitogen-activated protein kinase kinase 5 (MAP2K5, marker 12161), mitogen-activated protein kinase kinase 5 (MAP2K5, marker 12162), mitogen-activated protein kinase kinase 7 (MAP2K7, marker 12163), mitogen-activated protein kinase kinase kinase 7 (MAP2K7, marker 12164), mitogen-activated protein kinase kinase kinase 10 (MAP3K10, marker 12165), mitogen-activated protein kinase kinase kinase 11 (MAP3K11, marker 12166) ),mitogen-activated protein kinase kinase kinase 13(MAP3K13,marker 12167),mitogen-activated protein kinase kinase kinase 13(MAP3K13,marker 12168),mitogen-activated protein kinase kinase kinase 13(MAP3K13,marker 12169),mitogen-activated protein kinase kinase kinase 13 (MAP3K13, marker 12170), mitogen-activated protein kinase kinase kinase 13 (MAP3K13, marker 12171), MAP3K14 antisense RNA 1 (MAP3K14-AS1, marker 12172), mitogen-activated protein kinase kinase kinase 15 (MAP3K15 , marker 12173), mitogen-activated protein kinase kinase kinase 19 (MAP3K19, marker 12174), mitogen-activated protein kinase kinase kinase 19 (MAP3K19, marker 12175), mitogen-activated protein kinase kinase kinase 2 (MAP3K2, marker 12176), mitogen-activated protein kinase kinase kinase 2(MAP3K2, marker 12177),mitogen-activated protein kinase kinase kinase 2(MAP3K2, marker 12178),mitogen-activated protein kinase kinase kinase 3(MAP3K3, marker 12179),mitogen-activated protein kinase kinase kinase 6 (MAP3K6, marker 12180), mitogen-activated protein kinase kinase kinase 6 (MAP3K6, marker 12181), MAP3K7 C-terminal like (MAP3K7CL, marker 12182), mitogen-activated protein kinase kinase kinase 8 (MAP3K8, marker 12183) ),microtubule associated protein 4(MAP4, marker 12184),mitogen-activated protein kinase kinase kinase kinase 1(MAP4K1,marker 12185),mitogen-activated protein kinase kinase kinase kinase 1(MAP4K1,marker 12186),mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2, marker 12187), microtubule associated protein 6 (MAP6, marker 12188), MAP6 domain containing 1 (MAP6D1, marker 12189), MAP7 domain containing 3 (MAP7D3, marker 12190), mitogen-activated protein kinase 1 (MAPK1, marker 12191), mitogen-activated protein kinase 1 (MAPK1, marker 12192), mitogen-activated protein kinase 10 (MAPK10, marker 12193), mitogen-activated protein kinase 10 (MAPK10, marker 12194), mitogen-activated protein kinase 11 (MAPK11, marker 12195), mitogen-activated protein kinase 11 (MAPK11, marker 12196), mitogen-activated protein kinase 11 (MAPK11, marker 12197), mitogen-activated protein kinase 12 (MAPK12, marker 12198), mitogen- activated protein kinase 15 (MAPK15, marker 12199), mitogen-activated protein kinase 15 (MAPK15, marker 12200), mitogen-activated protein kinase 4 (MAPK4, marker 12201), mitogen-activated protein kinase 4 (MAPK4, marker 12202), mitogen-activated protein kinase 4(MAPK4, marker 12203),mitogen-activated protein kinase 6(MAPK6, marker 12204),mitogen-activated protein kinase 8 interacting protein 1(MAPK8IP1, marker 12205),mitogen-activated protein kinase 8 interacting protein 2(MAPK8IP2, marker 12206), mitogen-activated protein kinase 8 interacting protein 2(MAPK8IP2, marker 12207), mitogen-activated protein kinase 8 interacting protein 3(MAPK8IP3, marker 12208), mitogen-activated protein kinase 8 interacting protein 3( MAPK8IP3, marker 12209), mitogen-activated protein kinase 8 interacting protein 3(MAPK8IP3, marker 12210), mitogen-activated protein kinase 8 interacting protein 3(MAPK8IP3, marker 12211),MAPKAPK5 antisense RNA 1(MAPKAPK5-AS1, marker 12212) ,mitogen-activated protein kinase binding protein 1(MAPKBP1, marker 12213),microtubule-associated protein, RP/EB family, member 2(MAPRE2,marker 12214),microtubule-associated protein, RP/EB family, member 3(MAPRE3, marker 12215), microtubule-associated protein, RP/EB family, member 3(MAPRE3, marker 12216), microtubule-associated protein, RP/EB family, member 3(MAPRE3, marker 12217), microtubule-associated protein, RP/EB family, member 3(MAPRE3, marker 12218), microtubule associated protein tau(MAPT, marker 12219), microtubule associated protein tau(MAPT, marker 12220), microtubule associated protein tau(MAPT, marker 12221), microtubule associated protein tau(MAPT , marker 12222), microtubule associated protein tau(MAPT, marker 12223), MAPT antisense RNA 1(MAPT-AS1, marker 12224), MAPT antisense RNA 1(MAPT-AS1, marker 12225), membrane associated ring finger 1(1- Mar, marker 12226), membrane associated ring finger 1(1-Mar, marker 12227), membrane associated ring finger 1(1-Mar, marker 12228), membrane associated ring finger 1(1-Mar, marker 12229), membrane associated ring finger 10(10-Mar, marker 12230),membrane associated ring finger 10(10-Mar,marker 12231),membrane associated ring finger 11(11-Mar,marker 12232),membrane associated ring finger 3(3-Mar, marker 12233), membrane associated ring finger 6(6-Mar, marker 12234), membrane associated ring finger 6(6-Mar, marker 12235), membrane associated ring finger 6(6-Mar, marker 12236), membrane associated ring finger 7(7-Mar, marker 12237),membrane associated ring finger 7(7-Mar,marker 12238),membrane associated ring finger 8(8-Mar,marker 12239),membrane associated ring finger 9(9-Mar,marker 12240 ), macrophage receptor with collagenous structure (MARCO, marker 12241), MAP/microtubule affinity-regulating kinase 1 (MARK1, marker 12242), MAP/microtubule affinity-regulating kinase 3 (MARK3, marker 12243), MARVEL domain containing 1 (MARVELD1) , marker 12244), MAS1 proto-oncogene, G protein-coupled receptor (MAS1, marker 12245), MAS1 proto-oncogene like, G protein-coupled receptor (MAS1L, marker 12246), mannan-binding lectin serine peptidase 1 (C4/ C2 activating component of Ra-reactive factor) (MASP1, marker 12247), mannan-binding lectin serine peptidase 1 (C4/C2 activating component
of Ra-reactive factor) (MASP1, marker 12248), mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) (MASP1, marker 12249), mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) (MASP1, marker 12250), mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) (MASP1, marker 12251), mannan-binding lectin serine peptidase 2 (MASP2 , marker 12252), mannan-binding lectin serine peptidase 2 (MASP2, marker 12253), mannan-binding lectin serine peptidase 2 (MASP2, marker 12254), microtubule associated serine/threonine kinase 1 (MAST1, marker 12255), microtubule associated serine /threonine kinase 2(MAST2, marker 12256), microtubule associated serine/threonine kinase 2(MAST2, marker 12257), microtubule associated serine/threonine kinase 3(MAST3, marker 12258), microtubule associated serine/threonine kinase family member 4(MAST4 ,marker 12259),microtubule associated serine/threonine kinase family member 4(MAST4,marker 12260),microtubule associated serine/threonine kinase family member 4(MAST4,marker 12261),microtubule associated serine/threonine kinase family member 4(MAST4,marker 12262),matrilin 1, cartilage matrix protein(MATN1, marker 12263),matrilin 1, cartilage matrix protein(MATN1, marker 12264),MATN1 antisense RNA 1(MATN1-AS1,marker 12265),MATN1 antisense RNA 1(MATN1-AS1 ,marker 12266),matrilin 2(MATN2,marker 12267),matrilin 4(MATN4,marker 12268),MAU2 sister chromatid cohesion factor(MAU2,marker 12269),MAU2 sister chromatid cohesion factor(MAU2,marker 12270),MAU2 sister chromatid cohesion factor (MAU2, marker 12271), MYC associated factor X (MAX, marker 12272), myoglobin (MB, marker 12273), Mab-21 domain containing 1 (MB21D1, marker 12274), Marker 12275), Mab-21 domain containing 1(MB21D1, Marker 12276), methyl-CpG binding domain protein 1(MBD1, Marker 12277), methyl-CpG binding domain protein 2(MBD2, Marker 12278), methyl-CpG binding domain protein 3-like 1(MBD3L1, marker 12279),methyl-CpG binding domain protein 3-like 1(MBD3L1, marker 12280),methyl-CpG binding domain protein 3-like 2(MBD3L2, marker 12281),methyl-CpG binding domain protein 5(MBD5, marker 12282),methyl-CpG binding domain protein 5(MBD5, marker 12283),methyl-CpG binding domain protein 6(MBD6, marker 12284),mannose-binding lectin (protein C) 2, soluble( MBL2, marker 12285), metallo-beta-lactamase domain containing 2(MBLAC2, marker 12286), muscleblind like splicing regulator 1(MBNL1, marker 12287), muscleblind like splicing regulator 1(MBNL1, marker 12288), muscleblind like splicing regulator 1 (MBNL1, marker 12289), MBNL1 antisense RNA 1 (MBNL1-AS1, marker 12290), MBNL1 antisense RNA 1 (MBNL1-AS1, marker 12291), muscleblind-like splicing regulator 2 (MBNL2, marker 12292), muscleblind-like splicing regulator 2 (MBNL2, marker 12293), muscleblind-like splicing regulator 3 (MBNL3, marker 12294), myelin basic protein (MBP, marker 12295), myelin basic protein (MBP, marker 12296), myelin basic protein (MBP, marker 12297) ), myelin basic protein (MBP, marker 12298), myelin basic protein (MBP, marker 12299), membrane bound transcription factor peptidase, site 2 (MBTPS2, marker 12300), melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) (MC1R, marker 12301), melanocortin 2 receptor (adrenocorticotropic hormone) (MC2R, marker 12302), melanocortin 2 receptor (adrenocorticotropic hormone) (MC2R, marker 12303), melanocortin 2 receptor (adrenocorticotropic hormone) (MC2R, marker 12304), melanocortin 3 receptor ( MC3R, marker 12305), melanocortin 4 receptor (MC4R, marker 12306), melanoma cell adhesion molecule (MCAM, marker 12308), methylcrotonoyl-CoA carboxylase 2 (MCCC2, marker 12309), mast cell-expressed membrane protein 1(MCEMP1, marker 12310),MCF.2 cell line derived transforming sequence(MCF2,marker 12311),MCF.2 cell line derived transforming sequence(MCF2,marker 12312),MCF.2 cell line derived transforming sequence sequence like(MCF2L, marker 12313),MCF.2 cell line derived transforming sequence like(MCF2L,marker 12314),MCF.2 cell line derived transforming sequence like(MCF2L,marker 12315),MCF.2 cell line derived transforming sequence like (MCF2L, marker 12316), MCF.2 cell line derived transforming sequence like(MCF2L, marker 12317),MCF.2 cell line derived transforming sequence like(MCF2L, marker 12318),MCF2L antisense RNA 1(MCF2L-AS1, marker 12319 ), MCF.2 cell line derived transforming sequence-like 2 (MCF2L2, marker 12320), multiple coagulation factor deficiency 2 (MCFD2, marker 12321), melanin-concentrating hormone receptor 1 (MCHR1, marker 12322), melanin-concentrating hormone receptor 1 (MCHR1, marker 12323), melanin-concentrating hormone receptor 2 (MCHR2, marker 12324), MCHR2 antisense RNA 1 (MCHR2-AS1, marker 12325), MCHR2 antisense RNA 1 (MCHR2-AS1, marker 12326), minichromosome maintenance complex component 3 associated protein (MCM3AP, marker 12327), minichromosome maintenance complex component 3 associated protein (MCM3AP, marker 12328), MCM3AP antisense RNA 1 (MCM3AP-AS1, marker 12329), MCM3AP antisense RNA 1 (MCM3AP-AS1, marker 12330) ,minichromosome maintenance complex component 4(MCM4, marker 12331),minichromosome maintenance 8 homologous recombination repair factor(MCM8, marker 12332),MCM8 antisense RNA 1(MCM8-AS1,marker 12333),minichromosome maintenance 9 homologous recombination repair factor(MCM9, marker 12334), minichromosome maintenance complex binding protein(MCMBP, marker 12335), minichromosome maintenance domain containing 2(MCMDC2, marker 12336), minichromosome maintenance domain containing 2(MCMDC2, marker 12337), mucolipin 2(MCOLN2, marker 12338), mucolipin 3 (MCOLN3, marker 12339), mucolipin 3 (MCOLN3, marker 12340), microcephalin 1 (MCPH1, marker 12341), microcephalin 1 (MCPH1, marker 12342), microcephalin 1 (MCPH1, marker 12343), MCPH1 antisense RNA 1 (MCPH1 -AS1, marker 12344), multiple C2 domains, transmembrane 1(MCTP1, marker 12345), multiple C2 domains, transmembrane 2(MCTP2, marker 12346), multiple C2 domains, transmembrane 2(MCTP2, marker 12347), multiple C2 domains, transmembrane 2(MCTP2, marker 12348), multiple C2 domains, transmembrane 2(MCTP2, marker 12349), multiple C2 domains, transmembrane 2(MCTP2, marker 12350), malignant T-cell amplified sequence 1(MCTS1, marker 12351), MAM domain containing glycosylphosphatidylinositol anchor 1(MDGA1, marker 12352),MAM domain containing glycosylphosphatidylinositol anchor 1(MDGA1, marker 12353),MAM domain containing glycosylphosphatidylinositol anchor 1(MDGA1, marker 12354),MAM domain containing glycosylphosphatidylinositol anchor 2(MDGA2, Marker 12355) ,MAM domain containing glycosylphosphatidylinositol anchor 2(MDGA2, marker 12356), malate dehydrogenase 1B(MDH1B, marker 12357),MDM2 proto-oncogene, E3 ubiquitin protein ligase(MDM2, marker 12358),MDM2 proto-oncogene, E3 ubiquitin protein ligase( MDM2, marker 12359), MDM2 proto-oncogene, E3 ubiquitin protein ligase (MDM2, marker 12360), midasin AAA ATPase 1 (MDN1, marker 12361), myelodysplastic syndrome 2 translocation associated (MDS2, marker 12362), malic enzyme 1, NADP (+)-dependent, cytosolic (ME1, marker 12363), malic enzyme 3, NADP(+)-dependent, mitochondrial (ME3, marker 12364), MDS1 and EVI1 complex locus (MECOM, marker 12365), MDS1 and EVI1 complex locus (MECOM, marker 12366), MDS1 and EVI1 complex locus (MECOM, marker 12367), mediator complex subunit 12 (MED12, marker 12368), mediator complex subunit 12 like (MED12L, marker 12369), mediator complex subunit 13 (MED13, marker 12370), mediator complex subunit 13-like(MED13L, marker 12371), mediator complex subunit 14(MED14, marker 12372), mediator complex subunit 14(MED14, marker 12373), mediator complex subunit 14(MED14, marker 12374), mediator complex subunit 18(MED18, marker 12375), mediator complex subunit 23(MED23, marker 12376), mediator complex subunit 24(MED24, marker 12377), mediator complex subunit 25(MED25, marker 12378), mediator complex subunit 25(MED25, marker 12379), mediator complex subunit 26 (MED26, marker 12380), mediator complex subunit 26 (MED26, marker 12381), mediator complex subunit 27 (MED27, marker 12382), mediator complex subunit 28 (MED28, marker 12383), mediator complex subunit 28 (MED28, marker 12384), mediator complex subunit 28 (MED28, marker 12385), mediator complex subunit 30 (MED30, marker 12386), mediator complex subunit 31 (MED31, marker 12387), mesenteric estrogen-dependent adipogenesis (MEDAG, marker 12388), myocyte enhancer factor 2B /// MEF2BNB-MEF2B readthrough(MEF2B /// MEF2BNB-MEF2B, marker 12389), myocyte enhancer factor 2C(MEF2C, marker 12390), myocyte enhancer factor 2C(MEF2C, marker 12391), myocyte enhancer factor 2C (MEF2C, marker 12392), MEF2C antisense RNA 1 (MEF2C-AS1, marker 12393), myocyte enhancer factor 2D (MEF2D, marker 12394), myocyte enhancer factor 2D (MEF2D, marker 12395), maternally expressed 3 ( non-protein coding)(MEG3, marker 12396),maternally expressed 3 (non-protein coding)(MEG3,marker 12397),maternally expressed 3 (non-protein coding)(MEG3,marker 12398),maternally expressed 3 (non- protein coding)(MEG3, marker 12399),maternally expressed 3 (non-protein coding)(MEG3,marker 12400),maternally expressed 8 (non-protein coding)(MEG8,marker 12401),multiple EGF-like-domains 10( MEGF10, marker 12402), multiple EGF-like-domains 11 (MEGF11, marker 12403), multiple EGF-like-domains 11 (MEGF11, marker 12404), multiple EGF-like-domains 11 (MEGF11, marker 12405), multiple EGF -like-domains 6(MEGF6, marker 12406), multiple EGF-like-domains 9(MEGF9, marker 12407), meiotic double-stranded break formation protein 1(MEI1, marker 12408), meiotic double-stranded break formation protein 1( MEI1, marker 12409), meiosis/spermiogenesis associated 1(MEIG1, marker 12410), meiotic kinetochore factor(MEIKIN, marker 12411), meiosis specific with OB domains(MEIOB, marker 12412), meiosis specific with coiled-coil domain(MEIOC, marker 12413), meiosis specific with coiled-coil domain(MEIOC, marker 12414), meiosis specific with coiled-coil domain(MEIOC, marker 12415), meiosis specific with coiled-coil domain(MEIOC, marker 12416), Meis homeobox 1( MEIS1, marker 12417), Meis homeobox 3 (MEIS3, marker 12418), mesenchyme homeobox 2 (MEOX2, marker 12419), mesenchyme homeobox 2 (MEOX2, marker 12420), meprin A, alpha (PABA peptide hydrolase) (MEP1A, marker 12421) ),meprin A, beta(MEP1B, marker 12422
), matrix extracellular phosphoglycoprotein (MEPE, marker 12423), MER proto-oncogene, tyrosine kinase (MERTK, marker 12424), mesoderm development candidate 2 (MESDC2, marker 12425), mesoderm posterior bHLH transcription factor 1 (MESP1, marker 12426), mesoderm posterior bHLH transcription factor 1(MESP1, marker 12427), mesoderm posterior bHLH transcription factor 1(MESP1, marker 12428), mesoderm posterior bHLH transcription factor 2(MESP2, marker 12429), methionyl aminopeptidase type 1D (mitochondrial)(METAP1D, marker 12430), methionyl aminopeptidase type 1D (mitochondrial)(METAP1D, marker 12431), methionyl aminopeptidase type 1D (mitochondrial)(METAP1D, marker 12432), meteorin, glial cell differentiation regulator(METRN, marker 12433), methyltransferase like 10(METTL10, marker 12434), methyltransferase like 12 /// small nucleolar RNA, H/ACA box 57(METTL12 /// SNORA57, marker 12435), methyltransferase like 14(METTL14, marker 12436), methyltransferase like 15(METTL15, marker 12437), methyltransferase like 15(METTL15, marker 12438), methyltransferase like 15(METTL15, marker 12439), methyltransferase like 15(METTL15, marker 12440), methyltransferase like 15(METTL15, marker 12441), methyltransferase like 17(METTL17, marker 12442), methyltransferase like 20(METTL20, marker 12443), methyltransferase like 20(METTL20, marker 12444), methyltransferase like 20(METTL20, marker 12445), methyltransferase like 20(METTL20, marker 12446), methyltransferase like 20(METTL20, marker 12447), methyltransferase like 21A(METTL21A, marker 12448), methyltransferase like 21C(METTL21C, marker 12449), methyltransferase like 21E, pseudogene(METTL21EP, marker 12450), methyltransferase like 22(METTL22, marker 12451), methyltransferase like 5(METTL5, marker 12452) ), methyltransferase like 6(METTL6, marker 12453), methyltransferase like 6(METTL6, marker 12454), methyltransferase like 6(METTL6, marker 12455), methyltransferase like 7A(METTL7A, marker 12456), methyltransferase like 7A(METTL7A, marker 12457 ), methyltransferase like 7A (METTL7A, marker 12458), methyltransferase like 8 (METTL8, marker 12459), mex-3 RNA binding family member C (MEX3C, marker 12460), mex-3 RNA binding family member C (MEX3C, marker 12461) ), mex-3 RNA binding family member C (MEX3C, marker 12462), mex-3 RNA binding family member D (MEX3D, marker 12463), mex-3 RNA binding family member D (MEX3D, marker 12464), microfibrillar associated protein 3 like (MFAP3L, marker 12465), microfibrillar associated protein 3 like (MFAP3L, marker 12466), microfibrillar associated protein 3 like (MFAP3L, marker 12467), microfibrillar associated protein 4 (MFAP4, marker 12468), antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5(MFI2, marker 12469),antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5(MFI2, marker 12470),antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5(MFI2, Marker 12471), MFI2 antisense RNA 1 (MFI2-AS1, Marker 12472), mitofusin 2 (MFN2, Marker 12473), MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase (MFNG, Marker 12474), MFNG O-fucosylpeptide 3- beta-N-acetylglucosaminyltransferase(MFNG, marker 12475),MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase(MFNG, marker 12476),major facilitator superfamily domain containing 14B(MFSD14B,marker 12477),major facilitator superfamily domain containing 2A( MFSD2A, marker 12478), major facilitator superfamily domain containing 3(MFSD3, marker 12479), major facilitator superfamily domain containing 4(MFSD4, marker 12480), major facilitator superfamily domain containing 4(MFSD4, marker 12481), major facilitator superfamily domain containing 4(MFSD4, marker 12482), major facilitator superfamily domain containing 4(MFSD4, marker 12483), major facilitator superfamily domain containing 6(MFSD6, marker 12484), major facilitator superfamily domain containing 6-like(MFSD6L, marker 12485), major facilitator superfamily domain containing 7(MFSD7, marker 12486),major facilitator superfamily domain containing 7(MFSD7, marker 12487),MGA, MAX dimerization protein(MGA, marker 12488),maltase-glucoamylase(MGAM, marker 12489),maltase-glucoamylase 2 (putative)(MGAM2, marker 12490),mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase(MGAT3, marker 12491),mannosyl (beta-1,4-)-glycoprotein beta -1,4-N-acetylglucosaminyltransferase (MGAT3, marker 12492), mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase (MGAT3, marker 12493), mannosyl (alpha-1,3- )-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A(MGAT4A, marker 12494),mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A(MGAT4A, marker 12495) ),mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A(MGAT4A, marker 12496),MGAT4 family, member C(MGAT4C, marker 12497),MGAT4 family, member C( MGAT4C, marker 12498), MGAT4 family, member D (MGAT4D, marker 12499), MGAT4 family, member E, pseudogene (MGAT4EP, marker 12500), mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N -acetyl-glucosaminyltransferase (MGAT5, marker 12501), mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B (MGAT5B, marker 12502), uncharacterized protein MGC10814 (MGC10814, marker 12503),uncharacterized protein MGC12916(MGC12916,marker 12504),uncharacterized protein MGC12916(MGC12916,marker 12505),uncharacterized protein MGC12916(MGC12916,marker 12506),uncharacterized protein MGC15885(MGC15885,marker 12507),uncharacter ized LOC85009(MGC16025, Marker 12508 ), uncharacterized protein MGC16142(MGC16142, marker 12509), uncharacterized protein MGC16275(MGC16275, marker 12510), uncharacterized protein MGC16275(MGC16275, marker 12511), uncharacterized protein MGC20647(MGC20647, marker 12512), uncharacterized MGC273 82 (MGC27382, marker 12513) ,uncharacterized protein MGC2889(MGC2889, marker 12514),uncharacterized LOC153163(MGC32805,marker 12515),uncharacterized LOC153163(MGC32805,marker 12516),sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase) pseudogene(MGC34 796, marker 12517), uncharacterized LOC441058(MGC39584, marker 12518),uncharacterized protein MGC40069(MGC40069,marker 12519),uncharacterized protein MGC40069(MGC40069,marker 12520),uncharacterized protein MGC40069(MGC40069,marker 12521),uncharacterized protein MGC40069 /// T-cell receptor alpha constant /// T cell receptor alpha joining 17 /// T cell receptor alpha joining 56 /// T cell receptor alpha variable 20 /// T cell receptor alpha variable 38-1 /// T cell receptor delta variable 2 /// YME1-like 1 ATPase(MGC40069 /// TRAC /// TRAJ17 /// TRAJ56 /// TRAV20 /// TRAV38-1 /// TRDV2 /// YME1L1, marker 12522), uncharacterized LOC284365(MGC45922, marker 12523) ,uncharacterized LOC79150(MGC4859, marker 12524),ADP-ribosylation factor pseudogene(MGC57346,marker 12525),meningioma expressed antigen 5 (hyaluronidase)(MGEA5,marker 12526),meningioma expressed antigen 5 (hyaluronidase)(MGEA5,marker 12527), matrix Gla protein (MGP, marker 12528), matrix Gla protein (MGP, marker 12529), microsomal glutathione S-transferase 1 (MGST1, marker 12530), microsomal glutathione S-transferase 3 (MGST3, marker 12531), melanoma inhibitory activity ( MIA, marker 12532), melanoma inhibitory activity 2(MIA2, marker 12533), melanoma inhibitory activity 2(MIA2, marker 12534), MIAT neighbor (non-protein coding)(MIATNB, marker 12535), mindbomb E3 ubiquitin protein ligase 2( MIB2, marker 12536), mindbomb E3 ubiquitin protein ligase 2(MIB2, marker 12537), microtubule associated monooxygenase, calponin and LIM domain containing 2(MICAL2, marker 12538), microtubule associated monooxygenase, calponin and LIM domain containing 2(MICAL2, marker 12539),microtubule associated monooxygenase, calponin and LIM domain containing 3(MICAL3, marker 12540),MICAL C-terminal like(MICALCL, marker 12541),MICAL-like 2(MICALL2, marker 12542),MICAL-like 2(MICALL2, marker 12543), midnolin(MIDN, marker 12544), mesoderm induction early response 1, transcriptional regulator(MIER1, marker 12545), mesoderm induction early response 1, family member 2(MIER2, marker 12546), mesoderm induction early response 1, family member 3(MIER3, marker 12547), mast cell immunoglobulin-like receptor 1(MILR1, marker 12548), MYC induced nuclear antigen(MINA, marker 12549), MYC-induced long noncoding RNA(MINCR, marker 12550), MYC-induced long noncoding RNA (MINCR, marker 12551), misshapen-like kinase 1 (MINK1, marker 12552), misshapen-like kinase 1 (MINK1, marker 12553), misshapen-like kinase 1 (MINK1, marker 12554), mitochondrial inner membrane organizing system 1 pseudogene 1(MINOS1P1, marker 12555), myo-inositol oxygenase(MIOX, marker 12556), major intrinsic protein of lens fiber(MIP, marker 12557), mitochondrial intermediate peptidase pseudogene 3(MIPEPP3, marker 12558), mitochondrial intermediate peptidase pseudogene 3 (MIPEPP3, marker 12559), mirror-image polydactyly 1 (MIPOL1, marker 12560), mirror-image polydactyly 1 (MIPOL1, marker 12561), MIR124-2 host gene (MIR124-2HG, marker 12562), MIR133A1 host gene (non-protein coding)(MIR133A1HG, marker 12563),MIR133A1 host gene (non-protein coding)(MIR133A1HG, marker 12564),MIR137 host gene /// microRNA 2682(MIR137HG /// MIR2682, marker 12565),MIR137 host gene /// microRNA 2682(MIR137HG /// MIR2682, Marker 12566), MIR155 host gene(MIR155HG, Marker 12567), miR-17-92 cluster host gene(MIR17HG, Marker 12568), MIR194-2 host gene(MIR194- 2HG, marker 12569), MIR194-2 host gene (MIR194-2HG, marker 12570), MIR2052 host gene (MIR2052HG, marker 12571), MIR205 host gene (MIR205HG, marker 12572), MIR210 host gene (MIR210HG, marker 12573), MIR210 host gene (MIR210HG, marker 12574), MIR31 host gene (MIR31HG, marker 12575), MIR3663 host gene (MIR3663HG, marker 12576), MIR3681 host gene (MIR3681HG, marker 12577), MIR3681 host gene (MIR3681HG, marker 12578), MIR3945 host gene (MIR3945HG, marker 12579), MIR3976 host gene (MIR3976HG, marker 12580), MIR4290 host gene (MIR4290HG, marker 12581), microRNA 4296 (MIR4296, marker 12582), MIR4300 host gene (MIR4300HG, marker 12583) ,MIR4307 host gene (MIR4307HG, marker 12584), MIR4435-2 host gene (MIR4435-2HG, marker 12585), MIR4435-2 host gene (MIR4435-2HG, marker 12586), MIR4458 host gene (MIR4458HG, marker 12587), MIR4500 host gene (MIR4500HG, Marker 12588), MIR4697 host gene(MIR4697HG, Marker 12589), MIR4697 host gene(MIR4697HG
, marker 12590), microRNA 4755 (MIR4755, marker 12591), mir-497-195 cluster host gene (MIR497HG, marker 12592), microRNA 5188 (MIR5188, marker 12593), MIR548X host gene (MIR548XHG, marker 12594), MIR600 host gene /// spermatid perinuclear RNA binding protein(MIR600HG /// STRBP, marker 12595), microRNA 622(MIR622, marker 12596), MIR646 host gene(MIR646HG, marker 12597), MIR646 host gene(MIR646HG, marker 12598), MIR663A host gene (MIR663AHG, marker 12599), MIR670 host gene (MIR670HG, marker 12600), MIR7-3 host gene (MIR7-3HG, marker 12601), MIR7-3 host gene (MIR7-3HG, marker 12602), MIR9-3 host gene(MIR9-3HG, marker 12603),MIR9-3 host gene(MIR9-3HG, marker 12604),mir-99a-let-7c cluster host gene(MIR99AHG,marker 12605),mir-99a-let-7c cluster host gene(MIR99AHG, marker 12606),mir-99a-let-7c cluster host gene(MIR99AHG,marker 12607),MIRLET7B host gene(MIRLET7BHG,marker 12608),MIRLET7B host gene(MIRLET7BHG,marker 12609),MIRLET7B host gene( MIRLET7BHG, marker 12610), MIRLET7D host gene (MIRLET7DHG, marker 12611), MIS18 binding protein 1 (MIS18BP1, marker 12612), mitotic spindle positioning (MISP, marker 12613), microphthalmia-associated transcription factor (MITF, marker 12614), Mix paired-like homeobox(MIXL1, marker 12615),megakaryoblastic leukemia (translocation) 1(MKL1, marker 12616),megakaryoblastic leukemia (translocation) 1(MKL1, marker 12617),megakaryoblastic leukemia (translocation) 1(MKL1, marker 12618), MKL/myocardin-like 2(MKL2, marker 12619),MKL/myocardin-like 2(MKL2, marker 12620),MKL/myocardin-like 2(MKL2, marker 12621),muskelin 1, intracellular mediator containing kelch motifs(MKLN1, marker 12622), MAP interacting serine/threonine kinase 1 (MKNK1, marker 12623), MAP kinase interacting serine/threonine kinase 1 (MKNK1, marker 12624), MKNK1 antisense RNA 1 (MKNK1-AS1, marker 12625), makorin ring finger protein 2 (MKRN2, marker 12626), makorin ring finger protein 3 (MKRN3, marker 12627), makorin ring finger protein 7, pseudogene (MKRN7P, marker 12628), mohawk homeobox (MKX, marker 12629), mohawk homeobox (MKX, marker 12630), mohawk homeobox (MKX, marker 12631), melan-A (MLANA, marker 12632), melan-A (MLANA, marker 12633), megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1, marker 12634), muscular LMNA-interacting protein (MLIP, marker 12635), MLK7 antisense RNA 1(MLK7-AS1, marker 12636), myeloid/lymphoid or mixed-lineage leukemia; translocated to, 1(MLLT1, marker 12637), myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10(MLLT10, marker 12638), myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10 pseudogene 1(MLLT10P1, marker 12639), myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3(MLLT3, marker 12640 ), myeloid/lymphoid or mixed-lineage leukemia; translocated to, 4(MLLT4, marker 12641), myeloid/lymphoid or mixed-lineage leukemia; translocated to, 4(MLLT4, marker 12642), myeloid/lymphoid or mixed-lineage leukemia translocated to, 6(MLLT6, marker 12643), myeloid/lymphoid or mixed-lineage leukemia; translocated to, 6(MLLT6, marker 12644), motilin(MLN, marker 12645), motilin receptor(MLNR, marker 12646), MLX protein interacting(MLXIP, marker 12647),MLX interacting protein(MLXIP,marker 12648),MLX interacting protein-like(MLXIPL,marker 12649),malonyl-CoA decarboxylase(MLYCD,marker 12650),methylmalonic aciduria (cobalamin deficiency) cblA type (MMAA, marker 12651), methylmalonic aciduria (cobalamin deficiency) cblA type (MMAA, marker 12652), methylmalonic aciduria (cobalamin deficiency) cblA type (MMAA, marker 12653), methylmalonic aciduria (cobalamin deficiency) cblB type (MMAB, marker 12654) ),Miyoshi muscular dystrophy 2 /// monocyte to macrophage differentiation-associated 2(MMD2 /// MMD2, marker 12655),Miyoshi muscular dystrophy 2 /// monocyte to macrophage differentiation-associated 2(MMD2 /// MMD2, marker 12656 ), matrix metallopeptidase 1 (MMP1, marker 12657), matrix metallopeptidase 10 (MMP10, marker 12658), matrix metallopeptidase 11 (MMP11, marker 12659), matrix metallopeptidase 11 (MMP11, marker 12660), matrix metallopeptidase 12 (MMP12, marker 12661) ),matrix metallopeptidase 13(MMP13, marker 12662),matrix metallopeptidase 15 (membrane-inserted)(MMP15, marker 12663),matrix metallopeptidase 16 (membrane-inserted)(MMP16, marker 12664),matrix metallopeptidase 16 (membrane-inserted) (MMP16, Marker 12665),matrix metallopeptidase 16 (membrane-inserted)(MMP16, Marker 12666),matrix metallopeptidase 17 (membrane-inserted)(MMP17, Marker 12667),matrix metallopeptidase 19(MMP19, Marker 12668),matrix metallopeptidase 2 (MMP2, marker 12669), matrix metallopeptidase 2(MMP2, marker 12670), matrix metallopeptidase 20(MMP20, marker 12671), matrix metallopeptidase 21(MMP21, marker 12672), matrix metallopeptidase 23A (pseudogene) /// matrix metallopeptidase 23B( MMP23A /// MMP23B, marker 12673), matrix metallopeptidase 24 (membrane-inserted)(MMP24, marker 12674), matrix metallopeptidase 24 (membrane-inserted)(MMP24, marker 12675), matrix metallopeptidase 25(MMP25, marker 12676), MMP25 antisense RNA 1 (MMP25-AS1, marker 12677), MMP25 antisense RNA 1 (MMP25-AS1, marker 12678), matrix metallopeptidase 26 (MMP26, marker 12679), matrix metallopeptidase 27 (MMP27, marker 12680), matrix metallopeptidase 28( MMP28, marker 12681), matrix metallopeptidase 28 (MMP28, marker 12682), matrix metallopeptidase 28 (MMP28, marker 12683), matrix metallopeptidase 28 (MMP28, marker 12684), matrix metallopeptidase 28 (MMP28, marker 12685), matrix metallopeptidase 3( MMP3, marker 12686), matrix metallopeptidase 7 (MMP7, marker 12687), matrix metallopeptidase 8 (MMP8, marker 12688), matrix metallopeptidase 8 (MMP8, marker 12689), multimerin 2 (MMRN2, marker 12690), multimerin 2 (MMRN2, marker 12691), multimerin 2 (MMRN2, marker 12692), myeloid cell nuclear differentiation antigen (MNDA, marker 12693), MAX network transcriptional repressor (MNT, marker 12694), motor neuron and pancreas homeobox 1 (MNX1, marker 12695), MNX1 antisense RNA 1 (head to head) (MNX1-AS1, marker 12696), MOB kinase activator 3A (MOB3A, marker 12697), MOB kinase activator 3B (MOB3B, marker 12698), MOB kinase activator 3C (MOB3C, marker 12699), myelin-associated oligodendrocyte basic protein (MOBP, marker 12700), myelin-associated oligodendrocyte basic protein (MOBP, marker 12701), myelin-associated oligodendrocyte basic protein (MOBP, marker 12702), myelin-associated oligodendrocyte basic protein (MOBP, marker 12703) ), myelin-associated oligodendrocyte basic protein (MOBP, marker 12704), molybdenum cofactor synthesis 1 (MOCS1, marker 12705), myelin oligodendrocyte glycoprotein (MOG, marker 12706), myelin oligodendrocyte glycoprotein (MOG, marker 12707), myelin oligodendrocyte glycoprotein( MOG, marker 12708), myelin oligodendrocyte glycoprotein (MOG, marker 12709), monoacylglycerol O-acyltransferase 1 (MOGAT1, marker 12710), monoacylglycerol O-acyltransferase 2 (MOGAT2, marker 12711), monoacylglycerol O-acyltransferase 2 (MOGAT2, marker 12) 712 ), monoacylglycerol O-acyltransferase 3 (MOGAT3, marker 12713), MON2 homolog, regulator of endosome-to-Golgi trafficking (MON2, marker 12714), MOP-1 (MOP-1, marker 12715), MORC family CW-type zinc finger 1(MORC1, marker 12716),MORN repeat containing 1(MORN1,marker 12717),MORN repeat containing 1(MORN1,marker 12718),MORN repeat containing 1(MORN1,marker 12719),MORN repeat containing 1(MORN1,marker 12720), MORN repeat containing 1(MORN1, marker 12721),MORN repeat containing 5(MORN5, marker 12722),v-mos Moloney murine sarcoma viral oncogene homolog(MOS, marker 12723),Mov10 RISC complex RNA helicase like 1(MOV10L1 ,marker 12724),Mov10 RISC complex RNA helicase like 1(MOV10L1,marker 12725),monooxygenase, DBH-like 1(MOXD1,marker 12726),mitochondrial pyruvate carrier 1(MPC1,marker 12727),mannose-P-dolichol utilization defect 1 (MPDU1, marker 12728), macrophage expressed 1 (MPEG1, marker 12729), macrophage expressed 1 (MPEG1, marker 12730), M-phase phosphoprotein 6 (MPHOSPH6, marker 12731), M-phase phosphoprotein 8 (MPHOSPH8, marker 12732) ),MPL proto-oncogene, thrombopoietin receptor(MPL, marker 12733),MPL proto-oncogene, thrombopoietin receptor(MPL, marker 12734),MPL proto-oncogene, thrombopoietin receptor(MPL, marker 12735),myeloperoxidase(MPO, marker 12736) ), myeloperoxidase (MPO, marker 12737), membrane protein, palmitoylated 3 (MPP3, marker 12738), membrane protein, palmitoylated 4 (MPP4, marker 12739), membrane protein, palmitoylated 4 (MPP4, marker 12740), membrane protein, palmitoylated 7(MPP7, marker 12741), membrane protein, palmitoylated 7(MPP7, marker 12742), metallophosphoesterase domain containing 1(MPPED1, marker 12743), myosin phosphatase Rho interacting protein(MPRIP, marker 12744), myelin protein zero-like 1( MPZL1, marker 12745), myelin protein zero-like 2 (MPZL2, marker 12746), myelin protein zero-like 3 (MPZL3, marker 12747), myelin protein zero-like 3 (MPZL3, marker 12748), major histocompatibility complex, class I-related(MR1, Marker 12749), major histocompatibility complex, class I-related(MR1, Marker 12750), major histocompatibility complex, class I-related(MR1, Marker 12751), major histocompatibility complex, class I-related(MR1 ,marker 12752),major histocompatibility complex, class I-related(MR1,marker 12753),major histocompatibility complex, class I-related(MR1,marker 12754),melanocortin 2 receptor accessory protein(MRAP,marker 12755),melanocortin 2 receptor accessory protein (MRAP, marker 12756), melanocortin 2 receptor accessory protein (MRAP, marker 12757), mannose receptor, C type 1 (MRC1, marker 12758), mannose receptor, C type 2 (MRC2, marker 12759), MRE11 homolog A , double strand break repair nuclease (MRE11A, marker 12760), MRGPRF antisense RNA 1 (MRGPRF-AS1, marker 12761), MRGPRG antisense RNA 1 (MRGPRG-AS1, marker 12762), MAS-related GPR, member X1 (MRGPRX1, marker 12763), MAS-related GPR, member X2(MRGPRX2, marker 12764),MAS-related GPR, member X3(MRGPRX3, marker 12765),MAS-related GPR, member 12767),maestro(MRO,marker 12768),maestro(MRO,marker 12769),maestro(MRO,marker 12770),maestro heat-like repeat family member 1(MROH1,marker 12771),maestro heat-like repeat family member 1 (MROH1, marker 12772), maestro heat-like repeat family member 1 (MROH1, marker 12773), maestro heat-like repeat family member 2A (MROH2A, marker 12774), maestro heat-like repeat family member 2A (MROH2A, marker 12775) ), maestro heat-like repeat family member 2B(MROH2B, marker
-12776),maestro heat-like repeat family member 2B(MROH2B, marker 12777),maestro heat-like repeat family member 2B(MROH2B,marker 12778),maestro heat-like repeat family member 6(MROH6,marker 12779),maestro heat-like repeat family member 7(MROH7, marker 12780),maestro heat-like repeat family member 8(MROH8,marker 12781),maestro heat-like repeat family member 8(MROH8,marker 12782),maestro heat-like repeat family member 9 (MROH9, marker 12783), mitochondrial ribosomal protein L12 (MRPL12, marker 12784), mitochondrial ribosomal protein L20 (MRPL20, marker 12785), mitochondrial ribosomal protein L20 (MRPL20, marker 12786), mitochondrial ribosomal protein L23 (MRPL23, marker 12787), mitochondrial ribosomal protein L38 (MRPL38, marker 12788), mitochondrial ribosomal protein L39 (MRPL39, marker 12789), mitochondrial ribosomal protein L41 (MRPL41, marker 12790), mitochondrial ribosomal protein L45 pseudogene 2 (MRPL45P2, marker 12791), mitochondrial ribosomal protein L55 (MRPL55, marker 12792), mitochondrial ribosomal protein S11 pseudogene 1 (MRPS11P1, marker 12793), mitochondrial ribosomal protein S12 (MRPS12, marker 12794), mitochondrial ribosomal protein S18C (MRPS18C, marker 12795), mitochondrial ribosomal protein S 18C( MRPS18C, marker 12796), mitochondrial ribosomal protein S26 (MRPS26, marker 12797), mitochondrial ribosomal protein S27 (MRPS27, marker 12798), mitochondrial ribosomal protein S31 (MRPS31, marker 12799), mitochondrial ribosomal protein S31 (MRPS31, marker 12800) , mitochondrial ribosomal protein S33 (MRPS33, marker 12801), mitochondrial ribosomal protein S5 (MRPS5, marker 12802), MRS2 magnesium transporter (MRS2, marker 12803), murine retrovirus integration site 1 homolog (MRVI1, marker 12804), murine retrovirus integration site 1 homolog (MRVI1, marker 12805), MRVI1 antisense RNA 1 (MRVI1-AS1, marker 12806), membrane-spanning 4-domains, subfamily A, member 1 (MS4A1, marker 12807), membrane-spanning 4-domains, subfamily A, member 1(MS4A1, marker 12808),membrane-spanning 4-domains, subfamily A, member 1(MS4A1,marker 12809),membrane-spanning 4-domains, subfamily A, member 1(MS4A1,marker 12810),membrane-spanning 4-domains, subfamily A, member 12(MS4A12, marker 12811),membrane-spanning 4-domains, subfamily A, member 14(MS4A14, marker 12812),membrane-spanning 4-domains, subfamily A, member 15(MS4A15, marker 12813),membrane-spanning 4-domains, subfamily A, member 2(MS4A2,marker 12814),membrane-spanning 4-domains, subfamily A, member 2(MS4A2,marker 12815),membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)(MS4A3, marker 12816),membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)(MS4A3, marker 12817),membrane-spanning 4-domains, subfamily A, member 4A(MS4A4A, marker 12818),membrane-spanning 4-domains, subfamily A, member 4A(MS4A4A,marker 12819),membrane-spanning 4-domains, subfamily A, member 4A(MS4A4A,marker 12820),membrane -spanning 4-domains, subfamily A, member 5(MS4A5, marker 12821),membrane-spanning 4-domains, subfamily A, member 6A(MS4A6A, marker 12822),membrane-spanning 4-domains, subfamily A, member 6A( MS4A6A, marker 12823),membrane-spanning 4-domains, subfamily A, member 6A(MS4A6A,marker 12824),membrane-spanning 4-domains, subfamily A, member 6A(MS4A6A,marker 12825),membrane-spanning 4-domains , subfamily A, member 6A(MS4A6A, marker 12826),membrane-spanning 4-domains, subfamily A, member 6A(MS4A6A, marker 12827),membrane-spanning 4-domains, subfamily A, member 6A(MS4A6A, marker 12828) ,membrane-spanning 4-domains, subfamily A, member 6E(MS4A6E,marker 12829),membrane-spanning 4-domains, subfamily A, member 7(MS4A7,marker 12830),membrane-spanning 4-domains, subfamily A, member 7(MS4A7, marker 12831),membrane-spanning 4-domains, subfamily A, member 7(MS4A7,marker 12832),membrane-spanning 4-domains, subfamily A, member 8(MS4A8,marker 12833),Myb/SANT- like DNA-binding domain containing 4 with coiled-coils(MSANTD4, marker 12834),musculin(MSC,marker 12835),MSC antisense RNA 1(MSC-AS1,marker 12836),mutS homolog 4(MSH4,marker 12837),MSH5 -SAPCD1 readthrough (NMD candidate) /// suppressor APC domain containing 1(MSH5-SAPCD1 /// SAPCD1, marker 12838), mutS homolog 6(MSH6, marker 12839), musashi RNA binding protein 1(MSI1, marker 12840), musashi RNA binding protein 2 (MSI2, marker 12841), musashi RNA binding protein 2 (MSI2, marker 12842), male-specific lethal 1 homolog (Drosophila) (MSL1, marker 12843), mesothelin (MSLN, marker 12844), microseminoprotein, beta-(MSMB, marker 12845), microseminoprotein, beta-(MSMB, marker 12846), moesin (MSN, marker 12847), macrophage scavenger receptor 1(MSR1, marker 12848), macrophage scavenger receptor 1(MSR1, marker 12849), macrophage scavenger receptor 1 (MSR1, marker 12850), macrophage scavenger receptor 1 (MSR1, marker 12851), methionine sulfoxide reductase A (MSRA, marker 12852), methionine sulfoxide reductase B3 (MSRB3, marker 12853), macrophage stimulating 1-like( MST1L, marker 12854), macrophage stimulating 1-like (MST1L, marker 12855), macrophage stimulating 1 receptor (MST1R, marker 12856), myostatin (MSTN, marker 12857), msh homeobox 2 (MSX2, marker 12858), metallothionein 1G( MT1G, marker 12859), metallothionein 1M (MT1M, marker 12860), metallothionein 3 (MT3, marker 12861), metallothionein 4 (MT4, marker 12862), metastasis associated 1 family member 3 (MTA3, marker 12863), methylthioadenosine phosphorylase (MTAP , marker 12864), methylthioadenosine phosphorylase (MTAP, marker 12865), MDM2 binding protein (MTBP, marker 12866), MDM2 binding protein (MTBP, marker 12867), MDM2 binding protein (MTBP, marker 12868), mature T-cell proliferation 1 (MTCP1, marker 12869), mitochondrial fission regulator 1(MTFR1, marker 12870), mitochondrial fission regulator 2(MTFR2, marker 12871), mitochondrial ribosome-associated GTPase 2(MTG2, marker 12872), mitochondrial ribosome-associated GTPase 2(MTG2) , marker 12873), mitochondrial ribosome-associated GTPase 2(MTG2, marker 12874), methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase(MTHFD1, marker 12875), methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like( MTHFD1L, marker 12876),methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like(MTHFD2L, marker 12877),methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2-like(MTHFD2L, marker 12878),methylenetetrahydrofolate reductase (NAD(P)H)(MTHFR,marker 12879 ),methylenetetrahydrofolate reductase (NAD(P)H)(MTHFR, marker 12880),methylenetetrahydrofolate reductase (NAD(P)H)(MTHFR, marker 12881),5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase) // / ST20-MTHFS readthrough(MTHFS /// ST20-MTHFS, marker 12882),methenyltetrahydrofolate synthetase domain containing(MTHFSD,marker 12883),methenyltetrahydrofolate synthetase domain containing(MTHFSD,marker 12884),methenyltetrahydrofolate synthetase domain containing(MTHFSD,marker 12885) ,methenyltetrahydrofolate synthetase domain containing (MTHFSD, marker 12886), mitochondrial translational initiation factor 3 (MTIF3, marker 12887), metallothionein-like 5, testis-specific (tesmin) (MTL5, marker 12888), myotubularin related protein 1 (MTMR1, marker 12889), myotubularin related protein 10 (MTMR10, marker 12890), myotubularin related protein 11 (MTMR11, marker 12891), myotubularin related protein 14 (MTMR14, marker 12892), myotubularin related protein 3 (MTMR3, marker 12893), myotubularin related protein 6 (MTMR6, marker 12894), myotubularin related protein 7 (MTMR7, marker 12895), myotubularin related protein 7 (MTMR7, marker 12896), myotubularin related protein 7 (MTMR7, marker 12897), myotubularin related protein 8 (MTMR8, marker 12898) ), myotubularin related protein 8 (MTMR8, marker 12899), myotubularin related protein 9-like, pseudogene (MTMR9LP, marker 12900), melatonin receptor 1A (MTNR1A, marker 12901), melatonin receptor 1B (MTNR1B, marker 12902), mitochondrial tRNA translation optimization 1(MTO1, marker 12903), mechanistic target of rapamycin (serine/threonine kinase)(MTOR, marker 12904), mitochondrial translational release factor 1(MTRF1, marker 12905), mitochondrial translational release factor 1-like(MTRF1L, marker 12906), mitochondrial translational release factor 1-like(MTRF1L, marker 12907), metastasis suppressor 1(MTSS1, marker 12908), metastasis suppressor 1(MTSS1, marker 12909), metastasis suppressor 1(MTSS1, marker 12910), metastasis suppressor 1 -like(MTSS1L, marker 12911), metastasis suppressor 1-like(MTSS1L, marker 12912), microsomal triglyceride transfer protein(MTTP, marker 12913), maturin, neural progenitor differentiation regulator homolog (Xenopus)(MTURN, marker 12914), microtubule associated tumor suppressor 1(MTUS1, marker 12915), microtubule associated tumor suppressor candidate 2(MTUS2, marker 12916), microtubule associated tumor suppressor candidate 2(MTUS2, marker 12917), microtubule associated tumor suppressor candidate 2(MTUS2, marker 12918), MTUS2 antisense RNA 1(MTUS2-AS1, marker 12919), mucin 1, cell surface associated(MUC1, marker 12920), mucin 1, cell surface associated(MUC1, marker 12921), mucin 12, cell surface associated(MUC12, marker 12922 ), mucin 13, cell surface associated(MUC13, marker 12923), mucin 13, cell surface associated(MUC13, marker 12924), mucin 16, cell surface associated(MUC16, marker 12925), mucin 17, cell surface associated(MUC17, marker 12926), mucin 17, cell surface associated(MUC17, marker 12927), mucin 2, oligomeric mucus/gel-forming(MUC2, marker 12928), mucin 20, cell surface associated(MUC20, marker 12929), mucin 20, cell surface associated(MUC20, marker 12930),mucin 20, cell surface associated(MUC20, marker 12931),mucin 20, cell surface associated(MUC20, marker 12932),intestinal mucin-like(MUC3, marker 12933),intestinal mucin-like (MUC3, marker 12934), mucin 3B, cell surface associated(MUC3B, marker 12935), mucin 4, cell surface associated(MUC4, marker 12936), mucin 4, cell surface associated(MUC4, marker 12937), mucin 4, cell surface associated(MUC4, marker 12938), mucin 4, cell surface associated(MUC4, marker 12939), mucin 4, cell surface associated(MUC4, marker 12940), mucin 5AC, oligomeric mucus/gel-forming(MUC5AC, marker 12941) ,mucin 5AC, oligomeric mucus/gel-forming(MUC5AC, marker 12942),mucin 5AC, oligomeric mucus/gel-forming(MUC5AC, marker 12943),mucin 5B, oligomeric mucus/gel-forming(M
UC5B, marker 12944), mucin 5B, oligomeric mucus/gel-forming(MUC5B, marker 12945), mucin 6, oligomeric mucus/gel-forming(MUC6, marker 12946), mucin 6, oligomeric mucus/gel-forming(MUC6, marker 12947), mucin 7, secreted(MUC7, marker 12948), mucin 7, secreted(MUC7, marker 12949), mucin 8(MUC8, marker 12950), mucin 8(MUC8, marker 12951), mucin-like 1(MUCL1) , marker 12952), muscle, skeletal, receptor tyrosine kinase(MUSK, marker 12953), muscle, skeletal, receptor tyrosine kinase(MUSK, marker 12954), muscle, skeletal, receptor tyrosine kinase(MUSK, marker 12955), multivesicular body subunit 12B (MVB12B, marker 12956), multivesicular body subunit 12B (MVB12B, marker 12957), mevalonate kinase (MVK, marker 12958), MAX dimerization protein 1 (MXD1, marker 12959), matrix-remodelling associated 7 (MXRA7, marker 12960) ,myeloid-associated differentiation marker-like 2(MYADML2, marker 12961),v-myb avian myeloblastosis viral oncogene homolog(MYB,marker 12962),v-myb avian myeloblastosis viral oncogene homolog-like 1(MYBL1,marker 12963),myosin binding protein C, slow type (MYBPC1, marker 12964), myosin binding protein C, fast type (MYBPC2, marker 12965), myosin binding protein C, cardiac (MYBPC3, marker 12966), myosin binding protein H (MYBPH, marker 12967) ,MYCBP associated protein(MYCBPAP, marker 12968),MYCBP associated protein(MYCBPAP,marker 12969),v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog(MYCN,marker 12970),v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog(MYCN) , marker 12971), v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog (MYCN, marker 12972), MYCN opposite strand (MYCNOS, marker 12973), MYCN opposite strand (MYCNOS, marker 12974), MYCN upstream transcript (non-protein coding )(MYCNUT, marker 12975), myc target 1(MYCT1, marker 12976), myc target 1(MYCT1, marker 12977), myelin expression factor 2(MYEF2, marker 12978), myeloma overexpressed(MYEOV, marker 12979), myeloma overexpressed 2(MYEOV2, marker 12980), myogenic factor 5(MYF5, marker 12981), myogenic factor 6 (herculin)(MYF6, marker 12982), myosin, heavy chain 1, skeletal muscle, adult(MYH1, marker 12983), myosin, heavy chain 11, smooth muscle(MYH11, marker 12984),myosin, heavy chain 11, smooth muscle(MYH11,marker 12985),myosin, heavy chain 11, smooth muscle(MYH11,marker 12986),myosin, heavy chain 11, smooth muscle(MYH11,marker 12987),myosin, heavy chain 11, smooth muscle(MYH11,marker 12988),myosin, heavy chain 11, smooth muscle(MYH11,marker 12989),myosin, heavy chain 11, smooth muscle(MYH11,marker 12990), myosin, heavy chain 13, skeletal muscle(MYH13, marker 12991), myosin, heavy chain 14, non-muscle(MYH14, marker 12992), myosin, heavy chain 14, non-muscle(MYH14, marker 12993), myosin, heavy chain 14, non-muscle(MYH14, marker 12994),myosin, heavy chain 15(MYH15, marker 12995),myosin, heavy chain 16 pseudogene(MYH16,marker 12996),myosin, heavy chain 2, skeletal muscle, adult(MYH2, marker 12997), myosin, heavy chain 3, skeletal muscle, embryonic(MYH3, marker 12998), myosin, heavy chain 4, skeletal muscle(MYH4, marker 12999), myosin, heavy chain 6, cardiac muscle, alpha (MYH6, marker 13000), myosin, heavy chain 6, cardiac muscle, alpha /// myosin, heavy chain 7, cardiac muscle, beta(MYH6 /// MYH7, marker 13001), myosin, heavy chain 7, cardiac muscle, beta(MYH7, marker 13002), myosin, heavy chain 7B, cardiac muscle, beta(MYH7B, marker 13003), myosin, heavy chain 7B, cardiac muscle, beta(MYH7B, marker 13004), myosin, heavy chain 8, skeletal muscle , perinatal(MYH8, marker 13005), myosin, heavy chain 8, skeletal muscle, perinatal(MYH8, marker 13006), myosin light chain 1(MYL1, marker 13007), myosin light chain 2(MYL2, marker 13008), myosin light chain 9(MYL9, marker 13009), myosin regulatory light chain interacting protein(MYLIP, marker 13010), myosin regulatory light chain interacting protein(MYLIP, marker 13011), myosin light chain kinase(MYLK, marker 13012), myosin light chain kinase (MYLK, marker 13013), myosin light chain kinase (MYLK, marker 13014), myosin light chain kinase 2 (MYLK2, marker 13015), myosin light chain kinase 3 (MYLK3, marker 13016), myosin light chain kinase 3 (MYLK3, myosin light chain kinase 3 (MYLK3, marker 13018), myosin light chain kinase 3 (MYLK3, marker 13019), myosin light chain kinase 3 (MYLK3, marker 13020), myosin light chain kinase family member 4 (MYLK4, marker 13021), myosin light chain kinase family member 4(MYLK4, marker 13022), myosin light chain kinase family member 4(MYLK4, marker 13023), myosin light chain, phosphorylatable, fast skeletal muscle(MYLPF, marker 13024), myoneurin( MYNN, marker 13025), myoneurin (MYNN, marker 13026), myoneurin (MYNN, marker 13027), myosin XVA (MYO15A, marker 13028), myosin XVI (MYO16, marker 13031), myosin XVI (MYO16, marker 13032), myosin XVIIIB (MYO18B, marker 13033), myosin XVIIIB (MYO18B, marker 13034), myosin 13036), myosin IB (MYO1B, marker 13037), myosin ID (MYO1D, marker 13038), myosin IF (MYO1F, marker 13039), myosin IG (MYO1G, marker 13040), myosin IG (MYO1G, marker 13041), myosin IH (MYO1H, marker 13042), myosin IIIA (MYO3A, marker 13043), myosin IIIA (MYO3A, marker 13044), myosin IIIA (MYO3A, marker 13045), myosin IIIB (MYO3B, marker 13046), myosin IIIB (MYO3B, marker 13047) ), myosin VA(MYO5A, marker 13048), myosin VA(MYO5A, marker 13049), myosin VB(MYO5B, marker 13050), myosin VIIA(MYO7A, marker 13051), myosin VIIA(MYO7A, marker 13052), myosin VIIA( MYO7A, marker 13053), myosin VIIB (MYO7B, marker 13054), myosin VIIB (MYO7B, marker 13055), myosin VIIB (MYO7B, marker 13056), myosin IXA (MYO9A, marker 13057), myocilin, trabecular meshwork inducible glucocorticoid response( MYOC, marker 13058), myogenic differentiation 1 (MYOD1, marker 13059), myoferlin (MYOF, marker 13060), myogenin (myogenic factor 4) (MYOG, marker 13061), myomesin 1 (MYOM1, marker 13062), myomesin 2 (MYOM2) , marker 13063), myomesin 3 (MYOM3, marker 13064), myomesin 3 (MYOM3, marker 13065), myotilin (MYOT, marker 13066), myozenin 2 (MYOZ2, marker 13067), myozenin 2 (MYOZ2, marker 13068), myozenin 2 (MYOZ2, marker 13069), myozenin 3 (MYOZ3, marker 13070), myopalladin (MYPN, marker 13071), myelin regulatory factor (MYRF, marker 13072), myelin regulatory factor (MYRF, marker 13073), myelin regulatory factor-like (MYRFL, marker 13074), myosin VIIA and Rab interacting protein (MYRIP, marker 13075), Myb-like, SWIRM and MPN domains 1 (MYSM1, marker 13076), myelin transcription factor 1 (MYT1, marker 13077), myelin transcription factor 1(MYT1, marker 13078), myelin transcription factor 1(MYT1, marker 13079), myelin transcription factor 1-like(MYT1L, marker 13080), myelin transcription factor 1-like(MYT1L, marker 13081), myelin transcription factor 1- like (MYT1L, marker 13082), myelin transcription factor 1-like (MYT1L, marker 13083), myocardial zonula adherens protein (MYZAP, marker 13084), marginal zone B and B1 cell-specific protein (MZB1, marker 13085), marginal zone B and B1 cell-specific protein (MZB1, marker 13086), myeloid zinc finger 1 (MZF1, marker 13087), MZF1 antisense RNA 1 (MZF1-AS1, marker 13088), NEDD4 binding protein 2-like 1 (N4BP2L1, marker 13089) ),NEDD4 binding protein 2-like 1(N4BP2L1, marker 13090),NEDD4 binding protein 2-like 1(N4BP2L1, marker 13091),NEDD4 binding protein 2-like 1(N4BP2L1, marker 13092),NEDD4 binding protein 2-like 1 (N4BP2L1, marker 13093), NEDD4 binding protein 2-like 1 (N4BP2L1, marker 13094), NEDD4 binding protein 2-like 1 (N4BP2L1, marker 13095), NEDD4 binding protein 2-like 1 (N4BP2L1, marker 13096), NEDD4 binding protein 2-like 2(N4BP2L2, marker 13097),NEDD4 binding protein 2-like 2(N4BP2L2, marker 13098),N4BPL2 intronic transcript 2(N4BP2L2-IT2, marker 13099),N-6 adenine-specific DNA methyltransferase 1 (putative)(N6AMT1, marker 13100),N-6 adenine-specific DNA methyltransferase 1 (putative)(N6AMT1, marker 13101),N(alpha)-acetyltransferase 11, NatA catalytic subunit(NAA11, marker 13102),N(alpha )-acetyltransferase 15, NatA auxiliary subunit(NAA15, marker 13103),N(alpha)-acetyltransferase 16, NatA auxiliary subunit(NAA16, marker 13104),N(alpha)-acetyltransferase 30, NatC catalytic subunit(NAA30, marker 13105) ,N(alpha)-acetyltransferase 30, NatC catalytic subunit(NAA30, marker 13106),N(alpha)-acetyltransferase 35, NatC auxiliary subunit(NAA35, marker 13107),N-acylethanolamine acid amidase(NAAA, marker 13108),N -acylethanolamine acid amidase(NAAA, marker 13109),N-acetylated alpha-linked acidic dipeptidase 2(NAALAD2, marker 13110),N-acetylated alpha-linked acidic dipeptidase 2(NAALAD2, marker 13111),N-acetylated alpha-linked acidic dipeptidase 2(NAALAD2, marker 13112),N-acetylated alpha-linked acidic dipeptidase 2(NAALAD2, marker 13113),N-acetylated alpha-linked acidic dipeptidase-like 1(NAALADL1, marker 13114),N-acetylated alpha-linked acidic dipeptidase-like 1(NAALADL1, marker 13115),N-acetylated alpha-linked acidic dipeptidase-like 2(NAALADL2, marker 13116),N-acetylated alpha-linked acidic dipeptidase-like 2(NAALADL2, marker 13117),NAALADL2 antisense RNA 3 (NAALADL2-AS3, marker 13118), nucleic acid binding protein 1 (NABP1, marker 13119), nascent polypeptide-associated complex alpha subunit 2 (NACA2, marker 13120), nucleus accumbens associated 1, BEN and BTB (POZ) domain containing (NACC1, Marker 13121), NAD kinase (NADK, Marker 13122), NADK2 antisense RNA 1 (NADK2-AS1, Marker 13123), NAD synthetase 1 (NADSYN1, Marker 13124), NAD synthetase 1 (NADSYN1, Marker 13125), NAD synthetase 1 (NADSYN1, marker 13126), NAG18 mRNA (NAG18, marker 13127), N-acetylglucosaminidase, alpha (NAGLU, marker 13128), nuclear apoptosis inducing factor 1 (NAIF1, marker 13129), sodium leak channel, non selective (NALCN ,marker 13130),sodium channel, non selective(NALCN,marker 13131),sodium leak channel, non selective(NALCN,marker 13132),NALCN antisense RNA 1(NALCN-AS1,marker 13133),nanos homolog 2 (Drosophila) (NANOS2, marker 13134), nanos homolog 3 (Drosophila) (NANOS3, marker 13135), N-acetylneuraminic acid synthase (NANS, marker 13136), nucleosome assembly protein 1-like 4 (NAP1L4, marker 13137), nucleosome assembly protein 1 -like 4 (NAP1L4, marker 13138), NAPA antisense RNA 1 (NAPA-AS1, marker 13139), NAPA antisense RNA 1 (NAPA-AS1, marker 13140), N-ethylmaleimide-sensitive factor attachment protein, beta (NAPB, marker 13141),N-acyl phosphatidylethanolamine phospholipa
se D (NAPEPLD, marker 13142), napsin A aspartic peptidase (NAPSA, marker 13143), napsin B aspartic peptidase, pseudogene (NAPSB, marker 13144), napsin B aspartic peptidase, pseudogene (NAPSB, marker 13145), N-acetyltransferase 16 (GCN5-related, putative)(NAT16, marker 13146),N-acetyltransferase 16 (GCN5-related, putative)(NAT16, marker 13147),N-acetyltransferase 2 (arylamine N-acetyltransferase)(NAT2, marker 13148),N -acetyltransferase 8 (GCN5-related, putative)(NAT8, marker 13149),N-acetyltransferase 8 (GCN5-related, putative) /// N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene)(NAT8 // / NAT8B, marker 13150), N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene)(NAT8B, marker 13151), N-acetyltransferase domain containing 1(NATD1, marker 13152), neuron navigator 2(NAV2, marker 13153) ),neuron navigator 2(NAV2, marker 13154),neuron navigator 2(NAV2,marker 13155),NAV2 antisense RNA 2(NAV2-AS2,marker 13156),NAV2 antisense RNA 4(NAV2-AS4,marker 13157),NAV2 antisense RNA 5 (NAV2-AS5, marker 13158), NAV2 intronic transcript 1 (NAV2-IT1, marker 13159), neuron navigator 3 (NAV3, marker 13160), neuron navigator 3 (NAV3, marker 13161), neuron navigator 3 (NAV3, marker 13162), neuroblastoma amplified sequence(NBAS, marker 13163), neuroblastoma amplified sequence(NBAS, marker 13164), neuroblastoma associated transcript 1(NBAT1, marker 13165), neurobeachin like 1(NBEAL1, marker 13166), neurobeachin like 2(NBEAL2) , marker 13167), neurobeachin pseudogene 1 (NBEAP1, marker 13168), neurobeachin pseudogene 1 (NBEAP1, marker 13169), nibrin (NBN, marker 13170), neuroblastoma breakpoint family, member 3 (NBPF3, marker 13171), neuroblastoma breakpoint family, member 4(NBPF4, marker 13172), neuroblastoma breakpoint family, member 5, pseudogene(NBPF5P, marker 13173), neighbor of BRCA1 gene 1(NBR1, marker 13174), neighbor of BRCA1 gene 1(NBR1, marker 13175), neighbor of BRCA1 gene 2 (non-protein coding)(NBR2, marker 13176),neurocalcin delta(NCALD,marker 13177),neural cell adhesion molecule 1(NCAM1,marker 13178),neural cell adhesion molecule 1(NCAM1,marker 13179),neural cell adhesion molecule 1(NCAM1, marker 13180), neural cell adhesion molecule 2(NCAM2, marker 13181), neural cell adhesion molecule 2(NCAM2, marker 13182), neurocan(NCAN, marker 13183), non-SMC condensin II complex subunit H2 (NCAPH2, marker 13184), non-SMC condensin II complex subunit H2 (NCAPH2, marker 13185), neurochondrin (NCDN, marker 13186), neurochondrin (NCDN, marker 13187), neutrophil cytosolic factor 1 (NCF1, marker 13188), neutrophil cytosolic factor 1 /// neutrophil cytosolic factor 1B pseudogene /// neutrophil cytosolic factor 1C pseudogene(NCF1 /// NCF1B /// NCF1C, marker 13189), neutrophil cytosolic factor 2(NCF2, marker 13190), neutrophil cytosolic factor 4 (NCF4, marker 13191), neutrophil cytosolic factor 4 (NCF4, marker 13192), NCK-associated protein 1-like (NCKAP1L, marker 13193), NCK-associated protein 1-like (NCKAP1L, marker 13194), NCK-associated protein 1-like (NCKAP1L, marker 13195), NCK-associated protein 5 (NCKAP5, marker 13196), NCK-associated protein 5-like (NCKAP5L, marker 13197), NCK interacting protein with SH3 domain (NCKIPSD, marker 13198), NCK protein interacting with SH3 domain(NCKIPSD, marker 13199),NCK interacting protein with SH3 domain(NCKIPSD, marker 13200),nucleolin(NCL,marker 13201),nicalin(NCLN,marker 13202),nicalin(NCLN,marker 13203),nuclear receptor coactivator 3 (NCOA3, marker 13204), nuclear receptor coactivator 6 (NCOA6, marker 13205), nuclear receptor coactivator 7 (NCOA7, marker 13206), nuclear receptor coactivator 7 (NCOA7, marker 13207), nuclear receptor corepressor 1 (NCOR1, marker 13208), nuclear receptor corepressor 2 (NCOR2, marker 13209), nuclear receptor corepressor 2 (NCOR2, marker 13210), nuclear receptor corepressor 2 (NCOR2, marker 13211), nuclear receptor corepressor 2 (NCOR2, marker 13212), natural cytotoxicity triggering receptor 1(NCR1, marker 13213),natural cytotoxicity triggering receptor 1(NCR1, marker 13214),natural cytotoxicity triggering receptor 1(NCR1, marker 13215),natural cytotoxicity triggering receptor 2(NCR2, marker 13216),natural cytotoxicity triggering receptor 2(NCR2, marker 13217),natural cytotoxicity triggering receptor 3(NCR3,marker 13218),natural cytotoxicity triggering receptor 3(NCR3,marker 13219),natural cytotoxicity triggering receptor 3(NCR3,marker 13220),natural killer cell cytotoxicity receptor 3 ligand 1 (NCR3LG1, marker 13221), neuronal calcium sensor 1 (NCS1, marker 13222), nicastrin (NCSTN, marker 13223), nudE neurodevelopment protein 1 (NDE1, marker 13224), nudE neurodevelopment protein 1-like 1 (NDEL1, marker 13225), Nedd4 family protein 2 (NDFIP2, marker 13226), NADPH interacting diflavin oxidoreductase 1 (NDOR1, marker 13227), NADPH dependent diflavin oxidoreductase 1 (NDOR1, marker 13228), Norrie disease (pseudoglioma) (NDP, marker 13229) ,NDRG family member 2(NDRG2, marker 13230),N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1(NDST1, marker 13231),N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2(NDST2, marker 13232), N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 /// ZSWIM8 antisense RNA 1(NDST2 /// ZSWIM8-AS1, marker 13233),N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3(NDST3, marker 13234) ,N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4(NDST4, marker 13235),N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4(NDST4, marker 13236),NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa(NDUFA10, Marker 13237),NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa(NDUFA10, Marker 13238),NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa(NDUFA10, Marker 13239),NADH dehydrogenase (ubiquinone ) 1 alpha subcomplex, 10, 42kDa(NDUFA10, marker 13240),NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa(NDUFA11, marker 13241),NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa(NDUFA2, marker 13242), NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa(NDUFA2, marker 13243),NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2(NDUFA4L2, marker 13244),NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 5(NDUFA5, marker 13245),NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa(NDUFA7, marker 13246),NADH dehydrogenase (ubiquinone) complex I, assembly factor 5(NDUFAF5, marker 13247),NADH dehydrogenase (ubiquinone) complex I, assembly factor 6(NDUFAF6, marker 13248),NADH dehydrogenase (ubiquinone) complex I, assembly factor 6(NDUFAF6, marker 13249),NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa(NDUFB2, marker 13250), NDUFB2 antisense RNA 1(NDUFB2-AS1, Marker 13251), NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa(NDUFB6, Marker 13252),NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa(NDUFB7, Marker 13253), NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kDa (NADH-coenzyme Q reductase) (NDUFS1, Marker 13254), NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)( NDUFS4, marker 13255), NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (NDUFS7, marker 13256), NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa (NDUFV1, marker 13257), NDUFV2 antisense RNA 1(NDUFV2-AS1, marker 13258), NDUFV2 antisense RNA 1(NDUFV2-AS1, marker 13259), nuclear paraspeckle assembly transcript 1 (non-protein coding)(NEAT1, marker 13260), nebulin(NEB, marker 13261), nebulette (NEBL, marker 13262), nebulette (NEBL, marker 13263), nebulette (NEBL, marker 13264), NEBL antisense RNA 1 (NEBL-AS1, marker 13265), N-terminal EF-hand calcium binding protein 1 (NECAB1, marker 13266), NECAP endocytosis associated 2(NECAP2, marker 13267), neural precursor cell expressed, developmentally down-regulated 9(NEDD9, marker 13268), neural precursor cell expressed, developmentally down-regulated 9(NEDD9, marker 13269), neural precursor cell expressed, developmentally down-regulated 9(NEDD9, marker 13270), neurofilament, medium polypeptide(NEFM, marker 13271), neuronal growth regulator 1(NEGR1, marker 13272), neuronal growth regulator 1(NEGR1, marker 13273), neuronal growth regulator 1(NEGR1, marker 13274),neuronal growth regulator 1(NEGR1,marker 13275),NEGR1 intronic transcript 1(NEGR1-IT1,marker 13276),nei-like DNA glycosylase 1(NEIL1,marker 13277),nei-like DNA glycosylase 1 (NEIL1, marker 13278), NIMA-related kinase 1 (NEK1, marker 13279), NIMA-related kinase 1 (NEK1, marker 13280), NIMA-related kinase 10 (NEK10, marker 13281), NIMA-related kinase 11 (NEK11, marker 13282), NIMA-related kinase 11 (NEK11, marker 13283), NIMA-related kinase 4 (NEK4, marker 13284), NIMA-related kinase 5 (NEK5, marker 13285), NIMA-related kinase 5 ( NEK5, marker 13286), NIMA-related kinase 6 (NEK6, marker 13287), NIMA-related kinase 6 (NEK6, marker 13288), NIMA-related kinase 6 (NEK6, marker 13289), NIMA-related kinase 9 (NEK9, marker 13290), NIMA-related kinase 9 (NEK9, marker 13291), neural EGFL like 1 (NELL1, marker 13292), neural EGFL like 1 (NELL1, marker 13293), nuclear envelope integral membrane protein 2 (NEMP2, marker 13294) ,neudesin neurotrophic factor(NENF, marker 13295),neudesin neurotrophic factor(NENF,marker 13296),neudesin neurotrophic factor(NENF,marker 13297),neudesin neurotrophic factor(NENF,marker 13298),neogenin 1(NEO1,marker 13299), neuropilin (NRP) and tolloid (TLL)-like 1(NETO1, marker 13300),neuropilin (NRP) and tolloid (TLL)-like 1(NETO1, marker 13301),sialidase 2 (cytosolic sialidase)(NEU2, marker 13302) ,sialidase 3 (membrane sialidase)(NEU3, marker 13303),sialidase 3 (membrane sialidase)(NEU3, marker 13304),sialidase 4(NEU4, marker 13305),neuralized E3 ubiquitin protein ligase 1(NEURL1, marker 13306),neuralized E3 ubiquitin protein ligase 1(NEURL1, marker 13307), neuralized E3 ubiquitin protein ligase 2(NEURL2, marker 13308), neuralized E3 ubiquitin protein ligase 3(NEURL3, marker 13309), neuronal differentiation 1(NEUROD1, marker 13310), neuronal differentiation 1 (NEUROD1, marker 13311), neuronal differentiation 2 (NEUROD2, marker 13312), neuronal differentiation 2 (NEUROD2, marker 13313), neuronal differentiation 4 (NEUROD4, marker 13314), neuronal differentiation 6 (NEUROD6, marker 13315), neurogenin 1 (NEUROG1, marker 13316), neurogenin 2 (NEUROG2, marker 13317), neurogenin 3 (NEUROG3, marker 13318), NEXN antisense RNA 1 (NEXN-AS1, marker 13319), neurofibromin 1 (NF1, marker 133)
20), neurofibromin 1 (NF1, marker 13321), neurofibromin 1 (NF1, marker 13322), neurofibromin 2 (merlin) (NF2, marker 13323), NFAT activating protein with ITAM motif 1 (NFAM1, marker 13324), NFAT activating protein with ITAM motif 1(NFAM1, marker 13325), neurofascin(NFASC, marker 13326), neurofascin(NFASC, marker 13327), neurofascin(NFASC, marker 13328), neurofascin(NFASC, marker 13329), nuclear factor of activated T-cells , cytoplasmic, calcineurin-dependent 1(NFATC1, marker 13330),nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1(NFATC1, marker 13331),nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2( NFATC2, marker 13332), nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2(NFATC2, marker 13333), nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2(NFATC2, marker 13334), nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2(NFATC2, marker 13335),nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2(NFATC2, marker 13336),nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3(NFATC3, marker 13337),nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4(NFATC4, marker 13338),nuclear factor, erythroid 2(NFE2, marker 13339),nuclear factor, erythroid 4( NFE4, marker 13340), nuclear factor I/A (NFIA, marker 13341), nuclear factor I/A (NFIA, marker 13342), nuclear factor I/A (NFIA, marker 13343), nuclear factor I/A (NFIA, marker 13344), nuclear factor I/A (NFIA, marker 13345), nuclear factor I/A (NFIA, marker 13346), nuclear factor I/A (NFIA, marker 13347), NFIA antisense RNA 2 (NFIA-AS2, marker 13348), NFIA antisense RNA 2 (NFIA-AS2, marker 13349), NFIA antisense RNA 2 (NFIA-AS2, marker 13350), nuclear factor I/B (NFIB, marker 13351), nuclear factor I/B (NFIB, marker 13352),nuclear factor I/C (CCAAT-binding transcription factor)(NFIC,marker 13353),nuclear factor I/C (CCAAT-binding transcription factor)(NFIC,marker 13354),nuclear factor I/C (CCAAT-binding transcription factor) (NFIC, marker 13355), nuclear factor I/X (CCAAT-binding transcription factor) (NFIX, marker 13356), nuclear factor I/X (CCAAT-binding transcription factor) (NFIX, marker 13357), nuclear factor I/X (CCAAT-binding transcription factor)(NFIX, marker 13358),nuclear factor I/X (CCAAT-binding transcription factor)(NFIX, marker 13359),nuclear factor I/X (CCAAT-binding transcription factor)(NFIX , marker 13360), nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)(NFKB2, marker 13361), nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)(NFKB2 , marker 13362), nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA, marker 13363), nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta (NFKBID, marker 13364), nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta(NFKBID, marker 13365), nuclear factor related to kappaB binding protein(NFRKB, marker 13366), nuclear transcription factor, X-box binding 1(NFX1, marker 13367) , nuclear transcription factor Y subunit alpha (NFYA, marker 13368), nuclear transcription factor Y subunit gamma (NFYC, marker 13369), neuroglobin (NGB, marker 13370), neuroglobin (NGB, marker 13371), neuroguidin, EIF4E binding protein (NGDN ,marker 13372),neuronal guanine nucleotide exchange factor(NGEF,marker 13373),nerve growth factor (beta polypeptide)(NGF,marker 13374),neuroblastoma highly expressed 1(NHEG1,marker 13375),nescient helix-loop-helix 1( NHLH1, Marker 13376), nestcient helix-loop-helix 2 (NHLH2, Marker 13377), NHL repeat containing 2 (NHLRC2, Marker 13378), NHL repeat containing 2 (NHLRC2, Marker 13379), NHS-like 1 (NHSL1, Marker 13380), NHS-like 1 (NHSL1, marker 13381), NHS-like 2 (NHSL2, marker 13382), nidogen 1 (NID1, marker 13383), nucleolar protein interacting with the FHA domain of MKI67 (NIFK, marker 13384), NIFK antisense RNA 1 (NIFK-AS1, marker 13385), NIM1 serine/threonine protein kinase (NIM1K, marker 13386), ninein (GSK3B interacting protein) (NIN, marker 13387), ninein (GSK3B interacting protein) (NIN, marker 13388 ), ninein (GSK3B interacting protein)(NIN, marker 13389), ninjurin 2(NINJ2, marker 13390), NIPA-like domain containing 1(NIPAL1, marker 13391), NIPA-like domain containing 2(NIPAL2, marker 13392), NIPA-like domain containing 2(NIPAL2, marker 13393),NIPA-like domain containing 2(NIPAL2, marker 13394),NIPA-like domain containing 3(NIPAL3, marker 13395),NIPA-like domain containing 3(NIPAL3, marker 13396 ),NIPA-like domain containing 3(NIPAL3, marker 13397),NIPA-like domain containing 4(NIPAL4, marker 13398),nipsnap homolog 3B (C. elegans)(NIPSNAP3B, marker 13399),nipsnap homolog 3B (C. elegans ) (NIPSNAP3B, marker 13400), nipsnap homolog 3B (C. elegans) (NIPSNAP3B, marker 13401), nischarin (NISCH, marker 13402), nitrilase 1 (NIT1, marker 13403), Na+/K+ transporting ATPase interacting 2 (NKAIN2, Marker 13404), Na+/K+ transporting ATPase interacting 2(NKAIN2, Marker 13405), Na+/K+ transporting ATPase interacting 3(NKAIN3, Marker 13406), NFKB activating protein-like(NKAPL, Marker 13407), NFKB activating protein-like( NKAPL, marker 13408), NFKB activating protein pseudogene 1 (NKAPP1, marker 13409), naked cuticle homolog 1 (Drosophila) (NKD1, marker 13410), naked cuticle homolog 1 (Drosophila) (NKD1, marker 13411), naked cuticle homolog 1 (Drosophila)(NKD1, marker 13412),naked cuticle homolog 1 (Drosophila)(NKD1, marker 13413),natural killer cell granule protein 7(NKG7,marker 13414),natural killer cell triggering receptor(NKTR,marker 13415),natural killer cell triggering receptor (NKTR, marker 13416), natural killer cell triggering receptor (NKTR, marker 13417), NK1 homeobox 1 (NKX1-1, marker 13418), NK2 homeobox 1 (NKX2-1, marker 13419), NK2 homeobox 1 (NKX2-1, marker 13420), NKX2-1 antisense RNA 1 (NKX2-1-AS1, marker 13421), NK2 homeobox 2 (NKX2-2, marker 13422), NK2 homeobox 3 (NKX2-3, marker 13423), NK2 homeobox 5 (NKX2-5, marker 13424), NK2 homeobox 8 (NKX2-8, marker 13425), NK3 homeobox 1 (NKX3-1, marker 13426), NK3 homeobox 1 (NKX3-1, marker 13427), NK3 homeobox 1 (NKX3-1, marker 13428), NK3 homeobox 2 (NKX3-2, marker 13429), NK6 homeobox 1 (NKX6-1, marker 13430), NK6 homeobox 2 (NKX6-2, marker 13431), NK6 homeobox 3 ( NKX6-3, marker 13432), NK6 homeobox 3 (NKX6-3, marker 13433), neuroligin 2 (NLGN2, marker 13434), neuroligin 3 (NLGN3, marker 13435), neuroligin 3 (NLGN3, marker 13436), neuroligin 4, Y-linked(NLGN4Y, marker 13437), neuroligin 4, Y-linked(NLGN4Y, marker 13438), neurolysin (metallopeptidase M3 family)(NLN, marker 13439), NLR family, CARD domain containing 3(NLRC3, marker 13440), NLR family, CARD domain containing 4(NLRC4, marker 13441),NLR family, CARD domain containing 4(NLRC4, marker 13442),NLR family, CARD domain containing 5(NLRC5, marker 13443),NLR family, pyrin domain containing 1( NLRP1, marker 13444),NLR family, pyrin domain containing 1(NLRP1, marker 13445),NLR family, pyrin domain containing 1(NLRP1, marker 13446),NLR family, pyrin domain containing 10(NLRP10, marker 13447),NLR family , pyrin domain containing 11(NLRP11, marker 13448),NLR family, pyrin domain containing 12(NLRP12, marker 13449),NLR family, pyrin domain containing 12(NLRP12, marker 13450),NLR family, pyrin domain containing 13(NLRP13, marker 13451),NLR family, pyrin domain containing 14(NLRP14, marker 13452),NLR family, pyrin domain containing 2(NLRP2, marker 13453),NLR family, pyrin domain containing 3(NLRP3, marker 13454),NLR family, pyrin domain containing 3(NLRP3, marker 13455),NLR family, pyrin domain containing 3(NLRP3, marker 13456),NLR family, pyrin domain containing 4(NLRP4, marker 13457),NLR family, pyrin domain containing 5(NLRP5, marker 13458) ),NLR family, pyrin domain containing 6(NLRP6, marker 13459),NLR family, pyrin domain containing 8(NLRP8, marker 13460),NLR family, pyrin domain containing 9(NLRP9, marker 13461),neuromedin B receptor(NMBR, Marker 13462), NME/NM23 family member 8 (NME8, Marker 13463), NME/NM23 family member 9 (NME9, Marker 13464), nicotinamide nucleotide adenylyltransferase 1 (NMNAT1, Marker 13465), nicotinamide nucleotide adenylyltransferase 2 (NMNAT2, Marker 13466) ), nicotinamide nucleotide adenylyltransferase 3 (NMNAT3, marker 13467), nicotinamide riboside kinase 1 (NMRK1, marker 13468), neuromedin U receptor 1 (NMUR1, marker 13469), neuromedin U receptor 2 (NMUR2, marker 13470), nicotinamide N-methyltransferase (NNMT, marker 13471), nicotinamide nucleotide transhydrogenase(NNT, marker 13472), NOBOX oogenesis homeobox(NOBOX, marker 13473), nucleotide-binding oligomerization domain containing 1(NOD1, marker 13474), nucleotide-binding oligomerization domain containing 2(NOD2) , marker 13475), nodal growth differentiation factor (NODAL, marker 13476), nucleolar protein 10 (NOL10, marker 13477), nucleolar protein 12 (NOL12, marker 13478), nucleolar protein 3 (apoptosis repressor with CARD domain) (NOL3, marker 13479), nucleolar protein 3 (apoptosis repressor with CARD domain) (NOL3, marker 13480), nucleolar protein 3 (apoptosis repressor with CARD domain) (NOL3, marker 13481), nucleolar protein 4 (NOL4, marker 13482), nucleolar protein 4 (NOL4, marker 13483), nucleolar protein 4-like (NOL4L, marker 13484), nucleolar protein 4-like (NOL4L, marker 13485), nucleolar protein 4-like (NOL4L, marker 13486), NOP14 antisense RNA 1 (NOP14- AS1, marker 13487), NOP14 antisense RNA 1 (NOP14-AS1, marker 13488), NOP14 antisense RNA 1 (NOP14-AS1, marker 13489), NOP16 nucleolar protein (NOP16, marker 13490), NOP16 nucleolar protein (NOP16, marker 13491) ),nitric oxide synthase 1 (neuronal)(NOS1,marker 13492),nitric oxide synthase 1 (neuronal)(NOS1,marker 13493),nitric oxide synthase 1 (neuronal)(NOS1,marker 13494),nitric oxide synthase 1 (neuronal )(NOS1, marker 13495), nitric oxide synthase 1 (neuronal)(NOS1, marker 13496), nitric oxide synthase 1 (neuronal)(NOS1, marker 13497), nitric oxide synthase 1 (neuronal) adapter protein(NOS1AP, marker 13498 ), nitric oxide synthase 1 (neuronal) adapter protein (NOS1AP, marker 13499), nitric oxide synthase 3 (endothelial cell) (NOS3, marker 13500), nitric oxide synthase trafficking (NOSTRIN, marker 13501), notch 1 (NOTCH1, marker 13502), notch 3 (NOTCH3, marker 13503), notch 4 (NOTCH4, marker 13504), notch 4 (NOTCH4, marker 13505), notum pectinacetylesterase homolog (Drosophila) (NOTUM, marker 13506), nephroblastoma o
verexpressed(NOV, marker 13507), nephroblastoma overexpressed(NOV, marker 13508), neuro-oncological ventral antigen 1(NOVA1, marker 13509), neuro-oncological ventral antigen 2(NOVA2, marker 13510), neuro-oncological ventral antigen 2( NOVA2, Marker 13511), NADPH oxidase 1 (NOX1, Marker 13512), NADPH oxidase 1 (NOX1, Marker 13513), NADPH oxidase 1 (NOX1, Marker 13514), NADPH oxidase 1 (NOX1, Marker 13515), NADPH oxidase 3( NOX3, marker 13516), NADPH oxidase 4 (NOX4, marker 13517), NADPH oxidase, EF-hand calcium binding domain 5 (NOX5, marker 13518), NADPH oxidase, EF-hand calcium binding domain 5 (NOX5, marker 13519), NADPH oxidase activator 1 (NOXA1, marker 13520), NADPH oxidase organizer 1 (NOXO1, marker 13521), NADP-dependent oxidoreductase domain containing 1 (NOXRED1, marker 13522), nuclear pore associated protein 1 (NPAP1, marker 13523), neuronal PAS domain protein 1(NPAS1, marker 13524),neuronal PAS domain protein 1(NPAS1, marker 13525),neuronal PAS domain protein 2(NPAS2, marker 13526),neuronal PAS domain protein 2(NPAS2, marker 13527),neuronal PAS domain protein 2(NPAS2, marker 13528),neuronal PAS domain protein 2(NPAS2,marker 13529),neuronal PAS domain protein 2(NPAS2,marker 13530),neuronal PAS domain protein 3(NPAS3,marker 13531),neuronal PAS domain protein 3( NPAS3, marker 13532),neuronal PAS domain protein 3(NPAS3,marker 13533),neuronal PAS domain protein 3(NPAS3,marker 13534),neuronal PAS domain protein 3(NPAS3,marker 13535),neuronal PAS domain protein 3(NPAS3, marker 13536), neuronal PAS domain protein 3(NPAS3, marker 13537), neuronal PAS domain protein 3(NPAS3, marker 13538), neuronal PAS domain protein 3(NPAS3, marker 13539), neuronal PAS domain protein 4(NPAS4, marker 13540 ), neuronal PAS domain protein 4 (NPAS4, marker 13541), nuclear protein, ataxia-telangiectasia locus (NPAT, marker 13542), neuropeptide B (NPB, marker 13543), neuropeptides B/W receptor 1 (NPBWR1, marker 13544), neuropeptides B/W receptor 2(NPBWR2, marker 13545),Niemann-Pick disease, type C1(NPC1, marker 13546),Niemann-Pick disease, type C1(NPC1, marker 13547),Niemann-Pick disease, type C1(NPC1 , Marker 13548), NPC1-like 1 (NPC1L1, Marker 13549), NPC1-like 1 (NPC1L1, Marker 13550), NPC1-like 1 (NPC1L1, Marker 13551), nasopharyngeal carcinoma, down-regulated 1 (NPCDR1, Marker 13552) ), aminopeptidase puromycin sensitive(NPEPPS, marker 13553), neuropeptide FF-amide peptide precursor(NPFF, marker 13554), neuropeptide FF-amide peptide precursor(NPFF, marker 13555), neuropeptide FF receptor 1(NPFFR1, marker 13556), nephronophthisis 1 (juvenile) (NPHP1, marker 13557), nephronophthisis 3 (adolescent) (NPHP3, marker 13558), NPHP3 antisense RNA 1 (NPHP3-AS1, marker 13559), NPHP3 antisense RNA 1 (NPHP3-AS1, marker 13560), nephronophthisis 4 (NPHP4, marker 13561), nephrosis 1, congenital, Finnish type (nephrin) (NPHS1, marker 13562), nephrosis 2, idiopathic, steroid-resistant (podocin) (NPHS2, marker 13563), nuclear pore complex interacting protein family, member B15 /// pyridoxal-dependent decarboxylase domain containing 2, pseudogene(NPIPB15 /// PDXDC2P, marker 13564),N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase)(NPL, marker 13565),N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) (NPL, marker 13566), N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase) (NPL, marker 13567), nephronectin (NPNT, marker 13568), natriuretic peptide A (NPPA, marker 13569), natriuretic peptide C (NPPC, marker 13570) , natriuretic peptide receptor 1 (NPR1, marker 13571), natriuretic peptide receptor 2 (NPR2, marker 13572), natriuretic peptide receptor 3 (NPR3, marker 13573), natriuretic peptide receptor 3 (NPR3, marker 13574), NPR2-like, GATOR1 complex subunit (NPRL2, marker 13575), NPR3-like, GATOR1 complex subunit (NPRL3, marker 13576), novel prostate-specific antigen (NPSA, marker 13577), NPSR1 antisense RNA 1 (NPSR1-AS1, marker 13578), NPSR1 antisense RNA 1 (NPSR1-AS1, marker 13579), neuronal pentraxin I (NPTX1, marker 13580), neuronal pentraxin receptor (NPTXR, marker 13581), neuronal pentraxin receptor (NPTXR, marker 13582), neuropeptide VF precursor (NPVF, marker 13583) , neuropeptide W (NPW, marker 13584), neuropeptide Y (NPY, marker 13585), neuropeptide Y receptor Y2 (NPY2R, marker 13586), neuropeptide Y receptor Y2 (NPY2R, marker 13587), neuropeptide Y receptor Y5 (NPY5R, marker 13588) ), neuropeptide Y receptor Y6 (pseudogene) (NPY6R, marker 13589), neuropeptide Y receptor Y6 (pseudogene) (NPY6R, marker 13590), nuclear receptor subfamily 0, group B, member 1 (NR0B1, marker 13591), nuclear receptor subfamily 0, group B, member 1(NR0B1, marker 13592),nuclear receptor subfamily 0, group B, member 2(NR0B2,marker 13593),nuclear receptor subfamily 1, group D, member 1 /// thyroid hormone receptor, alpha( NR1D1 /// THRA, marker 13594), nuclear receptor subfamily 1, group D, member 1 /// thyroid hormone receptor, alpha(NR1D1 /// THRA, marker 13595), nuclear receptor subfamily 1, group H, member 4( NR1H4, marker 13596), nuclear receptor subfamily 1, group H, member 4(NR1H4, marker 13597), nuclear receptor subfamily 1, group H, member 4(NR1H4, marker 13598), nuclear receptor subfamily 1, group I, member 2 (NR1I2, marker 13599), nuclear receptor subfamily 1, group I, member 2(NR1I2, marker 13600), nuclear receptor subfamily 1, group I, member 3(NR1I3, marker 13601), nuclear receptor subfamily 1, group I, member 3 (NR1I3, marker 13602), nuclear receptor subfamily 2, group C, member 1 (NR2C1, marker 13603), nuclear receptor subfamily 2, group E, member 3 (NR2E3, marker 13604), nuclear receptor subfamily 2, group E, member 3 (NR2E3, marker 13605), NR2F1 antisense RNA 1 (NR2F1-AS1, marker 13606), NR2F1 antisense RNA 1 (NR2F1-AS1, marker 13607), NR2F2 antisense RNA 1 (NR2F2-AS1, marker 13608), nuclear receptor subfamily 2, group F, member 6(NR2F6, marker 13609),nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)(NR3C1, marker 13610),nuclear receptor subfamily 3, group C, member 2(NR3C2, marker 13611),nuclear receptor subfamily 4, group A, member 1(NR4A1, marker 13612),nuclear receptor subfamily 4, group A, member 1(NR4A1,marker 13613),nuclear receptor subfamily 4, group A, member 2(NR4A2, marker 13614), nuclear receptor subfamily 4, group A, member 2(NR4A2, marker 13615), nuclear receptor subfamily 4, group A, member 2(NR4A2, marker 13616), nuclear receptor subfamily 4, group A, member 3(NR4A3 , marker 13617), nuclear receptor subfamily 4, group A, member 3(NR4A3, marker 13618), nuclear receptor subfamily 4, group A, member 3(NR4A3, marker 13619), nuclear receptor subfamily 5, group A, member 1( NR5A1, marker 13620), nuclear receptor subfamily 5, group A, member 2 (NR5A2, marker 13621), nebulin-related anchoring protein (NRAP, marker 13622), nebulin-related anchoring protein (NRAP, marker 13623), nebulin-related anchoring protein(NRAP, marker 13624),neuronal cell adhesion molecule(NRCAM,marker 13625),NRDE-2, necessary for RNA interference, domain containing(NRDE2,marker 13626),NRDE-2, necessary for RNA interference, domain containing( NRDE2, marker 13627), neuronal regeneration related protein (NREP, marker 13628), nuclear respiratory factor 1 (NRF1, marker 13629), nuclear respiratory factor 1 (NRF1, marker 13630), neurogulin 1 (NRG1, marker 13631), neurogulin 1 (NRG1, marker 13632), neuregulin 1(NRG1, marker 13633), neuregulin 1(NRG1, marker 13634), neuregulin 1(NRG1, marker 13635), NRG1 intronic transcript 1(NRG1-IT1, marker 13636), neuregulin 2( NRG2, Marker 13637), Neuregulin 2(NRG2, Marker 13638), Neuregulin 2(NRG2, Marker 13639), Neuregulin 4(NRG4, Marker 13640), Neurogranin (protein kinase C substrate, RC3)(NRGN, Marker 13641), Nuclear receptor interacting protein 2 (NRIP2, marker 13642), neural retina leucine zipper (NRL, marker 13643), neural retina leucine zipper (NRL, marker 13644), neurotin 1 (NRN1, marker 13645), neuropilin 1 (NRP1, marker 13646) , neuropilin 1 (NRP1, marker 13647), neuropilin 2 (NRP2, marker 13648), neuropilin 2 (NRP2, marker 13649), negative regulator of reactive oxygen species (NRROS, marker 13650), neuronsin 1 (NRSN1, marker 13651), neurensin 2(NRSN2, marker 13652),neurturin(NRTN,marker 13653),neurexin 1(NRXN1,marker 13654),neurexin 1(NRXN1,marker 13655),neurexin 1(NRXN1,marker 13656),neurexin 2(NRXN2,marker) 13657), neuroxin 2 (NRXN2, marker 13658), neuroxin 3 (NRXN3, marker 13659), neuroxin 3 (NRXN3, marker 13660), neuroxin 3 (NRXN3, marker 13661), nervous system abundant protein 11 (NSAP11, marker 13662) ,N-ethylmaleimide-sensitive factor(NSF, marker 13663),NSFL1 (p97) cofactor (p47)(NSFL1C, marker 13664),NSFL1 (p97) cofactor (p47)(NSFL1C, marker 13665),neutral sphingomyelinase activation associated factor( NSMAF, marker 13666), NSE4 homolog A, SMC5-SMC6 complex component (NSMCE4A, marker 13667), NMDA receptor synaptonuclear signaling and neuronal migration factor (NSMF, marker 13668), NOP2/Sun domain family, member 3 (NSUN3, marker 13669) ),NOP2/Sun domain family, member 3(NSUN3, marker 13670),NOP2/Sun domain family, member 4(NSUN4, marker 13671),NOP2/Sun domain family, member 7(NSUN7, marker 13672),5'- nucleotidase, cytosolic IA(NT5C1A, marker 13673),5'-nucleotidase, cytosolic IB(NT5C1B, marker 13674),5'-nucleotidase, cytosolic IB(NT5C1B, marker 13675),5'-nucleotidase domain containing 1(NT5DC1, marker 13676),5-nucleotidase domain containing 2(NT5DC2, marker 13677),5-nucleotidase domain containing 2(NT5DC2, marker 13678),5'-nucleotidase domain containing 3(NT5DC3, marker 13679),5'-nucleotidase domain containing 4 (NT5DC4, marker 13680),5'-nucleotidase domain containing 4(NT5DC4, marker 13681),5'-nucleotidase domain containing 4(NT5DC4, marker 13682),5'-nucleotidase, ecto (CD73)(NT5E, marker 13683) ,5'-nucleotidase, ecto (CD73)(NT5E, marker 13684),5'-nucleotidase, ecto (CD73)(NT5E, marker 13685),5',3'-nucleotidase, mitochondrial(NT5M, marker 13686),neurotrophin 4 (NTF4, marker 13687), neurotrimin (NTM, marker 13688), N-terminal Xaa-Pro-Lys N-methyltransferase 1 (NTMT1, marker 13689), netrin 1 (NTN1, marker 13690), netrin 3 (NTN3, marker 13691), netrin 5 (NTN5, marker 13692), netrin 5 (NTN5, marker 13693), netrin G1 (NTNG1, marker 13694), netrin G1 (NTNG1, marker 13695), netrin G1 (NTNG1, marker 13696), netrin G2 (NTNG2, marker 13697), nucleoside-triphosphatase, cancer-related(NTPCR, marker 13698), neurotrophic tyrosine kinase, receptor, type 1(NTRK1, marker 13699), neurotrophic tyrosine kinase, receptor, type 2(NTRK2, marker 13700)
,neurotrophic tyrosine kinase, receptor, type 2(NTRK2,marker 13701),neurotrophic tyrosine kinase, receptor, type 2(NTRK2,marker 13702),neurotrophic tyrosine kinase, receptor, type 2(NTRK2,marker 13703),neurotrophic tyrosine kinase, receptor, type 2(NTRK2, marker 13704),neurotrophic tyrosine kinase, receptor, type 2(NTRK2, marker 13705),neurotrophic tyrosine kinase, receptor, type 3(NTRK3, marker 13706),neurotrophic tyrosine kinase, receptor, type 3( NTRK3, marker 13707), neurotrophic tyrosine kinase, receptor, type 3(NTRK3, marker 13708), neurotrophic tyrosine kinase, receptor, type 3(NTRK3, marker 13709), neurotrophic tyrosine kinase, receptor, type 3(NTRK3, marker 13710) ,neurotrophic tyrosine kinase, receptor, type 3(NTRK3,marker 13711),neurotrophic tyrosine kinase, receptor, type 3(NTRK3,marker 13712),neurotrophic tyrosine kinase, receptor, type 3(NTRK3,marker 13713),neurotrophic tyrosine kinase, receptor, type 3 (NTRK3, marker 13714), NTRK3 antisense RNA 1 (NTRK3-AS1, marker 13715), neurotensin receptor 1 (high affinity) (NTSR1, marker 13716), neurotensin receptor 2 (NTSR2, marker 13717), negative regulator of ubiquitin-like proteins 1(NUB1, marker 13718), negative regulator of ubiquitin-like proteins 1(NUB1, marker 13719), negative regulator of ubiquitin-like proteins 1(NUB1, marker 13720), nudC nuclear distribution protein(NUDC, marker 13721),NudC domain containing 2(NUDCD2,marker 13722),NudC domain containing 3(NUDCD3,marker 13723),NudC domain containing 3(NUDCD3,marker 13724),nudix hydrolase 12(NUDT12,marker 13725),nudix hydrolase 14 (NUDT14, marker 13726), nudix hydrolase 16 (NUDT16, marker 13727), nudix hydrolase 16 (NUDT16, marker 13728), nudix hydrolase 16 pseudogene 1 (NUDT16P1, marker 13729), nudix hydrolase 17 (NUDT17, marker 13730), nudix hydrolase 18 (NUDT18, marker 13731), nudix hydrolase 22 (NUDT22, marker 13732), nudix hydrolase 3 (NUDT3, marker 13733), nudix hydrolase 4 (NUDT4, marker 13734), nudix hydrolase 4 (NUDT4, marker 13735), nudix hydrolase 4 (NUDT4, marker 13736), nudix hydrolase 7 (NUDT7, marker 13737), nudix hydrolase 9 pseudogene 1 (NUDT9P1, marker 13738), nuclear mitotic apparatus protein 1 (NUMA1, marker 13739), nuclear mitotic apparatus protein 1 (NUMA1) , marker 13740), nuclear mitotic apparatus protein 1 (NUMA1, marker 13741), numb homolog (Drosophila)-like (NUMBL, marker 13742), nucleoporin 153kDa (NUP153, marker 13743), nucleoporin 188kDa (NUP188, marker 13744), nucleoporin 210kDa like (NUP210L, marker 13745), nucleoporin 210kDa pseudogene 1 (NUP210P1, marker 13746), nucleoporin 214kDa (NUP214, marker 13747), nucleoporin 50kDa (NUP50, marker 13748), nucleoporin 50kDa (NUP50, marker 13749),NUP50 antisense RNA 1 (head to head) (NUP50-AS1, marker 13750), nucleoporin 54kDa (NUP54, marker 13751), nucleoporin 54kDa (NUP54, marker 13752), nucleoporin 62kDa (NUP62, marker 13753), nucleoporin 62kDa C-terminal like (NUP62CL) , marker 13754), nucleoporin 88kDa (NUP88, marker 13755), nucleoporin 93kDa (NUP93, marker 13756), nuclear protein 1, transcriptional regulator (NUPR1, marker 13757), NUT midline carcinoma, family member 1 (NUTM1, marker 13758), NUT midline carcinoma, family member 1(NUTM1, marker 13759),NUT family member 2A /// NUT family member 2B /// NUT family member 2D /// NUT family member 2E(NUTM2A /// NUTM2B /// NUTM2D / // NUTM2E, marker 13760),NUT family member 2B(NUTM2B, marker 13761),NUT family member 2F(NUTM2F, marker 13762),NACHT and WD repeat domain containing 2(NWD2, marker 13763),nuclear RNA export factor 2 / // nuclear RNA export factor 2B(NXF2 /// NXF2B, marker 13764),nuclear RNA export factor 2 /// nuclear RNA export factor 2B(NXF2 /// NXF2B, marker 13765),nuclear RNA export factor 2 /// nuclear RNA export factor 2B(NXF2 /// NXF2B, marker 13766),nuclear RNA export factor 3(NXF3,marker 13767),nuclear RNA export factor 3(NXF3,marker 13768),nuclear RNA export factor 5(NXF5,marker 13769 ),nucleoredoxin-like 1(NXNL1,marker 13770),nucleoredoxin-like 2(NXNL2,marker 13771),neurexophilin and PC-esterase domain family, member 1(NXPE1,marker 13772),neurexophilin and PC-esterase domain family, member 1 (NXPE1, marker 13773), neuroxophilin and PC-esterase domain family, member 4 (NXPE4, marker 13774), neuroxophilin 1 (NXPH1, marker 13775), neuroxophilin 2 (NXPH2, marker 13776), neuroxophilin 2 (NXPH2, marker 13777) ), neuroxophilin 3 (NXPH3, marker 13778), neuroxophilin 4 (NXPH4, marker 13779), neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2 (NYAP2, marker 13780), nyctalopin (NYX, marker 13781), nyctalopin (NYX, Marker 13782), NADH dehydrogenase (ubiquinone) complex I, assembly factor 4(Ndufaf4, Marker 13783), out at first homolog(OAF, Marker 13784), out at first homolog(OAF, Marker 13785), 2'-5'- oligoadenylate synthetase 1(OAS1, marker 13786),2'-5'-oligoadenylate synthetase 1(OAS1, marker 13787),2'-5'-oligoadenylate synthetase 2(OAS2, marker 13788),2'-5'-oligoadenylate synthetase 2(OAS2, marker 13789),2'-5'-oligoadenylate synthetase 2(OAS2, marker 13790),2'-5'-oligoadenylate synthetase 2 /// 2'-5'-oligoadenylate synthetase 3(OAS2 /// OAS3, marker 13791),2'-5'-oligoadenylate synthetase 3(OAS3, marker 13792),2'-5'-oligoadenylate synthetase-like(OASL, marker 13793),2'-5'-oligoadenylate synthetase-like( OASL, marker 13794), ornithine decarboxylase antizyme 3(OAZ3, marker 13795), ornithine decarboxylase antizyme 3(OAZ3, marker 13796), oligonucleotide/oligosaccharide-binding fold containing 1(OBFC1, marker 13797), oligonucleotide/oligosaccharide-binding fold containing 1 (OBFC1, marker 13798), odorant binding protein 2A (OBP2A, marker 13799), odorant binding protein 2A (OBP2A, marker 13800), odorant binding protein 2A (OBP2A, marker 13801), odorant binding protein 2A /// odorant binding protein 2B(OBP2A /// OBP2B, marker 13802), odorant binding protein 2A /// odorant binding protein 2B(OBP2A /// OBP2B, marker 13803), odorant binding protein 2B(OBP2B, marker 13804), obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF(OBSCN, marker 13805), obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF(OBSCN, marker 13806), obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF(OBSCN, marker 13807), obscurin, cytoskeletal calmodulin and titin -interacting RhoGEF(OBSCN, marker 13808), obscurin-like 1(OBSL1, marker 13809), obscurin-like 1(OBSL1, marker 13810), oculocutaneous albinism II(OCA2, marker 13811), oculomedin(OCLM, marker 13812), oncomodulin 2 (OCM2, marker 13813), ovarian cancer-related protein 1 (OCR1, marker 13814), odontogenic, ameloblast asssassociated (ODAM, marker 13815), outer dense fiber of sperm tails 1 (ODF1, marker 13816), outer dense fiber of sperm tails 2-like(ODF2L, marker 13817),outer dense fiber of sperm tails 2-like(ODF2L,marker 13818),outer dense fiber of sperm tails 3(ODF3,marker 13819),outer dense fiber of sperm tails 3 (ODF3, marker 13820), outer dense fiber of sperm tails 3B(ODF3B, marker 13821), outer dense fiber of sperm tails 3B(ODF3B, marker 13822), outer dense fiber of sperm tails 3B(ODF3B, marker 13823), outer dense fiber of sperm tails 3B(ODF3B, marker 13824),outer dense fiber of sperm tails 3B(ODF3B,marker 13825),outer dense fiber of sperm tails 3-like 1(ODF3L1,marker 13826),outer dense fiber of sperm tails 3-like 2(ODF3L2, marker 13827), outer dense fiber of sperm tails 4(ODF4, marker 13828), outer dense fiber of sperm tails 4(ODF4, marker 13829), orofacial cleft 1 candidate 1(OFCC1, marker 13830) ,orofacial cleft 1 candidate 1(OFCC1, marker 13831),orofacial cleft 1 candidate 1(OFCC1,marker 13832),orofacial cleft 1 candidate 1(OFCC1,marker 13833),orofacial cleft 1 candidate 1(OFCC1,marker 13834),orofacial cleft 1 candidate 1(OFCC1, marker 13835),orofacial cleft 1 candidate 1(OFCC1,marker 13836),orofacial cleft 1 candidate 1(OFCC1,marker 13837),orofacial cleft 1 candidate 1(OFCC1,marker 13838),orofacial cleft 1 candidate 1(OFCC1, marker 13839),OFD1 pseudogene 6, Y-linked /// testis-specific transcript, Y-linked 9A (non-protein coding) /// testis-specific transcript, Y-linked 9B (non-protein coding)(OFD1P6Y /// TTTY9A /// TTTY9B, marker 13840),2-oxoglutarate and iron-dependent oxygenase domain containing 1(OGFOD1, marker 13841),opioid growth factor receptor pseudogene 1(OGFRP1, marker 13842),8- oxoguanine DNA glycosylase (OGG1, marker 13843), osteoglycin (OGN, marker 13844), osteoglycin (OGN, marker 13845), O-linked N-acetylglucosamine (GlcNAc) transferase (OGT, marker 13846), oncoprotein induced transcript 3 (OIT3, Marker 13847), OK/SW-CL.36 (OK/SW-CL.36, Marker 13848), OK/SW-CL.58 (OK/SW-CL.58, Marker 13849), Obg-like ATPase 1( OLA1, Marker 13850), oleoyl-ACP hydrolase (OLAH, Marker 13851), oleoyl-ACP hydrolase (OLAH, Marker 13852), oleoyl-ACP hydrolase (OLAH, Marker 13853), olfactomedin 1 (OLFM1, Marker 13854), olfactomedin 4 (OLFM4, marker 13855), olfactomedin family member 5, pseudogene /// ubiquilin-like(OLFM5P /// UBQLNL, marker 13856), olfactomedin like 1(OLFML1, marker 13857), oligodendrocyte transcription factor 1(OLIG1, marker 13858) , oligodendrocyte lineage transcription factor 2 (OLIG2, marker 13859), oligodendrocyte lineage transcription factor 2 (OLIG2, marker 13860), oligodendrocyte transcription factor 3 (OLIG3, marker 13861), oligodendrocyte maturation-associated long intergenic non-coding RNA (OLMALINC, marker 13862), oxidized low density lipoprotein (lectin-like) receptor 1 (OLR1, marker 13863), osteomodulin (OMD, marker 13864), osteomodulin (OMD, marker 13865), oligodendrocyte myelin glycoprotein (OMG, marker 13866), olfactory marker protein (OMP, marker 13867), one cut homeobox 1(ONECUT1, marker 13868), one cut homeobox 2(ONECUT2, marker 13869), one cut homeobox 2(ONECUT2, marker 13870), one cut homeobox 2(ONECUT2, marker 13871) ,one cut homeobox 2(ONECUT2, marker 13872),one cut homeobox 3(ONECUT3,marker 13873),oocyte expressed protein(OOEP,marker 13874),oocyte secreted protein 2(OOSP2,marker 13875),optic atrophy 1 (autosomal dominant )(OPA1, marker 13876), oligodendrocytic myelin paranodal and inner loop protein(OPALIN, marker 13877), opioid binding protein/cell adhesion molecule-like(OPCML, marker 13878), opioid binding protein/cell adhesion molecule-like(OPCML, Marker 13879), opsin 1 (cone pigments), long-wave-sensitive /// opsin 1 (cone pigments), medium-wave-sensitive /// opsin 1 (cone pigments), medium-wave-sensitive 2 /// opsin 1 (cone pigments), medium-wave-sensitive 3(OPN1LW /// OPN1MW //
/ OPN1MW2 /// OPN1MW3, marker 13880), opsin 1 (cone pigments), short-wave-sensitive(OPN1SW, marker 13881), opsin 4 (OPN4, marker 13882), opsin 5 (OPN5, marker 13883), opsin 5 (OPN5, marker 13884), opioid receptor, delta 1(OPRD1, marker 13885), opioid receptor, delta 1(OPRD1, marker 13886), opioid receptor, kappa 1(OPRK1, marker 13887), opioid receptor, kappa 1(OPRK1 , marker 13888), opiate receptor-like 1(OPRL1, marker 13889), opiate receptor-like 1(OPRL1, marker 13890), opioid receptor, mu 1(OPRM1, marker 13891), opioid receptor, mu 1(OPRM1, marker 13892), opioid receptor, mu 1(OPRM1, marker 13893), opticin(OPTC, marker 13894), olfactory receptor, family 10, subfamily A, member 3(OR10A3, marker 13895), olfactory receptor, family 10, subfamily A, member 3(OR10A3, marker 13896), olfactory receptor, family 10, subfamily A, member 4(OR10A4, marker 13897), olfactory receptor, family 10, subfamily A, member 5(OR10A5, marker 13898), olfactory receptor, family 10 , subfamily C, member 1 (gene/pseudogene)(OR10C1, marker 13899), olfactory receptor, family 10, subfamily D, member 1 pseudogene(OR10D1P, marker 13900), olfactory receptor, family 10, subfamily D, member 1 pseudogene( OR10D1P, marker 13901), olfactory receptor, family 10, subfamily D, member 3 (non-functional)(OR10D3, marker 13902), olfactory receptor, family 10, subfamily D, member 3 (non-functional)(OR10D3, marker 13903 ),olfactory receptor, family 10, subfamily H, member 1(OR10H1,marker 13904),olfactory receptor, family 10, subfamily H, member 2(OR10H2,marker 13905),olfactory receptor, family 10, subfamily H, member 3( OR10H3, marker 13906), olfactory receptor, family 10, subfamily J, member 1(OR10J1, marker 13907), olfactory receptor, family 11, subfamily A, member 1(OR11A1, marker 13908), olfactory receptor, family 12, subfamily D , member 2 (gene/pseudogene)(OR12D2, marker 13909), olfactory receptor, family 12, subfamily D, member 3(OR12D3, marker 13910), olfactory receptor, family 12, subfamily D, member 3 /// olfactory receptor, family 5, subfamily V, member 1(OR12D3 /// OR5V1, marker 13911), olfactory receptor, family 13, subfamily C, member 4(OR13C4, marker 13912), olfactory receptor, family 13, subfamily C, member 4(OR13C4 ,marker 13913),olfactory receptor, family 14, subfamily J, member 1(OR14J1,marker 13914),olfactory receptor, family 1, subfamily A, member 1(OR1A1,marker 13915),olfactory receptor, family 1, subfamily A, member 2(OR1A2, marker 13916), olfactory receptor, family 1, subfamily C, member 1(OR1C1, marker 13917), olfactory receptor, family 1, subfamily C, member 1(OR1C1, marker 13918), olfactory receptor, family 1 , subfamily D, member 2(OR1D2,marker 13919),olfactory receptor, family 1, subfamily D, member 5(OR1D5,marker 13920),olfactory receptor, family 1, subfamily E, member 1(OR1E1,marker 13921),olfactory receptor, family 1, subfamily E, member 1 /// olfactory receptor, family 1, subfamily E, member 2(OR1E1 /// OR1E2, marker 13922), olfactory receptor, family 1, subfamily E, member 3 (gene/pseudogene )(OR1E3, marker 13923), olfactory receptor, family 1, subfamily F, member 1(OR1F1, marker 13924), olfactory receptor, family 1, subfamily F, member 2, pseudogene(OR1F2P, marker 13925), olfactory receptor, family 1, subfamily G, member 1(OR1G1, marker 13926), olfactory receptor, family 1, subfamily I, member 1(OR1I1, marker 13927), olfactory receptor, family 1, subfamily J, member 2(OR1J2, marker 13928), olfactory receptor, family 1, subfamily J, member 2(OR1J2, marker 13929),olfactory receptor, family 1, subfamily J, member 4(OR1J4, marker 13930),olfactory receptor, family 1, subfamily J, member 4(OR1J4, marker 13931), olfactory receptor, family 1, subfamily Q, member 1(OR1Q1, marker 13932), olfactory receptor, family 1, subfamily Q, member 1(OR1Q1, marker 13933), olfactory receptor, family 1, subfamily R, member 1 pseudogene(OR1R1P, marker 13934), olfactory receptor, family 2, subfamily A, member 4(OR2A4, marker 13935), olfactory receptor, family 2, subfamily B, member 2(OR2B2, marker 13936), olfactory receptor, family 2 , subfamily B, member 3(OR2B3,marker 13937),olfactory receptor, family 2, subfamily B, member 6(OR2B6,marker 13938),olfactory receptor, family 2, subfamily C, member 1(OR2C1,marker 13939),olfactory receptor, family 2, subfamily C, member 3(OR2C3, marker 13940),olfactory receptor, family 2, subfamily F, member 1 (gene/pseudogene)(OR2F1, marker 13941),olfactory receptor, family 2, subfamily F, member 1 (gene/pseudogene) /// olfactory receptor, family 2, subfamily F, member 2(OR2F1 /// OR2F2, marker 13942), olfactory receptor, family 2, subfamily F, member 2(OR2F2, marker 13943), olfactory receptor, family 2, subfamily H, member 1(OR2H1, marker 13944),olfactory receptor, family 2, subfamily H, member 1(OR2H1, marker 13945),olfactory receptor, family 2, subfamily H, member 1(OR2H1, marker 13946),olfactory receptor, family 2, subfamily H, member 1(OR2H1,marker 13947),olfactory receptor, family 2, subfamily H, member 1(OR2H1,marker 13948),olfactory receptor, family 2, subfamily H, member 2 (OR2H2, marker 13949), olfactory receptor, family 2, subfamily H, member 2(OR2H2, marker 13950), olfactory receptor, family 2, subfamily H, member 4 pseudogene(OR2H4P, marker 13951), olfactory receptor, family 2, subfamily I, member 1 pseudogene(OR2I1P, marker 13952), olfactory receptor, family 2, subfamily J, member 1 (gene/pseudogene) /// olfactory receptor, family 2, subfamily J, member 2(OR2J1 /// OR2J2, marker 13953), olfactory receptor, family 2, subfamily J, member 2(OR2J2, marker 13954), olfactory receptor, family 2, subfamily J, member 3(OR2J3, marker 13955), olfactory receptor, family 2, subfamily K, member 2(OR2K2, marker 13956), olfactory receptor, family 2, subfamily K, member 2(OR2K2, marker 13957), olfactory receptor, family 2, subfamily L, member 13(OR2L13, marker 13958), olfactory receptor, family 2, subfamily L, member 1 pseudogene(OR2L1P, marker 13959), olfactory receptor, family 2, subfamily L, member 1 pseudogene(OR2L1P, marker 13960), olfactory receptor, family 2, subfamily L, member 2(OR2L2, marker 13961), olfactory receptor, family 2, subfamily L, member 2(OR2L2, marker 13962),olfactory receptor, family 2, subfamily L, member 2(OR2L2, marker 13963),olfactory receptor, family 2, subfamily M, member 4(OR2M4, marker 13964), olfactory receptor, family 2, subfamily M, member 4(OR2M4, marker 13965), olfactory receptor, family 2, subfamily S, member 2 (gene/pseudogene)(OR2S2, marker 13966), olfactory receptor, family 2 , subfamily W, member 1(OR2W1,marker 13967),olfactory receptor, family 3, subfamily A, member 1(OR3A1,marker 13968),olfactory receptor, family 3, subfamily A, member 2(OR3A2,marker 13969),olfactory receptor, family 3, subfamily A, member 3(OR3A3, marker 13970),olfactory receptor, family 4, subfamily A, member 1 pseudogene(OR4A1P, marker 13971),olfactory receptor, family 4, subfamily C, member 1 pseudogene(OR4C1P ,marker 13972),olfactory receptor, family 4, subfamily D, member 1(OR4D1,marker 13973),olfactory receptor, family 4, subfamily D, member 1(OR4D1,marker 13974),olfactory receptor, family 4, subfamily D, member 2(OR4D2, marker 13975), olfactory receptor, family 4, subfamily F, member 16 /// olfactory receptor, family 4, subfamily F, member 21 /// olfactory receptor, family 4, subfamily F, member 29 // / olfactory receptor, family 4, subfamily F, member 3 /// olfactory receptor, family 4, subfamily F, member 8 pseudogene(OR4F16 /// OR4F21 /// OR4F29 /// OR4F3 /// OR4F8P, marker 13976), olfactory receptor, family 51, subfamily A, member 10 pseudogene(OR51A10P, marker 13977),olfactory receptor, family 51, subfamily A, member 1 pseudogene(OR51A1P, marker 13978),olfactory receptor, family 51, subfamily B, member 2 ( gene/pseudogene)(OR51B2, marker 13979), olfactory receptor, family 51, subfamily B, member 4(OR51B4, marker 13980), olfactory receptor, family 51, subfamily B, member 5(OR51B5, marker 13981), olfactory receptor, family 51, subfamily B, member 5(OR51B5, marker 13982), olfactory receptor, family 51, subfamily B, member 6(OR51B6, marker 13983), olfactory receptor, family 51, subfamily E, member 1(OR51E1, marker 13984) ,olfactory receptor, family 51, subfamily E, member 2(OR51E2,marker 13985),olfactory receptor, family 51, subfamily E, member 2(OR51E2,marker 13986),olfactory receptor, family 51, subfamily E, member 2(OR51E2 ,marker 13987),olfactory receptor, family 51, subfamily I, member 1(OR51I1,marker 13988),olfactory receptor, family 51, subfamily I, member 2(OR51I2,marker 13989),olfactory receptor, family 51, subfamily J, member 1 (gene/pseudogene)(OR51J1, marker 13990), olfactory receptor, family 51, subfamily M, member 1(OR51M1, marker 13991), olfactory receptor, family 52, subfamily A, member 1(OR52A1, marker 13992), olfactory receptor, family 52, subfamily D, member 1(OR52D1, marker 13993),olfactory receptor, family 52, subfamily K, member 3 pseudogene(OR52K3P, marker 13994),olfactory receptor, family 5, subfamily AK, member 4 pseudogene( OR5AK4P, marker 13995), olfactory receptor, family 5, subfamily AK, member 4 pseudogene(OR5AK4P, marker 13996), olfactory receptor, family 5, subfamily E, member 1 pseudogene(OR5E1P, marker 13997), olfactory receptor, family 5, subfamily G, member 1 pseudogene(OR5G1P, marker 13998),olfactory receptor, family 5, subfamily H, member 1(OR5H1,marker 13999),olfactory receptor, family 5, subfamily H, member 1(OR5H1,marker 14000),olfactory receptor, family 5, subfamily I, member 1(OR5I1, marker 14001),olfactory receptor, family 5, subfamily J, member 2(OR5J2, marker 14002),olfactory receptor, family 5, subfamily J, member 2(OR5J2, marker 14003),olfactory receptor, family 5, subfamily K, member 1(OR5K1,marker 14004),olfactory receptor, family 5, subfamily L, member 2(OR5L2,marker 14005),olfactory receptor, family 5, subfamily L, member 2 (OR5L2, marker 14006), olfactory receptor, family 5, subfamily P, member 2(OR5P2, marker 14007), olfactory receptor, family 5, subfamily P, member 3(OR5P3, marker 14008), olfactory receptor, family 5, subfamily V, member 1(OR5V1, marker 14009), olfactory receptor, family 6, subfamily A, member 2(OR6A2, marker 14010), olfactory receptor, family 6, subfamily B, member 1(OR6B1, marker 14011), olfactory receptor, family 6, subfamily C, member 4
/// T cell receptor alpha joining 41(OR6C4 /// TRAJ41, marker 14012), olfactory receptor, family 6, subfamily W, member 1 pseudogene(OR6W1P, marker 14013), olfactory receptor, family 7, subfamily A, member 10 (OR7A10, marker 14014), olfactory receptor, family 7, subfamily A, member 17(OR7A17, marker 14015), olfactory receptor, family 7, subfamily A, member 5(OR7A5, marker 14016), olfactory receptor, family 7, subfamily C, member 1(OR7C1, marker 14017), olfactory receptor, family 7, subfamily C, member 2(OR7C2, marker 14018), olfactory receptor, family 7, subfamily D, member 2(OR7D2, marker 14019), olfactory receptor, family 7, subfamily E, member 111 pseudogene(OR7E111P, marker 14020), olfactory receptor, family 7, subfamily E, member 19 pseudogene(OR7E19P, marker 14021), olfactory receptor, family 7, subfamily E, member 24(OR7E24, marker 14022),olfactory receptor, family 7, subfamily E, member 2 pseudogene(OR7E2P,marker 14023),olfactory receptor, family 7, subfamily E, member 47 pseudogene(OR7E47P,marker 14024),olfactory receptor, family 8, subfamily B, member 8(OR8B8, marker 14025), olfactory receptor, family 8, subfamily D, member 1(OR8D1, marker 14026), olfactory receptor, family 8, subfamily D, member 2 (gene/pseudogene)(OR8D2, marker 14027), olfactory receptor, family 8, subfamily G, member 1 (gene/pseudogene)(OR8G1, marker 14028),olfactory receptor, family 8, subfamily G, member 2(OR8G2, marker 14029),olfactory receptor, family 8, subfamily G, member 2(OR8G2, marker 14030), olfactory receptor, family 9, subfamily A, member 1 pseudogene(OR9A1P, marker 14031), olfactory receptor, family 9, subfamily A, member 1 pseudogene(OR9A1P, marker 14032), ORAI calcium release -activated calcium modulator 2(ORAI2, marker 14033), oral cancer overexpressed 1(ORAOV1, marker 14034), origin recognition complex subunit 5(ORC5, marker 14035), uncharacterized protein, clone pT-Adv JuaX22(ORF1, marker 14036), orosomucoid 1 (ORM1, marker 14037), orosomucoid 1 /// orosomucoid 2 (ORM1 /// ORM2, marker 14038), orosomucoid 1 /// orosomucoid 2 (ORM1 /// ORM2, marker 14039), oxysterol binding protein (OSBP) , marker 14040), oxysterol binding protein 2 (OSBP2, marker 14041), oxysterol binding protein 2 (OSBP2, marker 14042), oxysterol binding protein-like 10 (OSBPL10, marker 14043), oxysterol binding protein-like 10 (OSBPL10, marker 14044), oxysterol binding protein-like 1A (OSBPL1A, marker 14045), oxysterol binding protein-like 5 (OSBPL5, marker 14046), oxysterol binding protein-like 5 (OSBPL5, marker 14047), oxysterol binding protein-like 7 (OSBPL7) , marker 14048), oxysterol binding protein-like 7 (OSBPL7, marker 14049), osteoclast associated, immunoglobulin-like receptor (OSCAR, marker 14050), OSER1 antisense RNA 1 (head to head) (OSER1-AS1, marker 14051), OSER1 antisense RNA 1 (head to head) (OSER1-AS1, marker 14052), oxidative stress induced growth inhibitor 1 (OSGIN1, marker 14053), oxidative stress induced growth inhibitor family member 2 (OSGIN2, marker 14054), oxidative stress induced growth inhibitor inhibitor family member 2 (OSGIN2, marker 14055), oncostatin M (OSM, marker 14056), oncostatin M (OSM, marker 14057), oncostatin M receptor (OSMR, marker 14058), odd-skipped related transciption factor 1 (OSR1, marker 14059), odd-skipped related transciption factor 2 (OSR2, marker 14060), oligosaccharyltransferase complex subunit pseudogene 1 (OSTCP1, marker 14061), osteopetrosis associated transmembrane protein 1 (OSTM1, marker 14062), OSTM1 antisense RNA 1 (OSTM1-AS1, marker 14063), ornithine carbamoyltransferase (OTC, marker 14064), otoferlin (OTOF, marker 14065), otoferlin (OTOF, marker 14066), otogelin-like (OTOGL, marker 14067), otopetrin 2 (OTOP2, marker 14068), otopetrin 2 (OTOP2, marker 14069), otoraplin (OTOR, marker 14070), otospiralin (OTOS, marker 14071), orthopedia homeobox (OTP, marker 14072), orthopedia homeobox (OTP, marker 14073), OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) ,marker 14074),OTU deubiquitinase, ubiquitin aldehyde binding 2(OTUB2,marker 14075),OTU deubiquitinase, ubiquitin aldehyde binding 2(OTUB2,marker 14076),OTU deubiquitinase 1(OTUD1,marker 14077),OTU deubiquitinase 4(OTUD4,marker 14078),OTU deubiquitinase 7A(OTUD7A, marker 14079),OTU deubiquitinase 7A(OTUD7A,marker 14080),OTU deubiquitinase 7A(OTUD7A,marker 14081),OTU deubiquitinase 7B(OTUD7B,marker 14082),OTU deubiquitinase with linear linkage specificity( OTULIN, marker 14083), OTX2 antisense RNA 1 (head to head)(OTX2-AS1, marker 14084), ovarian adenocarcinoma amplified long non-coding RNA (OVAAL, marker 14085), OVCH1 antisense RNA 1 (OVCH1-AS1, marker 14086) ), oviductal glycoprotein 1 (OVGP1, marker 14087), ovo-like zinc finger 1 (OVOL1, marker 14088), OVOL1 antisense RNA 1 (OVOL1-AS1, marker 14089), ovo-like zinc finger 2 (OVOL2, marker 14090) , ovo-like zinc finger 3 (OVOL3, marker 14091), 3-oxoacid CoA-transferase 2 (OXCT2, marker 14092), oxoglutarate (alpha-ketoglutarate) receptor 1 (OXGR1, marker 14093), oxidation resistance 1 (OXR1, marker 14094),oxytocin/neurophysin I prepropeptide(OXT, marker 14095),purinergic receptor P2X, ligand gated ion channel, 1(P2RX1, marker 14096),purinergic receptor P2X, ligand gated ion channel, 2(P2RX2, marker 14097),purinergic receptor P2X, ligand gated ion channel, 2(P2RX2, marker 14098),purinergic receptor P2X, ligand gated ion channel, 2(P2RX2, marker 14099),purinergic receptor P2X, ligand gated ion channel, 2(P2RX2, marker 14100), purinergic receptor P2X, ligand gated ion channel, 3(P2RX3, marker 14101),purinergic receptor P2X, ligand gated ion channel, 6(P2RX6, marker 14102),purinergic receptor P2X, ligand gated ion channel, 6(P2RX6, marker 14103) ,purinergic receptor P2X, ligand gated ion channel, 7(P2RX7, marker 14104),purinergic receptor P2X, ligand gated ion channel, 7(P2RX7, marker 14105),purinergic receptor P2Y, G-protein coupled, 1(P2RY1, marker 14106 ),purinergic receptor P2Y, G-protein coupled, 10(P2RY10,marker 14107),purinergic receptor P2Y, G-protein coupled, 10(P2RY10,marker 14108),purinergic receptor P2Y, G-protein coupled, 10(P2RY10,marker 14109),purinergic receptor P2Y, G-protein coupled, 11 /// PPAN-P2RY11 readthrough(P2RY11 /// PPAN-P2RY11, marker 14110),purinergic receptor P2Y, G-protein coupled, 12(P2RY12, marker 14111), purinergic receptor P2Y, G-protein coupled, 12(P2RY12, marker 14112),purinergic receptor P2Y, G-protein coupled, 13(P2RY13, marker 14113),purinergic receptor P2Y, G-protein coupled, 14(P2RY14, marker 14114) ,purinergic receptor P2Y, G-protein coupled, 2(P2RY2, marker 14115),pyrimidinergic receptor P2Y, G-protein coupled, 4(P2RY4, marker 14116),pyrimidinergic receptor P2Y, G-protein coupled, 6(P2RY6, marker 14117) ), purinergic receptor P2Y, G-protein coupled, 8(P2RY8, marker 14118), prolyl 3-hydroxylase 2(P3H2, marker 14119), prolyl 4-hydroxylase, alpha polypeptide II(P4HA2, marker 14120), prolyl 4-hydroxylase , alpha polypeptide III(P4HA3, marker 14121),prolyl 4-hydroxylase, alpha polypeptide III(P4HA3, marker 14122),poly(A) binding protein, cytoplasmic 1(PABPC1, marker 14123),poly(A) binding protein, cytoplasmic 1-like (PABPC1L, marker 14124), poly(A) binding protein, cytoplasmic 1-like (PABPC1L, marker 14125), poly(A) binding protein, cytoplasmic 5 (PABPC5, marker 14126), PARK2 co-regulated (PACRG , marker 14127), PARK2 co-regulated (PACRG, marker 14128), PARK2 co-regulated (PACRG, marker 14129), PACRG antisense RNA 1 (PACRG-AS1, marker 14130), PACRG antisense RNA 2 (PACRG-AS2, marker 14131), PACRG antisense RNA 2 (PACRG-AS2, marker 14132), PACRG antisense RNA 3 (PACRG-AS3, marker 14133), PARK2 co-regulated like (PACRGL, marker 14134), phosphofurin acidic cluster sorting protein 1 (PACS1, marker 14135), protein kinase C and casein kinase substrate in neurons 1 (PACSIN1, marker 14136), protein kinase C and casein kinase substrate in neurons 2 (PACSIN2, marker 14137), peptidyl arginine deiminase, type I (PADI1, marker 14138) , peptidyl arginine deiminase, type II (PADI2, marker 14139), peptidyl arginine deiminase, type III (PADI3, marker 14140), peptidyl arginine deiminase, type IV (PADI4, marker 14141), peptidyl arginine deiminase, type IV (PADI4, marker 14142), peptidyl arginine deiminase, type IV (PADI4, marker 14143), progestagen-associated endometrial protein (PAEP, marker 14144), platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (30kDa) (PAFAH1B2, marker 14145), platelet- activating factor acetylhydrolase 2(PAFAH2, marker 14146),phosphoprotein membrane anchor with glycosphingolipid microdomains 1(PAG1, marker 14147),P antigen family, member 1 (prostate associated)(PAGE1, marker 14148),P antigen family, member 4 (prostate associated) (PAGE4, marker 14149), P antigen family, member 5 (prostate associated) (PAGE5, marker 14150), phenylalanine hydroxylase (PAH, marker 14151), phenylalanine hydroxylase (PAH, marker 14152), phenylalanine hydroxylase (PAH, marker 14152) 14153), phenylalanine hydroxylase (PAH, marker 14154), poly(A) binding protein interacting protein 2 (PAIP2, marker 14155), p21 protein (Cdc42/Rac)-activated kinase 2 (PAK2, marker 14156), p21 protein (Cdc42) /Rac)-activated kinase 4(PAK4, marker 14157),p21 protein (Cdc42/Rac)-activated kinase 7(PAK7, marker 14158),p21 protein (Cdc42/Rac)-activated kinase 7(PAK7, marker 14159), palladin, cytoskeletal associated protein (PALLD, marker 14160), paralemmin 2 /// PALM2-AKAP2 readthrough (PALM2 /// PALM2-AKAP2, marker 14161), palmdelphin (PALMD, marker 14162), palmdelphin (PALMD, marker 14163), palmdelphin (PALMD, marker 14164), PAN3 antisense RNA 1 (PAN3-AS1, marker 14165), pantothenate kinase 2 (PANK2, marker 14166), pantothenate kinase 2 (PANK2, marker 14167), pannexin 2 (PANX2, marker 14168), pannexin 2 (PANX2, marker 14169), pannexin 2 (PANX2, marker 14170), pannexin 3 (PANX3, marker 14171), polyamine oxidase (exo-N4-amino) (PAOX, marker 14172), polyamine oxidase (exo-N4- amino) (PAOX, marker 14173), papilin, proteoglycan-like sulfated glycoprotein (PAPLN, marker 14174), poly(A) polymerase beta (PAPOLB, marker 14175), poly(A) polymerase beta (PAPOLB, marker 14176), poly (A) polymerase gamma(PAPOLG, marker 14177),poly(A) polymerase gamma(PAPOLG, marker 14178),pregnancy-associated plasma protein A, pappalysin 1(PAPPA, marker 14179),pregnancy-associated plasma protein A, pappalysin 1 (PAPPA, marker 14180),pregnancy-associated plasma protein A, pappalysin 1(PAPPA, marker 14181),pregnancy-associated plasma protein A, pappalysin 1(PAPPA, marker 1418
2),pregnancy-associated plasma protein A, pappalysin 1 (PAPPA, marker 14183), pappalysin 2 (PAPPA2, marker 14184), pappalysin 2 (PAPPA2, marker 14185), progestin and adipoQ receptor family member III (PAQR3, marker 14186) , progestin and adipoQ receptor family member V (PAQR5, marker 14187), progestin and adipoQ receptor family member VI (PAQR6, marker 14188), progestin and adipoQ receptor family member IX (PAQR9, marker 14189), PARD3 antisense RNA 1 (PARD3- AS1, marker 14190), par-3 family cell polarity regulator beta (PARD3B, marker 14191), par-3 family cell polarity regulator beta (PARD3B, marker 14192), par-3 family cell polarity regulator beta (PARD3B, marker 14193) ,par-3 family cell polarity regulator beta(PARD3B, marker 14194),par-6 family cell polarity regulator beta(PARD6B,marker 14195),par-6 family cell polarity regulator gamma(PARD6G,marker 14196),PARD6G antisense RNA 1 (PARD6G-AS1, marker 14197), parkin RBR E3 ubiquitin protein ligase(PARK2, marker 14198), parkin RBR E3 ubiquitin protein ligase(PARK2, marker 14199), parkin RBR E3 ubiquitin protein ligase(PARK2, marker 14200), poly( ADP-ribose) polymerase family member 10(PARP10, marker 14201),poly(ADP-ribose) polymerase family member 10(PARP10, marker 14202),poly(ADP-ribose) polymerase family member 10(PARP10, marker 14203),poly (ADP-ribose) polymerase family member 11(PARP11, marker 14204),poly(ADP-ribose) polymerase family member 14(PARP14, marker 14205),poly(ADP-ribose) polymerase family member 15(PARP15, marker 14206), poly(ADP-ribose) polymerase family member 15 (PARP15, marker 14207), poly(ADP-ribose) polymerase family member 3 (PARP3, marker 14208), PARP1 binding protein (PARPBP, marker 14209), prostate androgen-regulated transcript 1 (non-protein coding)(PART1, marker 14210),prostate androgen-regulated transcript 1 (non-protein coding)(PART1, marker 14211),prostate androgen-regulated transcript 1 (non-protein coding)(PART1, marker 14212) ,promoter of MAT2A antisense radiation-induced circulating long non-coding RNA(PARTICL, marker 14213),parvin, alpha(PARVA,marker 14214),parvin, alpha(PARVA,marker 14215),parvin, beta(PARVB,marker 14216) ,parvin, beta(PARVB, marker 14217),parvin, gamma(PARVG,marker 14218),parvin, gamma(PARVG,marker 14219),parvin, gamma(PARVG,marker 14220),PAS domain containing 1(PASD1,marker 14221 ),prostate and testis expressed 1(PATE1, marker 14222),prostate and testis expressed 1(PATE1,marker 14223),prostate and testis expressed 2(PATE2,marker 14224),protein associated with topoisomerase II homolog 1 (yeast)(PATL1 , marker 14225), protein associated with topoisomerase II homolog 2 (yeast)(PATL2, marker 14226), POZ (BTB) and AT hook containing zinc finger 1(PATZ1, marker 14227), paired box 1(PAX1, marker 14228), paired box 1(PAX1, marker 14229),paired box 1(PAX1,marker 14230),paired box 2(PAX2,marker 14231),paired box 3(PAX3,marker 14232),paired box 3(PAX3,marker 14233), paired box 4(PAX4, marker 14234),paired box 4(PAX4,marker 14235),paired box 5(PAX5,marker 14236),paired box 5(PAX5,marker 14237),paired box 7(PAX7,marker 14238), paired box 8(PAX8, marker 14239),paired box 8(PAX8,marker 14240),paired box 8(PAX8,marker 14241),paired box 8(PAX8,marker 14242),paired box 8(PAX8,marker 14243), paired box 8(PAX8, marker 14244),paired box 8(PAX8, marker 14245),PAX8 antisense RNA 1(PAX8-AS1,marker 14246),PAX8 antisense RNA 1(PAX8-AS1,marker 14247),PAX8 antisense RNA 1 (PAX8-AS1, marker 14248),paired box 9(PAX9,marker 14249),paired box 9(PAX9,marker 14250),PAXBP1 antisense RNA 1(PAXBP1-AS1,marker 14251),PAXBP1 antisense RNA 1(PAXBP1-AS1 ,marker 14252),PAXIP1 antisense RNA 2(PAXIP1-AS2,marker 14253),PAXIP1 antisense RNA 2(PAXIP1-AS2,marker 14254),phenazine biosynthesis-like protein domain containing(PBLD,marker 14255),prostate and breast cancer overexpressed 1(PBOV1, marker 14256), prosstate and breast cancer overexpressed 1(PBOV1, marker 14257), polybromo 1(PBRM1, marker 14258), pre-B-cell leukemia homeobox 1(PBX1, marker 14259), pre-B-cell leukemia homeobox 4(PBX4,marker 14260),prostate cancer associated 3 (non-protein coding)(PCA3,marker 14261),prostate cancer associated 3 (non-protein coding)(PCA3,marker 14262),prostate cancer associated transcript 18 ( non-protein coding)(PCAT18, marker 14263),prostate cancer associated transcript 19 (non-protein coding)(PCAT19, marker 14264),prostate cancer associated transcript 4 (non-protein coding)(PCAT4, marker 14265),prostate cancer associated transcript 4 (non-protein coding)(PCAT4, marker 14266), pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2(PCBD2, marker 14267), PCBP1 antisense RNA 1(PCBP1- AS1, marker 14268), PCBP1 antisense RNA 1 (PCBP1-AS1, marker 14269), PCBP1 antisense RNA 1 (PCBP1-AS1, marker 14270), PCBP1 antisense RNA 1 (PCBP1-AS1, marker 14271), poly(rC) binding protein 2 (PCBP2, marker 14272), poly(rC) binding protein 3 (PCBP3, marker 14273), propionyl-CoA carboxylase alpha subunit (PCCA, marker 14274), propionyl-CoA carboxylase alpha subunit (PCCA, marker 14275), propionyl -CoA carboxylase beta subunit (PCCB, marker 14276), protocadherin 1 (PCDH1, marker 14277), protocadherin 10 (PCDH10, marker 14278), protocadherin 10 (PCDH10, marker 14279), protocadherin 10 (PCDH10, marker 14280), protocadherin 11 X-linked(PCDH11X, marker 14281), protocadherin 11 X-linked /// protocadherin 11 Y-linked(PCDH11X /// PCDH11Y, marker 14282), protocadherin 11 // PCDH11Y, marker 14283), protocadherin-related 15 (PCDH15, marker 14284), protocadherin-related 15 (PCDH15, marker 14285), protocadherin 20 (PCDH20, marker 14286), protocadherin 7 (PCDH7, marker 14287), protocadherin 9 (PCDH9, marker 14288), protocadherin 9 (PCDH9, marker 14289), protocadherin 9 (PCDH9, marker 14290), protocadherin alpha 10 (PCDHA10, marker 14291), protocadherin alpha 2 (PCDHA2, marker 14292), protocadherin alpha 2 // / protocadherin alpha 3(PCDHA2 /// PCDHA3, marker 14293), protocadherin alpha 3(PCDHA3, marker 14294), protocadherin alpha 5(PCDHA5, marker 14295), protocadherin alpha 6(PCDHA6, marker 14296), protocadherin alpha 9(PCDHA9 , marker 14297), protocadherin alpha subfamily C, 1 (PCDHAC1, marker 14298), protocadherin alpha subfamily C, 2 (PCDHAC2, marker 14299), protocadherin beta 1 (PCDHB1, marker 14300), protocadherin beta 11 (PCDHB11, marker 14301) , protocadherin beta 13 (PCDHB13, marker 14302), protocadherin beta 14 (PCDHB14, marker 14303), protocadherin beta 15 (PCDHB15, marker 14304), protocadherin beta 15 (PCDHB15, marker 14305), protocadherin beta 16 (PCDHB16, marker 14306) , protocadherin beta 17 pseudogene (PCDHB17P, marker 14307), protocadherin beta 18 pseudogene (PCDHB18P, marker 14308), protocadherin beta 2 (PCDHB2, marker 14309), protocadherin beta 3 (PCDHB3, marker 14310), protocadherin beta 4 (PCDHB4, marker 14311), protocadherin beta 4 (PCDHB4, marker 14312), protocadherin beta 6 (PCDHB6, marker 14313), protocadherin beta 6 (PCDHB6, marker 14314), protocadherin beta 7 (PCDHB7, marker 14315), protocadherin beta 8 (PCDHB8, marker 14316), protocadherin beta 9 (PCDHB9, marker 14317), protocadherin gamma subfamily A, 1 (PCDHGA1, marker 14318), protocadherin gamma subfamily A, 10 (PCDHGA10, marker 14319), protocadherin gamma subfamily A, 11 (PCDHGA11, marker 14320) ), protocadherin gamma subfamily A, 11(PCDHGA11, marker 14321), protocadherin gamma subfamily A, 3(PCDHGA3, marker 14322), protocadherin gamma subfamily A, 3(PCDHGA3, marker 14323), protocadherin gamma subfamily A, 4(PCDHGA4, marker 14324), protocadherin gamma subfamily A, 8(PCDHGA8, marker 14325), protocadherin gamma subfamily A, 9(PCDHGA9, marker 14326), protocadherin gamma subfamily B, 6(PCDHGB6, marker 14327), protocadherin gamma subfamily B, 7( PCDHGB7, marker 14328), protocadherin gamma subfamily B, 7 (PCDHGB7, marker 14329), protocadherin gamma subfamily C, 3 (PCDHGC3, marker 14330), protocadherin gamma subfamily C, 4 (PCDHGC4, marker 14331), protocadherin gamma subfamily C, 4(PCDHGC4, marker 14332), protocadherin gamma subfamily C, 5(PCDHGC5, marker 14333), protocadherin gamma subfamily C, 5(PCDHGC5, marker 14334), PC-esterase domain containing 1A(PCED1A, marker 14335), PCED1B antisense RNA 1 (PCED1B-AS1, marker 14336), PCF11 anstisense RNA 1 (PCF11-AS1, marker 14337), PCGEM1, prostate-specific transcript (non-protein coding) (PCGEM1, marker 14338), PCGEM1, prostate-specific transcript (non -protein coding) (PCGEM1, marker 14339), polycomb group ring finger 1 (PCGF1, marker 14340), polycomb group ring finger 5 (PCGF5, marker 14341), polycomb group ring finger 5 (PCGF5, marker 14342), phosphoenolpyruvate carboxykinase 1 (soluble)(PCK1, marker 14343), piccolo presynaptic cytomatrix protein(PCLO, marker 14344),piccolo presynaptic cytomatrix protein(PCLO, marker 14345),protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1(PCMTD1 , marker 14346), protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2 (PCMTD2, marker 14347), PEST proteolytic signal containing nuclear protein (PCNP, marker 14348), pecanex homolog (Drosophila) (PCNX, marker 14349), pecanex homolog (Drosophila) (PCNX, marker 14350), pecanex homolog (Drosophila) (PCNX, marker 14351), pecanex-like 2 (Drosophila) (PCNXL2, marker 14352), pecanex-like 4 (Drosophila) (PCNXL4) ,marker 14353),pecanex-like 4 (Drosophila)(PCNXL4,marker 14354),pecanex-like 4 (Drosophila)(PCNXL4,marker 14355),Purkinje cell protein 2(PCP2,marker 14356),Purkinje cell protein 2(PCP2 ,marker 14357),Purkinje cell protein 4(PCP4,marker 14358),Purkinje cell protein 4 like 1(PCP4L1,marker 14359),proprotein convertase subtilisin/kexin type 1(PCSK1,marker 14360),proprotein convertase subtilisin/kexin type 2 (PCSK2, marker 14361), proprotein convertase subtilisin/kexin type 2(PCSK2, marker 14362), proprotein convertase subtilisin/kexin type 6(PCSK6, marker 14363), proprotein convertase subtilisin/kexin type 6(PCSK6, marker 14364), proprotein convertase subtilisin/kexin type 6(PCSK6, marker 14365),proprotein convertase subtilisin/kexin type 6(PCSK6, marker 14366),proprotein convertase subtilisin/kexin type 6(PCSK6, marker 14367),proprotein convertase subtilisin/kexin type 6(PCSK6) , marker 14368), phosphate cytidylyltransferase 2, ethanolamine (PCYT2, marker 14369), PDGFA associated protein 1 (PDAP1, marker 14370), phosducin (PDC, marker 14371), programmed cell death 1 (PDCD1, marker
-14372), programmed cell death 1 ligand 2 (PDCD1LG2, marker 14373), programmed cell death 1 ligand 2 (PDCD1LG2, marker 14374), programmed cell death 4 (neoplastic transformation inhibitor) (PDCD4, marker 14375), programmed cell death 7 (PDCD7, Marker 14376), phosducin like 2 (PDCL2, Marker 14377), phosphodiesterase 10A (PDE10A, Marker 14378), phosphodiesterase 10A (PDE10A, Marker 14379), phosphodiesterase 11A (PDE11A, Marker 14380), phosphodiesterase 11A (PDE11A, Marker 14381), Phosphodiesterase 11a (PDE11A, marker 14382), Phosphodiesterase 11a (PDE11A, marker 14383), Phosphodiesterase 12 (PDE12, Marker 14384), PHOSPHOD IESTERASE 12 (PDE12, Marker 14385), Phosphodiesterase 1a, Calmodulin-Dependent (PDE1A, marker 14386 ),phosphodiesterase 1A, calmodulin-dependent(PDE1A, marker 14387),phosphodiesterase 1A, calmodulin-dependent(PDE1A, marker 14388),phosphodiesterase 1A, calmodulin-dependent(PDE1A, marker 14389),phosphodiesterase 1A, calmodulin-dependent(PDE1A, marker 14390), phosphodiesterase 1A, calmodulin-dependent(PDE1A, marker 14391),phosphodiesterase 1A, calmodulin-dependent(PDE1A, marker 14392),phosphodiesterase 1B, calmodulin-dependent(PDE1B, marker 14393),phosphodiesterase 1C, calmodulin-dependent 70kDa (PDE1C, marker 14394),phosphodiesterase 1C, calmodulin-dependent 70kDa(PDE1C, marker 14395),phosphodiesterase 1C, calmodulin-dependent 70kDa(PDE1C, marker 14396),phosphodiesterase 1C, calmodulin-dependent 70kDa(PDE1C, marker 14397),phosphodiesterase 1C, calmodulin-dependent 70kDa(PDE1C, marker 14398),phosphodiesterase 1C, calmodulin-dependent 70kDa(PDE1C, marker 14399),phosphodiesterase 3A, cGMP-inhibited(PDE3A, marker 14400),phosphodiesterase 3A, cGMP-inhibited(PDE3A, marker 14401),phosphodiesterase 4A, cAMP-specific(PDE4A, marker 14402),phosphodiesterase 4A, cAMP-specific(PDE4A, marker 14403),phosphodiesterase 4A, cAMP-specific(PDE4A, marker 14404),phosphodiesterase 4A, cAMP-specific(PDE4A ,marker 14405),phosphodiesterase 4B, cAMP-specific(PDE4B,marker 14406),phosphodiesterase 4D, cAMP-specific(PDE4D,marker 14407),phosphodiesterase 4D, cAMP-specific(PDE4D,marker 14408),phosphodiesterase 4D, cAMP-specific (PDE4D, marker 14409),phosphodiesterase 4D, cAMP-specific(PDE4D, marker 14410),phosphodiesterase 4D, cAMP-specific(PDE4D, marker 14411),phosphodiesterase 4D interacting protein(PDE4DIP, marker 14412),phosphodiesterase 4D interacting protein(PDE4DIP ,marker 14413),phosphodiesterase 4D interacting protein(PDE4DIP,marker 14414),phosphodiesterase 5A, cGMP-specific(PDE5A,marker 14415),phosphodiesterase 5A, cGMP-specific(PDE5A,marker 14416),phosphodiesterase 5A, cGMP-specific(PDE5A , marker 14417), phosphodiesterase 5A, cGMP-specific(PDE5A, marker 14418),phosphodiesterase 5A, cGMP-specific(PDE5A, marker 14419),phosphodiesterase 6A, cGMP-specific, rod, alpha(PDE6A, marker 14420),phosphodiesterase 6B , cGMP-specific, rod, beta(PDE6B, marker 14421),phosphodiesterase 6C, cGMP-specific, cone, alpha prime(PDE6C, marker 14422),phosphodiesterase 6H, cGMP-specific, cone, gamma(PDE6H, marker 14423), phosphodiesterase 7A (PDE7A, marker 14424), phosphodiesterase 7A (PDE7A, marker 14425), phosphodiesterase 7B (PDE7B, marker 14426), phosphodiesterase 7B (PDE7B, marker 14427), phosphodiesterase 7B (PDE7B, marker 14428), phosphodiesterase 8A (PDE8A, Marker 14429), phosphodiesterase 8A (PDE8A, Marker 14430), phosphodiesterase 8B (PDE8B, Marker 14431), phosphodiesterase 8B (PDE8B, Marker 14432), phosphodiesterase 8B (PDE8B, Marker 14433), phosphodiesterase 9A (PDE9A, Marker 14434), platelet -derived growth factor beta polypeptide (PDGFB, marker 14435), platelet-derived growth factor beta polypeptide (PDGFB, marker 14436), platelet derived growth factor D (PDGFD, marker 14437), platelet-derived growth factor receptor, alpha polypeptide (PDGFRA , marker 14438), platelet-derived growth factor receptor, alpha polypeptide (PDGFRA, marker 14439), pyruvate dehydrogenase (lipoamide) alpha 2 (PDHA2, marker 14440), protein disulfide isomerase family A, member 2 (PDIA2, marker 14441), protein disulfide isomerase family A, member 2(PDIA2, marker 14442),protein disulfide isomerase family A, member 2(PDIA2, marker 14443),protein disulfide isomerase-like, testis expressed(PDILT, marker 14444),pyruvate dehydrogenase kinase, isozyme 1(PDK1, marker 14445),pyruvate dehydrogenase kinase, isozyme 4(PDK4, marker 14446),pyruvate dehydrogenase kinase, isozyme 4(PDK4, marker 14447),pyruvate dehydrogenase kinase, isozyme 4(PDK4, marker 14448),PDZ and LIM domain 2 (mystique)(PDLIM2, marker 14449),PDZ and LIM domain 3(PDLIM3, marker 14450),PDZ and LIM domain 4(PDLIM4, marker 14451),PDZ and LIM domain 4(PDLIM4, marker 14452),PDZ and LIM domain 4 (PDLIM4, marker 14453), PDZ and LIM domain 5 (PDLIM5, marker 14454), PDZ and LIM domain 5 (PDLIM5, marker 14455), PDZ and LIM domain 5 (PDLIM5, marker 14456), PDZ and LIM domain 5 (PDLIM5, marker 14457), PDZ and LIM domain 7 (enigma) (PDLIM7, marker 14458), 3-phosphoinositide dependent protein kinase 1 (PDPK1, marker 14459), 3-phosphoinositide dependent protein kinase 1 (PDPK1, marker 14460) ,3-phosphoinositide dependent protein kinase 1 (PDPK1, marker 14461), podoplanin (PDPN, marker 14462), PDS5 cohesin associated factor B (PDS5B, marker 14463), PDS5 cohesin associated factor B (PDS5B, marker 14464), PDS5 cohesin associated factor B (PDS5B, marker 14465), PDS5 cohesin associated factor B (PDS5B, marker 14466), prenyl (decaprenyl) diphosphate synthase, subunit 1 (PDSS1, marker 14467), prenyl (decaprenyl) diphosphate synthase, subunit 2 (PDSS2, marker 14468),prenyl (decaprenyl) diphosphate synthase, subunit 2(PDSS2, marker 14469),pancreatic and duodenal homeobox 1(PDX1, marker 14470),pancreatic and duodenal homeobox 1(PDX1, marker 14471),pancreatic and duodenal homeobox 1(PDX1) , marker 14472), pyridoxal-dependent decarboxylase domain containing 1(PDXDC1, marker 14473), pyridoxal-dependent decarboxylase domain containing 1(PDXDC1, marker 14474), pyridoxal (pyridoxine, vitamin B6) kinase(PDXK, marker 14475), prodynorphin( PDYN, Marker 14476), PDZ domain containing 2(PDZD2, Marker 14477), PDZ domain containing 2(PDZD2, Marker 14478), PDZ domain containing 3(PDZD3, Marker 14479), PDZ domain containing 3(PDZD3, Marker 14480), PDZ domain containing 7(PDZD7, marker 14481),PDZ domain containing 9(PDZD9, marker 14482),PDZK1 interacting protein 1(PDZK1IP1,marker 14483),PDZK1 interacting protein 1(PDZK1IP1,marker 14484),PDZ domain containing ring finger 3 (PDZRN3, marker 14485), PDZ domain containing ring finger 3 (PDZRN3, marker 14486), PDZRN3 antisense RNA 1 (PDZRN3-AS1, marker 14487), PDZ domain containing ring finger 4 (PDZRN4, marker 14488), pseudopodium-enriched atypical kinase 1 (PEAK1, marker 14489), pseudopodium-enriched atypical kinase 1 (PEAK1, marker 14490), phosphatidylethanolamine-binding protein 4 (PEBP4, marker 14491), platelet/endothelial cell adhesion molecule 1 (PECAM1, marker 14492), platelet/ endothelial cell adhesion molecule 1(PECAM1, marker 14493), platelet/endothelial cell adhesion molecule 1(PECAM1, marker 14494), platelet/endothelial cell adhesion molecule 1(PECAM1, marker 14495), paternally expressed 3(PEG3, marker 14496), paternally expressed 3(PEG3, marker 14497), PEG3 antisense RNA 1(PEG3-AS1, marker 14498), pellino E3 ubiquitin protein ligase family member 2(PELI2, marker 14499), pelota homolog (Drosophila)(PELO, marker 14500), proenkephalin (PENK, marker 14501), period circadian clock 1 (PER1, marker 14502), period circadian clock 1 (PER1, marker 14503), period circadian clock 2 (PER2, marker 14504), period circadian clock 3 (PER3, marker 14505) ),period circadian clock 3(PER3, marker 14506),period circadian clock 3(PER3,marker 14507),period circadian clock 3 pseudogene(PER4,marker 14508),period circadian clock 3 pseudogene(PER4,marker 14509),PPARGC1 and ESRR induced regulator, muscle 1(PERM1, marker 14510),PERP, TP53 apoptosis effector(PERP, marker 14511),PERP, TP53 apoptosis effector(PERP, marker 14512),pescadillo ribosomal biogenesis factor 1(PES1, marker 14513),peroxisomal biogenesis factor 11 gamma (PEX11G, marker 14514), peroxisomal biogenesis factor 14 (PEX14, marker 14515), peroxisomal biogenesis factor 16 (PEX16, marker 14516), peroxisomal biogenesis factor 2 (PEX2, marker 14517), peroxisomal biogenesis factor 26 (PEX26) , marker 14518), peroxisomal biogenesis factor 26 (PEX26, marker 14519), peroxisomal biogenesis factor 3 (PEX3, marker 14520), peroxisomal biogenesis factor 5-like (PEX5L, marker 14521), peroxisomal biogenesis factor 5-like (PEX5L, marker 14522), peroxisomal biogenesis factor 5-like (PEX5L, marker 14523), peroxisomal biogenesis factor 5-like (PEX5L, marker 14524), PEX5L antisense RNA 2 (PEX5L-AS2, marker 14525), platelet factor 4 variant 1 (PF4V1, Marker 14526), prefoldin subunit 4 (PFDN4, Marker 14527), 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 1 (PFKFB1, Marker 14528), 6-phosphofructo-2-kinase/fructose-2,6 -biphosphatase 1(PFKFB1, marker 14529),6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1(PFKFB1, marker 14530),6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2( PFKFB2, marker 14531),6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2(PFKFB2, marker 14532),6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2(PFKFB2, marker 14533 ),6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2(PFKFB2, marker 14534),6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4(PFKFB4, marker 14535),6- phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 /// urocortin 2(PFKFB4 /// UCN2, marker 14536), phosphofructokinase, platelet(PFKP, marker 14537), profilin family, member 4(PFN4, marker 14538 ),profilin family, member 4(PFN4,marker 14539),pepsinogen 3, group I (pepsinogen A) /// pepsinogen 4, group I (pepsinogen A) /// pepsinogen 5, group I (pepsinogen A)(PGA3 / // PGA4 /// PGA5, marker 14540), phosphoglycerate mutase 2 (muscle)(PGAM2, marker 14541), PGAM family member 5, serine/threonine protein phosphatase, mitochondrial(PGAM5, marker 14542), piggyBac transposable element derived 2( PGBD2, marker 14543), piggyBac transposable element derived 4 (PGBD4, marker 14544), piggyBac transposable element derived 5 (PGBD5, marker 14545), progastricsin (pepsinogen C) (PGC, marker 14546), progastricsin (pepsinogen C) (PGC, marker 14547), phosphogluconate dehydrogenase (PGD, marker 14548), phosphogluconate dehydrogenase (PGD, marker 14549), placental growth factor (PGF, marker 14550), phosphoglycerate
kinase 1 (PGK1, marker 14551), phosphoglycerate kinase 2 (PGK2, marker 14552), peptidoglycan recognition protein 1 (PGLYRP1, marker 14553), peptidoglycan recognition protein 2 (PGLYRP2, marker 14554), peptidoglycan recognition protein 3 (PGLYRP3, marker 14555) ), peptidoglycan recognition protein 4 (PGLYRP4, marker 14556), phosphoglucomutase 5 (PGM5, marker 14557), phosphoglucomutase 5 (PGM5, marker 14558), phosphoglucomutase 5 (PGM5, marker 14559), PGM5 antisense RNA 1 (PGM5-AS1, marker 14560), phosphoglucomutase 5 pseudogene 2 (PGM5P2, marker 14561), progesterone receptor (PGR, marker 14562), progesterone receptor (PGR, marker 14563), progesterone receptor (PGR, marker 14564), phosphatidylglycerophosphate synthase 1 (PGS1, marker 14565) ,phosphatase and actin regulator 1(PHACTR1, marker 14566),phosphatase and actin regulator 1(PHACTR1, marker 14567),PHACTR2 antisense RNA 1(PHACTR2-AS1, marker 14568),PHACTR2 antisense RNA 1(PHACTR2-AS1, marker 14569) ,phosphatase and actin regulator 3(PHACTR3, marker 14570),polyhomeotic homolog 2 (Drosophila)(PHC2, marker 14571),polyhomeotic homolog 2 (Drosophila)(PHC2, marker 14572),polyhomeotic homolog 3 (Drosophila)(PHC3, marker 14573) ), polyhomeotic homolog 3 (Drosophila) (PHC3, marker 14574), phosphate regulating endopeptidase homolog, X-linked (PHEX, marker 14575), PHEX antisense RNA 1 (PHEX-AS1, marker 14576), PHD finger protein 11 (PHF11, marker 14577), PHD finger protein 12 (PHF12, marker 14578), PHD finger protein 14 (PHF14, marker 14579), PHD finger protein 14 (PHF14, marker 14580), PHD finger protein 2 (PHF2, marker 14581), PHD finger protein 20-like 1(PHF20L1, marker 14582),PHD finger protein 21A(PHF21A, marker 14583),PHD finger protein 21A(PHF21A, marker 14584),PHD finger protein 24(PHF24, marker 14585),PHD finger protein 24( PHF24, marker 14586), PHD finger protein 2 pseudogene 1 (PHF2P1, marker 14587), PHD finger protein 3 (PHF3, marker 14588), PHD finger protein 7 (PHF7, marker 14589), PHD finger protein 7 (PHF7, marker 14590) ),PHD finger protein 8(PHF8, marker 14591),PHD finger protein 8(PHF8, marker 14592),phosphorylase kinase, beta(PHKB, marker 14593),phosphorylase kinase, gamma 1 (muscle)(PHKG1,marker 14594), phosphorylase kinase, gamma 1 (muscle)(PHKG1, marker 14595),phosphorylase kinase, gamma 2 (testis)(PHKG2, marker 14596),phosphorylase kinase, gamma 2 (testis)(PHKG2, marker 14597),pleckstrin homology-like domain , family A, member 2(PHLDA2, marker 14598),pleckstrin homology-like domain, family A, member 2(PHLDA2, marker 14599),pleckstrin homology-like domain, family B, member 1(PHLDB1, marker 14600),pleckstrin homology-like domain, family B, member 1(PHLDB1, marker 14601),pleckstrin homology-like domain, family B, member 2(PHLDB2, marker 14602),pleckstrin homology-like domain, family B, member 2(PHLDB2, marker 14602) 14603),pleckstrin homology-like domain, family B, member 2(PHLDB2, marker 14604),pleckstrin homology-like domain, family B, member 2(PHLDB2, marker 14605),pleckstrin homology-like domain, family B, member 3 (PHLDB3, marker 14606),pleckstrin homology-like domain, family B, member 3(PHLDB3, marker 14607),PH domain and leucine rich repeat protein phosphatase 1(PHLPP1, marker 14608),PH domain and leucine rich repeat protein phosphatase 2 (PHLPP2, marker 14609), phosphatase, orphan 1 (PHOSPHO1, marker 14610), paired-like homeobox 2a (PHOX2A, marker 14611), paired-like homeobox 2b (PHOX2B, marker 14612), PHD and ring finger domains 1 (PHRF1) , Marker 14613), phytanoyl-CoA 2-hydroxylase interacting protein (PHYHIP, Marker 14614), phytanoyl-CoA 2-hydroxylase interacting protein-like (PHYHIPL, Marker 14615), 5-phosphohydroxy-L-lysine phospho-lyase (PHYKPL, marker 14616), peptidase inhibitor 15(PI15, marker 14617), peptidase inhibitor 16(PI16, marker 14618), peptidase inhibitor 3, skin-derived(PI3, marker 14619), peptidase inhibitor 3, skin-derived(PI3, marker 14620) ), PILR alpha associated neural protein(PIANP, marker 14621), PILR alpha associated neural protein(PIANP, marker 14622), protein inhibitor of activated STAT 2(PIAS2, marker 14623), protein inhibitor of activated STAT 2(PIAS2, marker 14624) ), protein inhibitor of activated STAT 2(PIAS2, marker 14625), phosphotyrosine interaction domain containing 1(PID1, marker 14626), phosphotyrosine interaction domain containing 1(PID1, marker 14627), piezo-type mechanosensitive ion channel component 1(PIEZO1, marker 14628), piezo-type mechanosensitive ion channel component 1(PIEZO1, marker 14629), piezo-type mechanosensitive ion channel component 2(PIEZO2, marker 14630), piezo-type mechanosensitive ion channel component 2(PIEZO2, marker 14631), piezo -type mechanosensitive ion channel component 2(PIEZO2, marker 14632),piezo-type mechanosensitive ion channel component 2(PIEZO2,marker 14633),piezo-type mechanosensitive ion channel component 2(PIEZO2,marker 14634),phosphatidylinositol glycan anchor biosynthesis class G (PIGG, Marker 14635), phosphatidylinositol glycan anchor biosynthesis class G (PIGG, Marker 14636), phosphatidylinositol glycan anchor biosynthesis class K (PIGK, Marker 14637), phosphatidylinositol glycan anchor biosynthesis class L (PIGL, Marker 14638), phosphatidylinositol glycan anchor biosynthesis sis class L (PIGL, marker 14639), phosphatidylinositol glycan anchor biosynthesis class L (PIGL, marker 14640), phosphatidylinositol glycan anchor biosynthesis class O (PIGO, marker 14641), phosphatidylinositol glycan anchor biosynthesis class Q (PIGQ, marker 14642), polymeric immunoglobulin receptor(PIGR, marker 14643),polymeric immunoglobulin receptor(PIGR, marker 14644),phosphatidylinositol glycan anchor biosynthesis class , marker 14647),pregnancy-induced hypertension syndrome-related protein(PIH2, marker 14648),pregnancy-induced hypertension syndrome-related protein(PIH2, marker 14649),phosphoinositide-3-kinase adapter protein 1(PIK3AP1, marker 14650), phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha(PIK3C2A, marker 14651),phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha(PIK3C2A, marker 14652),phosphatidylinositol-4-phosphate 3-kinase , catalytic subunit type 2 alpha(PIK3C2A, marker 14653),phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma(PIK3C2G, marker 14654),phosphatidylinositol 3-kinase, catalytic subunit type 3(PIK3C3, marker 14655), phosphatidylinositol 3-kinase, catalytic subunit type 3(PIK3C3, marker 14656),phosphatidylinositol 3-kinase, catalytic subunit type 3(PIK3C3, marker 14657),phosphatidylinositol 3-kinase, catalytic subunit type 3(PIK3C3, marker 14658),phosphati dylinositol- 4,5-bisphosphate 3-kinase, catalytic subunit alpha(PIK3CA, marker 14659),phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha(PIK3CA, marker 14660),PIK3CD antisense RNA 1(PIK3CD-AS1, marker 14661), phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma(PIK3CG, marker 14662),phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma(PIK3CG, marker 14663),phosphatidylinositol-4,5 -bisphosphate 3-kinase, catalytic subunit gamma(PIK3CG, marker 14664),phosphoinositide-3-kinase interacting protein 1(PIK3IP1, marker 14665),phosphoinositide-3-kinase interacting protein 1(PIK3IP1, marker 14666),phosphoinositide-3- kinase interacting protein 1 (PIK3IP1, marker 14667), PIK3IP1 antisense RNA 1 (head to head) (PIK3IP1-AS1, marker 14668), phosphoinositide-3-kinase, regulatory subunit 2 (beta) (PIK3R2, marker 14669), phosphoinositide- 3-kinase, regulatory subunit 3 (gamma)(PIK3R3, marker 14670),phosphoinositide-3-kinase, regulatory subunit 3 (gamma)(PIK3R3, marker 14671),phosphoinositide-3-kinase, regulatory subunit 4(PIK3R4, marker 14672) ),phosphoinositide-3-kinase, regulatory subunit 4(PIK3R4, marker 14673),phosphoinositide-3-kinase, regulatory subunit 5(PIK3R5, marker 14674),phosphoinositide-3-kinase, regulatory subunit 5(PIK3R5, marker 14675), phosphoinositide-3-kinase, regulatory subunit 6(PIK3R6, marker 14676),phosphoinositide kinase, FYVE finger containing(PIKFYVE, marker 14677),phosphoinositide kinase, FYVE finger containing(PIKFYVE, marker 14678),paired immunoglobin-like type 2 receptor alpha (PILRA, marker 14679), paired immunoglobin-like type 2 receptor alpha (PILRA, marker 14680), peptidylprolyl cis/trans isomerase, NIMA-interacting 1 pseudogene 1 (PIN1P1, marker 14681), PINK1 antisense RNA (PINK1-AS, marker 14682), prolactin-induced protein (PIP, marker 14683), phosphatidylinositol-5-phosphate 4-kinase, type II, beta (PIP4K2B, marker 14684), phosphatidylinositol-4-phosphate 5-kinase, type I, beta (PIP5K1B, marker 14685), phosphatidylinositol-4-phosphate 5-kinase-like 1 (PIP5KL1, marker 14686), piwi-interacting RNA cluster 66 (PIRC66, marker 14687), piwi-interacting RNA cluster 76 (PIRC76, marker 14688), phosphoinositide- interacting regulator of transient receptor potential channels(PIRT, marker 14689),phosphatidylinositol transfer protein, cytoplasmic 1(PITPNC1, marker 14690),phosphatidylinositol transfer protein, membrane-associated 2(PITPNM2, marker 14691),phosphatidylinositol transfer protein, membrane-associated 2 (PITPNM2, marker 14692), phosphatidylinositol transfer protein, membrane-associated 2 (PITPNM2, marker 14693), PITPNM family member 3 (PITPNM3, marker 14694), pitrilysin metallopeptidase 1 (PITRM1, marker 14695), PITRM1 antisense RNA 1 (PITRM1- AS1, marker 14696), paired-like homeodomain 1 (PITX1, marker 14697), paired-like homeodomain 1 (PITX1, marker 14698), paired-like homeodomain 3 (PITX3, marker 14699), piwi-like RNA-mediated gene silencing 1(PIWIL1, marker 14700), piwi-like RNA-mediated gene silencing 2(PIWIL2, marker 14701), piwi-like RNA-mediated gene silencing 2(PIWIL2, marker 14702), piwi-like RNA-mediated gene silencing 2( PIWIL2, marker 14703), piwi-like RNA-mediated gene silencing 4(PIWIL4, marker 14704), polycystic kidney disease 1 (autosomal dominant)(PKD1, marker 14705), polycystic kidney disease 1 (autosomal dominant)(PKD1, marker 14706 ),polycystic kidney disease 1 like 1(PKD1L1,marker 14707),polycystic kidney disease 1 like 1(PKD1L1,marker 14708),polycystic kidney disease 1-like 2 (gene/pseudogene)(PKD1L2,marker 14709),polycystic kidney disease 1-like 2 (gene/pseudogene)(PKD1L2, marker 14710),polycystic kidney disease 1-like 2 (gene/ps
eudogene) (PKD1L2, marker 14711), polycystic kidney disease 2-like 2 (PKD2L2, marker 14712), polycystic kidney disease 2-like 2 (PKD2L2, marker 14713), polycystin (PKD) family receptor for egg jelly (PKDREJ, marker 14714),polycystic kidney and hepatic disease 1 (autosomal recessive)(PKHD1, marker 14715),polycystic kidney and hepatic disease 1 (autosomal recessive)(PKHD1, marker 14716),polycystic kidney and hepatic disease 1 (autosomal recessive)(PKHD1, marker 14717), polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1(PKHD1L1, marker 14718), polycystic kidney and hepatic disease 1 (autosomal recessive)-like 1(PKHD1L1, marker 14719), PKIA antisense RNA 1(PKIA -AS1, marker 14720),pyruvate kinase, liver and RBC(PKLR,marker 14721),pyruvate kinase, liver and RBC(PKLR,marker 14722),pyruvate kinase, liver and RBC(PKLR,marker 14723),protein kinase N2( PKN2, marker 14724), protein kinase N3(PKN3, marker 14725),PBX/knotted 1 homeobox 1(PKNOX1, marker 14726),PBX/knotted 1 homeobox 1(PKNOX1, marker 14727),PBX/knotted 1 homeobox 2(PKNOX2) , marker 14728), plakophilin 1 (PKP1, marker 14729), plakophilin 1 (PKP1, marker 14730), plakophilin 4 (PKP4, marker 14731), phospholipase A1 member A (PLA1A, marker 14732), phospholipase A2, group X (PLA2G10 , marker 14733),phospholipase A2, group XIIB(PLA2G12B, marker 14734),phospholipase A2, group XIIB(PLA2G12B, marker 14735),phospholipase A2, group IB (pancreas)(PLA2G1B, marker 14736),phospholipase A2, group IID( phospholipase A2, group IVD (cytosolic) (PLA2G4D, marker 14741), PLA2G4E antisense RNA 1 (PLA2G4E-AS1, marker 14742), PLA2G4E antisense RNA 1 (PLA2G4E-AS1, marker 14743), phospholipase A2, group IVF (PLA2G4F, marker 14744) ),phospholipase A2, group V(PLA2G5, marker 14745),phospholipase A2, group V(PLA2G5, marker 14746),phospholipase A2, group V(PLA2G5, marker 14747),phospholipase A2 receptor 1(PLA2R1, marker 14748),phospholipase A2 receptor 1 (PLA2R1, marker 14749), phospholipase A2 receptor 1 (PLA2R1, marker 14750), phospholipase A2 receptor 1 (PLA2R1, marker 14751), placenta specific 4 (PLAC4, marker 14752), placenta specific 4 (PLAC4, marker 14753) ), placenta specific 4 (PLAC4, marker 14754), PLAC8-like 1 (PLAC8L1, marker 14755), placenta specific 9 (PLAC9, marker 14756), phospholipase B1 (PLB1, marker 14757), phospholipase B1 (PLB1, marker 14758) ,PLBD1 antisense RNA 1(PLBD1-AS1,marker 14759),phospholipase B domain containing 2(PLBD2,marker 14760),phospholipase C, beta 1 (phosphoinositide-specific)(PLCB1,marker 14761),phospholipase C, beta 1 (phosphoinositide -specific)(PLCB1, marker 14762),phospholipase C, beta 2(PLCB2, marker 14763),phospholipase C, beta 2(PLCB2, marker 14764),phospholipase C, delta 3(PLCD3, marker 14765),phospholipase C, delta 4(PLCD4, marker 14766),phospholipase C, epsilon 1(PLCE1, marker 14767),phospholipase C, epsilon 1(PLCE1, marker 14768),phospholipase C, epsilon 1(PLCE1, marker 14769),phospholipase C, epsilon 1( PLCE1, marker 14770), PLCE1 antisense RNA 2 (PLCE1-AS2, marker 14771), PLCE1 antisense RNA 2 (PLCE1-AS2, marker 14772), phospholipase C, gamma 1 (PLCG1, marker 14773), PLCG1 antisense RNA 1 (PLCG1 -AS1, marker 14774), phospholipase C, gamma 2 (phosphatidylinositol-specific) (PLCG2, marker 14775), phospholipase C, gamma 2 (phosphatidylinositol-specific) (PLCG2, marker 14776), phospholipase C, eta 1 (PLCH1, marker 14777),phospholipase C, eta 1(PLCH1, marker 14778),PLCH1 antisense RNA 1(PLCH1-AS1,marker 14779),phospholipase C, eta 2(PLCH2,marker 14780),phospholipase C-like 1(PLCL1,marker 14781 ),phospholipase C-like 1(PLCL1, marker 14782),phospholipase C-like 2(PLCL2, marker 14783),phosphatidylinositol-specific phospholipase C, X domain containing 2(PLCXD2, marker 14784),phosphatidylinositol-specific phospholipase C, domain containing 3(PLCXD3, marker 14785), phosphatidylinositol-specific phospholipase C, ),phospholipase D1, phosphatidylcholine-specific(PLD1, marker 14789),phospholipase D1, phosphatidylcholine-specific(PLD1, marker 14790),phospholipase D1, phosphatidylcholine-specific(PLD1, marker 14791),phospholipase D1, phosphatidylcholine-specific(PLD1, marker 14792),phospholipase D1, phosphatidylcholine-specific(PLD1, marker 14793),phospholipase D1, phosphatidylcholine-specific(PLD1, marker 14794),phospholipase D family, member 4(PLD4, marker 14795),phospholipase D family, member 4( PLD4, marker 14796), phospholipase D family, member 5 (PLD5, marker 14797), phospholipase D family, member 6 (PLD6, marker 14798), phospholipase D family, member 6 (PLD6, marker 14799), pleckstrin (PLEK, marker 14800),pleckstrin(PLEK,marker 14801),pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2(PLEKHA2,marker 14802),pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 2(PLEKHA2,marker 14803),pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 3(PLEKHA3, marker 14804),pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4(PLEKHA4, marker 14805),pleckstrin homology domain containing, family A member 5(PLEKHA5, marker 14806),pleckstrin homology domain containing, family A member 6(PLEKHA6, marker 14807),pleckstrin homology domain containing, family A member 6(PLEKHA6, marker 14808),pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8(PLEKHA8, marker 14809), pleckstrin homology domain containing, family B (evectins) member 1(PLEKHB1, marker 14810), pleckstrin homology domain containing, family B (evectins) member 1(PLEKHB1, marker 14811 ),pleckstrin homology domain containing, family B (evectins) member 2(PLEKHB2, marker 14812),pleckstrin homology domain containing, family G (with RhoGef domain) member 3(PLEKHG3, marker 14813),pleckstrin homology domain containing, family G ( with RhoGef domain) member 3(PLEKHG3, marker 14814), pleckstrin homology domain containing, family G (with RhoGef domain) member 5(PLEKHG5, marker 14815), pleckstrin homology domain containing, family H (with MyTH4 domain) member 2(PLEKHH2 ,marker 14816),pleckstrin homology domain containing, family H (with MyTH4 domain) member 2(PLEKHH2,marker 14817),pleckstrin homology domain containing, family H (with MyTH4 domain) member 3(PLEKHH3,marker 14818),pleckstrin homology domain containing, family M (with RUN domain) member 1(PLEKHM1,marker 14819),pleckstrin homology domain containing, family M (with RUN domain) member 1 /// pleckstrin homology domain containing, family M (with RUN domain) member 1 pseudogene (PLEKHM1 /// PLEKHM1P, marker 14820), pleckstrin homology domain containing, family M, member 3(PLEKHM3, marker 14821), pleckstrin homology domain containing, family N member 1(PLEKHN1, marker 14822), pleckstrin homology domain containing, family S member 1(PLEKHS1, marker 14823), pleckstrin homology domain containing, family S member 1(PLEKHS1, marker 14824), plasminogen(PLG, marker 14825),plasminogen(PLG, marker 14826),plasminogen(PLG, marker 14827), plasminogen-like B1 /// plasminogen-like B2(PLGLB1 /// PLGLB2, marker 14828), plasminogen-like B1 /// plasminogen-like B2(PLGLB1 /// PLGLB2, marker 14829), plasminogen-like B2(PLGLB2 , marker 14830), peripin 1 (PLIN1, marker 14831), peripin 2 (PLIN2, marker 14832), peripin 4 (PLIN4, marker 14833), peripin 5 (PLIN5, marker 14834), peripin 5 (PLIN5, marker 14835), perilipin 5 (PLIN5, marker 14836), perilipin 5 (PLIN5, marker 14837), perilipin 5 (PLIN5, marker 14838), polo-like kinase 3 (PLK3, marker 14839), polo-like kinase 5 (PLK5, marker 14840) ,plasmolipin(PLLP,marker 14841),phospholamban(PLN,marker 14842),phospholamban(PLN,marker 14843),phospholamban(PLN,marker 14844),phospholipid phosphatase 7 (inactive)(PLPP7,marker 14845),phospholipid phosphatase related 1 (PLPPR1, marker 14846), phospholipid phosphatase related 4 (PLPPR4, marker 14847), phospholipid scramblase 1 (PLSCR1, marker 14848), phospholipid scramblase 2 (PLSCR2, marker 14849), phospholipid scramblase 2 (PLSCR2, marker 14850), plasmalemma vesicle protein associated(PLVAP, marker 14851),plexin domain containing 1(PLXDC1,marker 14852),plexin domain containing 1(PLXDC1,marker 14853),plexin domain containing 1(PLXDC1,marker 14854),plexin domain containing 2(PLXDC2,marker 14855), plexin A1 (PLXNA1, marker 14856), plexin A2 (PLXNA2, marker 14857), plexin A3 (PLXNA3, marker 14858), plexin A3 (PLXNA3, marker 14859), plexin A3 (PLXNA3, marker 14860), plexin A4 (PLXNA4, marker 14861), plexin A4 (PLXNA4, marker 14862), plexin A4 (PLXNA4, marker 14863), plexin A4 (PLXNA4, marker 14864), plexin B1 (PLXNB1, marker 14865), plexin B2 (PLXNB2, marker 14866) ), plexin B3 (PLXNB3, marker 14867), plexin C1 (PLXNC1, marker 14868), plexin C1 (PLXNC1, marker 14869), plexin D1 (PLXND1, marker 14870), peptidase M20 domain containing 1 (PM20D1, marker 14871), peptidase M20 domain containing 2(PM20D2, marker 14872),pro-melanin-concentrating hormone-like 1, pseudogene(PMCHL1, marker 14873),pro-melanin-concentrating hormone-like 1, pseudogene(PMCHL1, marker 14874),pro- melanin-concentrating hormone-like 1, pseudogene(PMCHL1, marker 14875),pro-melanin-concentrating hormone-like 1, pseudogene(PMCHL1, marker 14876),pro-melanin-concentrating hormone-like 2, pseudogene(PMCHL2, marker 14877 ), pro-melanin-concentrating hormone-like 2, pseudogene (PMCHL2, marker 14878), polyamine modulated factor 1 binding protein 1 (PMFBP1, marker 14879), promyelocytic leukemia (PML, marker 14880), promyelocytic leukemia (PML, marker 14881) ), promyelocytic leukemia (PML, marker 14882), promyelocytic leukemia (PML, marker 14883), promyelocytic leukemia (PML, marker 14884), promyelocytic leukemia (PML, marker 14885), peripheral myelin protein 2 (PMP2, marker 14886), peripheral myelin protein 2 (PMP2, marker 14887), peripheral myelin protein 22 (PMP22, marker 14888), peripheral myelin protein 22 (PMP22, marker 14889), peripheral myelin protein 22 (PMP22, marker 14890), peptidase (mitochondrial processing) beta( PMPCB, marker 14891), PMS1 homolog 1, mismatch re
pair system component(PMS1, marker 14892),PMS1 homolog 1, mismatch repair system component(PMS1, marker 14893),PMS1 homolog 1, mismatch repair system component(PMS1, marker 14894),PMS1 homolog 2, mismatch repair system component pseudogene 3 (PMS2P3, marker 14895), PMS1 homolog 2, mismatch repair system component pseudogene 4 (PMS2P4, marker 14896), pregnancy up-regulated nonubiquitous CaM kinase (PNCK, marker 14897), paroxysmal nonkinesigenic dyskinesia (PNKD, marker 14898), poly( A)-specific ribonuclease (PARN)-like domain containing 1 (PNLDC1, marker 14899), pancreatic lipase (PNLIP, marker 14900), pancreatic lipase-related protein 1 (PNLIPRP1, marker 14901), pancreatic lipase-related protein 1 (PNLIPRP1) , marker 14902), pancreatic lipase-related protein 2 (PNLIPRP2, marker 14903), pancreatic lipase-related protein 3 (PNLIPRP3, marker 14904), paraneoplastic Ma antigen 2 (PNMA2, marker 14905), paraneoplastic Ma antigen 3 (PNMA3, marker 14906), paraneoplastic Ma antigen family-like 2(PNMAL2, marker 14907), prepronociceptin(PNOC, marker 14908), patatin-like phospholipase domain containing 1(PNPLA1, marker 14909), patatin-like phospholipase domain containing 2(PNPLA2, marker 14910), patatin-like phospholipase domain containing 5(PNPLA5, marker 14911), patatin-like phospholipase domain containing 7(PNPLA7, marker 14912), patatin-like phospholipase domain containing 7(PNPLA7, marker 14913), podocan(PODN, marker 14914), podocan(PODN, marker 14915), podocan-like 1(PODNL1, marker 14916),premature ovarian failure, 1B(POF1B,marker 14917),premature ovarian failure, 1B(POF1B,marker 14918),premature ovarian failure, 1B (POF1B, marker 14919), protein O-fucosyltransferase 1 (POFUT1, marker 14920), protein O-fucosyltransferase 2 (POFUT2, marker 14921), protein O-fucosyltransferase 2 (POFUT2, marker 14922), protein O-fucosyltransferase 2( POFUT2, marker 14923), pogo transposable element with KRAB domain(POGK, marker 14924), polymerase (DNA directed), alpha 2, accessory subunit(POLA2, marker 14925), polymerase (DNA directed), alpha 2, accessory subunit(POLA2 , marker 14926), polymerase (DNA directed), beta(POLB, marker 14927), polymerase (DNA directed), beta(POLB, marker 14928), polymerase (DNA-directed), delta 3, accessory subunit(POLD3, marker 14929 ),polymerase (DNA-directed), delta interacting protein 3(POLDIP3, marker 14930),polymerase (DNA-directed), delta interacting protein 3(POLDIP3, marker 14931),polymerase (DNA-directed), delta interacting protein 3 / // ribosomal RNA processing 7 homolog B, pseudogene(POLDIP3 /// RRP7BP, marker 14932), polymerase (DNA-directed), epsilon 4, accessory subunit(POLE4, marker 14933), polymerase (DNA directed), gamma(POLG, marker 14934), polymerase (DNA directed), eta(POLH, marker 14935), polymerase (DNA directed), eta(POLH, marker 14936), polymerase (DNA directed), eta(POLH, marker 14937), polymerase (DNA directed ) kappa(POLK, marker 14938), polymerase (DNA directed), mu(POLM, marker 14939), polymerase (DNA directed) nu(POLN, marker 14940), polymerase (DNA directed) nu(POLN, marker 14941), polymerase (RNA) I polypeptide E (POLR1E, marker 14942), polymerase (RNA) II (DNA directed) polypeptide A, 220kDa (POLR2A, marker 14943), polymerase (RNA) II (DNA directed) polypeptide B, 140kDa (POLR2B, marker 14944), polymerase (RNA) II (DNA directed) polypeptide F (POLR2F, marker 14945), polymerase (RNA) II (DNA directed) polypeptide J2 (POLR2J2, marker 14946), polymerase (RNA) II (DNA directed) polypeptide J3 (POLR2J3, marker 14947), polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene (POLR2J4, marker 14948), polymerase (RNA) III (DNA directed) polypeptide A, 155kDa (POLR3A, marker 14949), polymerase (RNA) ) III (DNA directed) polypeptide B (POLR3B, marker 14950), polymerase (RNA) III (DNA directed) polypeptide B (POLR3B, marker 14951), polymerase (RNA) III (DNA directed) polypeptide E (80kD) (POLR3E, marker 14952), polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) (POLR3H, marker 14953), polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa (POLR3K, marker 14954), polymerase (RNA) ) mitochondrial (DNA directed)(POLRMT, marker 14955), polymerase (RNA) mitochondrial (DNA directed)(POLRMT, marker 14956), POM121 transmembrane nucleoporin(POM121, marker 14957), POM121 transmembrane nucleoporin-like 10, pseudogene(POM121L10P, Marker 14958), POM121 transmembrane nucleoporin-like 12 (POM121L12, Marker 14959), POM121 transmembrane nucleoporin-like 12 (POM121L12, Marker 14960), POM121 transmembrane nucleoporin-like 2 (POM121L2, Marker 14961), PO M121 transmembrane nucleoporin-like 8 pseudogene (POM121L8P, marker 14962), POM121 transmembrane nucleoporin-like 9, pseudogene(POM121L9P, marker 14963), POM121 transmembrane nucleoporin-like 9, pseudogene(POM121L9P, marker 14964), POM121 transmembrane nucleoporin-like 9, pseudogene(PO M121L9P, marker 14965 ), proopiomelanocortin(POMC, marker 14966), protein O-linked mannose N-acetylglucosaminyltransferase 1 (beta 1,2-)(POMGNT1, marker 14967), paraoxonase 1(PON1, marker 14968), paraoxonase 1(PON1, marker 14969) ,paraoxonase 2(PON2, marker 14970),paraoxonase 3(PON3, marker 14971),popeye domain containing 2(POPDC2,marker 14972),periostin, osteoblast specific factor(POSTN,marker 14973),periostin, osteoblast specific factor(POSTN, Marker 14974), POT1 antisense RNA 1(POT1-AS1, Marker 14975), POU class 1 homeobox 1(POU1F1, Marker 14976), POU class 2 associating factor 1(POU2AF1, Marker 14977), POU class 2 homeobox 1(POU2F1, Marker 14978), POU class 2 homeobox 2(POU2F2, Marker 14979), POU class 2 homeobox 2(POU2F2, Marker 14980), POU class 2 homeobox 2(POU2F2, Marker 14981), POU class 2 homeobox 2(POU2F2, Marker 14982 ),POU class 2 homeobox 2(POU2F2, marker 14983),POU class 2 homeobox 3(POU2F3,marker 14984),POU class 2 homeobox 3(POU2F3,marker 14985),POU class 3 homeobox 1(POU3F1,marker 14986), POU class 3 homeobox 1(POU3F1, marker 14987),POU class 3 homeobox 3(POU3F3, marker 14988),POU class 3 homeobox 3(POU3F3, marker 14989),POU class 3 homeobox 4(POU3F4, marker 14990),POU class 4 homeobox 1 (POU4F1, marker 14991), POU class 4 homeobox 2 (POU4F2, marker 14992), POU class 4 homeobox 3 (POU4F3, marker 14993), POU domain class 5, transcription factor 2 (POU5F2, marker 14994), POU class 6 homeobox 1(POU6F1, marker 14995),POU class 6 homeobox 1(POU6F1, marker 14996),POU class 6 homeobox 1(POU6F1, marker 14997),POU class 6 homeobox 1(POU6F1, marker 14998),POU class 6 homeobox 2 (POU6F2, marker 14999), POU6F2 antisense RNA 2 (POU6F2-AS2, marker 15000), uncharacterized LOC100192379 (PP12613, marker 15001), PP12708 (marker 15002), vegetable cell wall protein gp1 (PP13, marker 15003), uncharacterized LOC100130449(PP14571, marker 15004), uncharacterized LOC100130249(PP2672, marker 15005), protein phosphatase 2C-like domain containing 1(PP2D1, marker 15006), pyrophosphatase (inorganic) 2(PPA2, marker 15007), peroxisome proliferator-activated receptor alpha (PPARA, marker 15008), peroxisome proliferator-activated receptor alpha (PPARA, marker 15009), peroxisome proliferator-activated receptor alpha (PPARA, marker 15010), peroxisome proliferator-activated receptor alpha (PPARA, marker 15011), peroxisome proliferator-activated receptor alpha (PPARA, marker 15012), peroxisome proliferator-activated receptor alpha (PPARA, marker 15013), peroxisome proliferator-activated receptor alpha (PPARA, marker 15014), peroxisome proliferator-activated receptor delta (PPARD, marker 15015), peroxisome proliferator -activated receptor gamma (PPARG, marker 15016), peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (PPARGC1A, marker 15017), peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PPARGC1B, marker 15018), peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PPARGC1B, marker 15019), pro-platelet basic protein (PPBP, marker 15020), pro-platelet basic protein pseudogene 2 (PPBPP2, marker 15021), protein phosphatase, EF-hand calcium binding domain 1 (PPEF1) , marker 15022), protein phosphatase, EF-hand calcium binding domain 2(PPEF2, marker 15023), protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2(PPFIA2, marker 15024), protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2(PPFIA2, marker 15025),protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2( PPFIA2, marker 15026), protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 (PPFIA4, marker 15027), PTPRF interacting protein, binding protein 1 (liprin beta 1) (PPFIBP1, marker 15028), PTPRF interacting protein, binding protein 1 (liprin beta 1) (PPFIBP1, marker 15029), periphilin 1 (PPHLN1, marker 15030), peptidylprolyl isomerase A (cyclophilin A) (PPIA, marker 15031), peptidylprolyl isomerase A (cyclophilin A)-like 4A (PPIAL4A, marker 15032), peptidylprolyl isomerase E-like pseudogene (PPIEL, marker 15033), peptidylprolyl isomerase E-like pseudogene (PPIEL, marker 15034), peptidylprolyl isomerase H (cyclophilin H) (PPIH, marker 15035) ),peptidylprolyl isomerase (cyclophilin)-like 2(PPIL2, marker 15036),peptidylprolyl isomerase (cyclophilin)-like 2(PPIL2, marker 15037),peptidylprolyl isomerase (cyclophilin)-like 6(PPIL6, marker 15038),peptidylprolyl isomerase ( cyclophilin)-like 6(PPIL6, marker 15039), protein phosphatase, Mg2+/Mn2+ dependent, 1F(PPM1F, marker 15040), protein phosphatase, Mg2+/Mn2+ dependent, 1H(PPM1H, marker 15041), protein phosphatase, Mg2+/Mn2+ dependent, 1K(PPM1K, marker 15042),protein phosphatase, Mg2+/Mn2+ dependent, 1K(PPM1K,marker 15043),protein phosphatase, Mg2+/Mn2+ dependent, 1K(PPM1K,marker 15044),protein phosphatase, Mg2+/Mn2+ dependent, 1L(PPM1L, marker 15045), protein phosphatase, Mg2+/Mn2+ dependent, 1L(PPM1L, marker 15046), protein phosphatase, Mg2+/Mn2+ dependent, 1L(PPM1L, marker 15047), protein phosphatase, Mg2+/Mn2+ dependent, 1M( PPM1M, marker 15048), protein phosphatase, Mg2+/Mn2+ dependent, 1N (putative)(PPM1N, marker 15049), protein phosphatase methylesterase 1(PPME1, marker 15050), protoporphyrinogen oxidase(PPOX, marker 15051), protoporphyrinogen oxidase(PPOX, marker 15052), protein phosphatase 1, regulatory (inhibitor) subunit 11 (PPP1R11, marker 15053), protein phosphatase 1, regulatory (inhibitor) subunit 11 (PPP1R11, marker 15054), protein phosphatase 1,
regulatory subunit 12B(PPP1R12B, marker 15055), protein phosphatase 1, regulatory subunit 12B(PPP1R12B, marker 15056), protein phosphatase 1, regulatory subunit 12B(PPP1R12B, marker 15057), protein phosphatase 1, regulatory subunit 12B(PPP1R12B, marker 15058 ), protein phosphatase 1, regulatory subunit 12C(PPP1R12C, marker 15059), protein phosphatase 1, regulatory subunit 12C(PPP1R12C, marker 15060), protein phosphatase 1, regulatory (inhibitor) subunit 14D(PPP1R14D, marker 15061), protein phosphatase 1 , regulatory subunit 16B(PPP1R16B, marker 15062), protein phosphatase 1, regulatory subunit 17(PPP1R17, marker 15063), protein phosphatase 1, regulatory (inhibitor) subunit 1A(PPP1R1A, marker 15064), protein phosphatase 1, regulatory (inhibitor) subunit 1C(PPP1R1C, marker 15065), protein phosphatase 1, regulatory (inhibitor) subunit 2(PPP1R2, marker 15066), protein phosphatase 1, regulatory (inhibitor) subunit 2(PPP1R2, marker 15067), PPP1R26 antisense RNA 1(PPP1R26- AS1, marker 15068), PPP1R26 antisense RNA 1 (PPP1R26-AS1, marker 15069), protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9 (PPP1R2P9, marker 15070), protein phosphatase 1, regulatory subunit 32 (PPP1R32, marker 15071) ),protein phosphatase 1, regulatory subunit 36(PPP1R36, marker 15072),protein phosphatase 1, regulatory subunit 37(PPP1R37, marker 15073),protein phosphatase 1, regulatory subunit 37(PPP1R37, marker 15074),protein phosphatase 1, regulatory subunit 3A(PPP1R3A, marker 15075), protein phosphatase 1, regulatory subunit 3A(PPP1R3A, marker 15076), protein phosphatase 1, regulatory subunit 3B(PPP1R3B, marker 15077), protein phosphatase 1, regulatory subunit 3C(PPP1R3C, marker 15078), protein phosphatase 1, regulatory subunit 3D(PPP1R3D, marker 15079),protein phosphatase 1, regulatory subunit 3E(PPP1R3E, marker 15080),protein phosphatase 1, regulatory subunit 3E(PPP1R3E, marker 15081),protein phosphatase 1, regulatory subunit 3F( PPP1R3F, marker 15082), protein phosphatase 1, regulatory subunit 3F(PPP1R3F, marker 15083), protein phosphatase 1, regulatory subunit 3F(PPP1R3F, marker 15084), protein phosphatase 1, regulatory subunit 9A(PPP1R9A, marker 15085), protein phosphatase 1, regulatory subunit 9B(PPP1R9B, marker 15086), protein phosphatase 1, regulatory subunit 9B(PPP1R9B, marker 15087), protein phosphatase 2, regulatory subunit A, beta(PPP2R1B, marker 15088), protein phosphatase 2, regulatory subunit B, alpha(PPP2R2A, marker 15089), protein phosphatase 2, regulatory subunit B, beta(PPP2R2B, marker 15090), protein phosphatase 2, regulatory subunit B, gamma(PPP2R2C, marker 15091), protein phosphatase 2, regulatory subunit B, gamma( PPP2R2C, marker 15092), protein phosphatase 2, regulatory subunit B, gamma(PPP2R2C, marker 15093), protein phosphatase 2, regulatory subunit B, gamma(PPP2R2C, marker 15094), protein phosphatase 2, regulatory subunit B, gamma(PPP2R2C, marker 15095), protein phosphatase 2, regulatory subunit B'', gamma(PPP2R3C, marker 15096), protein phosphatase 2, regulatory subunit B'', gamma(PPP2R3C, marker 15097), protein phosphatase 2, regulatory subunit B', alpha (PPP2R5A, marker 15098), protein phosphatase 2, regulatory subunit B', beta(PPP2R5B, marker 15099), protein phosphatase 2, regulatory subunit B', gamma(PPP2R5C, marker 15100), protein phosphatase 2, regulatory subunit B', gamma (PPP2R5C, marker 15101), PPP3CB antisense RNA 1 (head to head) (PPP3CB-AS1, marker 15102), PPP3CB antisense RNA 1 (head to head) (PPP3CB-AS1, marker 15103), protein phosphatase 3, catalytic subunit , gamma isozyme(PPP3CC, marker 15104), protein phosphatase 3, catalytic subunit, gamma isozyme(PPP3CC, marker 15105), protein phosphatase 3, regulatory subunit B, beta(PPP3R2, marker 15106), protein phosphatase 3, regulatory subunit B, beta(PPP3R2, marker 15107), protein phosphatase 4, regulatory subunit 1-like (pseudogene)(PPP4R1L, marker 15108), protein phosphatase 4, regulatory subunit 1-like (pseudogene)(PPP4R1L, marker 15109), protein phosphatase 4, regulatory subunit 1-like (pseudogene)(PPP4R1L, marker 15110), protein phosphatase 4, regulatory subunit 3B(PPP4R3B, marker 15111), protein phosphatase 4, regulatory subunit 3C, pseudogene(PPP4R3CP, marker 15112), protein phosphatase 5, catalytic subunit (PPP5C, marker 15113), PPP5 tetratricopeptide repeat domain containing 1 (PPP5D1, marker 15114), PPP5 tetratricopeptide repeat domain containing 1 (PPP5D1, marker 15115), protein phosphatase 6, regulatory subunit 2 (PPP6R2, marker 15116), peptidylprolyl isomerase domain and WD repeat containing 1 (PPWD1, marker 15117), pancreatic polypeptide (PPY, marker 15118), pancreatic polypeptide 2, pseudogene (PPY2P, marker 15119), polyglutamine binding protein 1 (PQBP1, marker 15120), PQ loop repeat containing 1 (PQLC1, marker 15121),PQ loop repeat containing 2(PQLC2, marker 15122),PQ loop repeat containing 2-like(PQLC2L,marker 15123),PQ loop repeat containing 2-like(PQLC2L,marker 15124),PQ loop repeat containing 3 (PQLC3, marker 15125), prostate cancer susceptibility candidate 1 (PRAC1, marker 15126), prostate cancer susceptibility candidate 2 (PRAC2, marker 15127), PML-RARA regulated adapter molecule 1 (PRAM1, marker 15128), preferentially expressed antigen in melanoma(PRAME, marker 15129),PRAME family member 1 /// PRAME family member 13 /// PRAME family member 2(PRAMEF1 /// PRAMEF13 /// PRAMEF2, marker 15130),PRAME family member 10(PRAMEF10, marker 15131), PRAME family member 11 (PRAMEF11, marker 15132), PRAME family member 12 (PRAMEF12, marker 15133), proline-rich acidic protein 1 (PRAP1, marker 15134), proline-rich protein BstNI subfamily 1 (PRB1, marker 15135) ), proline-rich protein BstNI subfamily 1 (PRB1, marker 15136), proline-rich protein BstNI subfamily 1 (PRB1, marker 15137), proline-rich protein BstNI subfamily 4 (PRB4, marker 15138), prostate cancer-associated 47( PRCAT47, marker 15139), progressive rod-cone degeneration (PRCD, marker 15140), progressive rod-cone degeneration (PRCD, marker 15141), prolylcarboxypeptidase (PRCP, marker 15142), prolylcarboxypeptidase (PRCP, marker 15143), prolylcarboxypeptidase (PRCP, Marker 15144),PR domain containing 1, with ZNF domain(PRDM1,Marker 15145),PR domain containing 1, with ZNF domain(PRDM1,Marker 15146),PR domain containing 10(PRDM10,Marker 15147),PR domain containing 11( PRDM11, Marker 15148),PR domain containing 11(PRDM11, Marker 15149),PR domain containing 11(PRDM11, Marker 15150),PR domain containing 11(PRDM11, Marker 15151),PR domain containing 11(PRDM11, Marker 15152), PR domain containing 12(PRDM12, marker 15153),PR domain containing 13(PRDM13, marker 15154),PR domain containing 15(PRDM15, marker 15155),PR domain containing 15(PRDM15, marker 15156),PR domain containing 16(PRDM16) , Marker 15157), PR domain containing 2, with ZNF domain (PRDM2, Marker 15158), PR domain containing 6 (PRDM6, Marker 15159), PR domain containing 6 (PRDM6, Marker 15160), PR domain containing 7 (PRDM7, Marker 15161),PR domain containing 8(PRDM8, marker 15162),PR domain containing 8(PRDM8,marker 15163),PR domain containing 9(PRDM9,marker 15164),PRELI domain containing 3A(PRELID3A,marker 15165),proline/arginine -rich end leucine-rich repeat protein (PRELP, marker 15166), proline/arginine-rich end leucine-rich repeat protein (PRELP, marker 15167), proline/arginine-rich end leucine-rich repeat protein (PRELP, marker 15168) ,prolyl endopeptidase-like (PREPL, marker 15169), phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 (PREX1, marker 15170), phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2( PREX2, marker 15171), phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 (PREX2, marker 15172), phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2 (PREX2, marker 15173), perforin 1 (pore forming protein) (PRF1, marker 15174), proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein) (PRG2, marker 15175), proteoglycan 3 (PRG3, marker 15176), proteoglycan 4 ( PRG4, marker 15177), proline-rich protein HaeIII subfamily 1(PRH1, marker 15178), proline-rich protein HaeIII subfamily 1 /// PRH1-PRR4 readthrough /// proline rich 4 (lacrimal)(PRH1 /// PRH1- PRR4 /// PRR4, marker 15179), proline-rich protein HaeIII subfamily 1 /// proline-rich protein HaeIII subfamily 2 (PRH1 /// PRH2, marker 15180), PRICKLE2 antisense RNA 3 (PRICKLE2-AS3, marker 15181) ,primase, DNA, polypeptide 2 (58kDa)(PRIM2, marker 15182),primase, DNA, polypeptide 2 (58kDa)(PRIM2, marker 15183),protein kinase, AMP-activated, alpha 1 catalytic subunit(PRKAA1, marker 15184) ,protein kinase, cAMP-dependent, catalytic, gamma(PRKACG, marker 15185),protein kinase, AMP-activated, gamma 2 non-catalytic subunit(PRKAG2, marker 15186),protein kinase, AMP-activated, gamma 2 non-catalytic subunit (PRKAG2, marker 15187), PRKAG2 antisense RNA 1 (PRKAG2-AS1, marker 15188), PRKAG2 antisense RNA 1 (PRKAG2-AS1, marker 15189), PRKAG2 antisense RNA 1 (PRKAG2-AS1, marker 15190), protein kinase, AMP-activated, gamma 3 non-catalytic subunit (PRKAG3, marker 15191), protein kinase, cAMP-dependent, regulatory, type I, alpha (PRKAR1A, marker 15192), protein kinase C, alpha (PRKCA, marker 15193), protein kinase C, alpha (PRKCA, marker 15194), protein kinase C, alpha (PRKCA, marker 15195), PRKCA antisense RNA 1 (PRKCA-AS1, marker 15196), PRKCA antisense RNA 1 (PRKCA-AS1, marker 15197), protein kinase C, beta(PRKCB, marker 15198),protein kinase C, beta(PRKCB,marker 15199),protein kinase C, beta(PRKCB,marker 15200),protein kinase C, beta(PRKCB,marker 15201),protein kinase C , epsilon (PRKCE, marker 15202), protein kinase C, epsilon (PRKCE, marker 15203), protein kinase C, epsilon (PRKCE, marker 15204), protein kinase C, gamma (PRKCG, marker 15205), protein kinase C, gamma (PRKCG, marker 15206), protein kinase C, eta (PRKCH, marker 15207), PRKCQ antisense RNA 1 (PRKCQ-AS1, marker 15208), protein kinase C, zeta (PRKCZ, marker 15209), protein kinase D1 (PRKD1, marker 15210), protein kinase D2 (PRKD2, marker 15211), protein kinase D3 (PRKD3, marker 15212), protein kinase, DNA-activated, catalytic polypeptide (PRKDC, marker 15213), protein kinase, cGMP-dependent, type I( PRKG1, marker 15214), PRKG1 antisense RNA 1 (PRKG1-AS1, marker 15215), protein kinase, cGMP-dependent, type II (PRKG2, marker 15216), protein kinase, interferon-inducible double stranded RNA dependent activator (PRKRA, marker 15217
), protein kinase, X-linked, pseudogene 1(PRKXP1, marker 15218), protein kinase, X-linked, pseudogene 1(PRKXP1, marker 15219), protein kinase, protein kinase, Y-linked, pseudogene (PRKY, marker 15221), prolactin (PRL, marker 15222), prolactin releasing hormone (PRLH, marker 15223), prolactin releasing hormone receptor (PRLHR, marker 15224), prolactin receptor (PRLR, marker 15225), prolactin receptor (PRLR, marker 15226), prolactin receptor (PRLR, marker 15227), prolactin receptor (PRLR, marker 15228), prolactin receptor (PRLR, marker 15229), prolactin receptor (PRLR, marker 15230), prolactin receptor (PRLR, marker 15231), protamine 1 (PRM1, marker 15232), protamine 2 (PRM2, marker 15233), protamine 3 (PRM3, marker 15234), protein arginine methyltransferase 1 (PRMT1, marker 15235), protein arginine methyltransferase 2( PRMT2, marker 15236), protein arginine methyltransferase 2 (PRMT2, marker 15237), protein arginine methyltransferase 8 (PRMT8, marker 15238), protein arginine methyltransferase 8 (PRMT8, marker 15239), prion protein 2 (dublet) (PRND, marker 15240) ), prion protein 2 (dublet)(PRND, marker 15241), prion protein (testis specific)(PRNT, marker 15242), uncharacterized LOC28994(PRO0471, marker 15243), uncharacterized protein PRO1082(PRO1082, marker 15244), uncharacterized LOC55448( PRO1483, marker 15245), uncharacterized LOC29013(PRO1596, marker 15246), uncharacterized LOC100133319(PRO1804, marker 15247), uncharacterized protein PRO2012(PRO2012, marker 15248), uncharacterized protein PRO2012(PRO2012, marker 15249), uncharacterized protein PRO2 214(PRO2214, marker 15250), uncharacterized protein PRO2949(PRO2949, marker 15251), uncharacterized LOC100128329(PRO2958, marker 15252), protein C (inactivator of coagulation factors Va and VIIIa)(PROC, marker 15253), protein interacting with cyclin A1(PROCA1, marker 15254), proline dehydrogenase (oxidase) 2 (PRODH2, marker 15255), proline dehydrogenase (oxidase) 2 (PRODH2, marker 15256), prokineticin 1 (PROK1, marker 15257), prokineticin 2 (PROK2, marker 15258), prokineticin receptor 2 (PROKR2, marker 15259), proline rich, lacrimal 1 (PROL1, marker 15260), prominin 2 (PROM2, marker 15261), prominin 2 (PROM2, marker 15262), PROP paired-like homeobox 1 (PROP1, marker 15263), prolyl-tRNA synthetase associated domain containing 1, pseudogene(PRORSD1P, marker 15264),proline rich, Y-linked(PRORY, marker 15265),proline synthetase co-transcribed homolog (bacterial)(PROSC, marker 15266),proline synthetase co- transcribed homolog (bacterial)(PROSC, marker 15267),PROSER2 antisense RNA 1(PROSER2-AS1,marker 15268),PROSER2 antisense RNA 1(PROSER2-AS1,marker 15269),prospero homeobox 1(PROX1,marker 15270),prospero homeobox 1(PROX1, marker 15271), prospero homeobox 1(PROX1, marker 15272),prospero homeobox 1(PROX1, marker 15273),PROX1 antisense RNA 1(PROX1-AS1, marker 15274),prospero homeobox 2(PROX2, marker 15275) , protein Z, vitamin K-dependent plasma glycoprotein (PROZ, marker 15276), pre-mRNA processing factor 31 (PRPF31, marker 15277), peripherin (PRPH, marker 15278), phosphoribosyl pyrophosphate synthetase 1-like 1 (PRPS1L1, marker 15279) ), phosphoribosyl pyrophosphate synthetase-associated protein 1 (PRPSAP1, marker 15280), proline rich 14 (PRR14, marker 15281), proline rich 14-like (PRR14L, marker 15282), proline rich 14-like (PRR14L, marker 15283), proline rich 15-like (PRR15L, marker 15284), proline rich 16 (PRR16, marker 15285), proline rich 16 (PRR16, marker 15286), proline rich 18 (PRR18, marker 15287), proline rich 19 (PRR19, marker 15288) ), proline rich 20A /// proline rich 20B /// proline rich 20C /// proline rich 20D /// proline rich 20E(PRR20A /// PRR20B /// PRR20C /// PRR20D /// PRR20E, Marker 15289 ), proline rich 22(PRR22, marker 15290), proline rich 22(PRR22, marker 15291), proline rich 23 domain containing 1 /// proline rich 23 domain containing 2(PRR23D1 /// PRR23D2, marker 15292), proline rich 26 (PRR26, marker 15293), proline rich 26 (PRR26, marker 15294), proline rich 29 (PRR29, marker 15295), proline rich 30 (PRR30, marker 15296), proline rich 32 (PRR32, marker 15297), proline rich 34 (PRR34, marker 15298), PRR34 antisense RNA 1 (PRR34-AS1, marker 15299), proline rich 4 (lacrimal) (PRR4, marker 15300), PRR5-ARHGAP8 readthrough (PRR5-ARHGAP8, marker 15301), proline rich 5 like (PRR5L, marker 15302), proline rich 5 like (PRR5L, marker 15303), PRR7 antisense RNA 1 (PRR7-AS1, marker 15304), proline rich 9 (PRR9, marker 15305), proline rich Gla (G-carboxyglutamic acid ) 3 (transmembrane)(PRRG3, marker 15306), proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane)(PRRG4, marker 15307), PRRT3 antisense RNA 1(PRRT3-AS1, marker 15308), paired related homeobox 1( PRRX1, marker 15309), paired related homeobox 1 (PRRX1, marker 15310), paired related homeobox 1 (PRRX1, marker 15311), paired related homeobox 2 (PRRX2, marker 15312), PRRX2 antisense RNA 1 (PRRX2-AS1, marker 15313) ),protease, serine, 1 (trypsin 1)(PRSS1, marker 15314),protease, serine, 12 (neurotrypsin, motopsin)(PRSS12, marker 15315),protease, serine, 12 (neurotrypsin, motopsin)(PRSS12, marker 15316 ),protease, serine, 2 (trypsin 2)(PRSS2, marker 15317),protease, serine, 21 (testisin)(PRSS21, marker 15318),protease, serine, 23(PRSS23, marker 15319),protease, serine 27( PRSS27, marker 15320), protease, serine, 3(PRSS3, marker 15321), protease, serine, 3(PRSS3, marker 15322), protease, serine, 30, pseudogene(PRSS30P, marker 15323), protease, serine, 33( PRSS33, marker 15324), protease, serine, 33(PRSS33, marker 15325), protease, serine 36(PRSS36, marker 15326), protease, serine, 37(PRSS37, marker 15327), protease, serine, 3 pseudogene 1(PRSS3P1 , marker 15328), protease, serine 3 pseudogene 2 (PRSS3P2, marker 15329), protease, serine 50 (PRSS50, marker 15330), protease, serine, 54 (PRSS54, marker 15331), protease, serine, 55 (PRSS55, marker 15332), protease, serine, 58 (PRSS58, marker 15333), proteinase 3 (PRTN3, marker 15334), prune homolog 2 (Drosophila) (PRUNE2, marker 15335), periaxin (PRX, marker 15336), periaxin (PRX, marker 15337), PTPN13-like, Y-linked /// PTPN13-like, Y-linked 2 /// PTPN13-like, Y-linked pseudogene 3(PRY /// PRY2 /// PRYP3, marker 15338), prostate stem cell antigen (PSCA, marker 15339), pleckstrin and Sec7 domain containing (PSD, marker 15340), pleckstrin and Sec7 domain containing 2 (PSD2, marker 15341), pleckstrin and Sec7 domain containing 4 (PSD4, marker 15342), pleckstrin and Sec7 domain containing 4(PSD4, marker 15343),pleckstrin and Sec7 domain containing 4(PSD4, marker 15344),presenilin 1(PSEN1, marker 15345),presenilin 1(PSEN1, marker 15346),presenilin 1(PSEN1, marker 15347), presenilin 1(PSEN1, marker 15348),pregnancy specific beta-1-glycoprotein 1(PSG1, marker 15349),pregnancy specific beta-1-glycoprotein 1(PSG1, marker 15350),pregnancy specific beta-1-glycoprotein 1(PSG1, marker 15351),pregnancy specific beta-1-glycoprotein 11(PSG11, marker 15352),pregnancy specific beta-1-glycoprotein 2(PSG2, marker 15353),pregnancy specific beta-1-glycoprotein 3(PSG3, marker 15354),pregnancy specific beta-1-glycoprotein 3(PSG3, marker 15355),pregnancy specific beta-1-glycoprotein 3(PSG3, marker 15356),pregnancy specific beta-1-glycoprotein 3 /// pregnancy specific beta-1-glycoprotein 5(PSG3 /// PSG5, marker 15357),pregnancy specific beta-1-glycoprotein 4(PSG4, marker 15358),pregnancy specific beta-1-glycoprotein 4 /// pregnancy specific beta-1-glycoprotein 6(PSG4 /// PSG6, marker 15359),pregnancy specific beta-1-glycoprotein 5(PSG5, marker 15360),pregnancy specific beta-1-glycoprotein 6(PSG6, marker 15361),pregnancy specific beta-1-glycoprotein 6(PSG6, marker 15362),pregnancy specific beta-1-glycoprotein 6(PSG6, marker 15363),pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene)(PSG7, marker 15364),pregnancy specific beta-1-glycoprotein 9(PSG9, marker 15365),pregnancy specific beta-1-glycoprotein 9 (PSG9, marker 15366), pregnancy specific beta-1-glycoprotein 9 (PSG9, marker 15367), PC4 and SFRS1 interacting protein 1 (PSIP1, marker 15368), protein serine kinase H2 (PSKH2, marker 15369), proteasome subunit alpha 3 (PSMA3, marker 15370), proteasome subunit alpha 8 (PSMA8, marker 15371), proteasome subunit beta 1 (PSMB1, marker 15372), proteasome subunit beta 2 (PSMB2, marker 15373), proteasome subunit beta 7 (PSMB7, marker 15374), PSMB8 antisense RNA 1 (head to head) (PSMB8-AS1, marker 15375), PSMB8 antisense RNA 1 (head to head) (PSMB8-AS1, marker 15376), proteasome subunit beta 9 (PSMB9 , marker 15377), proteasome 26S subunit, non-ATPase 4 (PSMD4, marker 15378), proteasome 26S subunit, non-ATPase 5 (PSMD5, marker 15379), PSMD5 antisense RNA 1 (head to head) (PSMD5-AS1, marker 15380),PSMD5 antisense RNA 1 (head to head)(PSMD5-AS1, marker 15381),PSMD5 antisense RNA 1 (head to head)(PSMD5-AS1, marker 15382),proteasome 26S subunit, non-ATPase 6(PSMD6, marker 15383), PSMD6 antisense RNA 2 (PSMD6-AS2, marker 15384), proteasome 26S subunit, non-ATPase 9 (PSMD9, marker 15385), PSMG3 antisense RNA 1 (head to head) (PSMG3-AS1, marker 15386), proteasome (prosome, macropain) assembly chaperone 4(PSMG4, marker 15387),proteasome (prosome, macropain) assembly chaperone 4(PSMG4, marker 15388),proteasome (prosome, macropain) assembly chaperone 4(PSMG4, marker 15389),psoriasis susceptibility 1 candidate 1(PSORS1C1, marker 15390), psoriasis susceptibility 1 candidate 2(PSORS1C2, marker 15391), psoriasis susceptibility 1 candidate 3 (non-protein coding)(PSORS1C3, marker 15392), paraspeckle component 1(PSPC1, marker 15393), phosphoserine phosphatase (PSPH, marker 15394), persephin (PSPN, marker 15395), phosphoseryl-tRNA kinase (PSTK, marker 15396), proline-serine-threonine phosphatase interacting protein 1 (PSTPIP1, marker 15397), platelet-activating factor receptor( PTAFR, marker 15398), polypyrimidine tract binding protein 1 (PTBP1, marker 15399), polypyrimidine tract binding protein 1 (PTBP1, marker 15400), pentatricopeptide repeat domain 2 (PTCD2, marker 15401), patched 1 (PTCH1, marker 15402), patched 1(PTCH1, marker 15403),patched 1(PTCH1,marker 15404),patched 2(PTCH2,marker 15405),patched domain containing 1(PTCHD1,marker 15406),patched domain containing 2(PTCHD2,marker 15407),patched domain containing 4 (PTCHD4, marker 15408), pre T-cell antigen receptor alpha (PTCRA, marker 15409), phosphatase and tensin homolog (PTEN, marker 15410), phosphatase and tensin homolog (PTEN, marker 15411), prostaglandin D2 receptor ( DP)(PTGDR,Ma
marker 15412), prostaglandin D2 receptor (DP) (PTGDR, marker 15413), prostaglandin D2 receptor (DP) (PTGDR, marker 15414), prostaglandin D2 receptor 2 (PTGDR2, marker 15415), prostaglandin D2 receptor 2 (PTGDR2, marker 15416) ), prostaglandin D2 synthase 21kDa (brain) (PTGDS, marker 15417), prostaglandin D2 synthase 21kDa (brain) (PTGDS, marker 15418), prostaglandin E receptor 1 (PTGER1, marker 15419), prostaglandin E receptor 1 (PTGER1, marker 15420) ), prostaglandin E receptor 1 (PTGER1, marker 15421), prostaglandin E receptor 2 (PTGER2, marker 15422), prostaglandin E receptor 3 (subtype EP3) (PTGER3, marker 15423), prostaglandin E receptor 3 (subtype EP3) (PTGER3, marker 15424), prostaglandin E receptor 3 (subtype EP3)(PTGER3, marker 15425), prostaglandin E receptor 3 (subtype EP3)(PTGER3, marker 15426), prostaglandin E receptor 3 (subtype EP3)(PTGER3, marker 15427), prostaglandin E receptor 3 (subtype EP3)(PTGER3, marker 15428),prostaglandin E receptor 3 (subtype EP3)(PTGER3, marker 15429),prostaglandin E receptor 3 (subtype EP3)(PTGER3, marker 15430),prostaglandin E receptor 3 (subtype EP3)(PTGER3, marker 15431), prostaglandin E receptor 3 (subtype EP3)(PTGER3, marker 15432), prostaglandin E receptor 4 (subtype EP4)(PTGER4, marker 15433), PTGER4P2-CDK2AP2P2 readthrough transcribed pseudogene(PTGER4P2-CDK2AP2P2, marker 15434), prostaglandin E synthase (PTGES, marker 15435), prostaglandin E synthase (PTGES, marker 15436), prostaglandin E synthase 3 (cytosolic)-like (PTGES3L, marker 15437), prostaglandin F receptor (FP) (PTGFR, marker 15438), prostaglandin F receptor (FP) (PTGFR, marker 15439), prostaglandin I2 (prostacyclin) receptor (IP) (PTGIR, marker 15440), prostaglandin I2 (prostacyclin) receptor (IP) (PTGIR, marker 15441), prostaglandin- endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)(PTGS1, marker 15442),prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)(PTGS1, marker 15443),prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (PTGS1, marker 15444), prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) (PTGS1, marker 15445), prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (PTGS2, marker 15446), parathyroid hormone (PTH, marker 15447), parathyroid hormone 1 receptor (PTH1R, marker 15448), parathyroid hormone 2 receptor (PTH2R, marker 15449), parathyroid hormone-like hormone (PTHLH, marker 15450), parathyroid hormone-like hormone (PTHLH, marker 15451), parathyroid hormone-like hormone (PTHLH, marker 15452), protein tyrosine kinase 2 beta (PTK2B, marker 15453), protein tyrosine kinase 2 beta (PTK2B, marker 15454), protein tyrosine kinase 6 (PTK6) , marker 15455), protein tyrosine kinase 6 (PTK6, marker 15456), prothymosin, alpha (PTMA, marker 15457), parathymosin (PTMS, marker 15458), pleiotrophin (PTN, marker 15459), PTOV1 antisense RNA 1 (PTOV1-AS1 , Marker 15460), PTOV1 antisense RNA 1 (PTOV1-AS1, Marker 15461), PTOV1 antisense RNA 2 (PTOV1-AS2, Marker 15462), PTOV1 antisense RNA 2 (PTOV1-AS2, Marker 15463), PTOV1 antisense RNA 2 (PTOV1 -AS2, marker 15464), protein tyrosine phosphatase type IVA, member 1(PTP4A1, marker 15465), protein tyrosine phosphatase type IVA, member 3(PTP4A3, marker 15466), protein tyrosine phosphatase, non-receptor type 1(PTPN1, marker 15467), protein tyrosine phosphatase, non-receptor type 1(PTPN1, marker 15468), protein tyrosine phosphatase, non-receptor type 1(PTPN1, marker 15469), protein tyrosine phosphatase, non-receptor type 11(PTPN11, marker 15470) ,protein tyrosine phosphatase, non-receptor type 11(PTPN11, marker 15471),protein tyrosine phosphatase, non-receptor type 12(PTPN12, marker 15472),protein tyrosine phosphatase, non-receptor type 18 (brain-derived)(PTPN18, marker 15473), protein tyrosine phosphatase, non-receptor type 18 (brain-derived)(PTPN18, marker 15474), protein tyrosine phosphatase, non-receptor type 2(PTPN2, marker 15475), protein tyrosine phosphatase, non-receptor type 2 (PTPN2, marker 15476), protein tyrosine phosphatase, non-receptor type 2(PTPN2, marker 15477), protein tyrosine phosphatase, non-receptor type 21(PTPN21, marker 15478), protein tyrosine phosphatase, non-receptor type 21(PTPN21) , marker 15479), protein tyrosine phosphatase, non-receptor type 21(PTPN21, marker 15480), protein tyrosine phosphatase, non-receptor type 22 (lymphoid)(PTPN22, marker 15481), protein tyrosine phosphatase, non-receptor type 22 ( lymphoid)(PTPN22, marker 15482), protein tyrosine phosphatase, non-receptor type 22 (lymphoid)(PTPN22, marker 15483), protein tyrosine phosphatase, non-receptor type 22 (lymphoid)(PTPN22, marker 15484), protein tyrosine phosphatase , non-receptor type 23 (PTPN23, marker 15485), protein tyrosine phosphatase, non-receptor type 3 (PTPN3, marker 15486), protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte) (PTPN4, marker 15487), protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)(PTPN5, marker 15488),protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)(PTPN5, marker 15489),protein tyrosine phosphatase, non-receptor type 7( PTPN7, marker 15490), protein tyrosine phosphatase, non-receptor type 7(PTPN7, marker 15491), protein tyrosine phosphatase, non-receptor type 9(PTPN9, marker 15492), protein tyrosine phosphatase, receptor type, B(PTPRB, marker 15493),protein tyrosine phosphatase, receptor type, B(PTPRB,marker 15494),protein tyrosine phosphatase, receptor type, B(PTPRB,marker 15495),protein tyrosine phosphatase, receptor type, B(PTPRB,marker 15496),protein tyrosine phosphatase, receptor type, C(PTPRC, marker 15497),protein tyrosine phosphatase, receptor type, C(PTPRC, marker 15498),protein tyrosine phosphatase, receptor type, C(PTPRC, marker 15499),protein tyrosine phosphatase, receptor type, C(PTPRC, marker 15500), protein tyrosine phosphatase, receptor type, C(PTPRC, marker 15501), protein tyrosine phosphatase, receptor type, D(PTPRD, marker 15502), PTPRD antisense RNA 1(PTPRD-AS1, marker 15503) ,protein tyrosine phosphatase, receptor type, E(PTPRE,marker 15504),protein tyrosine phosphatase, receptor type, E(PTPRE,marker 15505),protein tyrosine phosphatase, receptor type, G(PTPRG,marker 15506),protein tyrosine phosphatase, receptor type, H(PTPRH, marker 15507),protein tyrosine phosphatase, receptor type, J(PTPRJ,marker 15508),protein tyrosine phosphatase, receptor type, J(PTPRJ,marker 15509),protein tyrosine phosphatase, receptor type, K( PTPRK, marker 15510), protein tyrosine phosphatase, receptor type, N(PTPRN, marker 15511), protein tyrosine phosphatase, receptor type, N polypeptide 2(PTPRN2, marker 15512), protein tyrosine phosphatase, receptor type, N polypeptide 2(PTPRN2) , marker 15513), protein tyrosine phosphatase, receptor type, N polypeptide 2(PTPRN2, marker 15514), protein tyrosine phosphatase, receptor type, N polypeptide 2(PTPRN2, marker 15515), protein tyrosine phosphatase, receptor type, N polypeptide 2( PTPRN2, marker 15516), protein tyrosine phosphatase, receptor type, O(PTPRO, marker 15517), protein tyrosine phosphatase, receptor type, O(PTPRO, marker 15518), protein tyrosine phosphatase, receptor type, R(PTPRR, marker 15519) ,protein tyrosine phosphatase, receptor type, R(PTPRR, marker 15520),protein tyrosine phosphatase, receptor type, S(PTPRS,marker 15521),protein tyrosine phosphatase, receptor type, T(PTPRT,marker 15522),peptidyl-tRNA hydrolase 1 homolog (PTRH1, marker 15523), pituitary tumor-transforming 2 (PTTG2, marker 15524), pumilio RNA binding family member 2 (PUM2, marker 15525), pumilio RNA binding family member 3 (PUM3, marker 15526), purine-rich element binding protein A (PURA, marker 15527), purine-rich element binding protein A (PURA, marker 15528), purine-rich element binding protein B (PURB, marker 15529), purine-rich element binding protein G (PURG, marker 15530), pseudouridylate synthase 10 (PUS10, marker 15531), pseudouridylate synthase 10 (PUS10, marker 15532), pseudouridylate synthase 7-like (PUS7L, marker 15533), parvalbumin (PVALB, marker 15534), poliovirus receptor (PVR, marker 15535) ), poliovirus receptor related immunoglobulin domain containing (PVRIG, marker 15536), poliovirus receptor-related 1 (herpesvirus entry mediator C) (PVRL1, marker 15537), poliovirus receptor-related 1 (herpesvirus entry mediator C) (PVRL1, marker 15538) ,PVRL3 antisense RNA 1(PVRL3-AS1, marker 15539),Pvt1 oncogene (non-protein coding)(PVT1, marker 15540),Pvt1 oncogene (non-protein coding)(PVT1, marker 15541),Pvt1 oncogene (non-protein coding) coding)(PVT1, marker 15542), Prader-Willi region non-protein coding RNA 1(PWRN1, marker 15543), Prader-Willi region non-protein coding RNA 1(PWRN1, marker 15544), Prader-Willi region non-protein coding RNA 1(PWRN1, marker 15545), Prader-Willi region non-protein coding RNA 2(PWRN2, marker 15546), Prader-Willi region non-protein coding RNA 2(PWRN2, marker 15547), PWWP domain containing 2A(PWWP2A ,marker 15548),PWWP domain containing 2A(PWWP2A,marker 15549),PWWP domain containing 2B(PWWP2B,marker 15550),PWWP domain containing 2B(PWWP2B,marker 15551),PX domain containing 1(PXDC1,marker 15552),peroxidasin like(PXDNL, marker 15553),PX domain containing serine/threonine kinase(PXK, marker 15554),peroxisomal membrane protein 4(PXMP4, marker 15555),peroxisomal, testis specific 1(PXT1, marker 15556),2-phosphoxylose phosphatase 1 (PXYLP1, marker 15557), PYCARD antisense RNA 1 (PYCARD-AS1, marker 15558), PYD (pyrin domain) containing 1 (PYDC1, marker 15559), phosphorylase, glycogen; brain (PYGB, marker 15560), pygopus family PHD finger 1(PYGO1, marker 15561),pygopus family PHD finger 1(PYGO1,marker 15562),pyrin and HIN domain family, member 1(PYHIN1,marker 15563),pyrin and HIN domain family, member 1(PYHIN1,marker 15564), pyridine nucleotide-disulphide oxidoreductase domain 1(PYROXD1, marker 15565),pyridine nucleotide-disulphide oxidoreductase domain 2(PYROXD2, marker 15566),pyridine nucleotide-disulphide oxidoreductase domain 2(PYROXD2, marker 15567),peptide YY(PYY, marker 15568) ,peptide YY(PYY, marker 15569),peptide YY, 2 (pseudogene)(PYY2, marker 15570),pregnancy-zone protein(PZP,marker 15571),QKI, KH domain containing, RNA binding(QKI,marker 15572), glutaminyl-peptide cyclotransferase-like (QPCTL, marker 15573), quinolinate phosphoribosyltransferase (QPRT, marker 15574), quinolinate phosphoribosyltran
sferase (QPRT, marker 15575), pyroglutamylated RFamide peptide receptor (QRFPR, marker 15576), glutamine-rich 1 (QRICH1, marker 15577), glutamine rich 2 (QRICH2, marker 15578), quiescin Q6 sulfhydryl oxidase 1 (QSOX1, marker 15579) ), quiescin Q6 sulfhydryl oxidase 2(QSOX2, marker 15580),queuine tRNA-ribosyltransferase domain containing 1(QTRTD1, marker 15581),queuine tRNA-ribosyltransferase domain containing 1(QTRTD1, marker 15582),R3H domain containing 1(R3HDM1, marker 15583), R3H domain containing-like(R3HDML, marker 15584),RAB11B, member RAS oncogene family(RAB11B, marker 15585),RAB11 family interacting protein 3 (class II)(RAB11FIP3, marker 15586),RAB14, member RAS oncogene family (RAB14, marker 15587),RAB18, member RAS oncogene family(RAB18, marker 15588),RAB18, member RAS oncogene family(RAB18, marker 15589),RAB20, member RAS oncogene family(RAB20, marker 15590),RAB21, member RAS oncogene family(RAB21, marker 15591),RAB26, member RAS oncogene family(RAB26, marker 15592),RAB27B, member RAS oncogene family(RAB27B, marker 15593),RAB27B, member RAS oncogene family(RAB27B, marker 15594),RAB28, member RAS oncogene family(RAB28, marker 15595),RAB28, member RAS oncogene family(RAB28, marker 15596),RAB29, member RAS oncogene family(RAB29, marker 15597),RAB2A, member RAS oncogene family(RAB2A, marker 15598), RAB30, member RAS oncogene family(RAB30, marker 15599),RAB37, member RAS oncogene family(RAB37, marker 15600),RAB3C, member RAS oncogene family(RAB3C, marker 15601),RAB3C, member RAS oncogene family(RAB3C, marker 15602) ),RAB3C, member RAS oncogene family(RAB3C,marker 15603),RAB3C, member RAS oncogene family(RAB3C,marker 15604),RAB3D, member RAS oncogene family(RAB3D,marker 15605),RAB3 GTPase activating protein subunit 1 (catalytic) (RAB3GAP1, marker 15606),RAB3 GTPase activating protein subunit 2 (non-catalytic)(RAB3GAP2, marker 15607),RAB3 GTPase activating protein subunit 2 (non-catalytic)(RAB3GAP2, marker 15608),RAB3A interacting protein (rabin3)- like 1(RAB3IL1, marker 15609),RAB3A interacting protein(RAB3IP,marker 15610),RAB3A interacting protein(RAB3IP,marker 15611),RAB3A interacting protein(RAB3IP,marker 15612),RAB40A, member RAS oncogene family(RAB40A,marker 15613) ),RAB40A, member RAS oncogene family-like(RAB40AL, marker 15614),RAB40B, member RAS oncogene family(RAB40B, marker 15615),RAB40B, member RAS oncogene family(RAB40B, marker 15616),RAB40C, member RAS oncogene family( RAB40C, marker 15617),RAB40C, member RAS oncogene family(RAB40C,marker 15618),RAB5A, member RAS oncogene family(RAB5A,marker 15619),RAB6A, member RAS oncogene family(RAB6A,marker 15620),RAB7A, member RAS oncogene family(RAB7A, marker 15621),RAB7A, member RAS oncogene family(RAB7A, marker 15622),RAB7B, member RAS oncogene family(RAB7B, marker 15623),RAB7B, member RAS oncogene family(RAB7B, marker 15624),RAB9B, member RAS oncogene family(RAB9B, marker 15625),RAB9B, member RAS oncogene family pseudogene 1(RAB9BP1, marker 15626),rabaptin, RAB GTPase binding effector protein 2(RABEP2, marker 15627),Rab9 effector protein with kelch motifs(RABEPK, marker 15628),RAB GTPase activating protein 1-like(RABGAP1L, marker 15629),RAB GTPase activating protein 1-like(RABGAP1L, marker 15630),ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)( RAC2, marker 15631), Rac GTPase activating protein 1 pseudogene (RACGAP1P, marker 15632), RAD18 E3 ubiquitin protein ligase (RAD18, marker 15633), RAD18 E3 ubiquitin protein ligase (RAD18, marker 15634), RAD21 antisense RNA 1 (RAD21- AS1, marker 15635), RAD21 cohesin complex component like 1 (RAD21L1, marker 15636), RAD21 cohesin complex component like 1 (RAD21L1, marker 15637), RAD23 homolog B, nucleotide excision repair protein (RAD23B, marker 15638), RAD51 recombinase( RAD51, marker 15639), RAD51 antisense RNA 1 (head to head)(RAD51-AS1, marker 15640), RAD51 paralog B(RAD51B, marker 15641), RAD51 paralog B(RAD51B, marker 15642), RAD51 paralog B(RAD51B, marker 15643), RAD51 paralog B(RAD51B, marker 15644), RAD51L3-RFFL readthrough /// ring finger and FYVE-like domain containing E3 ubiquitin protein ligase(RAD51L3-RFFL /// RFFL, marker 15645), RAD52 homolog, DNA repair protein (RAD52, marker 15646), RAD52 homolog, DNA repair protein (RAD52, marker 15647), RAD9 checkpoint clamp component B (RAD9B, marker 15648), RAD9 checkpoint clamp component B (RAD9B, marker 15649), ribonucleic acid export 1 (RAE1, marker 15650), retinoic acid early transcript 1E(RAET1E, marker 15651), recombination activating gene 1(RAG1, marker 15652), recombination activating gene 1(RAG1, marker 15653), recombination activating gene 2(RAG2, marker 15654) ),retinoic acid induced 1(RAI1, marker 15655),retinoic acid induced 1(RAI1, marker 15656),Ral GTPase activating protein, alpha subunit 1 (catalytic)(RALGAPA1, marker 15657),Ral GTPase activating protein, alpha subunit 1 (catalytic)(RALGAPA1, marker 15658), Ral GTPase activating protein, alpha subunit 1 (catalytic)(RALGAPA1, marker 15659), Ral GTPase activating protein, alpha subunit 1 (catalytic) /// Ral GTPase activating protein, alpha subunit 1 (catalytic) pseudogene(RALGAPA1 /// RALGAPA1P, marker 15660), Ral GTPase activating protein, alpha subunit 1 (catalytic) /// Ral GTPase activating protein, alpha subunit 1 (catalytic) pseudogene(RALGAPA1 /// RALGAPA1P, marker 15661 ),Ral GTPase activating protein, alpha subunit 2 (catalytic)(RALGAPA2, marker 15662),Ral GTPase activating protein, alpha subunit 2 (catalytic)(RALGAPA2, marker 15663),Ral GEF with PH domain and SH3 binding motif 1(RALGPS1 , Marker 15664), Ral GEF with PH domain and SH3 binding motif 1 (RALGPS1, Marker 15665), Ral GEF with PH domain and SH3 binding motif 2 (RALGPS2, Marker 15666), RALY antisense RNA 1 (RALY-AS1, Marker 15667) ),RALY RNA binding protein-like(RALYL, marker 15668),receptor (G protein-coupled) activity modifying protein 1(RAMP1,marker 15669),receptor (G protein-coupled) activity modifying protein 2(RAMP2,marker 15670) ,RAMP2 antisense RNA 1(RAMP2-AS1, marker 15671),RAMP2 antisense RNA 1(RAMP2-AS1,marker 15672),receptor (G protein-coupled) activity modifying protein 3(RAMP3,marker 15673),RAN binding protein 10( RANBP10, marker 15674), RAN binding protein 10 (RANBP10, marker 15675), RAN binding protein 17 (RANBP17, marker 15676), RAN binding protein 3 (RANBP3, marker 15677), RAN binding protein 3-like (RANBP3L, marker 15678) ), RAN binding protein 9 (RANBP9, marker 15679), RAP1A, member of RAS oncogene family (RAP1A, marker 15680), RAP1A, member of RAS oncogene family (RAP1A, marker 15681), RAP1 GTPase activating protein (RAP1GAP, marker 15682) ),RAP2A, member of RAS oncogene family(RAP2A,marker 15683),RAP2A, member of RAS oncogene family(RAP2A,marker 15684),RAP2C antisense RNA 1(RAP2C-AS1,marker 15685),Rap guanine nucleotide exchange factor 1( RAPGEF1, marker 15686), Rap guanine nucleotide exchange factor 2 (RAPGEF2, marker 15687), Rap guanine nucleotide exchange factor 2 (RAPGEF2, marker 15688), Rap guanine nucleotide exchange factor 3 (RAPGEF3, marker 15689), Rap guanine nucleotide exchange factor 3 (RAPGEF3, marker 15690), Rap guanine nucleotide exchange factor 4 (RAPGEF4, marker 15691), RAPGEF4 antisense RNA 1 (RAPGEF4-AS1, marker 15692), Rap guanine nucleotide exchange factor 5 (RAPGEF5, marker 15693), Rap guanine nucleotide exchange factor 5 (RAPGEF5, marker 15694), Rap guanine nucleotide exchange factor 6 (RAPGEF6, marker 15695), Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 (RAPH1, marker 15696), receptor-associated protein of the synapse(RAPSN, marker 15697), retinoic acid receptor, alpha(RARA, marker 15698), retinoic acid receptor, alpha(RARA, marker 15699), retinoic acid receptor, alpha(RARA, marker 15700), retinoic acid receptor, alpha( RARA, marker 15701), retinoic acid receptor, beta(RARB, marker 15702), retinoic acid receptor, beta(RARB, marker 15703), retinoic acid receptor, beta(RARB, marker 15704), retinoic acid receptor, gamma(RARG, marker 15705), retinoic acid receptor responder (tazarotene induced) 1(RARRES1, marker 15706), retinoic acid receptor responder (tazarotene induced) 1(RARRES1, marker 15707), retinoic acid receptor responder (tazarotene induced) 1(RARRES1, marker 15708) ), arginyl-tRNA synthetase 2, mitochondrial(RARS2, marker 15709),arginyl-tRNA synthetase 2, mitochondrial(RARS2, marker 15710),arginyl-tRNA synthetase 2, mitochondrial(RARS2, marker 15711),RAS p21 protein activator 3( RASA3, marker 15712),RAS protein activator like 1 (GAP1 like)(RASAL1, marker 15713),RAS protein activator like 2(RASAL2, marker 15714),RAS protein activator like 2(RASAL2, marker 15715),RAS protein activator like 2(RASAL2, marker 15716),RAS protein activator like 3(RASAL3,marker 15717),RASD family, member 2(RASD2,marker 15718),RAS and EF-hand domain containing(RASEF,marker 15719),RasGEF domain family member 1A (RASGEF1A, marker 15720), RasGEF domain family member 1B (RASGEF1B, marker 15721), RasGEF domain family member 1B (RASGEF1B, marker 15722), RasGEF domain family member 1C (RASGEF1C, marker 15723), Ras protein-specific guanine nucleotide -releasing factor 1(RASGRF1, marker 15724),Ras protein-specific guanine nucleotide-releasing factor 1(RASGRF1, marker 15725),Ras protein-specific guanine nucleotide-releasing factor 1(RASGRF1, marker 15726),Ras protein-specific guanine nucleotide-releasing factor 1(RASGRF1, marker 15727),RAS guanyl releasing protein 2 (calcium and DAG-regulated)(RASGRP2, marker 15728),RAS guanyl releasing protein 2 (calcium and DAG-regulated)(RASGRP2, marker 15729), RAS guanyl releasing protein 3 (calcium and DAG-regulated)(RASGRP3, marker 15730),RAS guanyl releasing protein 3 (calcium and DAG-regulated)(RASGRP3, marker 15731),RAS guanyl releasing protein 4(RASGRP4, marker 15732), RAS guanyl releasing protein 4(RASGRP4, marker 15733),Ras interacting protein 1(RASIP1, marker 15734),RAS-like, family 10, member A(RASL10A, marker 15735),RAS-like, family 10, member B(RASL10B ,marker 15736),RAS-like, family 11, member A(RASL11A,marker 15737),RAS-like, family 11, member B(RASL11B,marker 15738),RASSF1 antisense RNA 1(RASSF1-AS1,marker 15739), Ras association (RalGDS/AF-6) domain family (N-terminal) member 10(RASSF10, marker 15740),Ras association (RalGDS/AF-6) domain family member 4(RASSF4, marker 15741),Ras association (RalGDS/ AF-6) domain family member 4(RASSF4, marker 15742), Ras as
association (RalGDS/AF-6) domain family member 5(RASSF5, marker 15743),Ras association (RalGDS/AF-6) domain family member 5(RASSF5, marker 15744),Ras association (RalGDS/AF-6) domain family member 6(RASSF6, marker 15745), Ras association (RalGDS/AF-6) domain family member 6(RASSF6, marker 15746), Ras association (RalGDS/AF-6) domain family (N-terminal) member 8(RASSF8, Marker 15747), Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 (RASSF8, Marker 15748), RASSF8 atnisense RNA 1 (RASSF8-AS1, Marker 15749), Ras association (RalGDS/AF-6 ) domain family (N-terminal) member 9 (RASSF9, marker 15750), Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 (RASSF9, marker 15751), ribonucleoprotein, PTB-binding 2 (RAVER2) , marker 15752), retina and anterior neural fold homeobox 2(RAX2, marker 15753), RBAK downstream neighbor (non-protein coding)(RBAKDN, marker 15754), retinoblastoma binding protein 4 pseudogene 4(RBBP4P4, marker 15755), retinoblastoma binding protein 6 (RBBP6, marker 15756), retinoblastoma binding protein 6 (RBBP6, marker 15757), RBBP8 N-terminal like (RBBP8NL, marker 15758), retinoblastoma binding protein 9 (RBBP9, marker 15759), ribosome binding factor A (putative) (RBFA, Marker 15760), RBFA downstream neighbor (non-protein coding) (RBFADN, Marker 15761), RBFA downstream neighbor (non-protein coding) (RBFADN, Marker 15762), RNA binding protein, fox-1 homolog (C. elegans) 1(RBFOX1, marker 15763),RNA binding protein, fox-1 homolog (C. elegans) 1(RBFOX1, marker 15764),RNA binding protein, fox-1 homolog (C. elegans) 1(RBFOX1, marker 15765 ),RNA binding protein, fox-1 homolog (C. elegans) 2(RBFOX2, marker 15766),retinoblastoma-like 1(RBL1, marker 15767),retinoblastoma-like 1(RBL1, marker 15768),RBM12B antisense RNA 1( RBM12B-AS1, marker 15769), RBM14-RBM4 readthrough /// RNA binding motif protein 4 (RBM14-RBM4 /// RBM4, marker 15770), RNA binding motif protein 15 (RBM15, marker 15771), RNA binding motif protein 17 (RBM17, marker 15772),RNA binding motif protein 26(RBM26, marker 15773),RNA binding motif protein 26(RBM26, marker 15774),RBM26 antisense RNA 1(RBM26-AS1,marker 15775),RNA binding motif protein 33( RBM33, Marker 15776), RNA binding motif protein 33 (RBM33, Marker 15777), RNA binding motif protein 33 (RBM33, Marker 15778), RNA binding motif protein 34 (RBM34, Marker 15779), RNA binding motif protein 43 (RBM43, RNA binding motif protein 46 (RBM46, marker 15781), RNA binding motif protein 46 (RBM46, marker 15782), RNA binding motif protein 47 (RBM47, marker 15783), RNA binding motif protein 47 (RBM47, marker 15784) ),RNA binding motif protein 48(RBM48, marker 15785),RNA binding motif, single stranded interacting protein 2(RBMS2,marker 15786),RNA binding motif, single stranded interacting protein 2(RBMS2,marker 15787),RNA binding motif, single stranded interacting protein 3(RBMS3, marker 15788),RNA binding motif, single stranded interacting protein 3(RBMS3, marker 15789),RNA binding motif, single stranded interacting protein 3(RBMS3, marker 15790),RNA binding motif, single stranded protein interacting 3(RBMS3, marker 15791),RBMS3 antisense RNA 3(RBMS3-AS3,marker 15792),RNA binding motif protein, X-linked(RBMX, marker 15793),RNA binding motif protein, X-linked-like 2( RBMXL2, marker 15794), RNA binding motif protein, X-linked-like 2(RBMXL2, marker 15795), RNA binding motif protein, Y-linked, family 1, member A1 /// RNA binding motif protein, Y-linked, family 1, member B /// RNA binding motif protein, Y-linked, family 1, member D /// RNA binding motif protein, Y-linked, family 1, member E /// RNA binding motif protein, Y-linked , family 1, member F /// RNA binding motif protein, Y-linked, family 1, member J(RBMY1A1 /// RBMY1B /// RBMY1D /// RBMY1E /// RBMY1F /// RBMY1J, marker 15796), RNA binding motif protein, Y-linked, family 2, member A pseudogene /// RNA binding motif protein, Y-linked, family 2, member B pseudogene(RBMY2AP /// RBMY2BP, marker 15797),RNA binding motif protein, Y -linked, family 2, member F pseudogene(RBMY2FP, marker 15798),RNA binding motif protein, Y-linked, family 2, member F pseudogene(RBMY2FP, marker 15799),RNA binding motif protein, Y-linked, family 3, member A pseudogene (RBMY3AP, marker 15800), RNA binding motif protein, Y-linked, family 3, member A pseudogene (RBMY3AP, marker 15801), retinol binding protein 1, cellular (RBP1, marker 15802), retinol binding protein 2, cellular(RBP2, marker 15803), retinol binding protein 3, interstitial(RBP3, marker 15804), retinol binding protein 4, plasma(RBP4, marker 15805), retinol binding protein 5, cellular(RBP5, marker 15806), retinol binding protein 5, cellular(RBP5, marker 15807), recombination signal binding protein for immunoglobulin kappa J region(RBPJ, marker 15808), recombination signal binding protein for immunoglobulin kappa J region-like(RBPJL, marker 15809), RNA binding protein with multiple splicing (RBPMS, marker 15810), RNA binding protein with multiple splicing (RBPMS, marker 15811), RBPMS antisense RNA 1 (RBPMS-AS1, marker 15812), regulator of calcineurin 1 (RCAN1, marker 15813), regulator of chromosome condensation (RCC1) ) and BTB (POZ) domain containing protein 1(RCBTB1, marker 15814),regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1(RCBTB1, marker 15815),regulator of chromosome condensation (RCC1) and BTB ( POZ) domain containing protein 2 (RCBTB2, marker 15816), RCC1 domain containing 1 (RCCD1, marker 15817), Ras converting CAAX endopeptidase 1 (RCE1, marker 15818), RNA terminal phosphate cyclase-like 1 (RCL1, marker 15819), reticulocalbin 3, EF-hand calcium binding domain (RCN3, marker 15820), REST corepressor 1 (RCOR1, marker 15821), REST corepressor 3 (RCOR3, marker 15822), RCSD domain containing 1 (RCSD1, marker 15823), RCSD domain containing 1 (RCSD1, marker 15824), recoverin (RCVRN, marker 15825), retinal degeneration 3 (RD3, marker 15826), retinol dehydrogenase 10 (all-trans) (RDH10, marker 15827), retinol dehydrogenase 10 (all-trans) ( RDH10, Marker 15828), retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (RDH11, Marker 15829), retinol dehydrogenase 12 (all-trans/9-cis/11-cis) (RDH12, Marker 15830 ), retinol dehydrogenase 13 (all-trans/9-cis) (RDH13, marker 15831), retinol dehydrogenase 16 (all-trans) (RDH16, marker 15832), retinol dehydrogenase 5 (11-cis/9-cis) (RDH5 , marker 15833), retinol dehydrogenase 8 (all-trans) (RDH8, marker 15834), radixin (RDX, marker 15835), REC114 meiotic recombination protein (REC114, marker 15836), REC8 meiotic recombination protein (REC8, marker 15837), reversion-inducing-cysteine-rich protein with kazal motifs(RECK, marker 15838),RecQ helicase-like 5(RECQL5, marker 15839),RecQ helicase-like 5(RECQL5, marker 15840),RecQ helicase-like 5(RECQL5, marker 15841), regenerating islet-derived 1 alpha(REG1A, marker 15842), regenerating islet-derived 1 beta(REG1B, marker 15843), regenerating islet-derived 1 pseudogene(REG1P, marker 15844), regenerating islet-derived 3 alpha( REG3A, marker 15845), regenerating islet-derived 3 alpha (REG3A, marker 15846), regenerating islet-derived 3 gamma (REG3G, marker 15847), regenerating islet-derived family, member 4 (REG4, marker 15848), regenerating islet- derived family, member 4(REG4, marker 15849), regenerating islet-derived family, member 4(REG4, marker 15850), v-rel avian reticuloendotheliosis viral oncogene homolog(REL, marker 15851), RELT-like 1(RELL1, marker 15852), RAS (RAD and GEM)-like GTP-binding 1 (REM1, marker 15853), renin (REN, marker 15854), renin binding protein (RENBP, marker 15855), replication initiator 1 (REPIN1, marker 15856), replication initiator 1(REPIN1, marker 15857),RALBP1 associated Eps domain containing 1(REPS1, marker 15858),RALBP1 associated Eps domain containing 1(REPS1, marker 15859),RALBP1 associated Eps domain containing 2(REPS2, marker 15860),RALBP1 associated Eps domain containing 2(REPS2, marker 15861),arginine-glutamic acid dipeptide (RE) repeats(RERE,marker 15862),arginine-glutamic acid dipeptide (RE) repeats(RERE,marker 15863),arginine-glutamic acid dipeptide ( RE) repeats(RERE, marker 15864),RAS-like, estrogen-regulated, growth inhibitor(RERG,marker 15865),RAS-like, estrogen-regulated, growth inhibitor(RERG,marker 15866),RERG/RAS-like( RERGL, marker 15867), ret proto-oncogene(RET, marker 15868), ret proto-oncogene(RET, marker 15869), resistin(RETN, marker 15870), resistin like beta(RETNLB, marker 15871), resistin like beta( RETNLB, marker 15872),REV1, DNA directed polymerase(REV1,marker 15873),REX1, RNA exonuclease 1 homolog(REXO1,marker 15874),REX1, RNA exonuclease 1 homolog(REXO1,marker 15875),REX1, RNA exonuclease 1 homolog -like 1, pseudogene(REXO1L1P, marker 15876),ring finger and FYVE-like domain containing E3 ubiquitin protein ligase(RFFL,marker 15877),ring finger and FYVE-like domain containing E3 ubiquitin protein ligase(RFFL,marker 15878), ring finger and FYVE-like domain containing E3 ubiquitin protein ligase(RFFL, marker 15879),ret finger protein-like 1(RFPL1, marker 15880),RFPL1 antisense RNA 1(RFPL1S, marker 15881),RFPL1 antisense RNA 1 /// RFPL3 antisense (RFPL1S /// RFPL3S, marker 15882), ret finger protein-like 2 (RFPL2, marker 15883), ret finger protein-like 3 (RFPL3, marker 15884), RFPL3 antisense (RFPL3S, marker 15885), RFT1 homolog (RFT1, marker 15886),raftlin, lipid raft linker 1(RFTN1, marker 15887),raftlin family member 2(RFTN2, marker 15888),regulatory factor X, 1 (influences HLA class II expression)(RFX1, marker 15889), regulatory factor X, 2 (influences HLA class II expression)(RFX2, marker 15890),regulatory factor X, 2 (influences HLA class II expression)(RFX2, marker 15891),regulatory factor (RFX3, marker 15892), regulatory factor X, 4 (influences HLA class II expression)(RFX4, marker 15893), regulatory factor X, 4 (influences HLA class II expression)(RFX4, marker 15894), regulatory factor X, 6 (RFX6, marker 15895), retrotransposon gag domain containing 1(RGAG1, marker 15896), regulator of cell cycle(RGCC, marker 15897), regulator of cell cycle(RGCC, marker 15898), ral guanine nucleotide dissociation stimulator-like 3( RGL3, marker 15899), ral guanine nucleotide dissociation stimulator-like 3 (RGL3, marker 15900), ral guanine nucleotide dissociation stimulator-like 4 (RGL4, marker 15901), repulsive guidance molecule family member a (RGMA, marker 15902), repulsive guidance
molecule family member b(RGMB, marker 15903),RGMB antisense RNA 1(RGMB-AS1, marker 15904),RANBP2-like and GRIP domain containing 1 /// RANBP2-like and GRIP domain containing 2(RGPD1 /// RGPD2, Marker 15905), RGPD4 antisense RNA 1 (head to head)(RGPD4-AS1, Marker 15906), RANBP2-like and GRIP domain containing 5 /// RANBP2-like and GRIP domain containing 6 /// RANBP2-like and GRIP domain containing 8(RGPD5 /// RGPD6 /// RGPD8, marker 15907),retinal G protein coupled receptor(RGR, marker 15908),retinal G protein coupled receptor(RGR, marker 15909),retinal G protein coupled receptor(RGR, marker 15909) 15910),regulator of G-protein signaling 1(RGS1,marker 15911),regulator of G-protein signaling 1(RGS1,marker 15912),regulator of G-protein signaling 1(RGS1,marker 15913),regulator of G-protein signaling 10 (RGS10, marker 15914), regulator of G-protein signaling 11 (RGS11, marker 15915), regulator of G-protein signaling 11 (RGS11, marker 15916), regulator of G-protein signaling 11 (RGS11, marker 15917) ,regulator of G-protein signaling 12(RGS12, marker 15918),regulator of G-protein signaling 12(RGS12,marker 15919),regulator of G-protein signaling 12(RGS12,marker 15920),regulator of G-protein signaling 12 (RGS12, marker 15921),regulator of G-protein signaling 12(RGS12,marker 15922),regulator of G-protein signaling 12(RGS12,marker 15923),regulator of G-protein signaling 12(RGS12,marker 15924),regulator of G-protein signaling 13(RGS13, marker 15925),regulator of G-protein signaling 13(RGS13, marker 15926),regulator of G-protein signaling 13(RGS13, marker 15927),regulator of G-protein signaling 14(RGS14 , marker 15928), regulator of G-protein signaling 16 (RGS16, marker 15929), regulator of G-protein signaling 18 (RGS18, marker 15930), regulator of G-protein signaling 20 (RGS20, marker 15931), regulator of G -protein signaling 22 (RGS22, marker 15932), regulator of G-protein signaling 3 (RGS3, marker 15933), regulator of G-protein signaling 3 (RGS3, marker 15934), regulator of G-protein signaling 4 (RGS4, marker 15935),regulator of G-protein signaling 4(RGS4, marker 15936),regulator of G-protein signaling 4(RGS4,marker 15937),regulator of G-protein signaling 5(RGS5,marker 15938),regulator of G-protein signaling 5(RGS5, marker 15939),regulator of G-protein signaling 6(RGS6,marker 15940),regulator of G-protein signaling 6(RGS6,marker 15941),regulator of G-protein signaling 6(RGS6,marker 15942) ,regulator of G-protein signaling 6(RGS6, marker 15943),regulator of G-protein signaling 7(RGS7,marker 15944),regulator of G-protein signaling 7(RGS7,marker 15945),regulator of G-protein signaling 7 binding protein (RGS7BP, marker 15946), regulator of G-protein signaling 8 (RGS8, marker 15947), regulator of G-protein signaling 8 (RGS8, marker 15948), regulator of G-protein signaling 9 (RGS9, marker 15949) ,regulator of G protein signaling 9 binding protein(RGS9BP,marker 15950),regulator of G-protein signaling like 1(RGSL1,marker 15951),Rh-associated glycoprotein(RHAG,marker 15952),Rh-associated glycoprotein(RHAG,marker 15953),Rh-associated glycoprotein(RHAG, marker 15954),rhomboid domain containing 1(RHBDD1,marker 15955),rhomboid domain containing 1(RHBDD1,marker 15956),rhomboid 5 homolog 1 (Drosophila)(RHBDF1,marker 15957), rhomboid, veinlet-like 1 (Drosophila)(RHBDL1, marker 15958),rhomboid, veinlet-like 2 (Drosophila)(RHBDL2, marker 15959),rhomboid, veinlet-like 2 (Drosophila)(RHBDL2, marker 15960),rhomboid, veinlet-like 2 (Drosophila)(RHBDL2, marker 15961),rhomboid, veinlet-like 3 (Drosophila)(RHBDL3, marker 15962),rhomboid, veinlet-like 3 (Drosophila)(RHBDL3, marker 15963),rhomboid, veinlet- like 3 (Drosophila)(RHBDL3, marker 15964),Rh family, B glycoprotein (gene/pseudogene)(RHBG, marker 15965),Rh blood group, CcEe antigens(RHCE,marker 15966),Rh blood group, CcEe antigens // / Rh blood group, D antigen(RHCE /// RHD, marker 15967),Rh family, C glycoprotein(RHCG, marker 15968),Rh blood group, D antigen(RHD, marker 15969),Rh blood group, D antigen( RHD, marker 15970), Rh blood group, D antigen(RHD, marker 15971), Ras homolog enriched in brain(RHEB, marker 15972), Ras homolog enriched in brain(RHEB, marker 15973), rhodopsin(RHO, marker 15974) , rhodopsin (RHO, marker 15975), ras homolog family member A (RHOA, marker 15976), ras homolog family member B (RHOB, marker 15977), ras homolog family member B (RHOB, marker 15978), ras homolog family member B (RHOB, marker 15979), Rho-related BTB domain containing 2(RHOBTB2, marker 15980), Rho-related BTB domain containing 3(RHOBTB3, marker 15981), Rho-related BTB domain containing 3(RHOBTB3, marker 15982) homolog family member C (RHOC, marker 15983), ras homolog family member F (in filopodia) (RHOF, marker 15984), ras homolog family member F (in filopodia) (RHOF, marker 15985), ras homolog family member H (RHOH , marker 15986), ras homolog family member J(RHOJ, marker 15987), ras homolog family member J(RHOJ, marker 15988), ras homolog family member J(RHOJ, marker 15989), ras homolog family member J(RHOJ, marker 15990), ras homolog family member J (RHOJ, marker 15991), ras homolog family member J (RHOJ, marker 15992), ras homolog family member Q (RHOQ, marker 15993), ras homolog family member T1 (RHOT1, marker 15994) ,ras homolog family member V(RHOV,marker 15995),Rhox homeobox family, member 1(RHOXF1,marker 15996),Rhox homeobox family, member 2 /// Rhox homeobox family, member 2B(RHOXF2 /// RHOXF2B,marker 15997 ), rhophilin, Rho GTPase binding protein 1(RHPN1, marker 15998),RIB43A domain with coiled-coils 1(RIBC1, marker 15999),RIB43A domain with coiled-coils 1(RIBC1, marker 16000),RIB43A domain with coiled-coils 2(RIBC2, marker 16001), RPTOR independent companion of MTOR, complex 2(RICTOR, marker 16002), replication timing regulatory factor 1(RIF1, marker 16003), replication timing regulatory factor 1(RIF1, marker 16004), replication timing regulatory factor 1(RIF1, marker 16005), regulatory subunit of type II PKA R-subunit (RIIa) domain containing 1(RIIAD1, marker 16006), Rab interacting lysosomal protein-like 1 /// small nuclear ribonucleoprotein, U11/U12 35kDa subunit (RILPL1 /// SNRNP35, marker 16007), RIMS binding protein 2 (RIMBP2, marker 16008), RIMS binding protein 2 (RIMBP2, marker 16009), RIMS binding protein 2 (RIMBP2, marker 16010), RIMS binding protein 2 (RIMBP2) ,marker 16011),ribosomal modification protein rimK-like family member A(RIMKLA,marker 16012),ribosomal modification protein rimK-like family member A(RIMKLA,marker 16013),ribosomal modification protein rimK-like family member A(RIMKLA,marker 16014), regulating synaptic membrane exocytosis 1(RIMS1, marker 16015), regulating synaptic membrane exocytosis 1(RIMS1, marker 16016), regulating synaptic membrane exocytosis 1(RIMS1, marker 16017), regulating synaptic membrane exocytosis 2(RIMS2, marker 16018) ,regulating synaptic membrane exocytosis 4(RIMS4, marker 16019),Ras and Rab interactor 2(RIN2,marker 16020),Ras and Rab interactor 3(RIN3,marker 16021),Ras and Rab interactor 3(RIN3,marker 16022),Ras and Rab interactor 3(RIN3, marker 16023),Ras and Rab interactor 3(RIN3, marker 16024),RIO kinase 3(RIOK3, marker 16025),receptor-interacting serine-threonine kinase 4(RIPK4, marker 16026),ripply transcriptional repressor 1 (RIPPLY1, marker 16027), ripply transcriptional repressor 2 (RIPPLY2, marker 16028), Ras-like without CAAX 1 (RIT1, marker 16029), retinaldehyde binding protein 1 (RLBP1, marker 16030), relaxin 1 (RLN1, marker 16031), relaxin 3 (RLN3, marker 16032), RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing (RLTPR, marker 16033), regulator of microtubule dynamics 1 (RMDN1, marker 16034), regulator of microtubule dynamics 2 (RMDN2, marker 16035), regulator of microtubule dynamics 2(RMDN2, marker 16036), rhabdomyosarcoma 2 associated transcript (non-protein coding)(RMST, marker 16037), ribonuclease, RNase A family, 1 (pancreatic)(RNASE1, marker 16038),ribonuclease, RNase A family, 11 (non-active)(RNASE11, marker 16039),ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)(RNASE2, marker 16040),ribonuclease, RNase A family, 3 (RNASE3, marker 16041), ribonuclease, RNase A family, k6 (RNASE6, marker 16042), ribonuclease, RNase A family, 7 (RNASE7, marker 16043), ribonuclease, RNase A family, 7 (RNASE7, marker 16044), ribonuclease, RNase A family, 7 (RNASE7, marker 16045), ribonuclease H1 (RNASEH1, marker 16046), ribonuclease H2, subunit B (RNASEH2B, marker 16047), ribonuclease H2, subunit B (RNASEH2B, marker 16048), ribonuclease L ( 2',5'-oligoisoadenylate synthetase-dependent) (RNASEL, marker 16049), ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) (RNASEL, marker 16050), ribonuclease T2 (RNASET2, marker 16051), ribonuclease T2 (RNASET2, marker 16052), ribonuclease T2 (RNASET2, marker 16053), ribonuclease T2 (RNASET2, marker 16054), Rho family GTPase 2 (RND2, marker 16055), ring finger protein 103 (RNF103, marker 16056), ring finger protein 112 (RNF112, marker 16057), ring finger protein 130 (RNF130, marker 16058), ring finger protein 130 (RNF130, marker 16059), ring finger protein 133 (RNF133, marker 16060), RNF139 antisense RNA 1 (head to head) (RNF139-AS1, marker 16061), ring finger protein 14 (RNF14, marker 16062), ring finger protein 141 (RNF141, marker 16063), ring finger protein 141 (RNF141, marker 16064), ring finger protein 144A (RNF144A, marker 16065), RNF144A antisense RNA 1 (RNF144A-AS1, marker 16066), RNF144A antisense RNA 1 (RNF144A-AS1, marker 16067), RNF144A antisense RNA 1 (RNF144A-AS1, marker 16068), ring finger protein 144B (RNF144B, marker 16069),ring finger protein 144B(RNF144B,marker 16070),ring finger protein 145(RNF145,marker 16071),ring finger protein 148(RNF148,marker 16072),ring finger protein 150(RNF150,marker 16073),ring finger protein 150(RNF150, marker 16074),ring finger protein 151(RNF151,marker 16075),ring finger protein 152(RNF152,marker 16076),ring finger protein 152(RNF152,marker 16077),ring finger protein 157(RNF157,marker 16078 ), RNF157 antisense RNA 1(RNF157-AS1, marker 16079), ring finger protein 165(RNF165, marker 16080), ring finger protein 165(RNF165, marker 16081), ring finger protein 168, E3 ubiquitin protein ligase(RNF168, marker 16082),ring finger protein 17(RNF17, marker 16083),ring finger protein 17(RNF17,marker 16084),ring finger protein 17(RNF17,marker 16085),ring finger protein 17(RNF17,
marker 16086),ring finger protein 17(RNF17,marker 16087),ring finger protein 170(RNF170,marker 16088),ring finger protein 180(RNF180,marker 16089),ring finger protein 180(RNF180,marker 16090),ring finger protein 180(RNF180, marker 16091),ring finger protein 183(RNF183,marker 16092),RNF185 antisense RNA 1(RNF185-AS1,marker 16093),ring finger protein 186(RNF186,marker 16094),ring finger protein 187(RNF187 ,marker 16095),ring finger protein 187(RNF187,marker 16096),ring finger protein 187(RNF187,marker 16097),ring finger protein 19A,RBR E3 ubiquitin protein ligase(RNF19A,marker 16098),ring finger protein 207(RNF207) ,marker 16099),ring finger protein 207(RNF207,marker 16100),ring finger protein 207(RNF207,marker 16101),ring finger protein 207(RNF207,marker 16102),ring finger protein 208(RNF208,marker 16103),ring finger protein 212(RNF212, marker 16104),ring finger protein 212(RNF212,marker 16105),ring finger protein 212B(RNF212B,marker 16106),ring finger protein 213(RNF213,marker 16107),ring finger protein 213(RNF213, marker 16108),ring finger protein 213(RNF213,marker 16109),ring finger protein 213(RNF213,marker 16110),ring finger protein 215(RNF215,marker 16111),ring finger protein 216(RNF216,marker 16112),ring finger protein 217 (RNF217, marker 16113), RNF217 antisense RNA 1 (head to head) (RNF217-AS1, marker 16114), ring finger protein 219 (RNF219, marker 16115), ring finger protein 31 (RNF31, marker 16116), ring finger protein 31(RNF31, marker 16117),ring finger protein 32(RNF32,marker 16118),ring finger protein 32(RNF32,marker 16119),ring finger protein 32(RNF32,marker 16120),ring finger protein 39(RNF39, marker 16121), ring finger protein 40, E3 ubiquitin protein ligase (RNF40, marker 16122), ring finger protein 5, E3 ubiquitin protein ligase (RNF5, marker 16123), ring finger protein (C3H2C3 type) 6 (RNF6, marker 16124) ,ring finger protein 8, E3 ubiquitin protein ligase (RNF8, marker 16125), ring finger protein, transmembrane 1 (RNFT1, marker 16126), ring finger protein, transmembrane 2 (RNFT2, marker 16127), ribonuclease/angiogenin inhibitor 1 (RNH1) ,marker 16128),renalase, FAD-dependent amine oxidase(RNLS,marker 16129),RNA binding region (RNP1, RRM) containing 3(RNPC3,marker 16130),roundabout guidance receptor 2(ROBO2,marker 16131),roundabout guidance receptor 2 (ROBO2, marker 16132), roundabout guidance receptor 4 (ROBO4, marker 16133), roundabout guidance receptor 4 (ROBO4, marker 16134), Rho-associated, coiled-coil containing protein kinase 1 (ROCK1, marker 16135), Rho- associated, coiled-coil containing protein kinase 1(ROCK1, marker 16136),retinal outer segment membrane protein 1(ROM1, marker 16137),rhophilin associated tail protein 1(ROPN1, marker 16138),rhophilin associated tail protein 1(ROPN1, marker 16139), rhophilin associated tail protein 1(ROPN1, marker 16140), rhophilin associated tail protein 1 /// rhophilin associated tail protein 1B(ROPN1 /// ROPN1B, marker 16141), rhophilin associated tail protein 1-like(ROPN1L, marker 16142), rhophilin associated tail protein 1-like (ROPN1L, marker 16143), ROR1 antisense RNA 1 (ROR1-AS1, marker 16144), RAR-related orphan receptor A (RORA, marker 16145), RAR-related orphan receptor A( RORA, marker 16146), RAR-related orphan receptor A (RORA, marker 16147), RAR-related orphan receptor A (RORA, marker 16148), RAR-related orphan receptor A (RORA, marker 16149), RORA antisense RNA 1 ( RORA-AS1, marker 16150), RORA antisense RNA 1 (RORA-AS1, marker 16151), RAR-related orphan receptor B (RORB, marker 16152), RAR-related orphan receptor B (RORB, marker 16153), RAR-related orphan receptor C (RORC, marker 16154), RAR-related orphan receptor C (RORC, marker 16155), ROS proto-oncogene 1 , receptor tyrosine kinase (ROS1, marker 16156), ROS proto-oncogene 1 , receptor tyrosine kinase (ROS1 , marker 16157), retinitis pigmentosa 1 (autosomal dominant) (RP1, marker 16158), RP11-278J6.2 (marker 16159), RP11-322F10.2 (marker 16160), retinitis pigmentosa 1-like 1 (RP1L1, marker 16161) ), retinitis pigmentosa 2 (X-linked recessive) (RP2, marker 16162), retinitis pigmentosa 9 pseudogene (RP9P, marker 16163), replication protein A4 (RPA4, marker 16164), RPA interacting protein (RPAIN, marker 16165), RPA protein interacting (RPAIN, marker 16166), RPARP antisense RNA 1 (RPARP-AS1, marker 16167), ribulose-5-phosphate-3-epimerase (RPE, marker 16168), retinal pigment epithelium-specific protein 65kDa (RPE65, marker 16169) ), ribosome production factor 1 homolog (RPF1, marker 16170), ribosome production factor 1 homolog (RPF1, marker 16171), retinitis pigmentosa GTPase regulator interacting protein 1 (RPGRIP1, marker 16172), RPGRIP1-like (RPGRIP1L, marker 16173), rabphilin 3A(RPH3A, marker 16174),rabphilin 3A-like (without C2 domains)(RPH3AL,marker 16175),rabphilin 3A-like (without C2 domains)(RPH3AL,marker 16176),rabphilin 3A-like (without C2 domains) (RPH3AL, marker 16177), ribosomal protein L10 (RPL10, marker 16178), ribosomal protein L10 (RPL10, marker 16179), ribosomal protein L13 (RPL13, marker 16180), ribosomal protein L13a pseudogene 17 (RPL13AP17, marker 16181), ribosomal protein L15 (RPL15, marker 16182), ribosomal protein L18a /// small nucleolar RNA, H/ACA box 68 (RPL18A /// SNORA68, marker 16183), ribosomal protein L18 pseudogene 10 (RPL18P10, marker 16184), ribosomal protein L21 pseudogene 2 (RPL21P2, marker 16185), ribosomal protein L23a pseudogene 53 (RPL23AP53, marker 16186), RPL34 antisense RNA 1 (head to head) (RPL34-AS1, marker 16187), ribosomal protein L35a (RPL35A, marker 16188), ribosomal protein L35a (RPL35A, marker 16189), ribosomal protein L36a (RPL36A, marker 16190), ribosomal protein L3-like (RPL3L, marker 16191), ribosomal protein L5 (RPL5, marker 16192), ribosomal protein L5 /// small nucleolar RNA , H/ACA box 66(RPL5 /// SNORA66, marker 16193), ribosomal protein, large, P1(RPLP1, marker 16194), ribosomal protein, large, P2(RPLP2, marker 16195), ribosomal protein, large P2, pseudogene 1 (RPLP2P1, marker 16196), ribonuclease P/MRP 14kDa subunit (RPP14, marker 16197), ribonuclease P/MRP 25kDa subunit (RPP25, marker 16198), ribonuclease P/MRP 30kDa subunit (RPP30, marker 16199), ribonuclease P RNA component H1 (RPPH1, marker 16200), regulation of nuclear pre-mRNA domain containing 1B (RPRD1B, marker 16201), reprimo-like (RPRML, marker 16202), ribosomal protein S10 pseudogene 7 (RPS10P7, marker 16203), ribosomal protein S14 (RPS14, marker 16204), ribosomal protein S27 /// ribosomal protein S27 pseudogene 29 (RPS27 /// RPS27P29, marker 16205), ribosomal protein S27a (RPS27A, marker 16206), ribosomal protein S28 (RPS28, marker 16207), ribosomal protein S2 pseudogene 45 (RPS2P45, marker 16208), ribosomal protein S4, Y-linked 1 (RPS4Y1, marker 16209), ribosomal protein S6 (RPS6, marker 16210), ribosomal protein S6 kinase, 90kDa, polypeptide 2 (RPS6KA2, marker 16211) ), RPS6KA2 antisense RNA 1 (RPS6KA2-AS1, marker 16212), ribosomal protein S6 kinase, 90kDa, polypeptide 4 (RPS6KA4, marker 16213), ribosomal protein S6 kinase, 90kDa, polypeptide 5 (RPS6KA5, marker 16214), ribosomal protein S6 kinase, 90kDa, polypeptide 6 (RPS6KA6, marker 16215), ribosomal protein S6 kinase-like 1 (RPS6KL1, marker 16216), ribosomal protein S8 (RPS8, marker 16217), ribosomal protein S9 (RPS9, marker 16218), repetin (RPTN ,marker 16219),RNA pseudouridylate synthase domain containing 3(RPUSD3,marker 16220),RNA pseudouridylate synthase domain containing 3(RPUSD3,marker 16221),RCD1 required for cell differentiation1 homolog (S. pombe)(RQCD1,marker 16222),RCD1 required for cell differentiation1 homolog (S. pombe)(RQCD1, marker 16223),Ras-related associated with diabetes(RRAD, marker 16224),Ras-related associated with diabetes(RRAD, marker 16225),Ras-related associated with diabetes( RRAD, marker 16226), Ras-related GTP binding C (RRAGC, marker 16227), ribosome binding protein 1 (RRBP1, marker 16228), ribosome binding protein 1 (RRBP1, marker 16229), ras responsive element binding protein 1 (RREB1, marker 16230), ras responsive element binding protein 1(RREB1, marker 16231), ras responsive element binding protein 1(RREB1, marker 16232), ras responsive element binding protein 1(RREB1, marker 16233), retinal pigment epithelium-derived rhodopsin homolog (RRH, Marker 16234), RRN3 homolog, RNA polymerase I transcription factor pseudogene 1(RRN3P1, Marker 16235), RRN3 homolog, RNA polymerase I transcription factor pseudogene 1(RRN3P1, Marker 16236), RRN3 homolog, RNA polymerase I transcription factor pseudogene 2 (RRN3P2, marker 16237), RRN3 homolog, RNA polymerase I transcription factor pseudogene 3 (RRN3P3, marker 16238), ribosomal RNA processing 12 homolog (RRP12, marker 16239), ribosomal RNA processing 12 homolog (RRP12, marker 16240), ribosomal RNA processing 12 homolog (RRP12, marker 16241), ribosomal RNA processing 8, methyltransferase, homolog (yeast) (RRP8, marker 16242), ribosomal RNA processing 8, methyltransferase, homolog (yeast) (RRP8, marker 16243), RRS1 antisense RNA 1 (head to head)(RRS1-AS1, marker 16244), retinoschisin 1(RS1, marker 16245), retinoschisin 1(RS1, marker 16246), radical S-adenosyl methionine domain containing 2(RSAD2, marker 16247), radical S -adenosyl methionine domain containing 2(RSAD2, marker 16248),round spermatid basic protein 1-like(RSBN1L, marker 16249),REM2 and RAB-like small GTPase 1(RSG1,marker 16250),REM2 and RAB-like small GTPase 1 (RSG1, marker 16251), radial spoke head 1 homolog (Chlamydomonas)(RSPH1, marker 16252), radial spoke head 10 homolog B (Chlamydomonas) /// radial spoke head 10 homolog B2 (Chlamydomonas)(RSPH10B /// RSPH10B2, marker 16253), radial spoke head 14 homolog (Chlamydomonas)(RSPH14, marker 16254), radial spoke head 14 homolog (Chlamydomonas)(RSPH14, marker 16255), radial spoke 3 homolog (Chlamydomonas)(RSPH3, marker 16256), radial spoke head 4 homolog A (Chlamydomonas)(RSPH4A, marker 16257), radial spoke head 6 homolog A (Chlamydomonas)(RSPH6A, marker 16258), radial spoke head 9 homolog (Chlamydomonas)(RSPH9, marker 16259), R-spondin 1( RSPO1, Marker 16260), R-spondin 2(RSPO2, Marker 16261), Ras suppressor protein 1(RSU1, Marker 16262), Ras suppressor protein 1(RSU1, Marker 16263), Ras suppressor protein 1(RSU1, Marker 16264), Ras suppressor protein 1 pseudogene 2(RSU1P2, marker 16265), Ras suppressor protein 1 pseudogene 2(RSU1P2, marker 16266), retbindin(RTBDN, marker 16267), regulator of telomere elongation helicase 1 /// RTEL1-TNFRSF6B readthrough (NMD candid
ate)(RTEL1 /// RTEL1-TNFRSF6B, marker 16268), RTEL1-TNFRSF6B readthrough (NMD candidate)(RTEL1-TNFRSF6B, marker 16269), replication termination factor 2 domain containing 1(RTFDC1, marker 16270), replication termination factor 2 domain containing 1(RTFDC1, marker 16271), rhotekin(RTKN, marker 16272), rhotekin 2(RTKN2, marker 16273), reticulon 4 receptor-like 1(RTN4RL1, marker 16274), reticulon 4 receptor-like 2(RTN4RL2, marker 16275),receptor (chemosensory) transporter protein 1(RTP1, marker 16276),receptor (chemosensory) transporter protein 3(RTP3, marker 16277),receptor (chemosensory) transporter protein 3(RTP3, marker 16278),receptor (chemosensory) transporter protein 4 (RTP4, marker 16279), receptor (chemosensory) transporter protein 5 (putative) (RTP5, marker 16280), rotatin (RTTN, marker 16281), RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein (RUBCN , marker 16282), RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein(RUBCN, marker 16283), RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein(RUBCN, marker 16284), RUN and FYVE domain containing 1(RUFY1, marker 16285),RUN and FYVE domain containing 1(RUFY1, marker 16286),RUN and FYVE domain containing 2(RUFY2, marker 16287),RUN and FYVE domain containing 2(RUFY2, marker 16288),RUN and FYVE domain containing 2(RUFY2, marker 16289),RUN and FYVE domain containing 2(RUFY2, marker 16290),RUNDC3A antisense RNA 1(RUNDC3A-AS1, marker 16291),RUN domain containing 3B(RUNDC3B, marker 16292),RUN domain containing 3B(RUNDC3B, marker 16293),RUNX1 intronic transcript 1(RUNX1-IT1,marker 16294),runt-related transcription factor 1; translocated to, 1 (cyclin D-related)(RUNX1T1,marker 16295),runt-related transcription factor 1; translocated to, 1 (cyclin D-related)(RUNX1T1, marker 16296),runt-related transcription factor 1; translocated to, 1 (cyclin D-related)(RUNX1T1, marker 16297),runt-related transcription factor 2(RUNX2, marker 16298),runt-related transcription factor 2(RUNX2,marker 16299),runt-related transcription factor 2(RUNX2,marker 16300),runt-related transcription factor 2(RUNX2,marker 16301),runt-related transcription factor 2(RUNX2, marker 16302),runt-related transcription factor 3(RUNX3,marker 16303),runt-related transcription factor 3(RUNX3,marker 16304),runt-related transcription factor 3(RUNX3,marker 16305),RUSC1 antisense RNA 1(RUSC1-AS1, marker 16306),relaxin/insulin-like family peptide receptor 1(RXFP1,marker 16307),relaxin/insulin-like family peptide receptor 1(RXFP1,marker 16308),relaxin/insulin-like family peptide receptor 1 (RXFP1, marker 16309), relaxin/insulin-like family peptide receptor 2 (RXFP2, marker 16310), relaxin/insulin-like family peptide receptor 3 (RXFP3, marker 16311), retinoid X receptor beta (RXRB, marker 16312), retinoid ), ryanodine receptor 3 (RYR3, marker 16317), S100 calcium binding protein A1 (S100A1, marker 16318), S100 calcium binding protein A12 (S100A12, marker 16319), S100 calcium binding protein A2 (S100A2, marker 16320), S100 calcium binding protein A5 (S100A5, marker 16321), S100 calcium binding protein A6 (S100A6, marker 16322), S100 calcium binding protein A7 (S100A7, marker 16323), S100 calcium binding protein A7A (S100A7A, marker 16324), S100 calcium binding protein A8 (S100A8, marker 16325), S100 calcium binding protein A8 (S100A8, marker 16326), S100 calcium binding protein A8 (S100A8, marker 16327), S100 calcium binding protein A9 (S100A9, marker 16328), S100 calcium binding protein B( S100B, marker 16329), S100 calcium binding protein B (S100B, marker 16330), S100 calcium binding protein G (S100G, marker 16331), S100 calcium binding protein Z (S100Z, marker 16332), sphingosine-1-phosphate receptor 2( S1PR2, marker 16333), sphingosine-1-phosphate receptor 3 (S1PR3, marker 16334), sphingosine-1-phosphate receptor 4 (S1PR4, marker 16335), sphingosine-1-phosphate receptor 5 (S1PR5, marker 16336), sphingosine- 1-phosphate receptor 5 (S1PR5, marker 16337), sphingosine-1-phosphate receptor 5 (S1PR5, marker 16338), serum amyloid A1 /// serum amyloid A2 (SAA1 /// SAA2, marker 16339), serum amyloid A1 / // serum amyloid A2 /// SAA2-SAA4 readthrough(SAA1 /// SAA2 /// SAA2-SAA4, marker 16340),serum amyloid A3 pseudogene /// serum amyloid A4, constitutive(SAA3P /// SAA4, marker 16341 ), serum amyloid A4, constitutive (SAA4, marker 16342), SACS antisense RNA 1 (SACS-AS1, marker 16343), SACS antisense RNA 1 (SACS-AS1, marker 16344), SUMO1 activating enzyme subunit 1 (SAE1, marker 16345) ),S-antigen; retina and pineal gland (arrestin)(SAG, marker 16346),sarcoma antigen 1(SAGE1,marker 16347),sterile alpha motif domain containing 1(SAMD1,marker 16348),sterile alpha motif domain containing 10( SAMD10, marker 16349), sterile alpha motif domain containing 10(SAMD10, marker 16350), sterile alpha motif domain containing 12(SAMD12, marker 16351), sterile alpha motif domain containing 12(SAMD12, marker 16352), sterile alpha motif domain containing 14(SAMD14, marker 16353), sterile alpha motif domain containing 14(SAMD14, marker 16354), sterile alpha motif domain containing 14(SAMD14, marker 16355), sterile alpha motif domain containing 15(SAMD15, marker 16356), sterile alpha motif domain containing 15(SAMD15, marker 16357),sterile alpha motif domain containing 15(SAMD15, marker 16358),sterile alpha motif domain containing 3(SAMD3, marker 16359),sterile alpha motif domain containing 3(SAMD3, marker 16360),sterile alpha motif domain containing 4A(SAMD4A, marker 16361),sterile alpha motif domain containing 4A(SAMD4A, marker 16362),sterile alpha motif domain containing 4B(SAMD4B, marker 16363),sterile alpha motif domain containing 5(SAMD5, marker 16364) ,sterile alpha motif domain containing 5(SAMD5, marker 16365),sterile alpha motif domain containing 9(SAMD9,marker 16366),sterile alpha motif domain containing 9(SAMD9,marker 16367),sterile alpha motif domain containing 9-like(SAMD9L ,marker 16368),sterile alpha motif domain containing 9-like(SAMD9L,marker 16369),sterile alpha motif domain containing 9-like(SAMD9L,marker 16370),SAM domain and HD domain 1(SAMHD1,marker 16371),SAMM50 sorting and assembly machinery component(SAMM50, marker 16372),SAMM50 sorting and assembly machinery component(SAMM50, marker 16373),SAM domain, SH3 domain and nuclear localization signals 1(SAMSN1, marker 16374),SAM domain, SH3 domain and nuclear localization signals 1 (SAMSN1, marker 16375), SAM domain, SH3 domain and nuclear localization signals 1 (SAMSN1, marker 16376), Sin3A associated protein 25kDa (SAP25, marker 16377), Sin3A associated protein 30kDa (SAP30, marker 16378), SAP30-like (SAP30L, marker 16379), SAP30-like (SAP30L, marker 16380), SAP30-like (SAP30L, marker 16381), SAPCD1 antisense RNA 1 (SAPCD1-AS1, marker 16382), secretion associated, Ras related GTPase 1B (SAR1B, marker 16383), sarcosine dehydrogenase(SARDH, marker 16384), sarcosine dehydrogenase(SARDH, marker 16385), sarcosine dehydrogenase(SARDH, marker 16386), sarcosine dehydrogenase(SARDH, marker 16387), sarcosine dehydrogenase(SARDH, marker 16388), sterile alpha and TIR motif containing 1(SARM1, marker 16389),sterile alpha and TIR motif containing 1(SARM1, marker 16390),sterile alpha and TIR motif containing 1(SARM1, marker 16391),squamous cell carcinoma antigen recognized by T-cells 1(SART1, marker 16392), squamous cell carcinoma antigen recognized by T-cells 3(SART3, marker 16393),SAM and SH3 domain containing 3(SASH3, marker 16394),spermidine/spermine N1-acetyltransferase 1 /// zinc finger , SWIM-type containing 8(SAT1 /// ZSWIM8, marker 16395),SATB homeobox 1(SATB1, marker 16396),SATB homeobox 1(SATB1, marker 16397),SATB homeobox 2(SATB2, marker 16398),SATB2 antisense RNA 1(SATB2-AS1, Marker 16399), SATB2 antisense RNA 1(SATB2-AS1, Marker 16400), stabilizer of axonemal microtubules 1(SAXO1, Marker 16401), stabilizer of axonemal microtubules 2(SAXO2, Marker 16402), SAYSVFN motif domain containing 1(SAYSD1, marker 16403),SET binding factor 1(SBF1, marker 16404),SET binding factor 1(SBF1, marker 16405),SET binding factor 2(SBF2, marker 16406),SBF2 antisense RNA 1(SBF2-AS1 , marker 16407), strawberry notch homolog 1 (Drosophila)(SBNO1, marker 16408), strawberry notch homolog 1 (Drosophila)(SBNO1, marker 16409), strawberry notch homolog 2 (Drosophila)(SBNO2, marker 16410), strawberry notch homolog 2 (Drosophila) (SBNO2, marker 16411), suprabasin (SBSN, marker 16412), somatomedin B and thrombospondin type 1 domain containing (SBSPON, marker 16413), SR-related CTD-associated factor 11 (SCAF11, marker 16414), suppressor of cancer cell invasion(SCAI, marker 16415),secretory carrier membrane protein 4(SCAMP4,marker 16416),secretory carrier membrane protein 5(SCAMP5,marker 16417),secretory carrier membrane protein 5(SCAMP5,marker 16418),sphingolipid Ca2+ release mediating protein of endoplasmic reticulum(SCAMPER, marker 16419),SCAN domain containing 2 pseudogene(SCAND2P, marker 16420),SCAN domain containing 2 pseudogene(SCAND2P, marker 16421),SCAN domain containing 2 pseudogene(SCAND2P, marker 16422),SCAN domain containing 2 pseudogene(SCAND2P, marker 16423),S-phase cyclin A-associated protein in the ER(SCAPER, marker 16424),scavenger receptor class A, member 5(SCARA5, marker 16425),scavenger receptor class A, member 5( SCARA5, marker 16426), scavenger receptor class A, member 5 (SCARA5, marker 16427), scavenger receptor class B, member 1 (SCARB1, marker 16428), scavenger receptor class B, member 1 (SCARB1, marker 16429), scavenger receptor class F, member 1(SCARF1, marker 16430),scavenger receptor class F, member 1(SCARF1, marker 16431),scavenger receptor class F, member 2(SCARF2, marker 16432),scavenger receptor class F, member 2(SCARF2, marker 16433), scavenger receptor class F, member 2(SCARF2, marker 16434), small Cajal body-specific RNA 17 /// small nucleolar RNA host gene 22(SCARNA17 /// SNHG22, marker 16435), small Cajal body-specific RNA 17 /// small nucleolar RNA host gene 22(SCARNA17 /// SNHG22, marker 16436), small Cajal body-specific RNA 2(SCARNA2, marker 16437), scavenger receptor protein family member(SCART1, marker 16438),stearoyl- CoA desaturase 5(SCD5, marker 16439),stearoyl-CoA des
turase 5(SCD5, marker 16440), sciellin(SCEL, marker 16441), sciellin(SCEL, marker 16442), sciellin(SCEL, marker 16443), sciellin(SCEL, marker 16444), sec1 family domain containing 1(SCFD1, marker 16445),secretoglobin, family 1A, member 1 (uteroglobin)(SCGB1A1,marker 16446),secretoglobin, family 1C, member 1 /// secretoglobin, family 1C, member 2(SCGB1C1 /// SCGB1C2,marker 16447),secretoglobin, family 1D, member 1(SCGB1D1, marker 16448),secretoglobin, family 1D, member 2(SCGB1D2, marker 16449),secretoglobin, family 2A, member 1(SCGB2A1,marker 16450),secretoglobin, family 2A, member 2(SCGB2A2, marker 16451), secretoglobin, family 2B, member 2(SCGB2B2, marker 16452), secretoglobin, family 3A, member 1(SCGB3A1, marker 16453), secretagogin, EF-hand calcium binding protein(SCGN, marker 16454), SLP adapter and CSK interacting membrane protein(SCIMP, marker 16455),scinderin(SCIN,marker 16456),scinderin(SCIN,marker 16457),scinderin(SCIN,marker 16458),sodium channel and clathrin linker 1(SCLT1,marker 16459),sex comb on midleg-like 1 (Drosophila)(SCML1, marker 16460),sex comb on midleg-like 4 (Drosophila)(SCML4, marker 16461),sex comb on midleg-like 4 (Drosophila)(SCML4, marker 16462),sex comb on midleg-like 4 (Drosophila)(SCML4, marker 16463),sex comb on midleg-like 4 (Drosophila)(SCML4, marker 16464),sex comb on midleg-like 4 (Drosophila)(SCML4, marker 16465), sodium channel, voltage gated, type X alpha subunit(SCN10A, marker 16466),sodium channel, voltage gated, type XI alpha subunit(SCN11A, marker 16467),sodium channel, voltage gated, type XI alpha subunit(SCN11A, marker 16468) ,sodium channel, voltage gated, type XI alpha subunit(SCN11A, marker 16469),sodium channel, voltage gated, type I alpha subunit(SCN1A, marker 16470),sodium channel, voltage gated, type I alpha subunit(SCN1A, marker 16471) ),sodium channel, voltage gated, type I beta subunit(SCN1B, marker 16472),sodium channel, voltage gated, type II alpha subunit(SCN2A,marker 16473),sodium channel, voltage gated, type II alpha subunit(SCN2A,marker 16474),sodium channel, voltage gated, type II beta subunit(SCN2B, marker 16475),sodium channel, voltage gated, type II beta subunit(SCN2B, marker 16476),sodium channel, voltage gated, type II beta subunit(SCN2B, marker 16477), sodium channel, voltage gated, type III alpha subunit(SCN3A, marker 16478), sodium channel, voltage gated, type III beta subunit(SCN3B, marker 16479), sodium channel, voltage gated, type III beta subunit(SCN3B ,marker 16480),sodium channel, voltage gated, type IV alpha subunit(SCN4A,marker 16481),sodium channel, voltage gated, type IV beta subunit(SCN4B,marker 16482),sodium channel, voltage gated, type V alpha subunit( SCN5A, marker 16483), sodium channel, voltage gated, type VII alpha subunit(SCN7A, marker 16484), sodium channel, voltage gated, type VII alpha subunit(SCN7A, marker 16485), sodium channel, voltage gated, type VIII alpha subunit (SCN8A, marker 16486),sodium channel, voltage gated, type VIII alpha subunit(SCN8A,marker 16487),sodium channel, voltage gated, type VIII alpha subunit(SCN8A,marker 16488),sodium channel, voltage gated, type VIII alpha subunit(SCN8A, marker 16489), sodium channel, voltage gated, type IX alpha subunit(SCN9A, marker 16490), sodium channel, voltage gated, type IX alpha subunit(SCN9A, marker 16491), sodium channel, non voltage gated 1 alpha subunit(SCNN1A, marker 16492),sodium channel, non voltage gated 1 alpha subunit(SCNN1A, marker 16493),sodium channel, non voltage gated 1 beta subunit(SCNN1B, marker 16494),sodium channel, non voltage gated 1 delta subunit( SCNN1D, marker 16495), sodium channel, non voltage gated 1 gamma subunit(SCNN1G, marker 16496), sodium channel, non voltage gated 1 gamma subunit(SCNN1G, marker 16497), SCOC antisense RNA 1(SCOC-AS1, marker 16498) ,SCOC antisense RNA 1(SCOC-AS1,marker 16499),SCP2 sterol-binding domain containing 1(SCP2D1,marker 16500),serine carboxypeptidase 1(SCPEP1,marker 16501),stimulator of chondrogenesis 1(SCRG1,marker 16502),secernin 2 (SCRN2, marker 16503), secernin 3 (SCRN3, marker 16504), secernin 3 (SCRN3, marker 16505), scratch family zinc finger 1 (SCRT1, marker 16506), scratch family zinc finger 1 (SCRT1, marker 16507), secretin (SCT, marker 16508), secretin receptor (SCTR, marker 16509), secretin receptor (SCTR, marker 16510), secretin receptor (SCTR, marker 16511), signal peptide, CUB domain, EGF-like 1 (SCUBE1, marker 16512) ),signal peptide, CUB domain, EGF-like 3(SCUBE3, marker 16513),SCY1-like, kinase-like 1(SCYL1, marker 16514),SDCBP2 antisense RNA 1(SDCBP2-AS1,marker 16515),SDCBP2 antisense RNA 1 (SDCBP2-AS1, marker 16516), serologically defined colon cancer antigen 3 (SDCCAG3, marker 16517), succinate dehydrogenase complex subunit B, iron sulfur (Ip) (SDHB, marker 16518), succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa(SDHC, marker 16519), succinate dehydrogenase complex subunit D, integral membrane protein(SDHD, marker 16520), sidekick cell adhesion molecule 2(SDK2, marker 16521), sidekick cell adhesion molecule 2(SDK2, marker 16522), sidekick cell adhesion molecule 2(SDK2, marker 16523),serum deprivation response(SDPR,marker 16524),serum deprivation response(SDPR,marker 16525),short chain dehydrogenase/reductase family 16C, member 5(SDR16C5,marker 16526),short chain dehydrogenase/reductase family 42E, member 1(SDR42E1, marker 16527),short chain dehydrogenase/reductase family 42E, member 1(SDR42E1, marker 16528),short chain dehydrogenase/reductase family 9C, member 7(SDR9C7, marker 16529), serine dehydratase (SDS, marker 16530), SEBOX homeobox (SEBOX, marker 16531), SEC11 homolog C, signal peptidase complex subunit (SEC11C, marker 16532), SEC14-like lipid binding 1 (SEC14L1, marker 16533), SEC14-like 1 pseudogene 1 (SEC14L1P1, marker 16534), SEC14-like lipid binding 2 (SEC14L2, marker 16535), SEC14-like lipid binding 2 (SEC14L2, marker 16536), SEC14-like lipid binding 2 (SEC14L2, marker 16537), SEC14- like lipid binding 3(SEC14L3, marker 16538),SEC14-like lipid binding 3(SEC14L3,marker 16539),SEC14-like lipid binding 4(SEC14L4,marker 16540),SEC14-like lipid binding 4(SEC14L4,marker 16541), SEC16 homolog B, endoplasmic reticulum export factor(SEC16B, marker 16542),SEC16 homolog B, endoplasmic reticulum export factor(SEC16B, marker 16543),SEC16 homolog B, endoplasmic reticulum export factor(SEC16B, marker 16544),SEC16 homolog B, endoplasmic reticulum export factor (SEC16B, marker 16545), SEC16 homolog B, endoplasmic reticulum export factor (SEC16B, marker 16546), secretory blood group 1, pseudogene (SEC1P, marker 16547), SEC22 homolog B, vesicle trafficking protein (gene/pseudogene) (SEC22B, marker 16548), SEC22 homolog C, vesicle trafficking protein(SEC22C, marker 16549),SEC23 interacting protein(SEC23IP, marker 16550),SEC24 homolog D, COPII coat complex component(SEC24D, marker 16551),SEC24 homolog D, COPII coat complex component (SEC24D, marker 16552), SEC31 homolog B, COPII coat complex component (SEC31B, marker 16553), Sec61 translocon alpha 2 subunit (SEC61A2, marker 16554), Sec61 translocon beta subunit (SEC61B, marker 16555), SEC63 homolog, protein translocation regulator(SEC63, marker 16556),secreted and transmembrane 1(SECTM1, marker 16557),sel-1 suppressor of lin-12-like (C. elegans)(SEL1L, marker 16558),sel-1 suppressor of lin-12-like 2 (C. elegans)(SEL1L2, marker 16559), sel-1 suppressor of lin-12-like 3 (C. elegans)(SEL1L3, marker 16560), selectin E(SELE, marker 16561), selectin L (SELL, marker 16562), selectin P (granule membrane protein 140kDa, antigen CD62) (SELP, marker 16563), selectin P ligand (SELPLG, marker 16564), selectin P ligand (SELPLG, marker 16565), sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A(SEMA3A, marker 16566),sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B(SEMA3B, marker 16567),sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B(SEMA3B, marker 16568),sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D(SEMA3D, marker 16569) ,sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D(SEMA3D,marker 16570),sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E(SEMA3E,marker 16571),sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F(SEMA3F,marker 16572),sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F(SEMA3F , marker 16573), sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G(SEMA3G, marker 16574), sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A(SEMA4A, marker 16575), sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A(SEMA4A, marker 16576), sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D(SEMA4D, marker 16577),sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G(SEMA4G, marker 16578) ,sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G(SEMA4G,marker 16579),sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A(SEMA6A , marker 16580), sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C (SEMA6C, marker 16581), sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D (SEMA6D, marker 16582),sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D(SEMA6D,marker 16583),sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D(SEMA6D,marker 16584) ,semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group) (SEMA7A, marker 16585), semenogelin II (SEMG2, marker 16586), smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA (SENCR, marker 16587), selenoprotein P, plasma, 1(SEPP1, marker 16588), Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase(SEPSECS, marker 16589), SEPSECS antisense RNA 1 (head to head)(SEPSECS-AS1 , marker 16590), septin 1(1-Sep, marker 16591), septin 12(12-Sep,
marker 16592), septin 4(4-Sep, marker 16593), septin 4(4-Sep, marker 16594), septin 5 /// SEPT5-GP1BB readthrough(SEPT5 /// SEPT5-GP1BB, marker 16595), SEPT5- GP1BB readthrough (SEPT5-GP1BB, marker 16596), SEPT5-GP1BB readthrough (SEPT5-GP1BB, marker 16597), septin 7 (7-Sep, marker 16598), septin 7 pseudogene 2 (SEPT7P2, marker 16599), septin 7 pseudogene 9 (SEPT7P9, marker 16600), septin 8(8-Sep, marker 16601), septin 9(9-Sep, marker 16602), serine active site containing 1(SERAC1, marker 16603), secretion regulating guanine nucleotide exchange factor(SERGEF, marker 16604), serine hydrolase-like (pseudogene) /// serine hydrolase-like 2(SERHL /// SERHL2, marker 16605), serine hydrolase-like 2(SERHL2, marker 16606), serine hydrolase-like 2(SERHL2, marker 16607), serine incorporator 2 (SERINC2, marker 16608), serine incorporator 2 (SERINC2, marker 16609), serine incorporator 2 (SERINC2, marker 16610), stress-associated endoplasmic reticulum protein family member 2 (SERP2, marker 16611), stress-associated endoplasmic reticulum protein family member 2(SERP2, marker 16612),stress-associated endoplasmic reticulum protein family member 2(SERP2, marker 16613),stress-associated endoplasmic reticulum protein family member 2(SERP2, marker 16614),stress- associated endoplasmic reticulum protein family member 2(SERP2, marker 16615),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1(SERPINA1, marker 16616),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1(SERPINA1, marker 16617),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10(SERPINA10, marker 16618),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin) , member 12(SERPINA12, marker 16619),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 2 (gene/pseudogene)(SERPINA2, marker 16620),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase , antitrypsin), member 3(SERPINA3, marker 16621),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4(SERPINA4, marker 16622),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin ), member 6(SERPINA6, marker 16623),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7(SERPINA7, marker 16624),serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9(SERPINA9, marker 16625),serpin peptidase inhibitor, clade B (ovalbumin), member 1(SERPINB1, marker 16626),serpin peptidase inhibitor, clade B (ovalbumin), member 1(SERPINB1, marker 16627),serpin peptidase inhibitor , clade B (ovalbumin), member 10(SERPINB10, marker 16628),serpin peptidase inhibitor, clade B (ovalbumin), member 11 (gene/pseudogene)(SERPINB11, marker 16629),serpin peptidase inhibitor, clade B (ovalbumin), member 12(SERPINB12, marker 16630),serpin peptidase inhibitor, clade B (ovalbumin), member 13(SERPINB13, marker 16631),serpin peptidase inhibitor, clade B (ovalbumin), member 13(SERPINB13, marker 16632),serpin peptidase inhibitor , clade B (ovalbumin), member 13(SERPINB13, marker 16633),serpin peptidase inhibitor, clade B (ovalbumin), member 13(SERPINB13, marker 16634),serpin peptidase inhibitor, clade B (ovalbumin), member 13(SERPINB13, marker 16635), serpin peptidase inhibitor, clade B (ovalbumin), member 13(SERPINB13, marker 16636), serpin peptidase inhibitor, clade B (ovalbumin), member 2(SERPINB2, marker 16637), serpin peptidase inhibitor, clade B (ovalbumin) ), member 5(SERPINB5, marker 16638),serpin peptidase inhibitor, clade B (ovalbumin), member 5(SERPINB5, marker 16639),serpin peptidase inhibitor, clade B (ovalbumin), member 6(SERPINB6, marker 16640),serpin peptidase inhibitor, clade B (ovalbumin), member 8(SERPINB8, marker 16641),serpin peptidase inhibitor, clade B (ovalbumin), member 8(SERPINB8, marker 16642),serpin peptidase inhibitor, clade B (ovalbumin), member 9, pseudogene 1(SERPINB9P1, marker 16643),serpin peptidase inhibitor, clade C (antithrombin), member 1(SERPINC1, marker 16644),serpin peptidase inhibitor, clade C (antithrombin), member 1(SERPINC1, marker 16645),serpin peptidase inhibitor , clade D (heparin cofactor), member 1(SERPIND1, marker 16646),serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2(SERPINF2, marker 16647),serpin peptidase inhibitor, clade I (pancpin), member 2(SERPINI2, marker 16648),SERTA domain containing 4(SERTAD4, marker 16649),SERTA domain containing 4(SERTAD4, marker 16650),serine-rich and transmembrane domain containing 1(SERTM1, marker 16651), sestrin 3(SESN3, marker 16652),sestrin 3(SESN3,marker 16653),sestrin 3(SESN3,marker 16654),SET domain containing 1A(SETD1A,marker 16655),SET domain containing 4(SETD4,marker 16656),SET domain containing 5(SETD5, marker 16657),SET domain containing (lysine methyltransferase) 7(SETD7, marker 16658),SET domain, bifurcated 2(SETDB2, marker 16659),SET domain, bifurcated 2(SETDB2, marker 16660),SET domain, bifurcated 2(SETDB2,marker 16661),SET domain and mariner transposase fusion gene(SETMAR,marker 16662),seizure related 6 homolog (mouse)(SEZ6,marker 16663),seizure related 6 homolog (mouse)(SEZ6,marker 16664),seizure related 6 homolog (mouse)-like(SEZ6L,marker 16665),seizure related 6 homolog (mouse)-like(SEZ6L,marker 16666),seizure related 6 homolog (mouse)-like(SEZ6L,marker 16667) ,seizure related 6 homolog (mouse)-like(SEZ6L, marker 16668),seizure related 6 homolog (mouse)-like(SEZ6L, marker 16669),seizure related 6 homolog (mouse)-like 2(SEZ6L2, marker 16670), seizure related 6 homolog (mouse)-like 2(SEZ6L2, marker 16671),splicing factor 1(SF1,marker 16672),splicing factor 3b subunit 6(SF3B6,marker 16673),Scm-like with four mbt domains 2(SFMBT2, marker 16674), splicing factor proline/glutamine-rich (SFPQ, marker 16675), secreted frizzled-related protein 1 (SFRP1, marker 16676), secreted frizzled-related protein 4 (SFRP4, marker 16677), secreted frizzled-related protein 4 (SFRP4, marker 16678), secreted frizzled-related protein 5 (SFRP5, marker 16679), splicing factor, suppressor of white-apricot family (SFSWAP, marker 16680), SFT2 domain containing 1 (SFT2D1, marker 16681), SFT2 domain containing 3(SFT2D3, marker 16682), surfactant associated 2(SFTA2, marker 16683), surfactant associated 3(SFTA3, marker 16684), surfactant protein A1 /// surfactant protein A2(SFTPA1 /// SFTPA2, marker 16685), surfactant protein A2 (SFTPA2, marker 16686), surfactant protein B (SFTPB, marker 16687), surfactant protein B (SFTPB, marker 16688), surfactant protein C (SFTPC, marker 16689), surfactant protein C (SFTPC, marker 16690), surfactant protein C (SFTPC, marker 16691), surfactant protein C (SFTPC, marker 16692), surfactant protein C (SFTPC, marker 16693), surfactant protein D (SFTPD, marker 16694), sideroflexin 2 (SFXN2, marker 16695), sideroflexin 3 ( SFXN3, marker 16696), sideroflexin 4 (SFXN4, marker 16697), sideroflexin 5 (SFXN5, marker 16698), sideroflexin 5 (SFXN5, marker 16699), sideroflexin 5 (SFXN5, marker 16700), sarcoglycan alpha (SGCA, marker 16701) ,sarcoglycan delta(SGCD, marker 16702),sarcoglycan delta(SGCD,marker 16703),sarcoglycan delta(SGCD,marker 16704),sarcoglycan delta(SGCD,marker 16705),sarcoglycan delta(SGCD,marker 16706),sarcoglycan delta(SGCD ,marker 16707),sarcoglycan gamma(SGCG,marker 16708),sarcoglycan zeta(SGCZ,marker 16709),SH3-domain GRB2-like (endophilin) interacting protein 1(SGIP1,marker 16710),serum/glucocorticoid regulated kinase 2(SGK2) , marker 16711), serum/glucocorticoid regulated kinase 2 (SGK2, marker 16712), sphingomyelin synthase 2 (SGMS2, marker 16713), sphingosine-1-phosphate lyase 1 (SGPL1, marker 16714), sphingosine-1-phosphate phosphatase 2 ( SGPP2, marker 16715), sphingosine-1-phosphate phosphatase 2 (SGPP2, marker 16716), N-sulfoglucosamine sulfohydrolase (SGSH, marker 16717), small G protein signaling modulator 1 (SGSM1, marker 16718), small G protein signaling modulator 1 (SGSM1, marker 16719), small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta(SGTB, marker 16720), SH2 domain containing 1A(SH2D1A, marker 16721),SH2 domain containing 1A(SH2D1A, marker 16722),SH2 domain containing 1A(SH2D1A, marker 16723),SH2 domain containing 1A(SH2D1A,marker 16724),SH2 domain containing 1B(SH2D1B,marker 16725),SH2 domain containing 1B(SH2D1B,marker 16726),SH2 domain containing 3C(SH2D3C, marker 16727), SH2 domain containing 3C (SH2D3C, marker 16728), SH2 domain containing 4B (SH2D4B, marker 16729), SH2 domain containing 6 (SH2D6, marker 16730), SH3-domain binding protein 2 (SH3BP2, marker 16731), SH3-domain binding protein 4 (SH3BP4, marker 16732), SH3BP5 antisense RNA 1 (SH3BP5-AS1, marker 16733), SH3 domain containing 21 (SH3D21, marker 16734), SH3-domain GRB2-like 1 pseudogene 1 (SH3GL1P1, marker 16735), SH3-domain GRB2-like 1 pseudogene 1 (SH3GL1P1, marker 16736), SH3-domain GRB2-like 1 pseudogene 2 (SH3GL1P2, marker 16737), SH3-domain GRB2-like 1 pseudogene 2 (SH3GL1P2, marker 16738) ,SH3-domain GRB2-like 1 pseudogene 2(SH3GL1P2, marker 16739),SH3-domain GRB2-like 3(SH3GL3,marker 16740),SH3-domain GRB2-like 3(SH3GL3,marker 16741),SH3-domain GRB2- like endophilin B2 (SH3GLB2, marker 16742), SH3-domain GRB2-like endophilin B2 (SH3GLB2, marker 16743), SH3 and PX domains 2A (SH3PXD2A, marker 16744), SH3PXD2A antisense RNA 1 (SH3PXD2A-AS1, marker 16745), SH3 and PX domains 2B(SH3PXD2B, marker 16746),SH3 domain containing ring finger 2(SH3RF2,marker 16747),SH3 domain containing ring finger 2(SH3RF2,marker 16748),SH3 domain containing ring finger 2(SH3RF2,marker 16749) ,SH3 domain containing ring finger 2(SH3RF2, marker 16750),SH3 domain containing ring finger 3(SH3RF3,marker 16751),SH3RF3 antisense RNA 1(SH3RF3-AS1,marker 16752),SH3 domain and tetratricopeptide repeats 1(SH3TC1,marker 16753),SH3 domain and tetratricopeptide repeats 1(SH3TC1, marker 16754),SH3 domain and tetratricopeptide repeats 2(SH3TC2, marker 16755),SH3 domain and tetratricopeptide repeats 2(SH3TC2, marker 16756),SH3 domain and tetratricopeptide repeats 2(SH3TC2) ,marker 16757),SH3 and multiple ankyrin repeat domains 1(SHANK1,marker 16758),SH3 and multiple ankyrin repeat domains 1(SHANK1,marker 16759),SH3 and multiple ankyrin repeat domains 2(SHANK2,marker 16760),SH3 and multiple ankyrin repeat domains 2(SHANK2, marker 16761),SH
Src homology 2 domain containing adapter protein B( SHB, marker 16765), Src homology 2 domain containing adapter protein B (SHB, marker 16766), sex hormone-binding globulin (SHBG, marker 16767), SHC (Src homology 2 domain containing) transforming protein 3 (SHC3, marker 16768) ,SHC (Src homology 2 domain containing) family, member 4(SHC4, marker 16769),SHC (Src homology 2 domain containing) family, member 4(SHC4, marker 16770),SHC SH2-domain binding protein 1-like(SHCBP1L , marker 16771), Src homology 2 domain containing transforming protein D(SHD, marker 16772), Src homology 2 domain containing E(SHE, marker 16773), Src homology 2 domain containing E(SHE, marker 16774), sonic hedgehog(SHH , marker 16775), sonic hedgehog (SHH, marker 16776), shisa family member 2 (SHISA2, marker 16777), shisa family member 4 (SHISA4, marker 16778), shisa family member 6 (SHISA6, marker 16779), shisa family member 6 (SHISA6, marker 16780), shisa family member 6 (SHISA6, marker 16781), shisa family member 7 (SHISA7, marker 16782), shisa family member 8 (SHISA8, marker 16783), shisa family member 9 (SHISA9, marker 16784) ),serine hydroxymethyltransferase 1 (soluble)(SHMT1, marker 16785),serine hydroxymethyltransferase 1 (soluble)(SHMT1, marker 16786),short stature homeobox(SHOX,marker 16787),short stature homeobox 2(SHOX2,marker 16788),short stature homeobox 2(SHOX2, marker 16789), short stature homeobox 2(SHOX2, marker 16790), sedoheptulokinase /// transient receptor potential cation channel, subfamily V, member 1(SHPK /// TRPV1, marker 16791), shroom family member 1 (SHROOM1, marker 16792), shroom family member 1 (SHROOM1, marker 16793), shroom family member 3 (SHROOM3, marker 16794), shroom family member 4 (SHROOM4, marker 16795), sucrase-isomaltase (alpha-glucosidase)( SI, marker 16796), sialic acid acetylesterase (SIAE, marker 16797), sialic acid acetylesterase (SIAE, marker 16798), sialic acid acetylesterase (SIAE, marker 16799), siah E3 ubiquitin protein ligase 1 (SIAH1, marker 16800), siah E3 ubiquitin protein ligase family member 3 (SIAH3, marker 16801), SID1 transmembrane family, member 1 (SIDT1, marker 16802), sialic acid binding Ig-like lectin 1, sialoadhesin (SIGLEC1, marker 16803), sialic acid binding Ig-like lectin 10 (SIGLEC10, marker 16804), sialic acid binding Ig-like lectin 10 (SIGLEC10, marker 16805), sialic acid binding Ig-like lectin 11 (SIGLEC11, marker 16806), sialic acid binding Ig-like lectin 11 (SIGLEC11, marker 16807), sialic acid binding Ig-like lectin 15(SIGLEC15, marker 16808), sialic acid binding Ig-like lectin 16 (gene/pseudogene)(SIGLEC16, marker 16809), sialic acid binding Ig-like lectin 17, pseudogene( SIGLEC17P, marker 16810), sialic acid binding Ig-like lectin 5 (SIGLEC5, marker 16811), sialic acid binding Ig-like lectin 6 (SIGLEC6, marker 16812), sialic acid binding Ig-like lectin 6 (SIGLEC6, marker 16813) ,sialic acid binding Ig-like lectin 7(SIGLEC7, marker 16814),sialic acid binding Ig-like lectin 7(SIGLEC7, marker 16815),sialic acid binding Ig-like lectin 7(SIGLEC7, marker 16816),sialic acid binding Ig -like lectin 8(SIGLEC8, marker 16817),sialic acid binding Ig-like lectin 8(SIGLEC8, marker 16818),sialic acid binding Ig-like lectin 8(SIGLEC8, marker 16819),sialic acid binding Ig-like lectin 9( SIGLEC9, marker 16820), SIGLEC family like 1 (SIGLECL1, marker 16821), salt-inducible kinase 2 (SIK2, marker 16822), SIK family kinase 3 (SIK3, marker 16823), suppressor of IKBKE 1 (SIKE1, marker 16824) ,single-minded family bHLH transcription factor 1(SIM1, marker 16825),single-minded family bHLH transcription factor 1(SIM1, marker 16826),single-minded family bHLH transcription factor 1(SIM1, marker 16827),single-minded family bHLH transcription factor 2(SIM2, marker 16828),single-minded family bHLH transcription factor 2(SIM2, marker 16829),single-minded family bHLH transcription factor 2(SIM2, marker 16830),SIN3 transcription regulator family member A(SIN3A, marker 16831),SIN3 transcription regulator family member B(SIN3B,marker 16832),signal-induced proliferation-associated 1 like 1(SIPA1L1,marker 16833),signal-induced proliferation-associated 1 like 3(SIPA1L3,marker 16834),signal -induced proliferation-associated 1 like 3 (SIPA1L3, marker 16835), signal-regulatory protein alpha (SIRPA, marker 16836), signal-regulatory protein alpha (SIRPA, marker 16837), signal-regulatory protein beta 1 (SIRPB1, marker 16838) ), signal-regulatory protein beta 1 (SIRPB1, marker 16839), signal-regulatory protein beta 1 (SIRPB1, marker 16840), signal-regulatory protein beta 2 (SIRPB2, marker 16841), signal-regulatory protein delta (SIRPD, marker 16842), signal-regulatory protein gamma (SIRPG, marker 16843), signal-regulatory protein gamma (SIRPG, marker 16844), sirtuin 2 (SIRT2, marker 16845), sirtuin 4 (SIRT4, marker 16846), sirtuin 4 (SIRT4, marker 16847), sirtuin 5(SIRT5, marker 16848), sirtuin 5(SIRT5, marker 16849), sirtuin 5(SIRT5, marker 16850), sirtuin 5(SIRT5, marker 16851), sirtuin 5(SIRT5, marker 16852),signaling threshold regulating transmembrane adapter 1(SIT1, marker 16853),SIX homeobox 1(SIX1, marker 16854),SIX homeobox 1(SIX1, marker 16855),SIX homeobox 2(SIX2, marker 16856),SIX homeobox 2(SIX2, marker 16857) ), SIX homeobox 3 (SIX3, marker 16858), SIX homeobox 3 (SIX3, marker 16859), SIX3 antisense RNA 1 (SIX3-AS1, marker 16860), SIX homeobox 4 (SIX4, marker 16861), SIX homeobox 5 (SIX5 , marker 16862), SIX homeobox 6 (SIX6, marker 16863), src kinase associated phosphoprotein 1 (SKAP1, marker 16864), src kinase associated phosphoprotein 2 (SKAP2, marker 16865), src kinase associated phosphoprotein 2 (SKAP2, marker 16866) ,src kinase associated phosphoprotein 2(SKAP2, marker 16867),src kinase associated phosphoprotein 2(SKAP2, marker 16868),SKI-like proto-oncogene(SKIL, marker 16869),SKI-like proto-oncogene(SKIL, marker 16870) ,superkiller viralicidic activity 2-like 2 (S. cerevisiae)(SKIV2L2, marker 16871),Src-like-adaptor(SLA,marker 16872),Src-like-adaptor(SLA,marker 16873),Src-like-adaptor 2 (SLA2, marker 16874), Src-like-adaptor 2(SLA2, marker 16875), signaling lymphocytic activation molecule family member 1(SLAMF1, marker 16876), signaling lymphocytic activation molecule family member 1(SLAMF1, marker 16877), signaling lymphocytic activation molecule family member 1(SLAMF1, marker 16878),SLAM family member 6(SLAMF6, marker 16879),SLAM family member 7(SLAMF7, marker 16880),SLAM family member 7(SLAMF7, marker 16881),SLAM family member 7( SLAMF7, marker 16882), SLAM family member 8 (SLAMF8, marker 16883), SLAM family member 8 (SLAMF8, marker 16884), SLAM family member 9 (SLAMF9, marker 16885), SLAM family member 9 (SLAMF9, marker 16886), solute carrier family 10 (sodium/bile acid cotransporter), member 1(SLC10A1, marker 16887),solute carrier family 10 (sodium/bile acid cotransporter), member 2(SLC10A2, marker 16888),solute carrier family 10, member 4( SLC10A4, marker 16889),solute carrier family 10, member 7(SLC10A7,marker 16890),solute carrier family 10, member 7(SLC10A7,marker 16891),solute carrier family 10, member 7(SLC10A7,marker 16892),solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1(SLC11A1, marker 16893),solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1(SLC11A1, marker 16894),solute carrier family 11 (proton -coupled divalent metal ion transporter), member 1(SLC11A1, marker 16895),solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1(SLC11A1, marker 16896),solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2(SLC11A2, marker 16897),solute carrier family 11 (proton-coupled divalent metal ion transporter), member 2(SLC11A2,marker 16898),solute carrier family 12 (sodium/potassium/chloride transporter), member 1(SLC12A1, marker 16899),solute carrier family 12 (sodium/potassium/chloride transporter), member 1(SLC12A1,marker 16900),solute carrier family 12 (sodium/chloride transporter), member 3(SLC12A3,marker 16901), solute carrier family 12 (sodium/chloride transporter), member 3(SLC12A3, marker 16902),solute carrier family 12 (sodium/chloride transporter), member 3(SLC12A3, marker 16903),solute carrier family 12 (potassium/chloride transporter) , member 4(SLC12A4, marker 16904),solute carrier family 12 (potassium/chloride transporter), member 4(SLC12A4,marker 16905),solute carrier family 12 (potassium/chloride transporter), member 4(SLC12A4,marker 16906), solute carrier family 12 (potassium/chloride transporter), member 4(SLC12A4, marker 16907),solute carrier family 12 (potassium/chloride transporter), member 5(SLC12A5, marker 16908),solute carrier family 12 (potassium/chloride transporter) , member 6(SLC12A6, marker 16909),solute carrier family 12 (potassium/chloride transporter), member 6(SLC12A6,marker 16910),solute carrier family 12, member 9(SLC12A9,marker 16911),solute carrier family 13 (sodium /sulfate symporter), member 1(SLC13A1, marker 16912),solute carrier family 13 (sodium/sulfate symporter), member 1(SLC13A1, marker 16913),solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2(SLC13A2 , marker 16914),solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2(SLC13A2,marker 16915),solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3(SLC13A3,marker 16916),solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3(SLC13A3, marker 16917),solute carrier family 13 (sodium/sulfate symporter), member 4(SLC13A4, marker 16918),solute carrier family 13 (sodium-dependent citrate transporter), member 5(SLC13A5, marker 16919),solute carrier family 14 (urea transporter), member 1 (Kidd blood group)(SLC14A1,marker 16920),solute carrier family 14 (urea transporter), member 1 (Kidd blood group)(SLC14A1 , marker 16921), solute carrier family 14 (urea transporter), member 2 (SLC14A2, marker 16922), solute carrier family 15 (oligopeptide transporter), member 1 (SLC15A1, marker 16923), solute carrier family 15 (oligopeptide transporter), member 2(SLC15A2, marker 16924),solute carrier family 15 (oligopeptide transporter), member 2(SLC15A2,marker 16925),solute carrier family 15 (oligopeptide transporter)
ter), member 4(SLC15A4, marker 16926),solute carrier family 16, member 11(SLC16A11,marker 16927),solute carrier family 16, member 11(SLC16A11,marker 16928),SLC16A12 antisense RNA 1(SLC16A12-AS1,marker 16929),solute carrier family 16, member 6(SLC16A6,marker 16930),solute carrier family 16 (monocarboxylate transporter), member 7(SLC16A7,marker 16931),solute carrier family 16 (monocarboxylate transporter), member 7(SLC16A7,marker 16932),solute carrier family 16 (monocarboxylate transporter), member 7(SLC16A7,marker 16933),solute carrier family 16 (monocarboxylate transporter), member 8(SLC16A8,marker 16934),solute carrier family 17 (organic anion transporter), member 1(SLC17A1, marker 16935),solute carrier family 17 (organic anion transporter), member 1(SLC17A1,marker 16936),solute carrier family 17 (organic anion transporter), member 1(SLC17A1,marker 16937),solute carrier family 17 , member 2(SLC17A2, marker 16938),solute carrier family 17 (organic anion transporter), member 3(SLC17A3,marker 16939),solute carrier family 17, member 4(SLC17A4,marker 16940),solute carrier family 17, member 4 (SLC17A4, marker 16941),solute carrier family 17 (vesicular glutamate transporter), member 6(SLC17A6,marker 16942),solute carrier family 17 (vesicular glutamate transporter), member 7(SLC17A7,marker 16943),solute carrier family 17 ( vesicular glutamate transporter), member 7(SLC17A7, marker 16944),solute carrier family 17 (vesicular glutamate transporter), member 8(SLC17A8, marker 16945),solute carrier family 17 (vesicular nucleotide transporter), member 9(SLC17A9, marker 16946 ),solute carrier family 18 (vesicular monoamine transporter), member 1(SLC18A1,marker 16947),solute carrier family 18 (vesicular monoamine transporter), member 2(SLC18A2,marker 16948),solute carrier family 18 (vesicular monoamine transporter), member 2(SLC18A2, marker 16949),solute carrier family 18 (vesicular acetylcholine transporter), member 3(SLC18A3,marker 16950),solute carrier family 19 (folate transporter), member 1(SLC19A1,marker 16951),solute carrier family 19 (folate transporter), member 1(SLC19A1, marker 16952),solute carrier family 1 (glial high affinity glutamate transporter), member 2(SLC1A2,marker 16953),solute carrier family 1 (glial high affinity glutamate transporter), member 2( SLC1A2, marker 16954),solute carrier family 1 (glial high affinity glutamate transporter), member 2(SLC1A2,marker 16955),solute carrier family 1 (glial high affinity glutamate transporter), member 3(SLC1A3,marker 16956),solute carrier family 1 (glutamate/neutral amino acid transporter), member 4(SLC1A4, marker 16957),solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6(SLC1A6, marker 16958),solute carrier family 1 (glutamate transporter) , member 7(SLC1A7,marker 16959),solute carrier family 1 (glutamate transporter), member 7(SLC1A7,marker 16960),solute carrier family 1 (glutamate transporter), member 7(SLC1A7,marker 16961),solute carrier family 22 (organic cation transporter), member 1(SLC22A1, marker 16962),solute carrier family 22 (organic anion/urate transporter), member 11(SLC22A11, marker 16963),solute carrier family 22 (organic anion/urate transporter), member 12 (SLC22A12, marker 16964),solute carrier family 22 (organic anion/urate transporter), member 13(SLC22A13,marker 16965),solute carrier family 22, member 14(SLC22A14,marker 16966),solute carrier family 22 (organic cation/ carnitine transporter), member 16(SLC22A16, marker 16967),solute carrier family 22 (organic cation/carnitine transporter), member 16(SLC22A16, marker 16968),solute carrier family 22, member 17(SLC22A17, marker 16969),solute carrier family 22 (organic cation transporter), member 18 antisense(SLC22A18AS, marker 16970),solute carrier family 22 (organic cation transporter), member 2(SLC22A2, marker 16971),solute carrier family 22, member 23(SLC22A23, marker 16972) ,solute carrier family 22, member 23(SLC22A23,marker 16973),solute carrier family 22, member 23(SLC22A23,marker 16974),solute carrier family 22, member 24(SLC22A24,marker 16975),solute carrier family 22, member 25 (SLC22A25, marker 16976),solute carrier family 22 (organic cation transporter), member 3(SLC22A3, marker 16977),solute carrier family 22, member 31(SLC22A31,marker 16978),solute carrier family 22 (organic cation/zwitterion transporter ), member 4(SLC22A4,marker 16979),solute carrier family 22 (organic cation/carnitine transporter), member 5(SLC22A5,marker 16980),solute carrier family 22 (organic anion transporter), member 6(SLC22A6,marker 16981) ,solute carrier family 22 (organic anion transporter), member 6(SLC22A6,marker 16982),solute carrier family 22 (organic anion transporter), member 7(SLC22A7,marker 16983),solute carrier family 22 (organic anion transporter), member 7(SLC22A7, marker 16984),solute carrier family 22 (organic anion transporter), member 7(SLC22A7,marker 16985),solute carrier family 22 (organic anion transporter), member 7(SLC22A7,marker 16986),solute carrier family 22 (organic anion transporter), member 7(SLC22A7, marker 16987),solute carrier family 22 (organic anion transporter), member 8(SLC22A8,marker 16988),solute carrier family 22 (organic anion transporter), member 8(SLC22A8,marker 16989),solute carrier family 22 (organic anion transporter), member 9(SLC22A9,marker 16990),solute carrier family 23 (ascorbic acid transporter), member 1(SLC23A1,marker 16991),solute carrier family 23 (ascorbic acid transporter) , member 2(SLC23A2, marker 16992),solute carrier family 23 (ascorbic acid transporter), member 2(SLC23A2,marker 16993),solute carrier family 23, member 3(SLC23A3,marker 16994),solute carrier family 23, member 3 (SLC23A3, marker 16995),solute carrier family 24 (sodium/potassium/calcium exchanger), member 1(SLC24A1,marker 16996),solute carrier family 24 (sodium/potassium/calcium exchanger), member 1(SLC24A1,marker 16997) ,solute carrier family 24 (sodium/potassium/calcium exchanger), member 1(SLC24A1,marker 16998),solute carrier family 24 (sodium/potassium/calcium exchanger), member 2(SLC24A2,marker 16999),solute carrier family 24 ( sodium/potassium/calcium exchanger), member 2(SLC24A2, marker 17000),solute carrier family 24 (sodium/potassium/calcium exchanger), member 4(SLC24A4, marker 17001),solute carrier family 24 (sodium/potassium/calcium exchanger ), member 4(SLC24A4,marker 17002),solute carrier family 24 (sodium/potassium/calcium exchanger), member 4(SLC24A4,marker 17003),solute carrier family 24 (sodium/potassium/calcium exchanger), member 5(SLC24A5 , marker 17004), solute carrier family 25 (mitochondrial carrier), member 16 (SLC25A16, marker 17005), solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2 (SLC25A2, marker 17006), SLC25A21 antisense RNA 1 (SLC25A21- AS1, marker 17007), solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 (SLC25A23, marker 17008), solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 (SLC25A24, marker 17009), solute carrier family 25, member 27(SLC25A27, marker 17010),solute carrier family 25, member 27(SLC25A27,marker 17011),solute carrier family 25, member 27(SLC25A27,marker 17012),solute carrier family 25, member 27(SLC25A27, marker 17013),solute carrier family 25 (mitochondrial iron transporter), member 28(SLC25A28,marker 17014),solute carrier family 25 (mitochondrial carnitine/acylcarnitine carrier), member 29(SLC25A29,marker 17015),solute carrier family 25, member 30(SLC25A30, marker 17016),solute carrier family 25, member 30(SLC25A30,marker 17017),solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31(SLC25A31,marker 17018),solute carrier family 25, member 34(SLC25A34, marker 17019),solute carrier family 25, member 34(SLC25A34,marker 17020),solute carrier family 25, member 35(SLC25A35,marker 17021),solute carrier family 25, member 35(SLC25A35,marker 17022), solute carrier family 25 (pyrimidine nucleotide carrier), member 36(SLC25A36, marker 17023),solute carrier family 25 (pyrimidine nucleotide carrier), member 36(SLC25A36, marker 17024),solute carrier family 25 (mitochondrial iron transporter), member 37 (SLC25A37, marker 17025),solute carrier family 25 (mitochondrial iron transporter), member 37(SLC25A37,marker 17026),solute carrier family 25 (mitochondrial iron transporter), member 37(SLC25A37,marker 17027),solute carrier family 25 ( mitochondrial iron transporter), member 37(SLC25A37, marker 17028),solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 pseudogene 1(SLC25A3P1, marker 17029),solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4(SLC25A4, marker 17030),solute carrier family 25, member 41(SLC25A41, marker 17031),solute carrier family 25, member 42(SLC25A42, marker 17032),solute carrier family 25, member 42(SLC25A42, marker 17033) ,solute carrier family 25, member 42(SLC25A42,marker 17034),solute carrier family 25, member 42(SLC25A42,marker 17035),solute carrier family 25, member 45(SLC25A45,marker 17036),solute carrier family 25, member 45 (SLC25A45, marker 17037),solute carrier family 25, member 47(SLC25A47, marker 17038),solute carrier family 25, member 48(SLC25A48,marker 17039),solute carrier family 25, member 48(SLC25A48,marker 17040),SLC25A5 antisense RNA 1(SLC25A5-AS1, marker 17041),solute carrier family 25, member 53(SLC25A53,marker 17042),solute carrier family 26 (anion exchanger), member 1(SLC26A1,marker 17043),solute carrier family 26 (anion exchanger), member 1(SLC26A1, marker 17044),solute carrier family 26 (anion exchanger), member 1(SLC26A1,marker 17045),solute carrier family 26, member 10(SLC26A10,marker 17046),solute carrier family 26 (anion exchanger), member 3(SLC26A3, marker 17047),solute carrier family 26 (anion exchanger), member 3(SLC26A3,marker 17048),solute carrier family 26 (anion exchanger), member 4(SLC26A4,marker 17049),SLC26A4 antisense RNA 1(SLC26A4-AS1, marker 17050),solute carrier family 26 (anion exchanger), member 7(SLC26A7,marker 17051),solute carrier family 26 (anion exchanger), member 7(SLC26A7,marker 17052),solute carrier family 26 (anion exchanger), member 7(SLC26A7, marker 17053), solu
te carrier family 26 (anion exchanger), member 8(SLC26A8, marker 17054),solute carrier family 26 (anion exchanger), member 9(SLC26A9, marker 17055),solute carrier family 27 (fatty acid transporter), member 5(SLC27A5 , marker 17056),solute carrier family 28 (concentrative nucleoside transporter), member 1(SLC28A1,marker 17057),solute carrier family 28 (concentrative nucleoside transporter), member 1(SLC28A1,marker 17058),solute carrier family 28 (concentrative nucleoside transporter), member 2(SLC28A2, marker 17059),solute carrier family 28 (concentrative nucleoside transporter), member 3(SLC28A3,marker 17060),solute carrier family 28 (concentrative nucleoside transporter), member 3(SLC28A3,marker 17061), solute carrier family 29 (equilibrative nucleoside transporter), member 2(SLC29A2, marker 17062),solute carrier family 29 (equilibrative nucleoside transporter), member 2(SLC29A2, marker 17063),solute carrier family 29 (equilibrative nucleoside transporter), member 2 (SLC29A2, marker 17064),solute carrier family 29 (equilibrative nucleoside transporter), member 2(SLC29A2,marker 17065),solute carrier family 29 (equilibrative nucleoside transporter), member 4(SLC29A4,marker 17066),SLC2A1 antisense RNA 1( SLC2A1-AS1, marker 17067), solute carrier family 2 (facilitated glucose transporter), member 11 (SLC2A11, marker 17068), solute carrier family 2 (facilitated glucose transporter), member 13 (SLC2A13, marker 17069), solute carrier family 2 (facilitated glucose transporter), member 13(SLC2A13, marker 17070),solute carrier family 2 (facilitated glucose transporter), member 13(SLC2A13, marker 17071),solute carrier family 2 (facilitated glucose transporter), member 2(SLC2A2, marker 17072),solute carrier family 2 (facilitated glucose transporter), member 2(SLC2A2,marker 17073),solute carrier family 2 (facilitated glucose transporter), member 4(SLC2A4,marker 17074),SLC2A4 regulator(SLC2A4RG,marker 17075), solute carrier family 2 (facilitated glucose/fructose transporter), member 5(SLC2A5, marker 17076),solute carrier family 2 (facilitated glucose/fructose transporter), member 5(SLC2A5, marker 17077),solute carrier family 2 (facilitated glucose/ fructose transporter), member 5(SLC2A5, marker 17078),solute carrier family 2 (facilitated glucose transporter), member 9(SLC2A9, marker 17079),solute carrier family 2 (facilitated glucose transporter), member 9(SLC2A9,marker 17080) ,solute carrier family 2 (facilitated glucose transporter), member 9(SLC2A9,marker 17081),solute carrier family 30 (zinc transporter), member 1(SLC30A1,marker 17082),solute carrier family 30, member 10(SLC30A10,marker 17083 ),solute carrier family 30 (zinc transporter), member 2(SLC30A2,marker 17084),solute carrier family 30 (zinc transporter), member 2(SLC30A2,marker 17085),solute carrier family 30 (zinc transporter), member 3( SLC30A3, marker 17086),solute carrier family 30 (zinc transporter), member 4(SLC30A4,marker 17087),solute carrier family 30 (zinc transporter), member 4(SLC30A4,marker 17088),solute carrier family 30 (zinc transporter) , member 4(SLC30A4,marker 17089),solute carrier family 30 (zinc transporter), member 6(SLC30A6,marker 17090),solute carrier family 30 (zinc transporter), member 7(SLC30A7,marker 17091),solute carrier family 30 (zinc transporter), member 8(SLC30A8, marker 17092),solute carrier family 30 (zinc transporter), member 8(SLC30A8,marker 17093),solute carrier family 31 (copper transporter), member 2(SLC31A2,marker 17094), solute carrier family 32 (GABA vesicular transporter), member 1(SLC32A1, marker 17095),solute carrier family 33 (acetyl-CoA transporter), member 1(SLC33A1, marker 17096),solute carrier family 34 (type II sodium/phosphate cotransporter ), member 1(SLC34A1, marker 17097), solute carrier family 34 (type II sodium/phosphate cotransporter), member 1(SLC34A1, marker 17098), solute carrier family 34 (type II sodium/phosphate cotransporter), member 3(SLC34A3 , marker 17099), solute carrier family 35 (UDP-galactose transporter), member A2 (SLC35A2, marker 17100), solute carrier family 35 (GDP-fucose transporter), member C2 (SLC35C2, marker 17101), solute carrier family 35 ( UDP-GlcA/UDP-GalNAc transporter), member D1(SLC35D1, marker 17102),solute carrier family 35 (UDP-GlcNAc/UDP-glucose transporter), member D2(SLC35D2,marker 17103),solute carrier family 35, member D3 (SLC35D3, marker 17104),solute carrier family 35, member F3(SLC35F3,marker 17105),solute carrier family 35, member F4(SLC35F4,marker 17106),solute carrier family 35, member F5(SLC35F5,marker 17107),solute carrier family 35, member F5(SLC35F5, marker 17108),solute carrier family 35, member G2(SLC35G2,marker 17109),solute carrier family 35, member G3(SLC35G3,marker 17110),solute carrier family 35, member G3 // / solute carrier family 35, member G4 /// solute carrier family 35, member G5(SLC35G3 /// SLC35G4 /// SLC35G5, marker 17111), solute carrier family 36 (proton/amino acid symporter), member 1(SLC36A1, marker 17112),solute carrier family 36 (proton/amino acid symporter), member 1(SLC36A1,marker 17113),solute carrier family 37 (glucose-6-phosphate transporter), member 1(SLC37A1,marker 17114),solute carrier family 37 (glucose-6-phosphate transporter), member 2(SLC37A2, marker 17115),solute carrier family 38, member 1(SLC38A1,marker 17116),solute carrier family 38, member 10(SLC38A10,marker 17117),solute carrier family 38, member 10(SLC38A10, marker 17118),solute carrier family 38, member 10(SLC38A10,marker 17119),solute carrier family 38, member 10(SLC38A10,marker 17120),solute carrier family 38, member 11(SLC38A11,marker 17121),solute carrier family 38, member 3(SLC38A3,marker 17122),solute carrier family 38, member 4(SLC38A4,marker 17123),solute carrier family 38, member 9(SLC38A9,marker 17124),solute carrier family 39 ( solute carrier family 39 (zinc transporter), member 3(SLC39A3, marker 17128),solute carrier family 39 (zinc transporter), member 5(SLC39A5, marker 17129),solute carrier family 39 (zinc transporter), member 5(SLC39A5, marker 17130),solute carrier family 39 (zinc transporter), member 8(SLC39A8,marker 17131),solute carrier family 39 (zinc transporter), member 8(SLC39A8,marker 17132),solute carrier family 39 (zinc transporter), member 8 (SLC39A8, marker 17133),solute carrier family 39, member 9(SLC39A9,marker 17134),solute carrier family 39, member 9(SLC39A9,marker 17135),solute carrier family 3 (amino acid transporter heavy chain), member 1( SLC3A1, marker 17136),solute carrier family 40 (iron-regulated transporter), member 1(SLC40A1,marker 17137),solute carrier family 41 (magnesium transporter), member 2(SLC41A2,marker 17138),solute carrier family 41 (magnesium transporter), member 2(SLC41A2, marker 17139),solute carrier family 41 (magnesium transporter), member 2(SLC41A2,marker 17140),solute carrier family 43 (amino acid system L transporter), member 2(SLC43A2,marker 17141) ,solute carrier family 44 (choline transporter), member 1(SLC44A1,marker 17142),solute carrier family 44 (choline transporter), member 1(SLC44A1,marker 17143),solute carrier family 44, member 4(SLC44A4,marker 17144) ,solute carrier family 44, member 4(SLC44A4,marker 17145),solute carrier family 44, member 5(SLC44A5,marker 17146),solute carrier family 44, member 5(SLC44A5,marker 17147),solute carrier family 45, member 1 (SLC45A1, marker 17148),solute carrier family 45, member 2(SLC45A2,marker 17149),solute carrier family 45, member 2(SLC45A2,marker 17150),solute carrier family 45, member 4(SLC45A4,marker 17151),solute carrier family 46 (folate transporter), member 1(SLC46A1,marker 17152),solute carrier family 46 (folate transporter), member 1(SLC46A1,marker 17153),solute carrier family 46, member 2(SLC46A2,marker 17154),solute carrier family 46, member 3(SLC46A3, marker 17155),solute carrier family 47 (multidrug and toxin extrusion), member 2(SLC47A2, marker 17156),solute carrier family 48 (heme transporter), member 1(SLC48A1, marker 17157) ,solute carrier family 4 (anion exchanger), member 1 (Diego blood group)(SLC4A1, marker 17158),solute carrier family 4 (anion exchanger), member 1 (Diego blood group)(SLC4A1, marker 17159),solute carrier family 4, sodium bicarbonate transporter, member 10(SLC4A10,marker 17160),solute carrier family 4 (anion exchanger), member 3(SLC4A3,marker 17161),solute carrier family 4 (sodium bicarbonate cotransporter), member 4(SLC4A4,marker 17162 ),solute carrier family 4 (sodium bicarbonate cotransporter), member 4(SLC4A4,marker 17163),solute carrier family 4 (sodium bicarbonate cotransporter), member 4(SLC4A4,marker 17164),solute carrier family 4 (sodium bicarbonate cotransporter), member 4(SLC4A4, marker 17165),solute carrier family 4 (sodium bicarbonate cotransporter), member 5(SLC4A5,marker 17166),solute carrier family 4 (sodium bicarbonate cotransporter), member 5(SLC4A5,marker 17167),solute carrier family 4, sodium bicarbonate cotransporter, member 7(SLC4A7, marker 17168),solute carrier family 4, sodium bicarbonate cotransporter, member 8(SLC4A8, marker 17169),solute carrier family 4, sodium bicarbonate cotransporter, member 9(SLC4A9, marker 17170) ,solute carrier family 4, sodium bicarbonate cotransporter, member 9(SLC4A9, marker 17171),solute carrier family 51, alpha subunit(SLC51A,marker 17172),solute carrier family 51, beta subunit(SLC51B,marker 17173),solute carrier family 52 (riboflavin transporter), member 1(SLC52A1, marker 17174),solute carrier family 52 (riboflavin transporter), member 3(SLC52A3, marker 17175),solute carrier family 5 (sodium/glucose cotransporter), member 1(SLC5A1, marker 17176),solute carrier family 5 (sodium/glucose cotransporter), member 1(SLC5A1,marker 17177),solute carrier family 5 (sodium/sugar cotransporter), member 10(SLC5A10,marker 17178),solute carrier family 5 (sodium/ inositol cotransporter), member 11(SLC5A11, marker 17179),solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12(SLC5A12, marker 17180),solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12
(SLC5A12, marker 17181),solute carrier family 5 (sodium/monocarboxylate cotransporter), member 12(SLC5A12,marker 17182),solute carrier family 5 (sodium/glucose cotransporter), member 2(SLC5A2,marker 17183),solute carrier family 5 (glucose activated ion channel), member 4(SLC5A4, marker 17184),solute carrier family 5 (sodium/choline cotransporter), member 7(SLC5A7, marker 17185),solute carrier family 5 (sodium/choline cotransporter), member 7 (SLC5A7, marker 17186),solute carrier family 5 (sodium/monocarboxylate cotransporter), member 8(SLC5A8, marker 17187),solute carrier family 5 (sodium/sugar cotransporter), member 9(SLC5A9,marker 17188),solute carrier family 5 (sodium/sugar cotransporter), member 9(SLC5A9, marker 17189),solute carrier family 6 (neurotransmitter transporter), member 1(SLC6A1,marker 17190),solute carrier family 6 (neurotransmitter transporter), member 10, pseudogene // / solute carrier family 6 (neurotransmitter transporter), member 8(SLC6A10P /// SLC6A8, marker 17191),solute carrier family 6 (neurotransmitter transporter), member 10, pseudogene /// solute carrier family 6 (neurotransmitter transporter), member 8 (SLC6A10P /// SLC6A8, marker 17192),solute carrier family 6 (neurotransmitter transporter), member 11(SLC6A11,marker 17193),solute carrier family 6 (neurotransmitter transporter), member 11(SLC6A11,marker 17194),solute carrier family 6 (neurotransmitter transporter), member 11(SLC6A11, marker 17195),solute carrier family 6 (neurotransmitter transporter), member 12(SLC6A12, marker 17196),solute carrier family 6 (neurotransmitter transporter), member 13(SLC6A13, marker 17197) ,solute carrier family 6 (neurotransmitter transporter), member 13(SLC6A13,marker 17198),solute carrier family 6 (amino acid transporter), member 14(SLC6A14,marker 17199),solute carrier family 6 (neutral amino acid transporter), member 15(SLC6A15, marker 17200),solute carrier family 6 (neutral amino acid transporter), member 15(SLC6A15,marker 17201),solute carrier family 6, member 16(SLC6A16,marker 17202),solute carrier family 6 (neutral amino acid transporter) 17205 ),solute carrier family 6 (neutral amino acid transporter), member 19(SLC6A19,marker 17206),solute carrier family 6 (neutral amino acid transporter), member 19(SLC6A19,marker 17207),solute carrier family 6 (neutral amino acid transporter), member 19(SLC6A19, marker 17208),solute carrier family 6 (neurotransmitter transporter), member 2(SLC6A2,marker 17209),solute carrier family 6 (neurotransmitter transporter), member 2(SLC6A2,marker 17210),solute carrier family 6 (neurotransmitter transporter), member 2(SLC6A2, marker 17211),solute carrier family 6 (neurotransmitter transporter), member 2(SLC6A2, marker 17212),solute carrier family 6 (neurotransmitter transporter), member 2(SLC6A2, marker 17213 ),solute carrier family 6 (neurotransmitter transporter), member 2(SLC6A2,marker 17214),solute carrier family 6 (neurotransmitter transporter), member 2(SLC6A2,marker 17215),solute carrier family 6 (neurotransmitter transporter), member 2( SLC6A2, marker 17216),solute carrier family 6 (proline IMINO transporter), member 20(SLC6A20,marker 17217),solute carrier family 6 (proline IMINO transporter), member 20(SLC6A20,marker 17218),solute carrier family 6 (neurotransmitter transporter), member 4(SLC6A4, marker 17219),solute carrier family 6 (neurotransmitter transporter), member 4(SLC6A4,marker 17220),solute carrier family 6 (neurotransmitter transporter), member 4(SLC6A4,marker 17221),solute carrier family 6 (neurotransmitter transporter), member 5(SLC6A5, marker 17222),solute carrier family 6 (neurotransmitter transporter), member 5(SLC6A5, marker 17223),solute carrier family 6 (neurotransmitter transporter), member 6(SLC6A6, marker 17224 ),solute carrier family 6 (neurotransmitter transporter), member 6(SLC6A6,marker 17225),solute carrier family 6 (neurotransmitter transporter), member 7(SLC6A7,marker 17226),solute carrier family 6 (neurotransmitter transporter, glycine), member 9(SLC6A9, marker 17227),solute carrier family 7 (cationic amino acid transporter, y+ system), member 1(SLC7A1,marker 17228),solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10( SLC7A10, marker 17229), SLC7A11 antisense RNA 1 (SLC7A11-AS1, marker 17230), solute carrier family 7 (anionic amino acid transporter), member 13 (SLC7A13, marker 17231), solute carrier family 7, member 14 (SLC7A14, marker 17232),solute carrier family 7, member 14(SLC7A14, marker 17233),solute carrier family 7 (cationic amino acid transporter, y+ system), member 2(SLC7A2,marker 17234),solute carrier family 7 (cationic amino acid transporter, y+ system), member 2(SLC7A2, marker 17235),solute carrier family 7, member 4(SLC7A4,marker 17236),solute carrier family 7, member 4(SLC7A4,marker 17237),solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9(SLC7A9,marker 17238),solute carrier family 8 (sodium/calcium exchanger), member 1(SLC8A1,marker 17239),solute carrier family 8 (sodium/calcium exchanger), member 1 (SLC8A1, marker 17240),solute carrier family 8 (sodium/calcium exchanger), member 1(SLC8A1,marker 17241),solute carrier family 8 (sodium/calcium exchanger), member 1(SLC8A1,marker 17242),solute carrier family 8 (sodium/calcium exchanger), member 1(SLC8A1, marker 17243),solute carrier family 8 (sodium/calcium exchanger), member 1(SLC8A1, marker 17244),solute carrier family 8 (sodium/calcium exchanger), member 1 (SLC8A1, marker 17245),solute carrier family 8 (sodium/calcium exchanger), member 1(SLC8A1,marker 17246),solute carrier family 8 (sodium/calcium exchanger), member 1(SLC8A1,marker 17247),solute carrier family 8 (sodium/calcium exchanger), member 1(SLC8A1, marker 17248),SLC8A1 antisense RNA 1(SLC8A1-AS1, marker 17249),SLC8A1 antisense RNA 1(SLC8A1-AS1,marker 17250),solute carrier family 8 (sodium/ calcium exchanger), member 2(SLC8A2, marker 17251),solute carrier family 8 (sodium/calcium exchanger), member 3(SLC8A3,marker 17252),solute carrier family 8 (sodium/calcium exchanger), member 3(SLC8A3,marker 17253), solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 (SLC8B1, marker 17254), solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 (SLC9A1, marker 17255), solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2(SLC9A2, marker 17256),solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3(SLC9A3, marker 17257), solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2(SLC9A3R2, marker 17258),solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5(SLC9A5, marker 17259) ),solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5(SLC9A5, marker 17260),solute carrier family 9, subfamily A (NHE7, cation proton antiporter 7), member 7(SLC9A7, marker 17261) ),solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9(SLC9A9,marker 17262),solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9(SLC9A9,marker 17263) ),solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1(SLC9B1,marker 17264),solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1(SLC9B1,marker 17265 ),solute carrier family 9, subfamily B (NHA1, cation proton antiporter 1), member 1(SLC9B1,marker 17266),solute carrier family 9, member C2 (putative)(SLC9C2,marker 17267),solute carrier family 9, member C2 (putative)(SLC9C2, marker 17268),solute carrier organic anion transporter family, member 1A2(SLCO1A2,marker 17269),solute carrier organic anion transporter family, member 1A2(SLCO1A2,marker 17270),solute carrier organic anion transporter family, member 1A2(SLCO1A2, marker 17271),solute carrier organic anion transporter family, member 1B1(SLCO1B1,marker 17272),solute carrier organic anion transporter family, member 1B3(SLCO1B3,marker 17273),solute carrier organic anion transporter family, member 1C1 (SLCO1C1, marker 17274),solute carrier organic anion transporter family, member 1C1(SLCO1C1,marker 17275),solute carrier organic anion transporter family, member 2B1(SLCO2B1,marker 17276),solute carrier organic anion transporter family, member 2B1(SLCO2B1 ,marker 17277),solute carrier organic anion transporter family, member 3A1(SLCO3A1,marker 17278),solute carrier organic anion transporter family, member 4A1(SLCO4A1,marker 17279),SLCO4A1 antisense RNA 1(SLCO4A1-AS1,marker 17280), solute carrier organic anion transporter family, member 5A1(SLCO5A1, marker 17281),solute carrier organic anion transporter family, member 6A1(SLCO6A1, marker 17282),SMC5-SMC6 complex localization factor 1(SLF1, marker 17283),SMC5-SMC6 complex localization factor 2 (SLF2, marker 17284), SMC5-SMC6 complex localization factor 2 (SLF2, marker 17285), schlafen family member 11 (SLFN11, marker 17286), schlafen family member 13 (SLFN13, marker 17287), schlafen family member 5 (SLFN5, marker 17288), schlafen family member 5(SLFN5, marker 17289), schlafen family member 5(SLFN5, marker 17290), schlafen like 1(SLFNL1, marker 17291), schlafen like 1(SLFNL1, marker 17292), SLFNL1 antisense RNA 1 (SLFNL1-AS1, marker 17293), slit guidance ligand 1 (SLIT1, marker 17294), SLIT1 antisense RNA 1 (SLIT1-AS1, marker 17295), SLIT2 intronic transcript 1 (SLIT2-IT1, marker 17296), slit guidance ligand 3(SLIT3, marker 17297),slit guidance ligand 3(SLIT3, marker 17298),SLIT and NTRK-like family, member 1(SLITRK1, marker 17299),SLIT and NTRK-like family, member 2(SLITRK2, marker 17300),SLIT and NTRK-like family, member 3(SLITRK3, marker 17301),SLIT and NTRK-like family, member 4(SLITRK4, marker 17302),SLIT and NTRK-like family, member 5(SLITRK5, marker 17303) ,SLIT and NTRK-like family, member 6(SLITRK6, marker 17304),SLIT and NTRK-like family, member 6(SLITRK6, marker 17305),sarcolemma associated protein(SLMAP, marker 17306),sarcolipin(SLN,marker 17307) ,secretory leukocyte peptidase inhibitor
tor(SLPI, marker 17308), secreted LY6/PLAUR domain containing 1(SLURP1, marker 17309), SLX4 structure-specific endonuclease subunit(SLX4, marker 17310), SMAD1 antisense RNA 2(SMAD1-AS2, marker 17311), SMAD family member 2(SMAD2, marker 17312),SMAD family member 3(SMAD3,marker 17313),SMAD family member 4(SMAD4,marker 17314),SMAD5 antisense RNA 1(SMAD5-AS1,marker 17315),SMAD family member 6(SMAD6 , Marker 17316), SMAD family member 6 (SMAD6, Marker 17317), SMAD family member 6 (SMAD6, Marker 17318), SMAD family member 9 (SMAD9, Marker 17319), SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2(SMARCA2, marker 17320),SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2(SMARCA2, marker 17321),SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2(SMARCA2, marker 17322),SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2(SMARCA2, marker 17323),SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4(SMARCA4, marker 17324),SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4(SMARCA4, marker 17325),SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4(SMARCA4, marker 17326),SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1(SMARCB1, marker 17327),SWI/SNF related , matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 (SMARCD3, marker 17328), structural maintenance of chromosomes 1A (SMC1A, marker 17329), structural maintenance of chromosomes 1B (SMC1B, marker 17330), structural maintenance of chromosomes 3(SMC3, marker 17331), structural maintenance of chromosomes 5(SMC5, marker 17332), SMC5 antisense RNA 1 (head to head)(SMC5-AS1, marker 17333), structural maintenance of chromosomes flexible hinge domain containing 1(SMCHD1, marker 17334), structural maintenance of chromosomes flexible hinge domain containing 1(SMCHD1, marker 17335), single-pass membrane protein with coiled-coil domains 1(SMCO1, marker 17336), single-pass membrane protein with coiled-coil domains 3( SMCO3, marker 17337), sperm mitochondria-associated cysteine-rich protein(SMCP, marker 17338), Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)(SMCR5, marker 17339), Smith-Magenis syndrome chromosome region, candidate 8(SMCR8, marker 17340), single-pass membrane protein with aspartate-rich tail 1(SMDT1, marker 17341), SMG1 phosphatidylinositol 3-kinase-related kinase /// SMG1 pseudogene 1(SMG1 /// SMG1P1, marker 17342 ),SMG6 nonsense mediated mRNA decay factor(SMG6, marker 17343),SMG7 antisense RNA 1(SMG7-AS1,marker 17344),SMG7 antisense RNA 1(SMG7-AS1,marker 17345),SMG9 nonsense mediated mRNA decay factor(SMG9, marker 17346), small integral membrane protein 1 (Vel blood group) (SMIM1, marker 17347), small integral membrane protein 10 (SMIM10, marker 17348), small integral membrane protein 10 like 1 (SMIM10L1, marker 17349), small integral membrane protein 11A /// small integral membrane protein 11B(SMIM11A /// SMIM11B, marker 17350), small integral membrane protein 12(SMIM12, marker 17351), small integral membrane protein 14(SMIM14, marker 17352), small integral membrane protein 17 (SMIM17, marker 17353), small integral membrane protein 2(SMIM2, marker 17354), small integral membrane protein 2(SMIM2, marker 17355), SMIM2 antisense RNA 1(SMIM2-AS1, marker 17356), small integral membrane protein 21( SMIM21, marker 17357), small integral membrane protein 21 (SMIM21, marker 17358), small integral membrane protein 22 (SMIM22, marker 17359), small integral membrane protein 24 (SMIM24, marker 17360), small integral membrane protein 4 (SMIM4, marker 17361), small integral membrane protein 4 (SMIM4, marker 17362), small integral membrane protein 5 (SMIM5, marker 17363), small integral membrane protein 6 (SMIM6, marker 17364), small integral membrane protein 7 (SMIM7, marker 17365) ), small leucine-rich protein 1 (SMLR1, marker 17366), small leucine-rich protein 1 (SMLR1, marker 17367), SPARC related modular calcium binding 2 (SMOC2, marker 17368), spermine oxidase (SMOX, marker 17369), sphingomyelin phosphodiesterase 1, acid lysosomal(SMPD1, marker 17370),sphingomyelin phosphodiesterase 2, neutral membrane (neutral sphingomyelinase)(SMPD2, marker 17371),sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)(SMPD3, marker 17372),sphing omyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) (SMPD3, marker 17373), sphingomyelin phosphodiesterase, acid-like 3A (SMPDL3A, marker 17374), small muscle protein, X-linked (SMPX, marker 17375), submaxillary gland androgen regulated protein 3A (SMR3A, marker 17376), submaxillary gland androgen regulated protein 3A /// submaxillary gland androgen regulated protein 3B (SMR3A /// SMR3B, marker 17377), submaxillary gland androgen regulated protein 3B (SMR3B, marker 17378), smoothelin (SMTN, marker 17379), smoothelin-like 1(SMTNL1, marker 17380), smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans)(SMU1, marker 17381), single-strand-selective monofunctional uracil-DNA glycosylase 1(SMUG1, Marker 17382), SMAD specific E3 ubiquitin protein ligase 1(SMURF1, Marker 17383), SMAD specific E3 ubiquitin protein ligase 1(SMURF1, Marker 17384), SET and MYND domain containing 1(SMYD1, Marker 17385), SET and MYND domain containing 1(SMYD1, marker 17386),SET and MYND domain containing 2(SMYD2, marker 17387),SET and MYND domain containing 2(SMYD2, marker 17388),snail family zinc finger 1(SNAI1, marker 17389), SNAI3 antisense RNA 1 (SNAI3-AS1, marker 17390), SNAI3 antisense RNA 1 (SNAI3-AS1, marker 17391), synaptosome associated protein 25kDa (SNAP25, marker 17392), synaptosome associated protein 25kDa (SNAP25, marker 17393), synaptosome associated protein 91kDa (SNAP91, marker 17394), small nuclear RNA activating complex polypeptide 4 (SNAPC4, marker 17395), small nuclear RNA activating complex polypeptide 5 (SNAPC5, marker 17396), synuclein alpha (SNCA, marker 17397), synuclein alpha (SNCA) ,marker 17398), synuclein alpha interacting protein(SNCAIP,marker 17399),synuclein alpha interacting protein(SNCAIP,marker 17400),synuclein beta(SNCB,marker 17401),synuclein gamma(SNCG,marker 17402),synuclein gamma(SNCG, marker 17403), sushi, nidogen and EGF-like domains 1(SNED1, marker 17404), sushi, nidogen and EGF-like domains 1(SNED1, marker 17405), sushi, nidogen and EGF-like domains 1(SNED1, marker 17406) ),sushi, nidogen and EGF-like domains 1(SNED1, marker 17407),small nucleolar RNA host gene 10(SNHG10,marker 17408),small nucleolar RNA host gene 10(SNHG10,marker 17409),small nucleolar RNA host gene 17 /// small nucleolar RNA, H/ACA box 71B(SNHG17 /// SNORA71B, marker 17410), small nucleolar RNA host gene 4(SNHG4, marker 17411), small nucleolar RNA host gene 7 /// small nucleolar RNA, H /ACA box 17B(SNHG7 /// SNORA17B, marker 17412), small nucleolar RNA, H/ACA box 17B(SNORA17B, marker 17413), small nucleolar RNA, H/ACA box 37(SNORA37, marker 17414), small nucleolar RNA , H/ACA box 65(SNORA65, marker 17415), small nucleolar RNA, H/ACA box 68(SNORA68, marker 17416), small nucleolar RNA, H/ACA box 71A(SNORA71A, marker 17417), small nucleolar RNA, H /ACA box 71A(SNORA71A, marker 17418), small nucleolar RNA, H/ACA box 71B(SNORA71B, marker 17419), small nucleolar RNA, H/ACA box 74A(SNORA74A, marker 17420), small nucleolar RNA, H/ACA box 74A(SNORA74A, marker 17421), small nucleolar RNA, H/ACA box 74A(SNORA74A, marker 17422), small nucleolar RNA, H/ACA box 78(SNORA78, marker 17423), small nucleolar RNA, C/D box 114 -3(SNORD114-3, marker 17424), small nucleolar RNA, C/D box 3A /// small nucleolar RNA, C/D box 3B-1 /// small nucleolar RNA, C/D box 3B-2 // / small nucleolar RNA, C/D box 3C(SNORD3A /// SNORD3B-1 /// SNORD3B-2 /// SNORD3C, marker 17425),small nucleolar RNA, C/D box 8(SNORD8, marker 17426),small nucleolar RNA, C/D box 8(SNORD8, marker 17427),SNF related kinase(SNRK,marker 17428),SNF related kinase(SNRK,marker 17429),SNRK antisense RNA 1(SNRK-AS1,marker 17430),small nuclear ribonucleoprotein, U5 200kDa subunit(SNRNP200, marker 17431),small nuclear ribonucleoprotein, U5 200kDa subunit(SNRNP200, marker 17432),small nuclear ribonucleoprotein, U1 70kDa subunit(SNRNP70, marker 17433),small nuclear ribonucleoprotein polypeptide B(SNRPB2, marker 174 34 ),small nuclear ribonucleoprotein polypeptide N(SNRPN, marker 17435),small nuclear ribonucleoprotein polypeptide N(SNRPN,marker 17436),small nuclear ribonucleoprotein polypeptide N(SNRPN,marker 17437),small nuclear ribonucleoprotein polypeptide N(SNRPN,marker 17438), syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1)(SNTB1, marker 17439),syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1)(SNTB1, marker 17440),syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)(SNTB2, marker 17441),syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)(SNTB2, marker 17442),syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)(SNTB2, marker 17443),syntrophin, gamma 1(SNTG1, marker 17444),syntrophin, gamma 1(SNTG1, marker 17445),syntrophin, gamma 1(SNTG1, marker 17446), syntrophin, gamma 2 (SNTG2, marker 17447), syntrophin, gamma 2 (SNTG2, marker 17448), sentan, cilia apical structural protein (SNTN, marker 17449), SNU13 homolog, small nuclear ribonucleoprotein (U4/U6.U5 )(SNU13, marker 17450), sorting nexin 1 (SNX1, marker 17451), sorting nexin 18 (SNX18, marker 17452), sorting nexin 19 (SNX19, marker 17453), sorting nexin 2 (SNX2, marker 17454), sorting nexin 20(SNX20, marker 17455),sorting nexin 20(SNX20,marker 17456),sorting nexin 20(SNX20,marker 17457),sorting nexin 22(SNX22,marker 17458),sorting nexin 22(SNX22,marker 17459),sorting nexin 24(SNX24, marker 17460),sorting nexin 24(SNX24,marker 17461),sorting nexin 24(SNX24,marker 17462),sorting nexin 25(SNX25,marker 17463),sorting nexin 25(SNX25,marker 17464),sorting nexin 29(SNX29, marker 17465),sorting nexin 29(SNX29,marker 17466),sorting nexin 29(SNX29,marker 17467),sorting nexin 29(SNX29,marker 17468),sorting nexin 29 pseudogene 1 /// sorting nexin
29 pseudogene 2(SNX29P1 /// SNX29P2, marker 17469), sorting nexin 29 pseudogene 2(SNX29P2, marker 17470), sorting nexin 29 pseudogene 2(SNX29P2, marker 17471), sorting nexin 31(SNX31, marker 17472), sorting nexin 32 (SNX32, marker 17473), sorting nexin 32 (SNX32, marker 17474), sorting nexin 5 (SNX5, marker 17475), sorting nexin 8 (SNX8, marker 17476), sterol O-acyltransferase 1 (SOAT1, marker 17477), sterol O-acyltransferase 2 (SOAT2, marker 17478), sine oculis binding protein homolog (SOBP, marker 17479), sine oculis binding protein homolog (SOBP, marker 17480), sine oculis binding protein homolog (SOBP, marker 17481), sine oculis binding protein homolog (SOBP, marker 17482), sine oculis binding protein homolog (SOBP, marker 17483), sine oculis binding protein homolog (SOBP, marker 17484), sine oculis binding protein homolog (SOBP, marker 17485), suppressor of cytokine signaling 1 (SOCS1, marker 17486), suppressor of cytokine signaling 1 (SOCS1, marker 17487), suppressor of cytokine signaling 2 (SOCS2, marker 17488), SOCS2 antisense RNA 1 (SOCS2-AS1, marker 17489), suppressor of cytokine signaling 3 (SOCS3, marker 17490), superoxide dismutase 3, extracellular(SOD3, marker 17491), suppressor of glucose, autophagy associated 1(SOGA1, marker 17492), suppressor of glucose, autophagy associated 1(SOGA1, marker 17493), SOGA family member 3 (SOGA3, marker 17494), spermatogenesis and oogenesis specific basic helix-loop-helix 1 (SOHLH1, marker 17495), spermatogenesis and oogenesis specific basic helix-loop-helix 2 (SOHLH2, marker 17496), sorbin and SH3 domain containing 1 (SORBS1, marker 17497), sorbin and SH3 domain containing 2(SORBS2, marker 17498), sorbin and SH3 domain containing 2(SORBS2, marker 17499), sorbin and SH3 domain containing 2(SORBS2, marker 17500), sorbin and SH3 domain containing 2(SORBS2, marker 17501),sortilin-related VPS10 domain containing receptor 1(SORCS1, marker 17502),sortilin-related VPS10 domain containing receptor 2(SORCS2, marker 17503),sortilin-related VPS10 domain containing receptor 3(SORCS3, marker 17504), SORCS3 antisense RNA 1(SORCS3-AS1, marker 17505), sortilin-related receptor, L(DLR class) A repeats containing(SORL1, marker 17506), SOS Ras/Rac guanine nucleotide exchange factor 1(SOS1, marker 17507), SOS Ras/Rho guanine nucleotide exchange factor 2(SOS2, marker 17508), SOS Ras/Rho guanine nucleotide exchange factor 2(SOS2, marker 17509), sclerostin(SOST, marker 17510), sosondowah ankyrin repeat domain family member A (SOWAHA, marker 17511), SRY box 1 (SOX1, marker 17512), SRY box 1 (SOX1, marker 17513), SRY box 10 (SOX10, marker 17514), SRY box 13 (SOX13, marker 17515), SRY box 14 (SOX14, marker 17516), SRY box 17 (SOX17, marker 17517), SRY box 18 (SOX18, marker 17518), SRY box 21 (SOX21, marker 17519), SRY box 30 (SOX30, marker 17520), SRY box 30 (SOX30, marker 17521), SRY box 4 (SOX4, marker 17522), SRY box 5 (SOX5, marker 17523), SRY box 5 (SOX5, marker 17524), SRY box 5 (SOX5, marker 17525), SRY box 6 (SOX6, marker 17526), SRY box 6 (SOX6, marker 17527), SRY box 6 (SOX6, marker 17528), SRY box 6 (SOX6, marker 17529), SRY box 7 (SOX7, marker 17530), SP100 nuclear antigen (SP100, marker 17531),SP100 nuclear antigen(SP100,marker 17532),SP100 nuclear antigen(SP100,marker 17533),SP100 nuclear antigen(SP100,marker 17534),SP100 nuclear antigen(SP100,marker 17535),SP100 nuclear antigen (SP100, marker 17536),SP110 nuclear body protein(SP110,marker 17537),SP140 nuclear body protein(SP140,marker 17538),SP140 nuclear body protein-like(SP140L,marker 17539),SP140 nuclear body protein-like(SP140L , Marker 17540), SP140 nuclear body protein-like (SP140L, Marker 17541), Sp2 transcription factor (SP2, Marker 17542), Sp2 transcription factor (SP2, Marker 17543), SP2 antisense RNA 1 (SP2-AS1, Marker 17544) , Sp3 transcription factor (SP3, marker 17545), Sp3 transcription factor pseudogene (SP3P, marker 17546), Sp4 transcription factor (SP4, marker 17547), Sp7 transcription factor (SP7, marker 17548), Sp8 transcription factor (SP8, marker 17549) ),sperm acrosome associated 1(SPACA1, marker 17550),sperm acrosome associated 3(SPACA3,marker 17551),sperm acrosome associated 4(SPACA4,marker 17552),sperm acrosome associated 6(SPACA6,marker 17553),sperm acrosome associated 7 (SPACA7, marker 17554),sperm associated antigen 11A(SPAG11A,marker 17555),sperm associated antigen 11A /// sperm associated antigen 11B(SPAG11A /// SPAG11B,marker 17556),sperm associated antigen 11A /// sperm associated antigen 11B(SPAG11A /// SPAG11B, marker 17557),sperm associated antigen 11A /// sperm associated antigen 11B(SPAG11A /// SPAG11B, marker 17558),sperm associated antigen 11A /// sperm associated antigen 11B(SPAG11A /// SPAG11B, marker 17559), sperm associated antigen 16 (SPAG16, marker 17560), sperm associated antigen 16 (SPAG16, marker 17561), sperm associated antigen 17 (SPAG17, marker 17562), sperm associated antigen 4 (SPAG4, marker 17563), SPAG5 antisense RNA 1(SPAG5-AS1, marker 17564),SPAG5 antisense RNA 1(SPAG5-AS1, marker 17565),sperm associated antigen 6(SPAG6, marker 17566),sperm associated antigen 6(SPAG6, marker 17567),sperm associated antigen 8 (SPAG8, marker 17568), sperm associated antigen 8 (SPAG8, marker 17569), sperm associated antigen 9 (SPAG9, marker 17570), sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding) (SPAM1, marker 17571 ),sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)(SPAM1, marker 17572),sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)(SPAM1, marker 17573),sperm protein associated with the nucleus , X-linked, family member A1 /// SPANX family, member A2 /// SPANX family, member C(SPANXA1 /// SPANXA2 /// SPANXC, marker 17574), sperm protein associated with the nucleus, X-linked, family member A1 /// SPANX family, member A2 /// SPANX family, member C(SPANXA1 /// SPANXA2 /// SPANXC, marker 17575), SPANXA2 overlapping transcript 1(SPANXA2-OT1, marker 17576), spermatogenesis associated 1 (SPATA1, marker 17577),spermatogenesis associated 12(SPATA12,marker 17578),spermatogenesis associated 13(SPATA13,marker 17579),spermatogenesis associated 13(SPATA13,marker 17580),spermatogenesis associated 13(SPATA13,marker 17581),spermatogenesis associated 16 (SPATA16, marker 17582),spermatogenesis associated 17(SPATA17,marker 17583),spermatogenesis associated 17(SPATA17,marker 17584),spermatogenesis associated 18(SPATA18,marker 17585),spermatogenesis associated 19(SPATA19,marker 17586),spermatogenesis associated 21 (SPATA21, marker 17587),spermatogenesis associated 21(SPATA21,marker 17588),spermatogenesis associated 22(SPATA22,marker 17589),spermatogenesis associated 22(SPATA22,marker 17590),spermatogenesis associated 22(SPATA22,marker 17591),spermatogenesis associated 25 (SPATA25, marker 17592), spermatogenesis associated 3(SPATA3, marker 17593), SPATA3 antisense RNA 1 (head to head)(SPATA3-AS1, marker 17594), SPATA31 subfamily A, member 1 /// SPATA31 subfamily A, member 3 /// SPATA31 subfamily A, member 5 /// SPATA31 subfamily A, member 6 /// SPATA31 subfamily A, member 7(SPATA31A1 /// SPATA31A3 /// SPATA31A5 /// SPATA31A6 /// SPATA31A7, Marker 17595), SPATA31 subfamily C, member 2(SPATA31C2, marker 17596),SPATA31 subfamily D, member 1 /// SPATA31 subfamily D, member 3(SPATA31D1 /// SPATA31D3, marker 17597),SPATA31 subfamily E, member 1(SPATA31E1, marker 17598 ),SPATA31 subfamily E, member 1(SPATA31E1, marker 17599),spermatogenesis associated 32(SPATA32,marker 17600),spermatogenesis associated 32(SPATA32,marker 17601),spermatogenesis associated 4(SPATA4,marker 17602),spermatogenesis associated 41 (non -protein coding)(SPATA41, marker 17603),spermatogenesis associated 42 (non-protein coding)(SPATA42, marker 17604),spermatogenesis associated 45(SPATA45,marker 17605),spermatogenesis associated 5(SPATA5,marker 17606),spermatogenesis associated 5 (SPATA5, marker 17607),spermatogenesis associated 5-like 1(SPATA5L1,marker 17608),spermatogenesis associated 6-like(SPATA6L,marker 17609),spermatogenesis associated 6-like(SPATA6L,marker 17610),spermatogenesis associated 6-like( SPATA6L, marker 17611),spermatogenesis associated 6-like(SPATA6L,marker 17612),spermatogenesis associated 6-like(SPATA6L,marker 17613),spermatogenesis associated 8(SPATA8,marker 17614),spermatogenesis associated 9(SPATA9,marker 17615), spermatogenesis associated 9(SPATA9, marker 17616),spermatogenesis and centriole associated 1(SPATC1, marker 17617),spermatogenesis associated, serine-rich 1(SPATS1, marker 17618),spermatogenesis associated, serine-rich 2(SPATS2, marker 17619), spermatogenesis associated, serine-rich 2-like(SPATS2L, marker 17620),spermatogenesis associated, serine-rich 2-like(SPATS2L, marker 17621),SPC24, NDC80 kinetochore complex component(SPC24, marker 17622),signal peptidase complex subunit 2 (SPCS2, marker 17623), SAM pointed domain containing ETS transcription factor(SPDEF, marker 17624), SAM pointed domain containing ETS transcription factor(SPDEF, marker 17625), SAM pointed domain containing ETS transcription factor(SPDEF, marker 17626), spindle apparatus coiled-coil protein 1 (SPDL1, marker 17627), speedy/RINGO cell cycle regulator family member A (SPDYA, marker 17628), speedy/RINGO cell cycle regulator family member E1 (SPDYE1, marker 17629), sperm flagellar 2 (SPEF2) ,marker 17630),sperm flagellar 2(SPEF2,marker 17631),sperm flagellar 2(SPEF2,marker 17632),spermatid maturation 1(SPEM1,marker 17633),spen family transcriptional repressor(SPEN,marker 17634),spermatid associated(SPERT ,marker 17635),spermatid associated(SPERT,marker 17636),sperm equatorial segment protein 1(SPESP1,marker 17637),spastic paraplegia 11 (autosomal recessive)(SPG11,marker 17638),spastic paraplegia 11 (autosomal recessive)(SPG11, marker 17639), spastic paraplegia 11 (autosomal recessive) (SPG11, marker 17640), spastic paraplegia 20 (Troyer syndrome) (SPG20, marker 17641), SPG20 antisense RNA 1 (SPG20-AS1, marker 17642), spastic paraplegia 7 (pure and complicated autosomal recessive) (SPG7, marker 17643), SPHK1 interactor, AKAP domain containing (SPHKAP, marker 17644), Spi-1 proto-oncogene (SPI1, marker 17645), Spi-B transcription factor (Spi-1/PU. 1 related) (SPIB, marker 17646), Spi-C transcription factor (Spi-1/PU.1 related) (SPIC, marker 17647), spindle and centriole associated protein 1 (SPICE1, marker 17648), scaffolding protein involved in DNA repair(SP
IDR, marker 17649), scaffolding protein involved in DNA repair(SPIDR, marker 17650), scaffolding protein involved in DNA repair(SPIDR, marker 17651), spindlin family, member 2A(SPIN2A, marker 17652), serine peptidase inhibitor, Kazal type 13 (putative)(SPINK13, marker 17653),serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor)(SPINK2, marker 17654),serine peptidase inhibitor, Kazal type 4(SPINK4, marker 17655),serine peptidase inhibitor, Kazal type 6 (SPINK6, marker 17656), serine peptidase inhibitor, Kazal type 7 (putative) (SPINK7, marker 17657), serine peptidase inhibitor, Kunitz type, 3 (SPINT3, marker 17658), spire-type actin nucleation factor 2 (SPIRE2) , marker 17659), spire-type actin nucleation factor 2 (SPIRE2, marker 17660), spire-type actin nucleation factor 2 (SPIRE2, marker 17661), sialophorin (SPN, marker 17662), spinster homolog 3 (Drosophila) (SPNS3, marker 17663), SPO11 meiotic protein covalently bound to DSB(SPO11, marker 17664),SPOC domain containing 1(SPOCD1, marker 17665),SPOC domain containing 1(SPOCD1, marker 17666), sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3(SPOCK3, marker 17667),sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3(SPOCK3, marker 17668),sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3( SPOCK3, marker 17669), sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 (SPOCK3, marker 17670), spondin 1, extracellular matrix protein (SPON1, marker 17671), speckle-type POZ protein (SPOP, marker 17672), secreted phosphoprotein 2(SPP2, marker 17673), signal peptide peptidase like 2B(SPPL2B, marker 17674), signal peptide peptidase like 2C(SPPL2C, marker 17675), signal peptide peptidase like 3(SPPL3, marker 17676), signal peptide peptidase like 3(SPPL3, marker 17677),sprouty-related, EVH1 domain containing 2(SPRED2, marker 17678),sprouty-related, EVH1 domain containing 2(SPRED2, marker 17679),shadow of prion protein homolog (zebrafish)( SPRN, marker 17680), shadow of prion protein homolog (zebrafish) pseudogene 1 (SPRNP1, marker 17681), small proline-rich protein 1A (SPRR1A, marker 17682), small proline-rich protein 1A (SPRR1A, marker 17683), small proline-rich protein 1B (SPRR1B, marker 17684), small proline-rich protein 2B (SPRR2B, marker 17685), small proline-rich protein 2C (pseudogene) (SPRR2C, marker 17686), small proline-rich protein 2G (SPRR2G, marker 17687), small proline-rich protein 3 (SPRR3, marker 17688), small proline-rich protein 3 (SPRR3, marker 17689), sprouty RTK signaling antagonist 3 (SPRY3, marker 17690), SPRY4 intronic transcript 1 (SPRY4-IT1) , Marker 17691), SPRY domain containing 3(SPRYD3, Marker 17692), SPRY domain containing 7(SPRYD7, Marker 17693), spectrin, alpha, erythrocytic 1(SPTA1, Marker 17694), spectrin, alpha, non-erythrocytic 1(SPTAN1 , marker 17695), spectrin, alpha, non-erythrocytic 1(SPTAN1, marker 17696), spectrin, beta, erythrocytic(SPTB, marker 17697), spectrin, beta, erythrocytic(SPTB, marker 17698), spectrin, beta, non- erythrocytic 1(SPTBN1, marker 17699),spectrin, beta, non-erythrocytic 1(SPTBN1, marker 17700),spectrin, beta, non-erythrocytic 1(SPTBN1, marker 17701),spectrin, beta, non-erythrocytic 1(SPTBN1, Marker 17702), spectrin, beta, non-erythrocytic 1(SPTBN1, Marker 17703), spectrin, beta, non-erythrocytic 1(SPTBN1, Marker 17704), spectrin, beta, non-erythrocytic 4(SPTBN4, Marker 17705), spectrin , beta, non-erythrocytic 4(SPTBN4, marker 17706),spectrin, beta, non-erythrocytic 4(SPTBN4, marker 17707),spectrin, beta, non-erythrocytic 4(SPTBN4, marker 17708),spectrin, beta, non- erythrocytic 4 (SPTBN4, marker 17709), spectrin, beta, non-erythrocytic 5 (SPTBN5, marker 17710), serine palmitoyltransferase, long chain base subunit 2 (SPTLC2, marker 17711), serine palmitoyltransferase, long chain base subunit 3 (SPTLC3, marker 17712), serine palmitoyltransferase, long chain base subunit 3(SPTLC3, marker 17713), serine palmitoyltransferase, long chain base subunit 3(SPTLC3, marker 17714), serine palmitoyltransferase, small subunit B(SPTSSB, marker 17715), SPTY2D1 antisense RNA 1 (SPTY2D1-AS1, marker 17716), SPTY2D1 antisense RNA 1 (SPTY2D1-AS1, marker 17717), spexin hormone (SPX, marker 17718), spermatogenic leucine zipper 1 (SPZ1, marker 17719), sequestosome 1 (SQSTM1, marker 17720) ),sequestosome 1(SQSTM1, marker 17721),SRC proto-oncogene, non-receptor tyrosine kinase(SRC,marker 17722),SRC proto-oncogene, non-receptor tyrosine kinase(SRC,marker 17723),SRC proto-oncogene, non-receptor tyrosine kinase(SRC, marker 17724),SRC proto-oncogene, non-receptor tyrosine kinase(SRC, marker 17725),SRC proto-oncogene, non-receptor tyrosine kinase(SRC, marker 17726),SRC proto-oncogene , non-receptor tyrosine kinase (SRC, marker 17727), Snf2-related CREBBP activator protein (SRCAP, marker 17728), SRC kinase signaling inhibitor 1 (SRCIN1, marker 17729), SRC kinase signaling inhibitor 1 (SRCIN1, marker 17730), SRC kinase signaling inhibitor 1 (SRCIN1, marker 17731), steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (SRD5A2, marker 17732), steroid-5- alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) (SRD5A2, marker 17733), SRD5A3 antisense RNA 1 (SRD5A3-AS1, marker 17734), sterol regulatory element binding transcription factor 1 (SREBF1, marker 17735), splicing regulatory glutamine/lysine-rich protein 1 (SREK1, marker 17736), splicing regulatory glutamine/lysine-rich protein 1 (SREK1, marker 17737), SLIT-ROBO Rho GTPase activating protein 1 (SRGAP1, Marker 17738), SLIT-ROBO Rho GTPase activating protein 1 (SRGAP1, Marker 17739), SLIT-ROBO Rho GTPase activating protein 1 (SRGAP1, Marker 17740), SLIT-ROBO Rho GTPase activating protein 1 (SRGAP1, Marker 17741), SLIT -ROBO Rho GTPase activating protein 2(SRGAP2, marker 17742),SLIT-ROBO Rho GTPase activating protein 2(SRGAP2, marker 17743),SLIT-ROBO Rho GTPase activating protein 3(SRGAP3, marker 17744),SLIT-ROBO Rho GTPase activating protein 3 (SRGAP3, marker 17745), SLIT-ROBO Rho GTPase activating protein 3 (SRGAP3, marker 17746), serglycin (SRGN, marker 17747), serglycin (SRGN, marker 17748), serglycin (SRGN, marker 17749), sarcalumenin ( SRL, marker 17750), spermidine synthase pseudogene 1 (SRMP1, marker 17751), src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (SRMS, marker 17752), signal recognition particle 19kDa /// zinc finger ( CCCH type), RNA binding motif and serine/arginine rich 1(SRP19 /// ZRSR1, marker 17753), signal recognition particle 72kDa(SRP72, marker 17754), SRSF protein kinase 2(SRPK2, marker 17755), sushi-repeat containing protein, X-linked 2(SRPX2, marker 17756),sushi-repeat containing protein, X-linked 2(SRPX2, marker 17757),SRRM2 antisense RNA 1(SRRM2-AS1, marker 17758),serine/arginine repetitive matrix 3 SRRM3, marker 17759), serine/arginine repetitive matrix 3 (SRRM3, marker 17760), serine/arginine repetitive matrix 3 (SRRM3, marker 17761), serine/arginine repetitive matrix 4 (SRRM4, marker 17762), serine/arginine repetitive matrix 4 (SRRM4, marker 17763), serine/arginine repetitive matrix 4 (SRRM4, marker 17764), serine/arginine repetitive matrix 5 (SRRM5, marker 17765), serrate, RNA effector molecule (SRRT, marker 17766), serine/arginine- rich splicing factor 11 (SRSF11, marker 17767), serine/arginine-rich splicing factor 3 (SRSF3, marker 17768), serine/arginine-rich splicing factor 3 (SRSF3, marker 17769), serine/arginine-rich splicing factor 4 ( SRSF4, marker 17770), serine/arginine-rich splicing factor 4 (SRSF4, marker 17771), sex determining region Y (SRY, marker 17772), single-stranded DNA binding protein 2 (SSBP2, marker 17773), scavenger receptor cysteine rich family, 5 domains(SSC5D, marker 17774), slingshot protein phosphatase 1(SSH1, marker 17775), slingshot protein phosphatase 1(SSH1, marker 17776), slingshot protein phosphatase 2(SSH2, marker 17777), slingshot protein phosphatase 2(SSH2 , marker 17778), slingshot protein phosphatase 2 (SSH2, marker 17779), slingshot protein phosphatase 3 (SSH3, marker 17780), serine-rich single-pass membrane protein 1 (SSMEM1, marker 17781), serine-rich single-pass membrane protein 1 (SSMEM1, marker 17782), sarcospan (SSPN, marker 17783), sarcospan (SSPN, marker 17784), sarcospan (SSPN, marker 17785), sarcospan (SSPN, marker 17786), SCO-spondin (SSPO, marker 17787) ,signal sequence receptor, delta pseudogene 1(SSR4P1, marker 17788),SSSCA1 antisense RNA 1 (head to head)(SSSCA1-AS1,marker 17789),somatostatin receptor 1(SSTR1,marker 17790),somatostatin receptor 1(SSTR1,marker 17791), somatostatin receptor 2 (SSTR2, marker 17792), somatostatin receptor 2 (SSTR2, marker 17793), somatostatin receptor 2 (SSTR2, marker 17794), somatostatin receptor 2 (SSTR2, marker 17795), somatostatin receptor 3 (SSTR3, marker 17796), somatostatin receptor 4 (SSTR4, marker 17797), somatostatin receptor 5 (SSTR5, marker 17798), SSTR5 antisense RNA 1 (SSTR5-AS1, marker 17799), synovial sarcoma, X breakpoint 1 (SSX1, marker 17800), synovial sarcoma, X breakpoint 1(SSX1, marker 17801), synovial sarcoma, X breakpoint 2 /// synovial sarcoma, X breakpoint 2B(SSX2 /// SSX2B, marker 17803), synovial sarcoma, X breakpoint 2 /// synovial sarcoma, X breakpoint 2B(SSX2 /// SSX2B, marker 17804), synovial sarcoma, X breakpoint 2 /// synovial sarcoma, X breakpoint 2B /// synovial sarcoma, X breakpoint 3(SSX2 /// SSX2B /// SSX3, marker 17805), synovial sarcoma, , marker 17807), synovial sarcoma, X breakpoint 3(SSX3, marker 17808), synovial sarcoma, X breakpoint 3(SSX3, marker 17809), synovial sarcoma, X breakpoint 4 /// synovial sarcoma, / SSX4B, marker 17810), synovial sarcoma, X breakpoint 4 /// synovial sarcoma, X breakpoint 4B(SSX4 /// SSX4B, marker 17811), synovial sarcoma, X breakpoint 5(SSX5, marker 17812), suppression of tumorigenicity 14 (colon carcinoma)(ST14, marker 17813), suppression of tumorigenicity 18, zinc finger(ST18, marker 17814), suppression of tumorigenicity 18, zinc finger(ST18, marker 17815), suppression of tumorigenicity 18, zinc finger(ST18, marker 17816), suppression of tumorigenicity 18, zinc finger(ST18, marker 17817), suppressor of tumorigenicity 20(ST20, marker 17818), ST3 beta-g
alactoside alpha-2,3-sialyltransferase 1(ST3GAL1, marker 17819),ST3 beta-galactoside alpha-2,3-sialyltransferase 2(ST3GAL2, marker 17820),ST3 beta-galactoside alpha-2,3-sialyltransferase 2(ST3GAL2, marker 17821), ST3 beta-galactoside alpha-2,3-sialyltransferase 3(ST3GAL3, marker 17822),ST3 beta-galactoside alpha-2,3-sialyltransferase 3(ST3GAL3, marker 17823),ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3, marker 17824), ST3 beta-galactoside alpha-2, 3-sialyltransferase 3 (ST3GAL3, marker 17825), ST3 beta-galactoside alpha-2, 3-sialyltransferase 4 (ST3GAL4, marker 17826), ST3 beta-galactoside alpha-2,3-sialyltransferase 4(ST3GAL4, marker 17827),ST3GAL4 antisense RNA 1 (head to head)(ST3GAL4-AS1, marker 17828),ST3 beta-galactoside alpha-2,3-sialyltransferase 6(ST3GAL6 , marker 17829), ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 (ST6GAL1, marker 17830), ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 (ST6GAL2, marker 17831), ST6 (alpha-N-acetyl -neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (ST6GALNAC1, marker 17832),ST6 (alpha-N-acetyl-neuraminyl-2,3-beta- galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2(ST6GALNAC2, marker 17833),ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N- acetylgalactosaminide alpha-2,6-sialyltransferase 4 (ST6GALNAC4, marker 17834),ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (ST6GALNAC5, marker 17835), ST7 antisense RNA 1 (ST7-AS1, marker 17836), ST7 antisense RNA 2 (ST7-AS2, marker 17837), ST7 antisense RNA 2 (ST7-AS2, marker 17838), ST7 overlapping transcript 4 (ST7-OT4, marker 17839), suppression of tumorigenicity 7 like (ST7L, marker 17840), suppression of tumorigenicity 7 like (ST7L, marker 17841), ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1( ST8SIA1, marker 17842), ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1(ST8SIA1, marker 17843),ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2(ST8SIA2, marker 17844 ), ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 (ST8SIA3, marker 17845), ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 (ST8SIA4, marker 17846), ST8 alpha -N-acetyl-neuraminide alpha-2,8-sialyltransferase 4(ST8SIA4, marker 17847),ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4(ST8SIA4, marker 17848),ST8 alpha-N-acetyl -neuraminide alpha-2,8-sialyltransferase 4(ST8SIA4, marker 17849),ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5(ST8SIA5, marker 17850),ST8 alpha-N-acetyl-neuraminide alpha- 2,8-sialyltransferase 5 (ST8SIA5, marker 17851), ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 (ST8SIA5, marker 17852), ST8SIA6 antisense RNA 1 (ST8SIA6-AS1, marker 17853), stabilin 1 (STAB1, Marker 17854), Stabilin 1 (STAB1, Marker 17855), Stabilin 1 (STAB1, Marker 17856), Stabilin 1 (STAB1, Marker 17857), Stabilin 2 (STAB2, Marker 17858), Stabilin 2 (STAB2, Marker 17859), SH3 and cysteine rich domain 3 (STAC3, marker 17860), stromal antigen 1 (STAG1, marker 17861), stromal antigen 3 (STAG3, marker 17862), STAM antisense RNA 1 (head to head) (STAM-AS1, marker 17863), STAM binding protein-like 1 (STAMBPL1, marker 17864), signal transducing adapter family member 1 (STAP1, marker 17865), signal transducing adapter family member 1 (STAP1, marker 17866), steroidogenic acute regulatory protein (STAR, Marker 17867), StAR-related lipid transfer domain containing 10 (STARD10, Marker 17868), StAR-related lipid transfer domain containing 10 (STARD10, Marker 17869), StAR-related lipid transfer domain containing 13 (STARD13, Marker 17870), StAR -related lipid transfer domain containing 13(STARD13, marker 17871),STARD13 antisense RNA(STARD13-AS, marker 17872),STARD13 antisense RNA(STARD13-AS, marker 17873),StAR-related lipid transfer domain containing 5(STARD5, marker 17874), StAR-related lipid transfer domain containing 6(STARD6, marker 17875), signal transducer and activator of transcription 2(STAT2, marker 17876), signal transducer and activator of transcription 3 (acute-phase response factor)(STAT3, marker 17877), signal transducer and activator of transcription 4(STAT4, marker 17878), signal transducer and activator of transcription 5B(STAT5B, marker 17879), signal transducer and activator of transcription 6, interleukin-4 induced(STAT6, marker 17880), statherin (STATH, marker 17881), staufen double-stranded RNA binding protein 2 (STAU2, marker 17882), STAU2 antisense RNA 1 (STAU2-AS1, marker 17883), starch binding domain 1 (STBD1, marker 17884), STEAP family member 4(STEAP4, marker 17885), STEAP family member 4(STEAP4, marker 17886), STEAP family member 4(STEAP4, marker 17887), uncharacterized STGC3(STGC3, marker 17888), saitohin(STH, marker 17889), stromal interaction molecule 1 (STIM1, marker 17890), stromal interaction molecule 2 (STIM2, marker 17891), serine/threonine kinase 10 (STK10, marker 17892), serine/threonine kinase 16 (STK16, marker 17893), serine/threonine kinase 17a (STK17A , marker 17894), serine/threonine kinase 17b (STK17B, marker 17895), serine/threonine kinase 19 (STK19, marker 17896), serine/threonine kinase 24 (STK24, marker 17897), serine/threonine kinase 24 (STK24, marker 17898),serine/threonine kinase 24(STK24, marker 17899),STK24 antisense RNA 1(STK24-AS1,marker 17900),serine/threonine kinase 3(STK3,marker 17901),serine/threonine kinase 3(STK3,marker 17902) ),serine/threonine kinase 31(STK31, marker 17903),serine/threonine kinase 32A(STK32A,marker 17904),serine/threonine kinase 32A(STK32A,marker 17905),serine/threonine kinase 32A(STK32A,marker 17906), serine/threonine kinase 32A(STK32A, marker 17907),serine/threonine kinase 32B(STK32B,marker 17908),serine/threonine kinase 32B(STK32B,marker 17909),serine/threonine kinase 35(STK35,marker 17910),serine/ threonine kinase 35(STK35, marker 17911),serine/threonine kinase 38(STK38,marker 17912),serine/threonine kinase 38(STK38,marker 17913),serine/threonine kinase 38(STK38,marker 17914),serine/threonine kinase 4 (STK4, marker 17915), serine/threonine kinase 4 (STK4, marker 17916), STK4 antisense RNA 1 (head to head) (STK4-AS1, marker 17917), serine/threonine kinase 40 (STK40, marker 17918), serine/threonine kinase-like domain containing 1 (STKLD1, marker 17919), serine/threonine kinase-like domain containing 1 (STKLD1, marker 17920), stathmin 1 (STMN1, marker 17921), stathmin-like 4 (STMN4, marker 17922) ), stathmin-like 4 (STMN4, marker 17923), stomatin (STOM, marker 17924), stomatin (EPB72)-like 1 (STOML1, marker 17925), stomatin (EPB72)-like 1 (STOML1, marker 17926), stomatin (EPB72)-like 3(STOML3, marker 17927),stonin 1(STON1,marker 17928),storkhead box 1(STOX1,marker 17929),storkhead box 2(STOX2,marker 17930),sperm-tail PG-rich repeat containing 1 (STPG1, marker 17931), sperm-tail PG-rich repeat containing 2 (STPG2, marker 17932), stimulated by retinoic acid 6 (STRA6, marker 17933), STE20-related kinase adapter alpha (STRADA, marker 17934), stereocilin (STRC, marker 17935), stereocilin (STRC, marker 17936), striatin, calmodulin binding protein (STRN, marker 17937), striatin, calmodulin binding protein (STRN, marker 17938), striatin, calmodulin binding protein (STRN, marker 17939) , steroid sulfatase (microsomal), isozyme S (STS, marker 17940), syntaxin 11 (STX11, marker 17941), syntaxin 11 (STX11, marker 17942), STX17 antisense RNA 1 (STX17-AS1, marker 17943), STX18 antisense RNA 1 (head to head)(STX18-AS1, marker 17944), syntaxin 19 (STX19, marker 17945), syntaxin 1B (STX1B, marker 17946), syntaxin 6 (STX6, marker 17947), syntaxin 7 (STX7, marker 17948) ,syntaxin 8(STX8, marker 17949),syntaxin binding protein 2(STXBP2,marker 17950),syntaxin binding protein 3(STXBP3,marker 17951),syntaxin binding protein 4(STXBP4,marker 17952),syntaxin binding protein 4(STXBP4, marker 17953), syntaxin binding protein 4 (STXBP4, marker 17954), syntaxin binding protein 5 (tomosyn) (STXBP5, marker 17955), STXBP5 antisense RNA 1 (STXBP5-AS1, marker 17956), STXBP5 antisense RNA 1 (STXBP5-AS1 , marker 17957), STXBP5 antisense RNA 1 (STXBP5-AS1, marker 17958), syntaxin binding protein 5-like (STXBP5L, marker 17959), syntaxin binding protein 5-like (STXBP5L, marker 17960), syntaxin binding protein 5-like (STXBP5L, marker 17961), syntaxin binding protein 6 (amisyn) (STXBP6, marker 17962), serine/threonine/tyrosine kinase 1 (STYK1, marker 17963), SUB1 homolog, transcriptional regulator (SUB1, marker 17964), SUCLA2 antisense RNA 1(SUCLG2-AS1, marker 17965), succinate-CoA ligase, alpha subunit(SUCLG1, marker 17966), SUCLG2 antisense RNA 1 (head to head)(SUCLG2-AS1, marker 17967), SUCLG2 antisense RNA 1 (head to head) )(SUCLG2-AS1, marker 17968), SUCLG2 antisense RNA 1 (head to head)(SUCLG2-AS1, marker 17969), succinate receptor 1(SUCNR1, marker 17970), suppressor of fused homolog (Drosophila)(SUFU, marker 17971 ),suppressor of fused homolog (Drosophila)(SUFU, marker 17972),suppressor of fused homolog (Drosophila)(SUFU,marker 17973),succinyl-CoA:glutarate-CoA transferase(SUGCT,marker 17974),SURP and G-patch domain containing 1(SUGP1, marker 17975),SGT1 homolog, MIS12 kinetochore complex assembly cochaperone pseudogene 1(SUGT1P1, marker 17976),SGT1 homolog, MIS12 kinetochore complex assembly cochaperone pseudogene 1(SUGT1P1, marker 17977),SGT1 homolog, MIS12 kinetochore complex assembly cochaperone pseudogene 3 (SUGT1P3, marker 17978), SGT1 homolog, MIS12 kinetochore complex assembly cochaperone pseudogene 3 (SUGT1P3, marker 17979), sulfotransferase family 1A member 1 (SULT1A1, marker 17980), sulfotransferase family 1B member 1 (SULT1B1, marker 17981) ), sulfotransferase family 1C member 2(SULT1C2, marker 17982), sulfotransferase family 1C member 2(SULT1C2, marker 17983), sulfotransferase family 1E member 1(SULT1E1, marker 17984), sulfotransferase family 1E member 1(SULT1E1, marker 17985), sulfotransferase family 2A member 1(SULT2A1, marker 17986),sulfotransferase family 2A member 1(SULT2A1, marker 17987),sulfotransferase family 2B member 1(SULT2B1, marker 17988),Sad1 and UNC84 domain containing 1(SUN1, marker 17989),Sad1 and UNC84 domain containing 3(SUN3, marker 17990),Sad1 and UNC84 domain containing 5(SUN5, marker 17991),Sad1 and UNC84 domain containing 5(SUN5, marker 17992),Sad1 and UNC84 domain containing 5(SUN5, marker 17993) ,SPT20 homolog, SAGA complex component(SUPT20H, marker 17994),SPT3 homolog, SAGA and STAGA complex component
nt(SUPT3H, marker 17995), SPT6 homolog, histone chaperone(SUPT6H, marker 17996), surfeit 1(SURF1, marker 17997), sushi domain containing 2(SUSD2, marker 17998), sushi domain containing 2(SUSD2, marker 17999) ,sushi domain containing 3(SUSD3, marker 18000),sushi domain containing 4(SUSD4,marker 18001),sushi domain containing 4(SUSD4,marker 18002),sushi domain containing 4(SUSD4,marker 18003),SUZ12 polycomb repressive complex 2 subunit(SUZ12, marker 18004), SUZ12 polycomb repressive complex 2 subunit(SUZ12, marker 18005), synaptic vesicle glycoprotein 2B(SV2B, marker 18006), synaptic vesicle glycoprotein 2B(SV2B, marker 18007), synaptic vesicle glycoprotein 2B(SV2B, marker 18008), synaptic vesicle glycoprotein 2C (SV2C, marker 18009), synaptic vesicle glycoprotein 2C (SV2C, marker 18010), synaptic vesicle glycoprotein 2C (SV2C, marker 18011), synaptic vesicle glycoprotein 2C (SV2C, marker 18012), sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1(SVEP1, marker 18013),sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1(SVEP1, marker 18014),sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1(SVEP1, marker 18015),sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1(SVEP1, marker 18016),sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1(SVEP1, marker 18017), sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1(SVEP1, marker 18018), supervillin(SVIL, marker 18019), SVIL antisense RNA 1(SVIL-AS1, marker 18020), SVIL antisense RNA 1( SVIL-AS1, marker 18021), SV2 related protein (SVOP, marker 18022), SV2 related protein (SVOP, marker 18023), SWAP switching B-cell complex 70kDa subunit (SWAP70, marker 18024), syntabulin (syntaxin-interacting)( SYBU, marker 18025), synaptonemal complex central element protein 1 (SYCE1, marker 18026), synaptonemal complex central element protein 1 (SYCE1, marker 18027), synaptonemal complex central element protein 1-like (SYCE1L, marker 18028), synaptonemal complex central protein element 2 (SYCE2, marker 18029), synaptonemal complex central element protein 3 (SYCE3, marker 18030), syncollin (SYCN, marker 18031), synaptonemal complex protein 1 (SYCP1, marker 18032), synaptonemal complex protein 1 (SYCP1, marker 18033), synaptonemal complex protein 2 (SYCP2, marker 18034), synaptonemal complex protein 2 (SYCP2, marker 18035), synaptonemal complex protein 3 (SYCP3, marker 18036), synaptonemal complex protein 3 (SYCP3, marker 18037), synapse defective 1 , Rho GTPase, homolog 1 (C. elegans)(SYDE1, marker 18038),synapse defective 1, Rho GTPase, homolog 1 (C. elegans)(SYDE1, marker 18039),synapse defective 1, Rho GTPase, homolog 2 (C elegans) (SYDE2, marker 18040), SYF2 pre-mRNA-splicing factor (SYF2, marker 18041), spleen tyrosine kinase (SYK, marker 18042), spleen tyrosine kinase (SYK, marker 18043), spleen tyrosine kinase (SYK, marker 18044), spleen tyrosine kinase (SYK, marker 18045), symplekin (SYMPK, marker 18046), synapsin I (SYN1, marker 18047), synapsin I (SYN1, marker 18048), synapsin II (SYN2, marker 18049), synapsin II(SYN2, marker 18050), syncoilin, intermediate filament protein(SYNC, marker 18051), synapse differentiation inducing 1-like(SYNDIG1L, marker 18052), spectrin repeat containing, nuclear envelope 1(SYNE1, marker 18053), spectrin repeat containing , nuclear envelope 1(SYNE1, marker 18054),spectrin repeat containing, nuclear envelope 1(SYNE1,marker 18055),spectrin repeat containing, nuclear envelope 1(SYNE1,marker 18056),spectrin repeat containing, nuclear envelope 1(SYNE1,marker 18057), spectrin repeat containing, nuclear envelope family member 3(SYNE3, marker 18060), spectrin repeat containing, nuclear envelope 2(SYNE2, marker 18059), synaptic Ras GTPase activating protein 1 (SYNGAP1, marker 18061), synaptogyrin 2 (SYNGR2, marker 18062), synaptogyrin 4 (SYNGR4, marker 18063), synaptojanin 1 (SYNJ1, marker 18064), synaptojanin 1 (SYNJ1, marker 18065), synaptojanin 2 (SYNJ2) , marker 18066), synaptojanin 2(SYNJ2, marker 18067), synaptopodin(SYNPO, marker 18068), synaptopodin(SYNPO, marker 18069), synaptopodin(SYNPO, marker 18070), synaptopodin 2(SYNPO2, marker 18071), synaptopodin 2( SYNPO2, marker 18072), synaptopodin 2 (SYNPO2, marker 18073), synaptopodin 2 (SYNPO2, marker 18074), synaptopodin 2 (SYNPO2, marker 18075), synaptopodin 2 (SYNPO2, marker 18076), synaptopodin 2 (SYNPO2, marker 18077) ) ,synaptopodin 2-like(SYNPO2L, marker 18078),synaptopodin 2-like(SYNPO2L,marker 18079),synaptoporin(SYNPR,marker 18080),SYNPR antisense RNA 1(SYNPR-AS1,marker 18081),synergin, gamma(SYNRG, marker 18082), synergin, gamma (SYNRG, marker 18083), synaptophysin (SYP, marker 18084), Sys1 golgi trafficking protein (SYS1, marker 18085), synaptotagmin XI (SYT11, marker 18086), synaptotagmin XII (SYT12, marker 18087) ,synaptotagmin XII(SYT12, marker 18088),synaptotagmin , marker 18093), synaptotagmin VII(SYT7, marker 18094), synaptotagmin VII(SYT7, marker 18095), synaptotagmin VII(SYT7, marker 18096), synaptotagmin VII(SYT7, marker 18097), synaptotagmin VII(SYT7, marker 18098), synaptotagmin VIII (SYT8, marker 18099), synaptotagmin IX (SYT9, marker 18100), synaptotagmin IX (SYT9, marker 18101), synaptotagmin IX (SYT9, marker 18102), synaptotagmin IX (SYT9, marker 18103) SYTL2, marker 18104), synaptotagmin-like 3(SYTL3, marker 18105), synaptotagmin-like 3(SYTL3, marker 18106), synaptotagmin-like 3(SYTL3, marker 18107), synaptotagmin-like 3(SYTL3, marker 18108), synaptotagmin-like 4(SYTL4, marker 18109),synaptotagmin-like 4(SYTL4,marker 18110),synaptotagmin-like 5(SYTL5,marker 18111),seizure threshold 2 homolog (mouse)(SZT2,marker 18112),seizure threshold 2 homolog (mouse)(SZT2, marker 18113),seizure threshold 2 homolog (mouse)(SZT2, marker 18114),trace amine associated receptor 1(TAAR1, marker 18115),trace amine associated receptor 2(TAAR2, marker 18116),trace amine associated receptor 3 (gene/pseudogene)(TAAR3, marker 18117),trace amine associated receptor 5(TAAR5, marker 18118),trace amine associated receptor 8(TAAR8, marker 18119),trace amine associated receptor 9 (gene/pseudogene) (TAAR9, marker 18120), TGF-beta activated kinase 1/MAP3K7 binding protein 2 (TAB2, marker 18121), TGF-beta activated kinase 1/MAP3K7 binding protein 3 (TAB3, marker 18122), TGF-beta activated kinase 1/ MAP3K7 binding protein 3(TAB3, marker 18123),tachykinin 4 (hemokinin)(TAC4, marker 18124),transforming, acidic coiled-coil containing protein 1(TACC1,marker 18125),transforming, acidic coiled-coil containing protein 1(TACC1) ,marker 18126),transforming, acidic coiled-coil containing protein 1(TACC1,marker 18127),transforming, acidic coiled-coil containing protein 2(TACC2,marker 18128),transforming, acidic coiled-coil containing protein 2(TACC2,marker 18129),transforming, acidic coiled-coil containing protein 3(TACC3, marker 18130),translational activator of mitochondrially encoded cytochrome c oxidase I(TACO1,marker 18131),tachykinin receptor 1(TACR1,marker 18132),tachykinin receptor 1(TACR1) , marker 18133), tachykinin receptor 1 (TACR1, marker 18134), tachykinin receptor 1 (TACR1, marker 18135), tachykinin receptor 2 (TACR2, marker 18136), tachykinin receptor 3 (TACR3, marker 18137), tumor-associated calcium signal transducer 2(TACSTD2, marker 18138), tumor-associated calcium signal transducer 2(TACSTD2, marker 18139), tumor-associated calcium signal transducer 2(TACSTD2, marker 18140), transcriptional adapter 1(TADA1, marker 18141), transcriptional adapter 2A (TADA2A, marker 18142), transcriptional adapter 2A (TADA2A, marker 18143), transcriptional adapter 3 (TADA3, marker 18144), TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa (TAF1, marker 18145) ,TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa(TAF1, marker 18146),TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa /// TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa-like(TAF1 /// TAF1L, marker 18147),TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa(TAF10, marker 18148),TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa (TAF10, marker 18149), TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa (TAF11, marker 18150), TAF1A antisense RNA 1 (TAF1A-AS1, marker 18151), TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa (TAF4, marker 18152), TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF) -associated factor, 65kDa(TAF6L, marker 18153),TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa(TAF6L, marker 18154),TATA box binding protein associated factor 7 like(TAF7L T- cell activation RhoGTPase activating protein(TAGAP, marker 18159),T-cell activation RhoGTPase activating protein(TAGAP, marker 18160),T-cell activation RhoGTPase activating protein(TAGAP,marker 18161),T-cell activation RhoGTPase activating protein(TAGAP, Marker 18162), T-cell activation RhoGTPase activating protein (TAGAP, Marker 18163), T-cell acute lymphocytic leukemia 1 (TAL1, Marker 18164), T-cell acute lymphocytic leukemia 1 (TAL1, Marker 18165), T-cell acute lymphocytic leukemia 1 (TAL1, marker 18166), T-cell acute lymphocytic leukemia 1 (TAL1, marker 18167), T-cell acute lymphocytic leukemia 2 (TAL2, marker 18168), T-cell acute lymphocytic leukemia 2 (TAL2, marker 18169) ),TAM41 mitochondrial translocator assembly and maintenance homolog(TAMM41, marker 18170),TAM41 mitochondrial translocator assembly and maintenance homolog(TAMM41, marker 18171),tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1(TANC1, marker 18172),tetratricopeptide repeat , ankyrin repeat and coiled-coil containing 1(TANC1, marker 18173),tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2(TANC2, marker 18174),TRAF family member-
associated NFKB activator (TANK, marker 18175), TAO kinase 1 (TAOK1, marker 18176), TAO kinase 2 (TAOK2, marker 18177), TAO kinase 2 (TAOK2, marker 18178), transporter 2, ATP-binding cassette, sub- family B (MDR/TAP)(TAP2, marker 18179),transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)(TAP2, marker 18180),TAP binding protein (tapasin)(TAPBP, marker 18181) ,TAP binding protein-like(TAPBPL, marker 18182),TAP binding protein-like(TAPBPL, marker 18183),transmembrane anterior posterior transformation 1(TAPT1,marker 18184),transmembrane anterior posterior transformation 1(TAPT1,marker 18185),transmembrane anterior posterior transformation 1(TAPT1, marker 18186),transmembrane anterior posterior transformation 1(TAPT1, marker 18187),transmembrane anterior posterior transformation 1(TAPT1, marker 18188),TCR gamma alternate reading frame protein /// T cell receptor gamma constant 1 /// T cell receptor gamma constant 2 /// T cell receptor gamma variable 9(TARP /// TRGC1 /// TRGC2 /// TRGV9, marker 18189),TCR gamma alternate reading frame protein /// T cell receptor gamma constant 1 /// T cell receptor gamma constant 2 /// T cell receptor gamma variable 9(TARP /// TRGC1 /// TRGC2 /// TRGV9, marker 18190),TCR gamma alternate reading frame protein /// T cell receptor gamma constant 1 /// T cell receptor gamma constant 2 /// T cell receptor gamma variable 9(TARP /// TRGC1 /// TRGC2 /// TRGV9, marker 18191), TCR gamma alternate reading frame protein /// T cell receptor gamma constant 1 /// T cell receptor gamma constant 2 /// T cell receptor gamma variable 9(TARP /// TRGC1 /// TRGC2 /// TRGV9, marker 18192),TCR gamma alternate reading frame protein / // T cell receptor gamma constant 2 /// T cell receptor gamma variable 1 (non-functional) /// T cell receptor gamma variable 3 /// T cell receptor gamma variable 5 /// T cell receptor gamma variable 5P ( pseudogene)(TARP /// TRGC2 /// TRGV1 /// TRGV3 /// TRGV5 /// TRGV5P, marker 18193), threonyl-tRNA synthetase-like 2(TARSL2, marker 18194), taste receptor, type 1, member 1(TAS1R1, marker 18195),taste receptor, type 1, member 1(TAS1R1, marker 18196),taste receptor, type 1, member 2(TAS1R2, marker 18197),taste receptor, type 2, member 1(TAS2R1, marker 18198),taste receptor, type 2, member 10(TAS2R10, marker 18199),taste receptor, type 2, member 13(TAS2R13, marker 18200),taste receptor, type 2, member 14(TAS2R14, marker 18201),taste receptor , type 2, member 16(TAS2R16, marker 18202),taste receptor, type 2, member 3(TAS2R3, marker 18203),taste receptor, type 2, member 38(TAS2R38, marker 18204),taste receptor, type 2, member 39(TAS2R39, Marker 18205), taste receptor, type 2, member 4(TAS2R4, Marker 18206), taste receptor, type 2, member 40(TAS2R40, Marker 18207), taste receptor, type 2, member 41(TAS2R41, Marker 18208),taste receptor, type 2, member 43 /// taste receptor, type 2, member 45(TAS2R43 /// TAS2R45, marker 18209),taste receptor, type 2, member 45(TAS2R45, marker 18210),taste receptor , type 2, member 5(TAS2R5, marker 18211),taste receptor, type 2, member 50(TAS2R50, marker 18212),taste receptor, type 2, member 64, pseudogene(TAS2R64P, marker 18213),taste receptor, type 2 , member 7(TAS2R7, marker 18214),taste receptor, type 2, member 8(TAS2R8, marker 18215),taste receptor, type 2, member 9(TAS2R9, marker 18216),taspase 1(TASP1, marker 18217),tyrosine aminotransferase (TAT, marker 18218), tyrosine aminotransferase (TAT, marker 18219), tyrosine aminotransferase (TAT, marker 18220), TatD DNase domain containing 2 (TATDN2, marker 18221), Tax1 (human T-cell leukemia virus type I) binding protein 3 (TAX1BP3, marker 18222), tafazzin (TAZ, marker 18223), thymus, brain and tests associated (TBATA, marker 18224), TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 (TBC1D1, marker 18225), TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1(TBC1D1, marker 18226), TBC1 domain family, member 10A(TBC1D10A, marker 18227),TBC1 domain family, member 10C(TBC1D10C, marker 18228), TBC1 domain family, member 12(TBC1D12, marker 18229),TBC1 domain family, member 16(TBC1D16, marker 18230),TBC1 domain family, member 21(TBC1D21, marker 18231),TBC1 domain family, member 22A( TBC1D22A, marker 18232), TBC1D22A antisense RNA 1 (TBC1D22A-AS1, marker 18233), TBC1 domain family, member 22B (TBC1D22B, marker 18234), TBC1 domain family, member 25 (TBC1D25, marker 18235), TBC1 domain family, member 26 (TBC1D26, marker 18236), TBC1 domain family, member 26 (TBC1D26, marker 18237), TBC1 domain family, member 26 /// TBC1 domain family, member 28 (TBC1D26 /// TBC1D28, marker 18238), TBC1 domain family , member 27(TBC1D27, marker 18239),TBC1 domain family, member 29(TBC1D29, marker 18240),TBC1 domain family, member 2B(TBC1D2B,marker 18241),TBC1 domain family, member 2B(TBC1D2B,marker 18242),TBC1 domain family, member 30(TBC1D30, marker 18243),TBC1 domain family, member 30(TBC1D30, marker 18244),TBC1 domain family, member 32(TBC1D32, marker 18245),TBC1 domain family, member 7(TBC1D7, marker 18246) ,TBC1 domain family, member 8B (with GRAM domain)(TBC1D8,marker 18247),TBC1 domain family, member 8B (with GRAM domain)(TBC1D8B,marker 18248),TBC1 domain family, member 8B (with GRAM domain)(TBC1D8B ,marker 18249),TBC1 domain family, member 8B (with GRAM domain)(TBC1D8B,marker 18250),tubulin folding cofactor D(TBCD,marker 18251),tubulin folding cofactor D(TBCD,marker 18252),tubulin folding cofactor D( TBCD, marker 18253), TBK1 binding protein 1 (TBKBP1, marker 18254), transducin (beta)-like 1X-linked (TBL1X, marker 18255), transducin (beta)-like 1 X-linked receptor 1 (TBL1XR1, marker 18256) ),transducin (beta)-like 1, Y-linked(TBL1Y, marker 18257),transducin (beta)-like 2(TBL2, marker 18258),transducin (beta)-like 3(TBL3, marker 18259),T- box, brain, 1(TBR1, marker 18260),transforming growth factor beta regulator 1(TBRG1,marker 18261),transforming growth factor beta regulator 1(TBRG1,marker 18262),T-box 1(TBX1,marker 18263),T -box 1(TBX1, marker 18264),T-box 1(TBX1,marker 18265),T-box 1(TBX1,marker 18266),T-box 1(TBX1,marker 18267),T-box 10(TBX10, Marker 18268), T-box 10 (TBX10, Marker 18269), T-box 15 (TBX15, Marker 18270), T-box 18 (TBX18, Marker 18271), T-box 18 (TBX18, Marker 18272), T- box 18 (TBX18, marker 18273), T-box 18 (TBX18, marker 18274), TBX18 antisense RNA 1 (TBX18-AS1, marker 18275), T-box 19 (TBX19, marker 18276), T-box 2 (TBX2) , Marker 18277), T-box 2 (TBX2, Marker 18278), T-box 2 (TBX2, Marker 18279), T-box 2 (TBX2, Marker 18280), TBX2 antisense RNA 1 (TBX2-AS1, Marker 18281) ,TBX2 antisense RNA 1(TBX2-AS1, marker 18282),T-box 20(TBX20,marker 18283),T-box 21(TBX21,marker 18284),T-box 22(TBX22,marker 18285),T-box 3 (TBX3, marker 18286), T-box 3 (TBX3, marker 18287), T-box 3 (TBX3, marker 18288), T-box 3 (TBX3, marker 18289), T-box 4 (TBX4, marker 18290) ),T-box 5(TBX5, marker 18291),T-box 5(TBX5,marker 18292),T-box 5(TBX5,marker 18293),T-box 5(TBX5,marker 18294),TBX5 antisense RNA 1 (TBX5-AS1, marker 18295), TBX5 antisense RNA 1 (TBX5-AS1, marker 18296), TBX5 antisense RNA 1 (TBX5-AS1, marker 18297), TBX5 antisense RNA 1 (TBX5-AS1, marker 18298), T- box 6(TBX6, marker 18299),T-box 6(TBX6, marker 18300),thromboxane A2 receptor(TBXA2R,marker 18301),thromboxane A2 receptor(TBXA2R,marker 18302),thromboxane A2 receptor(TBXA2R,marker 18303), thromboxane A synthase 1 (platelet) (TBXAS1, marker 18304), thromboxane A synthase 1 (platelet) (TBXAS1, marker 18305), tandem C2 domains, nuclear (TC2N, marker 18306), TRPM8 channel-associated factor 2 (TCAF2, marker 18307), TRPM8 channel-associated factor 2 (TCAF2, marker 18308), T cell activation inhibitor, mitochondrial (TCAIM, marker 18309), testicular cell adhesion molecule 1, pseudogene (TCAM1P, marker 18310), titin-cap (TCAP, marker 18311), transcription elongation factor A (SII), 1 (TCEA1, marker 18312), transcription elongation factor A (SII), 2 (TCEA2, marker 18313), transcription elongation factor A (SII), 3 (TCEA3, marker 18314) ,transcription elongation factor A (SII), 3(TCEA3, marker 18315),transcription elongation factor A (SII) N-terminal and central domain containing(TCEANC, marker 18316),transcription elongation factor A (SII) N-terminal and central domain containing(TCEANC, marker 18317), transcription elongation factor A (SII) N-terminal and central domain containing 2(TCEANC2, marker 18318), transcription elongation factor A (SII) N-terminal and central domain containing 2(TCEANC2, marker 18319), transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A) (TCEB3, marker 18320), transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A) (TCEB3, marker 18321), transcription elongation factor B polypeptide 3B (elongin A2)(TCEB3B, marker 18322), transcription elongation regulator 1(TCERG1, marker 18323), transcription elongation regulator 1(TCERG1, marker 18324), transcription factor 15 (basic helix-loop-helix)( TCF15, marker 18325), transcription factor 20 (AR1) (TCF20, marker 18326), transcription factor 21 (TCF21, marker 18327), transcription factor 21 (TCF21, marker 18328), transcription factor 24 (TCF24, marker 18329), transcription factor 25 (basic helix-loop-helix)(TCF25, marker 18330), transcription factor 3(TCF3, marker 18331), transcription factor 3(TCF3, marker 18332), transcription factor 3(TCF3, marker 18333), transcription factor 3 (TCF3, marker 18334), transcription factor 3 (TCF3, marker 18335), TCF4 antisense RNA 1 (TCF4-AS1, marker 18336), transcription factor 7-like 2 (T-cell specific, HMG-box) (TCF7L2, marker 18337), trichohyalin (TCHH, marker 18338), T-cell leukemia/lymphoma 6 (non-protein coding) (TCL6, marker 18339), T-cell leukemia/lymphoma 6 (non-protein coding) (TCL6, marker 18340) ,T-cell leukemia/lymphoma 6 (non-protein coding)(TCL6, marker 18341),T-cell leukemia/lymphoma 6 (non-protein coding)(TCL6, marker 18342),T-cell leukemia/lymphoma 6 (non -protein coding) (TCL6, marker 18343), T-cell leukemia/lymphoma 6 (non-protein coding) (TCL6, marker 18344), transcobalamin I (vitamin B12 binding protein, R binder family) (TCN1, marker 18345), uncharacterized LOC101928399(TCONS_00029157, marker 18346),t-complex 10(TCP10,marker 18347),t-complex 10-like(TCP10L,marker 18348),t-complex 10-like(TCP10L,marker 18349),t-complex 11 , testis-specific(TCP11, marker 18350),t-complex 11, testis-specific-like 2(TCP11L2,marker 18351),t-complex 11, testis-specific-like 2(TCP11L2,marker 183
52),t-complex 11, testis-specific-like 2(TCP11L2,marker 18353),t-complex 11, testis-specific-like 2(TCP11L2,marker 18354),t-complex 11, testis-specific-like 2 (TCP11L2, marker 18355),t-complex 11, testis-specific-like 2(TCP11L2,marker 18356),t-complex 11, testis-specific-like 2(TCP11L2,marker 18357),t-complex-associated-testis -expressed 1(TCTE1, marker 18358),t-complex-associated-testis-expressed 3(TCTE3,marker 18359),t-complex-associated-testis-expressed 3(TCTE3,marker 18360),t-complex-associated- testis-expressed 3 (TCTE3, marker 18361), Tctex1 domain containing 1 (TCTEX1D1, marker 18362), tectonic family member 2 (TCTN2, marker 18363), L-threonine dehydrogenase (pseudogene) (TDH, marker 18364), L-threonine dehydrogenase (pseudogene) (TDH, marker 18365), L-threonine dehydrogenase (pseudogene) (TDH, marker 18366), tryptophan 2,3-dioxygenase (TDO2, marker 18367), tryptophan 2,3-dioxygenase (TDO2, marker 18368) ,tyrosyl-DNA phosphodiesterase 1(TDP1, marker 18369),tudor domain containing 1(TDRD1, marker 18370),tudor domain containing 10(TDRD10, marker 18371),tudor domain containing 12(TDRD12, marker 18372),tudor domain containing 5 (TDRD5, marker 18373),tudor domain containing 6(TDRD6, marker 18374),tudor domain containing 9(TDRD9, marker 18375),tudor and KH domain containing(TDRKH,marker 18376),tudor and KH domain containing(TDRKH,marker 18377), TEA domain family member 2 (TEAD2, marker 18378), tec protein tyrosine kinase (TEC, marker 18379), trans-2,3-enoyl-CoA reductase (TECR, marker 18380), trans-2,3-enoyl -CoA reductase-like (TECRL, marker 18381), tectorin alpha (TECTA, marker 18382), tectorin alpha (TECTA, marker 18383), tectorin beta (TECTB, marker 18384), transmembrane epididymal protein 1 (TEDDM1, marker 18385), thyrotrophic embryonic factor (TEF, marker 18386), thyrotrophic embryonic factor (TEF, marker 18387), tektin 1 (TEKT1, marker 18388), tektin 2 (testicular) (TEKT2, marker 18389), tektin 3 (TEKT3, marker 18390), tektin 5 (TEKT5, marker 18391), tektin 5 (TEKT5, marker 18392), teneurin transmembrane protein 1 (TENM1, marker 18393), teneurin transmembrane protein 3 (TENM3, marker 18394), teneurin transmembrane protein 3 (TENM3, marker 18395) ,telomerase-associated protein 1(TEP1, marker 18396),testis, prostate and placenta expressed(TEPP,marker 18397),telomeric repeat binding factor 2(TERF2,marker 18398),telomerase reverse transcriptase(TERT,marker 18399),testin LIM domain protein(TES, marker 18400),tescalcin(TESC,marker 18401),thymocyte expressed, positive selection associated 1(TESPA1,marker 18402),thymocyte expressed, positive selection associated 1(TESPA1,marker 18403),tet methylcytosine dioxygenase 2( TET2, marker 18404), tet methylcytosine dioxygenase 3(TET3, marker 18405), testis expressed 10(TEX10, marker 18406), testis expressed 101(TEX101, marker 18407), testis expressed 11(TEX11, marker 18408), testis expressed 11 (TEX11, marker 18409), testis expressed 11(TEX11, marker 18410), testis expressed 12(TEX12, marker 18411), testis expressed 13A(TEX13A, marker 18412), testis expressed 13A(TEX13A, marker 18413), testis expressed 13B (TEX13B, marker 18414),testis expressed 22(TEX22,marker 18415),testis expressed 26(TEX26,marker 18416),TEX26 antisense RNA 1(TEX26-AS1,marker 18417),TEX26 antisense RNA 1(TEX26-AS1,marker 18418),TEX26 antisense RNA 1(TEX26-AS1,marker 18419),testis expressed 29(TEX29,marker 18420),testis expressed 33(TEX33,marker 18421),testis expressed 35(TEX35,marker 18422),testis expressed 36( TEX36, marker 18423), TEX36 antisense RNA 1(TEX36-AS1, marker 18424), testis expressed 37(TEX37, marker 18425), testis expressed 38(TEX38, marker 18426), testis expressed 41 (non-protein coding)(TEX41 ,marker 18427),testis expressed 43(TEX43,marker 18428),testis expressed 9(TEX9,marker 18429),testis expressed 9(TEX9,marker 18430),testis expressed 9(TEX9,marker 18431),transferrin(TF,marker 18432), transferrin(TF, marker 18433), transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)(TFAP2A, marker 18434), TFAP2A antisense RNA 1(TFAP2A-AS1, marker 18435), TFAP2A antisense RNA 1( TFAP2A-AS1, marker 18436), transcription factor AP-2 beta (activating enhancer binding protein 2 beta) (TFAP2B, marker 18437), transcription factor AP-2 delta (activating enhancer binding protein 2 delta) (TFAP2D, marker 18438), transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon)(TFAP2E, marker 18439), transcription factor B1, mitochondrial(TFB1M, marker 18440), transcription factor B1, mitochondrial(TFB1M, marker 18441), transcription factor B2, mitochondrial (TFB2M, marker 18442), transcription factor B2, mitochondrial(TFB2M, marker 18443), transcription factor B2, mitochondrial(TFB2M, marker 18444), transcription factor CP2-like 1(TFCP2L1, marker 18445), transcription factor Dp family, member 3 (TFDP3, marker 18446), transcription factor binding to IGHM enhancer 3 (TFE3, marker 18447), transcription factor EB (TFEB, marker 18448), transcription factor EB (TFEB, marker 18449), transcription factor EC (TFEC, marker 18450) ), transcription factor EC (TFEC, marker 18451), transcription factor EC (TFEC, marker 18452), trefoil factor 2 (TFF2, marker 18453), trefoil factor 3 (TFF3, marker 18454), TRK-fused gene (TFG, marker 18455), TRK-fused gene (TFG, marker 18456), tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) (TFPI, marker 18457), transferrin receptor 2 (TFR2, marker 18458), transferrin receptor 2 (TFR2, marker 18459) ), transferrin receptor 2 (TFR2, marker 18460), transferrin receptor (TFRC, marker 18461), transferrin receptor (TFRC, marker 18462), thyroglobulin (TG, marker 18463), TDP-glucose 4,6-dehydratase (TGDS, marker 18464), transforming growth factor alpha (TGFA, marker 18465), transforming growth factor alpha (TGFA, marker 18466), transforming growth factor beta 1 (TGFB1, marker 18467), transforming growth factor beta 2 (TGFB2, marker 18468), transforming growth factor beta 3 (TGFB3, marker 18469), transforming growth factor beta 3 (TGFB3, marker 18470), transforming growth factor beta receptor II (TGFBR2, marker 18471), TGFB-induced factor homeobox 1 (TGIF1, marker 18472), TGFB -induced factor homeobox 2-like, Y-linked(TGIF2LY, marker 18473),transglutaminase 1(TGM1,marker 18474),transglutaminase 2(TGM2,marker 18475),transglutaminase 2(TGM2,marker 18476),transglutaminase 2(TGM2, marker 18477), transglutaminase 3 (TGM3, marker 18478), transglutaminase 4 (TGM4, marker 18479), transglutaminase 4 (TGM4, marker 18480), transglutaminase 4 (TGM4, marker 18481), transglutaminase 5 (TGM5, marker 18482), transglutaminase 6 (TGM6, marker 18483), transglutaminase 7 (TGM7, marker 18484), trans-golgi network protein 2 (TGOLN2, marker 18485), tyrosine hydroxylase (TH, marker 18486), T helper type 2 locus control region associated RNA (TH2LCRR) , marker 18487), T helper type 2 locus control region associated RNA(TH2LCRR, marker 18488), thyroid adenoma associated(THADA, marker 18489), thyroid adenoma associated(THADA, marker 18490), thyroid adenoma associated(THADA, marker 18491) ,thyroid adenoma associated(THADA, marker 18492),THAP domain containing, apoptosis associated protein 2(THAP2, marker 18493),THAP domain containing, apoptosis associated protein 2(THAP2, marker 18494),THAP domain containing, apoptosis associated protein 3( THAP3, marker 18495), THAP domain containing 5 (THAP5, marker 18496), THAP domain containing 6 (THAP6, marker 18497), THAP domain containing 6 (THAP6, marker 18498), THAP7 antisense RNA 1 (THAP7-AS1, marker 18499) ),THAP7 antisense RNA 1(THAP7-AS1, marker 18500),thrombomodulin(THBD,marker 18501),thrombomodulin(THBD,marker 18502),thrombospondin 1(THBS1,marker 18503),THBS1(marker 18504),thyroid cancer-associated transcript 158 (THCAT158, marker 18505), theg spermatid protein (THEG, marker 18506), testis highly expressed protein 5 (THEG5, marker 18507), thioesterase superfamily member 5 (THEM5, marker 18508), thioesterase superfamily member 6 (THEM6, marker 18509), thymocyte selection associated(THEMIS, marker 18510), thymocyte selection associated(THEMIS, marker 18511), threonine synthase-like 1(THNSL1, marker 18512), threonine synthase-like 2(THNSL2, marker 18513), threonine synthase- like 2 (THNSL2, Marker 18514), THO complex 5 (THOC5, Marker 18515), Thrombopoietin (THPO, Marker 18516), Thrombopoietin (THPO, Marker 18517), Thrombopoietin (THPO, Marker 18518), Thyroid hormone receptor, alpha (THRA , marker 18519), thyroid hormone receptor, alpha (THRA, marker 18520), thyroid hormone receptor, alpha (THRA, marker 18521), uncharacterized LOC105371807 (THRA1/BTR, marker 18522), thyroid hormone receptor associated protein 3 (THRAP3, marker 18523), thyroid hormone receptor, beta(THRB, marker 18524), thyroid hormone responsive(THRSP, marker 18525), thyroid hormone responsive(THRSP, marker 18526), thyroid hormone responsive(THRSP, marker 18527), thrombospondin type 1 domain containing 4(THSD4, marker 18528),thrombospondin type 1 domain containing 4(THSD4,marker 18529),thrombospondin type 1 domain containing 4(THSD4,marker 18530),thrombospondin type 1 domain containing 4(THSD4,marker 18531),thrombospondin type 1 domain containing 4(THSD4, marker 18532),THSD4 antisense RNA 1(THSD4-AS1, marker 18533),thrombospondin type 1 domain containing 7A(THSD7A,marker 18534),thrombospondin type 1 domain containing 7B(THSD7B,marker 18535),THUMPD3 antisense RNA 1 (THUMPD3-AS1, marker 18536), TIA1 cytotoxic granule-associated RNA binding protein (TIA1, marker 18537), TGFB1-induced anti-apoptotic factor 1 (TIAF1, marker 18538), TIA1 cytotoxic granule-associated RNA binding protein -like 1 (TIAL1, marker 18539), T-cell lymphoma invasion and metastasis 2 (TIAM2, marker 18540), toll-like receptor adapter molecule 1 (TICAM1, marker 18541), toll-like receptor adapter molecule 2 /// TMED7 -TICAM2 readthrough(TICAM2 /// TMED7-TICAM2, marker 18542), tyrosine kinase with immunoglobulin-like and EGF-like domains 1(TIE1, marker 18543), TRAF-interacting protein with forkhead-associated domain(TIFA, marker 18544) ,TRAF-interacting protein with forkhead-associated domain(TIFA, marker 18545),TRAF-interacting protein with forkhead-associated domain, family member B(TIFAB, marker 18546),tigger transposable element derived 3(TIGD3, marker 18547),tigger transposable element derived 4(TIGD4, marker 18548),tigger transposable element derived 4(TIGD4, marker 18549),tigger transposable element derived 6(
TIGD6, marker 18550), T-cell immunoreceptor with Ig and ITIM domains (TIGIT, marker 18551), T-cell immunoglobulin and mucin domain containing 4 (TIMD4, marker 18552), translocase of inner mitochondrial membrane 13 homolog (yeast) (TIMM13 , marker 18553), translocase of inner mitochondrial membrane 17 homolog A (yeast) (TIMM17A, marker 18554), translocase of inner mitochondrial membrane 17 homolog B (yeast) (TIMM17B, marker 18555), translocase of inner mitochondrial membrane 23 homolog (yeast) )(TIMM23, marker 18556), translocase of inner mitochondrial membrane 8 homolog A (yeast)(TIMM8A, marker 18557), tubulointerstitial nephritis antigen(TINAG, marker 18558), tubulointerstitial nephritis antigen(TINAG, marker 18559), tubulointerstitial nephritis antigen( TINAG, marker 18560), tissue differentiation-inducing non-protein coding RNA (TINCR, marker 18561), tissue differentiation-inducing non-protein coding RNA (TINCR, marker 18562), TIPARP antisense RNA 1 (TIPARP-AS1, marker 18563) ,tight junction associated protein 1 (peripheral)(TJAP1, marker 18564),tight junction protein 2(TJP2, marker 18565),tight junction protein 2(TJP2, marker 18566),thymidine kinase 2, mitochondrial(TK2, marker 18567), thymidine kinase 2, mitochondrial (TK2, marker 18568), triokinase/FMN cyclase (TKFC, marker 18569), transketolase-like 1 (TKTL1, marker 18570), transketolase-like 1 (TKTL1, marker 18571), transketolase-like 2( TKTL2, marker 18572), TLC domain containing 2(TLCD2, marker 18573), TBC/LysM-associated domain containing 1(TLDC1, marker 18574), TBC/LysM-associated domain containing 1(TLDC1, marker 18575), TBC/LysM -associated domain containing 2(TLDC2, marker 18576),transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)(TLE1, marker 18577),transducin-like enhancer of split 6(TLE6, marker 18578),transducin -like enhancer of split 6(TLE6, marker 18579),transducin-like enhancer of split 6(TLE6,marker 18580),tousled-like kinase 1(TLK1,marker 18581),tousled-like kinase 1(TLK1,marker 18582) ,tousled-like kinase 1(TLK1, marker 18583),tousled-like kinase 2 /// tousled-like kinase 2 pseudogene 1(TLK2 /// TLK2P1,marker 18584),tolloid like 1(TLL1,marker 18585),tolloid like 1(TLL1, marker 18586),tolloid like 2(TLL2,marker 18587),tolloid like 2(TLL2,marker 18588),tolloid like 2(TLL2,marker 18589),talin 1(TLN1,marker 18590),talin 2 (TLN2, marker 18591), toll-like receptor 1 (TLR1, marker 18592), toll-like receptor 10 (TLR10, marker 18593), toll-like receptor 10 (TLR10, marker 18594), toll-like receptor 2 (TLR2) , marker 18595), toll-like receptor 3 (TLR3, marker 18596), toll-like receptor 3 (TLR3, marker 18597), toll-like receptor 4 (TLR4, marker 18598), toll-like receptor 4 (TLR4, marker 18599), toll-like receptor 4 (TLR4, marker 18600), toll-like receptor 4 (TLR4, marker 18601), toll-like receptor 5 (TLR5, marker 18602), toll-like receptor 6 (TLR6, marker 18603) ,toll-like receptor 6(TLR6, marker 18604),toll-like receptor 7(TLR7, marker 18605),toll-like receptor 7(TLR7, marker 18606),toll-like receptor 8(TLR8, marker 18607),toll -like receptor 8 (TLR8, marker 18608), TLR8 antisense RNA 1 (TLR8-AS1, marker 18609), toll-like receptor 9 (TLR9, marker 18610), T-cell leukemia homeobox 1 (TLX1, marker 18611), T -cell leukemia homeobox 2 (TLX2, marker 18612), T-cell leukemia homeobox 2 (TLX2, marker 18613), T-cell leukemia homeobox 3 (TLX3, marker 18614), TM2 domain containing 1 (TM2D1, marker 18615), TM2 domain containing 3(TM2D3, marker 18616),transmembrane 4 L six family member 1(TM4SF1, marker 18617),transmembrane 4 L six family member 1(TM4SF1, marker 18618),transmembrane 4 L six family member 20(TM4SF20, marker 18619 ),transmembrane 4 L six family member 4(TM4SF4, marker 18620),transmembrane 4 L six family member 5(TM4SF5,marker 18621),transmembrane 6 superfamily member 2(TM6SF2,marker 18622),transmembrane 6 superfamily member 2(TM6SF2, marker 18623), transmembrane 9 superfamily member 3 (TM9SF3, marker 18624), transmembrane BAX inhibitor motif containing 4 (TMBIM4, marker 18625), transmembrane channel like 1 (TMC1, marker 18626), transmembrane channel like 2 (TMC2, marker 18627) ,TMC3 antisense RNA 1(TMC3-AS1, marker 18628),transmembrane channel like 4(TMC4,marker 18629),transmembrane channel like 5(TMC5,marker 18630),transmembrane channel like 5(TMC5,marker 18631),transmembrane channel like 5(TMC5, marker 18632),transmembrane channel like 5(TMC5,marker 18633),transmembrane channel like 5(TMC5,marker 18634),transmembrane channel like 7(TMC7,marker 18635),transmembrane channel like 8(TMC8,marker 18636 ),transmembrane channel like 8(TMC8, marker 18637),transmembrane channel like 8(TMC8, marker 18638),transmembrane and coiled-coil domain family 1(TMCC1,marker 18639),transmembrane and coiled-coil domain family 1(TMCC1, marker 18640), transmembrane and coiled-coil domain family 1(TMCC1, marker 18641), TMCC1 antisense RNA 1 (head to head)(TMCC1-AS1, marker 18642), TMCC1 antisense RNA 1 (head to head)(TMCC1-AS1 ,marker 18643),transmembrane and coiled-coil domain family 2(TMCC2,marker 18644),transmembrane and coiled-coil domains 2(TMCO2,marker 18645),transmembrane and coiled-coil domains 3(TMCO3,marker 18646),transmembrane and coiled-coil domains 4(TMCO4, marker 18647),transmembrane and coiled-coil domains 4(TMCO4, marker 18648),transmembrane and coiled-coil domains 5A(TMCO5A, marker 18649),transmembrane and coiled-coil domains 5A(TMCO5A, marker 18650), transmembrane and coiled-coil domains 5A (TMCO5A, marker 18651), transmembrane and coiled-coil domains 5B, pseudogene (TMCO5B, marker 18652), transmembrane p24 trafficking protein 10 (TMED10, marker 18653), transmembrane p24 trafficking protein 3 (TMED3, marker 18654), transmembrane p24 trafficking protein 3 (TMED3, marker 18655), transmembrane p24 trafficking protein 3 (TMED3, marker 18656), transmembrane p24 trafficking protein 4 (TMED4, marker 18657), transmembrane p24 trafficking protein 4 ( TMED4, marker 18658), transmembrane p24 trafficking protein 5 (TMED5, marker 18659), transmembrane p24 trafficking protein 5 (TMED5, marker 18660), transmembrane p24 trafficking protein 5 (TMED5, marker 18661), transmembrane p24 trafficking protein 6 (TMED6, marker 18662), transmembrane p24 trafficking protein family member 8 (TMED8, marker 18663), transmembrane protein with EGF-like and two follistatin-like domains 2 (TMEFF2, marker 18664), transmembrane protein 100 (TMEM100, marker 18665), transmembrane protein 102 (TMEM102, marker 18666), transmembrane protein 106A (TMEM106A, marker 18667), transmembrane protein 106A (TMEM106A, marker 18668), transmembrane protein 106A (TMEM106A, marker 18669), transmembrane protein 106A (TMEM106A, marker 18670) ,transmembrane protein TMEM1 08 antisense RNA 1 (TMEM108-AS1, marker 18676), transmembrane protein 114 (TMEM114, marker 18677), transmembrane protein 116 (TMEM116, marker 18678), transmembrane protein 116 (TMEM116, marker 18679), transmembrane protein 117 (TMEM117, marker 18680) ,transmembrane protein 119(TMEM119, marker 18681),transmembrane protein 121(TMEM121,marker 18682),transmembrane protein 121(TMEM121,marker 18683),transmembrane protein 126B(TMEM126B,marker 18684),transmembrane protein 127(TMEM127,marker 18685 ) ,transmembrane protein 130(TMEM130, marker 18686),transmembrane protein 131(TMEM131,marker 18687),transmembrane protein 132A(TMEM132A,marker 18688),transmembrane protein 132A(TMEM132A,marker 18689),transmembrane protein 132A(TMEM132A,marker 1) 8690) ,transmembrane protein 132B(TMEM132B, marker 18691),transmembrane protein 132C(TMEM132C,marker 18692),transmembrane protein 132D(TMEM132D,marker 18693),transmembrane protein 132E(TMEM132E,marker 18694),transmembrane protein 134(TMEM134, Marker 18695) ,transmembrane protein 134(TMEM134, marker 18696),transmembrane protein 135(TMEM135,marker 18697),transmembrane protein 139(TMEM139,marker 18698),transmembrane protein 140(TMEM140,marker 18699),transmembrane protein 143(TMEM143,marker 18700) ,transmembrane protein 144(TMEM144, marker 18701),transmembrane protein 144(TMEM144,marker 18702),transmembrane protein 145(TMEM145,marker 18703),transmembrane protein 150B(TMEM150B,marker 18704),transmembrane protein 150C(TMEM150C,marker 187 05) ,transmembrane protein 151A(TMEM151A, marker 18706),transmembrane protein 151B(TMEM151B,marker 18707),transmembrane protein 151B(TMEM151B,marker 18708),transmembrane protein 151B(TMEM151B,marker 18709),transmembrane protein 155(TMEM155, Marker 18710) ,transmembrane protein 156(TMEM156, marker 18711),transmembrane protein 156(TMEM156,marker 18712),transmembrane protein 161B(TMEM161B,marker 18713),transmembrane protein 165(TMEM165,marker 18714),transmembrane protein 165(TMEM165,marker 18715 ) ,transmembrane protein 170A(TMEM170A, marker 18716),transmembrane protein 171(TMEM171,marker 18717),transmembrane protein 173(TMEM173,marker 18718),transmembrane protein 173(TMEM173,marker 18719),transmembrane protein 174(TMEM174,marker 18720 ) ,transmembrane protein 174(TMEM174, marker 18721),transmembrane protein 176A(TMEM176A,marker 18722),transmembrane protein 176B(TMEM176B,marker 18723),transmembrane protein 176B(TMEM176B,marker 18724),transmembrane protein 177(TMEM177,marker 1 8725) ,transmembrane protein 178B(TMEM178B, marker 18726),transmembrane protein 179(TMEM179,marker 18727),transmembrane protein 182(TMEM182,marker 18728),transmembrane protein 184A(TMEM184A,marker 18729),transmembrane protein 184A(TMEM184A,marker 1 8730) ,transmembrane protein 189(TMEM189, marker 18731),transmembrane protein 19(TMEM19,marker 18732),transmembrane protein 190(TMEM190,marker 18733),transmembrane protein 196(TMEM196,marker 18734),transmembrane protein 196(TMEM196,marker 18735) ,transmembrane protein 198(TMEM198, marker 18736),transmembrane protein 200C(TMEM200C,marker 18737),transmembrane protein 204(TMEM204,marker 18738),transmembrane protein 204(TMEM204,marker 18739),transmembrane protein 204(TMEM204,marker 18740 ) ,transmembrane protein 206(TMEM206, marker 18741),transmembrane protein 207(TMEM207,marker 18742),transmembrane protein 213(TMEM213,marker 18743),transmembrane protein 213(TMEM213,marker 18744),tra
nsmembrane protein 217 (TMEM217, marker 18745), transmembrane protein 218 (TMEM218, marker 18746), transmembrane protein 218 (TMEM218, marker 18747), transmembrane protein 219 (TMEM219, marker 18748), transmembrane protein 221 (TMEM221, marker 18749), Transmembrane Protein 221 (TMEM221, marker 18750), Transmembrane Protein 223 (TMEM223, marker 18751), Transmembrane Protein 223 (TMEM223, marker 18752), TransMembran E Protein 225 (TMEM225, marker 18753), Transmembrane Protein 229B (TMEM229B, marker 18754), transmembrane protein 229B(TMEM229B, marker 18755),transmembrane protein 229B(TMEM229B, marker 18756),transmembrane protein 232(TMEM232, marker 18757),transmembrane protein 232(TMEM232, marker 18758),transmembrane protein 232(TMEM232, marker 18759 ), transmembrane protein 234(TMEM234, marker 18760),transmembrane protein 234(TMEM234, marker 18761),transmembrane protein 235(TMEM235, marker 18762),transmembrane protein 238(TMEM238, marker 18763),transmembrane protein 239(TMEM239, marker 18764), transmembrane protein 239(TMEM239, marker 18765),transmembrane protein 242(TMEM242, marker 18766),transmembrane protein 242(TMEM242, marker 18767),transmembrane protein 245(TMEM245, marker 18768),transmembrane protein 25(TMEM25, marker 18769), transmembrane protein 252 (TMEM252, marker 18770), transmembrane protein 252 (TMEM252, marker 18771), TMEM254 antisense RNA 1 (TMEM254-AS1, marker 18772), transmembrane protein 255B (TMEM255B, marker 18773), transmembrane protein 257 (TMEM257, marker 18774), transmembrane protein 259 (TMEM259, marker 18775), transmembrane protein 259 (TMEM259, marker 18776), transmembrane protein 26 (TMEM26, marker 18777), TMEM26 antisense RNA 1 (TMEM26-AS1, marker 18778), TMEM26 antisense RNA 1 (TMEM26-AS1, marker 18779), transmembrane protein 262 (TMEM262, marker 18780), transmembrane protein 266 (TMEM266, marker 18781), transmembrane protein 30B (TMEM30B, marker 18782), transmembrane protein 31 (TMEM31, marker 18783), transmembrane protein 37 (TMEM37, marker 18784), transmembrane protein 38A (TMEM38A, marker 18785), transmembrane protein 39A (TMEM39A, marker 18786), transmembrane protein 43 (TMEM43, marker 18787), TMEM44 antisense RNA 1 (TMEM44-AS1, marker 18788 ), transmembrane protein 45B (TMEM45B, marker 18789), transmembrane protein 45B (TMEM45B, marker 18790), transmembrane protein 50B (TMEM50B, marker 18791), TMEM51 antisense RNA 1 (TMEM51-AS1, marker 18792), TMEM51 antisense RNA 1( TMEM51-AS1, marker 18793), transmembrane protein 52B (TMEM52B, marker 18794), transmembrane protein 53 (TMEM53, marker 18795), transmembrane protein 59 (TMEM59, marker 18796), transmembrane protein 59 (TMEM59, marker 18797), transmembrane protein 59-like (TMEM59L, marker 18798), transmembrane protein 61 (TMEM61, marker 18799), transmembrane protein 62 (TMEM62, marker 18800), transmembrane protein 63A (TMEM63A, marker 18801), transmembrane protein 63A (TMEM63A, marker 18802), transmembrane protein 63C (TMEM63C, marker 18803), transmembrane protein 67 (TMEM67, marker 18804), transmembrane protein 67 (TMEM67, marker 18805), transmembrane protein 67 (TMEM67, marker 18806), transmembrane protein 67 (TMEM67, marker 18807), transmembrane protein 67 (TMEM67, marker 18808), transmembrane protein 71 (TMEM71, marker 18809), transmembrane protein 72 (TMEM72, marker 18810), transmembrane protein 72 (TMEM72, marker 18811), TMEM72 antisense RNA 1 (TMEM72-AS1, marker 18812), transmembrane protein 74 (TMEM74, marker 18813), transmembrane protein 75 (TMEM75, marker 18814), transmembrane protein 79 (TMEM79, marker 18815), transmembrane protein 86A (TMEM86A, marker 18816), transmembrane protein 86A (TMEM86A, marker 18817), transmembrane protein 86A (TMEM86A, marker 18818), transmembrane protein 86B (TMEM86B, marker 18819), transmembrane protein 87A (TMEM87A, marker 18820), transmembrane protein 87A (TMEM87A, marker 18821), transmembrane protein 91 (TMEM91, marker 18822), TMEM92 antisense RNA 1 (TMEM92-AS1, marker 18823), transmembrane protein 94 (TMEM94, marker 18824), TATA element modulatory factor 1 (TMF1, marker 18825), TATA element modulatory factor 1 (TMF1, marker 18826), transmembrane inner ear (TMIE, marker 18827), transmembrane inner ear (TMIE, marker 18828), trimethyllysine hydroxylase, epsilon (TMLHE, marker 18829), tropomodulin 1 (TMOD1, marker 18830), tropomodulin 2 (neuronal) (TMOD2, marker 18831) ), tropomodulin 4 (muscle) /// vacuolar protein sorting 72 homolog (S. cerevisiae) (TMOD4 /// VPS72, marker 18832), thymopoietin (TMPO, marker 18833), transmembrane protease, serine 11B (TMPRSS11B, marker 18834) ,transmembrane protease, serine 11D(TMPRSS11D, marker 18835),transmembrane (C-terminal) protease, serine 12(TMPRSS12, marker 18836),transmembrane protease, serine 13(TMPRSS13,marker 18837),transmembrane protease, serine 13(TMPRSS13, marker 18838), transmembrane protease, serine 15 (TMPRSS15, marker 18839), transmembrane protease, serine 15 (TMPRSS15, marker 18840), transmembrane protease, serine 2 (TMPRSS2, marker 18841), transmembrane protease, serine 2 (TMPRSS2, marker 18842) ),transmembrane protease, serine 3(TMPRSS3, marker 18843),transmembrane protease, serine 3(TMPRSS3, marker 18844),transmembrane protease, serine 3(TMPRSS3, marker 18845),transmembrane protease, serine 4(TMPRSS4, marker 18846), transmembrane protease, serine 5(TMPRSS5, marker 18847),transmembrane protease, serine 6(TMPRSS6, marker 18848),transmembrane protease, serine 6(TMPRSS6, marker 18849),thymosin beta 4, Y-linked(TMSB4Y, marker 18850), transmembrane and tetratricopeptide repeat containing 1(TMTC1, marker 18851), thioredoxin-related transmembrane protein 3(TMX3, marker 18852), thioredoxin-related transmembrane protein 4(TMX4, marker 18853),TRAFs and NIK-associated protein(TNAP, marker 18854) ), tenascin C (TNC, marker 18855), tenascin C (TNC, marker 18856), tumor necrosis factor (TNF, marker 18857), tumor necrosis factor, alpha-induced protein 2 (TNFAIP2, marker 18858), tumor necrosis factor, alpha-induced protein 8(TNFAIP8, marker 18859), tumor necrosis factor, alpha-induced protein 8-like 2(TNFAIP8L2, marker 18860), tumor necrosis factor, alpha-induced protein 8-like 3(TNFAIP8L3, marker 18861), tumor necrosis factor receptor superfamily, member 10b(TNFRSF10B, marker 18862), tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain(TNFRSF10C, marker 18863), tumor necrosis factor receptor superfamily, member 13B(TNFRSF13B, marker 18864) ,tumor necrosis factor receptor superfamily, member 13C(TNFRSF13C,marker 18865),tumor necrosis factor receptor superfamily, member 13C(TNFRSF13C,marker 18866),tumor necrosis factor receptor superfamily, member 13C(TNFRSF13C,marker 18867),tumor necrosis factor receptor superfamily, member 14(TNFRSF14, marker 18868), tumor necrosis factor receptor superfamily, member 17(TNFRSF17, marker 18869), tumor necrosis factor receptor superfamily, member 18(TNFRSF18, marker 18870), tumor necrosis factor receptor superfamily, member 18( TNFRSF18, marker 18871), tumor necrosis factor receptor superfamily, member 19 (TNFRSF19, marker 18872), tumor necrosis factor receptor superfamily, member 1B (TNFRSF1B, marker 18873), tumor necrosis factor receptor superfamily, member 25 (TNFRSF25, marker 18874) ,tumor necrosis factor receptor superfamily, member 25(TNFRSF25, marker 18875),tumor necrosis factor receptor superfamily, member 4(TNFRSF4,marker 18876),tumor necrosis factor receptor superfamily, member 4(TNFRSF4,marker 18877),tumor necrosis factor receptor superfamily, member 9(TNFRSF9, marker 18878), tumor necrosis factor receptor superfamily, member 9(TNFRSF9, marker 18879), tumor necrosis factor receptor superfamily, member 9(TNFRSF9, marker 18880), tumor necrosis factor (ligand) superfamily, member 10(TNFSF10, marker 18881), tumor necrosis factor (ligand) superfamily, member 10(TNFSF10, marker 18882), tumor necrosis factor (ligand) superfamily, member 10(TNFSF10, marker 18883), tumor necrosis factor (ligand) superfamily, member 11(TNFSF11, marker 18884), tumor necrosis factor (ligand) superfamily, member 12(TNFSF12, marker 18885), TNFSF12-TNFSF13 readthrough /// tumor necrosis factor (ligand) superfamily, member 13(TNFSF12-TNFSF13 /// TNFSF13, marker 18886), TNFSF12-TNFSF13 readthrough /// tumor necrosis factor (ligand) superfamily, member 13(TNFSF12-TNFSF13 /// TNFSF13, marker 18887), tumor necrosis factor (ligand) superfamily, member 13(TNFSF13, marker 18888), tumor necrosis factor (ligand) superfamily, member 13b(TNFSF13B, marker 18889), tumor necrosis factor (ligand) superfamily, member 13b(TNFSF13B, marker 18890), tumor necrosis factor (ligand) superfamily, member 14(TNFSF14, marker 18891), tumor necrosis factor (ligand) superfamily, member 14(TNFSF14, marker 18892), tumor necrosis factor (ligand) superfamily, member 15(TNFSF15, marker 18893), tumor necrosis factor (ligand) superfamily, member 18(TNFSF18 , marker 18894), tumor necrosis factor (ligand) superfamily, member 8(TNFSF8, marker 18895), tumor necrosis factor (ligand) superfamily, member 8(TNFSF8, marker 18896), tumor necrosis factor (ligand) superfamily, member 8( TNFSF8, marker 18897), TNFAIP3 interacting protein 1(TNIP1, marker 18898), TNFAIP3 interacting protein 3(TNIP3, marker 18899), tyrosine kinase, non-receptor, 1(TNK1, marker 18900), tyrosine kinase, non-receptor, 2(TNK2, Marker 18901), tyrosine kinase, non-receptor, 2(TNK2, Marker 18902), tyrosine kinase, non-receptor, 2(TNK2, Marker 18903), tyrosine kinase, non-receptor, 2(TNK2, Marker 18904), TNK2 antisense RNA 1 (TNK2-AS1, marker 18905), tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase (TNKS, marker 18906), tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase (TNKS, marker 18907), tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase (TNKS, marker 18908), tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 (TNKS2, marker 18909), tenomodulin (TNMD, marker 18910) , tenascin N (TNN, marker 18911), troponin I type 1 (skeletal, slow) (TNNI1, marker 18912), troponin I type 2 (skeletal, fast) (TNNI2, marker 18913), TNNI3 interacting kinase (TNNI3K, marker 18914) ), troponin T type 2 (cardiac) (TNNT2, marker 18915), troponin T type 3 (skeletal, fast) (TNNT3, marker 18916), troponin T type 3 (skeletal, fast) (TNNT3, marker 18917), transition protein 1 (during histone to protamine replacement) (TNP1, marker 18918), transition protein 2 (during histone to protamine replacement) (TNP2, marker 18919), tran
sition protein 2 (during histone to protamine replacement) (TNP2, marker 18920), transportin 1 (TNPO1, marker 18921), transportin 1 (TNPO1, marker 18922), transportin 2 (TNPO2, marker 18923), tenascin R (TNR, marker) 18924), tenascin R(TNR, marker 18925), tenascin R(TNR, marker 18926), trinucleotide repeat containing 18(TNRC18, marker 18927), trinucleotide repeat containing 18(TNRC18, marker 18928), trinucleotide repeat containing 18(TNRC18, marker 18929), trinucleotide repeat containing 18(TNRC18, marker 18930), trinucleotide repeat containing 18(TNRC18, marker 18931), trinucleotide repeat containing 6A(TNRC6A, marker 18932), trinucleotide repeat containing 6A(TNRC6A, marker 18933), trinucleotide repeat containing 6C(TNRC6C, marker 18934), trinucleotide repeat containing 6C(TNRC6C, marker 18935), trinucleotide repeat containing 6C(TNRC6C, marker 18936), TNRC6C antisense RNA 1(TNRC6C-AS1, marker 18937), TNRC6C antisense RNA 1(TNRC6C -AS1, marker 18938), tensin 1 (TNS1, marker 18939), tensin 1 (TNS1, marker 18940), tensin 2 (TNS2, marker 18941), tensin 3 (TNS3, marker 18942), tensin 4 (TNS4, marker 18943) ),tensin 4(TNS4,marker 18944),tenascin XA (pseudogene) /// tenascin XB(TNXA /// TNXB,marker 18945),tenascin XA (pseudogene) /// tenascin XB(TNXA /// TNXB,marker 18946), tenascin XA (pseudogene) /// tenascin XB(TNXA /// TNXB, marker 18947), tenascin XA (pseudogene) /// tenascin marker 18949), tenascin XB (TNXB, marker 18950), tenascin XB (TNXB, marker 18951), tenascin TOB2, marker 18954), TOLLIP antisense RNA 1 (head to head)(TOLLIP-AS1, marker 18955), target of myb1 like 2 membrane trafficking protein(TOM1L2, marker 18956), target of myb1 like 2 membrane trafficking protein(TOM1L2, marker 18957), tonsoku-like, DNA repair protein (TONSL, marker 18958), TONSL antisense RNA 1 (TONSL-AS1, marker 18959), topoisomerase (DNA) I, mitochondrial (TOP1MT, marker 18960), topoisomerase (DNA) I pseudogene 2(TOP1P2, marker 18961), topoisomerase (DNA) I pseudogene 2(TOP1P2, marker 18962), topoisomerase (DNA) II alpha(TOP2A, marker 18963), torsin family 1, member A (torsin A)(TOR1A, marker 18964), torsin A interacting protein 1(TOR1AIP1, marker 18965), torsin A interacting protein 1(TOR1AIP1, marker 18966), torsin A interacting protein 1(TOR1AIP1, marker 18967), torsin A interacting protein 1(TOR1AIP1, marker 18968) ,torsin A interacting protein 2(TOR1AIP2, marker 18969),torsin A interacting protein 2(TOR1AIP2,marker 18970),torsin family 2, member A(TOR2A,marker 18971),torsin family 4, member A(TOR4A,marker 18972) ,thymocyte selection-associated high mobility group box(TOX, marker 18973),TOX high mobility group box family member 3(TOX3, marker 18974),tumor protein p53 regulated apoptosis inducing protein 1(TP53AIP1,marker 18975),tumor protein p53 regulated apoptosis inducing protein 1(TP53AIP1, marker 18976), tumor protein p53 regulated apoptosis inducing protein 1(TP53AIP1, marker 18977), tumor protein p53 regulated apoptosis inducing protein 1(TP53AIP1, marker 18978), tumor protein p53 inducible protein 11(TP53I11, marker 18979), tumor protein p53 inducible protein 11(TP53I11, marker 18980), tumor protein p53 inducible nuclear protein 1(TP53INP1, marker 18981), tumor protein p53 inducible nuclear protein 1(TP53INP1, marker 18982), TP53 target 3 family member H, pseudogene(TP53TG3HP, marker 18983), TP53 target 5(TP53TG5, marker 18984), TP53 target 5(TP53TG5, marker 18985), tumor protein p63(TP63, marker 18986), tumor protein p63(TP63, marker 18987), protein tumor p63(TP63, marker 18988), tumor protein p63(TP63, marker 18989), tumor protein p63(TP63, marker 18990), tumor protein p63(TP63, marker 18991), tumor protein p73(TP73, marker 18992), tumor protein p73 (TP73, marker 18993), tumor protein p73 (TP73, marker 18994), TP73 antisense RNA 1 (TP73-AS1, marker 18995), trophoblast glycoprotein-like (TPBGL, marker 18996), two pore segment channel 1( TPCN1, marker 18997), two pore segment channel 2(TPCN2, marker 18998), tumor protein D52-like 3(TPD52L3, marker 18999), tumor protein D52-like 3(TPD52L3, marker 19000), tubulin polyglutamylase complex subunit 1( TPGS1, marker 19001), tubulin polyglutamylase complex subunit 2 (TPGS2, marker 19002), tubulin polyglutamylase complex subunit 2 (TPGS2, marker 19003), tubulin polyglutamylase complex subunit 2 (TPGS2, marker 19004), tryptophan hydroxylase 1 (TPH1, marker 19005) ), tryptophan hydroxylase 1 (TPH1, marker 19006), tryptophan hydroxylase 1 (TPH1, marker 19007), tryptophan hydroxylase 2 (TPH2, marker 19008), triosephosphate isomerase 1 (TPI1, marker 19009), tropomyosin 1 (alpha) (TPM1, tropomyosin 2 (beta) (TPM2, marker 19011), tropomyosin 2 (beta) (TPM2, marker 19012), tropomyosin 3 (TPM3, marker 19013), tropomyosin 3 (TPM3, marker 19014), tropomyosin 3 pseudogene 4 (TPM3P4, marker 19015), tropomyosin 4 (TPM4, marker 19016), thiopurine S-methyltransferase (TPMT, marker 19017), thyroid peroxidase (TPO, marker 19018), tripeptidyl peptidase I (TPP1, marker 19019), tripeptidyl peptidase II( TPP2, marker 19020), tubulin polymerization promoting protein(TPPP, marker 19021), tubulin polymerization promoting protein(TPPP, marker 19022), tubulin polymerization promoting protein(TPPP, marker 19023), tubulin polymerization promoting protein(TPPP, marker 19024), tubulin polymerization-promoting protein family member 2 (TPPP2, marker 19025), tubulin polymerization-promoting protein family member 2 (TPPP2, marker 19026), tubulin polymerization-promoting protein family member 3 (TPPP3, marker 19027), tumor protein p63 regulated 1 (TPRG1, marker 19028),tetra-peptide repeat homeobox-like(TPRXL, marker 19029),tryptase alpha/beta 1(TPSAB1, marker 19030),tryptase alpha/beta 1(TPSAB1, marker 19031),tryptase alpha/beta 1 /// tryptase beta 2 (gene/pseudogene)(TPSAB1 /// TPSB2, marker 19032), tryptase alpha/beta 1 /// tryptase beta 2 (gene/pseudogene)(TPSAB1 /// TPSB2, marker 19033), tryptase alpha/beta 1 /// tryptase beta 2 (gene/pseudogene)(TPSAB1 /// TPSB2, marker 19034), tryptase alpha/beta 1 /// tryptase beta 2 (gene/pseudogene)(TPSAB1 /// TPSB2, marker 19035), tryptase alpha/beta 1 /// tryptase beta 2 (gene/pseudogene)(TPSAB1 /// TPSB2, marker 19036), tryptase alpha/beta 1 /// tryptase beta 2 (gene/pseudogene)(TPSAB1 // / TPSB2, marker 19037), tryptase delta 1 (TPSD1, marker 19038), tyrosylprotein sulfotransferase 2 (TPST2, marker 19039), TPT1 antisense RNA 1 (TPT1-AS1, marker 19040), transmembrane phosphatase with tensin homology (TPTE, marker 19041) ),transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 1(TPTE2P1, marker 19042),transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 2(TPTE2P2, marker 19043),transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 5( TPTE2P5, marker 19044), transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 5(TPTE2P5, marker 19045), transmembrane phosphoinositide 3-phosphatase and tensin homolog 2 pseudogene 6(TPTE2P6, marker 19046), transmembrane phosphatase with tensinology homolog pseudogene 1 ( TPTEP1, marker 19047), transmembrane phosphatase with tensin homology pseudogene 1(TPTEP1, marker 19048), transmembrane phosphatase with tensin homology pseudogene 1(TPTEP1, marker 19049), transformer 2 alpha homolog (Drosophila)(TRA2A, marker 19050), transformer 2 beta homolog (Drosophila)(TRA2B, marker 19051),TraB domain containing 2A(TRABD2A, marker 19052),TraB domain containing 2B(TRABD2B, marker 19053),TraB domain containing 2B(TRABD2B, marker 19054),TraB domain containing 2B( TRABD2B, marker 19055), T-cell receptor alpha constant (TRAC, marker 19056), T-cell receptor alpha constant (TRAC, marker 19057), T-cell receptor alpha constant /// T cell receptor alpha joining 17 /// T cell receptor alpha variable 20 /// T cell receptor delta variable 2(TRAC /// TRAJ17 /// TRAV20 /// TRDV2, marker 19058), TNFRSF1A-associated via death domain(TRADD, marker 19059), TNFRSF1A-associated via death domain (TRADD, marker 19060), TNF receptor-associated factor 1 (TRAF1, marker 19061), TNF receptor-associated factor 1 (TRAF1, marker 19062), TNF receptor-associated factor 3 interacting protein 1 (TRAF3IP1, marker 19063 ),TRAF3 interacting protein 2(TRAF3IP2, marker 19064),TRAF3IP2 antisense RNA 1(TRAF3IP2-AS1,marker 19065),TRAF3IP2 antisense RNA 1(TRAF3IP2-AS1,marker 19066),TRAF3IP2 antisense RNA 1(TRAF3IP2-AS1,marker 19067 ),TRAF3 interacting protein 3(TRAF3IP3, marker 19068),TRAF3 interacting protein 3(TRAF3IP3,marker 19069),TRAF3 interacting protein 3(TRAF3IP3,marker 19070),TRAF3 interacting protein 3(TRAF3IP3,marker 19071),TNF receptor-associated factor 5 (TRAF5, marker 19072), TNF receptor-associated factor 7, E3 ubiquitin protein ligase (TRAF7, marker 19073), TRAF-type zinc finger domain containing 1 (TRAFD1, marker 19074), T cell receptor alpha joining 20 // / T cell receptor alpha variable 36/delta variable 7(TRAJ20 /// TRAV36DV7, marker 19075),trafficking protein, kinesin binding 1(TRAK1, marker 19076),TNF receptor-associated protein 1(TRAP1, marker 19077),trafficking protein particle complex 11 (TRAPPC11, marker 19078),trafficking protein particle complex 12 (TRAPPC12, marker 19079),trafficking protein particle complex 13 (TRAPPC13, marker 19080),trafficking protein particle complex 2 (TRAPPC2, marker 19081),trafficking protein particle complex 3-like(TRAPPC3L, marker 19082),trafficking protein particle complex 4(TRAPPC4,marker 19083),trafficking protein particle complex 9(TRAPPC9,marker 19084),trafficking protein particle complex 9(TRAPPC9,marker 19085),T cell receptor associated transmembrane adapter 1 (TRAT1, marker 19086), T cell receptor alpha variable 10 (TRAV10, marker 19087), T cell receptor alpha variable 12-1 (TRAV12-1, marker 19088), T cell receptor alpha variable 12-2 (TRAV12) -2, marker 19089), T cell receptor alpha variable 12-2 (TRAV12-2, marker 19090), T cell receptor alpha variable 12-3 (TRAV12-3, marker 19091), T cell receptor alpha variable 13-1( TRAV13-1, Marker 19092), T cell receptor alpha variable 13-2 (TRAV13-2, Marker 19093), T cell receptor alpha variable 16 (TRAV16, Marker 19094), T cell receptor alpha variable 17 /// T cell receptor delta variable 2(TRAV17 /// TRDV2, marker 19095),T cell receptor alpha variable 20(TRAV20, marker 19096),T cell r
eceptor alpha variable 21 (TRAV21, marker 19097), T cell receptor alpha variable 22 (TRAV22, marker 19098), T cell receptor alpha variable 23/delta variable 6 (TRAV23DV6, marker 19099), T cell receptor alpha variable 24 (TRAV24, Marker 19100), T cell receptor alpha variable 25 (TRAV25, Marker 19101), T cell receptor alpha variable 26-2 (TRAV26-2, Marker 19102), T cell receptor alpha variable 30 (TRAV30, Marker 19103), T cell receptor alpha variable 34 (TRAV34, marker 19104), T cell receptor alpha variable 39 (TRAV39, marker 19105), T cell receptor alpha variable 40 (TRAV40, marker 19106), T cell receptor alpha variable 5 (TRAV5, marker 19107), T cell receptor alpha variable 8-1 (TRAV8-1, marker 19108), T cell receptor alpha variable 8-6 (TRAV8-6, marker 19109), T cell receptor alpha variable 9-2 (TRAV9-2, marker 19110), T cell receptor beta variable 10-2(TRBV10-2, marker 19111),T cell receptor beta variable 16 (gene/pseudogene)(TRBV16, marker 19112),T cell receptor beta variable 21-1 (pseudogene)(TRBV21-1 , marker 19113), T cell receptor beta variable 24-1 (TRBV24-1, marker 19114), T cell receptor beta variable 25-1 (TRBV25-1, marker 19115), T cell receptor beta variable 27 (TRBV27, marker 19116) ),T cell receptor beta variable 5-2 (pseudogene)(TRBV5-2, marker 19117),T cell receptor beta variable 7-3(TRBV7-3,marker 19118),T cell receptor beta variable 7-8(TRBV7- 8, marker 19119), T cell receptor delta constant (TRDC, marker 19120), tRNA aspartic acid methyltransferase 1 (TRDMT1, marker 19121), tRNA aspartic acid methyltransferase 1 (TRDMT1, marker 19122), triadin (TRDN, marker 19123), triadin (TRDN, marker 19124), triadin (TRDN, marker 19125), T cell receptor delta variable 3 (TRDV3, marker 19126), T cell receptor delta variable 3 (TRDV3, marker 19127), trehalase (TREH, marker 19128), triggering receptor expressed on myeloid cells 1(TREM1, marker 19129),triggering receptor expressed on myeloid cells 2(TREM2, marker 19130),triggering receptor expressed on myeloid cells-like 1(TREML1, marker 19131),triggering receptor expressed on myeloid cells -like 2(TREML2, marker 19132), triggering receptor expressed on myeloid cells-like 3, pseudogene(TREML3P, marker 19133), triggering receptor expressed on myeloid cells-like 3, pseudogene(TREML3P, marker 19134), triggering receptor expressed on myeloid cells-like 4(TREML4, marker 19135),triggering receptor expressed on myeloid cells-like 4(TREML4, marker 19136),triggering receptor expressed on myeloid cells-like 4(TREML4, marker 19137),triggering receptor expressed on myeloid cells -like 5, pseudogene(TREML5P, marker 19138), transcriptional regulating factor 1(TRERF1, marker 19139), three prime repair exonuclease 1(TREX1, marker 19140), three prime repair exonuclease 2(TREX2, marker 19141), T cell receptor gamma locus antisense RNA 1 (TRG-AS1, marker 19142), T cell receptor gamma variable 5 (TRGV5, marker 19143), T cell receptor gamma variable 5 (TRGV5, marker 19144), T cell receptor gamma variable 7 (pseudogene)( TRGV7, marker 19145), thyrotropin-releasing hormone (TRH, marker 19146), TRHDE antisense RNA 1 (TRHDE-AS1, marker 19147), TRHDE antisense RNA 1 (TRHDE-AS1, marker 19148), thyrotropin-releasing hormone receptor (TRHR ,marker 19149),tribbles pseudokinase 1(TRIB1,marker 19150),tribbles pseudokinase 3(TRIB3,marker 19151),tripartite motif containing 10(TRIM10,marker 19152),tripartite motif containing 10(TRIM10,marker 19153),tripartite motif containing 10(TRIM10, marker 19154),tripartite motif containing 10(TRIM10,marker 19155),tripartite motif containing 14(TRIM14,marker 19156),tripartite motif containing 14(TRIM14,marker 19157),tripartite motif containing 15(TRIM15,marker 19158 ),tripartite motif containing 15(TRIM15, marker 19159),tripartite motif containing 15(TRIM15,marker 19160),tripartite motif containing 16-like(TRIM16L,marker 19161),tripartite motif containing 17(TRIM17,marker 19162),tripartite motif containing 2(TRIM2, marker 19163),tripartite motif containing 2(TRIM2,marker 19164),tripartite motif containing 25(TRIM25,marker 19165),tripartite motif containing 29(TRIM29,marker 19166),tripartite motif containing 29(TRIM29,marker 19167),tripartite motif containing 29(TRIM29, marker 19168),tripartite motif containing 3(TRIM3,marker 19169),tripartite motif containing 3(TRIM3,marker 19170),tripartite motif containing 3(TRIM3,marker 19171),tripartite motif containing 31(TRIM31, marker 19172),tripartite motif containing 31(TRIM31,marker 19173),tripartite motif containing 31(TRIM31,marker 19174),tripartite motif containing 34 /// TRIM6-TRIM34 readthrough(TRIM34 /// TRIM6-TRIM34, marker 19175),tripartite motif containing 36(TRIM36,marker 19176),tripartite motif containing 36(TRIM36,marker 19177),tripartite motif containing 36(TRIM36,marker 19178),tripartite motif containing 38(TRIM38,marker 19179),tripartite motif containing 4(TRIM4, marker 19180),tripartite motif containing 4(TRIM4,marker 19181),tripartite motif containing 40(TRIM40,marker 19182),tripartite motif containing 42(TRIM42,marker 19183),tripartite motif containing 42(TRIM42,marker 19184),tripartite motif containing 42(TRIM42,marker 19185),tripartite motif containing 43 /// tripartite motif containing 43B(TRIM43 /// TRIM43B,marker 19186),tripartite motif containing 43 /// tripartite motif containing 43B(TRIM43 / // TRIM43B, marker 19187), tripartite motif containing 44 (TRIM44, marker 19188), tripartite motif containing 46 (TRIM46, marker 19189), tripartite motif containing 48 (TRIM48, marker 19190), tripartite motif containing 49 /// tripartite motif containing 49B /// tripartite motif containing 49C(TRIM49 /// TRIM49B /// TRIM49C, marker 19191), tripartite motif containing 5(TRIM5, marker 19192), tripartite motif containing 50(TRIM50, marker 19193), tripartite motif containing 50 (TRIM50, marker 19194),tripartite motif containing 50(TRIM50,marker 19195),tripartite motif-containing 51(TRIM51,marker 19196),TRIM52 antisense RNA 1 (head to head)(TRIM52-AS1,marker 19197),tripartite motif containing 54(TRIM54, marker 19198),tripartite motif containing 55(TRIM55,marker 19199),tripartite motif containing 55(TRIM55,marker 19200),tripartite motif containing 58(TRIM58,marker 19201),tripartite motif containing 58(TRIM58,marker 19202),tripartite motif containing 62(TRIM62, marker 19203),tripartite motif containing 63, E3 ubiquitin protein ligase(TRIM63,marker 19204),tripartite motif containing 64E, pseudogene(TRIM64EP,marker 19205),tripartite motif containing 65(TRIM65, marker 19206),tripartite motif containing 66(TRIM66,marker 19207),tripartite motif containing 66(TRIM66,marker 19208),tripartite motif containing 67(TRIM67,marker 19209),tripartite motif containing 69(TRIM69,marker 19210),tripartite motif containing 7(TRIM7, marker 19211),tripartite motif containing 7(TRIM7, marker 19212),tripartite motif containing 7(TRIM7, marker 19213),tripartite motif containing 72, E3 ubiquitin protein ligase(TRIM72, marker 19214),tripartite motif containing 73 /// tripartite motif containing 74(TRIM73 /// TRIM74, marker 19215),tripartite motif containing 73 /// tripartite motif containing 74(TRIM73 /// TRIM74, marker 19216),tripartite motif containing 78, pseudogene(TRIM78P, marker 19217),tripartite motif containing 8(TRIM8,marker 19218),tripartite motif containing 8(TRIM8,marker 19219),tripartite motif containing 9(TRIM9,marker 19220),tripartite motif family like 1(TRIML1,marker 19221),trio Rho guanine nucleotide exchange factor(TRIO, marker 19222),trio Rho guanine nucleotide exchange factor(TRIO, marker 19223),trio Rho guanine nucleotide exchange factor(TRIO, marker 19224),trio Rho guanine nucleotide exchange factor(TRIO, marker 19225) ,TRIO and F-actin binding protein (TRIOBP, marker 19226),TRIO and F-actin binding protein (TRIOBP, marker 19227),thyroid hormone receptor interactor 11 (TRIP11, marker 19228),thyroid hormone receptor interactor 6 (TRIP6, marker 19229), triple QxxK/R motif containing(TRIQK, marker 19230),tRNA methyltransferase O(TRMO, marker 19231),tRNA methyltransferase 1(TRMT1, marker 19232),tRNA methyltransferase 10A(TRMT10A, marker 19233),tRNA methyltransferase 10B( TRMT10B, marker 19234),tRNA methyltransferase 10B(TRMT10B, marker 19235),tRNA methyltransferase 2 homolog B(TRMT2B, marker 19236),tRNA methyltransferase 44 homolog (S. cerevisiae)(TRMT44, marker 19237),tRNA methyltransferase 44 homolog (S cerevisiae) (TRMT44, marker 19238), tRNA selenocysteine 1 associated protein 1 (TRNAU1AP, marker 19239), TMF1-regulated nuclear protein 1 (TRNP1, marker 19240), trophinin (TRO, marker 19241), transient receptor potential cation channel, subfamily A, member 1(TRPA1, marker 19242),transient receptor potential cation channel, subfamily A, member 1(TRPA1, marker 19243),transient receptor potential cation channel, subfamily C, member 2, pseudogene(TRPC2, marker 19244), transient receptor potential cation channel, subfamily C, member 3(TRPC3, marker 19245),transient receptor potential cation channel, subfamily C, member 3(TRPC3, marker 19246),transient receptor potential cation channel, subfamily C, member 4(TRPC4, marker 19247), transient receptor potential cation channel, subfamily C, member 4(TRPC4, marker 19248),transient receptor potential cation channel, subfamily C, member 5(TRPC5, marker 19249),TRPC5 opposite strand(TRPC5OS, marker 19250), transient receptor potential cation channel, subfamily C, member 7(TRPC7, marker 19251),transient receptor potential cation channel, subfamily C, member 7(TRPC7, marker 19252),transient receptor potential cation channel, subfamily M, member 1(TRPM1, marker 19253), transient receptor potential cation channel, subfamily M, member 1(TRPM1, marker 19254), transient receptor potential cation channel, subfamily M, member 1(TRPM1, marker 19255), transient receptor potential cation channel, subfamily M, member 2 (TRPM2, marker 19256), TRPM2 antisense RNA (TRPM2-AS, marker 19257), transient receptor potential cation channel, subfamily M, member 3 (TRPM3, marker 19258), transient receptor potential cation channel, subfamily M, member 3( TRPM3, marker 19259), transient receptor potential cation channel, subfamily M, member 3(TRPM3, marker 19260), transient receptor potential cation channel, subfamily M, member 3(TRPM3, marker 19261), transient receptor potential cation channel, subfamily M , member
3(TRPM3, marker 19262), transient receptor potential cation channel, subfamily M, member 5(TRPM5, marker 19263), transient receptor potential cation channel, subfamily M, member 6(TRPM6, marker 19264), subfamily M, member 6(TRPM6, marker 19265),transient receptor potential cation channel, subfamily M, member 6(TRPM6, marker 19266),transient receptor potential cation channel, subfamily M, member 6(TRPM6,marker 19267),transient receptor potential cation channel, subfamily M, member 7(TRPM7, marker 19268),transient receptor potential cation channel, subfamily M, member 7(TRPM7, marker 19269),transient receptor potential cation channel, subfamily M, member 8(TRPM8, marker 19270 ),transient receptor potential cation channel, subfamily M, member 8(TRPM8, marker 19271),transient receptor potential cation channel, subfamily V, member 2(TRPV2,marker 19272),transient receptor potential cation channel, subfamily V, member 2( TRPV2, marker 19273), transient receptor potential cation channel, subfamily V, member 3(TRPV3, marker 19274), transient receptor potential cation channel, subfamily V, member 3(TRPV3, marker 19275), transient receptor potential cation channel, subfamily V , member 4(TRPV4, marker 19276),transient receptor potential cation channel, subfamily V, member 5(TRPV5, marker 19277),transient receptor potential cation channel, subfamily V, member 5(TRPV5,marker 19278),transient receptor potential cation channel, subfamily V, member 6(TRPV6, marker 19279),transient receptor potential cation channel, subfamily V, member 6(TRPV6, marker 19280),TruB pseudouridine (psi) synthase family member 1(TRUB1, marker 19281),TruB pseudouridine (psi) synthase family member 1(TRUB1, marker 19282), trypsinogen-like pseudogene(TRY2P, marker 19283), tuberous sclerosis 2(TSC2, marker 19284),TSC22 domain family, member 1(TSC22D1, marker 19285),TSC22 domain family, member 1(TSC22D1, marker 19286),TSC22D1 antisense RNA 1(TSC22D1-AS1, marker 19287),TSC22D1 antisense RNA 1(TSC22D1-AS1, marker 19288),TSC22 domain family, member 2(TSC22D2, marker 19289), TSC22 domain family, member 2(TSC22D2, marker 19290),TSC22 domain family, member 3(TSC22D3, marker 19291),TSC22 domain family, member 4(TSC22D4, marker 19292),TSEN54 tRNA splicing endonuclease subunit(TSEN54, marker 19293) ,testis specific 10(TSGA10,marker 19294),testis specific 10(TSGA10,marker 19295),testis specific 10(TSGA10,marker 19296),testis specific 10(TSGA10,marker 19297),testis specific 10 interacting protein(TSGA10IP,marker 19298), testis specific 13 (TSGA13, marker 19299), thyroid stimulating hormone, beta (TSHB, marker 19300), thyroid stimulating hormone receptor (TSHR, marker 19301), thyroid stimulating hormone receptor (TSHR, marker 19302), thyroid stimulating hormone receptor(TSHR, marker 19303), teashirt zinc finger homeobox 1(TSHZ1, marker 19304), teashirt zinc finger homeobox 1(TSHZ1, marker 19305), teashirt zinc finger homeobox 2(TSHZ2, marker 19306), teashirt zinc finger homeobox 2( TSHZ2, marker 19307), teashirt zinc finger homeobox 2(TSHZ2, marker 19308), teashirt zinc finger homeobox 2(TSHZ2, marker 19309), teashirt zinc finger homeobox 2(TSHZ2, marker 19310), teashirt zinc finger homeobox 2(TSHZ2, marker 19311), TSIX transcript, XIST antisense RNA (TSIX, marker 19312), testis-specific serine kinase substrate (TSKS, marker 19313), testis-specific serine kinase substrate (TSKS, marker 19314), t-SNARE domain containing 1( TSNARE1, marker 19315), t-SNARE domain containing 1(TSNARE1, marker 19316), translin-associated factor ),tetraspanin 10(TSPAN10, marker 19320),tetraspanin 16(TSPAN16,marker 19321),tetraspanin 16(TSPAN16,marker 19322),tetraspanin 16(TSPAN16,marker 19323),tetraspanin 17(TSPAN17,marker 19324),tetraspanin 3( TSPAN3, marker 19325),tetraspanin 3(TSPAN3,marker 19326),tetraspanin 32(TSPAN32,marker 19327),tetraspanin 8(TSPAN8,marker 19328),thrombospondin-type laminin G domain and EAR repeats(TSPEAR,marker 19329),thrombospondin -type laminin G domain and EAR repeats(TSPEAR, marker 19330),thrombospondin-type laminin G domain and EAR repeats(TSPEAR, marker 19331),TSPEAR antisense RNA 2(TSPEAR-AS2, marker 19332),TSPEAR antisense RNA 2(TSPEAR -AS2, marker 19333), translocator protein 2(TSPO2, marker 19334), testis specific protein, Y-linked 1(TSPY1, marker 19335), testis specific protein, Y-linked 1 /// testis specific protein, Y-linked 10 /// testis specific protein, Y-linked 2 /// testis specific protein, Y-linked 3 /// testis specific protein, Y-linked 4 /// testis specific protein, Y-linked 8(TSPY1 /// TSPY10 /// TSPY2 /// TSPY3 /// TSPY4 /// TSPY8, marker 19336), testis specific protein, Y-linked 26, pseudogene(TSPY26P, marker 19337), TSPY-like 1(TSPYL1, marker 19338), TSPY-like 6(TSPYL6, marker 19339),TSR3, 20S rRNA accumulation, homolog (S. cerevisiae)(TSR3, marker 19340),TSR3, 20S rRNA accumulation, homolog (S. cerevisiae)(TSR3, marker 19341),testis -specific serine kinase 1B (TSSK1B, marker 19342), testis-specific serine kinase 2 (TSSK2, marker 19343), testis-specific serine kinase 2 (TSSK2, marker 19344), testis-specific serine kinase 3 (TSSK3, marker 19345) ,testis-specific serine kinase 4(TSSK4, marker 19346),testis-specific serine kinase 6(TSSK6,marker 19347),testis-specific serine kinase 6(TSSK6,marker 19348),testis-specific serine kinase 6(TSSK6,marker 19349), thiosulfate sulfurtransferase (rhodanese)-like domain containing 2(TSTD2, marker 19350), tau tubulin kinase 1(TTBK1, marker 19351), tau tubulin kinase 1(TTBK1, marker 19352), tau tubulin kinase 2(TTBK2, marker 19353), tau tubulin kinase 2 (TTBK2, marker 19354), tau tubulin kinase 2 (TTBK2, marker 19355), tau tubulin kinase 2 (TTBK2, marker 19356), tetratricopeptide repeat domain 12 (TTC12, marker 19357), tetratricopeptide repeat domain 16 (TTC16, marker 19358), tetratricopeptide repeat domain 17 (TTC17, marker 19359), tetratricopeptide repeat domain 17 (TTC17, marker 19360), tetratricopeptide repeat domain 21A (TTC21A, marker 19361), tetratricopeptide repeat domain 21A (TTC21A, marker 19362) ),tetratricopeptide repeat domain 21B(TTC21B, marker 19363),tetratricopeptide repeat domain 22(TTC22,marker 19364),tetratricopeptide repeat domain 22(TTC22,marker 19365),tetratricopeptide repeat domain 22(TTC22,marker 19366),tetratricopeptide repeat domain 22 (TTC22, Marker 19367), tetratricopeptide repeat domain 23 (TTC23, Marker 19368), tetratricopeptide repeat domain 23 (TTC23, Marker 19369), tetratricopeptide repeat domain 23 (TTC23, Marker 19370), tetratricopeptide repeat domain 23-like (TTC23L, Marker 19371),tetratricopeptide repeat domain 23-like(TTC23L, marker 19372),tetratricopeptide repeat domain 25(TTC25,marker 19373),tetratricopeptide repeat domain 26(TTC26,marker 19374),tetratricopeptide repeat domain 28(TTC28,marker 19375),tetratricopeptide repeat domain 28 (TTC28, marker 19376), TTC28 antisense RNA 1 (TTC28-AS1, marker 19377), TTC28 antisense RNA 1 (TTC28-AS1, marker 19378), tetratricopeptide repeat domain 33 (TTC33, marker 19379), tetratrico repeat peptide domain 36 (TTC36, marker 19380), tetratricopeptide repeat domain 38 (TTC38, marker 19381), tetratricopeptide repeat domain 38 (TTC38, marker 19382), tetratricopeptide repeat domain 39A (TTC39A, marker 19383), tetratricopeptide repeat domain 39A (TTC39A, marker 19384) ),tetratricopeptide repeat domain 41, pseudogene(TTC41P, marker 19385),tetratricopeptide repeat domain 41, pseudogene(TTC41P,marker 19386),tetratricopeptide repeat domain 5(TTC5,marker 19387),tetratricopeptide repeat domain 6(TTC6,marker 19388), tetratricopeptide repeat domain 6(TTC6, marker 19389),tetratricopeptide repeat domain 6(TTC6,marker 19390),tetratricopeptide repeat domain 7A(TTC7A,marker 19391),tetratricopeptide repeat domain 7A(TTC7A,marker 19392),tetratricopeptide repeat domain 9(TTC9 , marker 19393), tetratricopeptide repeat domain 9B (TTC9B, marker 19394), tetratricopeptide repeat domain 9B (TTC9B, marker 19395), tetratricopeptide repeat domain 9C (TTC9C, marker 19396), transcription termination factor, RNA polymerase II (TTF2, marker 19397) ), tubulin tyrosine ligase(TTL, marker 19398), tubulin tyrosine ligase-like family member 10(TTLL10, marker 19399), tubulin tyrosine ligase-like family member 10(TTLL10, marker 19400), tubulin tyrosine ligase-like family member 10 (TTLL10, marker 19401), tubulin tyrosine ligase-like family member 11 (TTLL11, marker 19402), tubulin tyrosine ligase-like family member 11 (TTLL11, marker 19403), tubulin tyrosine ligase-like family member 11 (TTLL11, marker 19404 ), TTLL11 intronic transcript 1(TTLL11-IT1, marker 19405), tubulin tyrosine ligase-like family member 13, pseudogene(TTLL13P, marker 19406), tubulin tyrosine ligase-like family member 13, pseudogene(TTLL13P, marker 19407), tubulin tyrosine ligase-like family member 2(TTLL2, marker 19408), tubulin tyrosine ligase-like family member 3(TTLL3, marker 19409), tubulin tyrosine ligase-like family member 3(TTLL3, marker 19410), tubulin tyrosine ligase-like family member 4(TTLL4, marker 19411), tubulin tyrosine ligase-like family member 5(TTLL5, marker 19412), tubulin tyrosine ligase-like family member 5(TTLL5, marker 19413), tubulin tyrosine ligase-like family member 5(TTLL5, marker 19414), tubulin tyrosine ligase-like family member 5 (TTLL5, marker 19415), tubulin tyrosine ligase-like family member 5 (TTLL5, marker 19416), tubulin tyrosine ligase-like family member 6 (TTLL6, marker 19417), TTLL7 intronic transcript 1(TTLL7-IT1, marker 19418), tubulin tyrosine ligase-like family member 9(TTLL9, marker 19419), tubulin tyrosine ligase-like family member 9(TTLL9, marker 19420), tubulin tyrosine ligase-like family member 9 (TTLL9, marker 19421), titin (TTN, marker 19422), titin (TTN, marker 19423), titin (TTN, marker 19424), titin (TTN, marker 19425), titin (TTN, marker 19426), tocopherol (alpha ) transfer protein(TTPA, marker 19427), testis-specific transcript, Y-linked 1 (non-protein coding) /// testis-specific transcript, Y-linked 1B (non-protein coding)(TTTY1 /// TTTY1B, marker 19428),testis-specific transcript, Y-linked 10 (non-protein coding)(TTTY10,marker 19429),testis-specific transcript, Y-linked 11 (non-protein coding)(TTTY11,marker 19430),testis- specific transcript, Y-linked
12 (non-protein coding)(TTTY12, marker 19431),testis-specific transcript, Y-linked 13 (non-protein coding)(TTTY13,marker 19432),testis-specific transcript, Y-linked 14 (non-protein coding )(TTTY14, marker 19433), testis-specific transcript, Y-linked 14 (non-protein coding)(TTTY14, marker 19434), testis-specific transcript, Y-linked 15 (non-protein coding)(TTTY15, marker 19435 ),testis-specific transcript, Y-linked 2 (non-protein coding) /// testis-specific transcript, Y-linked 2B (non-protein coding)(TTTY2 /// TTTY2B, marker 19436),testis-specific transcript , Y-linked 4 (non-protein coding) /// testis-specific transcript, Y-linked 4B (non-protein coding) /// testis-specific transcript, Y-linked 4C (non-protein coding)(TTTY4 / // TTTY4B /// TTTY4C, marker 19437), testis-specific transcript, Y-linked 5 (non-protein coding)(TTTY5, marker 19438), testis-specific transcript, Y-linked 6 (non-protein coding) / // testis-specific transcript, Y-linked 6B (non-protein coding)(TTTY6 /// TTTY6B, marker 19439),testis-specific transcript, Y-linked 7 (non-protein coding)(TTTY7, marker 19440), testis-specific transcript, Y-linked 7 (non-protein coding) /// testis-specific transcript, Y-linked 7B (non-protein coding)(TTTY7 /// TTTY7B, marker 19441),testis-specific transcript, Y -linked 7 (non-protein coding) /// testis-specific transcript, Y-linked 7B (non-protein coding)(TTTY7 /// TTTY7B, marker 19442),testis-specific transcript, Y-linked 8 (non- protein coding) /// testis-specific transcript, Y-linked 8B (non-protein coding)(TTTY8 /// TTTY8B, marker 19443),testis-specific transcript, Y-linked 8 (non-protein coding) /// testis-specific transcript, Y-linked 8B (non-protein coding)(TTTY8 /// TTTY8B, marker 19444), tweety family member 2(TTYH2, marker 19445), tubby bipartite transcription factor(TUB, marker 19446), tubby bipartite transcription factor (TUB, marker 19447), tubby bipartite transcription factor (TUB, marker 19448), tubulin, alpha 1b (TUBA1B, marker 19449), tubulin, alpha 4b (TUBA4B, marker 19450), tubulin, alpha 8 (TUBA8, marker 19451), tubulin, alpha-like 3(TUBAL3, marker 19452), tubulin, beta 1 class VI(TUBB1, marker 19453), tubulin, beta 1 class VI(TUBB1, marker 19454), tubulin, beta 7, pseudogene(TUBB7P , marker 19455), tubulin, epsilon 1 (TUBE1, marker 19456), tubulin, gamma complex associated protein 2 (TUBGCP2, marker 19457), tubulin, gamma complex associated protein 3 (TUBGCP3, marker 19458), tubulin, gamma complex associated protein 6 (TUBGCP6, marker 19459), taurine up-regulated 1 (non-protein coding) (TUG1, marker 19460), tubby like protein 1 (TULP1, marker 19461), tubby like protein 2 (TULP2, marker 19462), tubby like protein 4(TULP4, marker 19463), tumor suppressor candidate 3(TUSC3, marker 19464), tumor suppressor candidate 5(TUSC5, marker 19465), tumor suppressor candidate 7 (non-protein coding)(TUSC7, marker 19466), tumor suppressor candidate 7 (non-protein coding)(TUSC7, marker 19467), tumor suppressor candidate 8 (non-protein coding)(TUSC8, marker 19468), twinfilin actin binding protein 1(TWF1, marker 19469), twinfilin actin binding protein 1( TWF1, marker 19470), twinfilin actin binding protein 1 (TWF1, marker 19471), twist family bHLH transcription factor 2 (TWIST2, marker 19472), TXK tyrosine kinase (TXK, marker 19473), taxilin alpha (TXLNA, marker 19474), taxilin beta(TXLNB, marker 19475), taxilin gamma pseudogene, Y-linked(TXLNGY, marker 19476), taxilin gamma pseudogene, Y-linked(TXLNGY, marker 19477), taxilin gamma pseudogene, Y-linked(TXLNGY, marker 19478) ,taxilin gamma pseudogene, Y-linked(TXLNGY, marker 19479),taxilin gamma pseudogene, Y-linked(TXLNGY, marker 19480),thioredoxin domain containing 16(TXNDC16,marker 19481),thioredoxin domain containing 2 (spermatozoa)(TXNDC2, marker 19482), thioredoxin domain containing 2 (spermatozoa) (TXNDC2, marker 19483), thioredoxin domain containing 8 (spermatozoa) (TXNDC8, marker 19484), thioredoxin-like 1 (TXNL1, marker 19485), thioredoxin reductase 1 (TXNRD1, marker 19486), thioredoxin reductase 2 (TXNRD2, marker 19487), thymidine phosphorylase (TYMP, marker 19488), thymidine phosphorylase (TYMP, marker 19489), thymidylate synthetase (TYMS, marker 19490), tyrosinase (TYR, marker 19491), tyrosinase( TYR, marker 19492), tyrosinase (TYR, marker 19493), TYRO3P protein tyrosine kinase pseudogene (TYRO3P, marker 19494), TYRO3P protein tyrosine kinase pseudogene (TYRO3P, marker 19495), TYRO protein tyrosine kinase binding protein (TYROBP, marker 19496) ,tyrosinase-related protein 1(TYRP1, marker 19497),trypsin domain containing 1(TYSND1,marker 19498),trypsin domain containing 1(TYSND1,marker 19499),U2 small nuclear RNA auxiliary factor 1 /// U2 small nuclear RNA auxiliary factor 1-like 5(U2AF1 /// U2AF1L5, marker 19500),U2 small nuclear RNA auxiliary factor 1-like 4(U2AF1L4, marker 19501),U2 small nuclear RNA auxiliary factor 2(U2AF2, marker 19502),U2 small nuclear RNA auxiliary factor 2(U2AF2, marker 19503), uveal autoantigen with coiled-coil domains and ankyrin repeats(UACA, marker 19504), ubiquitin-like modifier activating enzyme 1(UBA1, marker 19505), ubiquitin-like modifier activating enzyme 6( UBA6, marker 19506), ubiquitin-like modifier activating enzyme 6 (UBA6, marker 19507), ubiquitin-like modifier activating enzyme 6 (UBA6, marker 19508), ubiquitin-like modifier activating enzyme 7 (UBA7, marker 19509), ubiquitin- like modifier activating enzyme 7(UBA7, marker 19510),UBAC2 antisense RNA 1(UBAC2-AS1,marker 19511),UBA-like domain containing 1(UBALD1,marker 19512),UBA-like domain containing 1(UBALD1,marker 19513) ,ubiquitin associated protein 1 like(UBAP1L, marker 19514),ubiquitin associated protein 1 like(UBAP1L, marker 19515),ubiquitin associated and SH3 domain containing A(UBASH3A,marker 19516),ubiquitin associated and SH3 domain containing B(UBASH3B,marker 19517), ubiquitin conjugating enzyme E2B (UBE2B, marker 19518), ubiquitin conjugating enzyme E2B (UBE2B, marker 19519), ubiquitin conjugating enzyme E2D 1 (UBE2D1, marker 19520), ubiquitin conjugating enzyme E2D 3 (UBE2D3, marker 19521), ubiquitin -conjugating enzyme E2D 4 (putative)(UBE2D4, marker 19522), ubiquitin conjugating enzyme E2D N-terminal like (pseudogene)(UBE2DNL, marker 19523),UBE2E2 antisense RNA 1 (head to head)(UBE2E2-AS1, marker 19524) ,ubiquitin conjugating enzyme E2G 2(UBE2G2, marker 19525),ubiquitin conjugating enzyme E2H(UBE2H,marker 19526),ubiquitin conjugating enzyme E2I(UBE2I,marker 19527),ubiquitin conjugating enzyme E2I(UBE2I,marker 19528),ubiquitin conjugating enzyme E2I (UBE2I, marker 19529), ubiquitin-conjugating enzyme E2, J1 (UBE2J1, marker 19530), ubiquitin-conjugating enzyme E2, J2 (UBE2J2, marker 19531), ubiquitin-conjugating enzyme E2O (UBE2O, marker 19532), ubiquitin conjugating enzyme E2Q family-like 1(UBE2QL1, marker 19533), ubiquitin-conjugating enzyme E2S(UBE2S, marker 19534), ubiquitin-conjugating enzyme E2U (putative)(UBE2U, marker 19535), ubiquitin-conjugating enzyme E2U (putative)(UBE2U, marker 19536), ubiquitin-conjugating enzyme E2U (putative) (UBE2U, marker 19537), ubiquitin-conjugating enzyme E2W (putative) (UBE2W, marker 19538), ubiquitin-conjugating enzyme E2W (putative) (UBE2W, marker 19539), ubiquitin protein ligase E3A (UBE3A, marker 19540), ubiquitin protein ligase E3A (UBE3A, marker 19541), ubiquitin protein ligase E3A (UBE3A, marker 19542), ubiquitin protein ligase E3B (UBE3B, marker 19543), ubiquitin protein ligase E3B (UBE3B, marker 19544), ubiquitin protein ligase E3B (UBE3B, marker 19545), ubiquitin protein ligase E3C (UBE3C, marker 19546), ubiquitin protein ligase E3C (UBE3C, marker 19547), ubiquitin protein ligase E3C (UBE3C, marker 19548), ubiquitin protein ligase E3D (UBE3D, marker 19549), ubiquitin protein ligase E3D (UBE3D, marker 19550), UbiA prenyltransferase domain containing 1 (UBIAD1, marker 19551), ubiquitin-like 4B (UBL4B, marker 19552), ubinuclein 2 (UBN2, marker 19553) ), ubiquitin 3(UBQLN3, marker 19554), ubiquitin protein ligase E3 component n-recognin 2(UBR2, marker 19555), ubiquitin protein ligase E3 component n-recognin 2(UBR2, marker 19556), ubiquitin protein ligase E3 component n- recognin 3 (putative) (UBR3, marker 19557), ubiquitin protein ligase E3 component n-recognin 3 (putative) (UBR3, marker 19558), ubiquitin protein ligase E3 component n-recognin 4 (UBR4, marker 19559), ubiquitin protein ligase E3 component n-recognin 4 (UBR4, marker 19560), ubiquitin protein ligase E3 component n-recognin 4 (UBR4, marker 19561), upstream binding transcription factor, RNA polymerase I (UBTF, marker 19562), UBX domain protein 1 (UBXN1) , marker 19563), UBX domain protein 10 (UBXN10, marker 19564), UBX domain protein 10 (UBXN10, marker 19565), UBX domain protein 10 (UBXN10, marker 19566), UBXN10 antisense RNA 1 (UBXN10-AS1, marker 19567) , UBX domain protein 11 (UBXN11, marker 19568), UBX domain protein 4 (UBXN4, marker 19569), UBXN7 antisense RNA 1 (UBXN7-AS1, marker 19570), urothelial cancer associated 1 (non-protein coding) (UCA1, marker 19571), ubiquitin C-terminal hydrolase L5 (UCHL5, marker 19572), ubiquitin C-terminal hydrolase L5 (UCHL5, marker 19573), uridine-cytidine kinase 1-like 1 (UCKL1, marker 19574), upper zone of growth plate and cartilage matrix associated (UCMA, marker 19575), urocortin (UCN, marker 19576), urocortin 3 (UCN3, marker 19577), uncoupling protein 1 (mitochondrial, proton carrier) (UCP1, marker 19578), uncoupling protein 3 (mitochondrial, proton carrier) (UCP3, marker 19579), uncoupling protein 3 (mitochondrial, proton carrier) (UCP3, marker 19580), UFM1-specific ligase 1 (UFL1, marker 19581), UFM1-specific peptidase 1 (inactive) (UFSP1, marker 19582 ), uncharacterized LOC643763 (UG0898H09, marker 19583), UDP-glucose glycoprotein glucosyltransferase 2 (UGGT2, marker 19584), UDP-glucose glycoprotein glucosyltransferase 2 (UGGT2, marker 19585), UDP-glucose glycoprotein glucosyltransferase 2 (UGGT2, marker 19586) ), UDP glucuronosyltransferase 1 family, polypeptide A1(UGT1A1, marker 19587),UDP glucuronosyltransferase 1 family, polypeptide A1 /// UDP glucuronosyltransferase 1 family, polypeptide A10 /// UDP glucuronosyltransferase 1 family, polypeptide A3 /// UDP glucuronosyltransferase 1 family, polypeptide A4 /// UDP glucuronosyltransferase 1 family, polypeptide A5 /// UDP glucuronosyltransferase 1 family, polypeptide A6 /// UDP glucuronosyltransferase 1 family, polypeptide A7 /// UDP glucuronosyltransferase 1 family, polypeptide A8 /// UDP glucuron
osyltransferase 1 family, polypeptide A9(UGT1A1 /// UGT1A10 /// UGT1A3 /// UGT1A4 /// UGT1A5 /// UGT1A6 /// UGT1A7 /// UGT1A8 /// UGT1A9, Marker 19588), UDP glucuronosyltransferase 1 family, polypeptide A1 /// UDP glucuronosyltransferase 1 family, polypeptide A10 /// UDP glucuronosyltransferase 1 family, polypeptide A3 /// UDP glucuronosyltransferase 1 family, polypeptide A4 /// UDP glucuronosyltransferase 1 family, polypeptide A5 /// UDP glucuronosyltransferase 1 family, polypeptide A6 /// UDP glucuronosyltransferase 1 family, polypeptide A7 /// UDP glucuronosyltransferase 1 family, polypeptide A8 /// UDP glucuronosyltransferase 1 family, polypeptide A9(UGT1A1 /// UGT1A10 /// UGT1A3 /// UGT1A4 /// UGT1A5 /// UGT1A6 /// UGT1A7 /// UGT1A8 /// UGT1A9, marker 19589), UDP glucuronosyltransferase 1 family, polypeptide A1 /// UDP glucuronosyltransferase 1 family, polypeptide A10 /// UDP glucuronosyltransferase 1 family, polypeptide A3 // / UDP glucuronosyltransferase 1 family, polypeptide A4 /// UDP glucuronosyltransferase 1 family, polypeptide A5 /// UDP glucuronosyltransferase 1 family, polypeptide A6 /// UDP glucuronosyltransferase 1 family, polypeptide A7 /// UDP glucuronosyltransferase 1 family, polypeptide A8 // / UDP glucuronosyltransferase 1 family, polypeptide A9(UGT1A1 /// UGT1A10 /// UGT1A3 /// UGT1A4 /// UGT1A5 /// UGT1A6 /// UGT1A7 /// UGT1A8 /// UGT1A9, marker 19590), UDP glucuronosyltransferase 1 family, polypeptide A1 /// UDP glucuronosyltransferase 1 family, polypeptide A10 /// UDP glucuronosyltransferase 1 family, polypeptide A4 /// UDP glucuronosyltransferase 1 family, polypeptide A6 /// UDP glucuronosyltransferase 1 family, polypeptide A8 /// UDP glucuronosyltransferase 1 family, polypeptide A9(UGT1A1 /// UGT1A10 /// UGT1A4 /// UGT1A6 /// UGT1A8 /// UGT1A9, Marker 19591), UDP glucuronosyltransferase 1 family, polypeptide A6(UGT1A6, Marker 19592), UDP glucuronosyltransferase 1 family, polypeptide A8(UGT1A8, marker 19593), UDP glucuronosyltransferase 1 family, polypeptide A8 /// UDP glucuronosyltransferase 1 family, polypeptide A9(UGT1A8 /// UGT1A9, marker 19594), UDP glucuronosyltransferase 2 family, polypeptide A1, complex locus /// UDP glucuronosyltransferase 2 family, polypeptide A2(UGT2A1 /// UGT2A2, marker 19595),UDP glucuronosyltransferase 2 family, polypeptide A3(UGT2A3, marker 19596),UDP glucuronosyltransferase 2 family, polypeptide B15(UGT2B15, marker 19597),UDP glucuronosyltransferase 2 families , polypeptide B15(UGT2B15, marker 19598), UDP glucuronosyltransferase 2 family, polypeptide B15 /// UDP glucuronosyltransferase 2 family, polypeptide B17(UGT2B15 /// UGT2B17, marker 19599), UDP glucuronosyltransferase 2 family, polypeptide B4(UGT2B4, marker 19600 ), UDP glycosyltransferase 3 family, polypeptide A1 (UGT3A1, marker 19601), UHRF1 binding protein 1 (UHRF1BP1, marker 19602), UHRF1 binding protein 1-like (UHRF1BP1L, marker 19603), UHRF1 binding protein 1-like (UHRF1BP1L, marker 19604), UL16 binding protein 1 (ULBP1, marker 19605), UL16 binding protein 2 (ULBP2, marker 19606), UL16 binding protein 2 (ULBP2, marker 19607), UL16 binding protein 3 (ULBP3, marker 19608), unc-51 like autophagy activating kinase 2 (ULK2, marker 19609), unc-51 like kinase 4 (ULK4, marker 19610), uromodulin (UMOD, marker 19611), uromodulin-like 1 (UMODL1, marker 19612), UMODL1 antisense RNA 1 (UMODL1 -AS1, marker 19613), uridine monophosphate synthetase (UMPS, marker 19614), unc-119 lipid binding chaperone B (UNC119B, marker 19615), unc-13 homolog A (C. elegans) (UNC13A, marker 19616), unc- 13 homolog A (C. elegans) (UNC13A, marker 19617), unc-13 homolog C (C. elegans) (UNC13C, marker 19618), unc-13 homolog C (C. elegans) (UNC13C, marker 19619), unc -13 homolog C (C. elegans)(UNC13C, marker 19620), unc-13 homolog C (C. elegans)(UNC13C, marker 19621), unc-13 homolog D (C. elegans)(UNC13D, marker 19622), unc-13 homolog D (C. elegans) (UNC13D, marker 19623), unc-13 homolog D (C. elegans) (UNC13D, marker 19624), unc-45 myosin chaperone B (UNC45B, marker 19625), unc-5 netrin receptor A (UNC5A, marker 19626), UNC5B antisense RNA 1 (UNC5B-AS1, marker 19627), unc-5 netrin receptor C (UNC5C, marker 19628), unc-5 netrin receptor C (UNC5C, marker 19629), unc -5 netrin receptor C (UNC5C, marker 19630), unc-5 netrin receptor C (UNC5C, marker 19631), unc-5 family C-terminal like (UNC5CL, marker 19632), unc-80 homolog (C. elegans)( UNC80, marker 19633), unc-80 homolog (C. elegans)(UNC80, marker 19634), unc-80 homolog (C. elegans)(UNC80, marker 19635), unc-93 homolog A (C. elegans)(UNC93A , marker 19636), unc-93 homolog A (C. elegans)(UNC93A, marker 19637), unc-93 homolog B1 (C. elegans)(UNC93B1, marker 19638),unc-93 homolog B1 (C. elegans)( UNC93B1, Marker 19639), unkempt family zinc finger-like(UNKL, Marker 19640), ureidopropionase, beta(UPB1, Marker 19641), ureidopropionase, beta(UPB1, Marker 19642), ureidopropionase, beta(UPB1, Marker 19643), ureidopropionase , beta(UPB1, marker 19644),UPF3 regulator of nonsense transcripts homolog B (yeast)(UPF3B, marker 19645),uroplakin 1A(UPK1A, marker 19646),uroplakin 1B(UPK1B,marker 19647),uroplakin 1B(UPK1B,marker) 19648), uroplakin 2 (UPK2, marker 19649), uroplakin 3A (UPK3A, marker 19650), uridine phosphorylase 2 (UPP2, marker 19651), uridine phosphorylase 2 (UPP2, marker 19652), ubiquinol-cytochrome c reductase complex assembly factor 2 (UQCC2, marker 19653), ubiquinol-cytochrome c reductase complex assembly factor 2 (UQCC2, marker 19654), ubiquinol-cytochrome c reductase binding protein (UQCRB, marker 19655), ubiquinol-cytochrome c reductase core protein II (UQCRC2, marker 19656) ),URB1 ribosome biogenesis 1 homolog (S. cerevisiae)(URB1, marker 19657),URB1 ribosome biogenesis 1 homolog (S. cerevisiae)(URB1, marker 19658),URB1 antisense RNA 1 (head to head)(URB1-AS1, marker 19659), upregulator of cell proliferation (URGCP, marker 19660), URI1, prefoldin-like chaperone (URI1, marker 19661), ubiquitin related modifier 1 (URM1, marker 19662), urocanate hydratase 1 (UROC1, marker 19663), uroporphyrinogen decarboxylase (UROD, marker 19664), U6 snRNA biogenesis 1 (USB1, marker 19665), upstream transcription factor family member 3 (USF3, marker 19666), upstream transcription factor family member 3 (USF3, marker 19667), upstream transcription factor family member 3 (USF3, marker 19668), Usher syndrome 1C (USH1C, marker 19669), Usher syndrome 1C (USH1C, marker 19670), Usher syndrome 1C (USH1C, marker 19671), Usher syndrome 2A (autosomal recessive, mild) (USH2A, marker 19672), Usher syndrome 1C binding protein 1(USHBP1, marker 19673), ubiquitin specific peptidase 15(USP15, marker 19674), ubiquitin specific peptidase 2(USP2, marker 19675), ubiquitin specific peptidase 2(USP2, marker 19676), ubiquitin specific peptidase 2 (USP2, marker 19677), ubiquitin specific peptidase 22 (USP22, marker 19678), ubiquitin specific peptidase 22 (USP22, marker 19679), ubiquitin specific peptidase 22 (USP22, marker 19680), ubiquitin specific peptidase 22 (USP22) , marker 19681), ubiquitin specific peptidase 25(USP25, marker 19682), ubiquitin specific peptidase 26(USP26, marker 19683), USP27X antisense RNA 1 (head to head)(USP27X-AS1, marker 19684), ubiquitin specific peptidase 29( USP29, marker 19685), USP3 antisense RNA 1 (USP3-AS1, marker 19686), USP30 antisense RNA 1 (USP30-AS1, marker 19687), ubiquitin specific peptidase 31 (USP31, marker 19688), ubiquitin specific peptidase 32 pseudogene 2( USP32P2, Marker 19689), ubiquitin specific peptidase 33 (USP33, Marker 19690), ubiquitin specific peptidase 34 (USP34, Marker 19691), ubiquitin specific peptidase 36 (USP36, Marker 19692), ubiquitin specific peptidase 38 (USP38, Marker 19693), ubiquitin specific peptidase 4 (proto-oncogene) (USP4, marker 19694), ubiquitin specific peptidase 42 (USP42, marker 19695), ubiquitin specific peptidase 42 (USP42, marker 19696), ubiquitin specific peptidase 46 (USP46, marker 19697), USP46 antisense RNA 1(USP46-AS1, marker 19698), ubiquitin specific peptidase 48(USP48, marker 19699), ubiquitin specific peptidase 49(USP49, marker 19700), ubiquitin specific peptidase 49(USP49, marker 19701), ubiquitin specific peptidase 49( USP49, Marker 19702), ubiquitin specific peptidase 49 (USP49, Marker 19703), ubiquitin specific peptidase 53 (USP53, Marker 19704), ubiquitin specific peptidase 6 (USP6, Marker 19705), ubiquitin specific peptidase 6 (USP6, Marker 19706), ubiquitin specific peptidase 6 (USP6, marker 19707), USP6 N-terminal like (USP6NL, marker 19708), ubiquitin specific peptidase 9, Y-linked (USP9Y, marker 19709), ubiquitin specific peptidase 9, Y-linked (USP9Y, marker 19710), ubiquitin specific peptidase like 1 (USPL1, marker 19711), UST antisense RNA 1 (UST-AS1, marker 19712), UST antisense RNA 1 (UST-AS1, marker 19713), UTP11-like, U3 small nucleolar ribonucleoprotein ( yeast) (UTP11L, marker 19714), UTP6, small subunit (SSU) processome component, homolog (yeast) (UTP6, marker 19715), urotensin 2 (UTS2, marker 19716), urotensin 2 (UTS2, marker 19717), urotensin 2B (UTS2B, marker 19718), urotensin 2 receptor(UTS2R, marker 19719), ubiquitously transcribed tetratricopeptide repeat containing, Y-linked(UTY, marker 19720), ubiquitously transcribed tetratricopeptide repeat containing, Y-linked(UTY, marker 19721), UV stimulated scaffold protein A (UVSSA, marker 19722), Vac14 homolog (S. cerevisiae) (VAC14, marker 19723), Vac14 homolog (S. cerevisiae) (VAC14, marker 19724), VAC14 antisense RNA 1 (VAC14-AS1, marker 19725) ),vesicle associated membrane protein 1(VAMP1, marker 19726),vesicle associated membrane protein 1(VAMP1,marker 19727),vesicle associated membrane protein 2(VAMP2,marker 19728),vesicle associated membrane protein 2(VAMP2,marker 19729), vesicle associated membrane protein 5 (VAMP5, marker 19730), vesicle associated membrane protein 5 (VAMP5, marker 19731), VANGL planar cell polarity protein 1 (VANGL1, marker 19732), VAMP associated protein A (VAPA, marker 19733), VAMP associated protein A (VAPA, marker 19734), VAMP (vesicle-associated membrane protein)-associated protein B and C (VAPB, marker 19735), vasohibin 1 (VASH1, marker 19736), vasohibin 1 (VASH1, marker 19737), vasohibin 1 (VASH1, marker 19738), vasohibin 2 (VASH2, marker 19739), vav 1 guanine nucleotide exchange factor (VAV1, marker 19740), vav 2 guanine nucleotide exchange factor (VAV2, marker 19741), vav 3 guanine nucleotide exchange factor (VAV3) , marker 19742), ventral anterior homeobox 2 (VAX2, marker 19743), vinculin (VCL, marker 19744), valosin c
ontaining protein (p97)/p47 complex interacting protein 1(VCPIP1, marker 19745), valosin containing protein lysine (K) methyltransferase(VCPKMT, marker 19746), variable charge, X-linked 2(VCX2, marker 19747), variable charge, X-linked 2(VCX2, marker 19748), variable charge, Y-linked /// variable charge, Y-linked 1B(VCY /// VCY1B, marker 19749), voltage-dependent anion channel 1(VDAC1, marker 19750) ,vitamin D (1,25- dihydroxyvitamin D3) receptor(VDR,marker 19751),vitamin D (1,25- dihydroxyvitamin D3) receptor(VDR,marker 19752),vitamin D (1,25- dihydroxyvitamin D3) receptor(VDR , marker 19753), vitamin D (1,25- dihydroxyvitamin D3) receptor (VDR, marker 19754), vascular endothelial growth factor C (VEGFC, marker 19755), VENT homeobox (VENTX, marker 19756), VENT homeobox pseudogene 1 (VENTXP1) , marker 19757), VENT homeobox pseudogene 1(VENTXP1, marker 19758), ventricular zone expressed PH domain containing 1(VEPH1, marker 19759), ventricular zone expressed PH domain containing 1(VEPH1, marker 19760), VGF nerve growth factor inducible( VGF, marker 19761), vestigial-like family member 1 (VGLL1, marker 19762), vestigial-like family member 1 (VGLL1, marker 19763), vestigial-like family member 2 (VGLL2, marker 19764), von Hippel-Lindau tumor vasoactive intestinal peptide receptor 2 (VIPR2, marker 19769), vasoactive intestinal peptide receptor 2 (VIPR2, marker 19770), vasoactive intestinal peptide receptor 2 (VIPR2, marker 19771), vitrin (VIT, marker 19772), VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) (VMA21, Marker 19773), VMA21 vacuolar H+-ATPase homolog (S. cerevisiae) (VMA21, Marker 19774), vitelline membrane outer layer 1 homolog (chicken) (VMO1, Marker 19775), vitelline membrane outer layer 1 homolog (chicken) (VMO1, vomeronasal 1 receptor 1(VN1R1, marker 19777), vomeronasal 1 receptor 108 pseudogene(VN1R108P, marker 19778), vomeronasal 1 receptor 10 pseudogene(VN1R10P, marker 19779), vomeronasal 1 receptor 2(VN1R2, marker 19780), vomeronasal 1 receptor 3 (gene/pseudogene) (VN1R3, marker 19781), vomeronasal 1 receptor 4 (VN1R4, marker 19782), vomeronasal 1 receptor 5 (gene/pseudogene) (VN1R5, marker 19783), vanin 1 (VNN1, marker 19784) ), vanin 1 (VNN1, marker 19785), vanin 2 (VNN2, marker 19786), vanin 3 (VNN3, marker 19787), vanin 3 (VNN3, marker 19788), vanin 3 (VNN3, marker 19789), Vpr (HIV -1) binding protein (VPRBP, marker 19790), pre-B lymphocyte 1 (VPREB1, marker 19791), pre-B lymphocyte 3 (VPREB3, marker 19792), vacuum protein sorting 13 homolog A (S. cerevisiae) (VPS13A, marker 19793), vacuum protein sorting 13 homolog A (S. cerevisiae) (VPS13A, marker 19794), VPS13A antisense RNA 1 (VPS13A-AS1, marker 19795), vacuum protein sorting 13 homolog B (yeast) (VPS13B, marker 19796) ,vacuolar protein sorting 13 homolog B (yeast)(VPS13B, marker 19797),vacuolar protein sorting 13 homolog C (S. cerevisiae)(VPS13C,marker 19798),vacuolar protein sorting 13 homolog C (S. cerevisiae)(VPS13C,marker 19799), vacuum protein sorting 13 homolog D (S. cerevisiae) (VPS13D, marker 19800), vacuum protein sorting 16 homolog (S. cerevisiae) (VPS16, marker 19801), VPS26 retromer complex component A (VPS26A, marker 19802), VPS29 retromer complex component (VPS29, marker 19803), vacuum protein sorting 33 homolog A (S. cerevisiae) (VPS33A, marker 19804), VPS35 retromer complex component (VPS35, marker 19805), vacuum protein sorting 36 homolog (S. cerevisiae) (VPS36, marker 19806), vacuum protein sorting 37 homolog C (S. cerevisiae) (VPS37C, marker 19807), vacuum protein sorting 37 homolog D (S. cerevisiae) (VPS37D, marker 19808), vacuum protein sorting 45 homolog (S cerevisiae)(VPS45, marker 19809),VPS50 EARP/GARPII complex subunit(VPS50, marker 19810),VPS50 EARP/GARPII complex subunit(VPS50, marker 19811),vacuolar protein sorting 53 homolog (S. cerevisiae)(VPS53, marker 19812), vacuum protein sorting 53 homolog (S. cerevisiae) (VPS53, marker 19813), vacuum protein sorting 53 homolog (S. cerevisiae) (VPS53, marker 19814), vacuum protein sorting 53 homolog (S. cerevisiae) (VPS53, marker 19815), vacuum protein sorting 53 homolog (S. cerevisiae)(VPS53, marker 19816), vacuum protein sorting 8 homolog (S. cerevisiae)(VPS8, marker 19817), vacuum protein sorting 8 homolog (S. cerevisiae)(VPS8 , marker 19818), VPS9 domain containing 1 (VPS9D1, marker 19819), VPS9D1 antisense RNA 1 (VPS9D1-AS1, marker 19820), vaccinia related kinase 3 (VRK3, marker 19821), vaccinia related kinase 3 (VRK3, marker 19822) ,vaccinia related kinase 3(VRK3, marker 19823),V-set and immunoglobulin domain containing 1(VSIG1, marker 19824),V-set and immunoglobulin domain containing 2(VSIG2, marker 19825),V-set and immunoglobulin domain containing 2 (VSIG2, marker 19826),V-set and immunoglobulin domain containing 4(VSIG4, marker 19827),V-set and transmembrane domain containing 1(VSTM1, marker 19828),V-set and transmembrane domain containing 2A(VSTM2A, marker 19829) ),V-set and transmembrane domain containing 2A(VSTM2A, marker 19830),V-set and transmembrane domain containing 2A(VSTM2A, marker 19831),VSTM2A overlapping transcript 1(VSTM2A-OT1, marker 19832),V-set and transmembrane domain containing 4(VSTM4, marker 19833),V-set and transmembrane domain containing 4(VSTM4, marker 19834),V-set and transmembrane domain containing 4(VSTM4, marker 19835),V-set and transmembrane domain containing 4(VSTM4 ,marker 19836),V-set and transmembrane domain containing 4(VSTM4,marker 19837),V-set and transmembrane domain containing 4(VSTM4,marker 19838),visual system homeobox 1(VSX1,marker 19839),visual system homeobox 1 (VSX1, marker 19840), visual system homeobox 1(VSX1, marker 19841), visual system homeobox 1(VSX1, marker 19842),vesicle (multivesicular body) trafficking 1(VTA1, marker 19843),vesicle transport through interaction with t- SNAREs 1A (VTI1A, marker 19844), von Willebrand factor A domain containing 1 (VWA1, marker 19845), von Willebrand factor A domain containing 1 (VWA1, marker 19846), von Willebrand factor A domain containing 3B (VWA3B, marker 19847) ,von Willebrand factor A domain containing 3B(VWA3B, marker 19848),von Willebrand factor A domain containing 3B(VWA3B, marker 19849),von Willebrand factor A domain containing 3B(VWA3B,marker 19850),von Willebrand factor A domain containing 3B (VWA3B, marker 19851),von Willebrand factor A domain containing 5B1(VWA5B1, marker 19852),von Willebrand factor A domain containing 5B1(VWA5B1, marker 19853),von Willebrand factor A domain containing 5B2(VWA5B2, marker 19854),von Willebrand factor A domain containing 5B2(VWA5B2, marker 19855),von Willebrand factor A domain containing 7(VWA7, marker 19856),VWA8 antisense RNA 1 (head to head)(VWA8-AS1, marker 19857),VWA8 antisense RNA 1 ( head to head) (VWA8-AS1, marker 19858), von Willebrand factor A domain containing 9 (VWA9, marker 19859), von Willebrand factor C domain containing 2 (VWC2, marker 19860), von Willebrand factor D and EGF domains (VWDE , marker 19861), von Willebrand factor (VWF, marker 19862), tryptophanyl tRNA synthetase 2, mitochondrial (WARS2, marker 19863), Wiskott-Aldrich syndrome (WAS, marker 19864), WASH and IL9R antisense RNA 2 (WASIR2, marker 19865) ), Wiskott-Aldrich syndrome-like (WASL, marker 19866), WBP2 N-terminal like (WBP2NL, marker 19867), Williams-Beuren syndrome chromosome region 16 (WBSCR16, marker 19868), Williams-Beuren syndrome chromosome region 16 (WBSCR16) , Marker 19869), Williams Beuren syndrome chromosome region 22 (WBSCR22, Marker 19870), Williams Beuren syndrome chromosome region 27 (WBSCR27, Marker 19871), Williams-Beuren syndrome chromosome region 28 (WBSCR28, Marker 19872), WD repeat and FYVE domain containing 2(WDFY2, marker 19873),WDFY3 antisense RNA 2(WDFY3-AS2,marker 19874),WDFY3 antisense RNA 2(WDFY3-AS2,marker 19875),WDFY3 antisense RNA 2(WDFY3-AS2,marker 19876),WDFY family member 4(WDFY4, marker 19877),WDFY family member 4(WDFY4,marker 19878),WD repeat domain 1(WDR1,marker 19879),WDR11 antisense RNA 1(WDR11-AS1,marker 19880),WDR11 antisense RNA 1(WDR11 -AS1, marker 19881), WD repeat domain 13 (WDR13, marker 19882), WD repeat domain 17 (WDR17, marker 19883), WD repeat domain 17 (WDR17, marker 19884), WD repeat domain 19 (WDR19, marker 19885) ,WD repeat domain 19(WDR19, marker 19886),WD repeat domain 26(WDR26,marker 19887),WD repeat domain 27(WDR27,marker 19888),WD repeat domain 27(WDR27,marker 19889),WD repeat domain 27( WDR27, marker 19890), WD repeat domain 3 (WDR3, marker 19891), WD repeat domain 31 (WDR31, marker 19892), WD repeat domain 31 (WDR31, marker 19893), WD repeat domain 33 (WDR33, marker 19894), WD repeat domain 38 (WDR38, marker 19895), WD repeat domain 38 (WDR38, marker 19896), WD repeat domain 41 (WDR41, marker 19897), WD repeat domain 44 (WDR44, marker 19898), WD repeat domain 49 (WDR49) , Marker 19899), WD repeat domain 49 (WDR49, Marker 19900), WD repeat domain 55 (WDR55, Marker 19901), WD repeat domain 60 (WDR60, Marker 19902), WD repeat domain 60 (WDR60, Marker 19903), WD repeat domain 61(WDR61, marker 19904),WD repeat domain 62(WDR62,marker 19905),WD repeat domain 62(WDR62,marker 19906),WD repeat domain 63(WDR63,marker 19907),WD repeat domain 64(WDR64, marker 19908), WD repeat domain 66 (WDR66, marker 19909), WD repeat domain 66 (WDR66, marker 19910), WD repeat domain 7 (WDR7, marker 19911), WD repeat domain 72 (WDR72, marker 19912), WD repeat domain 72(WDR72, marker 19913),WD repeat domain 72(WDR72,marker 19914),WD repeat domain 73(WDR73,marker 19915),WD repeat domain 73(WDR73,marker 19916),WD repeat domain 74(WDR74,marker 19917),WD repeat domain 78(WDR78,marker 19918),WD repeat domain 78(WDR78,marker 19919),WD repeat domain 78(WDR78,marker 19920),WD repeat domain 78(WDR78,marker 19921),WD repeat domain 78 (WDR78, marker 19922), WD repeat domain 86 (WDR86, marker 19923), WDR86 antisense RNA 1 (WDR86-AS1, marker 19924), WD repeat domain 87 (WDR87, marker 19925), WD repeat domain 88 (WDR88, marker 19926),WD repeat domain 88(WDR88,marker 19927),WD repeat domain 90(WDR90,marker 19928),WD repeat domain 90(WDR90,marker 19929),WD repeat domain 91(WDR91,marker 19930),WD repeat domain 91 (WDR91, marker 19931), WD repeat domain 93 (WDR93, marker 19932), WD repeat domain 97 (WDR97, marker 19933), WEE2 antisense RNA 1 (WEE2-AS1, marker 19
934),WAP four-disulfide core domain 1(WFDC1, marker 19935),WAP four-disulfide core domain 10A(WFDC10A, marker 19936),WAP four-disulfide core domain 10B(WFDC10B, marker 19937),WAP four-disulfide core domain 11 (WFDC11, marker 19938), WAP four-disulfide core domain 12 (WFDC12, marker 19939), WAP four-disulfide core domain 13 (WFDC13, marker 19940), WAP four-disulfide core domain 2 (WFDC2, marker 19941) ,WAP four-disulfide core domain 2(WFDC2, marker 19942),WAP four-disulfide core domain 3(WFDC3, marker 19943),WAP four-disulfide core domain 5(WFDC5, marker 19944),WAP four-disulfide core domain 6 (WFDC6, marker 19945),WAP four-disulfide core domain 8(WFDC8, marker 19946),WAP four-disulfide core domain 8(WFDC8, marker 19947),WAP four-disulfide core domain 8(WFDC8, marker 19948),WAP four-disulfide core domain 9(WFDC9, marker 19949),WAP four-disulfide core domain 9(WFDC9, marker 19950),WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2(WFIKKN2, marker 19951),WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2(WFIKKN2, marker 19952),WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 2(WHAMMP2, marker 19953),WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 2 /// WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 3(WHAMMP2 /// WHAMMP3, marker 19954),WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 2 /// WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 3(WHAMMP2 /// WHAMMP3, marker 19955),WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 2 /// WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 3(WHAMMP2 /// WHAMMP3, Marker 19956), WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 2 /// WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 3(WHAMMP2 /// WHAMMP3, Marker 19957), Wolf -Hirschhorn syndrome candidate 1-like 1(WHSC1L1, marker 19958),WAS/WASL interacting protein family, member 1(WIPF1,marker 19959),WAS/WASL interacting protein family, member 1(WIPF1,marker 19960),WAS/WASL WNT1 inducible signaling pathway protein 1( WISP1, marker 19964), WNT1 inducible signaling pathway protein 1 (WISP1, marker 19965), WNT1 inducible signaling pathway protein 1 (WISP1, marker 19966), WNT1 inducible signaling pathway protein 1 (WISP1, marker 19967), WNT1 inducible signaling pathway protein 2 (WISP2, marker 19968), WNT1 inducible signaling pathway protein 3 (WISP3, marker 19969), WNT1 inducible signaling pathway protein 3 (WISP3, marker 19970), widely interspaced zinc finger motifs (WIZ, marker 19971), WNK lysine deficient protein kinase 1 (WNK1, marker 19972), WNK lysine deficient protein kinase 1 (WNK1, marker 19973), WNK lysine deficient protein kinase 2 (WNK2, marker 19974), WNK lysine deficient protein kinase 2 (WNK2, marker 19975), WNK lysine deficient protein kinase 2 (WNK2, marker 19976), WNK lysine deficient protein kinase 2 (WNK2, marker 19977), WNK lysine deficient protein kinase 3 (WNK3, marker 19978), WNK lysine deficient protein kinase 4 (WNK4, marker 19979), wingless-type MMTV integration site family, member 1(WNT1, marker 19980),wingless-type MMTV integration site family, member 10A(WNT10A, marker 19981),wingless-type MMTV integration site family, member 10A(WNT10A, marker 19982) ,wingless-type MMTV integration site family, member 10B(WNT10B, marker 19983),wingless-type MMTV integration site family, member 11(WNT11,marker 19984),wingless-type MMTV integration site family, member 16(WNT16,marker 19985) ),wingless-type MMTV integration site family, member 16(WNT16, marker 19986),wingless-type MMTV integration site family member 2(WNT2,marker 19987),wingless-type MMTV integration site family, member 4(WNT4,marker 19988 ),wingless-type MMTV integration site family, member 4(WNT4,marker 19989),wingless-type MMTV integration site family, member 5B(WNT5B,marker 19990),wingless-type MMTV integration site family, member 6(WNT6,marker 19991),wingless-type MMTV integration site family, member 6(WNT6, marker 19992),wingless-type MMTV integration site family, member 7A(WNT7A,marker 19993),wingless-type MMTV integration site family, member 7B(WNT7B, marker 19994),wingless-type MMTV integration site family, member 7B(WNT7B,marker 19995),wingless-type MMTV integration site family, member 8A(WNT8A,marker 19996),wingless-type MMTV integration site family, member 9A(WNT9A , marker 19997), wingless-type MMTV integration site family, member 9B(WNT9B, marker 19998),Werner helicase interacting protein 1(WRNIP1, marker 19999),WSC domain containing 2(WSCD2, marker 20000),WSC domain containing 2( WSCD2, marker 20001), Wilms tumor 1(WT1, marker 20002), Wilms tumor 1(WT1, marker 20003), WT1 antisense RNA(WT1-AS, marker 20004), Wilms tumor 1 associated protein(WTAP, marker 20005), Wilms tumor 1 associated protein(WTAP, marker 20006),WW and C2 domain containing 1(WWC1, marker 20007),WW and C2 domain containing 1(WWC1, marker 20008),WW and C2 domain containing 1(WWC1, marker 20009) ,WW and C2 domain containing 1(WWC1, marker 20010),WW and C2 domain containing 2(WWC2, marker 20011),WWC2 antisense RNA 2(WWC2-AS2,marker 20012),WW domain containing oxidoreductase(WWOX,marker 20013) ,WW domain containing E3 ubiquitin protein ligase 2(WWP2, marker 20014),WW domain containing E3 ubiquitin protein ligase 2(WWP2, marker 20015),WWTR1 antisense RNA 1(WWTR1-AS1,marker 20016),WWTR1 antisense RNA 1(WWTR1 -AS1, Marker 20017), XIAP associated factor 1(XAF1, Marker 20018), XIAP associated factor 1(XAF1, Marker 20019), XIAP associated factor 1(XAF1, Marker 20020), antigen family, member 1E(XAGE1B /// XAGE1E, marker 20021),X antigen family, member 2(XAGE2, marker 20022),X antigen family, member 3(XAGE3, marker 20023),chemokine (C motif) ligand 1( XCL1, marker 20024), chemokine (C motif) ligand 1(XCL1, marker 20025), chemokine (C motif) ligand 1 /// chemokine (C motif) ligand 2(XCL1 /// XCL2, marker 20026), chemokine ( C motif) receptor 1 (XCR1, marker 20027), chemokine (C motif) receptor 1 (XCR1, marker 20028), xanthine dehydrogenase (XDH, marker 20029), xanthine dehydrogenase (XDH, marker 20030), Xg blood group (XG, marker 20031), Xg blood group (XG, marker 20032), Xg blood group /// Xg pseudogene, Y-linked 2 (XG /// XGY2, marker 20033), xin actin binding repeat containing 1 (XIRP1, marker 20034) ,xin actin binding repeat containing 2(XIRP2, marker 20035),X inactive specific transcript (non-protein coding)(XIST, marker 20036),X inactive specific transcript (non-protein coding)(XIST, marker 20037),X inactive specific transcript (non-protein coding)(XIST, marker 20038),X inactive specific transcript (non-protein coding)(XIST, marker 20039),X inactive specific transcript (non-protein coding)(XIST, marker 20040),X inactive specific transcript (non-protein coding)(XIST, marker 20041),X inactive specific transcript (non-protein coding)(XIST, marker 20042),X-linked Kx blood group related 4(XKR4, marker 20043),X- linked Kx blood group related 6(XKR6, marker 20044),X-linked Kx blood group related 6(XKR6, marker 20045),X-linked Kx blood group related 6(XKR6, marker 20046),X-linked Kx blood group related 7(XKR7, marker 20047),X-linked Kx blood group related, X-linked(XKRX,marker 20048),X-linked Kx blood group related, Y-linked /// X-linked Kx blood group related, Y- linked 2(XKRY /// XKRY2, Marker 20049), X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound(XPNPEP2, Marker 20050), 20051), X-prolyl aminopeptidase 3, mitochondrial (XPNPEP3, marker 20052), exportin 7 (XPO7, marker 20053), xenotropic and polytropic retrovirus receptor 1 (XPR1, marker 20054), X-ray repair complementing defective repair in Chinese hamster cells 3(XRCC3, marker 20055), X-ray repair complementing defective repair in Chinese hamster cells 4(XRCC4, marker 20056), X-ray repair complementing defective repair in Chinese hamster cells 6(XRCC6, marker 20057), (XRCC6BP1, marker 20058),5'-3' exoribonuclease 1(XRN1, marker 20059),5'-3' exoribonuclease 1(XRN1, marker 20060),X-ray radiation resistance associated 1(XRRA1, marker 20061),X -ray radiation resistance associated 1(XRRA1, marker 20062),xylulokinase homolog (H. influenzae)(XYLB, marker 20063),xylulokinase homolog (H. influenzae)(XYLB, marker 20064),xylulokinase homolog (H. influenzae)(XYLB , marker 20065), xylulokinase homolog (H. influenzae) (XYLB, marker 20066), xylosyltransferase I (XYLT1, marker 20067), xylosyltransferase II (XYLT2, marker 20068), YY1 associated factor 2 (YAF2, marker 20069), Y box binding protein 1 (YBX1, marker 20070), Y box binding protein 3 (YBX3, marker 20071), YES proto-oncogene 1, Src family tyrosine kinase (YES1, marker 20072), Yip1 interacting factor homolog B (S. cerevisiae) ( YIF1B, Marker 20073), Yip1 interacting factor homolog B (S. cerevisiae) (YIF1B, Marker 20074), Yip1 domain family member 4 (YIPF4, Marker 20075), Yip1 domain family member 4 (YIPF4, Marker 20076), YjeF N- terminal domain containing 3(YJEFN3, marker 20077),YME1-like 1 ATPase(YME1L1, marker 20078),YME1-like 1 ATPase(YME1L1, marker 20079),YME1-like 1 ATPase(YME1L1, marker 20080),YME1-like 1 ATPase(YME1L1, marker 20081),yippee like 2(YPEL2,marker 20082),yippee like 2(YPEL2,marker 20083),yippee like 3(YPEL3,marker 20084),yippee likepee 4(YPEL4,marker 20085),YTH domain containing 1(YTHDC1, marker 20086), YTHDF3 antisense RNA 1 (head to head)(YTHDF3-AS1, marker 20087), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon pseudogene 7(YWHAEP7, marker 20088), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon pseudogene 7(YWHAEP7, marker 20089),tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta(YWHAH, marker 20090),tyrosine 3-monooxygenase/tryptophan 5- monooxygenase activation protein, eta (YWHAH, marker 20091), zinc ac
tivated ligand-gated ion channel(ZACN, marker 20092),zinc binding alcohol dehydrogenase domain containing 2(ZADH2, marker 20093),zinc binding alcohol dehydrogenase domain containing 2(ZADH2, marker 20094),zinc binding alcohol dehydrogenase domain containing 2(ZADH2) , marker 20095), zinc binding alcohol dehydrogenase domain containing 2(ZADH2, marker 20096), zonadhesin (gene/pseudogene) (ZAN, marker 20097), zonadhesin (gene/pseudogene) (ZAN, marker 20098), zonadhesin (gene/pseudogene) ) (ZAN, marker 20099), zonadhesin (gene/pseudogene) (ZAN, marker 20100), zonadhesin (gene/pseudogene) (ZAN, marker 20101), zeta chain of T cell receptor associated protein kinase 70kDa (ZAP70, marker 20102) ,zeta chain of T cell receptor associated protein kinase 70kDa(ZAP70, marker 20103),zygote arrest 1(ZAR1,marker 20104),zygote arrest 1(ZAR1,marker 20105),zinc finger, B-box domain containing(ZBBX,marker 20106),zinc finger, BED-type containing 2(ZBED2, marker 20107),ZBED3 antisense RNA 1(ZBED3-AS1, marker 20108),ZBED3 antisense RNA 1(ZBED3-AS1, marker 20109),ZBED3 antisense RNA 1(ZBED3 -AS1, marker 20110), zinc finger, BED-type containing 4 (ZBED4, marker 20111), zinc finger, BED-type containing 6 (ZBED6, marker 20112), Z-DNA binding protein 1 (ZBP1, marker 20113), Z-DNA binding protein 1(ZBP1, marker 20114),zinc finger and BTB domain containing 1(ZBTB1, marker 20115),zinc finger and BTB domain containing 1(ZBTB1, marker 20116),zinc finger and BTB domain containing 10(ZBTB10 ZBTB11 antisense RNA 1 (ZBTB11-AS1, marker 20121),zinc finger and BTB domain containing 17(ZBTB17, marker 20122),zinc finger and BTB domain containing 20(ZBTB20, marker 20123),zinc finger and BTB domain containing 20(ZBTB20, marker 20124) ,zinc finger and BTB domain containing 20(ZBTB20, marker 20125),zinc finger and BTB domain containing 20(ZBTB20, marker 20126),zinc finger and BTB domain containing 20(ZBTB20, marker 20127),zinc finger and BTB domain containing 20 (ZBTB20, marker 20128), ZBTB20 antisense RNA 1 (ZBTB20-AS1, marker 20129), zinc finger and BTB domain containing 22 (ZBTB22, marker 20130), zinc finger and BTB domain containing 24 (ZBTB24, marker 20131), zinc finger and BTB domain containing 32(ZBTB32, marker 20132),zinc finger and BTB domain containing 33(ZBTB33, marker 20133),zinc finger and BTB domain containing 37(ZBTB37, marker 20134),zinc finger and BTB domain containing 38(ZBTB38, marker 20135),zinc finger and BTB domain containing 40(ZBTB40, marker 20136),zinc finger and BTB domain containing 42(ZBTB42, marker 20137),zinc finger and BTB domain containing 43(ZBTB43, marker 20138),zinc finger and BTB domain containing 45(ZBTB45, marker 20139),zinc finger and BTB domain containing 46(ZBTB46, marker 20140),ZBTB46 antisense RNA 1(ZBTB46-AS1, marker 20141),zinc finger and BTB domain containing 47(ZBTB47, marker 20142) ,zinc finger and BTB domain containing 47(ZBTB47, marker 20143),zinc finger and BTB domain containing 7A(ZBTB7A, marker 20144),zinc finger and BTB domain containing 7A(ZBTB7A, marker 20145),zinc finger and BTB domain containing 7A (ZBTB7A, marker 20146),zinc finger and BTB domain containing 7A(ZBTB7A, marker 20147),zinc finger and BTB domain containing 7B(ZBTB7B, marker 20148),zinc finger and BTB domain containing 7C(ZBTB7C, marker 20149),zinc finger and BTB domain containing 7C(ZBTB7C, marker 20150),zinc finger, C2HC-type containing 1A(ZC2HC1A, marker 20151),zinc finger, C2HC-type containing 1B(ZC2HC1B, marker 20152),zinc finger, C2HC-type containing 1C(ZC2HC1C, marker 20153),zinc finger CCCH-type containing 10(ZC3H10,marker 20154),zinc finger CCCH-type containing 10(ZC3H10,marker 20155),zinc finger CCCH-type containing 12B(ZC3H12B,marker 20156), zinc finger CCCH-type containing 12C(ZC3H12C, marker 20157),zinc finger CCCH-type containing 12D(ZC3H12D, marker 20158),zinc finger CCCH-type containing 13(ZC3H13, marker 20159),zinc finger CCCH-type containing 14( ZC3H14, marker 20160),zinc finger CCCH-type containing 15(ZC3H15, marker 20161),zinc finger CCCH-type containing 18(ZC3H18, marker 20162),zinc finger CCCH-type containing 3(ZC3H3, marker 20163),zinc finger CCCH-type containing 4(ZC3H4, marker 20164),zinc finger CCCH-type containing 6(ZC3H6, marker 20165),zinc finger CCCH-type containing 7B(ZC3H7B, marker 20166),zinc finger CCCH-type containing 7B(ZC3H7B, marker 20167),zinc finger CCCH-type, antiviral 1-like(ZC3HAV1L,marker 20168),zinc finger, C4H2 domain containing(ZC4H2,marker 20169),zinc finger, CCHC domain containing 13(ZCCHC13,marker 20170),zinc finger , CCHC domain containing 14(ZCCHC14, marker 20171),zinc finger, CCHC domain containing 14(ZCCHC14, marker 20172),zinc finger, CCHC domain containing 2(ZCCHC2, marker 20173),zinc finger, CCHC domain containing 3(ZCCHC3, marker 20174),zinc finger, CCHC domain containing 3(ZCCHC3,marker 20175),zinc finger, CCHC domain containing 4(ZCCHC4,marker 20176),zinc finger, CCHC domain containing 5(ZCCHC5,marker 20177),zinc finger, CW type with PWWP domain 1(ZCWPW1, marker 20178),zinc finger, CW type with PWWP domain 1(ZCWPW1, marker 20179),zinc finger, CW type with PWWP domain 2(ZCWPW2, marker 20180),zinc finger, CW type with PWWP domain 2(ZCWPW2, marker 20181),zinc finger, DHHC-type containing 1(ZDHHC1, marker 20182),zinc finger, DHHC-type containing 1(ZDHHC1, marker 20183),zinc finger, DHHC-type containing 13(ZDHHC13) , marker 20184), zinc finger, DHHC-type containing 14 (ZDHHC14, marker 20185), zinc finger, DHHC-type containing 14 (ZDHHC14, marker 20186), zinc finger, DHHC-type containing 17 (ZDHHC17, marker 20187), zinc finger, DHHC-type containing 18(ZDHHC18, marker 20188),zinc finger, DHHC-type containing 18(ZDHHC18, marker 20189),zinc finger, DHHC-type containing 18(ZDHHC18, marker 20190),zinc finger, DHHC- type containing 19(ZDHHC19, marker 20191),zinc finger, DHHC-type containing 2(ZDHHC2, marker 20192),zinc finger, DHHC-type containing 21(ZDHHC21, marker 20193),zinc finger, DHHC-type containing 21(ZDHHC21 ,marker 20194),zinc finger, DHHC-type containing 21(ZDHHC21,marker 20195),zinc finger, DHHC-type containing 21(ZDHHC21,marker 20196),zinc finger, DHHC-type containing 22(ZDHHC22,marker 20197), zinc finger, DHHC-type containing 24(ZDHHC24, marker 20198),zinc finger, DHHC-type containing 3(ZDHHC3, marker 20199),zinc finger, DHHC-type containing 4(ZDHHC4, marker 20200),zinc finger, DHHC- type containing 8(ZDHHC8, marker 20201),zinc finger, DHHC-type containing 8 pseudogene 1(ZDHHC8P1, marker 20202),zinc finger E-box binding homeobox 1(ZEB1, marker 20203),zinc finger E-box binding homeobox 2 (ZEB2, marker 20204), zinc finger E-box binding homeobox 2(ZEB2, marker 20205), zinc finger E-box binding homeobox 2(ZEB2, marker 20206), zyg-11 related, cell cycle regulator(ZER1, marker 20207 ),zyg-11 related, cell cycle regulator(ZER1, marker 20208),zinc finger, AN1-type domain 4(ZFAND4,marker 20209),zinc finger, AN1-type domain 5(ZFAND5,marker 20210),zinc finger, C3H1-type containing(ZFC3H1, marker 20211),zinc finger homeobox 2(ZFHX2, marker 20212),zinc finger homeobox 3(ZFHX3, marker 20213),zinc finger homeobox 3(ZFHX3, marker 20214),zinc finger homeobox 3(ZFHX3 , marker 20215), zinc finger homeobox 3 (ZFHX3, marker 20216), zinc finger homeobox 4 (ZFHX4, marker 20217), ZFHX4 antisense RNA 1 (ZFHX4-AS1, marker 20218), ZFHX4 antisense RNA 1 (ZFHX4-AS1, marker 20219), ZFP1 zinc finger protein (ZFP1, marker 20220), ZFP1 zinc finger protein (ZFP1, marker 20221), ZFP14 zinc finger protein (ZFP14, marker 20222), ZFP2 zinc finger protein (ZFP2, marker 20223), ZFP28 zinc finger protein(ZFP28, marker 20224),ZFP28 zinc finger protein(ZFP28,marker 20225),ZFP28 zinc finger protein(ZFP28,marker 20226),ZFP36 ring finger protein-like 1(ZFP36L1,marker 20227),ZFP36 ring finger protein-like 1 (ZFP36L1, marker 20228), ZFP36 ring finger protein-like 2 (ZFP36L2, marker 20229), ZFP41 zinc finger protein (ZFP41, marker 20230), ZFP41 zinc finger protein (ZFP41, marker 20231), ZFP57 zinc finger protein (ZFP57 , marker 20232), ZFP64 zinc finger protein (ZFP64, marker 20233), ZFP64 zinc finger protein (ZFP64, marker 20234), ZFP90 zinc finger protein (ZFP90, marker 20235), ZFP92 zinc finger protein (ZFP92, marker 20236), zinc finger protein-like 1(ZFPL1, marker 20237),zinc finger protein, FOG family member 1(ZFPM1, marker 20238),zinc finger RNA binding protein 2(ZFR2, marker 20239),zinc finger protein, X-linked /// zinc finger protein, Y-linked(ZFX /// ZFY, marker 20240),zinc finger protein, Y-linked(ZFY, marker 20241),zinc finger protein, Y-linked(ZFY, marker 20242),zinc finger, FYVE domain containing 16(ZFYVE16, marker 20243),zinc finger, FYVE domain containing 16(ZFYVE16, marker 20244),zinc finger, FYVE domain containing 16(ZFYVE16, marker 20245),zinc finger, FYVE domain containing 28(ZFYVE28, marker 20246) ),zinc finger, FYVE domain containing 28(ZFYVE28,marker 20247),zinc finger, FYVE domain containing 28(ZFYVE28,marker 20248),zymogen granule protein 16(ZG16,marker 20249),zymogen granule protein 16B(ZG16B,marker 20250 ),zinc finger, GATA-like protein 1(ZGLP1, marker 20251),zinc finger, GRF-type containing 1(ZGRF1, marker 20252),zinc finger, GRF-type containing 1(ZGRF1, marker 20253),zinc fingers and homeoboxes 2(ZHX2, marker 20254),zinc fingers and homeoboxes 3(ZHX3, marker 20255),Zic family member 1(ZIC1,marker 20256),Zic family member 1(ZIC1,marker 20257),Zic family member 4(ZIC4, marker 20258), Zic family member 4(ZIC4, marker 20259),zinc finger, imprinted 2(ZIM2, marker 20260),zinc finger, imprinted 3(ZIM3, marker 20261),zinc finger with KRAB and SCAN domains 7(ZKSCAN7, marker 20262),zinc finger with KRAB and SCAN domains 8(ZKSCAN8,marker 20263),zinc finger with KRAB and SCAN domains 8(ZKSCAN8,marker 20264),zinc finger, matrin-type 1(ZMAT1,marker 20265),zinc finger , MIZ-type containing 1(ZMIZ1, marker 20266),zinc finger, MIZ-type containing 1(ZMIZ1, marker 20267),ZMIZ1 antisense RNA 1(ZMIZ1-AS1, marker 20268),zinc finger, MIZ-type containing 2( ZMIZ2, marker 20269),zinc finger, MIZ-type containing 2(ZMIZ2, marker 20270),zinc finger, MYM-type 2(ZMYM2, marker 20271),zinc finger, MYM-type 2(ZMYM2, marker 20272),zinc finger, MYM
-type 2(ZMYM2, marker 20273),zinc finger, MYM-type 3(ZMYM3, marker 20274),zinc finger, MYM-type 6(ZMYM6, marker 20275),zinc finger, MYM-type 6(ZMYM6, marker 20276) ),zinc finger, MYM-type 6(ZMYM6, marker 20277),zinc finger, MYND-type containing 10(ZMYND10, marker 20278),zinc finger, MYND-type containing 10(ZMYND10, marker 20279),zinc finger, MYND -type containing 11(ZMYND11, marker 20280),zinc finger, MYND-type containing 12(ZMYND12, marker 20281),zinc finger, MYND-type containing 15(ZMYND15, marker 20282),zinc finger, MYND-type containing 8( ZMYND8, marker 20283), zinc finger protein 10 (ZNF10, marker 20284), zinc finger protein 107 (ZNF107, marker 20285), zinc finger protein 117 (ZNF117, marker 20286), zinc finger protein 131 (ZNF131, marker 20287), zinc finger protein 132(ZNF132, marker 20288),zinc finger protein 135(ZNF135, marker 20289),zinc finger protein 138(ZNF138, marker 20290),zinc finger protein 148(ZNF148, marker 20291),zinc finger protein 154(ZNF154 , marker 20292), zinc finger protein 157 (ZNF157, marker 20293), zinc finger protein 160 (ZNF160, marker 20294), zinc finger protein 160 (ZNF160, marker 20295), zinc finger protein 169 (ZNF169, marker 20296), zinc finger protein 169(ZNF169, marker 20297),zinc finger protein 169(ZNF169, marker 20298),zinc finger protein 17(ZNF17, marker 20299),zinc finger protein 17(ZNF17, marker 20300),zinc finger protein 175(ZNF175, marker 20301), zinc finger protein 180 (ZNF180, marker 20302), zinc finger protein 181 (ZNF181, marker 20303), zinc finger protein 19 (ZNF19, marker 20304), ZNF205 antisense RNA 1 (ZNF205-AS1, marker 20305), zinc finger protein 207 (ZNF207, marker 20306), zinc finger protein 208 (ZNF208, marker 20307), zinc finger protein 208 (ZNF208, marker 20308), zinc finger protein 208 (ZNF208, marker 20309), ZNF213 antisense RNA 1 (head to head)(ZNF213-AS1, marker 20310),zinc finger protein 214(ZNF214,marker 20311),zinc finger protein 214(ZNF214,marker 20312),zinc finger protein 214(ZNF214,marker 20313),zinc finger protein 215( ZNF215, Marker 20314), Zinc finger protein 219(ZNF219, Marker 20315), Zinc finger protein 219(ZNF219, Marker 20316), Zinc finger protein 221(ZNF221, Marker 20317), Zinc finger protein 221(ZNF221, Marker 20318), zinc finger protein 224(ZNF224, marker 20319),zinc finger protein 224(ZNF224, marker 20320),zinc finger protein 226(ZNF226, marker 20321),zinc finger protein 226(ZNF226, marker 20322),zinc finger protein 229(ZNF229 , marker 20323), zinc finger protein 229 (ZNF229, marker 20324), zinc finger protein 230 (ZNF230, marker 20325), zinc finger protein 230 (ZNF230, marker 20326), zinc finger protein 233 (ZNF233, marker 20327), zinc finger protein 233(ZNF233, marker 20328),zinc finger protein 234(ZNF234, marker 20329),zinc finger protein 235(ZNF235, marker 20330),zinc finger protein 235(ZNF235, marker 20331),zinc finger protein 24(ZNF24, marker 20332),zinc finger protein 24(ZNF24,marker 20333),zinc finger protein 248(ZNF248,marker 20334),zinc finger protein 248(ZNF248,marker 20335),zinc finger protein 25(ZNF25,marker 20336),zinc finger protein 25(ZNF25, marker 20337),zinc finger protein 250(ZNF250,marker 20338),zinc finger protein 252, pseudogene(ZNF252P,marker 20339),zinc finger protein 252, pseudogene(ZNF252P,marker 20340),ZNF252P antisense RNA 1 (ZNF252P-AS1, marker 20341),zinc finger protein 257(ZNF257,marker 20342),zinc finger protein 259 pseudogene 1(ZNF259P1,marker 20343),zinc finger protein 263(ZNF263,marker 20344),zinc finger protein 264(ZNF264 , marker 20345), zinc finger protein 268 (ZNF268, marker 20346), zinc finger protein 271, pseudogene (ZNF271P, marker 20347), zinc finger protein 276 (ZNF276, marker 20348), zinc finger protein 276 (ZNF276, marker 20349) ,zinc finger protein 277(ZNF277, marker 20350),zinc finger protein 28(ZNF28,marker 20351),zinc finger protein 280A(ZNF280A,marker 20352),zinc finger protein 280B(ZNF280B,marker 20353),zinc finger protein 283( ZNF283, Marker 20354), Zinc finger protein 287(ZNF287, Marker 20355), Zinc finger protein 287(ZNF287, Marker 20356), Zinc finger protein 292(ZNF292, Marker 20357), ZNF295 antisense RNA 1(ZNF295-AS1, Marker 20358 ),zinc finger protein 296(ZNF296, marker 20359),zinc finger protein 29, pseudogene(ZNF29P,marker 20360),zinc finger protein 29, pseudogene(ZNF29P,marker 20361),zinc finger protein 3(ZNF3,marker 20362), zinc finger protein 3(ZNF3, marker 20363),zinc finger protein 3(ZNF3, marker 20364),zinc finger protein 300 pseudogene 1 (functional)(ZNF300P1, marker 20365),zinc finger protein 311(ZNF311, marker 20366),zinc finger protein 316(ZNF316, marker 20367),ZNF32 antisense RNA 3(ZNF32-AS3,marker 20368),ZNF32 antisense RNA 3(ZNF32-AS3,marker 20369),zinc finger protein 321, pseudogene /// ZNF816-ZNF321P readthrough( ZNF321P /// ZNF816-ZNF321P, marker 20370),zinc finger protein 321, pseudogene /// ZNF816-ZNF321P readthrough(ZNF321P /// ZNF816-ZNF321P, marker 20371),zinc finger protein 324B(ZNF324B, marker 20372),zinc finger protein 324B(ZNF324B, marker 20373),zinc finger protein 326(ZNF326, marker 20374),zinc finger protein 333(ZNF333, marker 20375),zinc finger protein 333(ZNF333, marker 20376),zinc finger protein 333(ZNF333, marker 20377),zinc finger protein 333(ZNF333,marker 20378),zinc finger protein 333(ZNF333,marker 20379),zinc finger protein 333(ZNF333,marker 20380),zinc finger protein 335(ZNF335,marker 20381),zinc finger protein 335 (ZNF335, marker 20382), zinc finger protein 335 (ZNF335, marker 20383), zinc finger protein 33A (ZNF33A, marker 20384), zinc finger protein 33A (ZNF33A, marker 20385), zinc finger protein 33B (ZNF33B, marker 20386),zinc finger protein 33B(ZNF33B, marker 20387),zinc finger protein 341(ZNF341,marker 20388),zinc finger protein 341(ZNF341,marker 20389),zinc finger protein 343(ZNF343,marker 20390),zinc finger protein 345 (ZNF345, marker 20391), zinc finger protein 346 (ZNF346, marker 20392), zinc finger protein 350 (ZNF350, marker 20393), zinc finger protein 354C (ZNF354C, marker 20394), zinc finger protein 355, pseudogene (ZNF355P, marker 20395),zinc finger protein 362(ZNF362,marker 20396),zinc finger protein 362(ZNF362,marker 20397),zinc finger protein 365(ZNF365,marker 20398),zinc finger protein 365(ZNF365,marker 20399),zinc finger protein 366(ZNF366, marker 20400),zinc finger protein 366(ZNF366,marker 20401),zinc finger protein 37A(ZNF37A,marker 20402),zinc finger protein 37B, pseudogene(ZNF37BP,marker 20403),zinc finger protein 37B, pseudogene (ZNF37BP, marker 20404),zinc finger protein 37B, pseudogene(ZNF37BP, marker 20405),zinc finger protein 382(ZNF382, marker 20406),zinc finger protein 384(ZNF384, marker 20407),zinc finger protein 385C(ZNF385C, marker 20408),zinc finger protein 385C(ZNF385C, marker 20409),zinc finger protein 385D(ZNF385D,marker 20410),zinc finger protein 385D(ZNF385D,marker 20411),zinc finger protein 385D(ZNF385D,marker 20412),zinc finger protein 391(ZNF391, marker 20413),zinc finger protein 391(ZNF391,marker 20414),zinc finger protein 391(ZNF391,marker 20415),zinc finger protein 394(ZNF394,marker 20416),zinc finger protein 395(ZNF395,marker 20417 ),zinc finger protein 395(ZNF395, marker 20418),zinc finger protein 396(ZNF396,marker 20419),zinc finger protein 396(ZNF396,marker 20420),zinc finger protein 396(ZNF396,marker 20421),zinc finger protein 396 (ZNF396, marker 20422),zinc finger protein 396(ZNF396,marker 20423),zinc finger protein 397(ZNF397,marker 20424),zinc finger protein 397(ZNF397,marker 20425),zinc finger protein 407(ZNF407,marker 20426) ,zinc finger protein 407(ZNF407, marker 20427),zinc finger protein 407(ZNF407,marker 20428),zinc finger protein 41(ZNF41,marker 20429),zinc finger protein 41(ZNF41,marker 20430),zinc finger protein 41( ZNF41, Marker 20431), Zinc finger protein 414 (ZNF414, Marker 20432), Zinc finger protein 417 (ZNF417, Marker 20433), Zinc finger protein 425 (ZNF425, Marker 20434), Zinc finger protein 425 (ZNF425, Marker 20435), zinc finger protein 428(ZNF428, marker 20436),zinc finger protein 429(ZNF429, marker 20437),zinc finger protein 438(ZNF438, marker 20438),zinc finger protein 439(ZNF439, marker 20439),zinc finger protein 44(ZNF44 ,marker 20440),zinc finger protein 44(ZNF44,marker 20441),zinc finger protein 44(ZNF44,marker 20442),zinc finger protein 440(ZNF440,marker 20443),zinc finger protein 440(ZNF440,marker 20444),zinc finger protein 441(ZNF441, marker 20445),zinc finger protein 441(ZNF441, marker 20446),zinc finger protein 442(ZNF442, marker 20447),zinc finger protein 443(ZNF443, marker 20448),zinc finger protein 443(ZNF443, marker 20449),zinc finger protein 449(ZNF449,marker 20450),zinc finger protein 451(ZNF451,marker 20451),zinc finger protein 460(ZNF460,marker 20452),zinc finger protein 460(ZNF460,marker 20453),zinc finger protein 460(ZNF460, marker 20454),zinc finger protein 461(ZNF461,marker 20455),zinc finger protein 462(ZNF462,marker 20456),zinc finger protein 467(ZNF467,marker 20457),zinc finger protein 471(ZNF471,marker 20458),zinc finger protein 471(ZNF471, marker 20459),zinc finger protein 471(ZNF471,marker 20460),zinc finger protein 474(ZNF474,marker 20461),zinc finger protein 479(ZNF479,marker 20462),zinc finger protein 479(ZNF479, marker 20463),zinc finger protein 479 /// zinc finger protein 733, pseudogene(ZNF479 /// ZNF733P, marker 20464),zinc finger protein 483(ZNF483, marker 20465),zinc finger protein 483(ZNF483, marker 20466),zinc finger protein 484(ZNF484,marker 20467),zinc finger protein 485(ZNF485,marker 20468),zinc finger protein 488(ZNF488,marker 20469),zinc finger protein 491(ZNF491,marker 20470),zinc finger protein 492(ZNF492, marker 20471),zinc finger protein 493(ZNF493, marker 20472),zinc finger protein 496(ZNF496, marker 20473),zinc finger protein 497(ZNF497, marker 20474),zinc finger protein 502(ZNF502, marker 20475),zinc finger protein 502(ZNF502, marker 20476),zinc finger protein 503(ZNF503,marker 20477),zinc finger protein 503(ZNF503,marker 20478),zinc finger protein 503(ZNF503,marker 20479),ZNF503 antisense RNA 1 (ZNF503-AS1, marker 20480), ZNF503 antisense RNA 2 (ZNF503-AS2, marker 20481), ZNF503 antisense RNA 2 (ZNF503-AS2, marker 20482), ZNF503 antisense RNA 2 (ZNF503-AS2, marker 20483), ZNF503 antisense RNA 2(ZNF503-AS2, marker 20484),zinc finger protein 506(ZNF506, marker 20485),zinc finger protein 507(
ZNF507, Marker 20486), Zinc finger protein 517 (ZNF517, Marker 20487), Zinc finger protein 518A (ZNF518A, Marker 20488), Zinc finger protein 518B (ZNF518B, Marker 20489), Zinc finger protein 524 (ZNF524, Marker 20490), zinc finger protein 527 (ZNF527, marker 20491), zinc finger protein 529 (ZNF529, marker 20492), ZNF529 antisense RNA 1 (ZNF529-AS1, marker 20493), zinc finger protein 530 (ZNF530, marker 20494), zinc finger protein 536 (ZNF536, marker 20495),zinc finger protein 536(ZNF536,marker 20496),zinc finger protein 536(ZNF536,marker 20497),zinc finger protein 540(ZNF540,marker 20498),zinc finger protein 540(ZNF540,marker 20499) ,zinc finger protein 541(ZNF541, marker 20500),zinc finger protein 543(ZNF543,marker 20501),zinc finger protein 544(ZNF544,marker 20502),zinc finger protein 546(ZNF546,marker 20503),zinc finger protein 546( ZNF546, Marker 20504), Zinc finger protein 546 (ZNF546, Marker 20505), Zinc finger protein 547 (ZNF547, Marker 20506), Zinc finger protein 547 (ZNF547, Marker 20507), Zinc finger protein 548 (ZNF548, Marker 20508), zinc finger protein 549(ZNF549, marker 20509),zinc finger protein 550(ZNF550, marker 20510),zinc finger protein 551(ZNF551, marker 20511),zinc finger protein 551(ZNF551, marker 20512),zinc finger protein 551(ZNF551 , marker 20513), zinc finger protein 552 (ZNF552, marker 20514), zinc finger protein 555 (ZNF555, marker 20515), zinc finger protein 555 (ZNF555, marker 20516), zinc finger protein 555 (ZNF555, marker 20517), zinc finger protein 556(ZNF556, marker 20518),zinc finger protein 557(ZNF557, marker 20519),zinc finger protein 557(ZNF557, marker 20520),zinc finger protein 560(ZNF560, marker 20521),zinc finger protein 562(ZNF562, marker 20522),zinc finger protein 563(ZNF563,marker 20523),zinc finger protein 567(ZNF567,marker 20524),zinc finger protein 568(ZNF568,marker 20525),zinc finger protein 568(ZNF568,marker 20526),zinc finger protein 568(ZNF568, marker 20527),zinc finger protein 568(ZNF568,marker 20528),zinc finger protein 568(ZNF568,marker 20529),zinc finger protein 570(ZNF570,marker 20530),ZNF571 antisense RNA 1(ZNF571-AS1 , marker 20531), zinc finger protein 572 (ZNF572, marker 20532), zinc finger protein 575 (ZNF575, marker 20533), zinc finger protein 577 (ZNF577, marker 20534), zinc finger protein 578 (ZNF578, marker 20535), zinc finger protein 578(ZNF578, marker 20536),zinc finger protein 579(ZNF579, marker 20537),zinc finger protein 583(ZNF583, marker 20538),zinc finger protein 583(ZNF583, marker 20539),zinc finger protein 585A(ZNF585A, marker 20540),zinc finger protein 585B(ZNF585B,marker 20541),zinc finger protein 586(ZNF586,marker 20542),zinc finger protein 594(ZNF594,marker 20543),zinc finger protein 595(ZNF595,marker 20544),zinc finger protein 595 /// zinc finger protein 718(ZNF595 /// ZNF718, marker 20545),zinc finger protein 595 /// zinc finger protein 718(ZNF595 /// ZNF718, marker 20546),zinc finger protein 596(ZNF596, marker 20547),zinc finger protein 597(ZNF597, marker 20548),zinc finger protein 598(ZNF598, marker 20549),zinc finger protein 599(ZNF599, marker 20550),zinc finger protein 599(ZNF599, marker 20551),zinc finger protein 605 (ZNF605, marker 20552), zinc finger protein 611 (ZNF611, marker 20553), zinc finger protein 613 (ZNF613, marker 20554), zinc finger protein 614 (ZNF614, marker 20555), zinc finger protein 620 (ZNF620, marker 20556) ),zinc finger protein 621(ZNF621, marker 20557),zinc finger protein 624(ZNF624,marker 20558),zinc finger protein 625(ZNF625,marker 20559),zinc finger protein 626(ZNF626,marker 20560),zinc finger protein 641 (ZNF641, marker 20561), zinc finger protein 641 (ZNF641, marker 20562), zinc finger protein 645 (ZNF645, marker 20563), zinc finger protein 646 (ZNF646, marker 20564), ZNF649 antisense RNA 1 (ZNF649-AS1, marker 20565),zinc finger protein 653(ZNF653, marker 20566),zinc finger protein 653(ZNF653,marker 20567),zinc finger protein 662(ZNF662,marker 20568),zinc finger protein 663, pseudogene(ZNF663P,marker 20569),zinc finger protein 664(ZNF664, marker 20570),zinc finger protein 667(ZNF667, marker 20571),zinc finger protein 668(ZNF668, marker 20572),zinc finger protein 672(ZNF672, marker 20573),zinc finger protein 674(ZNF674, marker 20574),zinc finger protein 677(ZNF677,marker 20575),zinc finger protein 678(ZNF678,marker 20576),zinc finger protein 681(ZNF681,marker 20577),zinc finger protein 683(ZNF683,marker 20578),zinc finger protein 688(ZNF688, marker 20579),zinc finger protein 688(ZNF688, marker 20580),zinc finger protein 688(ZNF688, marker 20581),zinc finger protein 688(ZNF688, marker 20582),zinc finger protein 696(ZNF696, marker 20583),zinc finger protein 697(ZNF697, marker 20584),zinc finger protein 7(ZNF7,marker 20585),zinc finger protein 7(ZNF7,marker 20586),zinc finger protein 7(ZNF7,marker 20587),zinc finger protein 701(ZNF701, marker 20588),zinc finger protein 704(ZNF704,marker 20589),zinc finger protein 704(ZNF704,marker 20590),zinc finger protein 704(ZNF704,marker 20591),zinc finger protein 704(ZNF704,marker 20592 ),zinc finger protein 705G(ZNF705G, marker 20593),zinc finger protein 709(ZNF709,marker 20594),zinc finger protein 709(ZNF709,marker 20595),zinc finger protein 709(ZNF709,marker 20596),zinc finger protein 709 (ZNF709, marker 20597),zinc finger protein 71(ZNF71,marker 20598),zinc finger protein 71(ZNF71,marker 20599),zinc finger protein 71(ZNF71,marker 20600),zinc finger protein 710(ZNF710,marker 20601) ,zinc finger protein 710(ZNF710, marker 20602),zinc finger protein 710(ZNF710,marker 20603),zinc finger protein 713(ZNF713,marker 20604),zinc finger protein 717(ZNF717,marker 20605),zinc finger protein 717( ZNF717, marker 20606),zinc finger protein 720(ZNF720,marker 20607),zinc finger protein 727(ZNF727,marker 20608),zinc finger protein 732(ZNF732,marker 20609),zinc finger protein 732(ZNF732,marker 20610), zinc finger protein 736(ZNF736, marker 20611),zinc finger protein 736(ZNF736, marker 20612),zinc finger protein 740(ZNF740, marker 20613),zinc finger protein 740(ZNF740, marker 20614),zinc finger protein 746(ZNF746 , marker 20615), zinc finger protein 749 (ZNF749, marker 20616), zinc finger protein 750 (ZNF750, marker 20617), zinc finger protein 75a (ZNF75A, marker 20618), zinc finger protein 76 (ZNF76, marker 20619), zinc finger protein 763(ZNF763, marker 20620),zinc finger protein 763(ZNF763, marker 20621),zinc finger protein 765(ZNF765, marker 20622),zinc finger protein 771(ZNF771, marker 20623),zinc finger protein 771(ZNF771, marker 20624),zinc finger protein 771(ZNF771,marker 20625),zinc finger protein 771(ZNF771,marker 20626),zinc finger protein 775(ZNF775,marker 20627),zinc finger protein 775(ZNF775,marker 20628),zinc finger protein 775(ZNF775, marker 20629),zinc finger protein 777(ZNF777,marker 20630),zinc finger protein 777(ZNF777,marker 20631),zinc finger protein 780A(ZNF780A,marker 20632),zinc finger protein 780B(ZNF780B,marker 20633),zinc finger protein 780B(ZNF780B, marker 20634),zinc finger protein 780B(ZNF780B,marker 20635),zinc finger protein 780B(ZNF780B,marker 20636),zinc finger protein 781(ZNF781,marker 20637),zinc finger protein 781(ZNF781, marker 20638),zinc finger protein 782(ZNF782,marker 20639),zinc finger protein 787(ZNF787,marker 20640),zinc finger protein 789(ZNF789,marker 20641),zinc finger protein 79(ZNF79,marker 20642 ),ZNF790 antisense RNA 1(ZNF790-AS1, marker 20643),ZNF790 antisense RNA 1(ZNF790-AS1,marker 20644),zinc finger protein 80(ZNF80,marker 20645),zinc finger protein 80(ZNF80,marker 20646), zinc finger protein 800(ZNF800, marker 20647),zinc finger protein 800(ZNF800, marker 20648),zinc finger protein 804A(ZNF804A,marker 20649),zinc finger protein 804B(ZNF804B,marker 20650),zinc finger protein 808(ZNF808 , marker 20651), zinc finger protein 81 (ZNF81, marker 20652), zinc finger protein 81 (ZNF81, marker 20653), zinc finger protein 81 (ZNF81, marker 20654), zinc finger protein 81 (ZNF81, marker 20655), zinc finger protein 814(ZNF814, marker 20656),zinc finger protein 814(ZNF814, marker 20657),zinc finger protein 815, pseudogene /// zinc finger protein 890, pseudogene(ZNF815P /// ZNF890P, marker 20658),zinc finger protein 821(ZNF821, marker 20659),zinc finger protein 829(ZNF829,marker 20660),zinc finger protein 831(ZNF831,marker 20661),zinc finger protein 831(ZNF831,marker 20662),zinc finger protein 835(ZNF835,marker 20663 ),zinc finger protein 836(ZNF836, marker 20664),zinc finger protein 837(ZNF837,marker 20665),zinc finger protein 843(ZNF843,marker 20666),zinc finger protein 844(ZNF844,marker 20667),zinc finger protein 846 (ZNF846, marker 20668), zinc finger protein 846 (ZNF846, marker 20669), zinc finger protein 852 (ZNF852, marker 20670), zinc finger protein 853 (ZNF853, marker 20671), zinc finger protein 861, pseudogene (ZNF861P, marker 20672),zinc finger protein 862(ZNF862, marker 20673),zinc finger protein 876, pseudogene(ZNF876P,marker 20674),zinc finger protein 91(ZNF91,marker 20675),zinc finger protein 93(ZNF93,marker 20676),zinc finger protein 99(ZNF99, marker 20677),zinc finger protein 99(ZNF99, marker 20678),zinc finger, HIT-type containing 2(ZNHIT2, marker 20679),zinc finger, HIT-type containing 6(ZNHIT6, marker 20680) ,zinc ribbon domain containing 1(ZNRD1, marker 20681),zinc ribbon domain containing 1(ZNRD1, marker 20682),zinc ribbon domain containing 1(ZNRD1, marker 20683),zinc ribbon domain containing 1(ZNRD1, marker 20684),ZNRD1 antisense RNA 1(ZNRD1-AS1, marker 20685),ZNRD1 antisense RNA 1(ZNRD1-AS1, marker 20686),ZNRD1 antisense RNA 1(ZNRD1-AS1,marker 20687),ZNRD1 antisense RNA 1(ZNRD1-AS1,marker 20688) ,ZNRD1 antisense RNA 1(ZNRD1-AS1, marker 20689),zinc and ring finger 1, E3 ubiquitin protein ligase(ZNRF1, marker 20690),zinc and ring finger 2, E3 ubiquitin protein ligase(ZNRF2, marker 20691),zinc and ring finger 2 pseudogene 1(ZNRF2P1, marker 20692),zinc and ring finger 4(ZNRF4, marker 20693),zona pellucida glycoprotein 1 (sperm receptor)(ZP1,marker 20694),zona pellucida glycoprotein 2 (sperm receptor)(ZP2, marker 20695), zona pellucida glycoprotein 4 (ZP4, marker 20696), zona pellucida binding protein (ZPBP, marker 20697), zona pellucida binding protein 2 (ZPBP2, marker 20698), zona pellucida-like domain containing 1 (ZPLD1, marker 20699) ),zona pellucida-like domain containing 1(ZPLD1, marker
-20700), ZPR1 zinc finger(ZPR1, marker 20701),ZRANB2 antisense RNA 1(ZRANB2-AS1, marker 20702),zinc finger, RAN-binding domain containing 3(ZRANB3, marker 20703),zinc finger, RAN-binding domain containing 3(ZRANB3, marker 20704),zinc finger and SCAN domain containing 1(ZSCAN1, marker 20705),zinc finger and SCAN domain containing 12(ZSCAN12, marker 20706),zinc finger and SCAN domain containing 12 pseudogene 1(ZSCAN12P1, marker 20707),ZSCAN16 antisense RNA 1(ZSCAN16-AS1, marker 20708),ZSCAN16 antisense RNA 1(ZSCAN16-AS1,marker 20709),zinc finger and SCAN domain containing 18(ZSCAN18,marker 20710),zinc finger and SCAN domain containing 20 (ZSCAN20, marker 20711),zinc finger and SCAN domain containing 20(ZSCAN20, marker 20712),zinc finger and SCAN domain containing 20(ZSCAN20, marker 20713),zinc finger and SCAN domain containing 23(ZSCAN23, marker 20714),zinc finger and SCAN domain containing 30(ZSCAN30, marker 20715),zinc finger and SCAN domain containing 30(ZSCAN30, marker 20716),zinc finger and SCAN domain containing 30(ZSCAN30, marker 20717),zinc finger and SCAN domain containing 4(ZSCAN4 ,marker 20718),zinc finger and SCAN domain containing 4(ZSCAN4,marker 20719),zinc finger and SCAN domain containing 5A(ZSCAN5A,marker 20720),zinc finger, SWIM-type containing 1(ZSWIM1,marker 20721),zinc finger , SWIM-type containing 2(ZSWIM2, marker 20722),zinc finger, SWIM-type containing 4(ZSWIM4, marker 20723),zinc finger, SWIM-type containing 8(ZSWIM8, marker 20724),zinc finger, X-linked, duplicated A(ZXDA, marker 20725),zinc finger, X-linked, duplicated A /// zinc finger, X-linked, duplicated B(ZXDA /// ZXDB, marker 20726),zinc finger, X-linked, duplicated A /// zinc finger, X-linked, duplicated B(ZXDA /// ZXDB, marker 20727),zinc finger, X-linked, duplicated B(ZXDB, marker 20728),ZXD family zinc finger C(ZXDC, marker 20729) ,zyg-11 family member A, cell cycle regulator(ZYG11A, marker 20730),zyxin(ZYX,marker 20731),zinc finger, ZZ-type with EF-hand domain 1(ZZEF1,marker 20732),zinc finger, ZZ- This is a marker defined as type with EF-hand domain 1 (ZZEF1, marker 20733).
In this way, Marker 1 to Marker 20733 can be used as markers for selecting human tissue-specific stem/progenitor cells.

These tissue-specific markers can be obtained by, for example, performing genetic analysis using a microarray on the obtained colonies to select cells that express the tissue-specific marker. Furthermore, antigen expression analysis can be performed using flow cytology to select cells that express tissue-specific markers.
No matter what tissue-specific marker is used to select human tissue stem cells/human tissue progenitor cells, human tissue stem cells/human tissue progenitor cells express one or more markers that can be objectively confirmed. . Such markers include, for example, in the case of human pancreatic tissue-derived specific stem/progenitor cells, at least PDX1, PTF1A, NGN3, NEUROD, ISL1, NKX6.1, CA2, GLP1R, and one or more of these markers. If the expression of human mesenchymal cell-derived specific stem/progenitor cells can be confirmed, at least CD73, CD105, CD55, CD59, CD71, CD166, IGF1, HGF, FGF2, VEGFA, EGF, one or both of these. Expression of markers in more than one species can be confirmed.

In the present invention, cells are selected that express tissue-specific markers and do not express markers specifically expressed in ES/iPS cells (undifferentiated markers). This makes it possible to select more appropriate human tissue-specific stem/progenitor cells, and is expected to have the effect of improving the reproducibility of the present invention and the performance of the selected cell group.
Markers specifically expressed in iPS cells include OCT3/4, SOX2, NANOG, etc., and cells that strongly express these can be excluded to select human tissue stem cells/human tissue progenitor cells. .

<<Experimental example I. Human pancreatic iTS/iTP cells >>
1. Pancreatic cells were obtained from the University of Alberta in the United States with the consent of the relatives of human brain-dead donors and in accordance with research ethics regulations, and used in experiments.
2. The procedure for producing human pancreatic iTS/iTP cells is shown in Figure 1A. A plasmid vector incorporating reprogramming factors (OCT4, SOX2, KLF4, MYC, or OCT4, p53 shRNA, SOX2, KLF4, L-MYC, LIN28) is introduced into pancreatic cells by electroporation and reprogrammed. I did it.
3. Seven days after the gene introduction, cells were collected with trypsin, and 1×10 ⁵ cells per 100 mm Petri dish were seeded onto MEF feeder cells. The next day, the ESC medium was replaced with bFGF-containing ESC medium, culture was continued from 30 to 45 days after gene introduction, and colonies were observed.

<Experiment results>
1. The results are shown in Figures 2 and 3 and Table 1.
(1) Sixty-four colonies were obtained by introducing six factors (OCT4, p53 shRNA, SOX2, KLF4, L-MYC, and LIN28) (Figure 2B).
(2) Among the clones obtained, 26 clones showed morphology similar to ES/iPS cells. Furthermore, teratoma formation was confirmed in all mice within 60 days after transplantation into mice (Table 1).
(3) The remaining 38 clones showed iTP cell-like morphology similar to intestinal endoderm (GTE). Teratoma formation was not observed in these clones for 150 days after transplantation into mice (Table 1).
(4) When we evaluated the expression of PDX1, a marker for pancreatic stem/progenitor cells, in 8 of the 38 clones, expression of PDX1 mRNA was confirmed in all clones (Figure 2C). When plasmid incorporation into the chromosome was examined, no plasmid incorporation was observed in all eight clones examined (Figure 2D).

(5) To confirm reproducibility, we conducted an investigation using pancreatic cells from five types of donors, and PDX1 mRNA expression was confirmed in all donors (Figure 3A). Among these, plasmid incorporation into the chromosome was investigated for iTP05, iTP11, iTP25, iTP36, and iTP45, which had high PDX1 expression in each donor, and no plasmid incorporation was observed in all five clones investigated (Fig. 3B).

(6) In subsequent studies, clones with the highest expression of PDX1 mRNA (iTP05, iTP11, iTP25, iTP36, iTP45) were selected as appropriate and used in experiments.

2. Figures 4 and 5 show the results of examining the expression of markers for ES cells, endodermal cells, and pancreatic cells in iTP cells by RT-PCR. In the figure, iP indicates iPS cells, iT indicates iTP cells, Pa indicates human pancreatic cells (containing more than 80% islet cells), and GT indicates GTE cells (intestinal endoderm cells: produced by inducing differentiation of iPS cells). . Furthermore, each number in FIG. 5 indicates the number of the iTP cell clone (see FIG. 3A).
(1) In iTP cells, the expression of ES cell markers OCT4, SOX2, and NANOG was significantly lower than in iPS cells (Figure 4A, Figure 5A).
(2) In iTP cells, the endodermal markers FOXA2, HNF1β, HNF4α, and HNF6 were expressed to the same extent as in the positive control GTE cells (Figure 4B, Figure 5B).
(3) In iTP cells, expression of pancreatic cell markers PDX1, PTF1A, and CA2 was observed, while NEUROD, ILS1, and NKX6.1 remained at relatively low levels compared to pancreatic cells (Fig. 4C, Figure 5C).

3. Figure 6 shows the results.
(1) While pancreatic cells proliferated slowly and almost stopped growing after 30 days, iTP cells proliferated at a faster rate. In addition, no morphological change or decrease in proliferation rate was observed in iTP cells for over 30 days (Figure 6A).
(2) While no decrease in the proliferation rate of iPS cells was observed up to 120 days, the proliferation of iTP cells stopped from 100 to 120 days (15 to 20 passages) (Figure 6A ).
(3) From these results, it is thought that the produced iTP cells have the properties of progenitor cells rather than stem cells.

(4) iTP cells expressed more insulin protein and mRNA than iPS cells (Fig. 6B, C).
Insulin-positive cells were detected as cells positive for both insulin and C-peptide in order to eliminate false-positive detection due to uptake of insulin in the culture medium into dead cells. As a result, the percentage of insulin-positive cells was 15.4±1.8%.

(5) Compared to iPS cells, iTP cells showed 2 to 3 times more significant insulin secretion under both low and high glucose concentrations (Figure 6D).
(6) The stimulation index (insulin secretion amount due to high concentration glucose/insulin secretion amount due to low concentration glucose) in iTP cells was higher than that in iPS cells, although it was not significant.

4. The results of bisulfite sequence analysis are shown in Figure 7.
(1) In iTP cells, the promoter regions of OCT4 and NANOG remained methylated, but in iPS cells, they were found to be demethylated.
(2) Additionally, it was found that the promoter region of PDX1 was demethylated in iTP cells, while it remained methylated in iPS cells.

5. Figure 8 shows the results of microarray analysis.
(1) Of the 54,613 genes analyzed, the difference was 7.6% between iPS cells and iTP cells, 9.9% between pancreatic cells and iTP cells, and 16.5% between iPS cells and pancreatic cells, respectively. confirmed (Figure 8A). These results suggest that the expression pattern of iTP cells is closer to iPS cells and somewhat different from that of pancreatic cells.
(2) Cluster analysis also showed that iTP cells were more similar to iPS cells than to pancreatic cells (Figure 8B).

6. Figure 9 shows the results of inducing the differentiation of iPS cells and iTP cells using the established methods of hepatocyte differentiation, neuroectodermal differentiation, and mesodermal differentiation, and comparing the mRNA between each cell. .
(1) Albumin and α1-AT, which are hepatocyte markers, were highly expressed in iPS cells that had been induced to differentiate, but not in other cells (Figures 9A and B).
(2) In addition, the mesodermal markers PECAM1 and MIXL1 were highly expressed in iPS cells that had been induced to differentiate, but not in other cells (Figures 9C and D).
(3) Furthermore, the neuroectodermal markers ZIC1 and SOX1 were highly expressed in iPS cells that had been induced to differentiate, but not in other cells (Fig. 9E, F).
(4) These results showed that iPS cells can be induced to differentiate into various types of cells, whereas iTP cells in this study were limited to pancreatic cell-specific differentiation.

<< Experimental Example II. Human mesenchymal cell-derived iTS/iTP cells >>
1. Human adipose-derived mesenchymal stem cells (hereinafter referred to as hADSCs) derived from a woman in her 40s were purchased and used (Lonza Japan Co., Ltd., passage number 1). These cells were cultured, and loss of proliferation ability was confirmed at passage number 14. In the subsequent studies, those with passage numbers 4 to 7 were used as controls in each experiment.
2. The procedure for producing human mesenchymal cell-derived iTS/iTP cells is shown in Figure 10. Human mesenchymal cell-derived iTS/iTP cells were generated using Simplicon RNA Reprogramming Kit (manufactured by Merck & Co., Ltd.). RNA vectors expressing reprogramming factors (OCT4, SOX2, KLF4, GLIS1) were introduced into hADSCs that had lost their ability to proliferate. After gene introduction, culture was performed in ADMEM medium, and B18R protein was added until day 16. 16 days after gene introduction, the medium was replaced with hADSC medium.

<Experiment results>
1. Figure 11 shows the results.
(1) After culture, hADSC lost its proliferation ability at passage number 14 (Fig. 11D).
(2) When gene transfer was performed on hADSCs 10 days after passage 14, they gradually proliferated after gene transfer (Figure 11A). The cells 9 days after gene transfer were separately passaged as hiTS-M cells with proliferation ability and used for the study.
(3) hiTS-M cells showed a morphology similar to fibroblasts (Fig. 11A).
(4) In RT-PCR analysis, no RNA vector was detected in hiTS-M cells after 5 passages after gene introduction (Figure 11B).
(5) In qRT-PCR analysis, ES cell markers NANOG, OCT4, and SOX2 were detected in hiPS cells. On the other hand, neither marker was detected in hiTS-M cells (passage number 29) and hADSCs (passage number 5) (Fig. 11C).
(6) When we investigated the expression of mRNA to evaluate telomerase activity, no expression of telomerase mRNA was observed in hADSCs (passage number 9) and hiTS-M cells (passage number 14+9) (Figure 11E ).

2. Figure 12 shows the results of surface antigen analysis using flow cytometry. In addition, for hiTS-M cells, those 7 passages after gene introduction into hADSC14 passages were used, and for hADSCs, those from 7th passage were used.
(1) Expression of integrin β-1 (CD29) was confirmed at 98.37% in hiTS-M cells and at 99.75% in hADSCs (Figures 12A and B).
(2) 100% expression of Thy-1 (CD90) was confirmed in both hiTS-M cells and hADSCs (Fig. 12C, D).
(3) Regarding hyaluronate receptor/phagocytic glycoprotein-1 (CD44), expression was observed at 99.87% in hiTS-M cells and 100% in hADSCs (Fig. 12E, F).
(4) Protein tyrosine phospatase, receptor type (CD45) was hardly expressed at 2.81% in hiTS-M cells and 1.54% in hADSCs (Fig. 12G, H).
(5) Leukocyte common antigen (CD34) was hardly expressed at 2.35% in hiTS-M cells and 1.74% in hADSCs (Fig. 12I, J).

3. Figure 13 shows the results. Furthermore, for hiTS-M cells, those 6 passages after gene introduction into hADSC14 passages were used, and for hADSCs, those from 6th passage were used.
(1) When the expression of mRNA for hADSC-specific markers CD73, CD105, CD55, CD59, CD71, and CD166 was examined, their expression was confirmed in both hiTS-M cells and hADSC (Figure 13A). Among these, only CD71 showed significantly higher expression in hiTS-M cells than in hADSCs. Furthermore, hiTS-M cells showed significantly lower expression of CD105 and CD55 than hADSCs.
(2) In addition, expression of IGF1, HGF, FGF2, VEGFA, and EGF mRNA was confirmed in both hiTS-M cells and hADSCs (Figure 13B). Among these, hiTS-M cells showed significantly higher expression of HGF and FGF2, approximately 4 to 5 times higher than hADSCs. Furthermore, hiTS-M cells showed significantly lower expression of VEGFA and EGF than hADSCs.
(3) When the expression of CD73 and CD105 was examined at the protein level by flow cytology and immunostaining, almost 100% expression was confirmed in both hiTS-M cells and hADSCs (Fig. 13C, D).

5. Figure 14 shows the results.
(1) Figure 14A shows the results of attempting to induce differentiation of hiTS-M cells into adipocytes.
(2) hiTS-M cells (14+7) were cultured for 7 days in adipogenic differentiation medium (DM-2, manufactured by Zen-Bio). Thereafter, the cells were cultured in an adipocyte maintenance medium (Adipocyte Maintenance Medium, AM-1, manufactured by Zen-Bio), and the medium was replaced every 3 days. Note that the same operation was performed for hADSCs (passage number 7).
(3) When stained with Oil Red O, a marker for adipocytes, both hiTS-M cells and hADSCs, which had been induced to differentiate, were stained (Figure 14A).

(4) Figure 14B shows the results of an attempt to induce differentiation of hiTS-M cells into osteoblasts.
(5) hiTS-M cells (14+7) were cultured for 10 days in osteoblast differentiation induction medium (MSC Go Rapid OsteogenicXF, manufactured by Cosmo Bio). Note that the same operation was performed for hADSCs (passage number 3).
(6) When Alizarin Red S staining was performed, all hiTS-M cells and hADSCs that had undergone differentiation induction were stained (Figure 14B). Furthermore, when we examined the expression of mRNA for RUNX2, an osteoblast marker, hiTS-M cells and hADSCs showed high expression.
(7) These results revealed that hiTS-M cells can be induced to differentiate into osteoblasts.

6. The results of bisulfite sequence analysis are shown in Figure 15.
(1) In hiTS-M cells and hADSCs, the promoter regions of OCT4 and NANOG remained methylated, but in iPS cells, they were found to be demethylated.
(2) From this result, it was found that methylation in OCT4 and NANOG in hiTS-M cells is similar to that in hADSCs and different from that in iPS cells.

7. Figure 16 shows the results of microarray analysis. Furthermore, for hiTS-M cells, those 6 passages after gene introduction into hADSC14 passages were used, and for hADSCs, those from 6th passage were used.
(1) Among the 54613 genes analyzed, the difference of 2-fold or more was 2.13% between hADSCs and hiTS-M cells, 19.53% between iPS cells and hiTS-M cells, and 20.78% between iPS cells and hADSCs. , respectively, were confirmed (Figure 16A). These results suggest that the expression pattern of hiTS-M cells is closer to hADSCs and different from that of iPS cells.
(2) Cluster analysis also showed that hiTS-M cells were closer to hADSCs than to iPS cells (Figure 16B).

Claims (4)

human somatic cells derived from pancreatic tissue,
From a cell group subcultured with gene introduction of reprogramming factors,
Excluding cells exhibiting a morphology identical to or similar to ES/iPS cells, cells exhibiting morphology identical to or similar to human pancreatic tissue-specific stem/progenitor cells are primarily selected;
From the primary selected cells,
Secondary selection of cells in which the expression of ES cell markers is significantly lower than that of ES/iPS cells, and the expression of endoderm and pancreatic cell markers is significantly higher than that of ES/iPS cells,
Use for pharmaceuticals or medical materials, characterized in that only human pancreatic tissue-specific stem/progenitor cells can be obtained by transplanting the second selection cells into mice and performing a third selection of cells that do not form teratoma. Method for producing human pancreatic tissue-specific stem/progenitor cells.
human somatic cells derived from pancreatic tissue,
From a cell group subcultured with gene introduction of reprogramming factors,
Excluding cells exhibiting a morphology identical to or similar to ES/iPS cells, cells exhibiting morphology identical to or similar to human pancreatic tissue-specific stem/progenitor cells are primarily selected;
From the primary selected cells,
ES/iPS cells with significantly lower expression of ES cell markers than ES/iPS cells, and one or more of PDX1, PTF1A, NGN3, NEUROD, ISL1, NKX6.1, CA2, GLP1R Secondary selection of cells with significantly higher status compared to
Use for pharmaceuticals or medical materials, characterized in that only human pancreatic tissue-specific stem/progenitor cells can be obtained by transplanting the second selection cells into mice and performing a third selection of cells that do not form teratoma. Method for producing human pancreatic tissue-specific stem/progenitor cells.
human somatic cells derived from pancreatic tissue,
From a cell group subcultured by gene introduction of reprogramming factors consisting of multiple combinations of OCT3/4, SOX2, KLF4, c-MYC, L-MYC, Nanog, LIN28, SV40LT, p53 shRNA, and GLIS1,
Excluding cells exhibiting a morphology identical to or similar to ES/iPS cells, cells exhibiting morphology identical to or similar to human pancreatic tissue-specific stem/progenitor cells are primarily selected;
From the primary selected cells,
ES/iPS cells with significantly lower expression of ES cell markers than ES/iPS cells, and one or more of PDX1, PTF1A, NGN3, NEUROD, ISL1, NKX6.1, CA2, GLP1R Secondary selection of cells with significantly higher status compared to
Use for pharmaceuticals or medical materials, characterized in that only human pancreatic tissue-specific stem/progenitor cells can be obtained by transplanting the second selection cells into mice and performing a third selection of cells that do not form teratoma. Method for producing human pancreatic tissue-specific stem/progenitor cells.
human somatic cells derived from pancreatic tissue,
From a cell group subcultured with gene introduction of reprogramming factors,
Excluding cells exhibiting a morphology identical to or similar to ES/iPS cells, cells exhibiting morphology identical to or similar to human pancreatic tissue-specific stem/progenitor cells are primarily selected;
From the primary selected cells,
ES/iPS cells with significantly lower expression of ES cell markers than ES/iPS cells, and one or more of PDX1, PTF1A, NGN3, NEUROD, ISL1, NKX6.1, CA2, GLP1R Secondary selection of cells with significantly higher status compared to
A human for use in pharmaceuticals or medical materials, characterized in that only human pancreatic tissue-specific stem/progenitor cells can be obtained by transplanting the secondary selection cells into mice and performing tertiary selection of cells that do not form teratoma. Method for selecting pancreatic tissue-specific stem/progenitor cells.